ASSI,ASSORGA,CUB,CHEI,CI,ASSCA,T,TII,ASSTY,VAI,Descri,ASSSUBCEFR,RELT,CONFSCO,SI,SRASSI,BAFO
7524,Rattus norvegicus,Intermediate,CHEMBL618647,,,50597,2113.0,A,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7525,Rattus norvegicus,Intermediate,CHEMBL618648,,,50597,2113.0,A,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,N,1,1,,BAO_0000218
7526,Rattus norvegicus,Intermediate,CHEMBL618649,,,50597,2113.0,A,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7527,Rattus norvegicus,Intermediate,CHEMBL618650,,,50597,2107.0,A,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7528,Rattus norvegicus,Intermediate,CHEMBL618651,,,50597,2107.0,A,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,N,1,1,,BAO_0000218
7529,Rattus norvegicus,Intermediate,CHEMBL876497,,,50597,2107.0,A,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7530,Rattus norvegicus,Intermediate,CHEMBL618652,,,50597,2048.0,A,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7531,Rattus norvegicus,Intermediate,CHEMBL618653,,,50597,2048.0,A,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,N,1,1,,BAO_0000218
7532,Rattus norvegicus,Intermediate,CHEMBL618654,,,50597,2048.0,A,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7533,Rattus norvegicus,Intermediate,CHEMBL618655,,,50597,,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,N,1,1,,BAO_0000218
7534,Rattus norvegicus,Intermediate,CHEMBL618656,,,50597,,A,,Compound was tested for solubility in water,,N,1,1,,BAO_0000218
7535,,Intermediate,CHEMBL618657,,,22229,,P,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,U,0,1,,BAO_0000100
7536,Rattus norvegicus,Intermediate,CHEMBL618658,,,50597,,A,,Solubility was determined,,N,1,1,,BAO_0000218
7537,Rattus norvegicus,Intermediate,CHEMBL618659,,,50597,,A,,solubility in water (ug/mL) at 37 degree C.,,N,1,1,,BAO_0000218
7538,Rattus norvegicus,Intermediate,CHEMBL618660,,,50597,,A,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,N,1,1,,BAO_0000218
7539,Rattus norvegicus,Intermediate,CHEMBL618661,,,50597,,A,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,N,1,1,,BAO_0000218
7540,Rattus norvegicus,Intermediate,CHEMBL873807,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
7541,Rattus norvegicus,Intermediate,CHEMBL618662,,,50597,,A,,Half life in Dawley rat,,N,1,1,,BAO_0000218
7542,Rattus norvegicus,Intermediate,CHEMBL618663,,,50597,,A,,Half life period after 3 mg/kg iv administration,,N,1,1,,BAO_0000218
7543,Rattus norvegicus,Intermediate,CHEMBL618664,,,50597,,A,,Half life period after 3 mg/kg iv administration in rat,,N,1,1,,BAO_0000218
7544,Rattus norvegicus,Intermediate,CHEMBL618665,,,50597,,A,,Half life period after 3 mg/kg iv administration in the rat,,N,1,1,,BAO_0000218
7545,Rattus norvegicus,Intermediate,CHEMBL876498,,,50597,,A,,Half life period in female Sprague-Dawley rats,,N,1,1,,BAO_0000218
7546,Rattus norvegicus,Intermediate,CHEMBL618666,,,50597,,A,,Half life period in rat,,N,1,1,,BAO_0000218
7547,Rattus norvegicus,Intermediate,CHEMBL620440,,,50597,,A,,Half-life in rats was determined,,N,1,1,,BAO_0000218
7548,Rattus norvegicus,Intermediate,CHEMBL620441,,,50597,,A,,Half-life in rats with metabolic oxidation,,N,1,1,,BAO_0000218
7549,Rattus norvegicus,Intermediate,CHEMBL620442,,,50597,,A,,Half-life in rats,,N,1,1,,BAO_0000218
7550,Rattus norvegicus,Intermediate,CHEMBL620443,,,50597,,A,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1,1,,BAO_0000218
7551,Rattus norvegicus,Intermediate,CHEMBL620444,,,50597,,A,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1,1,,BAO_0000218
7552,Rattus norvegicus,Intermediate,CHEMBL620445,,,50597,,A,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1,1,,BAO_0000218
7553,Rattus norvegicus,Intermediate,CHEMBL620446,,,50597,,A,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1,1,,BAO_0000218
7554,Rattus norvegicus,Intermediate,CHEMBL620447,,,50597,1969.0,A,,Biological half-life measured in plasma of rat,,N,1,1,,BAO_0000218
7555,Rattus norvegicus,Intermediate,CHEMBL621129,,,50597,1969.0,A,,Biological half-life measured in plasma of rat; 22-25,,N,1,1,,BAO_0000218
7556,Rattus norvegicus,Intermediate,CHEMBL621130,,,50597,1969.0,A,,Biological half-life measured in plasma of rat; 9-16,,N,1,1,,BAO_0000218
7557,Rattus norvegicus,Intermediate,CHEMBL873808,,,50597,,A,,Compound was evaluated for its half life when administered intravenously in rat,,N,1,1,,BAO_0000218
7558,Rattus norvegicus,Intermediate,CHEMBL876598,,,50597,,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,N,1,1,,BAO_0000218
7559,Rattus norvegicus,Intermediate,CHEMBL621131,,,50597,,A,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,N,1,1,,BAO_0000218
7560,Rattus norvegicus,Intermediate,CHEMBL621132,,,50597,,A,,Half life (T1/2) after oral administration in rat,,N,1,1,,BAO_0000218
7561,Rattus norvegicus,Intermediate,CHEMBL621133,,,50597,,A,,Half life of compound after iv administration of 20 mg/kg dose in rat,,N,1,1,,BAO_0000218
7562,Rattus norvegicus,Expert,CHEMBL621312,,,50597,,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
7563,Rattus norvegicus,Intermediate,CHEMBL621313,,,50597,,A,,Half life of compound was determined in rat,,N,1,1,,BAO_0000218
7564,Rattus norvegicus,Intermediate,CHEMBL621314,,,50597,178.0,A,,Half life of compound was determined in rat blood,,N,1,1,,BAO_0000218
7565,Rattus norvegicus,Intermediate,CHEMBL621315,,,50597,,A,,Half life at 1 mg/kg was determined in rat,,N,1,1,,BAO_0000218
7566,Rattus norvegicus,Intermediate,CHEMBL621316,,,50597,,A,,Half life at 10 mg/kg was determined in rat,,N,1,1,,BAO_0000218
7567,Rattus norvegicus,Intermediate,CHEMBL621317,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
7568,Rattus norvegicus,Intermediate,CHEMBL621318,,,50597,,A,,Half life in rats in hours,,N,1,1,,BAO_0000218
7569,Rattus norvegicus,Intermediate,CHEMBL621319,,,50597,,A,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,1,1,,BAO_0000218
7570,Rattus norvegicus,Intermediate,CHEMBL621377,,,50597,,A,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,N,1,1,,BAO_0000218
7571,Rattus norvegicus,Intermediate,CHEMBL621378,,,50597,,A,,Half life was determined,,N,1,1,,BAO_0000218
7572,Rattus norvegicus,Intermediate,CHEMBL876599,,,50597,,A,,Half life after i.v. administration,,N,1,1,,BAO_0000218
7573,Rattus norvegicus,Intermediate,CHEMBL621379,,,50597,,A,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,N,1,1,,BAO_0000218
7574,Rattus norvegicus,Intermediate,CHEMBL621380,,,50597,1969.0,A,,Half life in rat plasma,,N,1,1,,BAO_0000218
7575,Rattus norvegicus,Intermediate,CHEMBL621381,,,50597,1969.0,A,,Half life in rat plasma; Not detected,,N,1,1,,BAO_0000218
7576,Rattus norvegicus,Intermediate,CHEMBL618515,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
7577,Rattus norvegicus,Intermediate,CHEMBL618516,,,50597,,A,,Half life period of compound was determined after peroral administration,,N,1,1,,BAO_0000218
7578,Rattus norvegicus,Intermediate,CHEMBL618517,,,50597,,A,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,N,1,1,,BAO_0000218
7579,Rattus norvegicus,Intermediate,CHEMBL618518,,,50597,,A,,Half life period in rat,,N,1,1,,BAO_0000218
7580,Rattus norvegicus,Intermediate,CHEMBL618519,,,50597,,A,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,1,1,,BAO_0000218
7581,Rattus norvegicus,Intermediate,CHEMBL618698,,,50597,,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,1,1,,BAO_0000218
7582,Rattus norvegicus,Intermediate,CHEMBL618862,,,50597,,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,N,1,1,,BAO_0000218
7583,Rattus norvegicus,Intermediate,CHEMBL618863,,,50597,,A,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
7584,Rattus norvegicus,Intermediate,CHEMBL618864,,,50597,,A,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
7585,Rattus norvegicus,Intermediate,CHEMBL618865,,,50597,,A,,Half life time in rat the dose of 2 mg/kg,,N,1,1,,BAO_0000218
7586,Rattus norvegicus,Intermediate,CHEMBL618866,,,50597,,A,,Half-life 24 hr after 10 mg/kg iv administration in rats,,N,1,1,,BAO_0000218
7587,Rattus norvegicus,Intermediate,CHEMBL618867,,,50597,,A,,Half-life 24 hr after 2 mg/kg iv administration in rats,,N,1,1,,BAO_0000218
7588,Rattus norvegicus,Intermediate,CHEMBL875828,,,50597,,A,,Half-life consistent with the observed metabolic steady state in rats,,N,1,1,,BAO_0000218
7589,Rattus norvegicus,Intermediate,CHEMBL618868,,,50597,,A,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,1,1,,BAO_0000218
7590,Rattus norvegicus,Intermediate,CHEMBL618869,,,50597,,A,,Half-life for oxidative metabolic stability was determined using male human,,N,1,1,,BAO_0000218
7591,Rattus norvegicus,Intermediate,CHEMBL618870,,,50597,,A,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,N,1,1,,BAO_0000218
7592,Rattus norvegicus,Intermediate,CHEMBL618871,,,50597,1969.0,A,,Half-life in rat plasma,,N,1,1,,BAO_0000218
7593,Rattus norvegicus,Intermediate,CHEMBL618872,,,50597,1969.0,A,,Half-life in rat plasma was determined,,N,1,1,,BAO_0000218
7594,Rattus norvegicus,Intermediate,CHEMBL873816,,,50597,,A,,Half-life in rats was determined,,N,1,1,,BAO_0000218
7595,,Autocuration,CHEMBL618873,,,22224,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,U,0,1,,BAO_0000218
7596,,Autocuration,CHEMBL621602,,,22224,,A,,Area under curve after oral dose of 0.1 mg//kg,,U,0,1,,BAO_0000019
7597,,Autocuration,CHEMBL621603,,,22224,,A,,Area under curve after oral dose of 0.3 mg/kg,,U,0,1,,BAO_0000218
7598,,Autocuration,CHEMBL621604,,,22224,,A,,Area under curve after oral dose of 1 mg/kg,,U,0,1,,BAO_0000218
7599,,Autocuration,CHEMBL621605,,,22224,,A,,Area under curve after oral dose of 10 mg/kg,,U,0,1,,BAO_0000218
7600,,Autocuration,CHEMBL621606,,,22224,,A,,Area under curve after oral dose of 23.4 mg/kg,,U,0,1,,BAO_0000218
7601,,Autocuration,CHEMBL621607,,,22224,,A,,Area under curve after oral dose of 3 mg/kg,,U,0,1,,BAO_0000218
7602,,Autocuration,CHEMBL621608,,,22224,,A,,Area under curve after oral dose of 3.87 mg/kg,,U,0,1,,BAO_0000218
7603,,Autocuration,CHEMBL621609,,,22224,,A,,Area under curve was determined,,U,0,1,,BAO_0000019
7604,,Autocuration,CHEMBL621610,,,22224,,A,,Area under curve at a dose of 10 mg/kg,,U,0,1,,BAO_0000218
7605,Rattus norvegicus,Intermediate,CHEMBL621611,,,50597,,A,,Area under curve was determined; ND=No data,,N,1,1,,BAO_0000218
7606,Rattus norvegicus,Intermediate,CHEMBL621612,,,50597,,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7607,Rattus norvegicus,Intermediate,CHEMBL622308,,,50597,,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7608,Rattus norvegicus,Intermediate,CHEMBL622309,,,50597,,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7609,Rattus norvegicus,Intermediate,CHEMBL622310,,,50597,,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7610,Rattus norvegicus,Intermediate,CHEMBL622311,,,50597,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7611,Rattus norvegicus,Intermediate,CHEMBL622312,,,50597,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,N,1,1,,BAO_0000218
7612,Rattus norvegicus,Intermediate,CHEMBL622931,,,50597,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7613,Rattus norvegicus,Intermediate,CHEMBL622932,,,50597,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,N,1,1,,BAO_0000218
7614,Rattus norvegicus,Intermediate,CHEMBL622736,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7615,Rattus norvegicus,Intermediate,CHEMBL622737,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7616,Rattus norvegicus,Intermediate,CHEMBL622738,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7617,Rattus norvegicus,Intermediate,CHEMBL622739,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7618,Rattus norvegicus,Intermediate,CHEMBL622740,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7619,Rattus norvegicus,Intermediate,CHEMBL622741,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7620,Rattus norvegicus,Intermediate,CHEMBL622742,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,1,1,,BAO_0000218
7621,Rattus norvegicus,Intermediate,CHEMBL622743,,,50597,1969.0,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,N,1,1,,BAO_0000218
7622,Mus musculus,Intermediate,CHEMBL622744,,,50594,1969.0,A,,AUC in mice,,N,1,1,,BAO_0000218
7623,,Autocuration,CHEMBL624134,,,22224,,A,,Area under curve was measured from the graph obtained from concentration Vs time,,U,0,1,,BAO_0000019
7624,,Autocuration,CHEMBL624135,,,22224,,A,,Area under curve value of compound per hour after oral administration,,U,0,1,,BAO_0000019
7625,Rattus norvegicus,Intermediate,CHEMBL624136,,,50597,,A,,Area under curve was determined after oral administration in rats,,N,1,1,,BAO_0000218
7626,Rattus norvegicus,Intermediate,CHEMBL624137,,,50597,,A,,Area under curve was determined after oral administration in rats; No data,,N,1,1,,BAO_0000218
7627,Rattus norvegicus,Intermediate,CHEMBL624320,,,50597,,A,,Area under curve was determined after oral administration in rats;No data,,N,1,1,,BAO_0000218
7628,Canis lupus familiaris,Intermediate,CHEMBL624321,,,50588,,A,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,1,1,,BAO_0000218
7629,Rattus norvegicus,Intermediate,CHEMBL624322,,,50597,,A,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,1,1,,BAO_0000218
7630,Rattus norvegicus,Intermediate,CHEMBL624323,,,50597,,A,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,N,1,1,,BAO_0000218
7631,Rattus norvegicus,Intermediate,CHEMBL624324,,,50597,,A,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,N,1,1,,BAO_0000218
7632,Rattus norvegicus,Intermediate,CHEMBL624325,,,50597,,A,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,N,1,1,,BAO_0000218
7633,Rattus norvegicus,Intermediate,CHEMBL624326,,,50597,,A,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,N,1,1,,BAO_0000218
7634,Rattus norvegicus,Intermediate,CHEMBL624327,,,50597,,A,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,N,1,1,,BAO_0000218
7635,Rattus norvegicus,Intermediate,CHEMBL624328,,,50597,,A,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,N,1,1,,BAO_0000218
7636,Canis lupus familiaris,Intermediate,CHEMBL627848,,,50588,,A,,Area under curve was determined in Dogs after peroral administration,,N,1,1,,BAO_0000218
7637,Rattus norvegicus,Intermediate,CHEMBL627849,,,50597,,A,,Area under curve was determined in Rats after peroral administration,,N,1,1,,BAO_0000218
7638,Rattus norvegicus,Intermediate,CHEMBL627850,,,50597,,A,,Area under curve was determined in carotid blood of rat when administered intradermally,,N,1,1,,BAO_0000218
7639,Rattus norvegicus,Intermediate,CHEMBL627851,,,50597,,A,,Area under curve was determined in portal blood of rat when administered intradermally,,N,1,1,,BAO_0000218
7640,Mus musculus,Intermediate,CHEMBL627852,,,50594,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
7641,Mus musculus,Intermediate,CHEMBL627853,,,50594,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
7642,Mus musculus,Intermediate,CHEMBL627854,,,50594,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,1,1,,BAO_0000218
7643,Mus musculus,Intermediate,CHEMBL627855,,,50594,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
7644,Mus musculus,Intermediate,CHEMBL627856,,,50594,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,1,1,,BAO_0000218
7645,Mus musculus,Intermediate,CHEMBL875339,,,50594,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
7646,Mus musculus,Intermediate,CHEMBL627857,,,50594,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,N,1,1,,BAO_0000218
7647,Rattus norvegicus,Intermediate,CHEMBL627858,,,50597,2106.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,N,1,1,,BAO_0000218
7648,Rattus norvegicus,Intermediate,CHEMBL627859,,,50597,178.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7649,Rattus norvegicus,Intermediate,CHEMBL627860,,,50597,955.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7650,Rattus norvegicus,Intermediate,CHEMBL627019,,,50597,948.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7651,Rattus norvegicus,Intermediate,CHEMBL627020,,,50597,2107.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7652,Rattus norvegicus,Intermediate,CHEMBL627021,,,50597,2048.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7653,Rattus norvegicus,Intermediate,CHEMBL627022,,,50597,2385.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7654,Rattus norvegicus,Intermediate,CHEMBL627023,,,50597,,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7655,Rattus norvegicus,Intermediate,CHEMBL627024,,,50597,2106.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7656,Rattus norvegicus,Intermediate,CHEMBL627025,,,50597,2046.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7657,Rattus norvegicus,Intermediate,CHEMBL627026,,,50597,2113.0,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7658,Rattus norvegicus,Intermediate,CHEMBL627027,,,50597,178.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7659,Rattus norvegicus,Intermediate,CHEMBL627028,,,50597,955.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7660,Rattus norvegicus,Intermediate,CHEMBL627029,,,50597,948.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7661,Rattus norvegicus,Intermediate,CHEMBL627030,,,50597,2113.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7662,Rattus norvegicus,Intermediate,CHEMBL627031,,,50597,2107.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7663,Rattus norvegicus,Intermediate,CHEMBL627032,,,50597,2048.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7664,Rattus norvegicus,Intermediate,CHEMBL627033,,,50597,2385.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7665,Rattus norvegicus,Intermediate,CHEMBL627034,,,50597,,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7666,Rattus norvegicus,Intermediate,CHEMBL627035,,,50597,2106.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7667,Rattus norvegicus,Intermediate,CHEMBL627036,,,50597,2046.0,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7668,Rattus norvegicus,Intermediate,CHEMBL875340,,,50597,178.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7669,Rattus norvegicus,Intermediate,CHEMBL627037,,,50597,948.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7670,Rattus norvegicus,Intermediate,CHEMBL627038,,,50597,2113.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7671,Rattus norvegicus,Intermediate,CHEMBL627039,,,50597,2107.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7672,Rattus norvegicus,Intermediate,CHEMBL627040,,,50597,2385.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7673,Rattus norvegicus,Intermediate,CHEMBL624663,,,50597,2106.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7674,Rattus norvegicus,Intermediate,CHEMBL625963,,,50597,2046.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7675,Rattus norvegicus,Intermediate,CHEMBL876799,,,50597,955.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7676,Rattus norvegicus,Intermediate,CHEMBL626133,,,50597,2048.0,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7677,Rattus norvegicus,Intermediate,CHEMBL626134,,,50597,,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,N,1,1,,BAO_0000218
7678,Rattus norvegicus,Intermediate,CHEMBL626135,,,50597,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
7679,Rattus norvegicus,Intermediate,CHEMBL626136,,,50597,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
7680,Rattus norvegicus,Intermediate,CHEMBL626137,,,50597,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,N,1,1,,BAO_0000218
7681,Rattus norvegicus,Intermediate,CHEMBL626138,,,50597,,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
7682,Rattus norvegicus,Intermediate,CHEMBL626139,,,50597,,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
7683,Rattus norvegicus,Intermediate,CHEMBL626140,,,50597,,A,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1,1,,BAO_0000218
7684,Rattus norvegicus,Intermediate,CHEMBL626141,,,50597,,A,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1,1,,BAO_0000218
7685,Rattus norvegicus,Intermediate,CHEMBL626142,,,50597,,A,,C24h in rat p.o. at 20 mg/kg concentration,,N,1,1,,BAO_0000218
7686,Rattus norvegicus,Intermediate,CHEMBL627930,,,50597,2385.0,A,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7687,Rattus norvegicus,Intermediate,CHEMBL627931,,,50597,2385.0,A,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,N,1,1,,BAO_0000218
7688,Rattus norvegicus,Intermediate,CHEMBL627932,,,50597,2385.0,A,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7689,Rattus norvegicus,Intermediate,CHEMBL627933,,,50597,2106.0,A,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7690,Rattus norvegicus,Intermediate,CHEMBL627934,,,50597,2106.0,A,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,N,1,1,,BAO_0000218
7691,Rattus norvegicus,Intermediate,CHEMBL627935,,,50597,2106.0,A,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,N,1,1,,BAO_0000218
7692,Rattus norvegicus,Intermediate,CHEMBL627936,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7693,Rattus norvegicus,Intermediate,CHEMBL627937,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7694,Rattus norvegicus,Intermediate,CHEMBL627938,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7695,Rattus norvegicus,Intermediate,CHEMBL627939,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
7696,Rattus norvegicus,Intermediate,CHEMBL627940,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7697,Rattus norvegicus,Intermediate,CHEMBL627941,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7698,Rattus norvegicus,Intermediate,CHEMBL876800,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7699,Rattus norvegicus,Intermediate,CHEMBL627942,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7700,Rattus norvegicus,Intermediate,CHEMBL627943,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7701,Rattus norvegicus,Intermediate,CHEMBL627944,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,N,1,1,,BAO_0000218
7702,Rattus norvegicus,Intermediate,CHEMBL627945,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
7703,Rattus norvegicus,Intermediate,CHEMBL628584,,,50597,178.0,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,N,1,1,,BAO_0000218
7704,Rattus norvegicus,Intermediate,CHEMBL628585,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,N,1,1,,BAO_0000218
7705,Rattus norvegicus,Intermediate,CHEMBL628586,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,N,1,1,,BAO_0000218
7706,Rattus norvegicus,Intermediate,CHEMBL628587,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,N,1,1,,BAO_0000218
7707,Rattus norvegicus,Intermediate,CHEMBL628588,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,N,1,1,,BAO_0000218
7708,Rattus norvegicus,Intermediate,CHEMBL628589,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,N,1,1,,BAO_0000218
7709,Rattus norvegicus,Intermediate,CHEMBL625304,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,N,1,1,,BAO_0000218
7710,Rattus norvegicus,Intermediate,CHEMBL625305,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,N,1,1,,BAO_0000218
7711,Rattus norvegicus,Intermediate,CHEMBL625306,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,N,1,1,,BAO_0000218
7712,Rattus norvegicus,Intermediate,CHEMBL625307,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,N,1,1,,BAO_0000218
7713,Rattus norvegicus,Intermediate,CHEMBL625308,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,N,1,1,,BAO_0000218
7714,Rattus norvegicus,Intermediate,CHEMBL627740,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,N,1,1,,BAO_0000218
7715,Rattus norvegicus,Intermediate,CHEMBL627741,,,50597,178.0,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,N,1,1,,BAO_0000218
7716,Rattus norvegicus,Intermediate,CHEMBL627742,,,50597,178.0,A,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7717,Rattus norvegicus,Intermediate,CHEMBL627743,,,50597,178.0,A,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
7718,Rattus norvegicus,Intermediate,CHEMBL627744,,,50597,178.0,A,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
7719,Rattus norvegicus,Intermediate,CHEMBL627745,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7720,Rattus norvegicus,Intermediate,CHEMBL627746,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7721,Rattus norvegicus,Intermediate,CHEMBL627747,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7722,Rattus norvegicus,Intermediate,CHEMBL876810,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
7723,Rattus norvegicus,Intermediate,CHEMBL627748,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7724,Rattus norvegicus,Intermediate,CHEMBL627749,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7725,Rattus norvegicus,Intermediate,CHEMBL627750,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7726,Rattus norvegicus,Intermediate,CHEMBL618728,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7727,Rattus norvegicus,Intermediate,CHEMBL618729,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7728,Rattus norvegicus,Intermediate,CHEMBL618730,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,N,1,1,,BAO_0000218
7729,Rattus norvegicus,Intermediate,CHEMBL618731,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,N,1,1,,BAO_0000218
7730,Rattus norvegicus,Intermediate,CHEMBL618732,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,N,1,1,,BAO_0000218
7731,Rattus norvegicus,Intermediate,CHEMBL618733,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,N,1,1,,BAO_0000218
7732,Rattus norvegicus,Intermediate,CHEMBL618734,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,N,1,1,,BAO_0000218
7733,Rattus norvegicus,Intermediate,CHEMBL618735,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,N,1,1,,BAO_0000218
7734,Rattus norvegicus,Intermediate,CHEMBL876602,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,N,1,1,,BAO_0000218
7735,Rattus norvegicus,Intermediate,CHEMBL618736,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,N,1,1,,BAO_0000218
7736,Rattus norvegicus,Intermediate,CHEMBL618737,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,N,1,1,,BAO_0000218
7737,Rattus norvegicus,Intermediate,CHEMBL618738,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,N,1,1,,BAO_0000218
7738,Rattus norvegicus,Intermediate,CHEMBL618739,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,N,1,1,,BAO_0000218
7739,Rattus norvegicus,Intermediate,CHEMBL618740,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,N,1,1,,BAO_0000218
7740,Rattus norvegicus,Intermediate,CHEMBL618741,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7741,Rattus norvegicus,Intermediate,CHEMBL618742,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
7742,Rattus norvegicus,Intermediate,CHEMBL618743,,,50597,10000001.0,A,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
7743,Rattus norvegicus,Intermediate,CHEMBL618744,,,50597,1969.0,A,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,N,1,1,,BAO_0000218
7744,Rattus norvegicus,Intermediate,CHEMBL618745,,,50597,,A,,Half-life in male rat,,N,1,1,,BAO_0000218
7745,Rattus norvegicus,Intermediate,CHEMBL620479,,,50597,,A,,Half-life in rat after peroral administration at 10 mg/kg concentration,,N,1,1,,BAO_0000218
7746,Rattus norvegicus,Intermediate,CHEMBL620480,,,50597,,A,,Half-life in rat after peroral administration at 5 mg/kg concentration,,N,1,1,,BAO_0000218
7747,Rattus norvegicus,Intermediate,CHEMBL620481,,,50597,,A,,Half-life in rat at a dose of 3 mg/kg,,N,1,1,,BAO_0000218
7748,Rattus norvegicus,Intermediate,CHEMBL620482,,,50597,,A,,Half-life was evaluated in rats,,N,1,1,,BAO_0000218
7749,Rattus norvegicus,Intermediate,CHEMBL876603,,,50597,,A,,Half-life was measured in rat,,N,1,1,,BAO_0000218
7750,Rattus norvegicus,Intermediate,CHEMBL620483,,,50597,,A,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,N,1,1,,BAO_0000218
7751,Rattus norvegicus,Intermediate,CHEMBL620484,,,50597,,A,,Half-life period in rats after intravenous administration at 5 mg/kg,,N,1,1,,BAO_0000218
7752,Rattus norvegicus,Intermediate,CHEMBL620485,,,50597,,A,,Half-life period in rat at 10 mg/kg,,N,1,1,,BAO_0000218
7753,Rattus norvegicus,Intermediate,CHEMBL620486,,,50597,,A,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
7754,Rattus norvegicus,Intermediate,CHEMBL620487,,,50597,,A,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,N,1,1,,BAO_0000218
7755,Rattus norvegicus,Intermediate,CHEMBL620488,,,50597,,A,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,N,1,1,,BAO_0000218
7756,Rattus norvegicus,Intermediate,CHEMBL620489,,,50597,,A,,Half-life time in rat the dose of 2 mg/kg,,N,1,1,,BAO_0000218
7757,Rattus norvegicus,Intermediate,CHEMBL620490,,,50597,,A,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,N,1,1,,BAO_0000218
7758,Rattus norvegicus,Intermediate,CHEMBL620491,,,50597,,A,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,N,1,1,,BAO_0000218
7759,Rattus norvegicus,Intermediate,CHEMBL876604,,,50597,1969.0,A,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,1,1,,BAO_0000218
7760,Rattus norvegicus,Intermediate,CHEMBL620492,,,50597,,A,,Oral half life was determined,,N,1,1,,BAO_0000218
7761,Rattus norvegicus,Intermediate,CHEMBL620493,,,50597,,A,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
7762,Rattus norvegicus,Intermediate,CHEMBL620494,,,50597,,A,,Pharmacokinetic property (t1/2) in rat,,N,1,1,,BAO_0000218
7763,Rattus norvegicus,Intermediate,CHEMBL620495,,,50597,1969.0,A,,Plasma elimination half-life was determined,,N,1,1,,BAO_0000218
7764,Rattus norvegicus,Intermediate,CHEMBL620496,,,50597,1969.0,A,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,1,1,,BAO_0000218
7765,Rattus norvegicus,Intermediate,CHEMBL620497,,,50597,1969.0,A,,Plasma half life was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
7766,Rattus norvegicus,Intermediate,CHEMBL620498,,,50597,1969.0,A,,Plasma half-life was determined,,N,1,1,,BAO_0000218
7767,Rattus norvegicus,Intermediate,CHEMBL620499,,,50597,1969.0,A,,Plasma half-life following oral administration in Fisher rats,,N,1,1,,BAO_0000218
7768,Rattus norvegicus,Intermediate,CHEMBL620500,,,50597,1969.0,A,,Plasma half-life in rat,,N,1,1,,BAO_0000218
7769,Rattus norvegicus,Intermediate,CHEMBL873809,,,50597,1969.0,A,,Plasmatic Half-life after intravenous administration to rat,,N,1,1,,BAO_0000218
7770,Rattus norvegicus,Intermediate,CHEMBL620501,,,50597,,A,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,1,1,,BAO_0000218
7771,Rattus norvegicus,Intermediate,CHEMBL620502,,,50597,,A,,Terminal half life after intravenous administration (1 mg/kg) in rat,,N,1,1,,BAO_0000218
7772,Rattus norvegicus,Intermediate,CHEMBL620503,,,50597,,A,,Terminal half life in Rat at a oral dose of 5 mg/kg,,N,1,1,,BAO_0000218
7773,Rattus norvegicus,Intermediate,CHEMBL620504,,,50597,,A,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,1,1,,BAO_0000218
7774,Rattus norvegicus,Intermediate,CHEMBL876605,,,50597,,A,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,N,1,1,,BAO_0000218
7775,Rattus norvegicus,Intermediate,CHEMBL620505,,,50597,,A,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,N,1,1,,BAO_0000218
7776,Rattus norvegicus,Intermediate,CHEMBL873811,,,50597,1969.0,A,,plasma half life was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
7777,Rattus norvegicus,Expert,CHEMBL624016,,,50597,,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
7778,Rattus norvegicus,Intermediate,CHEMBL624017,,,50597,,A,,Half life of compound determined in rat,,N,1,1,,BAO_0000218
7779,Rattus norvegicus,Intermediate,CHEMBL624018,,,50597,,A,,Mean residence time determined in rat,,N,1,1,,BAO_0000218
7780,Rattus norvegicus,Intermediate,CHEMBL624019,,,50597,,A,,Plasma half life determined in rat,,N,1,1,,BAO_0000218
7781,Rattus norvegicus,Intermediate,CHEMBL624020,,,50597,955.0,A,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,N,1,1,,BAO_0000218
7782,Rattus norvegicus,Intermediate,CHEMBL624201,,,50597,,A,,Compound was evaluated for pharmacokinetic parameter maximum time period,,N,1,1,,BAO_0000218
7783,Rattus norvegicus,Intermediate,CHEMBL872528,,,50597,,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,1,1,,BAO_0000218
7784,Rattus norvegicus,Intermediate,CHEMBL624202,,,50597,,A,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
7785,Rattus norvegicus,Intermediate,CHEMBL624203,,,50597,,A,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
7786,Rattus norvegicus,Intermediate,CHEMBL624350,,,50597,,A,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
7787,Rattus norvegicus,Intermediate,CHEMBL621320,,,50597,,A,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
7788,Rattus norvegicus,Intermediate,CHEMBL621321,,,50597,,A,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,1,1,,BAO_0000218
7789,Rattus norvegicus,Intermediate,CHEMBL621322,,,50597,,A,,Maximum time (Tmax) required to reach Cmax in rats,,N,1,1,,BAO_0000218
7790,Rattus norvegicus,Intermediate,CHEMBL621323,,,50597,,A,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
7791,Rattus norvegicus,Intermediate,CHEMBL621324,,,50597,,A,,Maximum time of clearance of compound in rats after peroral administration,,N,1,1,,BAO_0000218
7792,Rattus norvegicus,Intermediate,CHEMBL621325,,,50597,,A,,Maximum time at the dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
7793,Rattus norvegicus,Intermediate,CHEMBL875837,,,50597,1969.0,A,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,N,1,1,,BAO_0000218
7794,Rattus norvegicus,Intermediate,CHEMBL621326,,,50597,1969.0,A,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,N,1,1,,BAO_0000218
7795,Rattus norvegicus,Intermediate,CHEMBL621327,,,50597,,A,,Tmax in Guinea pig (PO dose),,N,1,1,,BAO_0000218
7796,Rattus norvegicus,Intermediate,CHEMBL621328,,,50597,,A,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
7797,Rattus norvegicus,Intermediate,CHEMBL621329,,,50597,,A,,Pharmacokinetic parameter (Tmax) in rat,,N,1,1,,BAO_0000218
7798,Rattus norvegicus,Intermediate,CHEMBL621330,,,50597,,A,,Pharmacokinetic parameter (Tmax) was estimated,,N,1,1,,BAO_0000218
7799,Rattus norvegicus,Intermediate,CHEMBL621331,,,50597,,A,,Pharmacokinetic property (Tmax) in rat,,N,1,1,,BAO_0000218
7800,Rattus norvegicus,Intermediate,CHEMBL621332,,,50597,,A,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,1,1,,BAO_0000218
7801,Rattus norvegicus,Intermediate,CHEMBL621333,,,50597,,A,,T max in Rat at a oral dose of 5 mg/kg,,N,1,1,,BAO_0000218
7802,Rattus norvegicus,Intermediate,CHEMBL621334,,,50597,,A,,T max was determined at 10 mg/kg po dose in rats,,N,1,1,,BAO_0000218
7803,Mus musculus,Intermediate,CHEMBL621335,,,50594,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,1,1,,BAO_0000218
7804,Canis lupus familiaris,Intermediate,CHEMBL621336,,,50588,,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,N,1,1,,BAO_0000218
7805,Rattus norvegicus,Intermediate,CHEMBL621337,,,50597,,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,N,1,1,,BAO_0000218
7806,Canis lupus familiaris,Intermediate,CHEMBL621338,,,50588,,A,,Area under curve was measured after i.v. administration into Beagle dog.,,N,1,1,,BAO_0000218
7807,Canis lupus familiaris,Intermediate,CHEMBL875838,,,50588,,A,,Area under curve was measured after iv administration into Beagle dog,,N,1,1,,BAO_0000218
7808,Canis lupus familiaris,Intermediate,CHEMBL621339,,,50588,,A,,Area under curve was measured after po administration into Beagle dog,,N,1,1,,BAO_0000218
7809,Canis lupus familiaris,Intermediate,CHEMBL621340,,,50588,,A,,Area under curve was measured after po administration into Beagle dog.,,N,1,1,,BAO_0000218
7810,,Autocuration,CHEMBL621341,,,22224,,A,,Area under curve was measured at peroral dose of 3 mg/kg,,U,0,1,,BAO_0000218
7811,,Autocuration,CHEMBL621342,,,22224,,A,,Area under curve was measured by using concentration Vs time,,U,0,1,,BAO_0000019
7812,,Autocuration,CHEMBL621343,,,22224,,A,,Area under curve was measured by using concentration Vs time; not tested,,U,0,1,,BAO_0000019
7813,Mus musculus,Intermediate,CHEMBL621344,,,50594,,A,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,N,1,1,,BAO_0000218
7814,Mus musculus,Intermediate,CHEMBL621345,,,50594,,A,,Area under curve(AUC) was measured in mice after oral administration.,,N,1,1,,BAO_0000218
7815,,Autocuration,CHEMBL621346,,,22224,,A,,Area under curve(AUC) value of the compound,,U,0,1,,BAO_0000019
7816,,Autocuration,CHEMBL621347,,,22224,,A,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,U,0,1,,BAO_0000218
7817,Canis lupus familiaris,Intermediate,CHEMBL621348,,,50588,,A,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,N,1,1,,BAO_0000218
7818,,Autocuration,CHEMBL621349,,,22224,178.0,A,,Area under curve(carotid artery) was determined by the availability in blood,,U,0,1,,BAO_0000019
7819,,Autocuration,CHEMBL621350,,,22224,178.0,A,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,U,0,1,,BAO_0000019
7820,,Autocuration,CHEMBL875839,,,22224,178.0,A,,Area under curve(carotid artery) was determined by the availability in blood; No data,,U,0,1,,BAO_0000019
7821,,Autocuration,CHEMBL620211,,,22224,178.0,A,,Area under curve(portal vein) was determined by the availability in blood,,U,0,1,,BAO_0000019
7822,,Autocuration,CHEMBL620212,,,22224,178.0,A,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,U,0,1,,BAO_0000019
7823,,Autocuration,CHEMBL620213,,,22224,178.0,A,,Area under curve(portal vein) was determined by the availability in blood; No data,,U,0,1,,BAO_0000019
7824,Macaca mulatta,Intermediate,CHEMBL620214,,,50797,1969.0,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,1,1,,BAO_0000218
7825,Macaca mulatta,Intermediate,CHEMBL620215,,,50797,1969.0,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,1,1,,BAO_0000218
7826,Macaca mulatta,Intermediate,CHEMBL620216,,,50797,1969.0,A,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,N,1,1,,BAO_0000218
7827,Canis lupus familiaris,Intermediate,CHEMBL620888,,,50588,1969.0,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,N,1,1,,BAO_0000218
7828,Canis lupus familiaris,Intermediate,CHEMBL620889,,,50588,1969.0,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,N,1,1,,BAO_0000218
7829,,Autocuration,CHEMBL620890,,,22224,1969.0,A,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,U,0,1,,BAO_0000019
7830,Rattus norvegicus,Intermediate,CHEMBL620891,,,50597,1969.0,A,,Area under plasma time curve determined in male rat,,N,1,1,,BAO_0000218
7831,,Autocuration,CHEMBL620892,,,22224,,A,,Area under the MAP curve measured over 5 min.,,U,0,1,,BAO_0000019
7832,Mus musculus,Intermediate,CHEMBL621079,,,50594,,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,N,1,1,,BAO_0000218
7833,Mus musculus,Intermediate,CHEMBL621080,,,50594,,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,N,1,1,,BAO_0000218
7834,Canis lupus familiaris,Intermediate,CHEMBL621081,,,50588,,A,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
7835,Cricetinae,Intermediate,CHEMBL621082,,,100712,,A,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
7836,Rattus norvegicus,Intermediate,CHEMBL621083,,,50597,,A,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
7837,Canis lupus familiaris,Intermediate,CHEMBL621084,,,50588,,A,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,N,1,1,,BAO_0000218
7838,Canis lupus familiaris,Intermediate,CHEMBL621085,,,50588,,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,N,1,1,,BAO_0000218
7839,Canis lupus familiaris,Intermediate,CHEMBL621086,,,50588,,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,N,1,1,,BAO_0000218
7840,Canis lupus familiaris,Intermediate,CHEMBL621087,,,50588,,A,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,1,1,,BAO_0000218
7841,Canis lupus familiaris,Intermediate,CHEMBL622607,,,50588,,A,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,N,1,1,,BAO_0000218
7842,Canis lupus familiaris,Intermediate,CHEMBL622608,,,50588,,A,,Serum AUC in marmosets (IV dose),,N,1,1,,BAO_0000218
7843,,Autocuration,CHEMBL624481,,,22224,,A,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,U,0,1,,BAO_0000019
7844,,Autocuration,CHEMBL624482,,,22224,,A,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,U,0,1,,BAO_0000019
7845,,Autocuration,CHEMBL624483,,,22224,,A,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,U,0,1,,BAO_0000019
7846,,Autocuration,CHEMBL624484,,,22224,,A,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,U,0,1,,BAO_0000019
7847,,Autocuration,CHEMBL624485,,,22224,,A,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,U,0,1,,BAO_0000019
7848,Rattus norvegicus,Intermediate,CHEMBL624486,,,50597,,A,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,N,1,1,,BAO_0000218
7849,,Autocuration,CHEMBL624487,,,22224,,A,,Area under the curve for the compound was calculated.,,U,0,1,,BAO_0000019
7850,,Autocuration,CHEMBL624488,,,22224,,A,,Area under the curve in concentration/ time,,U,0,1,,BAO_0000019
7851,Rattus norvegicus,Intermediate,CHEMBL624489,,,50597,,A,,Area under the curve administered intraintestinal in rats.,,N,1,1,,BAO_0000218
7852,Rattus norvegicus,Intermediate,CHEMBL625184,,,50597,,A,,Area under the curve administered intravenously in rats.,,N,1,1,,BAO_0000218
7853,,Autocuration,CHEMBL625185,,,22224,,A,,Area under the curve during intravenous administration,,U,0,1,,BAO_0000019
7854,,Autocuration,CHEMBL875954,,,22224,,A,,Area under the curve during intravenous administration; Not determined,,U,0,1,,BAO_0000019
7855,,Autocuration,CHEMBL625186,,,22224,,A,,Area under the curve during systemic administration,,U,0,1,,BAO_0000019
7856,,Autocuration,CHEMBL625187,,,22224,,A,,Area under the curve during systemic administration; Not determined,,U,0,1,,BAO_0000019
7857,,Autocuration,CHEMBL625188,,,22224,,A,,Area under the curve was calculated for the compound.,,U,0,1,,BAO_0000019
7858,Canis lupus familiaris,Intermediate,CHEMBL625189,,,50588,,A,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,N,1,1,,BAO_0000218
7859,Canis lupus familiaris,Intermediate,CHEMBL625190,,,50588,,A,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,N,1,1,,BAO_0000218
7860,Rattus norvegicus,Intermediate,CHEMBL621733,,,50597,,A,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
7861,Rattus norvegicus,Intermediate,CHEMBL621734,,,50597,,A,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
7862,Rattus norvegicus,Intermediate,CHEMBL621735,,,50597,,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,N,1,1,,BAO_0000218
7863,Rattus norvegicus,Intermediate,CHEMBL621736,,,50597,1969.0,A,,Clearance of the drug was measured in the plasma of rat; No data,,N,1,1,,BAO_0000218
7864,Rattus norvegicus,Intermediate,CHEMBL621737,,,50597,1969.0,A,,The pharmacokinetic parameter plasma clearance in vivo in rats,,N,1,1,,BAO_0000218
7865,Rattus norvegicus,Intermediate,CHEMBL621738,,,50597,,A,,Plasma clearance at the dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
7866,Rattus norvegicus,Intermediate,CHEMBL622806,,,50597,,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,1,1,,BAO_0000218
7867,Rattus norvegicus,Intermediate,CHEMBL623519,,,50597,,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,1,1,,BAO_0000218
7868,Rattus norvegicus,Intermediate,CHEMBL623520,,,50597,,A,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1,1,,BAO_0000218
7869,Rattus norvegicus,Intermediate,CHEMBL623521,,,50597,,A,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,1,1,,BAO_0000218
7870,Rattus norvegicus,Intermediate,CHEMBL623522,,,50597,,A,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,1,1,,BAO_0000218
7871,Rattus norvegicus,Intermediate,CHEMBL623523,,,50597,,A,,Clearance rate in rat,,N,1,1,,BAO_0000218
7872,Rattus norvegicus,Intermediate,CHEMBL623690,,,50597,,A,,Clearance rate in rat,,N,1,1,,BAO_0000218
7873,Rattus norvegicus,Intermediate,CHEMBL623691,,,50597,,A,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
7874,Rattus norvegicus,Intermediate,CHEMBL623692,,,50597,,A,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
7875,Rattus norvegicus,Intermediate,CHEMBL623693,,,50597,,A,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
7876,Rattus norvegicus,Intermediate,CHEMBL623694,,,50597,,A,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
7877,Rattus norvegicus,Intermediate,CHEMBL623695,,,50597,,A,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,N,1,1,,BAO_0000218
7878,Rattus norvegicus,Intermediate,CHEMBL623696,,,50597,,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,N,1,1,,BAO_0000218
7879,Rattus norvegicus,Intermediate,CHEMBL623697,,,50597,,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,N,1,1,,BAO_0000218
7880,Macaca mulatta,Intermediate,CHEMBL623698,,,22224,1969.0,A,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,0,1,,BAO_0000218
7881,Rattus norvegicus,Intermediate,CHEMBL623699,,,22224,1969.0,A,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,U,0,1,,BAO_0000218
7882,Rattus norvegicus,Intermediate,CHEMBL623700,,,50597,,A,,Mean (%CV) PK parameters for CL(mL/min/kg).,,N,1,1,,BAO_0000218
7883,Rattus norvegicus,Intermediate,CHEMBL623701,,,50597,,A,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,N,1,1,,BAO_0000218
7884,Rattus norvegicus,Intermediate,CHEMBL623702,,,50597,1969.0,A,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,N,1,1,,BAO_0000218
7885,Rattus norvegicus,Intermediate,CHEMBL623703,,,50597,,A,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,N,1,1,,BAO_0000218
7886,Rattus norvegicus,Intermediate,CHEMBL623704,,,50597,,A,,Plasma clearance in rat was determined,,N,1,1,,BAO_0000218
7887,Rattus norvegicus,Intermediate,CHEMBL623705,,,50597,,A,,Plasma clearance in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
7888,Rattus norvegicus,Intermediate,CHEMBL623706,,,50597,,A,,Plasma clearance in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
7889,Rattus norvegicus,Intermediate,CHEMBL623707,,,50597,,A,,Plasma clearance was determined,,N,1,1,,BAO_0000218
7890,Rattus norvegicus,Intermediate,CHEMBL623708,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
7891,Rattus norvegicus,Intermediate,CHEMBL623709,,,50597,,A,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,N,1,1,,BAO_0000218
7892,Rattus norvegicus,Intermediate,CHEMBL623710,,,50597,,A,,Plasma clearance in rat by iv administration,,N,1,1,,BAO_0000218
7893,Rattus norvegicus,Intermediate,CHEMBL623711,,,50597,,A,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,N,1,1,,BAO_0000218
7894,Rattus norvegicus,Intermediate,CHEMBL623712,,,50597,,A,,Plasma clearance in rat p.o.,,N,1,1,,BAO_0000218
7895,Rattus norvegicus,Intermediate,CHEMBL623713,,,50597,,A,,Plasma clearance in rats,,N,1,1,,BAO_0000218
7896,Rattus norvegicus,Intermediate,CHEMBL623714,,,50597,,A,,Plasma clearance was determined; ND denotes no data,,N,1,1,,BAO_0000218
7897,Rattus norvegicus,Intermediate,CHEMBL623715,,,50597,,A,,Plasma clearance was determined; ND denotes not determined,,N,1,1,,BAO_0000218
7898,Rattus norvegicus,Intermediate,CHEMBL623716,,,50597,,A,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,1,1,,BAO_0000218
7899,Rattus norvegicus,Intermediate,CHEMBL622980,,,50597,,A,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,1,1,,BAO_0000218
7900,Rattus norvegicus,Intermediate,CHEMBL622981,,,50597,,A,,Plasma administration to rats,,N,1,1,,BAO_0000218
7901,Rattus norvegicus,Intermediate,CHEMBL622982,,,50597,,A,,Plasma clearance of the compound in female Sprague-Dawley rats,,N,1,1,,BAO_0000218
7902,Rattus norvegicus,Intermediate,CHEMBL622983,,,50597,,A,,Plasma clearance was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
7903,Rattus norvegicus,Intermediate,CHEMBL622984,,,50597,,A,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,N,1,1,,BAO_0000218
7904,Rattus norvegicus,Intermediate,CHEMBL622985,,,50597,,A,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
7905,Rattus norvegicus,Intermediate,CHEMBL623631,,,50597,1969.0,A,,plasma clearance was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
7906,Rattus norvegicus,Intermediate,CHEMBL623632,,,50597,,A,,In vivo CL/F determined,,N,1,1,,BAO_0000218
7907,Rattus norvegicus,Intermediate,CHEMBL623633,,,50597,1969.0,A,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
7908,Rattus norvegicus,Intermediate,CHEMBL623634,,,50597,1969.0,A,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
7909,Rattus norvegicus,Intermediate,CHEMBL623635,,,50597,,A,,Compound was tested for the lower blood clearance in rat,,N,1,1,,BAO_0000218
7910,Rattus norvegicus,Intermediate,CHEMBL621195,,,50597,,A,,Evaluated for the low clearance in rat (in vivo),,N,1,1,,BAO_0000218
7911,Rattus norvegicus,Intermediate,CHEMBL621196,,,50597,,A,,Pharmacokinetic property (CLb)of the compound was determined in rat,,N,1,1,,BAO_0000218
7912,Rattus norvegicus,Intermediate,CHEMBL875287,,,50597,,A,,Rapid clearance after intravenous administration in rat was determined,,N,1,1,,BAO_0000218
7913,Rattus norvegicus,Intermediate,CHEMBL621197,,,50597,,A,,Clearance measured in rat,,N,1,1,,BAO_0000218
7914,Rattus norvegicus,Intermediate,CHEMBL621198,,,50597,1969.0,A,,Compound was evaluated for plasma clearance in rat,,N,1,1,,BAO_0000218
7915,Rattus norvegicus,Intermediate,CHEMBL621199,,,50597,1969.0,A,,Low plasma clearance was calculated in rat,,N,1,1,,BAO_0000218
7916,Rattus norvegicus,Intermediate,CHEMBL621200,,,50597,,A,,Pharmacokinetic property (Clp) in rat,,N,1,1,,BAO_0000218
7917,Rattus norvegicus,Intermediate,CHEMBL621201,,,50597,,A,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,N,1,1,,BAO_0000218
7918,Rattus norvegicus,Intermediate,CHEMBL621202,,,50597,,A,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,N,1,1,,BAO_0000218
7919,Rattus norvegicus,Intermediate,CHEMBL621203,,,50597,,A,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,N,1,1,,BAO_0000218
7920,Rattus norvegicus,Intermediate,CHEMBL621204,,,50597,,A,,Plasma clearance after IV dosing at 1 mg/kg in rat,,N,1,1,,BAO_0000218
7921,Rattus norvegicus,Intermediate,CHEMBL621205,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7922,Rattus norvegicus,Intermediate,CHEMBL621206,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7923,Rattus norvegicus,Intermediate,CHEMBL621207,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7924,Rattus norvegicus,Intermediate,CHEMBL621208,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7925,Rattus norvegicus,Intermediate,CHEMBL621209,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
7926,Rattus norvegicus,Intermediate,CHEMBL876484,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7927,Rattus norvegicus,Intermediate,CHEMBL621210,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7928,Rattus norvegicus,Intermediate,CHEMBL621211,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7929,Rattus norvegicus,Intermediate,CHEMBL621212,,,50597,948.0,A,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7930,Rattus norvegicus,Intermediate,CHEMBL621213,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,N,1,1,,BAO_0000218
7931,Rattus norvegicus,Intermediate,CHEMBL621214,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,N,1,1,,BAO_0000218
7932,Rattus norvegicus,Intermediate,CHEMBL621215,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,N,1,1,,BAO_0000218
7933,Rattus norvegicus,Intermediate,CHEMBL621216,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,N,1,1,,BAO_0000218
7934,Rattus norvegicus,Intermediate,CHEMBL621217,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,N,1,1,,BAO_0000218
7935,Rattus norvegicus,Intermediate,CHEMBL621218,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,N,1,1,,BAO_0000218
7936,Rattus norvegicus,Intermediate,CHEMBL621219,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,N,1,1,,BAO_0000218
7937,Rattus norvegicus,Intermediate,CHEMBL621220,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,N,1,1,,BAO_0000218
7938,Rattus norvegicus,Intermediate,CHEMBL621221,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,N,1,1,,BAO_0000218
7939,Rattus norvegicus,Intermediate,CHEMBL621222,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,N,1,1,,BAO_0000218
7940,Rattus norvegicus,Intermediate,CHEMBL621223,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,N,1,1,,BAO_0000218
7941,Rattus norvegicus,Intermediate,CHEMBL876485,,,50597,948.0,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,N,1,1,,BAO_0000218
7942,Rattus norvegicus,Intermediate,CHEMBL621224,,,50597,948.0,A,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7943,Rattus norvegicus,Intermediate,CHEMBL621225,,,50597,948.0,A,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
7944,Rattus norvegicus,Intermediate,CHEMBL621226,,,50597,948.0,A,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
7945,Rattus norvegicus,Intermediate,CHEMBL621227,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7946,Rattus norvegicus,Intermediate,CHEMBL621228,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7947,Rattus norvegicus,Intermediate,CHEMBL621229,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7948,Rattus norvegicus,Intermediate,CHEMBL621230,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
7949,Rattus norvegicus,Intermediate,CHEMBL621231,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,1,1,,BAO_0000218
7950,Rattus norvegicus,Intermediate,CHEMBL621232,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7951,Rattus norvegicus,Intermediate,CHEMBL621233,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7952,Rattus norvegicus,Intermediate,CHEMBL621234,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7953,Rattus norvegicus,Intermediate,CHEMBL621235,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,1,1,,BAO_0000218
7954,Rattus norvegicus,Intermediate,CHEMBL621236,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7955,Rattus norvegicus,Intermediate,CHEMBL621237,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
7956,Rattus norvegicus,Intermediate,CHEMBL876486,,,50597,2113.0,A,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
7957,Rattus norvegicus,Intermediate,CHEMBL622436,,,50597,160.0,A,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,N,1,1,,BAO_0000218
7958,Rattus norvegicus,Intermediate,CHEMBL622437,,,50597,160.0,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
7959,Rattus norvegicus,Intermediate,CHEMBL622438,,,50597,160.0,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,N,1,1,,BAO_0000218
7960,Rattus norvegicus,Intermediate,CHEMBL622439,,,50597,2107.0,A,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,N,1,1,,BAO_0000218
7961,Rattus norvegicus,Intermediate,CHEMBL622440,,,50597,2107.0,A,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
7962,Rattus norvegicus,Intermediate,CHEMBL622441,,,50597,2107.0,A,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
7963,Rattus norvegicus,Intermediate,CHEMBL622442,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7964,Rattus norvegicus,Intermediate,CHEMBL622443,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7965,Rattus norvegicus,Intermediate,CHEMBL622444,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7966,Rattus norvegicus,Intermediate,CHEMBL622445,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7967,Rattus norvegicus,Intermediate,CHEMBL622446,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,1,1,,BAO_0000218
7968,Rattus norvegicus,Intermediate,CHEMBL622447,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
7969,Rattus norvegicus,Intermediate,CHEMBL622448,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
7970,Rattus norvegicus,Intermediate,CHEMBL622449,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,1,1,,BAO_0000218
7971,Rattus norvegicus,Intermediate,CHEMBL622450,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
7972,Rattus norvegicus,Intermediate,CHEMBL622451,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,N,1,1,,BAO_0000218
7973,Rattus norvegicus,Intermediate,CHEMBL622452,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,N,1,1,,BAO_0000218
7974,Rattus norvegicus,Intermediate,CHEMBL622453,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,N,1,1,,BAO_0000218
7975,Rattus norvegicus,Intermediate,CHEMBL622454,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,N,1,1,,BAO_0000218
7976,Rattus norvegicus,Intermediate,CHEMBL622455,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,N,1,1,,BAO_0000218
7977,Rattus norvegicus,Intermediate,CHEMBL876024,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,N,1,1,,BAO_0000218
7978,Rattus norvegicus,Intermediate,CHEMBL622456,,,50597,,A,,T max was determined at 3 mg/kg po dose in rats,,N,1,1,,BAO_0000218
7979,Rattus norvegicus,Intermediate,CHEMBL622457,,,50597,,A,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
7980,Rattus norvegicus,Intermediate,CHEMBL622458,,,50597,,A,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
7981,Rattus norvegicus,Intermediate,CHEMBL622459,,,50597,,A,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,N,1,1,,BAO_0000218
7982,Rattus norvegicus,Intermediate,CHEMBL873343,,,50597,,A,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,N,1,1,,BAO_0000218
7983,Rattus norvegicus,Intermediate,CHEMBL622460,,,50597,,A,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,N,1,1,,BAO_0000218
7984,Rattus norvegicus,Intermediate,CHEMBL622461,,,50597,1969.0,A,,Time for maximum plasma concentration determined in rat,,N,1,1,,BAO_0000218
7985,Rattus norvegicus,Intermediate,CHEMBL622462,,,50597,1969.0,A,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,1,1,,BAO_0000218
7986,Rattus norvegicus,Intermediate,CHEMBL622463,,,50597,,A,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
7987,Rattus norvegicus,Intermediate,CHEMBL622464,,,50597,,A,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
7988,Rattus norvegicus,Intermediate,CHEMBL622465,,,50597,,A,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,N,1,1,,BAO_0000218
7989,Rattus norvegicus,Intermediate,CHEMBL622466,,,50597,,A,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
7990,Rattus norvegicus,Intermediate,CHEMBL622467,,,50597,,A,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,N,1,1,,BAO_0000218
7991,Rattus norvegicus,Intermediate,CHEMBL622468,,,50597,1969.0,A,,Time of maximum plasma concentration in rat,,N,1,1,,BAO_0000218
7992,Rattus norvegicus,Intermediate,CHEMBL876025,,,50597,1969.0,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
7993,Rattus norvegicus,Intermediate,CHEMBL622469,,,50597,1969.0,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,1,1,,BAO_0000218
7994,Rattus norvegicus,Intermediate,CHEMBL622470,,,50597,1969.0,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,1,1,,BAO_0000218
7995,Rattus norvegicus,Intermediate,CHEMBL622471,,,50597,,A,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,N,1,1,,BAO_0000218
7996,Rattus norvegicus,Intermediate,CHEMBL622472,,,50597,1969.0,A,,Time required to reach maximum concentration in rat plasma,,N,1,1,,BAO_0000218
7997,Rattus norvegicus,Intermediate,CHEMBL622473,,,50597,1969.0,A,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,1,1,,BAO_0000218
7998,Rattus norvegicus,Intermediate,CHEMBL624282,,,50597,1969.0,A,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,1,1,,BAO_0000218
7999,Rattus norvegicus,Intermediate,CHEMBL624283,,,50597,1969.0,A,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
8000,Rattus norvegicus,Intermediate,CHEMBL624284,,,50597,1969.0,A,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
8001,Rattus norvegicus,Intermediate,CHEMBL624285,,,50597,1969.0,A,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,1,1,,BAO_0000218
8002,Rattus norvegicus,Intermediate,CHEMBL624286,,,50597,,A,,Time to reach Cmax after oral administration to rats,,N,1,1,,BAO_0000218
8003,Rattus norvegicus,Intermediate,CHEMBL624287,,,50597,,A,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,N,1,1,,BAO_0000218
8004,Rattus norvegicus,Intermediate,CHEMBL624288,,,50597,,A,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,N,1,1,,BAO_0000218
8005,Rattus norvegicus,Intermediate,CHEMBL624289,,,50597,1969.0,A,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,N,1,1,,BAO_0000218
8006,Rattus norvegicus,Intermediate,CHEMBL873344,,,50597,1969.0,A,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
8007,Rattus norvegicus,Intermediate,CHEMBL619623,,,50597,,A,,Tmax after peroral administration (10 mg/kg) was determined in rat,,N,1,1,,BAO_0000218
8008,Rattus norvegicus,Expert,CHEMBL621399,,,50597,,A,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
8009,Rattus norvegicus,Intermediate,CHEMBL621400,,,50597,,A,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,N,1,1,,BAO_0000218
8010,Rattus norvegicus,Intermediate,CHEMBL621401,,,50597,,A,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,N,1,1,,BAO_0000218
8011,Rattus norvegicus,Intermediate,CHEMBL621402,,,50597,,A,,Tmax was determined,,N,1,1,,BAO_0000218
8012,Rattus norvegicus,Intermediate,CHEMBL621403,,,50597,,A,,Tmax was determined,,N,1,1,,BAO_0000218
8013,Rattus norvegicus,Intermediate,CHEMBL621121,,,50597,,A,,Tmax after oral administration in rat,,N,1,1,,BAO_0000218
8014,Rattus norvegicus,Intermediate,CHEMBL872525,,,50597,,A,,Tmax after peroral administration in rats at 2.4 uM/kg,,N,1,1,,BAO_0000218
8015,Rattus norvegicus,Intermediate,CHEMBL621122,,,50597,,A,,Tmax in male rat,,N,1,1,,BAO_0000218
8016,Rattus norvegicus,Intermediate,CHEMBL621123,,,50597,,A,,Tmax in rat at 10 mg/kg,,N,1,1,,BAO_0000218
8017,Rattus norvegicus,Intermediate,CHEMBL621124,,,50597,,A,,Tmax in rat by po administration at a dose of 40 mg/kg,,N,1,1,,BAO_0000218
8018,Rattus norvegicus,Intermediate,CHEMBL621125,,,50597,,A,,Tmax in rats,,N,1,1,,BAO_0000218
8019,Rattus norvegicus,Intermediate,CHEMBL621126,,,50597,,A,,Tmax was measured in rats after peroral administration at 5 mg/kg,,N,1,1,,BAO_0000218
8020,Rattus norvegicus,Intermediate,CHEMBL621127,,,50597,,A,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,N,1,1,,BAO_0000218
8021,Rattus norvegicus,Intermediate,CHEMBL621128,,,50597,,A,,Tmax value after administration of 20 mg/Kg oral dose in rat,,N,1,1,,BAO_0000218
8022,Rattus norvegicus,Intermediate,CHEMBL618263,,,50597,,A,,Tmax value at a dose of 10 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8023,Rattus norvegicus,Intermediate,CHEMBL618264,,,50597,,A,,Tmax value at a dose of 100 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8024,Rattus norvegicus,Intermediate,CHEMBL618265,,,50597,,A,,Tmax value at a dose of 50 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8025,Rattus norvegicus,Intermediate,CHEMBL618266,,,50597,1969.0,A,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,1,1,,BAO_0000218
8026,Rattus norvegicus,Intermediate,CHEMBL618267,,,50597,,A,,time required to reach maximum concentration (Cmax) after oral administration in rat,,N,1,1,,BAO_0000218
8027,Rattus norvegicus,Intermediate,CHEMBL618450,,,50597,1088.0,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,N,1,1,,BAO_0000218
8028,Rattus norvegicus,Intermediate,CHEMBL618451,,,50597,1088.0,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,N,1,1,,BAO_0000218
8029,Rattus norvegicus,Intermediate,CHEMBL618452,,,50597,,A,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,1,1,,BAO_0000218
8030,Rattus norvegicus,Intermediate,CHEMBL618453,,,50597,1088.0,A,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,N,1,1,,BAO_0000218
8031,Rattus norvegicus,Intermediate,CHEMBL618454,,,50597,1088.0,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,N,1,1,,BAO_0000218
8032,Rattus norvegicus,Intermediate,CHEMBL618455,,,50597,1088.0,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,N,1,1,,BAO_0000218
8033,Rattus norvegicus,Intermediate,CHEMBL618456,,,50597,,A,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,N,1,1,,BAO_0000218
8034,Rattus norvegicus,Intermediate,CHEMBL618457,,,50597,,A,,Compound distribution in rat tissues was determined,,N,1,1,,BAO_0000218
8035,Rattus norvegicus,Intermediate,CHEMBL618458,,,50597,,A,,Volume of distribution was evaluated in rat,,N,1,1,,BAO_0000218
8036,Rattus norvegicus,Intermediate,CHEMBL618459,,,50597,,A,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8037,Rattus norvegicus,Intermediate,CHEMBL876733,,,50597,,A,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8038,Canis lupus familiaris,Intermediate,CHEMBL618460,,,50588,,A,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,N,1,1,,BAO_0000218
8039,Rattus norvegicus,Intermediate,CHEMBL618461,,,50597,,A,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8040,,Autocuration,CHEMBL618462,,,22224,,A,,Area under the curve was determined after oral administration (300 uM/Kg),,U,0,1,,BAO_0000019
8041,Rattus norvegicus,Intermediate,CHEMBL618463,,,50597,,A,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8042,Rattus norvegicus,Intermediate,CHEMBL618464,,,50597,,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,N,1,1,,BAO_0000218
8043,Rattus norvegicus,Intermediate,CHEMBL618465,,,50597,,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8044,Rattus norvegicus,Intermediate,CHEMBL618466,,,50597,,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,N,1,1,,BAO_0000218
8045,Rattus norvegicus,Intermediate,CHEMBL618467,,,50597,,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,N,1,1,,BAO_0000218
8046,Rattus norvegicus,Intermediate,CHEMBL618468,,,50597,,A,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,1,1,,BAO_0000218
8047,Canis lupus familiaris,Intermediate,CHEMBL618469,,,50588,1969.0,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,N,1,1,,BAO_0000218
8048,Canis lupus familiaris,Intermediate,CHEMBL618470,,,50588,1969.0,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,N,1,1,,BAO_0000218
8049,,Autocuration,CHEMBL618471,,,22224,,A,,Plasma drug AUC in rat (PO dose),,U,0,1,,BAO_0000218
8050,Mus musculus,Intermediate,CHEMBL618472,,,50594,,A,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,N,1,1,,BAO_0000218
8051,,Autocuration,CHEMBL618473,,,22224,,A,,Area under was determined at a dose of 30 mg/kg,,U,0,1,,BAO_0000218
8052,Mustela putorius furo,Intermediate,CHEMBL621699,,,50506,,A,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,N,1,1,,BAO_0000218
8053,Rattus norvegicus,Intermediate,CHEMBL621700,,,50597,,A,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,N,1,1,,BAO_0000218
8054,Rattus norvegicus,Intermediate,CHEMBL621701,,,50597,,A,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,N,1,1,,BAO_0000218
8055,Mustela putorius furo,Intermediate,CHEMBL621702,,,50506,,A,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,N,1,1,,BAO_0000218
8056,Canis lupus familiaris,Intermediate,CHEMBL621703,,,50588,,A,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,N,1,1,,BAO_0000218
8057,Canis lupus familiaris,Intermediate,CHEMBL621704,,,50588,,A,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,N,1,1,,BAO_0000218
8058,Rattus norvegicus,Intermediate,CHEMBL624259,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,N,1,1,,BAO_0000218
8059,Rattus norvegicus,Intermediate,CHEMBL624260,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,N,1,1,,BAO_0000218
8060,Rattus norvegicus,Intermediate,CHEMBL624430,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,N,1,1,,BAO_0000218
8061,Rattus norvegicus,Intermediate,CHEMBL624431,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,N,1,1,,BAO_0000218
8062,Rattus norvegicus,Intermediate,CHEMBL624432,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,N,1,1,,BAO_0000218
8063,Rattus norvegicus,Intermediate,CHEMBL624433,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,N,1,1,,BAO_0000218
8064,Rattus norvegicus,Intermediate,CHEMBL624434,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,N,1,1,,BAO_0000218
8065,Rattus norvegicus,Intermediate,CHEMBL624435,,,50597,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,N,1,1,,BAO_0000218
8066,Mus musculus,Intermediate,CHEMBL618570,,,50594,,A,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,N,1,1,,BAO_0000218
8067,Mus musculus,Intermediate,CHEMBL618571,,,50594,,A,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,1,1,,BAO_0000218
8068,Mus musculus,Intermediate,CHEMBL618572,,,50594,,A,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,N,1,1,,BAO_0000218
8069,Mus musculus,Intermediate,CHEMBL618573,,,50594,,A,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,1,1,,BAO_0000218
8070,Mus musculus,Intermediate,CHEMBL619267,,,50594,,A,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,N,1,1,,BAO_0000218
8071,Mus musculus,Intermediate,CHEMBL619431,,,50594,,A,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,1,1,,BAO_0000218
8072,Mus musculus,Intermediate,CHEMBL619432,,,50594,,A,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,N,1,1,,BAO_0000218
8073,Mus musculus,Intermediate,CHEMBL619433,,,50594,,A,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,1,1,,BAO_0000218
8074,,Autocuration,CHEMBL619434,,,22224,1969.0,A,,AUC in mice after oral dose (50 mg/kg),,U,0,1,,BAO_0000218
8075,Mus musculus,Intermediate,CHEMBL619435,,,50594,1977.0,A,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,N,1,1,,BAO_0000218
8076,,Autocuration,CHEMBL619436,,,22224,1969.0,A,,AUC (0-4 hr) ug/ml/h,,U,0,1,,BAO_0000019
8077,Rattus norvegicus,Intermediate,CHEMBL619437,,,50597,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,N,1,1,,BAO_0000218
8078,,Autocuration,CHEMBL619438,,,22224,,A,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,U,0,1,,BAO_0000218
8079,Mus musculus,Intermediate,CHEMBL619439,,,50594,,A,,Compound was evaluated for Area under curve in mice,,N,1,1,,BAO_0000218
8080,Rattus norvegicus,Intermediate,CHEMBL619440,,,50597,,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,1,1,,BAO_0000218
8081,,Autocuration,CHEMBL619441,,,22224,,F,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,U,0,1,,BAO_0000218
8082,Rattus norvegicus,Intermediate,CHEMBL619442,,,50597,,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,1,1,,BAO_0000218
8083,,Autocuration,CHEMBL875156,,,22224,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,U,0,1,,BAO_0000019
8084,,Autocuration,CHEMBL619443,,,22224,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,U,0,1,,BAO_0000019
8085,,Autocuration,CHEMBL619444,,,22224,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,U,0,1,,BAO_0000019
8086,,Autocuration,CHEMBL623464,,,22224,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,U,0,1,,BAO_0000019
8087,Mus musculus,Intermediate,CHEMBL623465,,,50594,,A,,Compound was evaluated for area under curve when administered through oral route in mouse,,N,1,1,,BAO_0000218
8088,Rattus norvegicus,Intermediate,CHEMBL623466,,,50597,,A,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,N,1,1,,BAO_0000218
8089,Rattus norvegicus,Intermediate,CHEMBL623467,,,50597,,A,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,N,1,1,,BAO_0000218
8090,Rattus norvegicus,Intermediate,CHEMBL623468,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8091,Rattus norvegicus,Intermediate,CHEMBL622660,,,50597,,A,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,1,1,,BAO_0000218
8092,Rattus norvegicus,Intermediate,CHEMBL622661,,,50597,,A,,Plasma clearance rate in Sprague-Dawley rats,,N,1,1,,BAO_0000218
8093,Rattus norvegicus,Intermediate,CHEMBL622662,,,50597,,F,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
8094,Rattus norvegicus,Intermediate,CHEMBL622663,,,50597,,A,,Pharmacokinetic property (total body clearance) in rat,,N,1,1,,BAO_0000218
8095,Rattus norvegicus,Intermediate,CHEMBL622664,,,50597,,A,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,N,1,1,,BAO_0000218
8096,Rattus norvegicus,Intermediate,CHEMBL622665,,,50597,,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
8097,Rattus norvegicus,Intermediate,CHEMBL622666,,,50597,,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
8098,Rattus norvegicus,Intermediate,CHEMBL621615,,,50597,,A,,Cl in rat i.v. at 2 mg/kg concentration,,N,1,1,,BAO_0000218
8099,Rattus norvegicus,Intermediate,CHEMBL621616,,,50597,,A,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
8100,Rattus norvegicus,Intermediate,CHEMBL621617,,,50597,,A,,Clearance was determined,,N,1,1,,BAO_0000218
8101,Rattus norvegicus,Intermediate,CHEMBL621618,,,50597,,A,,Clearance by intravenous administration of 3.4 mg/kg in rat,,N,1,1,,BAO_0000218
8102,Rattus norvegicus,Intermediate,CHEMBL621619,,,50597,,A,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
8103,Rattus norvegicus,Intermediate,CHEMBL621620,,,50597,,A,,Clearance rate after i.v. administration in rats,,N,1,1,,BAO_0000218
8104,Rattus norvegicus,Intermediate,CHEMBL621786,,,50597,,A,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
8105,Rattus norvegicus,Intermediate,CHEMBL621787,,,50597,,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,1,1,,BAO_0000218
8106,Rattus norvegicus,Intermediate,CHEMBL621788,,,50597,,A,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,N,1,1,,BAO_0000218
8107,Rattus norvegicus,Intermediate,CHEMBL621789,,,50597,,A,,Clearance (Cl) after oral administration in rat,,N,1,1,,BAO_0000218
8108,Rattus norvegicus,Intermediate,CHEMBL621790,,,50597,,A,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,N,1,1,,BAO_0000218
8109,Rattus norvegicus,Intermediate,CHEMBL621791,,,50597,1969.0,A,,Compound was tested for plasma clearance in rat,,N,1,1,,BAO_0000218
8110,Rattus norvegicus,Intermediate,CHEMBL621792,,,50597,,A,,In vitro microsome metabolism clearance in rat was determined,Microsomes,N,1,1,,BAO_0000218
8111,Rattus norvegicus,Intermediate,CHEMBL621793,,,50597,,A,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,N,1,1,,BAO_0000218
8112,Rattus norvegicus,Intermediate,CHEMBL621794,,,50597,,A,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8113,Rattus norvegicus,Intermediate,CHEMBL621795,,,50597,1969.0,A,,In vivo plasma clearance was determined,,N,1,1,,BAO_0000218
8114,Rattus norvegicus,Intermediate,CHEMBL621796,,,50597,,A,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,N,1,1,,BAO_0000218
8115,Rattus norvegicus,Intermediate,CHEMBL621797,401.0,,50597,2107.0,A,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,N,1,1,,BAO_0000218
8116,Rattus norvegicus,Intermediate,CHEMBL621798,,,50597,,A,,Pharmacokinetic property (Plasma clearance) was measured in rat,,N,1,1,,BAO_0000218
8117,Rattus norvegicus,Intermediate,CHEMBL621799,,,50597,,A,,Pharmacokinetic property (clearance) in rat i.v.,,N,1,1,,BAO_0000218
8118,Rattus norvegicus,Intermediate,CHEMBL621800,,,50597,,A,,"Plasma Clearance was evaluated in rats, iv",,N,1,1,,BAO_0000218
8119,Rattus norvegicus,Intermediate,CHEMBL621801,,,50597,,A,,Plasma clearance (in vivo) in rats was determined,,N,1,1,,BAO_0000218
8120,Rattus norvegicus,Intermediate,CHEMBL621802,,,50597,,A,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,N,1,1,,BAO_0000218
8121,Rattus norvegicus,Intermediate,CHEMBL618596,,,50597,,A,,Plasma clearance was determined,,N,1,1,,BAO_0000218
8122,Rattus norvegicus,Intermediate,CHEMBL618597,,,50597,,A,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,N,1,1,,BAO_0000218
8123,Rattus norvegicus,Intermediate,CHEMBL618598,,,50597,,A,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,N,1,1,,BAO_0000218
8124,Rattus norvegicus,Intermediate,CHEMBL618599,,,50597,,A,,Plasma clearance in rats,,N,1,1,,BAO_0000218
8125,Rattus norvegicus,Intermediate,CHEMBL618600,,,50597,,A,,Plasma clearance rate determined in rat,,N,1,1,,BAO_0000218
8126,Rattus norvegicus,Intermediate,CHEMBL618601,,,50597,,A,,Plasma clearance was determined in rat,,N,1,1,,BAO_0000218
8127,Rattus norvegicus,Intermediate,CHEMBL618602,,,50597,,A,,Plasma clearance was determined,,N,1,1,,BAO_0000218
8128,Rattus norvegicus,Intermediate,CHEMBL618603,,,50597,,A,,Plasma clearance value in rat,,N,1,1,,BAO_0000218
8129,Rattus norvegicus,Intermediate,CHEMBL618604,,,50597,2107.0,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,1,1,,BAO_0000218
8130,Rattus norvegicus,Intermediate,CHEMBL618605,,,50597,,A,,Clearance in rat,,N,1,1,,BAO_0000218
8131,Rattus norvegicus,Intermediate,CHEMBL618606,,,50597,,A,,Total body clearance in rat i.v. at 2 mg/kg concentration,,N,1,1,,BAO_0000218
8132,Rattus norvegicus,Intermediate,CHEMBL618607,,,50597,,A,,Clearance of compound in rats after intravenous administration,,N,1,1,,BAO_0000218
8133,Rattus norvegicus,Intermediate,CHEMBL618608,,,50597,,A,,Clearance after iv administration to rats,,N,1,1,,BAO_0000218
8134,Rattus norvegicus,Intermediate,CHEMBL618609,,,50597,,A,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,1,1,,BAO_0000218
8135,Rattus norvegicus,Intermediate,CHEMBL618610,,,50597,,A,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,1,1,,BAO_0000218
8136,Rattus norvegicus,Intermediate,CHEMBL618611,,,50597,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,N,1,1,,BAO_0000218
8137,Rattus norvegicus,Intermediate,CHEMBL618612,,,50597,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,1,1,,BAO_0000218
8138,Rattus norvegicus,Intermediate,CHEMBL618613,,,50597,,A,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,1,1,,BAO_0000218
8139,Rattus norvegicus,Intermediate,CHEMBL621076,,,50597,,A,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,1,1,,BAO_0000218
8140,Rattus norvegicus,Intermediate,CHEMBL621077,,,50597,,A,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,1,1,,BAO_0000218
8141,Rattus norvegicus,Intermediate,CHEMBL621078,,,50597,,A,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,N,1,1,,BAO_0000218
8142,Rattus norvegicus,Intermediate,CHEMBL621251,,,50597,,A,,Clearance in rat,,N,1,1,,BAO_0000218
8143,Rattus norvegicus,Intermediate,CHEMBL621252,,,50597,,A,,Clearance in rat after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
8144,Rattus norvegicus,Intermediate,CHEMBL621253,,,50597,,A,,Clearance in rat.,,N,1,1,,BAO_0000218
8145,Rattus norvegicus,Intermediate,CHEMBL621254,,,50597,,A,,Clearance rate following an oral dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
8146,Rattus norvegicus,Intermediate,CHEMBL621255,,,50597,,A,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,N,1,1,,BAO_0000218
8147,Rattus norvegicus,Intermediate,CHEMBL621256,,,50597,1969.0,A,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,N,1,1,,BAO_0000218
8148,Rattus norvegicus,Intermediate,CHEMBL621257,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,N,1,1,,BAO_0000218
8149,Rattus norvegicus,Intermediate,CHEMBL621258,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,N,1,1,,BAO_0000218
8150,Rattus norvegicus,Intermediate,CHEMBL621259,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,N,1,1,,BAO_0000218
8151,Rattus norvegicus,Intermediate,CHEMBL621260,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,N,1,1,,BAO_0000218
8152,Rattus norvegicus,Intermediate,CHEMBL876494,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,N,1,1,,BAO_0000218
8153,Rattus norvegicus,Intermediate,CHEMBL621261,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,N,1,1,,BAO_0000218
8154,Rattus norvegicus,Intermediate,CHEMBL621262,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,N,1,1,,BAO_0000218
8155,Rattus norvegicus,Intermediate,CHEMBL621263,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,1,1,,BAO_0000218
8156,Rattus norvegicus,Intermediate,CHEMBL621264,,,50597,2107.0,A,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
8157,Rattus norvegicus,Intermediate,CHEMBL621265,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
8158,Rattus norvegicus,Intermediate,CHEMBL621266,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,N,1,1,,BAO_0000218
8159,Rattus norvegicus,Intermediate,CHEMBL621267,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,N,1,1,,BAO_0000218
8160,Rattus norvegicus,Intermediate,CHEMBL621268,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
8161,Rattus norvegicus,Intermediate,CHEMBL621269,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,N,1,1,,BAO_0000218
8162,Rattus norvegicus,Intermediate,CHEMBL621270,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,N,1,1,,BAO_0000218
8163,Rattus norvegicus,Intermediate,CHEMBL621271,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,N,1,1,,BAO_0000218
8164,Rattus norvegicus,Intermediate,CHEMBL621272,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,N,1,1,,BAO_0000218
8165,Rattus norvegicus,Intermediate,CHEMBL621273,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,N,1,1,,BAO_0000218
8166,Rattus norvegicus,Intermediate,CHEMBL621274,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,N,1,1,,BAO_0000218
8167,Rattus norvegicus,Intermediate,CHEMBL876495,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,N,1,1,,BAO_0000218
8168,Rattus norvegicus,Intermediate,CHEMBL621275,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,N,1,1,,BAO_0000218
8169,Rattus norvegicus,Intermediate,CHEMBL621276,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
8170,Rattus norvegicus,Intermediate,CHEMBL621277,,,50597,2385.0,A,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
8171,Rattus norvegicus,Intermediate,CHEMBL621278,,,50597,160.0,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
8172,Rattus norvegicus,Intermediate,CHEMBL621279,,,50597,160.0,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,N,1,1,,BAO_0000218
8173,Rattus norvegicus,Intermediate,CHEMBL621280,,,50597,160.0,A,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,N,1,1,,BAO_0000218
8174,Rattus norvegicus,Intermediate,CHEMBL621281,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,N,1,1,,BAO_0000218
8175,Rattus norvegicus,Intermediate,CHEMBL621282,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,N,1,1,,BAO_0000218
8176,Rattus norvegicus,Intermediate,CHEMBL621283,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,1,1,,BAO_0000218
8177,Rattus norvegicus,Intermediate,CHEMBL621284,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,N,1,1,,BAO_0000218
8178,Rattus norvegicus,Intermediate,CHEMBL621285,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,N,1,1,,BAO_0000218
8179,Rattus norvegicus,Intermediate,CHEMBL621286,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
8180,Rattus norvegicus,Intermediate,CHEMBL623220,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,N,1,1,,BAO_0000218
8181,Rattus norvegicus,Intermediate,CHEMBL623221,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,N,1,1,,BAO_0000218
8182,Rattus norvegicus,Intermediate,CHEMBL876029,,,50597,2106.0,A,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,N,1,1,,BAO_0000218
8183,Rattus norvegicus,Intermediate,CHEMBL623222,,,50597,945.0,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,N,1,1,,BAO_0000218
8184,Rattus norvegicus,Intermediate,CHEMBL623223,,,50597,945.0,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,N,1,1,,BAO_0000218
8185,Rattus norvegicus,Intermediate,CHEMBL621445,,,50597,945.0,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,N,1,1,,BAO_0000218
8186,Rattus norvegicus,Intermediate,CHEMBL621446,,,50597,178.0,A,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8187,Rattus norvegicus,Intermediate,CHEMBL621447,,,50597,178.0,A,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8188,Rattus norvegicus,Intermediate,CHEMBL619681,,,50597,178.0,A,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8189,Rattus norvegicus,Intermediate,CHEMBL619682,,,50597,178.0,A,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8190,Rattus norvegicus,Intermediate,CHEMBL619683,,,50597,178.0,A,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8191,Rattus norvegicus,Intermediate,CHEMBL619684,,,50597,955.0,A,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8192,Rattus norvegicus,Intermediate,CHEMBL619685,,,50597,955.0,A,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8193,Rattus norvegicus,Intermediate,CHEMBL619686,,,50597,955.0,A,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8194,Rattus norvegicus,Intermediate,CHEMBL619687,,,50597,955.0,A,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8195,Rattus norvegicus,Intermediate,CHEMBL619688,,,50597,955.0,A,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8196,Rattus norvegicus,Intermediate,CHEMBL619689,,,50597,948.0,A,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8197,Rattus norvegicus,Intermediate,CHEMBL619690,,,50597,948.0,A,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8198,Rattus norvegicus,Intermediate,CHEMBL619691,,,50597,948.0,A,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8199,Rattus norvegicus,Intermediate,CHEMBL619692,,,50597,,A,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
8200,Rattus norvegicus,Expert,CHEMBL619693,,,50597,,A,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
8201,Rattus norvegicus,Intermediate,CHEMBL619694,,,50597,,A,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,N,1,1,,BAO_0000218
8202,Rattus norvegicus,Intermediate,CHEMBL619695,,,50597,,A,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,N,1,1,,BAO_0000218
8203,Rattus norvegicus,Intermediate,CHEMBL619696,,,50597,,A,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,N,1,1,,BAO_0000218
8204,Rattus norvegicus,Intermediate,CHEMBL619697,,,50597,,A,,Compound was evaluated for volume of distribution in rat,,N,1,1,,BAO_0000218
8205,Rattus norvegicus,Intermediate,CHEMBL619698,,,50597,,A,,Steady state volume distribution was determined; steady state(ss),,N,1,1,,BAO_0000218
8206,Rattus norvegicus,Intermediate,CHEMBL619699,,,50597,,A,,Steady state volume of distribution after iv administration to rats,,N,1,1,,BAO_0000218
8207,Rattus norvegicus,Intermediate,CHEMBL619700,,,50597,,A,,Steady state volume of distribution dosing at 3 mg/kg iv,,N,1,1,,BAO_0000218
8208,Rattus norvegicus,Intermediate,CHEMBL619701,,,50597,,A,,The compound was evaluated for volume of distribution in rat,,N,1,1,,BAO_0000218
8209,Rattus norvegicus,Intermediate,CHEMBL619702,,,50597,,A,,The compound was tested for volume of distribution in rat,,N,1,1,,BAO_0000218
8210,Rattus norvegicus,Intermediate,CHEMBL620335,,,50597,,A,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,N,1,1,,BAO_0000218
8211,Rattus norvegicus,Intermediate,CHEMBL620336,,,50597,,A,,Volume distribution (VD) after oral administration in rat,,N,1,1,,BAO_0000218
8212,Rattus norvegicus,Intermediate,CHEMBL620337,,,50597,,A,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,1,1,,BAO_0000218
8213,Rattus norvegicus,Intermediate,CHEMBL620520,,,50597,,A,,Volume distribution in rat,,N,1,1,,BAO_0000218
8214,Rattus norvegicus,Intermediate,CHEMBL620521,,,50597,,A,,Volume distribution in rat,,N,1,1,,BAO_0000218
8215,Rattus norvegicus,Intermediate,CHEMBL875825,,,50597,,A,,Volume distribution in rat after peroral administration at 10 mg/kg,,N,1,1,,BAO_0000218
8216,Rattus norvegicus,Intermediate,CHEMBL620522,,,50597,,A,,Volume distribution in rat after peroral administration at 5 mg/kg,,N,1,1,,BAO_0000218
8217,Rattus norvegicus,Intermediate,CHEMBL620523,,,50597,,A,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
8218,Rattus norvegicus,Intermediate,CHEMBL620524,,,50597,,A,,Volume of distribution in rat.,,N,1,1,,BAO_0000218
8219,Rattus norvegicus,Intermediate,CHEMBL620525,,,50597,,A,,Volume of distribution in rat,,N,1,1,,BAO_0000218
8220,Rattus norvegicus,Intermediate,CHEMBL620526,,,50597,,A,,Volume of distribution in rat,,N,1,1,,BAO_0000218
8221,Rattus norvegicus,Intermediate,CHEMBL620527,,,50597,,A,,Volume of distribution in rat by iv administration,,N,1,1,,BAO_0000218
8222,Rattus norvegicus,Intermediate,CHEMBL620528,,,50597,,A,,Volume of distribution in rats,,N,1,1,,BAO_0000218
8223,Rattus norvegicus,Intermediate,CHEMBL620529,,,50597,,A,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,1,1,,BAO_0000218
8224,Rattus norvegicus,Intermediate,CHEMBL620530,,,50597,,A,,Volume distribution at the dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
8225,Rattus norvegicus,Intermediate,CHEMBL620531,,,50597,,A,,Steady state volume of distribution was determined,,N,1,1,,BAO_0000218
8226,Macaca mulatta,Intermediate,CHEMBL620532,,,22224,,A,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,0,1,,BAO_0000218
8227,Rattus norvegicus,Intermediate,CHEMBL620533,,,22224,,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,U,0,1,,BAO_0000218
8228,Rattus norvegicus,Intermediate,CHEMBL620534,,,22224,,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,U,0,1,,BAO_0000218
8229,Rattus norvegicus,Intermediate,CHEMBL620535,,,50597,,A,,Mean (%CV) PK parameters for Vdss(mL/kg).,,N,1,1,,BAO_0000218
8230,Rattus norvegicus,Intermediate,CHEMBL875826,,,50597,,A,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
8231,Rattus norvegicus,Intermediate,CHEMBL620536,,,50597,,A,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
8232,Rattus norvegicus,Intermediate,CHEMBL620537,,,50597,,A,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8233,Rattus norvegicus,Intermediate,CHEMBL618526,,,50597,,A,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,N,1,1,,BAO_0000218
8234,Rattus norvegicus,Intermediate,CHEMBL618527,,,50597,,A,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,N,1,1,,BAO_0000218
8235,Rattus norvegicus,Intermediate,CHEMBL618528,,,50597,,A,,Pharmacokinetic property (Vdss) in rat,,N,1,1,,BAO_0000218
8236,Rattus norvegicus,Intermediate,CHEMBL618529,,,50597,,A,,Pharmacokinetic property (vdss) was measured in rat,,N,1,1,,BAO_0000218
8237,Rattus norvegicus,Intermediate,CHEMBL618530,,,50597,,A,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
8238,Rattus norvegicus,Intermediate,CHEMBL618531,,,50597,,A,,Volume of distribution in rat,,N,1,1,,BAO_0000218
8239,Rattus norvegicus,Intermediate,CHEMBL618532,,,50597,,A,,The pharmacokinetic parameter volume of distribution in vivo in rats,,N,1,1,,BAO_0000218
8240,Rattus norvegicus,Intermediate,CHEMBL618533,,,50597,,F,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
8241,Rattus norvegicus,Intermediate,CHEMBL618534,,,50597,,A,,Vdss in rat i.v. at 2 mg/kg concentration,,N,1,1,,BAO_0000218
8242,Rattus norvegicus,Intermediate,CHEMBL618535,,,50597,,A,,Volume distribution after intravenous administration (1 mg/kg) in rat,,N,1,1,,BAO_0000218
8243,Rattus norvegicus,Intermediate,CHEMBL618536,,,50597,,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,1,1,,BAO_0000218
8244,Rattus norvegicus,Intermediate,CHEMBL618537,,,50597,,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,1,1,,BAO_0000218
8245,Rattus norvegicus,Intermediate,CHEMBL618538,,,50597,,A,,Volume distribution at a dose of 10 uM/kg in rat was determined,,N,1,1,,BAO_0000218
8246,Rattus norvegicus,Intermediate,CHEMBL618539,,,50597,,A,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,1,1,,BAO_0000218
8247,Rattus norvegicus,Intermediate,CHEMBL618540,,,50597,,A,,Volume distribution was calculated in rat,,N,1,1,,BAO_0000218
8248,Rattus norvegicus,Intermediate,CHEMBL618541,,,50597,,A,,Volume distribution was determined,,N,1,1,,BAO_0000218
8249,Rattus norvegicus,Intermediate,CHEMBL618542,,,50597,,A,,Volume of distribution after intravenous administration was evaluated in rat,,N,1,1,,BAO_0000218
8250,Rattus norvegicus,Intermediate,CHEMBL622544,,,50597,,A,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,1,1,,BAO_0000218
8251,Rattus norvegicus,Intermediate,CHEMBL622545,,,50597,,A,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,N,1,1,,BAO_0000218
8252,Rattus norvegicus,Intermediate,CHEMBL622546,,,50597,,A,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,1,1,,BAO_0000218
8253,Rattus norvegicus,Intermediate,CHEMBL622547,,,50597,,A,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,N,1,1,,BAO_0000218
8254,Rattus norvegicus,Intermediate,CHEMBL622548,,,50597,,A,,Volume of distribution in steady state was determined in rat,,N,1,1,,BAO_0000218
8255,Rattus norvegicus,Intermediate,CHEMBL622549,,,50597,,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,N,1,1,,BAO_0000218
8256,Rattus norvegicus,Intermediate,CHEMBL622550,,,50597,,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,1,1,,BAO_0000218
8257,Mus musculus,Intermediate,CHEMBL622551,,,50594,,A,,Compound was evaluated for area under curve when administered through oral route to mouse,,N,1,1,,BAO_0000218
8258,Rattus norvegicus,Intermediate,CHEMBL622552,,,50597,,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,1,1,,BAO_0000218
8259,Rattus norvegicus,Intermediate,CHEMBL622553,,,50597,,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,1,1,,BAO_0000218
8260,,Autocuration,CHEMBL622554,,,22224,,F,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,U,0,1,,BAO_0000218
8261,Canis lupus familiaris,Intermediate,CHEMBL622555,,,50588,,A,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,N,1,1,,BAO_0000218
8262,Mus musculus,Intermediate,CHEMBL622556,,,50594,,A,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,N,1,1,,BAO_0000218
8263,Mus musculus,Intermediate,CHEMBL622557,,,50594,,A,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,N,1,1,,BAO_0000218
8264,Mus musculus,Intermediate,CHEMBL622558,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,N,1,1,,BAO_0000218
8265,Mus musculus,Intermediate,CHEMBL622559,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,N,1,1,,BAO_0000218
8266,Canis lupus familiaris,Intermediate,CHEMBL622560,,,50588,,A,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,N,1,1,,BAO_0000218
8267,Rattus norvegicus,Intermediate,CHEMBL622561,,,50597,,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,1,1,,BAO_0000218
8268,Rattus norvegicus,Intermediate,CHEMBL622562,,,50597,,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,N,1,1,,BAO_0000218
8269,Rattus norvegicus,Intermediate,CHEMBL622563,,,50597,,A,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,1,1,,BAO_0000218
8270,,Autocuration,CHEMBL622564,,,22224,,A,,Concentration of compound in Central nervous system,,U,0,1,,BAO_0000019
8271,,Autocuration,CHEMBL622565,,,22224,,A,,Concentration of compound in Central nervous system; Not detectable,,U,0,1,,BAO_0000019
8272,Mus musculus,Intermediate,CHEMBL622566,,,50594,,A,,"Concentration of diester in the blood, following oral administration in mice",,N,1,1,,BAO_0000218
8273,Mus musculus,Intermediate,CHEMBL624515,,,50594,,A,,"Concentration of monoester in the blood, following oral administration in mice",,N,1,1,,BAO_0000218
8274,Mus musculus,Intermediate,CHEMBL624516,,,50594,,A,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,N,1,1,,BAO_0000218
8275,,Autocuration,CHEMBL624517,,,22224,,A,,Evaluated for Pharmacokinetic property: Area under the curve,,U,0,1,,BAO_0000019
8276,Mus musculus,Intermediate,CHEMBL624518,,,50594,,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,N,1,1,,BAO_0000218
8277,Macaca fascicularis,Intermediate,CHEMBL624519,,,100710,,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,N,1,1,,BAO_0000218
8278,Macaca fascicularis,Intermediate,CHEMBL624520,,,100710,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8279,Macaca fascicularis,Intermediate,CHEMBL624521,,,100710,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8280,Macaca fascicularis,Intermediate,CHEMBL624522,,,100710,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8281,Macaca fascicularis,Intermediate,CHEMBL624523,,,100710,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8282,Macaca fascicularis,Intermediate,CHEMBL624409,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,1,1,,BAO_0000218
8283,Macaca fascicularis,Intermediate,CHEMBL624410,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,N,1,1,,BAO_0000218
8284,Macaca fascicularis,Intermediate,CHEMBL624411,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,1,1,,BAO_0000218
8285,Macaca fascicularis,Intermediate,CHEMBL623531,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,N,1,1,,BAO_0000218
8286,Macaca fascicularis,Intermediate,CHEMBL623532,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,N,1,1,,BAO_0000218
8287,Macaca fascicularis,Intermediate,CHEMBL623533,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,N,1,1,,BAO_0000218
8288,Macaca fascicularis,Intermediate,CHEMBL623534,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,1,1,,BAO_0000218
8289,Mus musculus,Intermediate,CHEMBL623535,,,50594,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8290,Mus musculus,Intermediate,CHEMBL623536,,,50594,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8291,Mus musculus,Intermediate,CHEMBL623537,,,50594,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8292,Mus musculus,Intermediate,CHEMBL623538,,,50594,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8293,Mus musculus,Intermediate,CHEMBL623539,,,50594,,A,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8294,Mus musculus,Intermediate,CHEMBL623540,,,50594,,A,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,N,1,1,,BAO_0000218
8295,Mus musculus,Intermediate,CHEMBL623541,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,N,1,1,,BAO_0000218
8296,Mus musculus,Intermediate,CHEMBL623542,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,N,1,1,,BAO_0000218
8297,Mus musculus,Intermediate,CHEMBL623543,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,N,1,1,,BAO_0000218
8298,Mus musculus,Intermediate,CHEMBL623544,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,N,1,1,,BAO_0000218
8299,Mus musculus,Intermediate,CHEMBL623545,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,N,1,1,,BAO_0000218
8300,Mus musculus,Intermediate,CHEMBL623546,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,N,1,1,,BAO_0000218
8301,Rattus norvegicus,Intermediate,CHEMBL623547,,,50597,1969.0,A,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
8302,Rattus norvegicus,Intermediate,CHEMBL623548,,,50597,,A,,High i.v. clearance in Dawley rats,,N,1,1,,BAO_0000218
8303,Rattus norvegicus,Intermediate,CHEMBL623549,,,50597,2107.0,A,,In vitro clearance in rat liver microsomes,Microsomes,N,1,1,,BAO_0000218
8304,Rattus norvegicus,Intermediate,CHEMBL623550,,,50597,2107.0,A,,Intrinsic clearance in rat liver microsomes was determined,Microsomes,N,1,1,,BAO_0000218
8305,Rattus norvegicus,Intermediate,CHEMBL875276,401.0,,50597,2107.0,A,,Intrinsic clearance in rat hepatocytes was determined,,N,1,1,,BAO_0000218
8306,Rattus norvegicus,Intermediate,CHEMBL621872,,,50597,,A,,Plasma Clearance was determined,,N,1,1,,BAO_0000218
8307,Rattus norvegicus,Intermediate,CHEMBL621873,,,50597,,A,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,N,1,1,,BAO_0000218
8308,Rattus norvegicus,Intermediate,CHEMBL621874,,,50597,,A,,Plasma clearance in rat.,,N,1,1,,BAO_0000218
8309,Rattus norvegicus,Intermediate,CHEMBL621875,,,50597,,A,,Plasma clearance in rats,,N,1,1,,BAO_0000218
8310,Rattus norvegicus,Intermediate,CHEMBL621876,,,50597,,A,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,N,1,1,,BAO_0000218
8311,Rattus norvegicus,Intermediate,CHEMBL621877,,,50597,,A,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,N,1,1,,BAO_0000218
8312,Rattus norvegicus,Intermediate,CHEMBL621878,,,50597,,A,,Plasma clearance was measured in rat,,N,1,1,,BAO_0000218
8313,Rattus norvegicus,Intermediate,CHEMBL621879,,,50597,,A,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,1,1,,BAO_0000218
8314,Rattus norvegicus,Intermediate,CHEMBL621880,,,50597,1969.0,A,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,N,1,1,,BAO_0000218
8315,Rattus norvegicus,Intermediate,CHEMBL621881,,,50597,,A,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,N,1,1,,BAO_0000218
8316,Rattus norvegicus,Intermediate,CHEMBL621882,,,50597,,A,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,1,1,,BAO_0000218
8317,Rattus norvegicus,Intermediate,CHEMBL875283,,,50597,,A,,Total clearance at 1 mg/kg was determined in rat,,N,1,1,,BAO_0000218
8318,Rattus norvegicus,Intermediate,CHEMBL621883,,,50597,,A,,Total clearance at 10 mg/kg was determined in rat,,N,1,1,,BAO_0000218
8319,Rattus norvegicus,Intermediate,CHEMBL621884,,,50597,,A,,Clearance in rat,,N,1,1,,BAO_0000218
8320,Rattus norvegicus,Intermediate,CHEMBL621885,,,50597,,A,,Plasma clearance rate determined in rats,,N,1,1,,BAO_0000218
8321,Rattus norvegicus,Intermediate,CHEMBL621886,,,50597,,A,,Clearance of compound in rat was evaluated,,N,1,1,,BAO_0000218
8322,Rattus norvegicus,Intermediate,CHEMBL621887,,,50597,1969.0,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,1,1,,BAO_0000218
8323,Rattus norvegicus,Intermediate,CHEMBL621888,,,50597,,A,,Pharmacokinetic property (blood clearance) in rat,,N,1,1,,BAO_0000218
8324,Rattus norvegicus,Intermediate,CHEMBL621889,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8325,Rattus norvegicus,Intermediate,CHEMBL621890,,,50597,,A,,Plasma clearance in rats,,N,1,1,,BAO_0000218
8326,Rattus norvegicus,Intermediate,CHEMBL621891,,,50597,2107.0,A,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,N,1,1,,BAO_0000218
8327,Rattus norvegicus,Intermediate,CHEMBL621892,,,50597,,A,,Clearance in Dawley rat,,N,1,1,,BAO_0000218
8328,Rattus norvegicus,Intermediate,CHEMBL621893,,,50597,,A,,Clearance rat,,N,1,1,,BAO_0000218
8329,Rattus norvegicus,Intermediate,CHEMBL621894,,,50597,,A,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,N,1,1,,BAO_0000218
8330,Rattus norvegicus,Intermediate,CHEMBL621895,,,50597,,A,,Clearance rat; Not determined,,N,1,1,,BAO_0000218
8331,Rattus norvegicus,Intermediate,CHEMBL875284,,,50597,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,N,1,1,,BAO_0000218
8332,Rattus norvegicus,Intermediate,CHEMBL618699,,,50597,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,1,1,,BAO_0000218
8333,Rattus norvegicus,Intermediate,CHEMBL618700,,,50597,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,1,1,,BAO_0000218
8334,Rattus norvegicus,Intermediate,CHEMBL618701,,,50597,,A,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,1,1,,BAO_0000218
8335,Rattus norvegicus,Intermediate,CHEMBL876600,,,50597,1969.0,A,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,1,1,,BAO_0000218
8336,Rattus norvegicus,Intermediate,CHEMBL618702,,,50597,,A,,Clearance of compound in rat after 1 mg/kg i.v. administration,,N,1,1,,BAO_0000218
8337,Rattus norvegicus,Intermediate,CHEMBL618703,,,50597,,A,,Compound was evaluated for Hepatic clearance in rat,,N,1,1,,BAO_0000218
8338,Rattus norvegicus,Intermediate,CHEMBL618704,,,50597,,A,,In vivo clearance after 5 mg/kg dose,,N,1,1,,BAO_0000218
8339,Rattus norvegicus,Intermediate,CHEMBL618705,,,50597,1969.0,A,,Compound was tested for plasma clearance in rats,,N,1,1,,BAO_0000218
8340,Rattus norvegicus,Intermediate,CHEMBL618706,,,50597,,A,,Hepatic clearance after intravenous administration was evaluated in rat,,N,1,1,,BAO_0000218
8341,Rattus norvegicus,Intermediate,CHEMBL618707,,,50597,,A,,Lower clearance in rat (i.v.) at 0.5 mpk,,N,1,1,,BAO_0000218
8342,Rattus norvegicus,Intermediate,CHEMBL618708,,,50597,1969.0,A,,Pharmacokinetic parameter expressed as plasma clearance in rat,,N,1,1,,BAO_0000218
8343,Rattus norvegicus,Intermediate,CHEMBL618709,,,50597,,A,,Pharmacokinetic property (Clp) in rat,,N,1,1,,BAO_0000218
8344,Rattus norvegicus,Intermediate,CHEMBL618710,,,50597,,A,,Plasma clearance in Sprague-Dawley rats,,N,1,1,,BAO_0000218
8345,Rattus norvegicus,Intermediate,CHEMBL618711,,,50597,,A,,Plasma clearance (Clp) in rat,,N,1,1,,BAO_0000218
8346,Rattus norvegicus,Intermediate,CHEMBL618712,,,50597,,A,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
8347,Rattus norvegicus,Intermediate,CHEMBL618713,,,50597,,A,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,N,1,1,,BAO_0000218
8348,Rattus norvegicus,Intermediate,CHEMBL618714,,,50597,,A,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
8349,Rattus norvegicus,Intermediate,CHEMBL618715,,,50597,,A,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,1,1,,BAO_0000218
8350,Rattus norvegicus,Intermediate,CHEMBL618716,,,50597,,A,,Plasma clearance in rat was determined,,N,1,1,,BAO_0000218
8351,Rattus norvegicus,Intermediate,CHEMBL876601,,,50597,,A,,Plasma clearance measured in rat,,N,1,1,,BAO_0000218
8352,Rattus norvegicus,Intermediate,CHEMBL618717,,,50597,,A,,Plasma clearance was calculated in rat,,N,1,1,,BAO_0000218
8353,Rattus norvegicus,Intermediate,CHEMBL618718,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8354,Rattus norvegicus,Intermediate,CHEMBL618719,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8355,Rattus norvegicus,Intermediate,CHEMBL618720,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8356,Rattus norvegicus,Intermediate,CHEMBL618721,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8357,Rattus norvegicus,Intermediate,CHEMBL621477,,,50597,,A,,Plasma clearance in rats,,N,1,1,,BAO_0000218
8358,Rattus norvegicus,Intermediate,CHEMBL621478,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
8359,Rattus norvegicus,Intermediate,CHEMBL621479,,,50597,,A,,Plasma clearance was evaluated in rat,,N,1,1,,BAO_0000218
8360,Rattus norvegicus,Intermediate,CHEMBL621480,,,50597,,A,,Plasma clearance was evaluated in rat; Not tested,,N,1,1,,BAO_0000218
8361,Rattus norvegicus,Intermediate,CHEMBL621481,,,50597,,A,,Plasma clearance rate was determined for the compound in rat,,N,1,1,,BAO_0000218
8362,Rattus norvegicus,Intermediate,CHEMBL621482,,,50597,,A,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,N,1,1,,BAO_0000218
8363,Rattus norvegicus,Intermediate,CHEMBL621483,,,50597,,A,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,1,1,,BAO_0000218
8364,Rattus norvegicus,Intermediate,CHEMBL621484,,,50597,,A,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,N,1,1,,BAO_0000218
8365,Rattus norvegicus,Intermediate,CHEMBL621485,,,50597,948.0,A,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8366,Rattus norvegicus,Intermediate,CHEMBL621486,,,50597,948.0,A,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8367,Rattus norvegicus,Intermediate,CHEMBL621487,,,50597,160.0,A,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8368,Rattus norvegicus,Intermediate,CHEMBL621488,,,50597,160.0,A,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8369,Rattus norvegicus,Intermediate,CHEMBL621489,,,50597,160.0,A,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8370,Rattus norvegicus,Intermediate,CHEMBL621490,,,50597,160.0,A,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8371,Rattus norvegicus,Intermediate,CHEMBL621491,,,50597,160.0,A,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8372,Rattus norvegicus,Intermediate,CHEMBL621492,,,50597,2113.0,A,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8373,Rattus norvegicus,Intermediate,CHEMBL621493,,,50597,2113.0,A,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8374,Rattus norvegicus,Intermediate,CHEMBL621494,,,50597,2113.0,A,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8375,Rattus norvegicus,Intermediate,CHEMBL621495,,,50597,2113.0,A,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8376,Rattus norvegicus,Intermediate,CHEMBL621496,,,50597,2113.0,A,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8377,Rattus norvegicus,Intermediate,CHEMBL621497,,,50597,2107.0,A,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8378,Rattus norvegicus,Intermediate,CHEMBL621498,,,50597,2107.0,A,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8379,Rattus norvegicus,Intermediate,CHEMBL621499,,,50597,2107.0,A,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8380,Rattus norvegicus,Intermediate,CHEMBL618634,,,50597,2107.0,A,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8381,Rattus norvegicus,Intermediate,CHEMBL618635,,,50597,2107.0,A,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8382,Rattus norvegicus,Intermediate,CHEMBL618636,,,50597,2048.0,A,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8383,Rattus norvegicus,Intermediate,CHEMBL619737,,,50597,2048.0,A,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8384,Rattus norvegicus,Intermediate,CHEMBL619738,,,50597,2048.0,A,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8385,Rattus norvegicus,Intermediate,CHEMBL624329,,,50597,2048.0,A,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8386,Rattus norvegicus,Intermediate,CHEMBL624330,,,50597,2048.0,A,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8387,Rattus norvegicus,Intermediate,CHEMBL624331,,,50597,2385.0,A,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8388,Rattus norvegicus,Intermediate,CHEMBL624332,,,50597,2385.0,A,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8389,Rattus norvegicus,Intermediate,CHEMBL624333,,,50597,2385.0,A,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8390,Rattus norvegicus,Intermediate,CHEMBL624334,,,50597,2385.0,A,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8391,Rattus norvegicus,Intermediate,CHEMBL624335,,,50597,2385.0,A,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8392,Rattus norvegicus,Intermediate,CHEMBL620016,,,50597,2106.0,A,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8393,Rattus norvegicus,Intermediate,CHEMBL620169,,,50597,2106.0,A,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8394,Rattus norvegicus,Intermediate,CHEMBL620170,,,50597,2106.0,A,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8395,Rattus norvegicus,Intermediate,CHEMBL620171,,,50597,2106.0,A,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8396,Rattus norvegicus,Intermediate,CHEMBL620172,,,50597,2106.0,A,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8397,Rattus norvegicus,Intermediate,CHEMBL620173,,,50597,945.0,A,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8398,Rattus norvegicus,Intermediate,CHEMBL620174,,,50597,945.0,A,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8399,Rattus norvegicus,Intermediate,CHEMBL620175,,,50597,945.0,A,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8400,Rattus norvegicus,Intermediate,CHEMBL620176,,,50597,945.0,A,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8401,Rattus norvegicus,Intermediate,CHEMBL620177,,,50597,945.0,A,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8402,Rattus norvegicus,Intermediate,CHEMBL620178,,,50597,2037.0,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8403,Rattus norvegicus,Intermediate,CHEMBL620179,,,50597,2037.0,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8404,Rattus norvegicus,Intermediate,CHEMBL620180,,,50597,,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8405,Rattus norvegicus,Intermediate,CHEMBL620181,,,50597,,A,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,N,1,1,,BAO_0000218
8406,Rattus norvegicus,Intermediate,CHEMBL620182,,,50597,,A,,Volume of distribution of compound in rats after intravenous administration,,N,1,1,,BAO_0000218
8407,Rattus norvegicus,Intermediate,CHEMBL620183,,,50597,,A,,Volume of distribution in rat,,N,1,1,,BAO_0000218
8408,Rattus norvegicus,Intermediate,CHEMBL620184,,,50597,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,N,1,1,,BAO_0000218
8409,Rattus norvegicus,Intermediate,CHEMBL620185,,,50597,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,1,1,,BAO_0000218
8410,Rattus norvegicus,Intermediate,CHEMBL620186,,,50597,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,1,1,,BAO_0000218
8411,Rattus norvegicus,Intermediate,CHEMBL620187,,,50597,,A,,Volume of distribution was determined in Dawley rat,,N,1,1,,BAO_0000218
8412,Rattus norvegicus,Intermediate,CHEMBL620188,,,50597,,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8413,Rattus norvegicus,Intermediate,CHEMBL620189,,,50597,,A,,Volume of distribution was reported in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8414,Rattus norvegicus,Intermediate,CHEMBL620190,,,50597,,A,,Volumes of distribution in rat after peroral administration,,N,1,1,,BAO_0000218
8415,Rattus norvegicus,Intermediate,CHEMBL620191,,,50597,,A,,Volumes of distribution in rat after po administration,,N,1,1,,BAO_0000218
8416,Rattus norvegicus,Intermediate,CHEMBL620192,,,50597,,A,,Volumes of distribution in rat after po administration; Not determined,,N,1,1,,BAO_0000218
8417,Rattus norvegicus,Intermediate,CHEMBL620193,,,50597,,A,,Pharmacokinetic property (Volume) in rat i.v.,,N,1,1,,BAO_0000218
8418,Rattus norvegicus,Intermediate,CHEMBL620194,,,50597,,A,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,N,1,1,,BAO_0000218
8419,Rattus norvegicus,Intermediate,CHEMBL876730,,,50597,,A,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,N,1,1,,BAO_0000218
8420,Rattus norvegicus,Intermediate,CHEMBL620195,,,50597,,A,,Volume distribution in rat after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
8421,Rattus norvegicus,Intermediate,CHEMBL620196,,,50597,,A,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
8422,Rattus norvegicus,Intermediate,CHEMBL620197,,,50597,,A,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,1,1,,BAO_0000218
8423,Rattus norvegicus,Intermediate,CHEMBL620198,,,50597,,A,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,N,1,1,,BAO_0000218
8424,Rattus norvegicus,Intermediate,CHEMBL620199,,,50597,,A,,Volume of distribution in rats,,N,1,1,,BAO_0000218
8425,Rattus norvegicus,Intermediate,CHEMBL620200,,,50597,,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,N,1,1,,BAO_0000218
8426,Rattus norvegicus,Intermediate,CHEMBL620201,,,50597,,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,N,1,1,,BAO_0000218
8427,Rattus norvegicus,Intermediate,CHEMBL620202,,,50597,,A,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8428,Rattus norvegicus,Intermediate,CHEMBL620203,,,50597,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8429,Rattus norvegicus,Intermediate,CHEMBL620204,,,50597,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,N,1,1,,BAO_0000218
8430,Rattus norvegicus,Intermediate,CHEMBL620205,,,50597,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8431,Rattus norvegicus,Intermediate,CHEMBL624664,,,50597,,A,,Pharmacokinetic parameter (Vss) in rat,,N,1,1,,BAO_0000218
8432,Rattus norvegicus,Intermediate,CHEMBL624665,,,50597,,A,,Pharmacokinetic property (Volume) in rat i.v.,,N,1,1,,BAO_0000218
8433,Rattus norvegicus,Intermediate,CHEMBL624666,,,50597,,A,,Pharmacokinetic property (Vss) in rat,,N,1,1,,BAO_0000218
8434,Rattus norvegicus,Intermediate,CHEMBL624667,,,50597,,A,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,1,1,,BAO_0000218
8435,Rattus norvegicus,Intermediate,CHEMBL624668,,,50597,,A,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8436,Rattus norvegicus,Intermediate,CHEMBL624669,,,50597,,A,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8437,Rattus norvegicus,Intermediate,CHEMBL624670,,,50597,,A,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8438,Rattus norvegicus,Intermediate,CHEMBL624671,,,50597,,A,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8439,Rattus norvegicus,Intermediate,CHEMBL624672,,,50597,,A,,Steady state volume distribution in rat,,N,1,1,,BAO_0000218
8440,Rattus norvegicus,Intermediate,CHEMBL624673,,,50597,1969.0,A,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,N,1,1,,BAO_0000218
8441,Rattus norvegicus,Intermediate,CHEMBL624674,,,50597,,A,,Steady state volume of distribution determined in rat,,N,1,1,,BAO_0000218
8442,Rattus norvegicus,Intermediate,CHEMBL624675,,,50597,,A,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,1,1,,BAO_0000218
8443,Rattus norvegicus,Intermediate,CHEMBL621728,,,50597,,A,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
8444,Rattus norvegicus,Intermediate,CHEMBL621729,,,50597,,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,N,1,1,,BAO_0000218
8445,Rattus norvegicus,Intermediate,CHEMBL621730,,,50597,,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,N,1,1,,BAO_0000218
8446,Rattus norvegicus,Intermediate,CHEMBL621731,,,50597,,A,,Volume distribution in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
8447,Rattus norvegicus,Intermediate,CHEMBL621732,,,50597,,A,,Volume distribution in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
8448,Rattus norvegicus,Intermediate,CHEMBL621908,,,50597,,A,,Volume in steady state distribution value was determined,,N,1,1,,BAO_0000218
8449,Rattus norvegicus,Intermediate,CHEMBL875347,,,50597,,A,,Volume in steady state distribution value was determined; ND denotes no data,,N,1,1,,BAO_0000218
8450,Rattus norvegicus,Intermediate,CHEMBL621909,,,50597,,A,,Volume in steady state distribution value was determined; ND denotes not determined,,N,1,1,,BAO_0000218
8451,Rattus norvegicus,Intermediate,CHEMBL621910,,,50597,,A,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,1,1,,BAO_0000218
8452,Rattus norvegicus,Intermediate,CHEMBL621911,,,50597,,A,,Volume of distribution at steady state was evaluated in rats,,N,1,1,,BAO_0000218
8453,Rattus norvegicus,Intermediate,CHEMBL621912,,,50597,,A,,Volume of distribution at steady state was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
8454,Rattus norvegicus,Intermediate,CHEMBL621913,,,50597,,A,,Volume of distribution in steady state was determined in rat,,N,1,1,,BAO_0000218
8455,Rattus norvegicus,Intermediate,CHEMBL621914,,,50597,,A,,Volume of distribution in steady state was determined in rat,,N,1,1,,BAO_0000218
8456,Rattus norvegicus,Intermediate,CHEMBL621915,,,50597,,A,,Volume of distribution after i.v. administration,,N,1,1,,BAO_0000218
8457,Rattus norvegicus,Intermediate,CHEMBL621916,,,50597,,A,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,1,1,,BAO_0000218
8458,Mus musculus,Intermediate,CHEMBL621917,,,50594,2107.0,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,1,1,,BAO_0000218
8459,Mus musculus,Intermediate,CHEMBL621918,,,50594,2107.0,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,1,1,,BAO_0000218
8460,Mus musculus,Intermediate,CHEMBL621919,,,50594,2106.0,A,,Biodistribution of compound (oxidized form) in spleen tissue,,N,1,1,,BAO_0000218
8461,Mus musculus,Intermediate,CHEMBL621920,,,50594,2106.0,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,N,1,1,,BAO_0000218
8462,Mus musculus,Intermediate,CHEMBL621921,,,50594,2106.0,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,N,1,1,,BAO_0000218
8463,Mus musculus,Intermediate,CHEMBL622401,,,50594,2106.0,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8464,Mus musculus,Intermediate,CHEMBL875348,,,50594,2106.0,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,1,1,,BAO_0000218
8465,Mus musculus,Intermediate,CHEMBL622402,,,50594,2106.0,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,1,1,,BAO_0000218
8466,Mus musculus,Intermediate,CHEMBL622403,,,50594,178.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,N,1,1,,BAO_0000218
8467,Mus musculus,Intermediate,CHEMBL622404,,,50594,178.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8468,Mus musculus,Intermediate,CHEMBL622405,,,50594,955.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,N,1,1,,BAO_0000218
8469,Mus musculus,Intermediate,CHEMBL622406,,,50594,955.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8470,Mus musculus,Intermediate,CHEMBL622407,,,50594,955.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8471,Mus musculus,Intermediate,CHEMBL622408,,,50594,948.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,N,1,1,,BAO_0000218
8472,Mus musculus,Intermediate,CHEMBL622409,,,50594,948.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8473,Mus musculus,Intermediate,CHEMBL622410,,,50594,948.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8474,Mus musculus,Intermediate,CHEMBL622411,,,50594,2113.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,N,1,1,,BAO_0000218
8475,Mus musculus,Intermediate,CHEMBL627864,,,50594,2113.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,1,1,,BAO_0000218
8476,Mus musculus,Intermediate,CHEMBL627865,,,50594,2113.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8477,Mus musculus,Intermediate,CHEMBL627866,,,50594,2107.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,N,1,1,,BAO_0000218
8478,Mus musculus,Intermediate,CHEMBL627751,,,50594,2107.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8479,Mus musculus,Intermediate,CHEMBL627752,,,50594,2106.0,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,N,1,1,,BAO_0000218
8480,Mus musculus,Intermediate,CHEMBL627753,,,50594,2106.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,1,1,,BAO_0000218
8481,Mus musculus,Intermediate,CHEMBL627754,,,50594,2106.0,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,1,1,,BAO_0000218
8482,Mus musculus,Intermediate,CHEMBL627755,,,50594,,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,N,1,1,,BAO_0000218
8483,Mus musculus,Intermediate,CHEMBL627756,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8484,Mus musculus,Intermediate,CHEMBL627757,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8485,Mus musculus,Intermediate,CHEMBL627758,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8486,Mus musculus,Intermediate,CHEMBL627759,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8487,Mus musculus,Intermediate,CHEMBL627760,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8488,Mus musculus,Intermediate,CHEMBL627761,,,50594,955.0,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8489,Mus musculus,Intermediate,CHEMBL876811,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8490,Mus musculus,Intermediate,CHEMBL627762,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8491,Mus musculus,Intermediate,CHEMBL627763,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8492,Mus musculus,Intermediate,CHEMBL627764,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8493,Mus musculus,Intermediate,CHEMBL627765,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8494,Mus musculus,Intermediate,CHEMBL627766,,,50594,948.0,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8495,Mus musculus,Intermediate,CHEMBL627767,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8496,Mus musculus,Intermediate,CHEMBL627768,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8497,Mus musculus,Intermediate,CHEMBL628422,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8498,Mus musculus,Intermediate,CHEMBL628423,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8499,Rattus norvegicus,Intermediate,CHEMBL628424,,,50597,,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,N,1,1,,BAO_0000218
8500,Rattus norvegicus,Intermediate,CHEMBL628425,,,50597,,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,N,1,1,,BAO_0000218
8501,Rattus norvegicus,Intermediate,CHEMBL628426,,,50597,,A,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,N,1,1,,BAO_0000218
8502,Rattus norvegicus,Intermediate,CHEMBL628427,,,50597,,A,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,1,1,,BAO_0000218
8503,Rattus norvegicus,Intermediate,CHEMBL626938,,,50597,,A,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,1,1,,BAO_0000218
8504,Rattus norvegicus,Intermediate,CHEMBL626939,,,50597,,A,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,1,1,,BAO_0000218
8505,Rattus norvegicus,Intermediate,CHEMBL626940,,,50597,,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8506,Rattus norvegicus,Intermediate,CHEMBL626941,,,50597,,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8507,Rattus norvegicus,Intermediate,CHEMBL626942,,,50597,,A,,Plasma clearance was reported in Sprague-Dawley rat,,N,1,1,,BAO_0000218
8508,Rattus norvegicus,Intermediate,CHEMBL876812,,,50597,,A,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,N,1,1,,BAO_0000218
8509,Rattus norvegicus,Intermediate,CHEMBL626943,,,50597,,A,,Plasma clearance of compound in rats was evaluated,,N,1,1,,BAO_0000218
8510,Rattus norvegicus,Intermediate,CHEMBL626944,,,50597,,A,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,N,1,1,,BAO_0000218
8511,Rattus norvegicus,Intermediate,CHEMBL626945,,,50597,,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,N,1,1,,BAO_0000218
8512,Rattus norvegicus,Intermediate,CHEMBL626946,,,50597,,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,1,1,,BAO_0000218
8513,Rattus norvegicus,Intermediate,CHEMBL626856,,,50597,,A,,Plasma clearance rate in Sprague-Dawley rats,,N,1,1,,BAO_0000218
8514,Rattus norvegicus,Intermediate,CHEMBL626857,,,50597,,A,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,N,1,1,,BAO_0000218
8515,Rattus norvegicus,Intermediate,CHEMBL626858,,,50597,1969.0,A,,The compound was evaluated for plasma clearance in rat,,N,1,1,,BAO_0000218
8516,Rattus norvegicus,Intermediate,CHEMBL627018,,,50597,1969.0,A,,Total plasma clearance in rat,,N,1,1,,BAO_0000218
8517,Rattus norvegicus,Intermediate,CHEMBL625331,,,50597,178.0,A,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,N,1,1,,BAO_0000218
8518,Rattus norvegicus,Intermediate,CHEMBL625332,,,50597,178.0,A,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,N,1,1,,BAO_0000218
8519,Rattus norvegicus,Intermediate,CHEMBL877590,,,50597,,A,,C max was determined at 10 mg/kg po dose in rats,,N,1,1,,BAO_0000218
8520,Rattus norvegicus,Intermediate,CHEMBL625333,,,50597,,A,,C max was determined at 3 mg/kg po dose in rats,,N,1,1,,BAO_0000218
8521,Rattus norvegicus,Intermediate,CHEMBL625334,,,50597,,A,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,N,1,1,,BAO_0000218
8522,Rattus norvegicus,Intermediate,CHEMBL625335,,,50597,,A,,Cmax after single intravenous bolus of 1 mg/kg in rats,,N,1,1,,BAO_0000218
8523,Rattus norvegicus,Intermediate,CHEMBL625336,,,50597,,A,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,N,1,1,,BAO_0000218
8524,Rattus norvegicus,Intermediate,CHEMBL625337,,,50597,,A,,Cmax 24 hr after 10 mg/kg oral administration in rats,,N,1,1,,BAO_0000218
8525,Rattus norvegicus,Intermediate,CHEMBL625338,,,50597,,A,,Cmax 24 hr after 2 mg/kg oral administration in rats,,N,1,1,,BAO_0000218
8526,Rattus norvegicus,Intermediate,CHEMBL625339,,,50597,1969.0,A,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
8527,Rattus norvegicus,Intermediate,CHEMBL625340,,,50597,,A,,Cmax in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
8528,Rattus norvegicus,Intermediate,CHEMBL625341,,,50597,,A,,Cmax in rat after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
8529,Rattus norvegicus,Intermediate,CHEMBL622687,,,50597,,A,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,N,1,1,,BAO_0000218
8530,Rattus norvegicus,Intermediate,CHEMBL622688,,,50597,1969.0,A,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,N,1,1,,BAO_0000218
8531,Rattus norvegicus,Intermediate,CHEMBL622689,,,50597,178.0,A,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,N,1,1,,BAO_0000218
8532,Rattus norvegicus,Intermediate,CHEMBL620295,,,50597,178.0,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,N,1,1,,BAO_0000218
8533,Rattus norvegicus,Intermediate,CHEMBL620296,,,50597,,A,,Cmax after 10 mg/kg oral administration in rat,,N,1,1,,BAO_0000218
8534,Rattus norvegicus,Intermediate,CHEMBL620297,,,50597,,A,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,N,1,1,,BAO_0000218
8535,Rattus norvegicus,Intermediate,CHEMBL620298,,,50597,,A,,Cmax after IV dosing at 1 mg/kg in rat; no data,,N,1,1,,BAO_0000218
8536,Rattus norvegicus,Intermediate,CHEMBL620299,,,50597,,A,,Cmax after oral administration at 20 mpk in rats,,N,1,1,,BAO_0000218
8537,Rattus norvegicus,Intermediate,CHEMBL620300,,,50597,,A,,Cmax after oral administration at 20 mpk in rats; Not performed.,,N,1,1,,BAO_0000218
8538,Rattus norvegicus,Intermediate,CHEMBL620301,,,50597,,A,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,N,1,1,,BAO_0000218
8539,Rattus norvegicus,Intermediate,CHEMBL620302,,,50597,,A,,Cmax after oral administration in rat,,N,1,1,,BAO_0000218
8540,Rattus norvegicus,Intermediate,CHEMBL620303,,,50597,,A,,Cmax after oral administration at a dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
8541,Rattus norvegicus,Intermediate,CHEMBL620304,,,50597,,A,,Cmax after oral administration at a dose of 4 mg/kg in rat,,N,1,1,,BAO_0000218
8542,Rattus norvegicus,Intermediate,CHEMBL620305,,,50597,,A,,Cmax in rats after 20 mg/kg oral dose,,N,1,1,,BAO_0000218
8543,Rattus norvegicus,Intermediate,CHEMBL620306,,,50597,,A,,Cmax after peroral administration in rats at 2.4 uM/kg,,N,1,1,,BAO_0000218
8544,Rattus norvegicus,Intermediate,CHEMBL620307,,,50597,,A,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
8545,Rattus norvegicus,Intermediate,CHEMBL620308,,,50597,,A,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
8546,Rattus norvegicus,Intermediate,CHEMBL620309,,,50597,,A,,Cmax by administering at 20 mg/kg p.o. in rats,,N,1,1,,BAO_0000218
8547,Rattus norvegicus,Intermediate,CHEMBL620310,,,50597,,A,,Cmax in male rat,,N,1,1,,BAO_0000218
8548,Rattus norvegicus,Intermediate,CHEMBL620311,,,50597,,A,,Cmax in rat,,N,1,1,,BAO_0000218
8549,Rattus norvegicus,Intermediate,CHEMBL620312,,,50597,,A,,Cmax in rat,,N,1,1,,BAO_0000218
8550,Rattus norvegicus,Intermediate,CHEMBL620313,,,50597,,A,,Cmax in rat,,N,1,1,,BAO_0000218
8551,Rattus norvegicus,Intermediate,CHEMBL620314,,,50597,,A,,Cmax in rat at 10 mg/kg,,N,1,1,,BAO_0000218
8552,Rattus norvegicus,Intermediate,CHEMBL620315,,,50597,,A,,Cmax in rat at the dose of 1 mg/kg i.v.,,N,1,1,,BAO_0000218
8553,Rattus norvegicus,Intermediate,CHEMBL620316,,,50597,,A,,Cmax in rat by po administration at a dose of 40 mg/kg,,N,1,1,,BAO_0000218
8554,Rattus norvegicus,Intermediate,CHEMBL620317,,,50597,,A,,Cmax in rat p.o. at 20 mg/kg concentration,,N,1,1,,BAO_0000218
8555,Rattus norvegicus,Intermediate,CHEMBL620318,,,50597,,A,,Cmax in rats,,N,1,1,,BAO_0000218
8556,Rattus norvegicus,Intermediate,CHEMBL620319,,,50597,,A,,Cmax in rats,,N,1,1,,BAO_0000218
8557,Rattus norvegicus,Intermediate,CHEMBL620320,,,50597,,A,,Cmax was evaluated after 20 uM/kg of peroral administration,,N,1,1,,BAO_0000218
8558,Rattus norvegicus,Intermediate,CHEMBL620321,,,50597,,A,,Cmax was measured in rats after peroral administration at 3 mg/kg,,N,1,1,,BAO_0000218
8559,Rattus norvegicus,Intermediate,CHEMBL620322,,,50597,,A,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,N,1,1,,BAO_0000218
8560,Rattus norvegicus,Intermediate,CHEMBL620323,,,50597,,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8561,Rattus norvegicus,Intermediate,CHEMBL620324,,,50597,1870.0,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8562,Rattus norvegicus,Intermediate,CHEMBL620325,,,50597,1870.0,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8563,Rattus norvegicus,Intermediate,CHEMBL620326,,,50597,10000000.0,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8564,Rattus norvegicus,Intermediate,CHEMBL620327,,,50597,10000000.0,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8565,Rattus norvegicus,Intermediate,CHEMBL620328,,,50597,,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8566,Rattus norvegicus,Intermediate,CHEMBL620329,,,50597,,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8567,Rattus norvegicus,Intermediate,CHEMBL620330,,,50597,1891.0,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8568,Rattus norvegicus,Intermediate,CHEMBL875286,,,50597,1891.0,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8569,Rattus norvegicus,Intermediate,CHEMBL620331,,,50597,,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8570,Rattus norvegicus,Intermediate,CHEMBL620332,,,50597,,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8571,Rattus norvegicus,Intermediate,CHEMBL620333,,,50597,2435.0,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8572,Rattus norvegicus,Intermediate,CHEMBL620334,,,50597,2435.0,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1,1,,BAO_0000218
8573,Rattus norvegicus,Intermediate,CHEMBL621015,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
8574,Rattus norvegicus,Intermediate,CHEMBL621016,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
8575,Rattus norvegicus,Intermediate,CHEMBL621191,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
8576,Rattus norvegicus,Intermediate,CHEMBL621192,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
8577,Rattus norvegicus,Intermediate,CHEMBL621193,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
8578,Rattus norvegicus,Intermediate,CHEMBL621194,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
8579,Rattus norvegicus,Intermediate,CHEMBL624204,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
8580,Rattus norvegicus,Intermediate,CHEMBL624205,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
8581,Rattus norvegicus,Intermediate,CHEMBL624206,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
8582,Rattus norvegicus,Intermediate,CHEMBL624207,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
8583,Rattus norvegicus,Intermediate,CHEMBL624208,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
8584,Rattus norvegicus,Intermediate,CHEMBL624209,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
8585,Rattus norvegicus,Intermediate,CHEMBL624210,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
8586,Rattus norvegicus,Intermediate,CHEMBL624211,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
8587,Rattus norvegicus,Intermediate,CHEMBL624212,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
8588,Rattus norvegicus,Intermediate,CHEMBL624213,,,50597,178.0,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
8589,Rattus norvegicus,Intermediate,CHEMBL876611,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
8590,Rattus norvegicus,Intermediate,CHEMBL624214,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
8591,Rattus norvegicus,Intermediate,CHEMBL624215,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
8592,Rattus norvegicus,Intermediate,CHEMBL624216,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
8593,Rattus norvegicus,Intermediate,CHEMBL624217,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
8594,Rattus norvegicus,Intermediate,CHEMBL624218,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
8595,Rattus norvegicus,Intermediate,CHEMBL624219,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
8596,Rattus norvegicus,Intermediate,CHEMBL624220,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
8597,Rattus norvegicus,Intermediate,CHEMBL624221,,,50597,178.0,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
8598,Rattus norvegicus,Intermediate,CHEMBL624222,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
8599,Rattus norvegicus,Intermediate,CHEMBL624223,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
8600,Rattus norvegicus,Intermediate,CHEMBL624224,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
8601,Rattus norvegicus,Intermediate,CHEMBL624225,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
8602,Rattus norvegicus,Intermediate,CHEMBL622420,,,50597,,A,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
8603,Rattus norvegicus,Intermediate,CHEMBL622421,,,50597,,A,,Volume of steady state distribution after i.v. administration in rats,,N,1,1,,BAO_0000218
8604,Rattus norvegicus,Intermediate,CHEMBL622422,,,50597,,A,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,N,1,1,,BAO_0000218
8605,Rattus norvegicus,Intermediate,CHEMBL622423,,,50597,,A,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,1,1,,BAO_0000218
8606,Rattus norvegicus,Intermediate,CHEMBL622424,,,50597,,A,,Vss was determined,,N,1,1,,BAO_0000218
8607,Rattus norvegicus,Intermediate,CHEMBL622425,,,50597,,A,,Vss in rat,,N,1,1,,BAO_0000218
8608,Rattus norvegicus,Intermediate,CHEMBL876612,,,50597,,A,,Vss was evaluated after 10 uM/kg of intra arterial administration,,N,1,1,,BAO_0000218
8609,Rattus norvegicus,Intermediate,CHEMBL622426,,,50597,,A,,volume of distribution at steady state was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
8610,Rattus norvegicus,Intermediate,CHEMBL622427,,,50597,,A,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
8611,Rattus norvegicus,Intermediate,CHEMBL622428,,,50597,,A,,Pharmacokinetic (PK) parameter Vz in rat,,N,1,1,,BAO_0000218
8612,Rattus norvegicus,Intermediate,CHEMBL622429,,,50597,,A,,Volume distribution in rats,,N,1,1,,BAO_0000218
8613,Rattus norvegicus,Intermediate,CHEMBL622430,,,50597,,A,,Volume of distribution in rat; No data,,N,1,1,,BAO_0000218
8614,Rattus norvegicus,Intermediate,CHEMBL622431,,,50597,,A,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
8615,Rattus norvegicus,Intermediate,CHEMBL622432,,,50597,2116.0,A,,% absorption predicted from in vitro rat ileum transport studies,,N,1,1,,BAO_0000218
8616,Rattus norvegicus,Intermediate,CHEMBL622433,,,50597,,A,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,1,1,,BAO_0000218
8617,Rattus norvegicus,Intermediate,CHEMBL622434,,,50597,,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,1,1,,BAO_0000218
8618,Rattus norvegicus,Intermediate,CHEMBL622435,,,50597,,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,N,1,1,,BAO_0000218
8619,Rattus norvegicus,Intermediate,CHEMBL618748,,,50597,,A,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,N,1,1,,BAO_0000218
8620,Rattus norvegicus,Intermediate,CHEMBL618749,,,50597,,A,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,1,1,,BAO_0000218
8621,Rattus norvegicus,Intermediate,CHEMBL618750,,,50597,,A,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,1,1,,BAO_0000218
8622,Rattus norvegicus,Intermediate,CHEMBL618751,,,50597,,A,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,1,1,,BAO_0000218
8623,Rattus norvegicus,Intermediate,CHEMBL618752,,,50597,,A,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,1,1,,BAO_0000218
8624,Rattus norvegicus,Intermediate,CHEMBL618753,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
8625,Rattus norvegicus,Intermediate,CHEMBL618754,,,50597,1969.0,A,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,N,1,1,,BAO_0000218
8626,Rattus norvegicus,Intermediate,CHEMBL618755,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
8627,Rattus norvegicus,Intermediate,CHEMBL618756,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
8628,Rattus norvegicus,Intermediate,CHEMBL618757,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
8629,Rattus norvegicus,Intermediate,CHEMBL618758,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
8630,Rattus norvegicus,Intermediate,CHEMBL621088,,,50597,,A,,Oral bioavailability in rat (dose 30 mg/kg),,N,1,1,,BAO_0000218
8631,Rattus norvegicus,Intermediate,CHEMBL621089,,,50597,,A,,Pharmacokinetic property (cLogP) in rat,,N,1,1,,BAO_0000218
8632,Rattus norvegicus,Intermediate,CHEMBL621090,,,50597,178.0,F,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,N,1,1,,BAO_0000218
8633,Rattus norvegicus,Intermediate,CHEMBL621091,,,50597,178.0,F,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,N,1,1,,BAO_0000218
8634,Rattus norvegicus,Intermediate,CHEMBL876731,,,50597,,A,,Clearance in rat.,,N,1,1,,BAO_0000218
8635,Rattus norvegicus,Intermediate,CHEMBL621092,,,50597,,A,,Compound was evaluated for its clearance when administered intravenously in rat,,N,1,1,,BAO_0000218
8636,Rattus norvegicus,Intermediate,CHEMBL621093,,,50597,,A,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
8637,Rattus norvegicus,Intermediate,CHEMBL621094,,,50597,,A,,Blood: Brain distribution ratio is determined in rat,,N,1,1,,BAO_0000218
8638,Rattus norvegicus,Intermediate,CHEMBL621095,,,50597,,A,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,N,1,1,,BAO_0000218
8639,Rattus norvegicus,Intermediate,CHEMBL621096,,,50597,,A,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,N,1,1,,BAO_0000218
8640,Rattus norvegicus,Intermediate,CHEMBL621097,,,50597,2113.0,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
8641,Rattus norvegicus,Intermediate,CHEMBL621098,,,50597,,F,,Percent dose excreted in 0-48 hours administered ip to male rat,,N,1,1,,BAO_0000218
8642,Rattus norvegicus,Intermediate,CHEMBL621099,,,50597,2037.0,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8643,Rattus norvegicus,Intermediate,CHEMBL621100,,,50597,2037.0,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8644,Rattus norvegicus,Intermediate,CHEMBL621101,,,50597,2037.0,A,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8645,Rattus norvegicus,Intermediate,CHEMBL621102,,,50597,2037.0,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8646,Rattus norvegicus,Intermediate,CHEMBL876732,,,50597,2037.0,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8647,Rattus norvegicus,Intermediate,CHEMBL621103,,,50597,,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8648,Rattus norvegicus,Intermediate,CHEMBL621104,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8649,Rattus norvegicus,Intermediate,CHEMBL621105,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8650,Rattus norvegicus,Intermediate,CHEMBL621106,,,50597,,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8651,Rattus norvegicus,Intermediate,CHEMBL621107,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8652,Rattus norvegicus,Intermediate,CHEMBL621108,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8653,Rattus norvegicus,Intermediate,CHEMBL621109,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8654,Mus musculus,Intermediate,CHEMBL621110,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8655,Mus musculus,Intermediate,CHEMBL621111,,,50594,2113.0,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8656,Mus musculus,Intermediate,CHEMBL622541,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8657,Mus musculus,Intermediate,CHEMBL622542,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8658,Mus musculus,Intermediate,CHEMBL622543,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8659,Mus musculus,Intermediate,CHEMBL624412,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8660,Mus musculus,Intermediate,CHEMBL624413,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8661,Mus musculus,Intermediate,CHEMBL624414,,,50594,2107.0,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8662,Mus musculus,Intermediate,CHEMBL624415,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8663,Mus musculus,Intermediate,CHEMBL624416,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8664,Mus musculus,Intermediate,CHEMBL624417,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8665,Mus musculus,Intermediate,CHEMBL624418,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8666,Mus musculus,Intermediate,CHEMBL624419,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8667,Mus musculus,Intermediate,CHEMBL624420,,,50594,2048.0,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8668,Mus musculus,Intermediate,CHEMBL624421,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8669,Mus musculus,Intermediate,CHEMBL624422,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8670,Mus musculus,Intermediate,CHEMBL624423,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8671,Mus musculus,Intermediate,CHEMBL625123,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8672,Mus musculus,Intermediate,CHEMBL625124,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8673,Mus musculus,Intermediate,CHEMBL625125,,,50594,2385.0,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8674,Mus musculus,Intermediate,CHEMBL625126,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8675,Mus musculus,Intermediate,CHEMBL626947,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8676,Mus musculus,Intermediate,CHEMBL626948,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8677,Mus musculus,Intermediate,CHEMBL626949,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8678,Mus musculus,Intermediate,CHEMBL626950,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8679,Mus musculus,Intermediate,CHEMBL626951,,,50594,14.0,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8680,Mus musculus,Intermediate,CHEMBL626952,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8681,Mus musculus,Intermediate,CHEMBL626953,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8682,Mus musculus,Intermediate,CHEMBL626954,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8683,Mus musculus,Intermediate,CHEMBL626955,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8684,Mus musculus,Intermediate,CHEMBL626956,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8685,Mus musculus,Intermediate,CHEMBL626957,,,50594,2106.0,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8686,Mus musculus,Intermediate,CHEMBL626958,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8687,Mus musculus,Intermediate,CHEMBL626959,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8688,Mus musculus,Intermediate,CHEMBL626960,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8689,Mus musculus,Intermediate,CHEMBL626961,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8690,Mus musculus,Intermediate,CHEMBL627589,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8691,Mus musculus,Intermediate,CHEMBL627590,,,50594,178.0,A,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,N,1,1,,BAO_0000218
8692,Mus musculus,Intermediate,CHEMBL627591,,,50594,,A,,Time taken for EC90 was determined when tested in mouse,,N,1,1,,BAO_0000218
8693,Mus musculus,Intermediate,CHEMBL627592,,,50594,,A,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,N,1,1,,BAO_0000218
8694,Mus musculus,Intermediate,CHEMBL627593,,,50594,,A,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,N,1,1,,BAO_0000218
8695,Mus musculus,Intermediate,CHEMBL627594,,,50594,,A,,Half life in mice,,N,1,1,,BAO_0000218
8696,Mus musculus,Intermediate,CHEMBL876813,,,50594,,A,,Half life period in mouse after 10 mg/Kg dose,,N,1,1,,BAO_0000218
8697,Mus musculus,Intermediate,CHEMBL627595,,,50594,,A,,Half life period in mouse after 10 mg/kg dose,,N,1,1,,BAO_0000218
8698,Mus musculus,Intermediate,CHEMBL627596,,,50594,,A,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,N,1,1,,BAO_0000218
8699,Rattus norvegicus,Intermediate,CHEMBL627597,,,50597,,A,,Cmax value at 5 mg/kg po was determined in rat,,N,1,1,,BAO_0000218
8700,Rattus norvegicus,Intermediate,CHEMBL627598,,,50597,,A,,Cmax value evaluated in rat,,N,1,1,,BAO_0000218
8701,Rattus norvegicus,Intermediate,CHEMBL627599,,,50597,955.0,A,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,N,1,1,,BAO_0000218
8702,Rattus norvegicus,Intermediate,CHEMBL627600,,,50597,,A,,Cmax value after administration of 20 mg/Kg oral dose in rat,,N,1,1,,BAO_0000218
8703,Rattus norvegicus,Intermediate,CHEMBL627601,,,50597,,A,,Cmax value at 1 mg/kg po in rat,,N,1,1,,BAO_0000218
8704,Rattus norvegicus,Intermediate,CHEMBL627776,,,50597,,A,,Cmax value at 5 mg/kg po in rat,,N,1,1,,BAO_0000218
8705,Rattus norvegicus,Intermediate,CHEMBL627777,,,50597,,A,,Cmax value at a dose of 10 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8706,Rattus norvegicus,Intermediate,CHEMBL627778,,,50597,,A,,Cmax value at a dose of 100 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8707,Rattus norvegicus,Intermediate,CHEMBL627779,,,50597,,A,,Cmax value at a dose of 50 mg/kg in male SD rats,,N,1,1,,BAO_0000218
8708,Rattus norvegicus,Intermediate,CHEMBL876814,,,50597,,A,,Cmax value in rats at 10 mg/kg,,N,1,1,,BAO_0000218
8709,Rattus norvegicus,Intermediate,CHEMBL627780,,,50597,,A,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,N,1,1,,BAO_0000218
8710,Rattus norvegicus,Intermediate,CHEMBL627781,,,50597,,A,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,N,1,1,,BAO_0000218
8711,Rattus norvegicus,Intermediate,CHEMBL627782,,,50597,,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,1,1,,BAO_0000218
8712,Rattus norvegicus,Intermediate,CHEMBL627783,,,50597,1969.0,A,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,N,1,1,,BAO_0000218
8713,Rattus norvegicus,Intermediate,CHEMBL627784,,,50597,1969.0,A,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,N,1,1,,BAO_0000218
8714,Rattus norvegicus,Intermediate,CHEMBL627785,,,50597,,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,N,1,1,,BAO_0000218
8715,Rattus norvegicus,Intermediate,CHEMBL627786,,,50597,,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,N,1,1,,BAO_0000218
8716,Rattus norvegicus,Intermediate,CHEMBL627787,,,50597,1969.0,A,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,N,1,1,,BAO_0000218
8717,Rattus norvegicus,Intermediate,CHEMBL627788,,,50597,1969.0,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,N,1,1,,BAO_0000218
8718,Rattus norvegicus,Intermediate,CHEMBL626579,,,50597,1969.0,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,N,1,1,,BAO_0000218
8719,Rattus norvegicus,Intermediate,CHEMBL626580,,,50597,1969.0,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,N,1,1,,BAO_0000218
8720,Rattus norvegicus,Intermediate,CHEMBL876815,,,50597,,A,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,N,1,1,,BAO_0000218
8721,Rattus norvegicus,Intermediate,CHEMBL626581,,,50597,1969.0,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,N,1,1,,BAO_0000218
8722,Rattus norvegicus,Intermediate,CHEMBL626582,,,50597,1969.0,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,N,1,1,,BAO_0000218
8723,Rattus norvegicus,Intermediate,CHEMBL626583,,,50597,,A,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,N,1,1,,BAO_0000218
8724,Rattus norvegicus,Intermediate,CHEMBL626205,,,50597,,A,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8725,Rattus norvegicus,Intermediate,CHEMBL626206,,,50597,,A,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8726,Rattus norvegicus,Intermediate,CHEMBL626207,,,50597,,A,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8727,Rattus norvegicus,Intermediate,CHEMBL623882,,,50597,,A,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
8728,Rattus norvegicus,Intermediate,CHEMBL623883,,,50597,,A,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,N,1,1,,BAO_0000218
8729,Rattus norvegicus,Intermediate,CHEMBL623884,,,50597,,A,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,N,1,1,,BAO_0000218
8730,Rattus norvegicus,Intermediate,CHEMBL623885,,,50597,1969.0,A,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,1,1,,BAO_0000218
8731,Rattus norvegicus,Intermediate,CHEMBL623886,,,50597,1969.0,A,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
8732,Rattus norvegicus,Intermediate,CHEMBL623887,,,50597,,A,,Maximal concentration in rat was determined,,N,1,1,,BAO_0000218
8733,Rattus norvegicus,Intermediate,CHEMBL623888,,,50597,,A,,Maximal concentration after i.v. administration,,N,1,1,,BAO_0000218
8734,Rattus norvegicus,Intermediate,CHEMBL623889,,,50597,1969.0,A,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
8735,Rattus norvegicus,Intermediate,CHEMBL623890,,,50597,1969.0,A,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
8736,Rattus norvegicus,Intermediate,CHEMBL623891,,,50597,1969.0,A,,Cmax in rat plasma after oral dose (50 mg/Kg),,N,1,1,,BAO_0000218
8737,Rattus norvegicus,Intermediate,CHEMBL623892,,,50597,1969.0,A,,Maximal plasma concentration was determined.,,N,1,1,,BAO_0000218
8738,Rattus norvegicus,Intermediate,CHEMBL623893,,,50597,1969.0,A,,Maximal plasma drug concentration was determined,,N,1,1,,BAO_0000218
8739,Rattus norvegicus,Intermediate,CHEMBL877616,,,50597,,A,,Maximal concentration in rats after peroral administration,,N,1,1,,BAO_0000218
8740,Rattus norvegicus,Intermediate,CHEMBL623894,,,50597,,A,,Maximum concentration in rat after 2 mg/kg peroral administration,,N,1,1,,BAO_0000218
8741,Rattus norvegicus,Intermediate,CHEMBL623895,,,50597,1969.0,A,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,N,1,1,,BAO_0000218
8742,Rattus norvegicus,Intermediate,CHEMBL623896,,,50597,,A,,Maximum concentration of compound in rat was evaluated.,,N,1,1,,BAO_0000218
8743,Rattus norvegicus,Intermediate,CHEMBL623897,,,50597,,A,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
8744,Rattus norvegicus,Intermediate,CHEMBL623898,,,50597,,A,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
8745,Rattus norvegicus,Intermediate,CHEMBL623899,,,50597,,A,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,1,1,,BAO_0000218
8746,Rattus norvegicus,Intermediate,CHEMBL623900,,,50597,,A,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
8747,Rattus norvegicus,Intermediate,CHEMBL623901,,,50597,,A,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,N,1,1,,BAO_0000218
8748,Rattus norvegicus,Intermediate,CHEMBL623902,,,50597,,A,,Maximum concentration was evaluated in rats,,N,1,1,,BAO_0000218
8749,Rattus norvegicus,Intermediate,CHEMBL623903,,,50597,1359.0,A,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,N,1,1,,BAO_0000218
8750,Rattus norvegicus,Intermediate,CHEMBL623904,,,50597,1969.0,A,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,N,1,1,,BAO_0000218
8751,Rattus norvegicus,Intermediate,CHEMBL877617,,,50597,1969.0,A,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,1,1,,BAO_0000218
8752,Rattus norvegicus,Intermediate,CHEMBL623905,,,50597,,A,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,N,1,1,,BAO_0000218
8753,Rattus norvegicus,Intermediate,CHEMBL623906,,,50597,,A,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,N,1,1,,BAO_0000218
8754,Rattus norvegicus,Intermediate,CHEMBL623907,,,50597,1969.0,A,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,1,1,,BAO_0000218
8755,Rattus norvegicus,Intermediate,CHEMBL623908,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
8756,Rattus norvegicus,Intermediate,CHEMBL623909,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
8757,Rattus norvegicus,Intermediate,CHEMBL623910,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
8758,Rattus norvegicus,Intermediate,CHEMBL623911,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
8759,Rattus norvegicus,Intermediate,CHEMBL623912,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
8760,Rattus norvegicus,Intermediate,CHEMBL624616,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
8761,Rattus norvegicus,Intermediate,CHEMBL624617,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
8762,Rattus norvegicus,Intermediate,CHEMBL624618,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
8763,Rattus norvegicus,Intermediate,CHEMBL624619,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
8764,Rattus norvegicus,Intermediate,CHEMBL624794,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
8765,Rattus norvegicus,Intermediate,CHEMBL624795,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
8766,Rattus norvegicus,Intermediate,CHEMBL623921,,,50597,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
8767,Rattus norvegicus,Intermediate,CHEMBL623922,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
8768,Rattus norvegicus,Intermediate,CHEMBL623923,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
8769,Rattus norvegicus,Intermediate,CHEMBL623924,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
8770,Rattus norvegicus,Intermediate,CHEMBL623925,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
8771,Rattus norvegicus,Intermediate,CHEMBL623926,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
8772,Rattus norvegicus,Intermediate,CHEMBL623927,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
8773,Rattus norvegicus,Intermediate,CHEMBL623928,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
8774,Rattus norvegicus,Intermediate,CHEMBL623929,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
8775,Rattus norvegicus,Intermediate,CHEMBL623930,,,50597,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
8776,Rattus norvegicus,Intermediate,CHEMBL623931,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
8777,Rattus norvegicus,Intermediate,CHEMBL622165,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
8778,Rattus norvegicus,Intermediate,CHEMBL621249,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
8779,Rattus norvegicus,Intermediate,CHEMBL621250,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
8780,Rattus norvegicus,Intermediate,CHEMBL621448,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
8781,Rattus norvegicus,Intermediate,CHEMBL621449,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
8782,Rattus norvegicus,Intermediate,CHEMBL621450,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
8783,Rattus norvegicus,Intermediate,CHEMBL621451,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
8784,Rattus norvegicus,Intermediate,CHEMBL621452,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
8785,Rattus norvegicus,Intermediate,CHEMBL621453,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
8786,Rattus norvegicus,Intermediate,CHEMBL621454,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
8787,Rattus norvegicus,Intermediate,CHEMBL621455,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
8788,Rattus norvegicus,Intermediate,CHEMBL621456,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
8789,Rattus norvegicus,Intermediate,CHEMBL625145,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
8790,Rattus norvegicus,Intermediate,CHEMBL875847,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
8791,Rattus norvegicus,Intermediate,CHEMBL625146,,,50597,955.0,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
8792,Rattus norvegicus,Intermediate,CHEMBL625147,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
8793,Rattus norvegicus,Intermediate,CHEMBL625148,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
8794,Rattus norvegicus,Intermediate,CHEMBL625149,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
8795,Rattus norvegicus,Intermediate,CHEMBL625150,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
8796,Rattus norvegicus,Intermediate,CHEMBL625151,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
8797,Rattus norvegicus,Intermediate,CHEMBL625152,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
8798,Rattus norvegicus,Intermediate,CHEMBL625153,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
8799,Rattus norvegicus,Intermediate,CHEMBL625154,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
8800,Rattus norvegicus,Intermediate,CHEMBL625155,,,50597,955.0,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
8801,Rattus norvegicus,Intermediate,CHEMBL625156,,,50597,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8802,Rattus norvegicus,Intermediate,CHEMBL624354,,,50597,,A,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8803,Rattus norvegicus,Intermediate,CHEMBL624355,,,50597,10000000.0,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8804,Rattus norvegicus,Intermediate,CHEMBL624356,,,50597,10000000.0,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8805,Rattus norvegicus,Intermediate,CHEMBL624357,,,50597,10000000.0,A,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8806,Rattus norvegicus,Intermediate,CHEMBL624358,,,50597,10000000.0,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8807,Rattus norvegicus,Intermediate,CHEMBL624359,,,50597,2435.0,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8808,Rattus norvegicus,Intermediate,CHEMBL624360,,,50597,2435.0,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8809,Rattus norvegicus,Intermediate,CHEMBL624361,,,50597,2435.0,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8810,Rattus norvegicus,Intermediate,CHEMBL624362,,,50597,2435.0,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8811,Rattus norvegicus,Intermediate,CHEMBL624363,,,50597,2435.0,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8812,Rattus norvegicus,Intermediate,CHEMBL624364,,,50597,178.0,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8813,Rattus norvegicus,Intermediate,CHEMBL624365,,,50597,178.0,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8814,Rattus norvegicus,Intermediate,CHEMBL624366,,,50597,178.0,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8815,Rattus norvegicus,Intermediate,CHEMBL624367,,,50597,178.0,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8816,Rattus norvegicus,Intermediate,CHEMBL624368,,,50597,955.0,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8817,Rattus norvegicus,Intermediate,CHEMBL624369,,,50597,955.0,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8818,Rattus norvegicus,Intermediate,CHEMBL624370,,,50597,955.0,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8819,Rattus norvegicus,Intermediate,CHEMBL625069,,,50597,955.0,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8820,Rattus norvegicus,Intermediate,CHEMBL625070,,,50597,955.0,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8821,Rattus norvegicus,Intermediate,CHEMBL626051,,,50597,948.0,A,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8822,Rattus norvegicus,Intermediate,CHEMBL626052,,,50597,948.0,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8823,Rattus norvegicus,Intermediate,CHEMBL626053,,,50597,948.0,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8824,Rattus norvegicus,Intermediate,CHEMBL626054,,,50597,948.0,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8825,Rattus norvegicus,Intermediate,CHEMBL626055,,,50597,948.0,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8826,Rattus norvegicus,Intermediate,CHEMBL626056,,,50597,2113.0,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8827,Rattus norvegicus,Intermediate,CHEMBL626057,,,50597,2113.0,A,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8828,Rattus norvegicus,Intermediate,CHEMBL625193,,,50597,2113.0,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8829,Rattus norvegicus,Intermediate,CHEMBL625194,,,50597,2113.0,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8830,Rattus norvegicus,Intermediate,CHEMBL625195,,,50597,2107.0,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8831,Rattus norvegicus,Intermediate,CHEMBL625196,,,50597,2107.0,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8832,Rattus norvegicus,Intermediate,CHEMBL625197,,,50597,2107.0,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8833,Rattus norvegicus,Intermediate,CHEMBL625198,,,50597,2107.0,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8834,Rattus norvegicus,Intermediate,CHEMBL627929,,,50597,2107.0,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8835,Rattus norvegicus,Intermediate,CHEMBL627074,,,50597,2048.0,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8836,Rattus norvegicus,Intermediate,CHEMBL627075,,,50597,2048.0,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8837,Rattus norvegicus,Intermediate,CHEMBL627076,,,50597,2048.0,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8838,Rattus norvegicus,Intermediate,CHEMBL627077,,,50597,2048.0,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8839,Rattus norvegicus,Intermediate,CHEMBL627078,,,50597,2048.0,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8840,Rattus norvegicus,Intermediate,CHEMBL627079,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8841,Mus musculus,Intermediate,CHEMBL873824,,,50594,,A,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,N,1,1,,BAO_0000218
8842,Mus musculus,Intermediate,CHEMBL627080,,,50594,1969.0,A,,Half life in mouse plasma was determined at dose 25 mg/kg,,N,1,1,,BAO_0000218
8843,Mus musculus,Intermediate,CHEMBL627081,,,50594,,A,,Half life was determined,,N,1,1,,BAO_0000218
8844,Mus musculus,Intermediate,CHEMBL627082,,,50594,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,1,1,,BAO_0000218
8845,Mus musculus,Intermediate,CHEMBL627083,,,50594,,A,,Half-life in male mice after 1 mg/kg intravenous dose,,N,1,1,,BAO_0000218
8847,Mus musculus,Intermediate,CHEMBL627085,,,50594,1969.0,A,,Half life in mice plasma,,N,1,1,,BAO_0000218
8848,Mus musculus,Intermediate,CHEMBL627086,,,50594,,A,,Half life in mouse,,N,1,1,,BAO_0000218
8849,Mus musculus,Intermediate,CHEMBL627087,,,50594,1969.0,A,,Half life in mouse plasma at dose 25 mg/kg,,N,1,1,,BAO_0000218
8850,Mus musculus,Intermediate,CHEMBL627088,,,50594,,A,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,N,1,1,,BAO_0000218
8851,Mus musculus,Intermediate,CHEMBL627089,,,50594,,A,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,N,1,1,,BAO_0000218
8852,Mus musculus,Intermediate,CHEMBL627090,,,50594,,A,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,N,1,1,,BAO_0000218
8853,Mus musculus,Intermediate,CHEMBL627091,,,50594,,A,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,N,1,1,,BAO_0000218
8854,Mus musculus,Intermediate,CHEMBL627092,,,50594,,A,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,N,1,1,,BAO_0000218
8855,Mus musculus,Intermediate,CHEMBL876785,,,50594,,A,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,N,1,1,,BAO_0000218
8856,Mus musculus,Intermediate,CHEMBL627093,,,50594,,A,,Half-life by iv administration in mouse,,N,1,1,,BAO_0000218
8857,Mus musculus,Intermediate,CHEMBL627094,,,50594,,A,,Half-life by oral administration in mouse,,N,1,1,,BAO_0000218
8858,Mus musculus,Intermediate,CHEMBL627095,,,50594,,A,,Half-life in mice,,N,1,1,,BAO_0000218
8859,Mus musculus,Intermediate,CHEMBL627096,,,50594,955.0,A,,Half-life using mouse brain homogenate,,N,1,1,,BAO_0000218
8860,Mus musculus,Intermediate,CHEMBL627097,,,50594,,A,,Half-life was measured in mice,,N,1,1,,BAO_0000218
8861,Mus musculus,Intermediate,CHEMBL627098,,,50594,,A,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
8862,Mus musculus,Intermediate,CHEMBL627099,,,50594,178.0,A,,Half-life period was determined in mouse blood,,N,1,1,,BAO_0000218
8863,Mus musculus,Intermediate,CHEMBL627100,,,50594,955.0,A,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,N,1,1,,BAO_0000218
8864,Mus musculus,Intermediate,CHEMBL627101,,,50594,1969.0,A,,Plasma half life in mouse,,N,1,1,,BAO_0000218
8865,Mus musculus,Intermediate,CHEMBL627102,,,50594,,A,,Stability of the peptide in the presence of mouse serum,,N,1,1,,BAO_0000218
8866,Mus musculus,Intermediate,CHEMBL627103,,,50594,,A,,Terminal half life of compound was determined in mouse,,N,1,1,,BAO_0000218
8867,Mus musculus,Intermediate,CHEMBL627104,,,50594,,A,,Terminal half life was evaluated in mice after intravenous administration,,N,1,1,,BAO_0000218
8868,Mus musculus,Intermediate,CHEMBL627105,,,50594,,A,,Terminal half life was evaluated in mice after oral administration,,N,1,1,,BAO_0000218
8869,Mus musculus,Intermediate,CHEMBL876786,,,50594,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,N,1,1,,BAO_0000218
8870,Mus musculus,Intermediate,CHEMBL873825,,,50594,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,N,1,1,,BAO_0000218
8871,Mus musculus,Intermediate,CHEMBL627106,,,50594,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,N,1,1,,BAO_0000218
8872,Mus musculus,Intermediate,CHEMBL626336,,,50594,,A,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,N,1,1,,BAO_0000218
8873,Mus musculus,Intermediate,CHEMBL877462,,,50594,,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,N,1,1,,BAO_0000218
8874,Mus musculus,Intermediate,CHEMBL626337,,,50594,,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,N,1,1,,BAO_0000218
8875,Mus musculus,Intermediate,CHEMBL626338,,,50594,,A,,Half life after intraperitoneal administration of 100 mg/kg in mice,,N,1,1,,BAO_0000218
8876,Mus musculus,Intermediate,CHEMBL626339,,,50594,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,N,1,1,,BAO_0000218
8877,Mus musculus,Intermediate,CHEMBL626340,,,50594,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,1,1,,BAO_0000218
8878,Mus musculus,Intermediate,CHEMBL625377,,,50594,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,N,1,1,,BAO_0000218
8879,Mus musculus,Intermediate,CHEMBL625378,,,50594,,A,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,N,1,1,,BAO_0000218
8880,Mus musculus,Intermediate,CHEMBL625379,,,50594,,A,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,N,1,1,,BAO_0000218
8881,Sus scrofa,Autocuration,CHEMBL625380,,,22224,,A,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,U,0,1,,BAO_0000251
8882,Sus scrofa,Autocuration,CHEMBL625381,,,22224,,A,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,U,0,1,,BAO_0000251
8883,Sus scrofa,Autocuration,CHEMBL625382,,,22224,,A,,Stability to porcine renal DHP-I,,U,0,1,,BAO_0000019
8884,Sus scrofa,Autocuration,CHEMBL873828,,,22224,,A,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,U,0,1,,BAO_0000218
8885,Sus scrofa,Autocuration,CHEMBL625383,,,22224,,A,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,U,0,1,,BAO_0000218
8886,Sus scrofa,Autocuration,CHEMBL625384,,,22224,,A,,Half-life of the parent prodrug in porcine esterase solution,,U,0,1,,BAO_0000019
8887,Sus scrofa,Autocuration,CHEMBL625385,,,22224,,A,,"First order rate constant, k was determined in in pig liver Esterase",,U,0,1,,BAO_0000019
8888,Sus scrofa,Autocuration,CHEMBL625386,,,22224,2107.0,A,,Half life of the in pig liver Esterase,,U,0,1,,BAO_0000221
8889,Sus scrofa,Autocuration,CHEMBL623571,,,22224,2107.0,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,U,0,1,,BAO_0000221
8890,Sus scrofa,Autocuration,CHEMBL623572,,,22224,2107.0,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,U,0,1,,BAO_0000221
8891,Sus scrofa,Autocuration,CHEMBL623573,,,22224,2107.0,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,U,0,1,,BAO_0000221
8892,Sus scrofa,Autocuration,CHEMBL623574,,,22224,2107.0,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,U,0,1,,BAO_0000221
8893,Sus scrofa,Autocuration,CHEMBL623575,,,22224,2107.0,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,U,0,1,,BAO_0000221
8894,Sus scrofa,Autocuration,CHEMBL623749,,,22224,2107.0,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,U,0,1,,BAO_0000221
8895,Sus scrofa,Autocuration,CHEMBL623750,,,22224,2107.0,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,U,0,1,,BAO_0000221
8896,Sus scrofa,Autocuration,CHEMBL623751,,,22224,2107.0,A,,Half-life in vitro in pig liver,,U,0,1,,BAO_0000221
8897,Sus scrofa,Autocuration,CHEMBL623752,,,22224,2107.0,A,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,U,0,1,,BAO_0000221
8898,Rattus norvegicus,Intermediate,CHEMBL623753,,,50597,1969.0,A,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,N,1,1,,BAO_0000218
8899,Rattus norvegicus,Intermediate,CHEMBL623754,,,50597,1969.0,A,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,1,1,,BAO_0000218
8900,Rattus norvegicus,Intermediate,CHEMBL623755,,,50597,1969.0,A,,Maximum concentration in rat plasma was determined,,N,1,1,,BAO_0000218
8901,Rattus norvegicus,Intermediate,CHEMBL623756,,,50597,,A,,Maximum concentration in rats,,N,1,1,,BAO_0000218
8902,Rattus norvegicus,Intermediate,CHEMBL623757,,,50597,,A,,Maximum concentration in rats at 1-2 hours,,N,1,1,,BAO_0000218
8903,Rattus norvegicus,Intermediate,CHEMBL623758,,,50597,,A,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,N,1,1,,BAO_0000218
8904,Rattus norvegicus,Intermediate,CHEMBL623759,,,50597,955.0,A,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,N,1,1,,BAO_0000218
8905,Rattus norvegicus,Intermediate,CHEMBL623760,,,50597,,A,,Maximum concentration at the dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
8906,Rattus norvegicus,Intermediate,CHEMBL623761,,,50597,,A,,Maximum concentration was evaluated in rats,,N,1,1,,BAO_0000218
8907,Rattus norvegicus,Intermediate,CHEMBL623762,,,50597,1969.0,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
8908,Rattus norvegicus,Intermediate,CHEMBL877594,,,50597,1969.0,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
8909,Rattus norvegicus,Intermediate,CHEMBL623763,,,50597,1969.0,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,N,1,1,,BAO_0000218
8910,Rattus norvegicus,Intermediate,CHEMBL623764,,,50597,1969.0,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,N,1,1,,BAO_0000218
8911,Rattus norvegicus,Intermediate,CHEMBL623765,,,50597,1969.0,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
8912,Rattus norvegicus,Intermediate,CHEMBL623766,,,50597,178.0,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,N,1,1,,BAO_0000218
8913,Rattus norvegicus,Intermediate,CHEMBL623767,,,50597,178.0,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,N,1,1,,BAO_0000218
8914,Rattus norvegicus,Intermediate,CHEMBL623768,,,50597,178.0,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,N,1,1,,BAO_0000218
8915,Rattus norvegicus,Intermediate,CHEMBL623769,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8916,Rattus norvegicus,Intermediate,CHEMBL623770,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8917,Rattus norvegicus,Intermediate,CHEMBL623771,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8918,Rattus norvegicus,Intermediate,CHEMBL623772,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8919,Rattus norvegicus,Intermediate,CHEMBL623773,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8920,Rattus norvegicus,Intermediate,CHEMBL623774,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8921,Rattus norvegicus,Intermediate,CHEMBL623775,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,1,1,,BAO_0000218
8922,Rattus norvegicus,Intermediate,CHEMBL623776,,,50597,,A,,Cmax in rat (PO dose),,N,1,1,,BAO_0000218
8923,Rattus norvegicus,Intermediate,CHEMBL622191,,,50597,1969.0,A,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
8924,Rattus norvegicus,Intermediate,CHEMBL622192,,,50597,1969.0,A,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
8925,Rattus norvegicus,Intermediate,CHEMBL622193,,,50597,1969.0,A,,Maximum plasma concentration determined in rat,,N,1,1,,BAO_0000218
8926,Rattus norvegicus,Intermediate,CHEMBL622194,,,50597,1969.0,A,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
8927,Rattus norvegicus,Intermediate,CHEMBL622195,,,50597,1969.0,A,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
8928,Rattus norvegicus,Intermediate,CHEMBL622196,,,50597,1969.0,A,,Maximum plasma concentration in rat,,N,1,1,,BAO_0000218
8929,Rattus norvegicus,Intermediate,CHEMBL622197,,,50597,1969.0,A,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,1,1,,BAO_0000218
8930,Rattus norvegicus,Intermediate,CHEMBL622198,,,50597,1969.0,A,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,N,1,1,,BAO_0000218
8931,Rattus norvegicus,Intermediate,CHEMBL622199,,,50597,1969.0,A,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,N,1,1,,BAO_0000218
8932,Rattus norvegicus,Intermediate,CHEMBL622200,,,50597,1969.0,A,,Maximum plasma concentration of compound was measured in rat,,N,1,1,,BAO_0000218
8933,Rattus norvegicus,Intermediate,CHEMBL622201,,,50597,1969.0,A,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,N,1,1,,BAO_0000218
8934,Rattus norvegicus,Intermediate,CHEMBL623990,,,50597,1969.0,A,,Maximum plasma concentration after oral administration to rats,,N,1,1,,BAO_0000218
8935,Rattus norvegicus,Intermediate,CHEMBL623991,,,50597,1969.0,A,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
8936,Rattus norvegicus,Intermediate,CHEMBL623992,,,50597,1969.0,A,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,N,1,1,,BAO_0000218
8937,Rattus norvegicus,Intermediate,CHEMBL623993,,,50597,1969.0,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
8938,Rattus norvegicus,Intermediate,CHEMBL623994,,,50597,1969.0,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,N,1,1,,BAO_0000218
8939,Rattus norvegicus,Intermediate,CHEMBL623995,,,50597,1969.0,F,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
8940,Rattus norvegicus,Intermediate,CHEMBL623996,,,50597,1969.0,F,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
8941,Rattus norvegicus,Intermediate,CHEMBL623997,,,50597,1969.0,F,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
8942,Rattus norvegicus,Intermediate,CHEMBL623998,,,50597,1969.0,A,,Maximum plasma concentration dosed orally in rats,,N,1,1,,BAO_0000218
8943,Rattus norvegicus,Intermediate,CHEMBL623999,,,50597,1969.0,A,,Maximum plasma concentration dosed orally in rats after 6 hours,,N,1,1,,BAO_0000218
8944,Rattus norvegicus,Intermediate,CHEMBL624000,,,50597,1969.0,A,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,N,1,1,,BAO_0000218
8945,Rattus norvegicus,Intermediate,CHEMBL624001,,,50597,1969.0,A,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,1,1,,BAO_0000218
8946,Rattus norvegicus,Intermediate,CHEMBL624002,,,50597,1969.0,A,,Maximum plasma concentration in rat after po administration,,N,1,1,,BAO_0000218
8947,Rattus norvegicus,Intermediate,CHEMBL624003,,,50597,1969.0,A,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
8948,Rattus norvegicus,Intermediate,CHEMBL624004,,,50597,1969.0,A,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,N,1,1,,BAO_0000218
8949,Rattus norvegicus,Intermediate,CHEMBL624005,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
8950,Rattus norvegicus,Intermediate,CHEMBL624006,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
8951,Rattus norvegicus,Intermediate,CHEMBL624007,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
8952,Rattus norvegicus,Intermediate,CHEMBL624008,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
8953,Rattus norvegicus,Intermediate,CHEMBL624009,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
8954,Rattus norvegicus,Intermediate,CHEMBL874387,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
8955,Rattus norvegicus,Intermediate,CHEMBL624010,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
8956,Rattus norvegicus,Intermediate,CHEMBL624011,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
8957,Rattus norvegicus,Intermediate,CHEMBL624012,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
8958,Rattus norvegicus,Intermediate,CHEMBL624013,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
8959,Rattus norvegicus,Intermediate,CHEMBL624736,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
8960,Rattus norvegicus,Intermediate,CHEMBL624737,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
8961,Rattus norvegicus,Intermediate,CHEMBL624738,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
8962,Rattus norvegicus,Intermediate,CHEMBL624739,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
8963,Rattus norvegicus,Intermediate,CHEMBL624740,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
8964,Rattus norvegicus,Intermediate,CHEMBL624896,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
8965,Rattus norvegicus,Intermediate,CHEMBL624897,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
8966,Rattus norvegicus,Intermediate,CHEMBL624108,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
8967,Rattus norvegicus,Intermediate,CHEMBL624109,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
8968,Rattus norvegicus,Intermediate,CHEMBL624110,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
8969,Rattus norvegicus,Intermediate,CHEMBL624111,,,50597,948.0,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
8970,Rattus norvegicus,Intermediate,CHEMBL624112,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
8971,Rattus norvegicus,Intermediate,CHEMBL624113,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
8972,Rattus norvegicus,Intermediate,CHEMBL619709,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
8973,Rattus norvegicus,Intermediate,CHEMBL619710,,,50597,948.0,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
8974,Rattus norvegicus,Intermediate,CHEMBL619711,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
8975,Rattus norvegicus,Intermediate,CHEMBL619712,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
8976,Rattus norvegicus,Intermediate,CHEMBL619713,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
8977,Rattus norvegicus,Intermediate,CHEMBL619714,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
8978,Rattus norvegicus,Intermediate,CHEMBL619715,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
8979,Rattus norvegicus,Intermediate,CHEMBL619716,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
8980,Rattus norvegicus,Intermediate,CHEMBL619717,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
8981,Rattus norvegicus,Intermediate,CHEMBL619718,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
8982,Rattus norvegicus,Intermediate,CHEMBL619719,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
8983,Rattus norvegicus,Intermediate,CHEMBL875329,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
8984,Rattus norvegicus,Intermediate,CHEMBL619720,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
8985,Rattus norvegicus,Intermediate,CHEMBL619721,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
8986,Rattus norvegicus,Intermediate,CHEMBL619722,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
8987,Rattus norvegicus,Intermediate,CHEMBL619723,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
8988,Rattus norvegicus,Intermediate,CHEMBL619724,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
8989,Rattus norvegicus,Intermediate,CHEMBL619725,,,50597,2113.0,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
8990,Rattus norvegicus,Intermediate,CHEMBL619726,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
8991,Rattus norvegicus,Intermediate,CHEMBL619727,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
8992,Rattus norvegicus,Intermediate,CHEMBL619728,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
8993,Rattus norvegicus,Intermediate,CHEMBL619729,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
8994,Rattus norvegicus,Intermediate,CHEMBL619730,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8995,Rattus norvegicus,Intermediate,CHEMBL619731,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8996,Rattus norvegicus,Intermediate,CHEMBL619732,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
8997,Rattus norvegicus,Intermediate,CHEMBL619733,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8998,Rattus norvegicus,Intermediate,CHEMBL619734,,,50597,2385.0,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
8999,Rattus norvegicus,Intermediate,CHEMBL619735,,,50597,14.0,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9000,Rattus norvegicus,Intermediate,CHEMBL875330,,,50597,14.0,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9001,Rattus norvegicus,Intermediate,CHEMBL628465,,,50597,14.0,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
9002,Rattus norvegicus,Intermediate,CHEMBL628466,,,50597,14.0,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9003,Rattus norvegicus,Intermediate,CHEMBL628467,,,50597,14.0,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9004,Rattus norvegicus,Intermediate,CHEMBL628468,,,50597,2106.0,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9005,Rattus norvegicus,Intermediate,CHEMBL628469,,,50597,2106.0,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9006,Rattus norvegicus,Intermediate,CHEMBL628470,,,50597,2106.0,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
9007,Rattus norvegicus,Intermediate,CHEMBL628471,,,50597,2106.0,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9008,Rattus norvegicus,Intermediate,CHEMBL628472,,,50597,2106.0,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9009,Rattus norvegicus,Intermediate,CHEMBL625191,,,50597,2046.0,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9010,Rattus norvegicus,Intermediate,CHEMBL625192,,,50597,2046.0,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9011,Rattus norvegicus,Intermediate,CHEMBL875337,,,50597,2046.0,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,1,1,,BAO_0000218
9012,Rattus norvegicus,Intermediate,CHEMBL626341,,,50597,2046.0,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9013,Rattus norvegicus,Intermediate,CHEMBL626342,,,50597,2046.0,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9014,Rattus norvegicus,Intermediate,CHEMBL621943,,,50597,2107.0,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,1,1,,BAO_0000218
9015,Rattus norvegicus,Intermediate,CHEMBL621944,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
9016,Rattus norvegicus,Intermediate,CHEMBL621945,,,50597,,A,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,N,1,1,,BAO_0000218
9017,Rattus norvegicus,Intermediate,CHEMBL621946,,,50597,,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,N,1,1,,BAO_0000218
9018,Rattus norvegicus,Intermediate,CHEMBL621947,,,50597,,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,1,1,,BAO_0000218
9019,Rattus norvegicus,Intermediate,CHEMBL621948,,,50597,,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,N,1,1,,BAO_0000218
9020,Rattus norvegicus,Intermediate,CHEMBL621949,,,50597,,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,1,1,,BAO_0000218
9021,Rattus norvegicus,Intermediate,CHEMBL621950,,,50597,,A,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,N,1,1,,BAO_0000218
9022,Rattus norvegicus,Intermediate,CHEMBL621951,,,50597,,A,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,N,1,1,,BAO_0000218
9023,Rattus norvegicus,Intermediate,CHEMBL621952,,,50597,178.0,A,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,N,1,1,,BAO_0000218
9024,Rattus norvegicus,Intermediate,CHEMBL621953,,,50597,2107.0,A,,Stability (%) in rat liver microsomes,,N,1,1,,BAO_0000218
9025,Rattus norvegicus,Intermediate,CHEMBL621954,,,50597,,A,,Area under curve was calculated after intravenous administration,,N,1,1,,BAO_0000218
9026,Rattus norvegicus,Intermediate,CHEMBL621955,,,50597,,A,,Area under the curve was calculated after iv administration in rat,,N,1,1,,BAO_0000218
9027,Rattus norvegicus,Intermediate,CHEMBL621956,,,50597,,A,,Area under the curve was calculated in rat after peroral administration,,N,1,1,,BAO_0000218
9028,Rattus norvegicus,Intermediate,CHEMBL621957,,,50597,,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,1,1,,BAO_0000218
9029,Rattus norvegicus,Intermediate,CHEMBL621958,,,50597,,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,N,1,1,,BAO_0000218
9030,Rattus norvegicus,Intermediate,CHEMBL621959,,,50597,,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,N,1,1,,BAO_0000218
9031,Rattus norvegicus,Intermediate,CHEMBL621960,,,50597,,A,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,N,1,1,,BAO_0000218
9032,Rattus norvegicus,Intermediate,CHEMBL621961,,,50597,,A,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,N,1,1,,BAO_0000218
9033,Rattus norvegicus,Intermediate,CHEMBL621962,,,50597,,A,,p value of the compound,,N,1,1,,BAO_0000218
9034,Rattus norvegicus,Intermediate,CHEMBL876787,,,50597,,F,,p value of the compound,,N,1,1,,BAO_0000218
9035,Rattus norvegicus,Intermediate,CHEMBL621963,,,50597,,A,,p value of the compound,,N,1,1,,BAO_0000218
9036,Rattus norvegicus,Intermediate,CHEMBL622637,,,50597,945.0,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9037,Rattus norvegicus,Intermediate,CHEMBL622638,,,50597,945.0,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9038,Rattus norvegicus,Intermediate,CHEMBL626561,,,50597,945.0,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9039,Oryctolagus cuniculus,Autocuration,CHEMBL626562,,,22224,,F,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,U,0,1,,BAO_0000019
9040,Oryctolagus cuniculus,Autocuration,CHEMBL626563,,,22224,,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,U,0,1,,BAO_0000218
9041,Oryctolagus cuniculus,Autocuration,CHEMBL626564,,,22224,,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,U,0,1,,BAO_0000218
9042,Oryctolagus cuniculus,Autocuration,CHEMBL626565,,,22224,,A,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,0,1,,BAO_0000218
9043,Oryctolagus cuniculus,Autocuration,CHEMBL626566,,,22224,,A,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,0,1,,BAO_0000218
9044,Oryctolagus cuniculus,Autocuration,CHEMBL626567,,,22224,,A,,Clearance rate in rabbits,,U,0,1,,BAO_0000218
9045,Oryctolagus cuniculus,Autocuration,CHEMBL626568,,,22224,,A,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,0,1,,BAO_0000218
9046,Oryctolagus cuniculus,Autocuration,CHEMBL626569,,,22224,,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,0,1,,BAO_0000218
9047,Oryctolagus cuniculus,Autocuration,CHEMBL626570,,,22224,,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,0,1,,BAO_0000218
9048,Oryctolagus cuniculus,Autocuration,CHEMBL626571,,,22224,,A,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,0,1,,BAO_0000218
9049,Oryctolagus cuniculus,Autocuration,CHEMBL626572,,,22224,,A,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,U,0,1,,BAO_0000218
9050,Oryctolagus cuniculus,Autocuration,CHEMBL626573,,,22224,1969.0,A,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,0,1,,BAO_0000218
9051,Oryctolagus cuniculus,Autocuration,CHEMBL626574,,,22224,2107.0,A,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,U,0,1,,BAO_0000251
9052,Oryctolagus cuniculus,Autocuration,CHEMBL626575,,,22224,2107.0,A,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,U,0,1,,BAO_0000251
9053,Oryctolagus cuniculus,Autocuration,CHEMBL626576,,,22224,,A,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,U,0,1,,BAO_0000218
9054,Oryctolagus cuniculus,Autocuration,CHEMBL626577,,,22224,,A,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,U,0,1,,BAO_0000218
9055,Oryctolagus cuniculus,Autocuration,CHEMBL626578,,,22224,,A,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,U,0,1,,BAO_0000218
9056,Oryctolagus cuniculus,Autocuration,CHEMBL625263,,,22224,,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,0,1,,BAO_0000218
9057,Oryctolagus cuniculus,Autocuration,CHEMBL625264,,,22224,,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,0,1,,BAO_0000218
9058,Oryctolagus cuniculus,Autocuration,CHEMBL625265,,,22224,,A,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,0,1,,BAO_0000218
9059,Oryctolagus cuniculus,Autocuration,CHEMBL625266,,,22224,,A,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,U,0,1,,BAO_0000251
9060,Oryctolagus cuniculus,Autocuration,CHEMBL876796,,,22224,,A,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,U,0,1,,BAO_0000251
9061,Oryctolagus cuniculus,Autocuration,CHEMBL625267,,,22224,,A,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,U,0,1,,BAO_0000218
9062,Oryctolagus cuniculus,Autocuration,CHEMBL625268,,,22224,1969.0,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,0,1,,BAO_0000218
9063,Oryctolagus cuniculus,Autocuration,CHEMBL625269,,,22224,1969.0,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,0,1,,BAO_0000218
9064,Oryctolagus cuniculus,Autocuration,CHEMBL624689,,,22224,1969.0,A,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,0,1,,BAO_0000218
9065,Oryctolagus cuniculus,Autocuration,CHEMBL624690,,,22224,,A,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,U,0,1,,BAO_0000218
9066,Oryctolagus cuniculus,Autocuration,CHEMBL624691,,,22224,1088.0,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,U,0,1,,BAO_0000218
9067,Oryctolagus cuniculus,Autocuration,CHEMBL624692,,,22224,1088.0,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,U,0,1,,BAO_0000218
9068,Oryctolagus cuniculus,Autocuration,CHEMBL624693,,,22224,,A,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,0,1,,BAO_0000218
9069,Oryctolagus cuniculus,Autocuration,CHEMBL624694,,,22224,,A,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,U,0,1,,BAO_0000218
9070,Oryctolagus cuniculus,Autocuration,CHEMBL877596,,,22224,,A,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,U,0,1,,BAO_0000221
9071,Oryctolagus cuniculus,Autocuration,CHEMBL624695,,,22224,,A,,Time within which only 10% of the drug was degraded,,U,0,1,,BAO_0000019
9072,Oryctolagus cuniculus,Autocuration,CHEMBL624696,,,22224,2107.0,A,,Half life period in rabbit liver homogenate,,U,0,1,,BAO_0000221
9073,Oryctolagus cuniculus,Autocuration,CHEMBL624697,,,22224,,A,,Half life value in rabbits,,U,0,1,,BAO_0000019
9074,Oryctolagus cuniculus,Autocuration,CHEMBL624698,,,22224,178.0,A,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,0,1,,BAO_0000218
9075,Oryctolagus cuniculus,Autocuration,CHEMBL624699,,,22224,178.0,A,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,0,1,,BAO_0000218
9076,Oryctolagus cuniculus,Autocuration,CHEMBL624700,,,22224,,A,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,U,0,1,,BAO_0000218
9077,Rattus norvegicus,Intermediate,CHEMBL622903,,,50597,1969.0,A,,AUC 0-8 hr value in rats at 10 mg/kg,,N,1,1,,BAO_0000218
9078,Rattus norvegicus,Intermediate,CHEMBL622904,,,50597,1969.0,A,,AUC after administration at 2000 mg/kg/day in rats,,N,1,1,,BAO_0000218
9079,Rattus norvegicus,Intermediate,CHEMBL622905,,,50597,1969.0,A,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,N,1,1,,BAO_0000218
9080,Rattus norvegicus,Intermediate,CHEMBL622906,,,50597,1969.0,A,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1,1,,BAO_0000218
9081,Rattus norvegicus,Intermediate,CHEMBL622907,,,50597,1969.0,A,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1,1,,BAO_0000218
9082,Rattus norvegicus,Intermediate,CHEMBL622908,,,50597,1969.0,A,,AUC in rat after oral administration at 10.5 mg/kg dose,,N,1,1,,BAO_0000218
9083,Rattus norvegicus,Intermediate,CHEMBL622909,,,50597,1969.0,A,,AUC in rat after oral administration at 11.2 mg/kg dose,,N,1,1,,BAO_0000218
9084,Rattus norvegicus,Intermediate,CHEMBL622910,,,50597,1969.0,A,,AUC in rat after oral administration at 9.7 mg/kg dose,,N,1,1,,BAO_0000218
9085,Rattus norvegicus,Intermediate,CHEMBL622911,,,50597,955.0,A,,AUC in rat brain after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
9086,Rattus norvegicus,Intermediate,CHEMBL622912,,,50597,1969.0,A,,AUC in rat p.o.,,N,1,1,,BAO_0000218
9087,Rattus norvegicus,Intermediate,CHEMBL622913,,,50597,1969.0,A,,AUC in rat p.o. at 20 mg/kg concentration,,N,1,1,,BAO_0000218
9088,Rattus norvegicus,Intermediate,CHEMBL622914,,,50597,1969.0,A,,AUC in rat plasma after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
9089,Rattus norvegicus,Intermediate,CHEMBL622915,,,50597,1969.0,A,,AUC in rats,,N,1,1,,BAO_0000218
9090,Rattus norvegicus,Intermediate,CHEMBL622916,,,50597,1969.0,A,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,N,1,1,,BAO_0000218
9091,Rattus norvegicus,Intermediate,CHEMBL622917,,,50597,1969.0,A,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,N,1,1,,BAO_0000218
9092,Rattus norvegicus,Intermediate,CHEMBL622918,,,50597,1969.0,A,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,1,1,,BAO_0000218
9093,Rattus norvegicus,Intermediate,CHEMBL622919,,,50597,1969.0,A,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,N,1,1,,BAO_0000218
9094,Rattus norvegicus,Intermediate,CHEMBL622920,,,50597,1969.0,A,,Maximum plasma concentration was evaluated in rat,,N,1,1,,BAO_0000218
9095,Rattus norvegicus,Intermediate,CHEMBL622921,,,50597,1969.0,A,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,1,1,,BAO_0000218
9096,Rattus norvegicus,Intermediate,CHEMBL622922,,,50597,1969.0,A,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,N,1,1,,BAO_0000218
9097,Rattus norvegicus,Intermediate,CHEMBL622923,,,50597,1969.0,A,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,1,1,,BAO_0000218
9098,Rattus norvegicus,Intermediate,CHEMBL877604,,,50597,1969.0,A,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
9099,Rattus norvegicus,Intermediate,CHEMBL622924,,,50597,1969.0,A,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,N,1,1,,BAO_0000218
9100,Rattus norvegicus,Intermediate,CHEMBL622925,,,50597,1969.0,A,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
9101,Rattus norvegicus,Intermediate,CHEMBL622926,,,50597,1969.0,A,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,N,1,1,,BAO_0000218
9102,Rattus norvegicus,Intermediate,CHEMBL623625,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9103,Rattus norvegicus,Expert,CHEMBL623626,,,50597,1969.0,A,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9104,Rattus norvegicus,Intermediate,CHEMBL623627,,,50597,1969.0,A,,Maximum plasma drug concentration was determined,,N,1,1,,BAO_0000218
9105,Rattus norvegicus,Intermediate,CHEMBL623628,,,50597,,A,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,N,1,1,,BAO_0000218
9106,Rattus norvegicus,Intermediate,CHEMBL623629,,,50597,1969.0,A,,Mean peak plasma concentration was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
9107,Rattus norvegicus,Intermediate,CHEMBL623630,,,50597,1969.0,A,,Mean peak plasma concentration was observed after oral administration in rat,,N,1,1,,BAO_0000218
9108,Rattus norvegicus,Intermediate,CHEMBL623804,,,50597,,A,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,N,1,1,,BAO_0000218
9109,Rattus norvegicus,Intermediate,CHEMBL623805,,,50597,,A,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
9110,Rattus norvegicus,Intermediate,CHEMBL623806,,,50597,1969.0,A,,Peak oral plasma concentration was determined in rats by oral administration,,N,1,1,,BAO_0000218
9111,Rattus norvegicus,Intermediate,CHEMBL623807,,,50597,1969.0,A,,Peak plasma concentration (Cmax) was determined,,N,1,1,,BAO_0000218
9112,Rattus norvegicus,Intermediate,CHEMBL623808,,,50597,1969.0,A,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
9113,Rattus norvegicus,Intermediate,CHEMBL623809,,,50597,1969.0,A,,Peak plasma concentration (Cmax) in rats,,N,1,1,,BAO_0000218
9114,Rattus norvegicus,Intermediate,CHEMBL623810,,,50597,1969.0,A,,Peak plasma concentration at 1 mg/kg peroral administration,,N,1,1,,BAO_0000218
9115,Rattus norvegicus,Intermediate,CHEMBL623811,,,50597,1969.0,A,,Peak plasma concentration in rat,,N,1,1,,BAO_0000218
9116,Rattus norvegicus,Intermediate,CHEMBL623812,,,50597,1969.0,A,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
9117,Rattus norvegicus,Intermediate,CHEMBL877605,,,50597,,A,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,N,1,1,,BAO_0000218
9118,Rattus norvegicus,Intermediate,CHEMBL623813,,,50597,,A,,Pharmacokinetic property (Cmax) in rat,,N,1,1,,BAO_0000218
9119,Rattus norvegicus,Intermediate,CHEMBL623814,,,50597,,A,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,1,1,,BAO_0000218
9120,Rattus norvegicus,Intermediate,CHEMBL623815,,,50597,,A,,Cmax in rat after 3mg/kg oral dose,,N,1,1,,BAO_0000218
9121,Rattus norvegicus,Intermediate,CHEMBL623816,,,50597,,A,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,N,1,1,,BAO_0000218
9122,Rattus norvegicus,Intermediate,CHEMBL623145,,,50597,,A,,Cmax in rats after 20 mg/kg oral dose,,N,1,1,,BAO_0000218
9123,Rattus norvegicus,Intermediate,CHEMBL623146,,,50597,1969.0,A,,Cmax in rat plasma after 30mg/kg oral dose,,N,1,1,,BAO_0000218
9124,Rattus norvegicus,Intermediate,CHEMBL623147,,,50597,1969.0,A,,Plasma concentration after oral administration of 100 mg/kg to rats,,N,1,1,,BAO_0000218
9125,Rattus norvegicus,Intermediate,CHEMBL623042,,,50597,955.0,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,1,1,,BAO_0000218
9126,Rattus norvegicus,Intermediate,CHEMBL623043,,,50597,,A,,Tested for the Cmax in rat at 10 mg/kg per orally,,N,1,1,,BAO_0000218
9127,Rattus norvegicus,Intermediate,CHEMBL623044,,,50597,,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9128,Rattus norvegicus,Intermediate,CHEMBL623045,,,50597,,A,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9129,Rattus norvegicus,Intermediate,CHEMBL623046,,,50597,,A,,Bioavailability as oral Cmax in rats at 30 mins,,N,1,1,,BAO_0000218
9130,Rattus norvegicus,Intermediate,CHEMBL623226,,,50597,,A,,Bioavailability as oral Cmax in rats at 6hr,,N,1,1,,BAO_0000218
9131,Rattus norvegicus,Intermediate,CHEMBL623227,,,50597,,A,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,N,1,1,,BAO_0000218
9132,Rattus norvegicus,Intermediate,CHEMBL623228,,,50597,,A,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,N,1,1,,BAO_0000218
9133,Rattus norvegicus,Intermediate,CHEMBL623229,,,50597,,A,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,N,1,1,,BAO_0000218
9134,Rattus norvegicus,Intermediate,CHEMBL623230,,,50597,1969.0,A,,The maximum plasma levels for the compounds were determined by LC-MS.,,N,1,1,,BAO_0000218
9135,Rattus norvegicus,Intermediate,CHEMBL623231,,,50597,1969.0,A,,mean peak plasma concentration was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
9136,Rattus norvegicus,Intermediate,CHEMBL623232,,,50597,1969.0,A,,mean peak plasma concentration was observed after oral administration in rat,,N,1,1,,BAO_0000218
9137,Rattus norvegicus,Intermediate,CHEMBL623233,,,50597,,A,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
9138,Rattus norvegicus,Intermediate,CHEMBL623234,,,50597,,A,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,N,1,1,,BAO_0000218
9139,Rattus norvegicus,Intermediate,CHEMBL623235,,,50597,,A,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,N,1,1,,BAO_0000218
9140,Rattus norvegicus,Intermediate,CHEMBL623236,,,50597,,A,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,N,1,1,,BAO_0000218
9141,Rattus norvegicus,Intermediate,CHEMBL623237,,,50597,,A,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,N,1,1,,BAO_0000218
9142,Rattus norvegicus,Intermediate,CHEMBL623238,,,50597,,A,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,N,1,1,,BAO_0000218
9143,Rattus norvegicus,Intermediate,CHEMBL623239,,,50597,,A,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,N,1,1,,BAO_0000218
9144,Rattus norvegicus,Intermediate,CHEMBL623240,,,22224,1969.0,A,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,U,0,1,,BAO_0000218
9145,Rattus norvegicus,Intermediate,CHEMBL623241,,,50597,1898.0,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,N,1,1,,BAO_0000218
9146,Rattus norvegicus,Intermediate,CHEMBL623242,,,50597,1898.0,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,N,1,1,,BAO_0000218
9147,Rattus norvegicus,Intermediate,CHEMBL874394,,,50597,,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,N,1,1,,BAO_0000218
9148,Rattus norvegicus,Intermediate,CHEMBL623243,,,50597,,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,N,1,1,,BAO_0000218
9149,Rattus norvegicus,Intermediate,CHEMBL623244,,,50597,,A,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9150,Rattus norvegicus,Intermediate,CHEMBL623245,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9151,Rattus norvegicus,Intermediate,CHEMBL623246,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9152,Rattus norvegicus,Intermediate,CHEMBL623247,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9153,Rattus norvegicus,Intermediate,CHEMBL623248,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9154,Rattus norvegicus,Intermediate,CHEMBL623249,,,50597,2113.0,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9155,Rattus norvegicus,Intermediate,CHEMBL625072,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9156,Rattus norvegicus,Intermediate,CHEMBL625073,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9157,Rattus norvegicus,Intermediate,CHEMBL625074,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9158,Rattus norvegicus,Intermediate,CHEMBL625075,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9159,Rattus norvegicus,Intermediate,CHEMBL625076,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9160,Rattus norvegicus,Intermediate,CHEMBL625077,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9161,Rattus norvegicus,Intermediate,CHEMBL625078,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9162,Rattus norvegicus,Intermediate,CHEMBL874395,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9163,Rattus norvegicus,Intermediate,CHEMBL625079,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9164,Rattus norvegicus,Intermediate,CHEMBL625080,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9165,Rattus norvegicus,Intermediate,CHEMBL625081,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9166,Rattus norvegicus,Intermediate,CHEMBL625082,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9167,Rattus norvegicus,Intermediate,CHEMBL625083,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9168,Rattus norvegicus,Intermediate,CHEMBL625084,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9169,Rattus norvegicus,Intermediate,CHEMBL625085,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9170,Rattus norvegicus,Intermediate,CHEMBL625086,,,50597,2107.0,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9171,Rattus norvegicus,Intermediate,CHEMBL625087,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9172,Rattus norvegicus,Intermediate,CHEMBL625088,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9173,Rattus norvegicus,Intermediate,CHEMBL622205,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9174,Rattus norvegicus,Intermediate,CHEMBL622206,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9175,Rattus norvegicus,Intermediate,CHEMBL622207,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9176,Rattus norvegicus,Intermediate,CHEMBL622366,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9177,Rattus norvegicus,Intermediate,CHEMBL622367,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9178,Rattus norvegicus,Intermediate,CHEMBL875331,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9179,Rattus norvegicus,Intermediate,CHEMBL622368,,,50597,2107.0,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9180,Rattus norvegicus,Intermediate,CHEMBL622369,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9181,Rattus norvegicus,Intermediate,CHEMBL622370,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9182,Rattus norvegicus,Intermediate,CHEMBL622371,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9183,Rattus norvegicus,Intermediate,CHEMBL622372,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9184,Rattus norvegicus,Intermediate,CHEMBL622373,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9185,Rattus norvegicus,Intermediate,CHEMBL622374,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9186,Rattus norvegicus,Intermediate,CHEMBL622375,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9187,Rattus norvegicus,Intermediate,CHEMBL622376,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9188,Rattus norvegicus,Intermediate,CHEMBL622377,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9189,Rattus norvegicus,Intermediate,CHEMBL622378,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9190,Rattus norvegicus,Intermediate,CHEMBL622379,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9191,Rattus norvegicus,Intermediate,CHEMBL622380,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9192,Rattus norvegicus,Intermediate,CHEMBL622381,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9193,Rattus norvegicus,Intermediate,CHEMBL622382,,,50597,2048.0,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9194,Rattus norvegicus,Intermediate,CHEMBL622383,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9195,Rattus norvegicus,Intermediate,CHEMBL875332,,,50597,945.0,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9196,Rattus norvegicus,Intermediate,CHEMBL622384,,,50597,945.0,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9197,Rattus norvegicus,Intermediate,CHEMBL622385,,,50597,945.0,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9198,Rattus norvegicus,Intermediate,CHEMBL622386,,,50597,945.0,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,1,1,,BAO_0000218
9199,Rattus norvegicus,Intermediate,CHEMBL622387,,,50597,,A,,The compound was tested for the plasma binding in rat,,N,1,1,,BAO_0000218
9200,Rattus norvegicus,Intermediate,CHEMBL622388,,,50597,,A,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,N,1,1,,BAO_0000218
9201,Rattus norvegicus,Intermediate,CHEMBL622389,,,50597,,A,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,N,1,1,,BAO_0000218
9202,Rattus norvegicus,Intermediate,CHEMBL622390,,,50597,,A,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,N,1,1,,BAO_0000218
9203,Rattus norvegicus,Intermediate,CHEMBL622391,,,50597,,A,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,N,1,1,,BAO_0000218
9204,Rattus norvegicus,Intermediate,CHEMBL622392,,,50597,,A,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,N,1,1,,BAO_0000218
9205,Rattus norvegicus,Intermediate,CHEMBL622393,,,50597,,A,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,N,1,1,,BAO_0000218
9206,Rattus norvegicus,Intermediate,CHEMBL622394,,,50597,,A,,Plasma level at 2 hr after administration of the compound,,N,1,1,,BAO_0000218
9207,Rattus norvegicus,Intermediate,CHEMBL622395,,,50597,,A,,plasma level at 2 hr after administration of the compound,,N,1,1,,BAO_0000218
9208,Rattus norvegicus,Intermediate,CHEMBL622396,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 1 min,,N,1,1,,BAO_0000218
9209,Rattus norvegicus,Intermediate,CHEMBL624894,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 10 min,,N,1,1,,BAO_0000218
9210,Rattus norvegicus,Intermediate,CHEMBL624895,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 10 mins,,N,1,1,,BAO_0000218
9211,Rattus norvegicus,Intermediate,CHEMBL624058,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 2 hr,,N,1,1,,BAO_0000218
9212,Rattus norvegicus,Intermediate,CHEMBL624059,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 3 min,,N,1,1,,BAO_0000218
9213,Rattus norvegicus,Intermediate,CHEMBL624060,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 3 mins,,N,1,1,,BAO_0000218
9214,Rattus norvegicus,Intermediate,CHEMBL624061,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 5 min,,N,1,1,,BAO_0000218
9215,Rattus norvegicus,Intermediate,CHEMBL624062,,,50597,1977.0,A,,Stability in rat serum measured as % recovery at 5 mins,,N,1,1,,BAO_0000218
9216,Rattus norvegicus,Intermediate,CHEMBL624063,,,50597,,A,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9217,Rattus norvegicus,Intermediate,CHEMBL624064,,,50597,,A,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9218,Rattus norvegicus,Intermediate,CHEMBL624065,,,50597,1969.0,A,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,N,1,1,,BAO_0000218
9219,Rattus norvegicus,Intermediate,CHEMBL624066,,,50597,1969.0,A,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,N,1,1,,BAO_0000218
9220,Rattus norvegicus,Intermediate,CHEMBL877490,,,50597,,A,,Half life tested in mature male rat at a dose of 30 mg/kg,,N,1,1,,BAO_0000218
9221,Rattus norvegicus,Intermediate,CHEMBL874442,,,50597,,A,,Half life after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
9222,Rattus norvegicus,Intermediate,CHEMBL626890,,,50597,,A,,Half life period after administration (30 mg/kg) in rat,,N,1,1,,BAO_0000218
9223,Rattus norvegicus,Intermediate,CHEMBL626891,,,50597,,A,,Half life period in rat after 5 mg/Kg dose,,N,1,1,,BAO_0000218
9224,Rattus norvegicus,Intermediate,CHEMBL626892,,,50597,,A,,Half life period in rat after 5 mg/kg dose,,N,1,1,,BAO_0000218
9225,Rattus norvegicus,Intermediate,CHEMBL626893,,,50597,,A,,Half life period was determined,,N,1,1,,BAO_0000218
9226,Rattus norvegicus,Intermediate,CHEMBL626894,,,50597,,A,,Half life period was evaluated in rat,,N,1,1,,BAO_0000218
9227,Rattus norvegicus,Intermediate,CHEMBL626895,,,50597,,A,,Half life period was evaluated in rat; 0.5-1.0,,N,1,1,,BAO_0000218
9228,Rattus norvegicus,Intermediate,CHEMBL626896,,,50597,,A,,Half life period was evaluated in rat; 5.9-7.5,,N,1,1,,BAO_0000218
9229,Rattus norvegicus,Intermediate,CHEMBL626897,,,50597,1969.0,A,,Half-life in rat plasma,,N,1,1,,BAO_0000218
9230,Rattus norvegicus,Intermediate,CHEMBL626898,,,50597,,A,,Half-life time in rat was determined,,N,1,1,,BAO_0000218
9231,Rattus norvegicus,Intermediate,CHEMBL626899,,,50597,,A,,Terminal half-life after iv administration to rats,,N,1,1,,BAO_0000218
9232,Rattus norvegicus,Intermediate,CHEMBL626900,,,50597,,A,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,N,1,1,,BAO_0000218
9233,Rattus norvegicus,Intermediate,CHEMBL626901,,,50597,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,N,1,1,,BAO_0000218
9234,Rattus norvegicus,Intermediate,CHEMBL626902,,,50597,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,N,1,1,,BAO_0000218
9235,Rattus norvegicus,Intermediate,CHEMBL626903,,,50597,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,N,1,1,,BAO_0000218
9236,Rattus norvegicus,Intermediate,CHEMBL874443,,,50597,,A,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,N,1,1,,BAO_0000218
9237,Rattus norvegicus,Intermediate,CHEMBL626904,,,50597,,A,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
9238,Rattus norvegicus,Intermediate,CHEMBL626905,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
9239,Rattus norvegicus,Intermediate,CHEMBL873830,,,50597,1969.0,A,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,1,1,,BAO_0000218
9240,Rattus norvegicus,Intermediate,CHEMBL626906,,,50597,,A,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,N,1,1,,BAO_0000218
9241,Rattus norvegicus,Intermediate,CHEMBL631076,,,50597,1969.0,A,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,1,1,,BAO_0000218
9242,Rattus norvegicus,Intermediate,CHEMBL631077,,,50597,1969.0,A,,Biological half-life was measured in plasma of rats,,N,1,1,,BAO_0000218
9243,Rattus norvegicus,Intermediate,CHEMBL631078,,,50597,,A,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,1,1,,BAO_0000218
9244,Rattus norvegicus,Intermediate,CHEMBL631079,,,50597,,A,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,N,1,1,,BAO_0000218
9245,Rattus norvegicus,Intermediate,CHEMBL631080,,,50597,,A,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,N,1,1,,BAO_0000218
9246,Rattus norvegicus,Intermediate,CHEMBL631081,,,50597,,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,N,1,1,,BAO_0000218
9247,Rattus norvegicus,Intermediate,CHEMBL631239,,,50597,,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,N,1,1,,BAO_0000218
9248,Rattus norvegicus,Intermediate,CHEMBL631240,,,50597,1969.0,A,,Compound was evaluated for plasma half life in rat,,N,1,1,,BAO_0000218
9249,Rattus norvegicus,Intermediate,CHEMBL631241,,,50597,1969.0,A,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,N,1,1,,BAO_0000218
9250,Rattus norvegicus,Intermediate,CHEMBL631242,,,50597,1969.0,A,,AUC value after administration of 20 mg/Kg oral dose in rat,,N,1,1,,BAO_0000218
9251,Rattus norvegicus,Intermediate,CHEMBL631243,,,50597,1969.0,A,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,N,1,1,,BAO_0000218
9252,Rattus norvegicus,Intermediate,CHEMBL874444,,,50597,1969.0,A,,AUC0-96 after administration at 50 mg/kg,,N,1,1,,BAO_0000218
9253,Rattus norvegicus,Intermediate,CHEMBL631244,,,50597,1969.0,A,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,N,1,1,,BAO_0000218
9254,Rattus norvegicus,Intermediate,CHEMBL631245,,,50597,,A,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,N,1,1,,BAO_0000218
9255,Rattus norvegicus,Intermediate,CHEMBL627162,,,50597,,A,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,N,1,1,,BAO_0000218
9256,Rattus norvegicus,Intermediate,CHEMBL627163,,,50597,,A,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,N,1,1,,BAO_0000218
9257,Rattus norvegicus,Intermediate,CHEMBL627164,,,50597,,A,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,N,1,1,,BAO_0000218
9258,Rattus norvegicus,Intermediate,CHEMBL627165,,,50597,2113.0,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,N,1,1,,BAO_0000218
9259,Rattus norvegicus,Intermediate,CHEMBL627166,,,50597,,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,N,1,1,,BAO_0000218
9260,Rattus norvegicus,Intermediate,CHEMBL627167,,,50597,,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,N,1,1,,BAO_0000218
9261,Rattus norvegicus,Intermediate,CHEMBL627822,,,50597,,A,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,N,1,1,,BAO_0000218
9262,Rattus norvegicus,Intermediate,CHEMBL627823,,,50597,,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
9263,Rattus norvegicus,Intermediate,CHEMBL627824,,,50597,,A,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,N,1,1,,BAO_0000218
9264,Rattus norvegicus,Intermediate,CHEMBL627825,,,50597,,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,1,1,,BAO_0000218
9265,Rattus norvegicus,Intermediate,CHEMBL627826,,,50597,,A,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,N,1,1,,BAO_0000218
9266,Rattus norvegicus,Intermediate,CHEMBL627827,,,50597,,A,,Area under curve (Pharmacokinetic property) was determined,,N,1,1,,BAO_0000218
9267,Rattus norvegicus,Intermediate,CHEMBL627828,,,50597,,A,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,N,1,1,,BAO_0000218
9268,Rattus norvegicus,Intermediate,CHEMBL627829,,,50597,,A,,Area under curve after intravenous administration (1 mg/kg) in rat,,N,1,1,,BAO_0000218
9269,Rattus norvegicus,Intermediate,CHEMBL627830,,,50597,,A,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,N,1,1,,BAO_0000218
9270,Rattus norvegicus,Intermediate,CHEMBL627831,,,50597,,A,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,N,1,1,,BAO_0000218
9271,Rattus norvegicus,Intermediate,CHEMBL627832,,,50597,,A,,Area under curve in male SD rats was observed after oral administration in rat,,N,1,1,,BAO_0000218
9272,Rattus norvegicus,Intermediate,CHEMBL627833,,,50597,,A,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,N,1,1,,BAO_0000218
9273,Rattus norvegicus,Expert,CHEMBL627834,,,50597,,A,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9274,Rattus norvegicus,Expert,CHEMBL628004,,,50597,,A,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9275,Rattus norvegicus,Intermediate,CHEMBL628005,,,50597,,A,,Area under curve at 5 mg/kg po was determined in rat,,N,1,1,,BAO_0000218
9276,Rattus norvegicus,Intermediate,CHEMBL628006,,,50597,,A,,Area under curve in Rat at a oral dose of 5 mg/kg,,N,1,1,,BAO_0000218
9277,Rattus norvegicus,Intermediate,CHEMBL628007,,,50597,,A,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,1,1,,BAO_0000218
9278,Rattus norvegicus,Intermediate,CHEMBL625676,,,50597,,A,,Area under curve was determined,,N,1,1,,BAO_0000218
9279,Rattus norvegicus,Intermediate,CHEMBL631309,,,50597,,A,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,N,1,1,,BAO_0000218
9280,Rattus norvegicus,Intermediate,CHEMBL631310,,,50597,,A,,Area under curve after intravenous administration at 3 mg/kg,,N,1,1,,BAO_0000218
9281,Rattus norvegicus,Intermediate,CHEMBL631311,,,50597,,A,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,N,1,1,,BAO_0000218
9282,Rattus norvegicus,Intermediate,CHEMBL631312,,,50597,,A,,Area under curve at 4 hr in rat,,N,1,1,,BAO_0000218
9283,Rattus norvegicus,Intermediate,CHEMBL631313,,,50597,,A,,Area under curve at a dose of 30 mg/kg,,N,1,1,,BAO_0000218
9284,Rattus norvegicus,Intermediate,CHEMBL631314,,,50597,,A,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
9285,Rattus norvegicus,Intermediate,CHEMBL631315,,,50597,,A,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
9286,Rattus norvegicus,Intermediate,CHEMBL631316,,,50597,,A,,Area under curve for a 2-mpk po dose in SD rats,,N,1,1,,BAO_0000218
9287,Rattus norvegicus,Intermediate,CHEMBL631317,,,50597,,A,,Area under curve in SD rats,,N,1,1,,BAO_0000218
9288,Rattus norvegicus,Intermediate,CHEMBL874471,,,50597,,A,,Area under curve in rat after oral administration at 13 mg/kg dose,,N,1,1,,BAO_0000218
9289,Rattus norvegicus,Intermediate,CHEMBL631318,,,50597,,A,,Area under curve in rat by po administration at 0-24 hr,,N,1,1,,BAO_0000218
9290,Rattus norvegicus,Intermediate,CHEMBL631319,,,50597,1969.0,A,,Area under curve in rat plasma,,N,1,1,,BAO_0000218
9291,Rattus norvegicus,Intermediate,CHEMBL631320,,,50597,,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,N,1,1,,BAO_0000218
9292,Rattus norvegicus,Intermediate,CHEMBL631321,,,50597,,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,N,1,1,,BAO_0000218
9293,Rattus norvegicus,Intermediate,CHEMBL631322,,,50597,,A,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,N,1,1,,BAO_0000218
9294,Rattus norvegicus,Intermediate,CHEMBL631323,,,50597,,A,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,N,1,1,,BAO_0000218
9295,Rattus norvegicus,Intermediate,CHEMBL631324,,,50597,,A,,Area under curve value in rat at a dose of 5 mg/kg,,N,1,1,,BAO_0000218
9296,Rattus norvegicus,Intermediate,CHEMBL631325,,,50597,,A,,Area under curve was determined after oral administration in rats,,N,1,1,,BAO_0000218
9297,Rattus norvegicus,Intermediate,CHEMBL631326,,,50597,,A,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
9298,Rattus norvegicus,Intermediate,CHEMBL631327,,,50597,,A,,Area under curve was determined after peroral administration in rat,,N,1,1,,BAO_0000218
9299,Rattus norvegicus,Intermediate,CHEMBL631328,,,50597,,A,,Area under curve was determined at a dose 30 mpk administered orally.,,N,1,1,,BAO_0000218
9300,Rattus norvegicus,Intermediate,CHEMBL631329,,,50597,,A,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
9301,Rattus norvegicus,Intermediate,CHEMBL627217,,,50597,,A,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,N,1,1,,BAO_0000218
9302,Rattus norvegicus,Intermediate,CHEMBL626352,,,50597,,A,,Area under curve was determined in male rat,,N,1,1,,BAO_0000218
9303,Rattus norvegicus,Intermediate,CHEMBL626353,,,50597,,A,,Area under curve was determined in rat after PO administration,,N,1,1,,BAO_0000218
9304,Rattus norvegicus,Intermediate,CHEMBL626354,,,50597,,A,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,N,1,1,,BAO_0000218
9305,Rattus norvegicus,Intermediate,CHEMBL626355,,,50597,,A,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,N,1,1,,BAO_0000218
9306,Rattus norvegicus,Intermediate,CHEMBL626356,,,50597,,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,N,1,1,,BAO_0000218
9307,Rattus norvegicus,Intermediate,CHEMBL626357,,,50597,,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,N,1,1,,BAO_0000218
9308,Rattus norvegicus,Intermediate,CHEMBL626358,,,50597,,A,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9309,Rattus norvegicus,Intermediate,CHEMBL626359,,,50597,,A,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9310,Rattus norvegicus,Intermediate,CHEMBL626360,,,50597,1969.0,A,,Peak plasma concentration in rat at a dose of 3 mg/kg,,N,1,1,,BAO_0000218
9311,Rattus norvegicus,Intermediate,CHEMBL626361,,,50597,,A,,Plasma concentration at 2 hr in rats was evaluated.,,N,1,1,,BAO_0000218
9312,Rattus norvegicus,Intermediate,CHEMBL626362,,,50597,,A,,Plasma concentration at 2 hr in rats was evaluated; Not available,,N,1,1,,BAO_0000218
9313,Rattus norvegicus,Intermediate,CHEMBL626363,,,50597,,A,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9314,Rattus norvegicus,Intermediate,CHEMBL626970,,,50597,,A,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9315,Rattus norvegicus,Intermediate,CHEMBL626971,,,50597,,A,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9316,Rattus norvegicus,Intermediate,CHEMBL626972,,,50597,1969.0,A,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9317,Rattus norvegicus,Intermediate,CHEMBL626973,,,50597,1969.0,A,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9318,Rattus norvegicus,Intermediate,CHEMBL626974,,,50597,1969.0,A,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9319,Rattus norvegicus,Intermediate,CHEMBL874592,,,50597,1969.0,A,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
9320,Rattus norvegicus,Intermediate,CHEMBL626975,,,50597,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,N,1,1,,BAO_0000218
9321,Rattus norvegicus,Intermediate,CHEMBL626976,,,50597,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,N,1,1,,BAO_0000218
9322,Rattus norvegicus,Intermediate,CHEMBL626977,,,50597,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,N,1,1,,BAO_0000218
9323,Rattus norvegicus,Intermediate,CHEMBL626978,,,50597,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,N,1,1,,BAO_0000218
9324,Rattus norvegicus,Intermediate,CHEMBL626979,,,50597,,A,,PK study was carried to determine the relative absorption ranking in rat.,,N,1,1,,BAO_0000218
9325,Rattus norvegicus,Intermediate,CHEMBL626980,,,50597,1969.0,A,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,N,1,1,,BAO_0000218
9326,Rattus norvegicus,Intermediate,CHEMBL626981,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,N,1,1,,BAO_0000218
9327,Rattus norvegicus,Intermediate,CHEMBL626982,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,N,1,1,,BAO_0000218
9328,Rattus norvegicus,Intermediate,CHEMBL626983,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,N,1,1,,BAO_0000218
9329,Rattus norvegicus,Intermediate,CHEMBL622522,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,N,1,1,,BAO_0000218
9330,Rattus norvegicus,Intermediate,CHEMBL622523,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,N,1,1,,BAO_0000218
9331,Rattus norvegicus,Intermediate,CHEMBL622524,,,50597,178.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,N,1,1,,BAO_0000218
9332,Rattus norvegicus,Intermediate,CHEMBL622525,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,N,1,1,,BAO_0000218
9333,Rattus norvegicus,Intermediate,CHEMBL622526,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,N,1,1,,BAO_0000218
9334,Rattus norvegicus,Intermediate,CHEMBL619849,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,N,1,1,,BAO_0000218
9335,Rattus norvegicus,Intermediate,CHEMBL619850,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,N,1,1,,BAO_0000218
9336,Rattus norvegicus,Intermediate,CHEMBL623864,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,N,1,1,,BAO_0000218
9337,Rattus norvegicus,Intermediate,CHEMBL623865,,,50597,955.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,N,1,1,,BAO_0000218
9338,Rattus norvegicus,Intermediate,CHEMBL623866,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,N,1,1,,BAO_0000218
9339,Rattus norvegicus,Intermediate,CHEMBL623867,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,N,1,1,,BAO_0000218
9340,Rattus norvegicus,Intermediate,CHEMBL877615,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,N,1,1,,BAO_0000218
9341,Rattus norvegicus,Intermediate,CHEMBL623868,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,N,1,1,,BAO_0000218
9342,Rattus norvegicus,Intermediate,CHEMBL623869,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,N,1,1,,BAO_0000218
9343,Rattus norvegicus,Intermediate,CHEMBL623870,,,50597,948.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,N,1,1,,BAO_0000218
9344,Rattus norvegicus,Intermediate,CHEMBL623871,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9345,Rattus norvegicus,Intermediate,CHEMBL623872,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9346,Rattus norvegicus,Intermediate,CHEMBL622129,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9347,Rattus norvegicus,Intermediate,CHEMBL622130,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9348,Rattus norvegicus,Intermediate,CHEMBL622131,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9349,Rattus norvegicus,Intermediate,CHEMBL622132,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9350,Rattus norvegicus,Intermediate,CHEMBL622133,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9351,Rattus norvegicus,Intermediate,CHEMBL622134,,,50597,2048.0,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9352,Rattus norvegicus,Intermediate,CHEMBL622135,,,50597,2048.0,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9353,Rattus norvegicus,Intermediate,CHEMBL622136,,,50597,2048.0,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9354,Rattus norvegicus,Intermediate,CHEMBL622137,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9355,Rattus norvegicus,Intermediate,CHEMBL622138,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9356,Rattus norvegicus,Intermediate,CHEMBL623017,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9357,Rattus norvegicus,Intermediate,CHEMBL623018,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9358,Rattus norvegicus,Intermediate,CHEMBL623019,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9359,Rattus norvegicus,Intermediate,CHEMBL623020,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9360,Rattus norvegicus,Intermediate,CHEMBL623021,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9361,Rattus norvegicus,Intermediate,CHEMBL623022,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9362,Rattus norvegicus,Intermediate,CHEMBL623023,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9363,Rattus norvegicus,Intermediate,CHEMBL623024,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9364,Rattus norvegicus,Intermediate,CHEMBL623025,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9365,Rattus norvegicus,Intermediate,CHEMBL620545,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9366,Rattus norvegicus,Intermediate,CHEMBL620546,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9367,Rattus norvegicus,Intermediate,CHEMBL620547,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9368,Rattus norvegicus,Intermediate,CHEMBL620548,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9369,Rattus norvegicus,Intermediate,CHEMBL620549,,,50597,2385.0,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9370,Rattus norvegicus,Intermediate,CHEMBL620550,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9371,Rattus norvegicus,Intermediate,CHEMBL620551,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9372,Rattus norvegicus,Intermediate,CHEMBL620552,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9373,Rattus norvegicus,Intermediate,CHEMBL620553,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9374,Rattus norvegicus,Intermediate,CHEMBL620554,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9375,Rattus norvegicus,Intermediate,CHEMBL875845,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9376,Rattus norvegicus,Intermediate,CHEMBL620555,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9377,Rattus norvegicus,Intermediate,CHEMBL620556,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9378,Rattus norvegicus,Intermediate,CHEMBL620557,,,50597,2385.0,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9379,Rattus norvegicus,Intermediate,CHEMBL620558,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9380,Rattus norvegicus,Intermediate,CHEMBL620559,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9381,Rattus norvegicus,Intermediate,CHEMBL622939,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9382,Rattus norvegicus,Intermediate,CHEMBL622940,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9383,Rattus norvegicus,Intermediate,CHEMBL622941,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9384,Rattus norvegicus,Intermediate,CHEMBL622942,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9385,Rattus norvegicus,Intermediate,CHEMBL622943,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9386,Rattus norvegicus,Intermediate,CHEMBL622944,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9387,Rattus norvegicus,Intermediate,CHEMBL622945,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9388,Rattus norvegicus,Intermediate,CHEMBL622946,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9389,Rattus norvegicus,Intermediate,CHEMBL622947,,,50597,,A,,Compound was evaluated for terminal half life in rat,,N,1,1,,BAO_0000218
9390,Rattus norvegicus,Intermediate,CHEMBL622948,,,50597,1969.0,A,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,N,1,1,,BAO_0000218
9391,Rattus norvegicus,Intermediate,CHEMBL622949,,,50597,1969.0,A,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,N,1,1,,BAO_0000218
9392,Rattus norvegicus,Intermediate,CHEMBL622950,,,50597,,A,,Compound was tested for its half life in rat,,N,1,1,,BAO_0000218
9393,Macaca mulatta,Intermediate,CHEMBL622951,,,22224,1969.0,A,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,U,0,1,,BAO_0000218
9394,Rattus norvegicus,Intermediate,CHEMBL622952,,,22224,1969.0,A,,Compound was tested for its plasma half life in Sprague Dawley rats,,U,0,1,,BAO_0000366
9395,Rattus norvegicus,Intermediate,CHEMBL622953,,,22224,1969.0,A,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,U,0,1,,BAO_0000366
9396,Rattus norvegicus,Intermediate,CHEMBL873818,,,50597,1969.0,A,,Compound was tested for plasma half-life period in rat,,N,1,1,,BAO_0000218
9397,Rattus norvegicus,Intermediate,CHEMBL622954,,,50597,,A,,Elimination half life after i.v. administration of compound in rats,,N,1,1,,BAO_0000218
9398,Rattus norvegicus,Intermediate,CHEMBL622955,,,50597,,A,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,N,1,1,,BAO_0000218
9399,Rattus norvegicus,Intermediate,CHEMBL875229,,,50597,,A,,Elimination half-life after IV dosing at 1 mg/kg in rat,,N,1,1,,BAO_0000218
9400,Rattus norvegicus,Intermediate,CHEMBL622956,,,50597,,A,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
9401,Rattus norvegicus,Intermediate,CHEMBL622957,,,50597,,A,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,N,1,1,,BAO_0000218
9402,Rattus norvegicus,Intermediate,CHEMBL622958,,,50597,955.0,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,1,1,,BAO_0000218
9403,Rattus norvegicus,Intermediate,CHEMBL622959,,,50597,1969.0,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,1,1,,BAO_0000218
9404,Rattus norvegicus,Intermediate,CHEMBL622960,,,50597,955.0,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,1,1,,BAO_0000218
9405,Rattus norvegicus,Intermediate,CHEMBL622961,,,50597,1969.0,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,1,1,,BAO_0000218
9406,Rattus norvegicus,Intermediate,CHEMBL622962,,,50597,,A,,Evaluated for the half life in rat (in vivo),,N,1,1,,BAO_0000218
9407,Rattus norvegicus,Intermediate,CHEMBL622963,,,50597,,A,,Hafl life in rat,,N,1,1,,BAO_0000218
9408,Rattus norvegicus,Intermediate,CHEMBL622964,,,50597,,A,,Hafl life rat,,N,1,1,,BAO_0000218
9409,Rattus norvegicus,Intermediate,CHEMBL622965,,,50597,,A,,Hafl life rat,,N,1,1,,BAO_0000218
9410,Rattus norvegicus,Intermediate,CHEMBL622966,,,50597,,A,,Hafl life rat; Not determined,,N,1,1,,BAO_0000218
9411,Rattus norvegicus,Intermediate,CHEMBL622967,,,50597,,A,,Hafl life rat; Not determined,,N,1,1,,BAO_0000218
9412,Rattus norvegicus,Intermediate,CHEMBL622968,,,50597,2113.0,A,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9413,Rattus norvegicus,Intermediate,CHEMBL622969,,,50597,2107.0,A,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9414,Rattus norvegicus,Intermediate,CHEMBL875327,,,50597,2048.0,A,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9415,Rattus norvegicus,Intermediate,CHEMBL628638,,,50597,,A,,Half life in rat after 1 mg/kg i.v. administration,,N,1,1,,BAO_0000218
9416,Rattus norvegicus,Intermediate,CHEMBL628639,,,50597,,A,,Half life in rat after 2 mg/kg peroral administration,,N,1,1,,BAO_0000218
9417,Rattus norvegicus,Intermediate,CHEMBL625840,,,50597,,A,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9418,Rattus norvegicus,Intermediate,CHEMBL625841,,,50597,,A,,Half life of 10 mg/kg oral dose determined in rats,,N,1,1,,BAO_0000218
9419,Rattus norvegicus,Intermediate,CHEMBL625842,,,50597,,A,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9420,Rattus norvegicus,Intermediate,CHEMBL625843,,,50597,,A,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9421,Rattus norvegicus,Intermediate,CHEMBL625844,,,50597,,A,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9422,Rattus norvegicus,Intermediate,CHEMBL873822,,,50597,,A,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9423,Rattus norvegicus,Intermediate,CHEMBL625845,,,50597,,A,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9424,Rattus norvegicus,Intermediate,CHEMBL627059,,,50597,,A,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9425,Rattus norvegicus,Intermediate,CHEMBL627060,,,50597,,A,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9426,Rattus norvegicus,Intermediate,CHEMBL627061,,,50597,,A,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
9427,Rattus norvegicus,Intermediate,CHEMBL627709,,,50597,,A,,Half life of compound at 5 mg/kg after po administration was determined in rat,,N,1,1,,BAO_0000218
9428,Rattus norvegicus,Intermediate,CHEMBL627710,,,50597,,A,,Half life of compound determined after intravenous administration to rat,,N,1,1,,BAO_0000218
9429,Rattus norvegicus,Intermediate,CHEMBL627711,,,50597,,A,,Half life of compound was determined in rat,,N,1,1,,BAO_0000218
9430,Rattus norvegicus,Intermediate,CHEMBL627712,,,50597,1969.0,A,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
9431,Rattus norvegicus,Intermediate,CHEMBL627713,,,50597,,A,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9432,Rattus norvegicus,Intermediate,CHEMBL627714,,,50597,,A,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9433,Macaca fascicularis,Intermediate,CHEMBL627889,,,22224,,A,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,U,0,1,,BAO_0000218
9434,Rattus norvegicus,Intermediate,CHEMBL627890,,,22224,,A,,Half life determined in rat by intravenous administration,,U,0,1,,BAO_0000218
9435,Rattus norvegicus,Intermediate,CHEMBL627891,,,50597,,A,,Half life determined in rats after iv administration,,N,1,1,,BAO_0000218
9436,Rattus norvegicus,Intermediate,CHEMBL627892,,,50597,1969.0,A,,Half life in rat plasma after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
9437,Rattus norvegicus,Intermediate,CHEMBL627893,,,50597,1969.0,A,,Half life in rat plasma after administration of 2 mg/kg iv,,N,1,1,,BAO_0000218
9438,Rattus norvegicus,Intermediate,CHEMBL627894,,,50597,1969.0,A,,Half life in rat plasma was determined,,N,1,1,,BAO_0000218
9439,Rattus norvegicus,Intermediate,CHEMBL627895,,,50597,1969.0,A,,Half life in rat plasma was determined; NA means not applicable,,N,1,1,,BAO_0000218
9440,Rattus norvegicus,Intermediate,CHEMBL627896,,,50597,,A,,Half life in rat was tested,,N,1,1,,BAO_0000218
9441,Rattus norvegicus,Intermediate,CHEMBL627897,,,50597,1969.0,A,,Half life measured in rat plasma,,N,1,1,,BAO_0000218
9442,Rattus norvegicus,Intermediate,CHEMBL627898,,,50597,,A,,Half life recorded in rats,,N,1,1,,BAO_0000218
9443,Rattus norvegicus,Intermediate,CHEMBL627899,,,50597,,A,,Half life was calculated,,N,1,1,,BAO_0000218
9444,Rattus norvegicus,Intermediate,CHEMBL873823,,,50597,,A,,Half life was calculated in rat,,N,1,1,,BAO_0000218
9445,Rattus norvegicus,Intermediate,CHEMBL627900,,,50597,,A,,Half life was determined,,N,1,1,,BAO_0000218
9446,Rattus norvegicus,Intermediate,CHEMBL627901,,,50597,,A,,Half life after 10 mg/kg oral administration in rat,,N,1,1,,BAO_0000218
9447,Rattus norvegicus,Intermediate,CHEMBL627902,,,50597,,A,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
9448,Rattus norvegicus,Intermediate,CHEMBL627903,,,50597,,A,,Half life after administering orally a dose of 30 mg/kg,,N,1,1,,BAO_0000218
9449,Rattus norvegicus,Intermediate,CHEMBL627904,,,50597,,A,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,N,1,1,,BAO_0000218
9450,Rattus norvegicus,Intermediate,CHEMBL627905,,,50597,,A,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,N,1,1,,BAO_0000218
9451,Rattus norvegicus,Intermediate,CHEMBL627906,,,50597,,A,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,N,1,1,,BAO_0000218
9452,Rattus norvegicus,Intermediate,CHEMBL627907,,,50597,,A,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,N,1,1,,BAO_0000218
9453,Rattus norvegicus,Intermediate,CHEMBL876783,,,50597,,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9454,Rattus norvegicus,Intermediate,CHEMBL627908,,,50597,,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,N,1,1,,BAO_0000218
9455,Rattus norvegicus,Intermediate,CHEMBL627909,,,50597,,A,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,1,1,,BAO_0000218
9456,Rattus norvegicus,Intermediate,CHEMBL627910,,,50597,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,N,1,1,,BAO_0000218
9457,Rattus norvegicus,Intermediate,CHEMBL627911,,,50597,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,N,1,1,,BAO_0000218
9458,Rattus norvegicus,Intermediate,CHEMBL627912,,,50597,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,N,1,1,,BAO_0000218
9459,Rattus norvegicus,Intermediate,CHEMBL627913,,,50597,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,N,1,1,,BAO_0000218
9460,Rattus norvegicus,Intermediate,CHEMBL627914,,,50597,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,N,1,1,,BAO_0000218
9461,Rattus norvegicus,Intermediate,CHEMBL627915,,,50597,,A,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,N,1,1,,BAO_0000218
9462,Rattus norvegicus,Intermediate,CHEMBL627916,,,50597,,A,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,N,1,1,,BAO_0000218
9463,Rattus norvegicus,Intermediate,CHEMBL627917,,,50597,,A,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
9464,Rattus norvegicus,Intermediate,CHEMBL627918,,,50597,,A,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,N,1,1,,BAO_0000218
9465,Rattus norvegicus,Intermediate,CHEMBL627919,,,50597,,A,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,N,1,1,,BAO_0000218
9466,Rattus norvegicus,Intermediate,CHEMBL627920,,,50597,,A,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,N,1,1,,BAO_0000218
9467,Rattus norvegicus,Intermediate,CHEMBL627921,,,50597,,A,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
9468,Rattus norvegicus,Intermediate,CHEMBL627922,,,50597,,A,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9469,Rattus norvegicus,Intermediate,CHEMBL876784,,,50597,,A,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9470,Rattus norvegicus,Intermediate,CHEMBL627923,,,50597,,A,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9471,Rattus norvegicus,Intermediate,CHEMBL626208,,,50597,,A,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9472,Rattus norvegicus,Intermediate,CHEMBL626209,,,50597,,A,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9473,Rattus norvegicus,Intermediate,CHEMBL626210,,,50597,,A,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
9474,Rattus norvegicus,Intermediate,CHEMBL627994,,,50597,1969.0,A,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,1,1,,BAO_0000218
9475,Rattus norvegicus,Intermediate,CHEMBL627995,,,50597,,A,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
9476,Rattus norvegicus,Intermediate,CHEMBL627996,,,50597,,A,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,N,1,1,,BAO_0000218
9477,Rattus norvegicus,Intermediate,CHEMBL627997,,,50597,,A,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,N,1,1,,BAO_0000218
9478,Rattus norvegicus,Intermediate,CHEMBL627998,,,50597,,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,N,1,1,,BAO_0000218
9479,Rattus norvegicus,Intermediate,CHEMBL628640,,,50597,,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,N,1,1,,BAO_0000218
9480,Rattus norvegicus,Intermediate,CHEMBL628641,,,50597,,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,N,1,1,,BAO_0000218
9481,Rattus norvegicus,Intermediate,CHEMBL628642,,,50597,,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,N,1,1,,BAO_0000218
9482,Rattus norvegicus,Intermediate,CHEMBL628643,,,50597,,A,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,N,1,1,,BAO_0000218
9483,Rattus norvegicus,Intermediate,CHEMBL628644,,,50597,,A,,Compound was tested for area under curve in rat,,N,1,1,,BAO_0000218
9484,Rattus norvegicus,Intermediate,CHEMBL628645,,,50597,,A,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,N,1,1,,BAO_0000218
9485,Rattus norvegicus,Intermediate,CHEMBL628646,,,50597,,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,1,1,,BAO_0000218
9486,Rattus norvegicus,Intermediate,CHEMBL628647,,,50597,,A,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,N,1,1,,BAO_0000218
9487,Rattus norvegicus,Intermediate,CHEMBL628648,,,50597,,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,1,1,,BAO_0000218
9488,Rattus norvegicus,Intermediate,CHEMBL625358,,,50597,,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,1,1,,BAO_0000218
9489,Rattus norvegicus,Intermediate,CHEMBL625359,,,50597,,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,1,1,,BAO_0000218
9490,Rattus norvegicus,Intermediate,CHEMBL625360,,,50597,,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,1,1,,BAO_0000218
9491,Rattus norvegicus,Intermediate,CHEMBL625361,,,50597,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,N,1,1,,BAO_0000218
9492,Rattus norvegicus,Intermediate,CHEMBL625362,,,50597,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,N,1,1,,BAO_0000218
9493,Rattus norvegicus,Intermediate,CHEMBL625363,,,50597,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,N,1,1,,BAO_0000218
9494,Rattus norvegicus,Intermediate,CHEMBL625364,,,50597,,A,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,1,1,,BAO_0000218
9495,Rattus norvegicus,Intermediate,CHEMBL625365,,,50597,,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
9496,Rattus norvegicus,Intermediate,CHEMBL625366,,,50597,,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
9497,Rattus norvegicus,Intermediate,CHEMBL625367,,,50597,,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
9498,Rattus norvegicus,Intermediate,CHEMBL625368,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,N,1,1,,BAO_0000218
9499,Rattus norvegicus,Intermediate,CHEMBL625369,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,N,1,1,,BAO_0000218
9500,Rattus norvegicus,Intermediate,CHEMBL625370,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,N,1,1,,BAO_0000218
9501,Rattus norvegicus,Intermediate,CHEMBL625371,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,N,1,1,,BAO_0000218
9502,Rattus norvegicus,Intermediate,CHEMBL625372,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,N,1,1,,BAO_0000218
9503,Rattus norvegicus,Intermediate,CHEMBL625373,,,50597,2113.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,N,1,1,,BAO_0000218
9504,Rattus norvegicus,Intermediate,CHEMBL625374,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,N,1,1,,BAO_0000218
9505,Rattus norvegicus,Intermediate,CHEMBL877593,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,N,1,1,,BAO_0000218
9506,Rattus norvegicus,Intermediate,CHEMBL625375,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,N,1,1,,BAO_0000218
9507,Rattus norvegicus,Intermediate,CHEMBL625376,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,N,1,1,,BAO_0000218
9508,Rattus norvegicus,Intermediate,CHEMBL621973,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,N,1,1,,BAO_0000218
9509,Rattus norvegicus,Intermediate,CHEMBL621974,,,50597,2107.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,N,1,1,,BAO_0000218
9510,Rattus norvegicus,Intermediate,CHEMBL621975,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,N,1,1,,BAO_0000218
9511,Rattus norvegicus,Intermediate,CHEMBL622166,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,N,1,1,,BAO_0000218
9512,Rattus norvegicus,Intermediate,CHEMBL622167,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,N,1,1,,BAO_0000218
9513,Rattus norvegicus,Intermediate,CHEMBL622168,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,N,1,1,,BAO_0000218
9514,Rattus norvegicus,Intermediate,CHEMBL622169,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,N,1,1,,BAO_0000218
9515,Rattus norvegicus,Intermediate,CHEMBL622170,,,50597,2048.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,N,1,1,,BAO_0000218
9516,Rattus norvegicus,Intermediate,CHEMBL622171,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,N,1,1,,BAO_0000218
9517,Rattus norvegicus,Intermediate,CHEMBL622172,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,N,1,1,,BAO_0000218
9518,Rattus norvegicus,Intermediate,CHEMBL622173,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,N,1,1,,BAO_0000218
9519,Rattus norvegicus,Intermediate,CHEMBL622174,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,N,1,1,,BAO_0000218
9520,Rattus norvegicus,Intermediate,CHEMBL622175,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,N,1,1,,BAO_0000218
9521,Rattus norvegicus,Intermediate,CHEMBL622176,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,N,1,1,,BAO_0000218
9522,Rattus norvegicus,Intermediate,CHEMBL622177,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,N,1,1,,BAO_0000218
9523,Rattus norvegicus,Intermediate,CHEMBL622178,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,N,1,1,,BAO_0000218
9524,Rattus norvegicus,Intermediate,CHEMBL622179,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,N,1,1,,BAO_0000218
9525,Rattus norvegicus,Intermediate,CHEMBL622180,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,N,1,1,,BAO_0000218
9526,Rattus norvegicus,Intermediate,CHEMBL622181,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9527,Rattus norvegicus,Intermediate,CHEMBL622182,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9528,Rattus norvegicus,Intermediate,CHEMBL622183,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9529,Rattus norvegicus,Intermediate,CHEMBL622184,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9530,Rattus norvegicus,Intermediate,CHEMBL622185,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9531,Rattus norvegicus,Intermediate,CHEMBL622186,,,50597,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9532,Rattus norvegicus,Intermediate,CHEMBL622187,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9533,Rattus norvegicus,Intermediate,CHEMBL625002,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9534,Rattus norvegicus,Intermediate,CHEMBL622090,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9535,Rattus norvegicus,Intermediate,CHEMBL622091,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9536,Rattus norvegicus,Intermediate,CHEMBL622092,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9537,Rattus norvegicus,Intermediate,CHEMBL622093,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9538,Rattus norvegicus,Intermediate,CHEMBL622094,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9539,Rattus norvegicus,Intermediate,CHEMBL622095,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9540,Rattus norvegicus,Intermediate,CHEMBL622264,,,50597,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9541,Rattus norvegicus,Intermediate,CHEMBL622265,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9542,Rattus norvegicus,Intermediate,CHEMBL622266,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9543,Rattus norvegicus,Intermediate,CHEMBL622267,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9544,Rattus norvegicus,Intermediate,CHEMBL622268,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9545,Rattus norvegicus,Intermediate,CHEMBL622269,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9546,Rattus norvegicus,Intermediate,CHEMBL625071,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9547,Rattus norvegicus,Intermediate,CHEMBL621621,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9548,Rattus norvegicus,Intermediate,CHEMBL621622,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9549,Rattus norvegicus,Intermediate,CHEMBL621623,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9550,Rattus norvegicus,Intermediate,CHEMBL621624,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9551,Rattus norvegicus,Intermediate,CHEMBL621625,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9552,Rattus norvegicus,Intermediate,CHEMBL621626,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9553,Rattus norvegicus,Intermediate,CHEMBL621627,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9554,Rattus norvegicus,Intermediate,CHEMBL621628,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9555,Rattus norvegicus,Intermediate,CHEMBL875328,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9556,Rattus norvegicus,Intermediate,CHEMBL621629,,,50597,2106.0,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9557,Rattus norvegicus,Intermediate,CHEMBL621630,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9558,Rattus norvegicus,Intermediate,CHEMBL621631,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9559,Rattus norvegicus,Intermediate,CHEMBL621632,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9560,Rattus norvegicus,Intermediate,CHEMBL621633,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9561,Rattus norvegicus,Intermediate,CHEMBL621634,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9562,Rattus norvegicus,Intermediate,CHEMBL621635,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9563,Rattus norvegicus,Intermediate,CHEMBL621636,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9564,Rattus norvegicus,Intermediate,CHEMBL621637,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9565,Rattus norvegicus,Intermediate,CHEMBL621638,,,50597,2106.0,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9566,Rattus norvegicus,Intermediate,CHEMBL618883,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9567,Rattus norvegicus,Intermediate,CHEMBL618884,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,1,1,,BAO_0000218
9568,Rattus norvegicus,Intermediate,CHEMBL628627,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9569,Rattus norvegicus,Intermediate,CHEMBL628628,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9570,Rattus norvegicus,Intermediate,CHEMBL628629,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,1,1,,BAO_0000218
9571,Rattus norvegicus,Intermediate,CHEMBL628630,,,50597,,A,,Half life after administering orally a dose of 3 mg/kg,,N,1,1,,BAO_0000218
9572,Rattus norvegicus,Intermediate,CHEMBL628631,,,50597,,A,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
9573,Rattus norvegicus,Intermediate,CHEMBL628632,,,50597,,A,,Half life after administering intravenously a dose of 1 mg/kg,,N,1,1,,BAO_0000218
9574,Rattus norvegicus,Intermediate,CHEMBL628633,,,50597,,A,,Half life after oral dosing in rats,,N,1,1,,BAO_0000218
9575,Rattus norvegicus,Intermediate,CHEMBL628634,,,50597,,A,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,N,1,1,,BAO_0000218
9576,Rattus norvegicus,Intermediate,CHEMBL627789,,,50597,,A,,Half life by intravenous administration of 3.4 mg/kg in rat,,N,1,1,,BAO_0000218
9577,Rattus norvegicus,Intermediate,CHEMBL627790,,,50597,,A,,Half life in rat,,N,1,1,,BAO_0000218
9578,Rattus norvegicus,Intermediate,CHEMBL627791,,,50597,,A,,Half life in rat,,N,1,1,,BAO_0000218
9579,Rattus norvegicus,Intermediate,CHEMBL627792,,,50597,,A,,Half life in rat,,N,1,1,,BAO_0000218
9580,Rattus norvegicus,Intermediate,CHEMBL627793,,,50597,,A,,Half life in rat after intravenous administration of the compound,,N,1,1,,BAO_0000218
9581,Rattus norvegicus,Intermediate,CHEMBL627794,,,50597,1969.0,A,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,N,1,1,,BAO_0000218
9582,Rattus norvegicus,Intermediate,CHEMBL627795,,,50597,,A,,Half life in rat after po administration of the compound,,N,1,1,,BAO_0000218
9583,Rattus norvegicus,Intermediate,CHEMBL627796,,,50597,,A,,Half life in rat after po administration of the compound; ND means Not determined,,N,1,1,,BAO_0000218
9584,Rattus norvegicus,Intermediate,CHEMBL875335,,,50597,1969.0,A,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,N,1,1,,BAO_0000218
9585,Rattus norvegicus,Intermediate,CHEMBL627797,,,50597,1969.0,A,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,N,1,1,,BAO_0000218
9586,Rattus norvegicus,Intermediate,CHEMBL627798,,,50597,,A,,Half life in rat i.v.,,N,1,1,,BAO_0000218
9587,Rattus norvegicus,Intermediate,CHEMBL627799,,,50597,,A,,Half life in rat i.v. at 2 mg/kg concentration,,N,1,1,,BAO_0000218
9588,Rattus norvegicus,Intermediate,CHEMBL627800,,,50597,,A,,Half life in rats,,N,1,1,,BAO_0000218
9589,Rattus norvegicus,Intermediate,CHEMBL627801,,,50597,,A,,Half life in rats after intravenous administration,,N,1,1,,BAO_0000218
9590,Rattus norvegicus,Intermediate,CHEMBL627802,,,50597,,A,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,N,1,1,,BAO_0000218
9591,Rattus norvegicus,Expert,CHEMBL627803,,,50597,,A,,Half life in rat,,N,1,1,,BAO_0000218
9592,Rattus norvegicus,Intermediate,CHEMBL873820,,,50597,,A,,Half life was evaluated after intravenous administration to rats,,N,1,1,,BAO_0000218
9593,Rattus norvegicus,Intermediate,CHEMBL627804,,,50597,,A,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,N,1,1,,BAO_0000218
9594,Rattus norvegicus,Intermediate,CHEMBL627805,,,50597,,A,,Half life was evaluated in rat,,N,1,1,,BAO_0000218
9595,Rattus norvegicus,Intermediate,CHEMBL627806,,,50597,,A,,Half life was evaluated in rat,,N,1,1,,BAO_0000218
9596,Rattus norvegicus,Intermediate,CHEMBL627107,,,50597,,A,,Half life was evaluated in rat; Not tested,,N,1,1,,BAO_0000218
9597,Rattus norvegicus,Intermediate,CHEMBL627108,,,50597,,A,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,N,1,1,,BAO_0000218
9598,Rattus norvegicus,Intermediate,CHEMBL627109,,,50597,,A,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,N,1,1,,BAO_0000218
9599,Rattus norvegicus,Intermediate,CHEMBL627110,,,50597,178.0,A,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,N,1,1,,BAO_0000218
9600,Primates,Intermediate,CHEMBL627111,,,22224,,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,0,1,,BAO_0000218
9601,Primates,Intermediate,CHEMBL627112,,,22224,,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,0,1,,BAO_0000218
9602,Rattus norvegicus,Intermediate,CHEMBL627113,,,22224,,A,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,U,0,1,,BAO_0000218
9603,Rattus norvegicus,Intermediate,CHEMBL627114,,,22224,,A,,Half life was measured in rat at dose of 30 mg/kg by po administration,,U,0,1,,BAO_0000218
9604,Rattus norvegicus,Intermediate,CHEMBL627115,,,50597,,A,,Half life (t1/2) was determined,,N,1,1,,BAO_0000218
9605,Rattus norvegicus,Intermediate,CHEMBL627116,,,50597,,A,,Half life period at a dose of 10 uM/kg in rat was determined,,N,1,1,,BAO_0000218
9606,Rattus norvegicus,Intermediate,CHEMBL627117,,,50597,,A,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,N,1,1,,BAO_0000218
9607,Rattus norvegicus,Intermediate,CHEMBL627118,,,50597,,A,,Half life period was determined,,N,1,1,,BAO_0000218
9608,Rattus norvegicus,Intermediate,CHEMBL627119,,,50597,,A,,Half life period after intravenous administration at 20 mpk in rats,,N,1,1,,BAO_0000218
9609,Rattus norvegicus,Intermediate,CHEMBL627120,,,50597,,A,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,N,1,1,,BAO_0000218
9610,Rattus norvegicus,Intermediate,CHEMBL626922,,,50597,,A,,Half life period after intravenous administration in rat,,N,1,1,,BAO_0000218
9611,Rattus norvegicus,Intermediate,CHEMBL626923,,,50597,,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,1,1,,BAO_0000218
9612,Rattus norvegicus,Intermediate,CHEMBL626924,,,50597,,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,1,1,,BAO_0000218
9613,Rattus norvegicus,Intermediate,CHEMBL626925,,,50597,1969.0,A,,Half life period in 80% rat plasma at 37 degree Centigrade,,N,1,1,,BAO_0000218
9614,Rattus norvegicus,Intermediate,CHEMBL626926,,,50597,,A,,Half life period in SD rats,,N,1,1,,BAO_0000218
9615,Rattus norvegicus,Intermediate,CHEMBL626927,,,50597,1969.0,A,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,N,1,1,,BAO_0000218
9616,Rattus norvegicus,Intermediate,CHEMBL626928,,,50597,1969.0,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,N,1,1,,BAO_0000218
9617,Rattus norvegicus,Intermediate,CHEMBL626929,,,50597,1969.0,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1,1,,BAO_0000218
9618,Rattus norvegicus,Intermediate,CHEMBL626930,,,50597,1969.0,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1,1,,BAO_0000218
9619,Rattus norvegicus,Intermediate,CHEMBL626931,,,50597,,A,,Half life period in rat,,N,1,1,,BAO_0000218
9620,Rattus norvegicus,Intermediate,CHEMBL626932,,,50597,,A,,Half life period in rat,,N,1,1,,BAO_0000218
9621,Rattus norvegicus,Intermediate,CHEMBL626933,,,50597,,A,,Half life period in rat,,N,1,1,,BAO_0000218
9622,Rattus norvegicus,Intermediate,CHEMBL873826,,,50597,,A,,Half life period in rat after oral administration at 10.5 mg/kg dose,,N,1,1,,BAO_0000218
9623,Rattus norvegicus,Intermediate,CHEMBL626934,,,50597,,A,,Half life period in rat after oral administration at 11.2 mg/kg dose,,N,1,1,,BAO_0000218
9624,Rattus norvegicus,Intermediate,CHEMBL626935,,,50597,,A,,Half life period in rat after oral administration at 13 mg/kg dose,,N,1,1,,BAO_0000218
9625,Rattus norvegicus,Intermediate,CHEMBL626936,,,50597,,A,,Half life period in rat after oral administration at 9.7 mg/kg dose,,N,1,1,,BAO_0000218
9626,Rattus norvegicus,Intermediate,CHEMBL626937,,,50597,,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
9627,Rattus norvegicus,Intermediate,CHEMBL625906,,,50597,,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
9628,Rattus norvegicus,Intermediate,CHEMBL625907,,,50597,,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,1,1,,BAO_0000218
9629,Rattus norvegicus,Intermediate,CHEMBL625908,,,50597,,A,,PK study was carried to determine AUC (area under curve) value in rat,,N,1,1,,BAO_0000218
9630,Rattus norvegicus,Intermediate,CHEMBL625909,,,50597,,A,,Pharmacokinetic parameter AUC after intravenous administration to rats,,N,1,1,,BAO_0000218
9631,Rattus norvegicus,Intermediate,CHEMBL625910,,,50597,,A,,Pharmacokinetic parameter AUC after oral administration to rats,,N,1,1,,BAO_0000218
9632,Rattus norvegicus,Intermediate,CHEMBL625911,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,N,1,1,,BAO_0000218
9633,Rattus norvegicus,Intermediate,CHEMBL625912,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,N,1,1,,BAO_0000218
9634,Rattus norvegicus,Intermediate,CHEMBL626538,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,N,1,1,,BAO_0000218
9635,Rattus norvegicus,Intermediate,CHEMBL876794,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,N,1,1,,BAO_0000218
9636,Rattus norvegicus,Intermediate,CHEMBL626539,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,N,1,1,,BAO_0000218
9637,Rattus norvegicus,Intermediate,CHEMBL626540,,,50597,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,N,1,1,,BAO_0000218
9638,Rattus norvegicus,Intermediate,CHEMBL626541,,,50597,,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,N,1,1,,BAO_0000218
9639,Rattus norvegicus,Intermediate,CHEMBL626542,,,50597,,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,N,1,1,,BAO_0000218
9640,Rattus norvegicus,Intermediate,CHEMBL626543,,,50597,,A,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,N,1,1,,BAO_0000218
9641,Rattus norvegicus,Intermediate,CHEMBL626544,,,50597,,A,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
9642,Rattus norvegicus,Intermediate,CHEMBL626545,,,50597,,A,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,N,1,1,,BAO_0000218
9643,Rattus norvegicus,Intermediate,CHEMBL626546,,,50597,,A,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
9644,Rattus norvegicus,Intermediate,CHEMBL626547,,,50597,,A,,Pharmacokinetic parameter area under curve was reported,,N,1,1,,BAO_0000218
9645,Rattus norvegicus,Intermediate,CHEMBL626548,,,50597,,A,,Pharmacokinetic property (AUC) in rat,,N,1,1,,BAO_0000218
9646,Rattus norvegicus,Intermediate,CHEMBL626549,,,50597,,A,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,1,1,,BAO_0000218
9647,Rattus norvegicus,Intermediate,CHEMBL626550,,,50597,,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,N,1,1,,BAO_0000218
9648,Rattus norvegicus,Intermediate,CHEMBL626551,,,50597,,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,N,1,1,,BAO_0000218
9649,Rattus norvegicus,Intermediate,CHEMBL623777,,,50597,,A,,Pharmacokinetic property was determined,,N,1,1,,BAO_0000218
9650,Rattus norvegicus,Intermediate,CHEMBL623778,,,50597,,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,N,1,1,,BAO_0000218
9651,Rattus norvegicus,Intermediate,CHEMBL623779,,,50597,,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,N,1,1,,BAO_0000218
9652,Rattus norvegicus,Intermediate,CHEMBL623780,,,50597,1969.0,A,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,1,1,,BAO_0000218
9653,Rattus norvegicus,Intermediate,CHEMBL622015,,,50597,1969.0,A,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,N,1,1,,BAO_0000218
9654,Rattus norvegicus,Intermediate,CHEMBL622016,,,50597,1969.0,A,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,N,1,1,,BAO_0000218
9655,Rattus norvegicus,Intermediate,CHEMBL622017,,,50597,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,N,1,1,,BAO_0000218
9656,Rattus norvegicus,Intermediate,CHEMBL622018,,,50597,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,N,1,1,,BAO_0000218
9657,Rattus norvegicus,Intermediate,CHEMBL622019,,,50597,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,N,1,1,,BAO_0000218
9658,Rattus norvegicus,Intermediate,CHEMBL622020,,,50597,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,N,1,1,,BAO_0000218
9659,Rattus norvegicus,Intermediate,CHEMBL622021,,,50597,,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,N,1,1,,BAO_0000218
9660,Rattus norvegicus,Intermediate,CHEMBL622022,,,50597,,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,N,1,1,,BAO_0000218
9661,Rattus norvegicus,Intermediate,CHEMBL622023,,,50597,,A,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,N,1,1,,BAO_0000218
9662,Rattus norvegicus,Intermediate,CHEMBL622024,,,50597,,A,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,N,1,1,,BAO_0000218
9663,Rattus norvegicus,Intermediate,CHEMBL622693,,,50597,,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,N,1,1,,BAO_0000218
9664,Rattus norvegicus,Intermediate,CHEMBL622694,,,50597,,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,N,1,1,,BAO_0000218
9665,Rattus norvegicus,Intermediate,CHEMBL622695,,,50597,,A,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9666,Rattus norvegicus,Intermediate,CHEMBL622696,,,50597,,A,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,1,1,,BAO_0000218
9667,Rattus norvegicus,Intermediate,CHEMBL622697,,,50597,,A,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,N,1,1,,BAO_0000218
9668,Rattus norvegicus,Intermediate,CHEMBL622874,,,50597,,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,N,1,1,,BAO_0000218
9669,Rattus norvegicus,Intermediate,CHEMBL622875,,,50597,,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,N,1,1,,BAO_0000218
9670,Rattus norvegicus,Intermediate,CHEMBL622876,,,50597,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,1,1,,BAO_0000218
9671,Rattus norvegicus,Intermediate,CHEMBL622877,,,50597,,A,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,1,1,,BAO_0000218
9672,Rattus norvegicus,Intermediate,CHEMBL622878,,,50597,,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,1,1,,BAO_0000218
9673,Rattus norvegicus,Intermediate,CHEMBL622879,,,50597,1969.0,A,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,N,1,1,,BAO_0000218
9674,Rattus norvegicus,Intermediate,CHEMBL877602,,,50597,,A,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,N,1,1,,BAO_0000218
9675,Rattus norvegicus,Intermediate,CHEMBL622880,,,50597,,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9676,Rattus norvegicus,Intermediate,CHEMBL622881,,,50597,,A,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9677,Rattus norvegicus,Intermediate,CHEMBL622882,,,50597,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9678,Rattus norvegicus,Intermediate,CHEMBL622883,,,50597,,A,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9679,Rattus norvegicus,Intermediate,CHEMBL622884,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,N,1,1,,BAO_0000218
9680,Rattus norvegicus,Intermediate,CHEMBL622885,,,50597,2046.0,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,N,1,1,,BAO_0000218
9681,Rattus norvegicus,Intermediate,CHEMBL622886,,,50597,,A,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,1,1,,BAO_0000218
9682,Rattus norvegicus,Intermediate,CHEMBL622887,,,50597,,A,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,1,1,,BAO_0000218
9683,Rattus norvegicus,Intermediate,CHEMBL622888,,,50597,1088.0,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,1,1,,BAO_0000218
9684,Rattus norvegicus,Intermediate,CHEMBL622889,,,50597,178.0,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9685,Rattus norvegicus,Intermediate,CHEMBL622890,,,50597,178.0,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9686,Rattus norvegicus,Intermediate,CHEMBL622891,,,50597,178.0,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9687,Rattus norvegicus,Intermediate,CHEMBL877603,,,50597,178.0,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9688,Rattus norvegicus,Intermediate,CHEMBL622892,,,50597,955.0,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9689,Rattus norvegicus,Intermediate,CHEMBL622893,,,50597,955.0,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9690,Rattus norvegicus,Intermediate,CHEMBL622894,,,50597,955.0,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9691,Rattus norvegicus,Intermediate,CHEMBL622895,,,50597,955.0,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9692,Rattus norvegicus,Intermediate,CHEMBL622896,,,50597,955.0,A,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,N,1,1,,BAO_0000218
9693,Rattus norvegicus,Intermediate,CHEMBL622897,,,50597,948.0,A,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9694,Rattus norvegicus,Intermediate,CHEMBL622898,,,50597,948.0,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9695,Rattus norvegicus,Intermediate,CHEMBL622899,,,50597,948.0,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9696,Rattus norvegicus,Intermediate,CHEMBL622900,,,50597,2113.0,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9697,Rattus norvegicus,Intermediate,CHEMBL624114,,,50597,2113.0,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9698,Rattus norvegicus,Intermediate,CHEMBL624115,,,50597,2113.0,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9699,Rattus norvegicus,Intermediate,CHEMBL624116,,,50597,2113.0,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9700,Rattus norvegicus,Intermediate,CHEMBL624117,,,50597,2107.0,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9701,Rattus norvegicus,Intermediate,CHEMBL624118,,,50597,2107.0,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9702,Rattus norvegicus,Intermediate,CHEMBL624119,,,50597,2107.0,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9703,Rattus norvegicus,Intermediate,CHEMBL624120,,,50597,2107.0,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9704,Rattus norvegicus,Intermediate,CHEMBL624121,,,50597,2048.0,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9705,Rattus norvegicus,Intermediate,CHEMBL624122,,,50597,2048.0,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9706,Rattus norvegicus,Intermediate,CHEMBL624123,,,50597,2048.0,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9707,Rattus norvegicus,Intermediate,CHEMBL624124,,,50597,2048.0,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9708,Rattus norvegicus,Intermediate,CHEMBL624125,,,50597,2385.0,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9709,Rattus norvegicus,Intermediate,CHEMBL624126,,,50597,2385.0,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9710,Rattus norvegicus,Intermediate,CHEMBL624127,,,50597,2385.0,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9711,Rattus norvegicus,Intermediate,CHEMBL624128,,,50597,2385.0,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9712,Rattus norvegicus,Intermediate,CHEMBL624129,,,50597,14.0,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9713,Rattus norvegicus,Intermediate,CHEMBL624130,,,50597,14.0,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9714,Rattus norvegicus,Intermediate,CHEMBL622340,,,50597,14.0,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9715,Rattus norvegicus,Intermediate,CHEMBL622341,,,50597,14.0,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9716,Rattus norvegicus,Intermediate,CHEMBL622342,,,50597,160.0,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9717,Rattus norvegicus,Intermediate,CHEMBL622343,,,50597,160.0,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9718,Rattus norvegicus,Intermediate,CHEMBL622344,,,50597,160.0,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9719,Rattus norvegicus,Intermediate,CHEMBL622345,,,50597,160.0,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9720,Rattus norvegicus,Intermediate,CHEMBL622346,,,50597,2106.0,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9721,Rattus norvegicus,Intermediate,CHEMBL622347,,,50597,2106.0,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9722,Rattus norvegicus,Intermediate,CHEMBL622348,,,50597,2106.0,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9723,Rattus norvegicus,Intermediate,CHEMBL622349,,,50597,2106.0,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9724,Rattus norvegicus,Intermediate,CHEMBL622350,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,1,1,,BAO_0000218
9725,Rattus norvegicus,Intermediate,CHEMBL622351,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,1,1,,BAO_0000218
9726,Rattus norvegicus,Intermediate,CHEMBL622352,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,1,1,,BAO_0000218
9727,Rattus norvegicus,Intermediate,CHEMBL622353,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,1,1,,BAO_0000218
9728,Rattus norvegicus,Intermediate,CHEMBL622354,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,1,1,,BAO_0000218
9729,Rattus norvegicus,Intermediate,CHEMBL622355,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,1,1,,BAO_0000218
9730,Rattus norvegicus,Intermediate,CHEMBL622356,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,1,1,,BAO_0000218
9731,Rattus norvegicus,Intermediate,CHEMBL622357,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,1,1,,BAO_0000218
9732,Rattus norvegicus,Intermediate,CHEMBL622358,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,1,1,,BAO_0000218
9733,Rattus norvegicus,Intermediate,CHEMBL622359,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,1,1,,BAO_0000218
9734,Rattus norvegicus,Intermediate,CHEMBL874393,,,50597,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,1,1,,BAO_0000218
9735,Rattus norvegicus,Intermediate,CHEMBL622872,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9736,Rattus norvegicus,Intermediate,CHEMBL622873,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9737,Rattus norvegicus,Intermediate,CHEMBL623047,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9738,Rattus norvegicus,Intermediate,CHEMBL623048,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9739,Rattus norvegicus,Intermediate,CHEMBL623049,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9740,Rattus norvegicus,Intermediate,CHEMBL623050,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9741,Rattus norvegicus,Intermediate,CHEMBL623051,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9742,Rattus norvegicus,Intermediate,CHEMBL623052,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9743,Rattus norvegicus,Intermediate,CHEMBL626343,,,50597,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9744,Rattus norvegicus,Intermediate,CHEMBL626344,,,50597,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,1,1,,BAO_0000218
9745,Rattus norvegicus,Intermediate,CHEMBL626345,,,50597,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,1,1,,BAO_0000218
9746,Rattus norvegicus,Intermediate,CHEMBL626346,,,50597,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,1,1,,BAO_0000218
9747,Rattus norvegicus,Intermediate,CHEMBL626347,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,1,1,,BAO_0000218
9748,Rattus norvegicus,Intermediate,CHEMBL626348,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,1,1,,BAO_0000218
9749,Rattus norvegicus,Intermediate,CHEMBL626349,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,1,1,,BAO_0000218
9750,Rattus norvegicus,Intermediate,CHEMBL626350,,,50597,,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,1,1,,BAO_0000218
9751,Rattus norvegicus,Intermediate,CHEMBL626351,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,1,1,,BAO_0000218
9752,Rattus norvegicus,Intermediate,CHEMBL627650,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,1,1,,BAO_0000218
9753,Rattus norvegicus,Intermediate,CHEMBL627651,,,50597,,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,1,1,,BAO_0000218
9754,Rattus norvegicus,Intermediate,CHEMBL627652,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,1,1,,BAO_0000218
9755,Rattus norvegicus,Intermediate,CHEMBL627653,,,50597,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,1,1,,BAO_0000218
9756,Rattus norvegicus,Intermediate,CHEMBL627654,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9757,Rattus norvegicus,Intermediate,CHEMBL627835,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,N,1,1,,BAO_0000218
9758,Rattus norvegicus,Intermediate,CHEMBL627836,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,N,1,1,,BAO_0000218
9759,Rattus norvegicus,Intermediate,CHEMBL627837,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,N,1,1,,BAO_0000218
9760,Rattus norvegicus,Intermediate,CHEMBL627838,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9761,Rattus norvegicus,Intermediate,CHEMBL875338,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,N,1,1,,BAO_0000218
9762,Rattus norvegicus,Intermediate,CHEMBL627839,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,N,1,1,,BAO_0000218
9763,Rattus norvegicus,Intermediate,CHEMBL627840,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,N,1,1,,BAO_0000218
9764,Rattus norvegicus,Intermediate,CHEMBL627841,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9765,Rattus norvegicus,Intermediate,CHEMBL627842,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,N,1,1,,BAO_0000218
9766,Rattus norvegicus,Intermediate,CHEMBL627843,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,N,1,1,,BAO_0000218
9767,Rattus norvegicus,Intermediate,CHEMBL627844,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,N,1,1,,BAO_0000218
9768,Rattus norvegicus,Intermediate,CHEMBL627845,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9769,Rattus norvegicus,Intermediate,CHEMBL627846,,,50597,,A,,Half life period in rat by iv administration at a dose of 3 mg/kg,,N,1,1,,BAO_0000218
9770,Rattus norvegicus,Intermediate,CHEMBL627847,,,50597,1969.0,A,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,N,1,1,,BAO_0000218
9771,Rattus norvegicus,Intermediate,CHEMBL873821,,,50597,1969.0,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,N,1,1,,BAO_0000218
9772,Rattus norvegicus,Intermediate,CHEMBL626079,,,50597,1969.0,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1,1,,BAO_0000218
9773,Rattus norvegicus,Intermediate,CHEMBL626080,,,50597,1969.0,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1,1,,BAO_0000218
9774,Rattus norvegicus,Intermediate,CHEMBL626081,,,50597,1969.0,A,,Half life period was evaluated in rat plasma,,N,1,1,,BAO_0000218
9775,Rattus norvegicus,Intermediate,CHEMBL875344,,,50597,1969.0,A,,Half life period was evaluated in rat plasma; Not tested,,N,1,1,,BAO_0000218
9776,Rattus norvegicus,Intermediate,CHEMBL626082,,,50597,,A,,Half life period was evaluated in rats,,N,1,1,,BAO_0000218
9777,Rattus norvegicus,Intermediate,CHEMBL626250,,,50597,,A,,"Half life period was evaluated in rats, iv",,N,1,1,,BAO_0000218
9778,Rattus norvegicus,Intermediate,CHEMBL626251,,,50597,,A,,Half life period after intravenous administration at 5 mg/kg in rat,,N,1,1,,BAO_0000218
9779,Rattus norvegicus,Intermediate,CHEMBL626252,,,50597,,A,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,1,1,,BAO_0000218
9780,Rattus norvegicus,Intermediate,CHEMBL626253,,,50597,,A,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,N,1,1,,BAO_0000218
9781,Rattus norvegicus,Intermediate,CHEMBL626254,,,50597,1969.0,A,,Half life stability of compound was evaluated in rat plasma,,N,1,1,,BAO_0000218
9782,Rattus norvegicus,Intermediate,CHEMBL626255,,,50597,,A,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,N,1,1,,BAO_0000218
9783,Rattus norvegicus,Intermediate,CHEMBL626256,,,50597,,A,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,1,1,,BAO_0000218
9784,Rattus norvegicus,Intermediate,CHEMBL626257,,,50597,,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,1,1,,BAO_0000218
9785,Rattus norvegicus,Intermediate,CHEMBL626258,,,50597,,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,N,1,1,,BAO_0000218
9786,Rattus norvegicus,Intermediate,CHEMBL626259,,,50597,,A,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,N,1,1,,BAO_0000218
9787,Rattus norvegicus,Intermediate,CHEMBL626260,,,50597,,A,,Half in rat i.v.,,N,1,1,,BAO_0000218
9788,Rattus norvegicus,Intermediate,CHEMBL875345,,,50597,,A,,Half period in rat after intravenous administration,,N,1,1,,BAO_0000218
9789,Rattus norvegicus,Intermediate,CHEMBL626261,,,50597,,A,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,N,1,1,,BAO_0000218
9790,Rattus norvegicus,Intermediate,CHEMBL626262,,,50597,2107.0,A,,Half-life measured in in vitro Cathepsin B assay in rat liver,,N,1,1,,BAO_0000218
9791,Rattus norvegicus,Intermediate,CHEMBL626263,,,50597,,A,,Half-life of compound was determined in rats,,N,1,1,,BAO_0000218
9792,Rattus norvegicus,Intermediate,CHEMBL625270,,,50597,,A,,Half-life at 10 mg/kg in rat upon intravenous administration,,N,1,1,,BAO_0000218
9793,Rattus norvegicus,Intermediate,CHEMBL625271,,,50597,,A,,Half-life determined in rat,,N,1,1,,BAO_0000218
9794,Rattus norvegicus,Intermediate,CHEMBL625272,,,50597,,A,,Half-life determined in rat,,N,1,1,,BAO_0000218
9795,Rattus norvegicus,Intermediate,CHEMBL625273,,,50597,955.0,A,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,N,1,1,,BAO_0000218
9796,Rattus norvegicus,Intermediate,CHEMBL625274,,,50597,1969.0,A,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,N,1,1,,BAO_0000218
9797,Rattus norvegicus,Intermediate,CHEMBL625275,,,50597,,A,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,1,1,,BAO_0000218
9798,Rattus norvegicus,Intermediate,CHEMBL625276,,,50597,1969.0,A,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,N,1,1,,BAO_0000218
9799,Rattus norvegicus,Intermediate,CHEMBL625277,,,50597,1969.0,A,,Half-life in rat plasma,,N,1,1,,BAO_0000218
9800,Rattus norvegicus,Intermediate,CHEMBL625278,,,50597,1969.0,A,,Half-life in rat plasma was determined,,N,1,1,,BAO_0000218
9801,Rattus norvegicus,Intermediate,CHEMBL625279,,,50597,1969.0,A,,Half-life in rat plasma; Not tested,,N,1,1,,BAO_0000218
9802,Rattus norvegicus,Intermediate,CHEMBL625280,,,50597,1977.0,A,,Half-life in rat serum,,N,1,1,,BAO_0000218
9803,Rattus norvegicus,Intermediate,CHEMBL876797,,,50597,1977.0,A,,Half-life in rat serum; na is not available,,N,1,1,,BAO_0000218
9804,Rattus norvegicus,Intermediate,CHEMBL625281,,,50597,,A,,Half-life was calculated in rat,,N,1,1,,BAO_0000218
9805,Rattus norvegicus,Intermediate,CHEMBL873827,,,50597,1969.0,A,,Half-life was calculated in rat plasma,,N,1,1,,BAO_0000218
9806,Rattus norvegicus,Intermediate,CHEMBL625282,,,50597,,A,,Half-life was determined,,N,1,1,,BAO_0000218
9807,Rattus norvegicus,Intermediate,CHEMBL625283,,,50597,,A,,Half-life was determined,,N,1,1,,BAO_0000218
9808,Rattus norvegicus,Intermediate,CHEMBL625284,,,50597,,A,,Half-life after administration of 20 mg/Kg oral dose in rat,,N,1,1,,BAO_0000218
9809,Rattus norvegicus,Intermediate,CHEMBL625285,,,50597,,A,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,N,1,1,,BAO_0000218
9810,Rattus norvegicus,Intermediate,CHEMBL625286,,,50597,,A,,Half-life after intravenous administration in female rat,,N,1,1,,BAO_0000218
9811,Rattus norvegicus,Intermediate,CHEMBL625287,,,50597,,A,,Half-life after intravenous administration in male rat,,N,1,1,,BAO_0000218
9812,Rattus norvegicus,Intermediate,CHEMBL625288,,,50597,,A,,Half-life after intravenous dose in rat,,N,1,1,,BAO_0000218
9813,Rattus norvegicus,Intermediate,CHEMBL625289,,,50597,2107.0,A,,Half-life in a rat liver homogenate preparation,,N,1,1,,BAO_0000218
9814,Rattus norvegicus,Intermediate,CHEMBL625290,,,50597,1969.0,A,,Half-life in plasma of rat,,N,1,1,,BAO_0000218
9815,Rattus norvegicus,Intermediate,CHEMBL876798,,,50597,1969.0,A,,Half-life in plasma of rat at dose of 3-10 mgkg,,N,1,1,,BAO_0000218
9816,Rattus norvegicus,Intermediate,CHEMBL625291,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9817,Rattus norvegicus,Intermediate,CHEMBL625292,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9818,Rattus norvegicus,Intermediate,CHEMBL625293,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9819,Rattus norvegicus,Intermediate,CHEMBL622832,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9820,Rattus norvegicus,Intermediate,CHEMBL622833,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9821,Rattus norvegicus,Intermediate,CHEMBL622834,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
9822,Rattus norvegicus,Intermediate,CHEMBL622835,,,50597,,A,,Half-life in rat after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
9823,Rattus norvegicus,Intermediate,CHEMBL622836,,,50597,,A,,Half-life in rat after po administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9824,Rattus norvegicus,Intermediate,CHEMBL622837,,,50597,,A,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,1,1,,BAO_0000218
9825,Rattus norvegicus,Intermediate,CHEMBL622838,,,50597,,A,,Half-life in rat at 3 mg/kg dose administered intravenously,,N,1,1,,BAO_0000218
9826,Rattus norvegicus,Intermediate,CHEMBL622839,,,50597,955.0,A,,Half-life in rat brain homogenate,,N,1,1,,BAO_0000218
9827,Rattus norvegicus,Intermediate,CHEMBL622840,,,50597,1969.0,A,,Half-life in rat plasma,,N,1,1,,BAO_0000218
9828,Rattus norvegicus,Intermediate,CHEMBL622841,,,50597,,A,,Half-life in rats,,N,1,1,,BAO_0000218
9829,Rattus norvegicus,Intermediate,CHEMBL622842,,,50597,,A,,Half-life in Dawley rats,,N,1,1,,BAO_0000218
9830,Rattus norvegicus,Intermediate,CHEMBL622843,,,50597,1969.0,A,,Half-life in vitro in rat plasma,,N,1,1,,BAO_0000218
9831,Rattus norvegicus,Intermediate,CHEMBL622844,,,50597,1969.0,A,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,N,1,1,,BAO_0000218
9832,Rattus norvegicus,Intermediate,CHEMBL622845,,,50597,,A,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,N,1,1,,BAO_0000218
9833,Rattus norvegicus,Intermediate,CHEMBL622846,,,50597,,A,,The area under the curve of compound was measured at the dose of 100 umol/kg,,N,1,1,,BAO_0000218
9834,Rattus norvegicus,Intermediate,CHEMBL622847,,,50597,,A,,The area under the curve of compound was measured at the dose of 300 umol/kg,,N,1,1,,BAO_0000218
9835,Rattus norvegicus,Intermediate,CHEMBL622848,,,50597,,A,,The area under the curve of compound was measured at the dose of 30 umol/kg,,N,1,1,,BAO_0000218
9836,Rattus norvegicus,Intermediate,CHEMBL622849,,,50597,,A,,Bioavailability as oral AUC in rats,,N,1,1,,BAO_0000218
9837,Rattus norvegicus,Intermediate,CHEMBL622850,,,50597,1969.0,A,,The plasma concentration versus time curve (AUC) was determined,,N,1,1,,BAO_0000218
9838,Rattus norvegicus,Intermediate,CHEMBL876807,,,50597,,A,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9839,Rattus norvegicus,Intermediate,CHEMBL622851,,,50597,,A,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9840,Rattus norvegicus,Intermediate,CHEMBL622852,,,50597,,A,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9841,Rattus norvegicus,Intermediate,CHEMBL622853,,,50597,,A,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,N,1,1,,BAO_0000218
9842,Rattus norvegicus,Intermediate,CHEMBL622854,,,50597,,A,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,N,1,1,,BAO_0000218
9843,Rattus norvegicus,Intermediate,CHEMBL622855,,,50597,,A,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,1,1,,BAO_0000218
9844,Rattus norvegicus,Intermediate,CHEMBL622856,,,50597,1969.0,A,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
9845,Rattus norvegicus,Intermediate,CHEMBL622857,,,50597,1969.0,A,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
9846,Rattus norvegicus,Intermediate,CHEMBL622858,,,50597,1969.0,A,,AUC in rat after po administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
9847,Rattus norvegicus,Intermediate,CHEMBL622859,,,50597,1969.0,A,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,N,1,1,,BAO_0000218
9848,Rattus norvegicus,Intermediate,CHEMBL622860,,,50597,,A,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,N,1,1,,BAO_0000218
9849,Rattus norvegicus,Intermediate,CHEMBL622861,,,50597,,A,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,N,1,1,,BAO_0000218
9850,Rattus norvegicus,Intermediate,CHEMBL622862,,,50597,,A,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,N,1,1,,BAO_0000218
9851,Rattus norvegicus,Intermediate,CHEMBL622863,,,50597,,A,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,N,1,1,,BAO_0000218
9852,Rattus norvegicus,Intermediate,CHEMBL623817,,,50597,,A,,Area under curve value 6 hr after po administration in rat,,N,1,1,,BAO_0000218
9853,Rattus norvegicus,Intermediate,CHEMBL623818,,,50597,,A,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
9854,Rattus norvegicus,Intermediate,CHEMBL623819,,,50597,,A,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,N,1,1,,BAO_0000218
9855,Rattus norvegicus,Intermediate,CHEMBL623820,,,50597,,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
9856,Rattus norvegicus,Intermediate,CHEMBL623821,,,50597,,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,N,1,1,,BAO_0000218
9857,Rattus norvegicus,Intermediate,CHEMBL623822,,,50597,1969.0,A,,AUC normalized for dose (AUCN) in rat,,N,1,1,,BAO_0000218
9858,Rattus norvegicus,Intermediate,CHEMBL623823,,,50597,,A,,Area under curve in rat after p.o. administration,,N,1,1,,BAO_0000218
9859,Rattus norvegicus,Intermediate,CHEMBL623824,,,50597,,A,,Area under curve in rat after p.o. administration,,N,1,1,,BAO_0000218
9860,Rattus norvegicus,Intermediate,CHEMBL623825,,,50597,,A,,Area under curve in rat after p.o. administration; Not determined,,N,1,1,,BAO_0000218
9861,Rattus norvegicus,Intermediate,CHEMBL622070,,,50597,,A,,Area under curve in rat after peroral administration,,N,1,1,,BAO_0000218
9862,Rattus norvegicus,Intermediate,CHEMBL622071,,,50597,,A,,Area under curve (carotid artery) value of the compound,,N,1,1,,BAO_0000218
9863,Rattus norvegicus,Intermediate,CHEMBL622072,,,50597,,A,,Bioavailability expressed as the area under curve of rat carotid artery,,N,1,1,,BAO_0000218
9864,Rattus norvegicus,Intermediate,CHEMBL622073,,,50597,,A,,Area under curve in male SD rats was observed after intravenous administration in rat,,N,1,1,,BAO_0000218
9865,Rattus norvegicus,Intermediate,CHEMBL622074,,,50597,,A,,Area under curve of the compound was determined,,N,1,1,,BAO_0000218
9866,Rattus norvegicus,Intermediate,CHEMBL622075,,,50597,,A,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,N,1,1,,BAO_0000218
9867,Rattus norvegicus,Intermediate,CHEMBL622076,,,50597,1969.0,A,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,N,1,1,,BAO_0000218
9868,Rattus norvegicus,Intermediate,CHEMBL622077,,,50597,1969.0,A,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,N,1,1,,BAO_0000218
9869,Rattus norvegicus,Intermediate,CHEMBL622078,,,50597,,A,,Area under curve (portal vein) value of the compound,,N,1,1,,BAO_0000218
9870,Rattus norvegicus,Intermediate,CHEMBL622079,,,50597,,A,,Bioavailability expressed as the area under curve of rat portal vein,,N,1,1,,BAO_0000218
9871,Rattus norvegicus,Intermediate,CHEMBL622080,,,50597,1969.0,A,,Area Under plasma concentration time curve in rat upon peroral administration,,N,1,1,,BAO_0000218
9872,Rattus norvegicus,Intermediate,CHEMBL877612,,,50597,,A,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,N,1,1,,BAO_0000218
9873,Rattus norvegicus,Intermediate,CHEMBL622081,,,50597,,A,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,N,1,1,,BAO_0000218
9874,Rattus norvegicus,Intermediate,CHEMBL622082,,,50597,,A,,Compound was evaluated for oral bioavailability in rats,,N,1,1,,BAO_0000218
9875,Rattus norvegicus,Intermediate,CHEMBL622083,,,50597,,A,,Compound was evaluated for oral bioavailability in rats after iv administration,,N,1,1,,BAO_0000218
9876,Rattus norvegicus,Intermediate,CHEMBL622084,,,50597,,A,,Compound was evaluated for oral bioavailability in rats; 30-80,,N,1,1,,BAO_0000218
9877,Rattus norvegicus,Intermediate,CHEMBL622085,,,50597,,A,,Compound was evaluated for oral bioavailability in rats; 50-60,,N,1,1,,BAO_0000218
9878,Rattus norvegicus,Intermediate,CHEMBL622086,,,50597,,A,,Compound was evaluated for oral bioavailability in rats; no data,,N,1,1,,BAO_0000218
9879,Rattus norvegicus,Intermediate,CHEMBL622087,,,50597,,A,,Compound was evaluated for oral bioavailability in rats; peptide,,N,1,1,,BAO_0000218
9880,Rattus norvegicus,Intermediate,CHEMBL622088,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,N,1,1,,BAO_0000218
9881,Rattus norvegicus,Intermediate,CHEMBL622089,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,N,1,1,,BAO_0000218
9882,Rattus norvegicus,Intermediate,CHEMBL623685,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,N,1,1,,BAO_0000218
9883,Rattus norvegicus,Intermediate,CHEMBL623686,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,N,1,1,,BAO_0000218
9884,Rattus norvegicus,Intermediate,CHEMBL623687,,,50597,945.0,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9885,Rattus norvegicus,Intermediate,CHEMBL623688,,,50597,945.0,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9886,Rattus norvegicus,Intermediate,CHEMBL623689,,,50597,945.0,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9887,Rattus norvegicus,Intermediate,CHEMBL622485,,,50597,945.0,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9888,Rattus norvegicus,Intermediate,CHEMBL622486,,,50597,2046.0,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9889,Rattus norvegicus,Intermediate,CHEMBL877613,,,50597,2046.0,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9890,Rattus norvegicus,Intermediate,CHEMBL622487,,,50597,2046.0,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9891,Rattus norvegicus,Intermediate,CHEMBL622488,,,50597,2046.0,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9892,Rattus norvegicus,Intermediate,CHEMBL622489,,,50597,948.0,A,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,1,1,,BAO_0000218
9893,Rattus norvegicus,Intermediate,CHEMBL622490,,,50597,1088.0,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1,1,,BAO_0000218
9894,Rattus norvegicus,Intermediate,CHEMBL622491,,,50597,1088.0,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,1,1,,BAO_0000218
9895,Rattus norvegicus,Intermediate,CHEMBL622492,,,50597,2107.0,A,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,N,1,1,,BAO_0000218
9896,Rattus norvegicus,Intermediate,CHEMBL622493,,,50597,1088.0,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1,1,,BAO_0000218
9897,Rattus norvegicus,Intermediate,CHEMBL622494,,,50597,1088.0,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,1,1,,BAO_0000218
9898,Rattus norvegicus,Intermediate,CHEMBL622495,,,50597,2385.0,A,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,1,1,,BAO_0000218
9899,Rattus norvegicus,Intermediate,CHEMBL622496,,,50597,,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,N,1,1,,BAO_0000218
9900,Rattus norvegicus,Intermediate,CHEMBL622497,,,50597,1088.0,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1,1,,BAO_0000218
9901,Rattus norvegicus,Intermediate,CHEMBL622498,,,50597,,A,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,N,1,1,,BAO_0000218
9902,Rattus norvegicus,Intermediate,CHEMBL624918,,,50597,1088.0,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,N,1,1,,BAO_0000218
9903,Rattus norvegicus,Intermediate,CHEMBL624919,,,50597,1088.0,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,N,1,1,,BAO_0000218
9904,Rattus norvegicus,Intermediate,CHEMBL624920,,,50597,178.0,A,,Biodistribution of compound in rat blood after 5 min of administration,,N,1,1,,BAO_0000218
9905,Rattus norvegicus,Intermediate,CHEMBL624921,,,50597,178.0,A,,Biodistribution of compound in rat blood after 5 min of administration.,,N,1,1,,BAO_0000218
9906,Rattus norvegicus,Intermediate,CHEMBL624922,,,50597,955.0,A,,Biodistribution of compound in rat brain after 5 min of administration,,N,1,1,,BAO_0000218
9907,Rattus norvegicus,Intermediate,CHEMBL624923,,,50597,948.0,A,,Biodistribution of compound in rat heart after 5 min of administration,,N,1,1,,BAO_0000218
9908,Rattus norvegicus,Intermediate,CHEMBL624924,,,50597,948.0,A,,Biodistribution of compound in rat heart after 5 min of administration.,,N,1,1,,BAO_0000218
9909,Rattus norvegicus,Intermediate,CHEMBL624925,,,50597,2113.0,A,,Biodistribution of compound in rat kidney after 5 min of administration,,N,1,1,,BAO_0000218
9910,Rattus norvegicus,Intermediate,CHEMBL624926,,,50597,2113.0,A,,Biodistribution of compound in rat kidney after 5 min of administration.,,N,1,1,,BAO_0000218
9911,Rattus norvegicus,Intermediate,CHEMBL624927,,,50597,2107.0,A,,Biodistribution of compound in rat liver after 5 min of administration,,N,1,1,,BAO_0000218
9912,Rattus norvegicus,Intermediate,CHEMBL874402,,,50597,2107.0,A,,Biodistribution of compound in rat liver after 5 min of administration.,,N,1,1,,BAO_0000218
9913,Rattus norvegicus,Intermediate,CHEMBL624928,,,50597,2048.0,A,,Biodistribution of compound in rat lung after 5 min of administration,,N,1,1,,BAO_0000218
9914,Rattus norvegicus,Intermediate,CHEMBL624929,,,50597,2048.0,A,,Biodistribution of compound in rat lung after 5 min of administration.,,N,1,1,,BAO_0000218
9915,Rattus norvegicus,Intermediate,CHEMBL624930,,,50597,2385.0,A,,Biodistribution of compound in rat muscle after 5 min of administration,,N,1,1,,BAO_0000218
9916,Rattus norvegicus,Intermediate,CHEMBL624931,,,50597,2385.0,A,,Biodistribution of compound in rat muscle after 5 min of administration.,,N,1,1,,BAO_0000218
9917,Rattus norvegicus,Intermediate,CHEMBL624932,,,50597,948.0,A,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9918,Rattus norvegicus,Intermediate,CHEMBL624933,,,50597,948.0,A,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9919,Rattus norvegicus,Intermediate,CHEMBL624934,,,50597,2107.0,A,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9920,Rattus norvegicus,Intermediate,CHEMBL624935,,,50597,2107.0,A,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9921,Rattus norvegicus,Intermediate,CHEMBL624936,,,50597,,A,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9922,Rattus norvegicus,Intermediate,CHEMBL624937,,,50597,,A,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9923,Rattus norvegicus,Intermediate,CHEMBL624938,,,50597,2106.0,A,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9924,Rattus norvegicus,Intermediate,CHEMBL624939,,,50597,2106.0,A,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9925,Rattus norvegicus,Intermediate,CHEMBL624940,,,50597,,A,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9926,Rattus norvegicus,Intermediate,CHEMBL874403,,,50597,,A,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,1,1,,BAO_0000218
9927,Rattus norvegicus,Intermediate,CHEMBL624941,,,50597,,A,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,N,1,1,,BAO_0000218
9928,Rattus norvegicus,Intermediate,CHEMBL624942,,,50597,1088.0,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,N,1,1,,BAO_0000218
9929,Rattus norvegicus,Intermediate,CHEMBL624943,,,50597,1088.0,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,N,1,1,,BAO_0000218
9930,Rattus norvegicus,Intermediate,CHEMBL624944,,,50597,,A,,% Bioavailability after 1 day of the drug administration in rats,,N,1,1,,BAO_0000218
9931,Rattus norvegicus,Intermediate,CHEMBL624945,,,50597,,A,,% Bioavailability after 4 day of the drug administration in rats,,N,1,1,,BAO_0000218
9932,Rattus norvegicus,Intermediate,CHEMBL624946,,,50597,,A,,Absolute bioavailability was evaluated in rat,,N,1,1,,BAO_0000218
9933,Rattus norvegicus,Intermediate,CHEMBL624947,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,N,1,1,,BAO_0000218
9934,Rattus norvegicus,Intermediate,CHEMBL624948,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,N,1,1,,BAO_0000218
9935,Rattus norvegicus,Intermediate,CHEMBL624949,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,N,1,1,,BAO_0000218
9936,Rattus norvegicus,Intermediate,CHEMBL622025,,,50597,2113.0,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9937,Rattus norvegicus,Intermediate,CHEMBL622026,,,50597,2113.0,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,N,1,1,,BAO_0000218
9938,Rattus norvegicus,Intermediate,CHEMBL622027,,,50597,2113.0,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,N,1,1,,BAO_0000218
9939,Rattus norvegicus,Intermediate,CHEMBL622028,,,50597,2113.0,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,N,1,1,,BAO_0000218
9940,Rattus norvegicus,Intermediate,CHEMBL622029,,,50597,2107.0,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9941,Rattus norvegicus,Intermediate,CHEMBL622208,,,50597,2107.0,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,N,1,1,,BAO_0000218
9942,Rattus norvegicus,Intermediate,CHEMBL622209,,,50597,2107.0,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,N,1,1,,BAO_0000218
9943,Rattus norvegicus,Intermediate,CHEMBL622210,,,50597,2107.0,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,N,1,1,,BAO_0000218
9944,Rattus norvegicus,Intermediate,CHEMBL622211,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9945,Rattus norvegicus,Intermediate,CHEMBL622212,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,N,1,1,,BAO_0000218
9946,Rattus norvegicus,Intermediate,CHEMBL622213,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,N,1,1,,BAO_0000218
9947,Rattus norvegicus,Intermediate,CHEMBL874404,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,N,1,1,,BAO_0000218
9948,Rattus norvegicus,Intermediate,CHEMBL620452,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9949,Rattus norvegicus,Intermediate,CHEMBL620453,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,N,1,1,,BAO_0000218
9950,Rattus norvegicus,Intermediate,CHEMBL620454,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,N,1,1,,BAO_0000218
9951,Rattus norvegicus,Intermediate,CHEMBL624067,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,N,1,1,,BAO_0000218
9952,Rattus norvegicus,Intermediate,CHEMBL624068,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9953,Rattus norvegicus,Intermediate,CHEMBL624069,,,50597,992.0,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,N,1,1,,BAO_0000218
9954,Rattus norvegicus,Intermediate,CHEMBL624070,,,50597,992.0,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,N,1,1,,BAO_0000218
9955,Rattus norvegicus,Intermediate,CHEMBL624071,,,50597,992.0,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,N,1,1,,BAO_0000218
9956,Rattus norvegicus,Intermediate,CHEMBL624072,,,50597,995.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9957,Rattus norvegicus,Intermediate,CHEMBL624073,,,50597,995.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,N,1,1,,BAO_0000218
9958,Rattus norvegicus,Intermediate,CHEMBL624788,,,50597,995.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,N,1,1,,BAO_0000218
9959,Rattus norvegicus,Intermediate,CHEMBL624789,,,50597,995.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,N,1,1,,BAO_0000218
9960,Rattus norvegicus,Intermediate,CHEMBL624790,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9961,Rattus norvegicus,Intermediate,CHEMBL624791,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,N,1,1,,BAO_0000218
9962,Rattus norvegicus,Intermediate,CHEMBL624792,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,N,1,1,,BAO_0000218
9963,Rattus norvegicus,Intermediate,CHEMBL624793,,,50597,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,N,1,1,,BAO_0000218
9964,Rattus norvegicus,Intermediate,CHEMBL877491,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,N,1,1,,BAO_0000218
9965,Rattus norvegicus,Intermediate,CHEMBL624957,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,N,1,1,,BAO_0000218
9966,Rattus norvegicus,Intermediate,CHEMBL624958,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,N,1,1,,BAO_0000218
9967,Rattus norvegicus,Intermediate,CHEMBL624959,,,50597,2385.0,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,N,1,1,,BAO_0000218
9968,Rattus norvegicus,Intermediate,CHEMBL624960,,,50597,,A,,Dissociation constant was determined,,N,1,1,,BAO_0000218
9969,Rattus norvegicus,Intermediate,CHEMBL624961,,,50597,,A,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,N,1,1,,BAO_0000218
9970,Rattus norvegicus,Intermediate,CHEMBL624962,,,50597,,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9971,Rattus norvegicus,Intermediate,CHEMBL624963,,,50597,,A,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
9972,Rattus norvegicus,Intermediate,CHEMBL624964,,,50597,,A,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,N,1,1,,BAO_0000218
9973,Rattus norvegicus,Intermediate,CHEMBL624965,,,50597,,A,,LogP value was evaluated in the in situ rat gut perfusion assay,,N,1,1,,BAO_0000218
9974,Rattus norvegicus,Intermediate,CHEMBL624966,,,50597,,A,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,1,1,,BAO_0000218
9975,Rattus norvegicus,Intermediate,CHEMBL624967,,,50597,,A,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,N,1,1,,BAO_0000218
9976,Rattus norvegicus,Intermediate,CHEMBL624968,,,50597,,A,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
9977,Rattus norvegicus,Intermediate,CHEMBL624969,,,50597,,A,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
9978,Rattus norvegicus,Expert,CHEMBL624970,,,50597,,F,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,N,1,1,,BAO_0000218
9979,Rattus norvegicus,Intermediate,CHEMBL624971,,,50597,,A,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,N,1,1,,BAO_0000218
9980,Rattus norvegicus,Intermediate,CHEMBL624972,,,50597,,A,,Half-life was evaluated after 20 uM/kg of peroral administration,,N,1,1,,BAO_0000218
9981,Rattus norvegicus,Intermediate,CHEMBL624973,,,50597,,A,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
9982,Rattus norvegicus,Intermediate,CHEMBL624974,,,50597,1969.0,A,,Half-life was evaluated in plasma of rat,,N,1,1,,BAO_0000218
9983,Rattus norvegicus,Intermediate,CHEMBL624975,,,50597,,A,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,N,1,1,,BAO_0000218
9984,Rattus norvegicus,Intermediate,CHEMBL877492,,,50597,,A,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
9985,Rattus norvegicus,Intermediate,CHEMBL624976,,,50597,,A,,Half-life was measured in rat after an iv dose of 1 mg/kg,,N,1,1,,BAO_0000218
9986,Rattus norvegicus,Intermediate,CHEMBL624977,,,50597,,A,,Half-life period of compound in rats after peroral administration,,N,1,1,,BAO_0000218
9987,Rattus norvegicus,Intermediate,CHEMBL626848,,,50597,1969.0,A,,Half-life period of compound was measured in rat plasma.,,N,1,1,,BAO_0000218
9988,Rattus norvegicus,Intermediate,CHEMBL626849,,,50597,1969.0,A,,Half-life period of compound was measured in rat plasma; ND is not determined,,N,1,1,,BAO_0000218
9989,Rattus norvegicus,Intermediate,CHEMBL626850,,,50597,1969.0,A,,Half-life period of compound was measured in rat plasma; not determined,,N,1,1,,BAO_0000218
9990,Rattus norvegicus,Intermediate,CHEMBL626851,,,50597,,A,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,1,1,,BAO_0000218
9991,Rattus norvegicus,Intermediate,CHEMBL626852,,,50597,,A,,Half-life period in rat by iv administration,,N,1,1,,BAO_0000218
9992,Rattus norvegicus,Intermediate,CHEMBL626853,,,50597,,A,,Half-life period in rats following intravenous administration at 2 mg/kg,,N,1,1,,BAO_0000218
9993,Rattus norvegicus,Intermediate,CHEMBL626854,,,50597,,A,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,1,1,,BAO_0000218
9994,Rattus norvegicus,Intermediate,CHEMBL627486,,,50597,,A,,Half-life period was determined for the compound in rat,,N,1,1,,BAO_0000218
9995,Rattus norvegicus,Intermediate,CHEMBL627487,,,50597,,A,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,N,1,1,,BAO_0000218
9996,Rattus norvegicus,Intermediate,CHEMBL627488,,,50597,,A,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,N,1,1,,BAO_0000218
9997,Rattus norvegicus,Intermediate,CHEMBL627489,,,50597,,A,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,N,1,1,,BAO_0000218
9998,Rattus norvegicus,Intermediate,CHEMBL627490,,,50597,,A,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,1,1,,BAO_0000218
9999,Rattus norvegicus,Intermediate,CHEMBL873829,,,50597,,A,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,N,1,1,,BAO_0000218
10000,Rattus norvegicus,Intermediate,CHEMBL627655,,,50597,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.,,N,1,1,,BAO_0000218
10001,Rattus norvegicus,Intermediate,CHEMBL625994,,,50597,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,1,1,,BAO_0000218
10002,Rattus norvegicus,Intermediate,CHEMBL625995,,,50597,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,1,1,,BAO_0000218
10003,Rattus norvegicus,Intermediate,CHEMBL625996,,,50597,,A,,Half-life in rat,,N,1,1,,BAO_0000218
10004,Rattus norvegicus,Intermediate,CHEMBL625850,,,50597,1969.0,A,,In vitro half life in rat plasma,,N,1,1,,BAO_0000218
10005,Rattus norvegicus,Intermediate,CHEMBL625851,,,50597,1969.0,A,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,N,1,1,,BAO_0000218
10006,Rattus norvegicus,Intermediate,CHEMBL625852,,,50597,,A,,In vitro half life in rat,,N,1,1,,BAO_0000218
10007,Rattus norvegicus,Intermediate,CHEMBL625853,,,50597,,A,,In vivo half life period after intravenous administration in rat,,N,1,1,,BAO_0000218
10008,Rattus norvegicus,Intermediate,CHEMBL625854,,,50597,,A,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,1,1,,BAO_0000218
10009,Rattus norvegicus,Intermediate,CHEMBL874450,,,50597,,A,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,1,1,,BAO_0000218
10010,Rattus norvegicus,Intermediate,CHEMBL625855,,,50597,,A,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10011,Rattus norvegicus,Intermediate,CHEMBL625856,,,50597,,A,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10012,Rattus norvegicus,Intermediate,CHEMBL625857,,,50597,,A,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10013,Rattus norvegicus,Intermediate,CHEMBL873831,,,50597,,A,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10014,Rattus norvegicus,Intermediate,CHEMBL625858,,,50597,,A,,Longer half-life in rat (i.v.) at 0.5 mpk,,N,1,1,,BAO_0000218
10015,Rattus norvegicus,Intermediate,CHEMBL625859,,,50597,,A,,Longer half-life in rat (p.o.) at 2.0 mpk,,N,1,1,,BAO_0000218
10016,Rattus norvegicus,Intermediate,CHEMBL625860,,,50597,,A,,Pharmacokinetic property (half life) in rat,,N,1,1,,BAO_0000218
10017,Rattus norvegicus,Intermediate,CHEMBL625861,,,50597,,A,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,N,1,1,,BAO_0000218
10018,Rattus norvegicus,Intermediate,CHEMBL625862,,,50597,,A,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
10019,Rattus norvegicus,Intermediate,CHEMBL625863,,,50597,,A,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,N,1,1,,BAO_0000218
10020,Rattus norvegicus,Intermediate,CHEMBL625864,,,50597,,A,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,N,1,1,,BAO_0000218
10021,Rattus norvegicus,Intermediate,CHEMBL625865,,,50597,,A,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,N,1,1,,BAO_0000218
10022,Rattus norvegicus,Intermediate,CHEMBL625866,,,50597,,A,,Pharmacokinetic half time was determined intravenously in rats.,,N,1,1,,BAO_0000218
10023,Rattus norvegicus,Intermediate,CHEMBL625867,,,50597,1969.0,A,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,N,1,1,,BAO_0000218
10024,Rattus norvegicus,Intermediate,CHEMBL625868,,,50597,1969.0,A,,Plasma half life of hydrolysis of the compound,,N,1,1,,BAO_0000218
10025,Rattus norvegicus,Intermediate,CHEMBL625869,,,50597,1969.0,A,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,N,1,1,,BAO_0000218
10026,Rattus norvegicus,Intermediate,CHEMBL874451,,,50597,1969.0,A,,Plasma half life period was calculated in rat,,N,1,1,,BAO_0000218
10027,Rattus norvegicus,Intermediate,CHEMBL625870,,,50597,1969.0,A,,Plasma half-life in Sprague-Dawley rats,,N,1,1,,BAO_0000218
10028,Rattus norvegicus,Intermediate,CHEMBL625871,,,50597,1969.0,A,,Plasma half-life in Sprague-Dawley rats; Not determined,,N,1,1,,BAO_0000218
10029,Rattus norvegicus,Intermediate,CHEMBL625872,,,50597,1969.0,A,,Plasma half-life in rats,,N,1,1,,BAO_0000218
10030,Rattus norvegicus,Intermediate,CHEMBL625873,,,50597,1969.0,A,,Plasma half-life in rats; <MQL,,N,1,1,,BAO_0000218
10031,Rattus norvegicus,Intermediate,CHEMBL625874,,,50597,1969.0,A,,Plasma half-life period (0-8 h) was determined,,N,1,1,,BAO_0000218
10032,Rattus norvegicus,Intermediate,CHEMBL625875,,,50597,1969.0,A,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10033,Rattus norvegicus,Intermediate,CHEMBL625876,,,50597,1969.0,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10034,Rattus norvegicus,Intermediate,CHEMBL631258,,,50597,1969.0,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10035,Rattus norvegicus,Intermediate,CHEMBL631259,,,50597,1969.0,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,N,1,1,,BAO_0000218
10036,Rattus norvegicus,Intermediate,CHEMBL631260,,,50597,1969.0,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,N,1,1,,BAO_0000218
10037,Rattus norvegicus,Intermediate,CHEMBL631261,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,N,1,1,,BAO_0000218
10038,Rattus norvegicus,Intermediate,CHEMBL631262,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,N,1,1,,BAO_0000218
10039,Rattus norvegicus,Intermediate,CHEMBL631263,,,50597,178.0,A,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,N,1,1,,BAO_0000218
10040,Rattus norvegicus,Intermediate,CHEMBL631264,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,N,1,1,,BAO_0000218
10041,Rattus norvegicus,Intermediate,CHEMBL631265,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,N,1,1,,BAO_0000218
10042,Rattus norvegicus,Intermediate,CHEMBL631266,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,N,1,1,,BAO_0000218
10043,Rattus norvegicus,Intermediate,CHEMBL631267,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,N,1,1,,BAO_0000218
10044,Rattus norvegicus,Intermediate,CHEMBL631268,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,N,1,1,,BAO_0000218
10045,Rattus norvegicus,Intermediate,CHEMBL631269,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,N,1,1,,BAO_0000218
10046,Rattus norvegicus,Intermediate,CHEMBL631270,,,50597,,A,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,N,1,1,,BAO_0000218
10047,Rattus norvegicus,Intermediate,CHEMBL631271,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,1,1,,BAO_0000218
10048,Rattus norvegicus,Intermediate,CHEMBL631272,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,N,1,1,,BAO_0000218
10049,Rattus norvegicus,Intermediate,CHEMBL631273,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,N,1,1,,BAO_0000218
10050,Rattus norvegicus,Intermediate,CHEMBL631274,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,N,1,1,,BAO_0000218
10051,Rattus norvegicus,Intermediate,CHEMBL631275,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,N,1,1,,BAO_0000218
10052,Rattus norvegicus,Intermediate,CHEMBL626984,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,N,1,1,,BAO_0000218
10053,Rattus norvegicus,Intermediate,CHEMBL626985,,,50597,948.0,A,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,N,1,1,,BAO_0000218
10054,Rattus norvegicus,Intermediate,CHEMBL626986,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,1,1,,BAO_0000218
10055,Rattus norvegicus,Intermediate,CHEMBL626987,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,N,1,1,,BAO_0000218
10056,Rattus norvegicus,Intermediate,CHEMBL626988,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,N,1,1,,BAO_0000218
10057,Rattus norvegicus,Intermediate,CHEMBL626989,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,N,1,1,,BAO_0000218
10058,Rattus norvegicus,Intermediate,CHEMBL626990,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,N,1,1,,BAO_0000218
10059,Rattus norvegicus,Intermediate,CHEMBL626991,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,N,1,1,,BAO_0000218
10060,Rattus norvegicus,Intermediate,CHEMBL626992,,,50597,2107.0,A,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,N,1,1,,BAO_0000218
10061,Rattus norvegicus,Intermediate,CHEMBL626993,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,N,1,1,,BAO_0000218
10062,Rattus norvegicus,Intermediate,CHEMBL874593,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,N,1,1,,BAO_0000218
10063,Rattus norvegicus,Intermediate,CHEMBL626994,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,N,1,1,,BAO_0000218
10064,Rattus norvegicus,Intermediate,CHEMBL626995,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,N,1,1,,BAO_0000218
10065,Rattus norvegicus,Intermediate,CHEMBL626190,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,N,1,1,,BAO_0000218
10066,Rattus norvegicus,Intermediate,CHEMBL626191,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,N,1,1,,BAO_0000218
10067,Rattus norvegicus,Intermediate,CHEMBL626364,,,50597,2048.0,A,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,N,1,1,,BAO_0000218
10068,Rattus norvegicus,Intermediate,CHEMBL626365,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,N,1,1,,BAO_0000218
10069,Rattus norvegicus,Intermediate,CHEMBL626366,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,N,1,1,,BAO_0000218
10070,Rattus norvegicus,Intermediate,CHEMBL626367,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,N,1,1,,BAO_0000218
10071,Rattus norvegicus,Intermediate,CHEMBL626368,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,N,1,1,,BAO_0000218
10072,Rattus norvegicus,Intermediate,CHEMBL626369,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,N,1,1,,BAO_0000218
10073,Rattus norvegicus,Intermediate,CHEMBL626370,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,N,1,1,,BAO_0000218
10074,Rattus norvegicus,Intermediate,CHEMBL626371,,,50597,,A,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,N,1,1,,BAO_0000218
10075,Rattus norvegicus,Intermediate,CHEMBL626372,,,50597,,A,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,N,1,1,,BAO_0000218
10076,Rattus norvegicus,Intermediate,CHEMBL626373,,,50597,,A,,Bioavailability after a dose of 10 mg/kg p.o.,,N,1,1,,BAO_0000218
10077,Rattus norvegicus,Intermediate,CHEMBL626374,,,50597,,A,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,N,1,1,,BAO_0000218
10078,Rattus norvegicus,Intermediate,CHEMBL626375,,,50597,,A,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,N,1,1,,BAO_0000218
10079,Rattus norvegicus,Intermediate,CHEMBL626376,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10080,Rattus norvegicus,Intermediate,CHEMBL626377,,,50597,,A,,Bioavailability in rat po was determined,,N,1,1,,BAO_0000218
10081,Rattus norvegicus,Intermediate,CHEMBL626378,,,50597,,A,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,N,1,1,,BAO_0000218
10082,Rattus norvegicus,Intermediate,CHEMBL626379,,,50597,,A,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,N,1,1,,BAO_0000218
10083,Rattus norvegicus,Intermediate,CHEMBL626380,,,50597,,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,1,1,,BAO_0000218
10084,Rattus norvegicus,Intermediate,CHEMBL626381,,,50597,,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,1,1,,BAO_0000218
10085,Rattus norvegicus,Intermediate,CHEMBL626382,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10086,Rattus norvegicus,Intermediate,CHEMBL626383,,,50597,,A,,Bioavailability in rat (Sprague-Dawley) (female),,N,1,1,,BAO_0000218
10087,Rattus norvegicus,Intermediate,CHEMBL874652,,,50597,,A,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,1,1,,BAO_0000218
10088,Rattus norvegicus,Intermediate,CHEMBL626384,,,50597,,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,N,1,1,,BAO_0000218
10089,Rattus norvegicus,Intermediate,CHEMBL626385,,,50597,,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,N,1,1,,BAO_0000218
10090,Rattus norvegicus,Intermediate,CHEMBL626386,,,50597,,A,,Bioavailability in rat at an oral dose of 2 mg/kg,,N,1,1,,BAO_0000218
10091,Rattus norvegicus,Intermediate,CHEMBL626387,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10092,Rattus norvegicus,Intermediate,CHEMBL626388,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10093,Rattus norvegicus,Intermediate,CHEMBL626389,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10094,Rattus norvegicus,Intermediate,CHEMBL626390,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10095,Rattus norvegicus,Intermediate,CHEMBL626391,,,50597,,A,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,N,1,1,,BAO_0000218
10096,Rattus norvegicus,Intermediate,CHEMBL626392,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10097,Rattus norvegicus,Intermediate,CHEMBL626393,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10098,Rattus norvegicus,Intermediate,CHEMBL623026,,,50597,,A,,Bioavailability was determined in rat,,N,1,1,,BAO_0000218
10099,Rattus norvegicus,Intermediate,CHEMBL623027,,,50597,,A,,Bioavailability,,N,1,1,,BAO_0000218
10100,Rattus norvegicus,Intermediate,CHEMBL623028,,,50597,,A,,Bioavailability,,N,1,1,,BAO_0000218
10101,Rattus norvegicus,Intermediate,CHEMBL623029,,,50597,,A,,Bioavailability in rat after 1 day dosing,,N,1,1,,BAO_0000218
10102,Rattus norvegicus,Intermediate,CHEMBL623030,,,50597,,A,,Bioavailability in rat after 4 day dosing,,N,1,1,,BAO_0000218
10103,Rattus norvegicus,Intermediate,CHEMBL623031,,,50597,,A,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,N,1,1,,BAO_0000218
10104,Rattus norvegicus,Intermediate,CHEMBL623032,,,50597,,A,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,N,1,1,,BAO_0000218
10105,Rattus norvegicus,Intermediate,CHEMBL623033,,,50597,,A,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
10106,Rattus norvegicus,Intermediate,CHEMBL623034,,,50597,,A,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,N,1,1,,BAO_0000218
10107,Rattus norvegicus,Intermediate,CHEMBL623035,,,50597,,A,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,1,1,,BAO_0000218
10108,Rattus norvegicus,Intermediate,CHEMBL623036,,,50597,,A,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1,1,,BAO_0000218
10109,Rattus norvegicus,Intermediate,CHEMBL623037,,,50597,,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,1,1,,BAO_0000218
10110,Rattus norvegicus,Intermediate,CHEMBL623038,,,50597,,A,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,N,1,1,,BAO_0000218
10111,Rattus norvegicus,Intermediate,CHEMBL874385,,,50597,1969.0,A,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,N,1,1,,BAO_0000218
10112,Rattus norvegicus,Intermediate,CHEMBL623039,,,50597,,A,,Bioavailability in rat (Fisher) (fasted),,N,1,1,,BAO_0000218
10113,Primates,Intermediate,CHEMBL623040,,,22224,,A,,Bioavailability in monkey after po administration of 10 mg/kg dose,,U,0,1,,BAO_0000218
10114,Primates,Intermediate,CHEMBL623041,,,22224,,A,,Oral bioavailability in monkey (dose 10 mg/kg),,U,0,1,,BAO_0000218
10115,Rattus norvegicus,Intermediate,CHEMBL623741,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10116,Rattus norvegicus,Intermediate,CHEMBL623742,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10117,Rattus norvegicus,Intermediate,CHEMBL623743,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10118,Rattus norvegicus,Intermediate,CHEMBL623744,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10119,Rattus norvegicus,Intermediate,CHEMBL623745,,,50597,,A,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,N,1,1,,BAO_0000218
10120,Rattus norvegicus,Intermediate,CHEMBL623746,,,50597,,A,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10121,Rattus norvegicus,Intermediate,CHEMBL623747,,,50597,,A,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,N,1,1,,BAO_0000218
10122,Rattus norvegicus,Intermediate,CHEMBL623748,,,22224,,A,,Bioavailability in rat after po administration of 30 mg/kg dose,,U,0,1,,BAO_0000218
10123,Rattus norvegicus,Intermediate,CHEMBL623916,,,22224,,A,,Bioavailability in rat after po administration of 30 mg/kg dose,,U,0,1,,BAO_0000218
10124,Rattus norvegicus,Intermediate,CHEMBL623917,,,50597,,A,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,1,1,,BAO_0000218
10125,Rattus norvegicus,Intermediate,CHEMBL623918,,,50597,,A,,Bioavailability in rat (dose 2 mg/kg i.v.),,N,1,1,,BAO_0000218
10126,Rattus norvegicus,Intermediate,CHEMBL874386,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10127,Rattus norvegicus,Intermediate,CHEMBL623919,,,50597,1969.0,A,,Bioavailability in rat; Only traces detected in rat plasma,,N,1,1,,BAO_0000218
10128,Rattus norvegicus,Intermediate,CHEMBL623920,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10129,Rattus norvegicus,Intermediate,CHEMBL623148,,,50597,,A,,Bioavailability upon oral administration of compound,,N,1,1,,BAO_0000218
10130,Rattus norvegicus,Intermediate,CHEMBL623149,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,N,1,1,,BAO_0000218
10131,Rattus norvegicus,Intermediate,CHEMBL623150,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10132,Rattus norvegicus,Intermediate,CHEMBL623151,,,50597,,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,N,1,1,,BAO_0000218
10133,Rattus norvegicus,Intermediate,CHEMBL623152,,,50597,,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,N,1,1,,BAO_0000218
10134,Rattus norvegicus,Expert,CHEMBL623153,,,50597,,F,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,N,1,1,,BAO_0000218
10135,Rattus norvegicus,Expert,CHEMBL623154,,,50597,,F,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,N,1,1,,BAO_0000218
10136,Rattus norvegicus,Intermediate,CHEMBL623155,,,50597,,A,,In vitro and metabolic stability was determined,,N,1,1,,BAO_0000218
10137,Rattus norvegicus,Intermediate,CHEMBL623156,,,50597,,A,,In vitro metabolic stability in rat hepatocytes,,N,1,1,,BAO_0000218
10138,Rattus norvegicus,Intermediate,CHEMBL623157,,,50597,,A,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,N,1,1,,BAO_0000218
10139,Rattus norvegicus,Intermediate,CHEMBL623158,401.0,,50597,2107.0,A,,Metabolic rate for compound was observed in rat hepatocytes,,N,1,1,,BAO_0000218
10140,Rattus norvegicus,Intermediate,CHEMBL623159,,,50597,,A,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,N,1,1,,BAO_0000218
10141,Rattus norvegicus,Intermediate,CHEMBL874390,,,50597,,A,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,N,1,1,,BAO_0000218
10142,Rattus norvegicus,Intermediate,CHEMBL623160,,,50597,,A,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,N,1,1,,BAO_0000218
10143,Rattus norvegicus,Intermediate,CHEMBL623161,,,50597,,A,,Metabolism of compound in rat S9 microsomes; Trace,,N,1,1,,BAO_0000218
10144,Rattus norvegicus,Intermediate,CHEMBL623162,,,50597,,A,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,N,1,1,,BAO_0000218
10145,Rattus norvegicus,Intermediate,CHEMBL623163,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,N,1,1,,BAO_0000218
10146,Rattus norvegicus,Intermediate,CHEMBL623164,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,N,1,1,,BAO_0000218
10147,Rattus norvegicus,Intermediate,CHEMBL623165,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,N,1,1,,BAO_0000218
10148,Rattus norvegicus,Intermediate,CHEMBL623166,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,N,1,1,,BAO_0000218
10149,Rattus norvegicus,Intermediate,CHEMBL624983,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,N,1,1,,BAO_0000218
10150,Rattus norvegicus,Intermediate,CHEMBL624984,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,N,1,1,,BAO_0000218
10151,Rattus norvegicus,Intermediate,CHEMBL624985,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,N,1,1,,BAO_0000218
10152,Rattus norvegicus,Intermediate,CHEMBL622970,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,N,1,1,,BAO_0000218
10153,Rattus norvegicus,Intermediate,CHEMBL622971,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,N,1,1,,BAO_0000218
10154,Rattus norvegicus,Intermediate,CHEMBL622972,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,N,1,1,,BAO_0000218
10155,Rattus norvegicus,Intermediate,CHEMBL622973,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,N,1,1,,BAO_0000218
10156,Rattus norvegicus,Intermediate,CHEMBL622974,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,N,1,1,,BAO_0000218
10157,Rattus norvegicus,Intermediate,CHEMBL622975,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,N,1,1,,BAO_0000218
10158,Rattus norvegicus,Intermediate,CHEMBL622976,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,N,1,1,,BAO_0000218
10159,Rattus norvegicus,Intermediate,CHEMBL622977,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,N,1,1,,BAO_0000218
10160,Rattus norvegicus,Intermediate,CHEMBL624351,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,1,1,,BAO_0000218
10161,Rattus norvegicus,Intermediate,CHEMBL624352,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,1,1,,BAO_0000218
10162,Rattus norvegicus,Intermediate,CHEMBL624353,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,1,1,,BAO_0000218
10163,Rattus norvegicus,Intermediate,CHEMBL622397,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,1,1,,BAO_0000218
10164,Rattus norvegicus,Intermediate,CHEMBL622398,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,N,1,1,,BAO_0000218
10165,Rattus norvegicus,Intermediate,CHEMBL622399,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,N,1,1,,BAO_0000218
10166,Rattus norvegicus,Intermediate,CHEMBL622400,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,1,1,,BAO_0000218
10167,Rattus norvegicus,Intermediate,CHEMBL628428,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,1,1,,BAO_0000218
10168,Rattus norvegicus,Intermediate,CHEMBL628590,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,N,1,1,,BAO_0000218
10169,Rattus norvegicus,Intermediate,CHEMBL628591,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,1,1,,BAO_0000218
10170,Rattus norvegicus,Intermediate,CHEMBL628592,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,N,1,1,,BAO_0000218
10171,Rattus norvegicus,Intermediate,CHEMBL628593,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,1,1,,BAO_0000218
10172,Rattus norvegicus,Intermediate,CHEMBL875333,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,N,1,1,,BAO_0000218
10173,Rattus norvegicus,Intermediate,CHEMBL628594,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,1,1,,BAO_0000218
10174,Rattus norvegicus,Intermediate,CHEMBL628595,,,50597,1969.0,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,N,1,1,,BAO_0000218
10175,Rattus norvegicus,Intermediate,CHEMBL628596,,,50597,1969.0,A,,Stability in rat plasma was determined,,N,1,1,,BAO_0000218
10176,Rattus norvegicus,Intermediate,CHEMBL628597,,,50597,1969.0,A,,Stability in rat plasma was determined; ND= no data,,N,1,1,,BAO_0000218
10177,Rattus norvegicus,Intermediate,CHEMBL628598,,,50597,1969.0,A,,Tested for plasma half life period in rat (0-8 hr),,N,1,1,,BAO_0000218
10178,Rattus norvegicus,Intermediate,CHEMBL628599,,,50597,1969.0,A,,Tested for plasma half life period in rat (0-8 hr); Not determined,,N,1,1,,BAO_0000218
10179,Rattus norvegicus,Intermediate,CHEMBL628600,,,50597,,A,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
10180,Rattus norvegicus,Intermediate,CHEMBL628601,,,50597,,A,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
10181,Rattus norvegicus,Intermediate,CHEMBL628602,,,50597,,A,,Tested for the half life in rat,,N,1,1,,BAO_0000218
10182,Rattus norvegicus,Intermediate,CHEMBL628603,,,50597,,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,N,1,1,,BAO_0000218
10183,Rattus norvegicus,Intermediate,CHEMBL628604,,,50597,,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,N,1,1,,BAO_0000218
10184,Rattus norvegicus,Intermediate,CHEMBL628605,,,50597,,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,N,1,1,,BAO_0000218
10185,Rattus norvegicus,Intermediate,CHEMBL628606,,,50597,,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,N,1,1,,BAO_0000218
10186,Rattus norvegicus,Intermediate,CHEMBL628607,,,50597,,A,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,N,1,1,,BAO_0000218
10187,Rattus norvegicus,Intermediate,CHEMBL628608,,,50597,,A,,The biological half life the compound was measured at the dose of 100 umol/kg,,N,1,1,,BAO_0000218
10188,Rattus norvegicus,Intermediate,CHEMBL628609,,,50597,,A,,The biological half life the compound was measured at the dose of 30 umol/kg,,N,1,1,,BAO_0000218
10189,Rattus norvegicus,Intermediate,CHEMBL628610,,,50597,1969.0,A,,The compound was evaluated for plasma half life period in rat,,N,1,1,,BAO_0000218
10190,Rattus norvegicus,Intermediate,CHEMBL873819,,,50597,,A,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
10191,Rattus norvegicus,Intermediate,CHEMBL628611,,,50597,,A,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
10192,Rattus norvegicus,Intermediate,CHEMBL628612,,,50597,,A,,The pharmacokinetic parameter half-life period in vivo in rats,,N,1,1,,BAO_0000218
10193,Rattus norvegicus,Intermediate,CHEMBL628613,,,50597,,A,,"The pharmacokinetic property, Half-life was determined",,N,1,1,,BAO_0000218
10194,Rattus norvegicus,Intermediate,CHEMBL628614,,,50597,,A,,"The pharmacokinetic property, Half-life in rat in vivo",,N,1,1,,BAO_0000218
10195,Rattus norvegicus,Intermediate,CHEMBL628615,,,50597,,A,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,N,1,1,,BAO_0000218
10196,Rattus norvegicus,Intermediate,CHEMBL628616,,,50597,,A,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,N,1,1,,BAO_0000218
10197,Rattus norvegicus,Intermediate,CHEMBL627924,,,50597,1969.0,A,,The plasma half life period in rats,,N,1,1,,BAO_0000218
10198,Rattus norvegicus,Intermediate,CHEMBL627925,,,50597,2107.0,A,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,N,1,1,,BAO_0000218
10199,Rattus norvegicus,Intermediate,CHEMBL627926,,,50597,,A,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,1,1,,BAO_0000218
10200,Rattus norvegicus,Intermediate,CHEMBL627927,,,50597,,A,,t1/2 (apparent elimination)of the compound was determined,,N,1,1,,BAO_0000218
10201,Rattus norvegicus,Intermediate,CHEMBL627928,,,50597,,A,,t1/2 value in rat,,N,1,1,,BAO_0000218
10202,Rattus norvegicus,Intermediate,CHEMBL627539,,,50597,,A,,Half life in rat,,N,1,1,,BAO_0000218
10203,Rattus norvegicus,Intermediate,CHEMBL876790,,,50597,1969.0,A,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,1,1,,BAO_0000218
10204,Rattus norvegicus,Intermediate,CHEMBL858186,,,50597,,A,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,N,1,1,,BAO_0000218
10205,Rattus norvegicus,Intermediate,CHEMBL627540,,,50597,,A,,Half-life period in fasted rats,,N,1,1,,BAO_0000218
10206,Rattus norvegicus,Intermediate,CHEMBL627541,,,50597,,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,N,1,1,,BAO_0000218
10207,Rattus norvegicus,Intermediate,CHEMBL627715,,,50597,,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,N,1,1,,BAO_0000218
10208,Rattus norvegicus,Intermediate,CHEMBL627716,,,50597,,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,1,1,,BAO_0000218
10209,Rattus norvegicus,Intermediate,CHEMBL627717,,,50597,,A,,Maximum time required to achieve Cmax was determined in rat,,N,1,1,,BAO_0000218
10210,Rattus norvegicus,Intermediate,CHEMBL627718,,,50597,,A,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
10211,Rattus norvegicus,Intermediate,CHEMBL627719,,,50597,,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,1,1,,BAO_0000218
10212,Rattus norvegicus,Intermediate,CHEMBL627720,,,50597,,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,N,1,1,,BAO_0000218
10213,Rattus norvegicus,Intermediate,CHEMBL627721,,,50597,,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,N,1,1,,BAO_0000218
10214,Rattus norvegicus,Intermediate,CHEMBL627722,,,50597,,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,N,1,1,,BAO_0000218
10215,Rattus norvegicus,Intermediate,CHEMBL627723,,,50597,,A,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10216,Rattus norvegicus,Intermediate,CHEMBL626058,,,50597,,A,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10217,Rattus norvegicus,Intermediate,CHEMBL626059,,,50597,,A,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10218,Rattus norvegicus,Intermediate,CHEMBL626060,,,50597,,A,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10219,Rattus norvegicus,Intermediate,CHEMBL626061,,,50597,1969.0,A,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
10220,Rattus norvegicus,Intermediate,CHEMBL876791,,,50597,,A,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
10221,Rattus norvegicus,Intermediate,CHEMBL626062,,,50597,,A,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,1,1,,BAO_0000218
10222,Rattus norvegicus,Intermediate,CHEMBL626063,,,50597,,A,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
10223,Rattus norvegicus,Intermediate,CHEMBL626064,,,50597,,A,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
10224,Rattus norvegicus,Intermediate,CHEMBL626065,,,50597,1969.0,A,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
10225,Rattus norvegicus,Intermediate,CHEMBL626066,,,50597,1969.0,A,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,1,1,,BAO_0000218
10226,Rattus norvegicus,Intermediate,CHEMBL626067,,,50597,,A,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
10227,Rattus norvegicus,Intermediate,CHEMBL626068,,,50597,,F,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,N,1,1,,BAO_0000218
10228,Rattus norvegicus,Intermediate,CHEMBL626069,,,50597,,F,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,N,1,1,,BAO_0000218
10229,Rattus norvegicus,Intermediate,CHEMBL626070,,,50597,,F,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,N,1,1,,BAO_0000218
10230,Rattus norvegicus,Intermediate,CHEMBL626071,,,50597,,F,,Percent total excretion of N-methoxyacetaminophen glucuronide,,N,1,1,,BAO_0000218
10231,Rattus norvegicus,Intermediate,CHEMBL626072,,,50597,,F,,Percent total excretion of N-methoxyacetaminophen sulfate,,N,1,1,,BAO_0000218
10232,Rattus norvegicus,Intermediate,CHEMBL626073,,,50597,,F,,Percent total excretion of acetaminophen,,N,1,1,,BAO_0000218
10233,Rattus norvegicus,Intermediate,CHEMBL626741,,,50597,2046.0,A,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,N,1,1,,BAO_0000218
10234,Rattus norvegicus,Intermediate,CHEMBL626742,,,50597,,A,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,N,1,1,,BAO_0000218
10235,Rattus norvegicus,Intermediate,CHEMBL626743,,,50597,,A,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,N,1,1,,BAO_0000218
10236,Rattus norvegicus,Intermediate,CHEMBL876792,,,50597,,A,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,N,1,1,,BAO_0000218
10237,Rattus norvegicus,Intermediate,CHEMBL626744,,,50597,,A,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,1,1,,BAO_0000218
10238,Rattus norvegicus,Intermediate,CHEMBL626745,,,50597,,A,,Compound was tested for antidiuretic activity in rats,,N,1,1,,BAO_0000218
10239,Rattus norvegicus,Intermediate,CHEMBL626746,,,50597,1969.0,A,,AUC in rat after 3mg/kg oral dose,,N,1,1,,BAO_0000218
10240,Rattus norvegicus,Intermediate,CHEMBL626747,,,50597,,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,N,1,1,,BAO_0000218
10241,Rattus norvegicus,Intermediate,CHEMBL626748,,,50597,,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,N,1,1,,BAO_0000218
10242,Rattus norvegicus,Intermediate,CHEMBL626749,,,50597,,A,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,N,1,1,,BAO_0000218
10243,Rattus norvegicus,Intermediate,CHEMBL626750,,,50597,,A,,Oral Bioavailability was determined,,N,1,1,,BAO_0000218
10244,Rattus norvegicus,Intermediate,CHEMBL626751,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10245,Rattus norvegicus,Intermediate,CHEMBL626913,,,50597,,A,,Oral bioavailability in rat; Not performed.,,N,1,1,,BAO_0000218
10246,Rattus norvegicus,Intermediate,CHEMBL626914,,,50597,,A,,Bioavailability,,N,1,1,,BAO_0000218
10247,Rattus norvegicus,Intermediate,CHEMBL626915,,,50597,,A,,Bioavailability was determined; ND denotes no data,,N,1,1,,BAO_0000218
10248,Rattus norvegicus,Intermediate,CHEMBL626916,,,50597,,A,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,N,1,1,,BAO_0000218
10249,Rattus norvegicus,Intermediate,CHEMBL626917,,,50597,,A,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,N,1,1,,BAO_0000218
10250,Rattus norvegicus,Intermediate,CHEMBL626918,,,50597,,A,,Binding towards rat plasma protein at 10 uM,,N,1,1,,BAO_0000218
10251,Rattus norvegicus,Intermediate,CHEMBL626919,,,50597,,A,,Binding towards rat plasma protein at 100 uM,,N,1,1,,BAO_0000218
10252,Rattus norvegicus,Intermediate,CHEMBL626920,,,50597,,A,,Bioavailability in rat (dose 20 mg/kg p.o.),,N,1,1,,BAO_0000218
10253,Rattus norvegicus,Intermediate,CHEMBL621976,,,50597,,A,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,1,1,,BAO_0000218
10254,Rattus norvegicus,Intermediate,CHEMBL877599,,,50597,,A,,Bioavailability in rat after 5 mg/kg oral gavage,,N,1,1,,BAO_0000218
10255,Rattus norvegicus,Intermediate,CHEMBL621977,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10256,Rattus norvegicus,Intermediate,CHEMBL621978,,,50597,,A,,Bioavailability in rat (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10257,Rattus norvegicus,Intermediate,CHEMBL621979,,,50597,,A,,Bioavailability in rat (dose 3 mg/kg p.o.),,N,1,1,,BAO_0000218
10258,Rattus norvegicus,Intermediate,CHEMBL621980,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10259,Rattus norvegicus,Intermediate,CHEMBL621981,,,50597,,A,,Bioavailability of the compound in rats after administration of 30 mg/kg,,N,1,1,,BAO_0000218
10260,Rattus norvegicus,Intermediate,CHEMBL621982,,,50597,,A,,Bioavailability after administration of 10 mg/kg in rats,,N,1,1,,BAO_0000218
10261,Rattus norvegicus,Intermediate,CHEMBL882953,,,50597,,A,,Bioavailability after administration of 2 mg/kg in rats,,N,1,1,,BAO_0000218
10262,Rattus norvegicus,Intermediate,CHEMBL621983,,,50597,,A,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,N,1,1,,BAO_0000218
10263,Rattus norvegicus,Intermediate,CHEMBL621984,,,50597,,A,,Bioavailability in dogs was determined; high,,N,1,1,,BAO_0000218
10264,Rattus norvegicus,Intermediate,CHEMBL621985,,,50597,,A,,Bioavailability in monkey after intravenous administration at 1 mpk,,N,1,1,,BAO_0000218
10265,Rattus norvegicus,Intermediate,CHEMBL621986,,,50597,,A,,Bioavailability in monkey after peroral administration at 10 mpk,,N,1,1,,BAO_0000218
10266,Rattus norvegicus,Intermediate,CHEMBL621987,,,50597,,A,,Bioavailability in rat after intravenous administration at 1 mpk,,N,1,1,,BAO_0000218
10267,Rattus norvegicus,Intermediate,CHEMBL877600,,,50597,,F,,Bioavailability in rat after intravenous administration at 2 mpk,,N,1,1,,BAO_0000218
10268,Rattus norvegicus,Intermediate,CHEMBL621988,,,50597,,A,,Bioavailability in rat after peroral administration at 30 mpk,,N,1,1,,BAO_0000218
10269,Rattus norvegicus,Intermediate,CHEMBL621989,,,50597,,F,,Bioavailability in rat after peroral administration at at 100 mpk,,N,1,1,,BAO_0000218
10270,Rattus norvegicus,Intermediate,CHEMBL621990,,,50597,,A,,Bioavailability in rats was evaluated,,N,1,1,,BAO_0000218
10271,Rattus norvegicus,Intermediate,CHEMBL621991,,,50597,,A,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,N,1,1,,BAO_0000218
10272,Rattus norvegicus,Intermediate,CHEMBL621992,,,50597,,A,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,N,1,1,,BAO_0000218
10273,Rattus norvegicus,Intermediate,CHEMBL621993,,,50597,,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,N,1,1,,BAO_0000218
10274,Rattus norvegicus,Intermediate,CHEMBL621994,,,50597,,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,N,1,1,,BAO_0000218
10275,Rattus norvegicus,Intermediate,CHEMBL621995,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10276,Rattus norvegicus,Intermediate,CHEMBL621996,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10277,Rattus norvegicus,Intermediate,CHEMBL621997,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg),,N,1,1,,BAO_0000218
10278,Rattus norvegicus,Intermediate,CHEMBL621998,,,50597,,A,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,1,1,,BAO_0000218
10279,Rattus norvegicus,Intermediate,CHEMBL621999,,,50597,,A,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,N,1,1,,BAO_0000218
10280,Rattus norvegicus,Intermediate,CHEMBL622000,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10281,Rattus norvegicus,Intermediate,CHEMBL622001,,,50597,,A,,Bioavailability was measured in rat after oral administration; 2-4,,N,1,1,,BAO_0000218
10282,Rattus norvegicus,Intermediate,CHEMBL622002,,,50597,,A,,Bioavailability was measured in rat after oral administration; 3-7,,N,1,1,,BAO_0000218
10283,Rattus norvegicus,Intermediate,CHEMBL622003,,,50597,,A,,Bioavailability in rat (intraduodenal administration),,N,1,1,,BAO_0000218
10284,Rattus norvegicus,Intermediate,CHEMBL877601,,,50597,,A,,Bioavailability in rat (intraduodenal administration),,N,1,1,,BAO_0000218
10285,Rattus norvegicus,Intermediate,CHEMBL624871,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10286,Rattus norvegicus,Intermediate,CHEMBL622004,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10287,Rattus norvegicus,Intermediate,CHEMBL882954,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,N,1,1,,BAO_0000218
10288,Rattus norvegicus,Intermediate,CHEMBL622005,,,50597,,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,N,1,1,,BAO_0000218
10289,Rattus norvegicus,Intermediate,CHEMBL622006,,,50597,,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,N,1,1,,BAO_0000218
10290,Rattus norvegicus,Intermediate,CHEMBL622007,,,50597,,A,,Bioavailability was measured in rat,,N,1,1,,BAO_0000218
10291,Rattus norvegicus,Intermediate,CHEMBL622008,,,50597,,A,,Bioavailability was reported,,N,1,1,,BAO_0000218
10292,Rattus norvegicus,Intermediate,CHEMBL622009,,,50597,,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10293,Rattus norvegicus,Intermediate,CHEMBL622010,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10294,Rattus norvegicus,Intermediate,CHEMBL622011,,,50597,,A,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,1,1,,BAO_0000218
10295,Rattus norvegicus,Intermediate,CHEMBL622012,,,50597,,A,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,N,1,1,,BAO_0000218
10296,Rattus norvegicus,Intermediate,CHEMBL622013,,,50597,,A,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,N,1,1,,BAO_0000218
10297,Rattus norvegicus,Intermediate,CHEMBL622014,,,50597,,A,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,1,1,,BAO_0000218
10298,Rattus norvegicus,Intermediate,CHEMBL624749,,,50597,,A,,Bioavailability was determined at 3 mg/kg po dose in rats,,N,1,1,,BAO_0000218
10299,Rattus norvegicus,Intermediate,CHEMBL624750,,,50597,,A,,Oral bioavailability in rat (dose 2 mg/kg),,N,1,1,,BAO_0000218
10300,Rattus norvegicus,Intermediate,CHEMBL624751,,,50597,,A,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
10301,Rattus norvegicus,Intermediate,CHEMBL624752,,,50597,,A,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,1,1,,BAO_0000218
10302,Rattus norvegicus,Intermediate,CHEMBL624753,,,50597,,A,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,1,1,,BAO_0000218
10303,Rattus norvegicus,Intermediate,CHEMBL624754,,,50597,,A,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
10304,Rattus norvegicus,Intermediate,CHEMBL624755,,,50597,,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,1,1,,BAO_0000218
10305,Rattus norvegicus,Intermediate,CHEMBL624756,,,50597,,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
10306,Rattus norvegicus,Intermediate,CHEMBL624757,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10307,Rattus norvegicus,Intermediate,CHEMBL624758,,,50597,,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,1,1,,BAO_0000218
10308,Rattus norvegicus,Intermediate,CHEMBL622270,,,50597,,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,1,1,,BAO_0000218
10309,Rattus norvegicus,Intermediate,CHEMBL622271,,,50597,,A,,Bioavailability in rat (Sprague-Dawley),,N,1,1,,BAO_0000218
10310,Rattus norvegicus,Intermediate,CHEMBL622272,,,50597,,A,,Bioavailability in rat at the dose of 2 mg/kg,,N,1,1,,BAO_0000218
10311,Rattus norvegicus,Intermediate,CHEMBL622273,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10312,Rattus norvegicus,Intermediate,CHEMBL622274,,,50597,,A,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10313,Rattus norvegicus,Intermediate,CHEMBL622275,,,50597,,A,,Bioavailability value of compound in rats was determined after peroral administration,,N,1,1,,BAO_0000218
10314,Rattus norvegicus,Intermediate,CHEMBL622276,,,50597,,A,,Oral bioavailability in rat (dose 20 mg/kg),,N,1,1,,BAO_0000218
10315,Rattus norvegicus,Intermediate,CHEMBL622277,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10316,Rattus norvegicus,Intermediate,CHEMBL622278,,,50597,,A,,Oral bioavailability in rat (dose 5 mg/kg),,N,1,1,,BAO_0000218
10317,Rattus norvegicus,Intermediate,CHEMBL622279,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10318,Rattus norvegicus,Intermediate,CHEMBL622280,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10319,Rattus norvegicus,Intermediate,CHEMBL624083,,,50597,,A,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,N,1,1,,BAO_0000218
10320,Rattus norvegicus,Intermediate,CHEMBL624084,,,50597,,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,N,1,1,,BAO_0000218
10321,Rattus norvegicus,Intermediate,CHEMBL624085,,,50597,,A,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,N,1,1,,BAO_0000218
10322,Rattus norvegicus,Intermediate,CHEMBL624086,,,50597,,A,,Compound was tested for bioavailability in rats,,N,1,1,,BAO_0000218
10323,Rattus norvegicus,Intermediate,CHEMBL624087,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10324,Rattus norvegicus,Intermediate,CHEMBL624088,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10325,Macaca mulatta,Intermediate,CHEMBL624089,,,22224,,A,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,U,0,1,,BAO_0000218
10326,Rattus norvegicus,Intermediate,CHEMBL624090,,,22224,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,U,0,1,,BAO_0000218
10327,Rattus norvegicus,Intermediate,CHEMBL624091,,,50597,,A,,Evaluated for the bioavailability in rat (in vivo),,N,1,1,,BAO_0000218
10328,Rattus norvegicus,Intermediate,CHEMBL624092,,,50597,,A,,F value of compound in rats was determined after peroral administration,,N,1,1,,BAO_0000218
10329,Rattus norvegicus,Intermediate,CHEMBL624093,,,50597,,A,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10330,Rattus norvegicus,Intermediate,CHEMBL624094,,,50597,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10331,Rattus norvegicus,Intermediate,CHEMBL624095,,,50597,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10332,Rattus norvegicus,Intermediate,CHEMBL624096,,,50597,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,1,1,,BAO_0000218
10333,Rattus norvegicus,Intermediate,CHEMBL624097,,,50597,,A,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,N,1,1,,BAO_0000218
10334,Rattus norvegicus,Intermediate,CHEMBL624098,,,50597,,A,,Maximum fall in carotid flow in rat,,N,1,1,,BAO_0000218
10335,Rattus norvegicus,Intermediate,CHEMBL874392,,,50597,,A,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,N,1,1,,BAO_0000218
10336,Rattus norvegicus,Intermediate,CHEMBL624099,,,50597,,A,,Oral bioavailability in rat (dose 5 mg/kg),,N,1,1,,BAO_0000218
10337,Rattus norvegicus,Intermediate,CHEMBL624100,,,50597,,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,1,1,,BAO_0000218
10338,Rattus norvegicus,Intermediate,CHEMBL624101,,,50597,,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,1,1,,BAO_0000218
10339,Rattus norvegicus,Intermediate,CHEMBL624102,,,50597,,A,,Oral bioavailability in rat (male Wistar),,N,1,1,,BAO_0000218
10340,Rattus norvegicus,Intermediate,CHEMBL624103,,,50597,,A,,Oral bioavailability after administration (30 mg/kg) in rat; good,,N,1,1,,BAO_0000218
10341,Rattus norvegicus,Intermediate,CHEMBL624104,,,50597,,A,,Oral bioavailability at the dose of 2 mg/kg in rat,,N,1,1,,BAO_0000218
10342,Rattus norvegicus,Intermediate,CHEMBL624105,,,50597,,A,,Oral bioavailability determined in rats,,N,1,1,,BAO_0000218
10343,Rattus norvegicus,Intermediate,CHEMBL624106,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,N,1,1,,BAO_0000218
10344,Rattus norvegicus,Intermediate,CHEMBL624107,,,50597,,A,,Oral bioavailability in rat (dose single 10 mg/kg),,N,1,1,,BAO_0000218
10345,Rattus norvegicus,Intermediate,CHEMBL623943,,,50597,,A,,Oral bioavailability in rat (dose single 10 mg/kg),,N,1,1,,BAO_0000218
10346,Rattus norvegicus,Intermediate,CHEMBL623944,,,50597,,A,,Oral bioavailability in rat (dose 5 mg/kg,,N,1,1,,BAO_0000218
10347,Rattus norvegicus,Intermediate,CHEMBL623945,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,N,1,1,,BAO_0000218
10348,Rattus norvegicus,Intermediate,CHEMBL623946,,,50597,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,N,1,1,,BAO_0000218
10349,Rattus norvegicus,Intermediate,CHEMBL623947,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,N,1,1,,BAO_0000218
10350,Rattus norvegicus,Intermediate,CHEMBL623948,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,N,1,1,,BAO_0000218
10351,Rattus norvegicus,Intermediate,CHEMBL623949,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,N,1,1,,BAO_0000218
10352,Rattus norvegicus,Intermediate,CHEMBL623950,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,N,1,1,,BAO_0000218
10353,Rattus norvegicus,Intermediate,CHEMBL874398,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,N,1,1,,BAO_0000218
10354,Rattus norvegicus,Intermediate,CHEMBL623951,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,N,1,1,,BAO_0000218
10355,Rattus norvegicus,Intermediate,CHEMBL623952,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,N,1,1,,BAO_0000218
10356,Rattus norvegicus,Intermediate,CHEMBL623953,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,N,1,1,,BAO_0000218
10357,Rattus norvegicus,Intermediate,CHEMBL623954,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,N,1,1,,BAO_0000218
10358,Rattus norvegicus,Intermediate,CHEMBL623955,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,N,1,1,,BAO_0000218
10359,Rattus norvegicus,Intermediate,CHEMBL623956,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,N,1,1,,BAO_0000218
10360,Rattus norvegicus,Intermediate,CHEMBL627807,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,N,1,1,,BAO_0000218
10361,Rattus norvegicus,Intermediate,CHEMBL627808,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,N,1,1,,BAO_0000218
10362,Rattus norvegicus,Intermediate,CHEMBL627809,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,N,1,1,,BAO_0000218
10363,Rattus norvegicus,Intermediate,CHEMBL627810,,,50597,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,N,1,1,,BAO_0000218
10364,Rattus norvegicus,Intermediate,CHEMBL627811,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,N,1,1,,BAO_0000218
10365,Rattus norvegicus,Intermediate,CHEMBL627812,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,N,1,1,,BAO_0000218
10366,Rattus norvegicus,Intermediate,CHEMBL627813,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,N,1,1,,BAO_0000218
10367,Rattus norvegicus,Intermediate,CHEMBL627814,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,N,1,1,,BAO_0000218
10368,Rattus norvegicus,Intermediate,CHEMBL875336,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,N,1,1,,BAO_0000218
10369,Rattus norvegicus,Intermediate,CHEMBL627815,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,N,1,1,,BAO_0000218
10370,Rattus norvegicus,Intermediate,CHEMBL627816,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,N,1,1,,BAO_0000218
10371,Rattus norvegicus,Intermediate,CHEMBL627817,,,50597,,A,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,N,1,1,,BAO_0000218
10372,Rattus norvegicus,Intermediate,CHEMBL627818,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,N,1,1,,BAO_0000218
10373,Rattus norvegicus,Intermediate,CHEMBL627819,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,N,1,1,,BAO_0000218
10374,Rattus norvegicus,Intermediate,CHEMBL627820,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,N,1,1,,BAO_0000218
10375,Rattus norvegicus,Intermediate,CHEMBL627821,,,50597,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,N,1,1,,BAO_0000218
10376,Rattus norvegicus,Intermediate,CHEMBL628464,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,1,1,,BAO_0000218
10377,Rattus norvegicus,Intermediate,CHEMBL626239,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,1,1,,BAO_0000218
10378,Rattus norvegicus,Intermediate,CHEMBL626240,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,N,1,1,,BAO_0000218
10379,Rattus norvegicus,Intermediate,CHEMBL626241,,,50597,,A,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,1,1,,BAO_0000218
10380,Rattus norvegicus,Intermediate,CHEMBL626242,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,N,1,1,,BAO_0000218
10381,Rattus norvegicus,Intermediate,CHEMBL626243,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,N,1,1,,BAO_0000218
10382,Rattus norvegicus,Intermediate,CHEMBL626244,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,1,1,,BAO_0000218
10383,Rattus norvegicus,Intermediate,CHEMBL626907,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,N,1,1,,BAO_0000218
10384,Rattus norvegicus,Intermediate,CHEMBL626908,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,1,1,,BAO_0000218
10385,Rattus norvegicus,Intermediate,CHEMBL626909,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,1,1,,BAO_0000218
10386,Rattus norvegicus,Intermediate,CHEMBL626910,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,1,1,,BAO_0000218
10387,Rattus norvegicus,Intermediate,CHEMBL875342,,,50597,,F,,Percent total excretion of acetaminophen cysteine conjugate,,N,1,1,,BAO_0000218
10388,Rattus norvegicus,Intermediate,CHEMBL626911,,,50597,,F,,Percent total excretion of acetaminophen glucuronide,,N,1,1,,BAO_0000218
10389,Rattus norvegicus,Intermediate,CHEMBL626912,,,50597,,F,,Percent total excretion of acetaminophen sulfate,,N,1,1,,BAO_0000218
10390,Rattus norvegicus,Intermediate,CHEMBL627065,,,50597,,F,,Percent total excretion of acetaminophen-mercapturic acid,,N,1,1,,BAO_0000218
10391,Rattus norvegicus,Intermediate,CHEMBL627066,,,50597,1088.0,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,N,1,1,,BAO_0000218
10392,Rattus norvegicus,Intermediate,CHEMBL627067,,,50597,,A,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
10393,ratrat,Autocuration,CHEMBL627068,,,22224,2385.0,A,,Biodistribution of compound in rat muscle after 5 min of administration,,U,0,1,,BAO_0000218
10394,ratrat,Autocuration,CHEMBL627069,,,22224,2385.0,A,,Biodistribution of compound in rat muscle after 5 min of administration.,,U,0,1,,BAO_0000218
10395,Ovis aries,Autocuration,CHEMBL627070,,,22224,,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10396,Ovis aries,Autocuration,CHEMBL627071,,,22224,,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10397,Ovis aries,Autocuration,CHEMBL627072,,,22224,,A,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10398,Ovis aries,Autocuration,CHEMBL627073,,,22224,,A,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10399,Ovis aries,Autocuration,CHEMBL625387,,,22224,,A,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10400,Ovis aries,Autocuration,CHEMBL625388,,,22224,,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10401,Ovis aries,Autocuration,CHEMBL625389,,,22224,1969.0,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10402,Ovis aries,Autocuration,CHEMBL875343,,,22224,1969.0,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,0,1,,BAO_0000218
10403,Serpentes,Intermediate,CHEMBL876795,,,50497,,A,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,N,1,1,,BAO_0000218
10404,Serpentes,Intermediate,CHEMBL626552,,,50497,,A,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,N,1,1,,BAO_0000218
10405,Serpentes,Intermediate,CHEMBL626553,,,50497,,A,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,N,1,1,,BAO_0000218
10406,Homo sapiens,Autocuration,CHEMBL626554,,,22224,1969.0,A,,The human biological plasma half life of the compound,,U,0,1,,BAO_0000366
10407,Rattus norvegicus,Intermediate,CHEMBL626555,,,50597,1088.0,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,1,1,,BAO_0000218
10408,Rattus norvegicus,Intermediate,CHEMBL626556,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,N,1,1,,BAO_0000218
10409,Rattus norvegicus,Intermediate,CHEMBL626557,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,N,1,1,,BAO_0000218
10410,Rattus norvegicus,Intermediate,CHEMBL626558,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,N,1,1,,BAO_0000218
10411,Rattus norvegicus,Intermediate,CHEMBL626559,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,1,1,,BAO_0000218
10412,Rattus norvegicus,Intermediate,CHEMBL626560,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,1,1,,BAO_0000218
10413,Rattus norvegicus,Intermediate,CHEMBL876803,,,50597,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,1,1,,BAO_0000218
10414,Rattus norvegicus,Intermediate,CHEMBL627964,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,N,1,1,,BAO_0000218
10415,Rattus norvegicus,Intermediate,CHEMBL627965,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,N,1,1,,BAO_0000218
10416,Rattus norvegicus,Intermediate,CHEMBL627966,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,N,1,1,,BAO_0000218
10417,Rattus norvegicus,Intermediate,CHEMBL627967,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,1,1,,BAO_0000218
10418,Rattus norvegicus,Intermediate,CHEMBL627968,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,1,1,,BAO_0000218
10419,Rattus norvegicus,Intermediate,CHEMBL627969,,,50597,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,1,1,,BAO_0000218
10420,Rattus norvegicus,Intermediate,CHEMBL627970,,,50597,,A,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,1,1,,BAO_0000218
10421,Rattus norvegicus,Intermediate,CHEMBL627971,,,50597,178.0,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,N,1,1,,BAO_0000218
10422,Rattus norvegicus,Intermediate,CHEMBL627972,,,50597,178.0,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,N,1,1,,BAO_0000218
10423,Homo sapiens,Expert,CHEMBL856029,,,180,,B,,Dissociation constant against binding to human cyclophilin A,,D,9,1,,BAO_0000357
10424,Bos taurus,Expert,CHEMBL627973,,,11591,,B,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,H,8,1,,BAO_0000019
10425,,Autocuration,CHEMBL627974,,,22224,,A,,-Log C was determined by performing the electroshock minimum test,,U,0,1,,BAO_0000019
10426,,Autocuration,CHEMBL627975,,,22224,,A,,-Log C was determined by performing the foot shock test,,U,0,1,,BAO_0000019
10427,,Autocuration,CHEMBL627976,,,22224,,A,,-Log C was determined by performing the incl screen test,,U,0,1,,BAO_0000019
10428,,Autocuration,CHEMBL627977,,,22224,,A,,-Log C was determined by performing the maximum electroshock test,,U,0,1,,BAO_0000019
10429,,Autocuration,CHEMBL627978,,,22224,,A,,-Log C was determined by performing the pentylenetetrazole test,,U,0,1,,BAO_0000019
10430,,Autocuration,CHEMBL627979,,,22224,,A,,Tested for experimental arotinoid inhibitory dose,,U,0,1,,BAO_0000019
10431,,Autocuration,CHEMBL876804,,,22224,,A,,Negative log transformed activity,,U,0,1,,BAO_0000019
10432,,Autocuration,CHEMBL627980,,,22224,,A,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,U,0,1,,BAO_0000019
10433,Cavia porcellus,Intermediate,CHEMBL627981,,,50512,,A,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,N,1,1,,BAO_0000218
10434,Cavia porcellus,Intermediate,CHEMBL627982,,,50512,,A,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,N,1,1,,BAO_0000218
10435,Cavia porcellus,Intermediate,CHEMBL627983,,,50512,,A,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,N,1,1,,BAO_0000218
10436,Cavia porcellus,Intermediate,CHEMBL627984,,,50512,2116.0,A,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,N,1,1,,BAO_0000218
10437,,Autocuration,CHEMBL627985,,,22229,,P,,Solubility in water was determined; values expressed as -log,,U,0,1,,BAO_0000100
10438,,Autocuration,CHEMBL627986,,,22224,,A,,Ratio of Kcat to that of Km was determined,,U,0,1,,BAO_0000019
10439,,Autocuration,CHEMBL627987,,,22224,,A,,Observed first order rate constant,,U,0,1,,BAO_0000019
10440,,Autocuration,CHEMBL627988,,,22224,,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,U,0,1,,BAO_0000019
10441,Rattus norvegicus,Intermediate,CHEMBL627989,,,50597,,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,N,1,1,,BAO_0000218
10442,Rattus norvegicus,Intermediate,CHEMBL627990,,,50597,,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,N,1,1,,BAO_0000218
10443,Rattus norvegicus,Intermediate,CHEMBL876805,,,50597,,A,,Oral Bioavailability after administration of 10 mg/kg in male rat,,N,1,1,,BAO_0000218
10444,Rattus norvegicus,Intermediate,CHEMBL627991,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,N,1,1,,BAO_0000218
10445,Rattus norvegicus,Intermediate,CHEMBL627992,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10446,Rattus norvegicus,Intermediate,CHEMBL627993,,,50597,,A,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,1,1,,BAO_0000218
10447,Rattus norvegicus,Intermediate,CHEMBL622817,,,50597,,A,,Oral bioavailability at 1 mg/kg was determined in rat,,N,1,1,,BAO_0000218
10448,Rattus norvegicus,Intermediate,CHEMBL622818,,,50597,,A,,Oral bioavailability at 10 mg/kg was determined in rat,,N,1,1,,BAO_0000218
10449,Rattus norvegicus,Intermediate,CHEMBL622819,,,50597,,A,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,N,1,1,,BAO_0000218
10450,Rattus norvegicus,Intermediate,CHEMBL872267,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10451,Rattus norvegicus,Intermediate,CHEMBL622820,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10452,Rattus norvegicus,Intermediate,CHEMBL622821,,,50597,,A,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,N,1,1,,BAO_0000218
10453,Rattus norvegicus,Intermediate,CHEMBL622822,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10454,Rattus norvegicus,Intermediate,CHEMBL622823,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10455,Rattus norvegicus,Intermediate,CHEMBL622824,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10456,Rattus norvegicus,Intermediate,CHEMBL622825,,,50597,,A,,Oral bioavailability in rat at a dose of 3 mg/kg,,N,1,1,,BAO_0000218
10457,Rattus norvegicus,Intermediate,CHEMBL622901,,,50597,,A,,Oral bioavailability in rat after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
10458,Rattus norvegicus,Intermediate,CHEMBL622902,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10459,Rattus norvegicus,Intermediate,CHEMBL621844,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10460,Rattus norvegicus,Intermediate,CHEMBL621845,,,50597,,A,,Oral bioavailability in Dawley rats,,N,1,1,,BAO_0000218
10461,Rattus norvegicus,Intermediate,CHEMBL621846,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10462,Rattus norvegicus,Intermediate,CHEMBL621847,,,50597,,A,,Oral bioavailability in rat (dose 30 mg/kg),,N,1,1,,BAO_0000218
10463,Rattus norvegicus,Intermediate,CHEMBL877609,,,50597,,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,1,1,,BAO_0000218
10464,Rattus norvegicus,Intermediate,CHEMBL621848,,,50597,,A,,Bioavailability in rat (dose 3 mg/kg i.v.),,N,1,1,,BAO_0000218
10465,Rattus norvegicus,Intermediate,CHEMBL621849,,,50597,,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,1,1,,BAO_0000218
10466,Rattus norvegicus,Intermediate,CHEMBL622030,,,50597,,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,1,1,,BAO_0000218
10467,Rattus norvegicus,Intermediate,CHEMBL622031,,,50597,,A,,Percent oral bioavailability determined in rats,,N,1,1,,BAO_0000218
10468,Rattus norvegicus,Intermediate,CHEMBL622032,,,50597,,A,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,1,1,,BAO_0000218
10469,Rattus norvegicus,Intermediate,CHEMBL622033,,,50597,,A,,The compound was evaluated for bioavailability in rats; 32-51,,N,1,1,,BAO_0000218
10470,Rattus norvegicus,Intermediate,CHEMBL622034,,,50597,,A,,Bioavailability in rat (dose 20 mg/kg p.o.),,N,1,1,,BAO_0000218
10471,Rattus norvegicus,Intermediate,CHEMBL622035,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10472,Rattus norvegicus,Intermediate,CHEMBL882966,,,50597,,A,,Bioavailability percent in rat at the dose of 2 mg/kg,,N,1,1,,BAO_0000218
10473,Rattus norvegicus,Intermediate,CHEMBL622036,,,50597,,A,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,N,1,1,,BAO_0000218
10474,Rattus norvegicus,Intermediate,CHEMBL622037,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10475,Rattus norvegicus,Intermediate,CHEMBL622038,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10476,Rattus norvegicus,Intermediate,CHEMBL622039,,,50597,,A,,Bioavailability in rats,,N,1,1,,BAO_0000218
10477,Rattus norvegicus,Intermediate,CHEMBL622040,,,50597,178.0,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10478,Rattus norvegicus,Intermediate,CHEMBL622041,,,50597,178.0,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10479,Rattus norvegicus,Intermediate,CHEMBL622042,,,50597,178.0,A,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10480,Rattus norvegicus,Intermediate,CHEMBL622043,,,50597,178.0,A,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10481,Rattus norvegicus,Intermediate,CHEMBL622044,,,50597,178.0,A,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10482,Rattus norvegicus,Intermediate,CHEMBL622045,,,50597,10000001.0,A,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10483,Rattus norvegicus,Intermediate,CHEMBL622046,,,50597,10000001.0,A,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10484,Rattus norvegicus,Intermediate,CHEMBL622047,,,50597,10000001.0,A,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10485,Rattus norvegicus,Intermediate,CHEMBL877610,,,50597,10000001.0,A,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10486,Rattus norvegicus,Intermediate,CHEMBL622048,,,50597,955.0,A,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10487,Rattus norvegicus,Intermediate,CHEMBL622049,,,50597,955.0,A,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10488,Rattus norvegicus,Intermediate,CHEMBL622050,,,50597,955.0,A,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10489,Rattus norvegicus,Intermediate,CHEMBL622051,,,50597,955.0,A,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10490,Rattus norvegicus,Intermediate,CHEMBL622052,,,50597,,A,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10491,Rattus norvegicus,Intermediate,CHEMBL622053,,,50597,,A,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10492,Rattus norvegicus,Intermediate,CHEMBL622054,,,50597,,A,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10493,Rattus norvegicus,Intermediate,CHEMBL622055,,,50597,,A,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10494,Rattus norvegicus,Intermediate,CHEMBL622056,,,50597,,A,,Oral bioavailability in rats was determined; High,,N,1,1,,BAO_0000218
10495,Rattus norvegicus,Intermediate,CHEMBL622057,,,50597,,A,,Oral bioavailability in the rat was determined,,N,1,1,,BAO_0000218
10496,Rattus norvegicus,Intermediate,CHEMBL628008,,,50597,,A,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,N,1,1,,BAO_0000218
10497,Rattus norvegicus,Intermediate,CHEMBL622058,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,N,1,1,,BAO_0000218
10498,Rattus norvegicus,Intermediate,CHEMBL622059,,,50597,,A,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10499,Rattus norvegicus,Intermediate,CHEMBL622060,,,50597,,A,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10500,Rattus norvegicus,Intermediate,CHEMBL622061,,,50597,,A,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10501,Rattus norvegicus,Intermediate,CHEMBL622062,,,50597,,A,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,1,1,,BAO_0000218
10502,Rattus norvegicus,Intermediate,CHEMBL622063,,,50597,,A,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,N,1,1,,BAO_0000218
10503,Rattus norvegicus,Expert,CHEMBL877611,,,50597,,A,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
10504,Rattus norvegicus,Intermediate,CHEMBL622064,,,50597,,A,,Oral bioavailability of compound in Sprague Dawley rats,,N,1,1,,BAO_0000218
10505,Rattus norvegicus,Intermediate,CHEMBL622065,,,50597,,A,,Oral bioavailability of compound in rat,,N,1,1,,BAO_0000218
10506,Rattus norvegicus,Intermediate,CHEMBL622066,,,50597,,A,,Oral bioavailability in rat (dose 2 mg/kg),,N,1,1,,BAO_0000218
10507,Rattus norvegicus,Intermediate,CHEMBL622067,,,50597,,A,,Oral bioavailability of compound in rat was determined,,N,1,1,,BAO_0000218
10508,Rattus norvegicus,Intermediate,CHEMBL622068,,,50597,,A,,Oral bioavailability of compound in rats,,N,1,1,,BAO_0000218
10509,Rattus norvegicus,Intermediate,CHEMBL622069,,,50597,,A,,Oral bioavailability of compound was determined in rats,,N,1,1,,BAO_0000218
10510,Rattus norvegicus,Intermediate,CHEMBL624796,,,50597,,A,,Oral bioavailability at a dose of 30 mg/kg in rats,,N,1,1,,BAO_0000218
10511,Rattus norvegicus,Intermediate,CHEMBL624797,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg),,N,1,1,,BAO_0000218
10512,Rattus norvegicus,Intermediate,CHEMBL623053,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg),,N,1,1,,BAO_0000218
10513,Rattus norvegicus,Intermediate,CHEMBL623054,,,50597,,A,,Oral bioavailability evaluated in rat,,N,1,1,,BAO_0000218
10514,Rattus norvegicus,Intermediate,CHEMBL623055,,,50597,,A,,Oral bioavailability in fasted rat,,N,1,1,,BAO_0000218
10515,Rattus norvegicus,Intermediate,CHEMBL623056,,,50597,,A,,Oral bioavailability in fed rat,,N,1,1,,BAO_0000218
10516,Rattus norvegicus,Intermediate,CHEMBL623057,,,50597,,A,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,N,1,1,,BAO_0000218
10517,Rattus norvegicus,Intermediate,CHEMBL623058,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10518,Rattus norvegicus,Intermediate,CHEMBL623059,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,1,1,,BAO_0000218
10519,Rattus norvegicus,Intermediate,CHEMBL623060,,,50597,,A,,Oral bioavailability in rat after administration of 10 mg/kg po,,N,1,1,,BAO_0000218
10520,Rattus norvegicus,Intermediate,CHEMBL623061,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10521,Rattus norvegicus,Intermediate,CHEMBL623062,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10522,Rattus norvegicus,Intermediate,CHEMBL623063,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10523,Rattus norvegicus,Intermediate,CHEMBL623064,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10524,Rattus norvegicus,Intermediate,CHEMBL623065,,,50597,,A,,Oral bioavailability in ratrs,,N,1,1,,BAO_0000218
10525,Rattus norvegicus,Intermediate,CHEMBL623066,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10526,Rattus norvegicus,Intermediate,CHEMBL623067,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10527,Rattus norvegicus,Intermediate,CHEMBL623068,,,50597,,A,,Oral bioavailability in rats was determined; High,,N,1,1,,BAO_0000218
10528,Rattus norvegicus,Intermediate,CHEMBL623069,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10529,Rattus norvegicus,Intermediate,CHEMBL623070,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10530,Rattus norvegicus,Intermediate,CHEMBL623071,,,50597,,A,,Oral bioavailability was calculated in rat,,N,1,1,,BAO_0000218
10531,Rattus norvegicus,Intermediate,CHEMBL623072,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10532,Rattus norvegicus,Intermediate,CHEMBL623073,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10533,Rattus norvegicus,Intermediate,CHEMBL623074,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10534,Rattus norvegicus,Intermediate,CHEMBL623075,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10535,Rattus norvegicus,Intermediate,CHEMBL623076,,,50597,,A,,Oral bioavailability after i.v. administration,,N,1,1,,BAO_0000218
10536,Rattus norvegicus,Intermediate,CHEMBL623077,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10537,Rattus norvegicus,Intermediate,CHEMBL623078,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley),,N,1,1,,BAO_0000218
10538,Rattus norvegicus,Intermediate,CHEMBL623079,,,50597,,A,,Oral bioavailability in Sprague-Dawley rats,,N,1,1,,BAO_0000218
10539,Rattus norvegicus,Intermediate,CHEMBL623080,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10540,Rattus norvegicus,Intermediate,CHEMBL623081,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10541,Rattus norvegicus,Intermediate,CHEMBL623082,,,50597,,A,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,N,1,1,,BAO_0000218
10542,Rattus norvegicus,Intermediate,CHEMBL874400,,,50597,,A,,Oral bioavailability in fasted rat,,N,1,1,,BAO_0000218
10543,Rattus norvegicus,Intermediate,CHEMBL623083,,,50597,,A,,Oral bioavailability in fed rat,,N,1,1,,BAO_0000218
10544,Rattus norvegicus,Intermediate,CHEMBL623084,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10545,Rattus norvegicus,Intermediate,CHEMBL623085,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10546,Rattus norvegicus,Intermediate,CHEMBL623086,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10547,Rattus norvegicus,Intermediate,CHEMBL623087,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10548,Rattus norvegicus,Intermediate,CHEMBL623088,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10549,Rattus norvegicus,Intermediate,CHEMBL623089,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10550,Rattus norvegicus,Intermediate,CHEMBL623090,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10551,Rattus norvegicus,Intermediate,CHEMBL623091,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10552,Rattus norvegicus,Intermediate,CHEMBL623092,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10553,Rattus norvegicus,Intermediate,CHEMBL623093,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10554,Rattus norvegicus,Intermediate,CHEMBL874401,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10555,Rattus norvegicus,Intermediate,CHEMBL623094,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10556,Rattus norvegicus,Intermediate,CHEMBL623095,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10557,Rattus norvegicus,Intermediate,CHEMBL623096,,,50597,,A,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,N,1,1,,BAO_0000218
10558,Rattus norvegicus,Intermediate,CHEMBL624913,,,50597,,A,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,N,1,1,,BAO_0000218
10559,Rattus norvegicus,Intermediate,CHEMBL624914,,,50597,,A,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,N,1,1,,BAO_0000218
10560,Rattus norvegicus,Intermediate,CHEMBL624915,,,50597,,A,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,N,1,1,,BAO_0000218
10561,Rattus norvegicus,Intermediate,CHEMBL624916,,,50597,,A,,Oral bioavailability in rat; Not measured,,N,1,1,,BAO_0000218
10562,Rattus norvegicus,Intermediate,CHEMBL624917,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10563,Rattus norvegicus,Intermediate,CHEMBL625157,,,50597,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,N,1,1,,BAO_0000218
10564,Rattus norvegicus,Intermediate,CHEMBL625158,,,50597,2107.0,A,,In vitro metabolic potential in rat liver microsomes,,N,1,1,,BAO_0000218
10565,Rattus norvegicus,Intermediate,CHEMBL625159,,,50597,,A,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,N,1,1,,BAO_0000218
10566,Rattus norvegicus,Intermediate,CHEMBL625160,,,50597,,A,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,N,1,1,,BAO_0000218
10567,Rattus norvegicus,Intermediate,CHEMBL625161,,,50597,,A,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,N,1,1,,BAO_0000218
10568,Rattus norvegicus,Intermediate,CHEMBL625162,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10569,Rattus norvegicus,Intermediate,CHEMBL625163,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10570,Rattus norvegicus,Intermediate,CHEMBL625164,,,50597,,A,,Oral bioavailability in rats at 10 mg/kg,,N,1,1,,BAO_0000218
10571,Rattus norvegicus,Intermediate,CHEMBL625165,,,50597,,A,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,1,1,,BAO_0000218
10572,Rattus norvegicus,Intermediate,CHEMBL625166,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10573,Rattus norvegicus,Intermediate,CHEMBL625167,,,50597,,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,N,1,1,,BAO_0000218
10574,Rattus norvegicus,Intermediate,CHEMBL625168,,,50597,,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,N,1,1,,BAO_0000218
10575,Rattus norvegicus,Intermediate,CHEMBL625169,,,50597,,A,,Plasma clearance of the compound,,N,1,1,,BAO_0000218
10576,Rattus norvegicus,Intermediate,CHEMBL626264,,,50597,,A,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,N,1,1,,BAO_0000218
10577,Rattus norvegicus,Intermediate,CHEMBL626265,,,50597,,A,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,N,1,1,,BAO_0000218
10578,Rattus norvegicus,Intermediate,CHEMBL626266,,,50597,1969.0,A,,The compound was tested for plasma clearance in rat,,N,1,1,,BAO_0000218
10579,Rattus norvegicus,Intermediate,CHEMBL626267,,,50597,1969.0,A,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,N,1,1,,BAO_0000218
10580,Rattus norvegicus,Intermediate,CHEMBL626268,,,50597,,A,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,N,1,1,,BAO_0000218
10581,Rattus norvegicus,Intermediate,CHEMBL626269,,,50597,,A,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,N,1,1,,BAO_0000218
10582,Rattus norvegicus,Intermediate,CHEMBL626270,,,50597,,A,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,N,1,1,,BAO_0000218
10583,Rattus norvegicus,Intermediate,CHEMBL626271,,,50597,,A,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,N,1,1,,BAO_0000218
10584,Rattus norvegicus,Intermediate,CHEMBL626272,,,50597,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,N,1,1,,BAO_0000218
10585,Rattus norvegicus,Intermediate,CHEMBL626273,,,50597,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,1,1,,BAO_0000218
10586,Rattus norvegicus,Intermediate,CHEMBL875346,,,50597,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,1,1,,BAO_0000218
10587,Rattus norvegicus,Intermediate,CHEMBL626274,,,50597,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,N,1,1,,BAO_0000218
10588,Rattus norvegicus,Intermediate,CHEMBL626275,,,50597,,A,,Compound was tested for protein binding in rat plasma,,N,1,1,,BAO_0000218
10589,Rattus norvegicus,Intermediate,CHEMBL624646,,,50597,,A,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,N,1,1,,BAO_0000218
10590,Rattus norvegicus,Intermediate,CHEMBL624647,,,50597,,A,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,N,1,1,,BAO_0000218
10591,Rattus norvegicus,Intermediate,CHEMBL624648,,,50597,2107.0,A,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,N,1,1,,BAO_0000218
10592,Rattus norvegicus,Intermediate,CHEMBL624649,,,50597,,A,,Area under curve ratio was determined (po/iv) in rat,,N,1,1,,BAO_0000218
10593,Rattus norvegicus,Intermediate,CHEMBL624650,,,50597,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10594,Rattus norvegicus,Intermediate,CHEMBL624651,,,50597,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10595,Rattus norvegicus,Intermediate,CHEMBL624652,,,50597,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10596,Rattus norvegicus,Intermediate,CHEMBL624653,,,50597,,A,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,N,1,1,,BAO_0000218
10597,Rattus norvegicus,Intermediate,CHEMBL624654,,,50597,,A,,Ratio of AUCbrain to AUCplasma,,N,1,1,,BAO_0000218
10598,Rattus norvegicus,Intermediate,CHEMBL624655,,,50597,,A,,Ratio of brain to plasma,,N,1,1,,BAO_0000218
10599,Rattus norvegicus,Intermediate,CHEMBL624656,,,50597,,A,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,N,1,1,,BAO_0000218
10600,Rattus norvegicus,Intermediate,CHEMBL624657,,,50597,,A,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,1,1,,BAO_0000218
10601,Rattus norvegicus,Intermediate,CHEMBL624658,,,50597,,A,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,1,1,,BAO_0000218
10602,Rattus norvegicus,Intermediate,CHEMBL624659,,,50597,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,N,1,1,,BAO_0000218
10603,Rattus norvegicus,Intermediate,CHEMBL624660,,,50597,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,N,1,1,,BAO_0000218
10604,Rattus norvegicus,Intermediate,CHEMBL624661,,,50597,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,N,1,1,,BAO_0000218
10605,Rattus norvegicus,Intermediate,CHEMBL624662,,,50597,,A,,Steady state brain :blood ratio was determined,,N,1,1,,BAO_0000218
10606,Rattus norvegicus,Intermediate,CHEMBL625199,,,50597,,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
10607,Rattus norvegicus,Intermediate,CHEMBL625200,,,50597,,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,1,1,,BAO_0000218
10608,Rattus norvegicus,Intermediate,CHEMBL625201,,,50597,,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1,1,,BAO_0000218
10609,Rattus norvegicus,Intermediate,CHEMBL625202,,,50597,,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,1,1,,BAO_0000218
10610,Rattus norvegicus,Intermediate,CHEMBL625203,,,50597,,A,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,N,1,1,,BAO_0000218
10611,Rattus norvegicus,Intermediate,CHEMBL625204,,,50597,,A,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,N,1,1,,BAO_0000218
10612,Rattus norvegicus,Intermediate,CHEMBL625205,,,50597,,A,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,N,1,1,,BAO_0000218
10613,Rattus norvegicus,Intermediate,CHEMBL625206,,,50597,,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,N,1,1,,BAO_0000218
10614,,Autocuration,CHEMBL625207,,,22224,,A,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,U,0,1,,BAO_0000019
10615,,Autocuration,CHEMBL625208,,,22224,,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,U,0,1,,BAO_0000019
10616,Homo sapiens,Intermediate,CHEMBL625209,495.0,,50587,,A,,In vivo absorption in Caco-2 cell line monolayers was determined,,N,1,1,,BAO_0000218
10617,,Autocuration,CHEMBL625210,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
10618,Rattus norvegicus,Intermediate,CHEMBL625211,,,50597,,A,,Area under curve was determine after peroral administration at 10 mpk in Rat,,N,1,1,,BAO_0000218
10619,Macaca mulatta,Intermediate,CHEMBL625212,,,50797,,A,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,N,1,1,,BAO_0000218
10620,Rattus norvegicus,Intermediate,CHEMBL625213,,,50597,,A,,Area under curve was determine after peroral administration at 160 mpk in Rat,,N,1,1,,BAO_0000218
10621,Rattus norvegicus,Intermediate,CHEMBL625214,,,50597,,A,,Area under curve was determine after peroral administration at 20 mpk in Rat,,N,1,1,,BAO_0000218
10622,Rattus norvegicus,Intermediate,CHEMBL874542,,,50597,,A,,Area under curve was determine after peroral administration at 50 mpk in Rat,,N,1,1,,BAO_0000218
10623,,Autocuration,CHEMBL625215,,,22229,,P,,Calculated partition coefficient (clogP) (AlogP),,U,0,1,,BAO_0000100
10624,,Autocuration,CHEMBL625216,,,22224,,A,,Activated partial thromboplastin time measured,,U,0,1,,BAO_0000019
10625,,Autocuration,CHEMBL625217,,,22224,,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,U,0,1,,BAO_0000100
10626,,Autocuration,CHEMBL625218,,,22224,,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,U,0,1,,BAO_0000100
10627,Canis lupus familiaris,Intermediate,CHEMBL622864,,,50588,1969.0,A,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,N,1,1,,BAO_0000218
10628,Rattus norvegicus,Intermediate,CHEMBL622865,,,50597,1969.0,A,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,N,1,1,,BAO_0000218
10629,Rattus norvegicus,Intermediate,CHEMBL622866,,,50597,1969.0,A,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,N,1,1,,BAO_0000218
10630,Canis lupus familiaris,Intermediate,CHEMBL622867,,,50588,1969.0,A,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,N,1,1,,BAO_0000218
10631,Cavia porcellus,Intermediate,CHEMBL876808,,,50512,1969.0,A,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,N,1,1,,BAO_0000218
10632,,Autocuration,CHEMBL627725,,,22224,955.0,A,,AUC in brain,,U,0,1,,BAO_0000019
10633,,Autocuration,CHEMBL627726,,,22224,1977.0,A,,AUC in serum,,U,0,1,,BAO_0000019
10634,,Autocuration,CHEMBL627727,,,22224,1969.0,A,,AUC was determined,,U,0,1,,BAO_0000019
10635,,Autocuration,CHEMBL627728,,,22224,1969.0,A,,AUC of the compound.,,U,0,1,,BAO_0000019
10636,,Autocuration,CHEMBL627729,,,22224,1969.0,A,,AUC value (0-4 hr),,U,0,1,,BAO_0000019
10637,,Autocuration,CHEMBL627730,,,22224,1969.0,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,U,0,1,,BAO_0000019
10638,,Autocuration,CHEMBL627731,,,22224,1969.0,A,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,U,0,1,,BAO_0000019
10639,,Autocuration,CHEMBL627732,,,22224,1969.0,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,U,0,1,,BAO_0000019
10640,,Autocuration,CHEMBL627733,,,22224,1969.0,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,U,0,1,,BAO_0000019
10641,Rattus norvegicus,Intermediate,CHEMBL627734,,,50597,1969.0,A,,AUC(area under curve) was determined after intravenous administration in rats,,N,1,1,,BAO_0000218
10642,Rattus norvegicus,Intermediate,CHEMBL627735,,,50597,1969.0,A,,AUC(area under curve) was determined after oral administration in rats,,N,1,1,,BAO_0000218
10643,Cavia porcellus,Intermediate,CHEMBL627736,,,50512,1969.0,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,N,1,1,,BAO_0000218
10644,Rattus norvegicus,Intermediate,CHEMBL876809,,,50597,1969.0,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,N,1,1,,BAO_0000218
10645,,Autocuration,CHEMBL627737,,,22224,,A,,Area Under Curve after oral dosing of 100 uM/Kg,,U,0,1,,BAO_0000019
10646,,Autocuration,CHEMBL627738,,,22224,,A,,Area Under Curve after oral dosing of 30 uM/Kg,,U,0,1,,BAO_0000019
10647,,Autocuration,CHEMBL627739,,,22224,,A,,Area Under Curve was measured by ploting the graph between concentration verses time,,U,0,1,,BAO_0000019
10648,Canis lupus familiaris,Intermediate,CHEMBL626143,,,50588,,A,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,N,1,1,,BAO_0000218
10649,Simiiformes,Autocuration,CHEMBL626144,,,22224,,A,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,U,0,1,,BAO_0000218
10650,Oryctolagus cuniculus,Intermediate,CHEMBL626145,,,50592,,A,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,N,1,1,,BAO_0000218
10651,Rattus norvegicus,Intermediate,CHEMBL626146,,,50597,,A,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,N,1,1,,BAO_0000218
10652,Rattus norvegicus,Intermediate,CHEMBL626147,,,50597,178.0,A,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,N,1,1,,BAO_0000218
10653,,Autocuration,CHEMBL626148,,,22224,,A,,Area under curve (AUC) was determined,,U,0,1,,BAO_0000019
10654,,Autocuration,CHEMBL626149,,,22224,,A,,Area under curve (AUC) following ip administration at 1 mg/kg,,U,0,1,,BAO_0000218
10655,,Autocuration,CHEMBL626150,,,22224,,A,,Area under curve (AUC) was determined; ND is Not determined,,U,0,1,,BAO_0000019
10656,Canis lupus familiaris,Intermediate,CHEMBL626151,,,50588,,A,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,N,1,1,,BAO_0000218
10657,Canis lupus familiaris,Intermediate,CHEMBL626152,,,50588,,A,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,N,1,1,,BAO_0000218
10658,Canis lupus familiaris,Intermediate,CHEMBL626153,,,50588,,A,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,N,1,1,,BAO_0000218
10659,,Autocuration,CHEMBL626154,,,22224,,A,,Area under curve (AUR) was determined,,U,0,1,,BAO_0000019
10660,,Autocuration,CHEMBL626155,,,22224,,A,,Area under curve at 1 uM/dg administered intravenously,,U,0,1,,BAO_0000019
10661,,Autocuration,CHEMBL626156,,,22224,,A,,Area under curve at 10 uM/dg administered perorally,,U,0,1,,BAO_0000019
10662,,Autocuration,CHEMBL626157,,,22224,,A,,Area under curve at 2 uM/dg administered intravenously,,U,0,1,,BAO_0000019
10663,,Autocuration,CHEMBL626158,,,22224,,A,,Area under curve at 20 uM/dg administered perorally,,U,0,1,,BAO_0000019
10664,Canis lupus familiaris,Intermediate,CHEMBL626159,,,50588,,A,,Area under curve at a peroral dose of 3 mg/kg in dog,,N,1,1,,BAO_0000218
10665,Rattus norvegicus,Intermediate,CHEMBL626160,,,50597,,A,,Area under curve at a peroral dose of 3 mg/kg in rat,,N,1,1,,BAO_0000218
10666,Canis lupus familiaris,Intermediate,CHEMBL626161,,,50588,,A,,Area under curve at an iv dose of 1 mg/kg in dog,,N,1,1,,BAO_0000218
10667,Rattus norvegicus,Intermediate,CHEMBL626162,,,50597,,A,,Area under curve at an iv dose of 1 mg/kg in rat,,N,1,1,,BAO_0000218
10668,,Autocuration,CHEMBL626163,,,22224,,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,U,0,1,,BAO_0000019
10669,,Autocuration,CHEMBL626164,,,22224,,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,U,0,1,,BAO_0000019
10670,Mus musculus,Intermediate,CHEMBL626165,,,50594,,A,,Area under curve measured as conc vs time after intravenous administration to mice.,,N,1,1,,BAO_0000218
10671,Mus musculus,Intermediate,CHEMBL626166,,,50594,,A,,Area under curve measured as conc vs time after peroral administration to mice.,,N,1,1,,BAO_0000218
10672,Canis lupus familiaris,Intermediate,CHEMBL626167,,,50588,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,1,1,,BAO_0000218
10673,Canis lupus familiaris,Intermediate,CHEMBL626168,,,50588,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,N,1,1,,BAO_0000218
10674,Canis lupus familiaris,Intermediate,CHEMBL877463,,,50588,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,N,1,1,,BAO_0000218
10675,Canis lupus familiaris,Intermediate,CHEMBL626169,,,50588,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,N,1,1,,BAO_0000218
10676,Rattus norvegicus,Intermediate,CHEMBL626170,,,50597,948.0,A,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10677,Rattus norvegicus,Intermediate,CHEMBL626171,,,50597,948.0,A,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10678,Rattus norvegicus,Intermediate,CHEMBL626172,,,50597,948.0,A,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10679,Rattus norvegicus,Intermediate,CHEMBL626173,,,50597,948.0,A,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10680,Rattus norvegicus,Intermediate,CHEMBL626174,,,50597,2113.0,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10681,Rattus norvegicus,Intermediate,CHEMBL626175,,,50597,2113.0,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10682,Rattus norvegicus,Intermediate,CHEMBL626176,,,50597,2113.0,A,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10683,Rattus norvegicus,Intermediate,CHEMBL626177,,,50597,2113.0,A,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10684,Rattus norvegicus,Intermediate,CHEMBL622499,,,50597,2113.0,A,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10685,Rattus norvegicus,Intermediate,CHEMBL622500,,,50597,2107.0,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10686,Rattus norvegicus,Intermediate,CHEMBL622501,,,50597,2107.0,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10687,Rattus norvegicus,Intermediate,CHEMBL622502,,,50597,2107.0,A,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10688,Rattus norvegicus,Intermediate,CHEMBL622503,,,50597,2107.0,A,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10689,Rattus norvegicus,Intermediate,CHEMBL877614,,,50597,2107.0,A,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10690,Rattus norvegicus,Intermediate,CHEMBL624839,,,50597,2048.0,A,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10691,Rattus norvegicus,Intermediate,CHEMBL624840,,,50597,2048.0,A,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10692,Rattus norvegicus,Intermediate,CHEMBL624841,,,50597,2048.0,A,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10693,Rattus norvegicus,Intermediate,CHEMBL624842,,,50597,2048.0,A,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10694,Rattus norvegicus,Intermediate,CHEMBL624843,,,50597,2385.0,A,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10695,Rattus norvegicus,Intermediate,CHEMBL624844,,,50597,2385.0,A,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10696,Rattus norvegicus,Intermediate,CHEMBL624845,,,50597,2385.0,A,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10697,Rattus norvegicus,Intermediate,CHEMBL621904,,,50597,2385.0,A,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,N,1,1,,BAO_0000218
10698,Rattus norvegicus,Intermediate,CHEMBL621905,,,50597,178.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10699,Rattus norvegicus,Intermediate,CHEMBL874382,,,50597,178.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10700,Rattus norvegicus,Intermediate,CHEMBL621906,,,50597,178.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10701,Rattus norvegicus,Intermediate,CHEMBL621907,,,50597,955.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10702,Rattus norvegicus,Intermediate,CHEMBL622096,,,50597,955.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10703,Rattus norvegicus,Intermediate,CHEMBL622097,,,50597,955.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10704,Rattus norvegicus,Intermediate,CHEMBL622098,,,50597,948.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10705,Rattus norvegicus,Intermediate,CHEMBL622099,,,50597,948.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10706,Rattus norvegicus,Intermediate,CHEMBL622100,,,50597,948.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10707,Rattus norvegicus,Intermediate,CHEMBL622101,,,50597,2113.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10708,Rattus norvegicus,Intermediate,CHEMBL622102,,,50597,2113.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10709,Rattus norvegicus,Intermediate,CHEMBL622103,,,50597,2113.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10710,Rattus norvegicus,Intermediate,CHEMBL622104,,,50597,2107.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10711,Rattus norvegicus,Intermediate,CHEMBL622105,,,50597,2107.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10712,Rattus norvegicus,Intermediate,CHEMBL622106,,,50597,2107.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10713,Rattus norvegicus,Intermediate,CHEMBL622107,,,50597,2048.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10714,Rattus norvegicus,Intermediate,CHEMBL622108,,,50597,2048.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10715,Rattus norvegicus,Intermediate,CHEMBL622109,,,50597,2048.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10716,Rattus norvegicus,Intermediate,CHEMBL622110,,,50597,2385.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10717,Rattus norvegicus,Intermediate,CHEMBL622111,,,50597,2385.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10718,Rattus norvegicus,Intermediate,CHEMBL874383,,,50597,2385.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10719,Rattus norvegicus,Intermediate,CHEMBL622112,,,50597,14.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10720,Rattus norvegicus,Intermediate,CHEMBL622113,,,50597,14.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10721,Rattus norvegicus,Intermediate,CHEMBL622114,,,50597,14.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,N,1,1,,BAO_0000218
10722,Rattus norvegicus,Intermediate,CHEMBL622115,,,50597,2106.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,N,1,1,,BAO_0000218
10723,Rattus norvegicus,Intermediate,CHEMBL622116,,,50597,2106.0,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,N,1,1,,BAO_0000218
10724,Rattus norvegicus,Intermediate,CHEMBL622117,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10725,Rattus norvegicus,Intermediate,CHEMBL622118,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10726,Rattus norvegicus,Intermediate,CHEMBL622119,,,50597,,A,,Oral bioavailability in rats at 6 mg/kg,,N,1,1,,BAO_0000218
10727,Rattus norvegicus,Intermediate,CHEMBL622120,,,50597,,A,,Oral bioavailability in rat (dose 6 mg/kg),,N,1,1,,BAO_0000218
10728,Rattus norvegicus,Intermediate,CHEMBL622121,,,50597,,A,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,N,1,1,,BAO_0000218
10729,Rattus norvegicus,Intermediate,CHEMBL622122,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10730,Rattus norvegicus,Intermediate,CHEMBL622123,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10731,Rattus norvegicus,Intermediate,CHEMBL622124,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10732,Rattus norvegicus,Intermediate,CHEMBL622125,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10733,Rattus norvegicus,Intermediate,CHEMBL622126,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10734,Rattus norvegicus,Intermediate,CHEMBL620455,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10735,Rattus norvegicus,Intermediate,CHEMBL620456,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10736,Rattus norvegicus,Intermediate,CHEMBL620457,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10737,Rattus norvegicus,Intermediate,CHEMBL620458,,,50597,,A,,Oral bioavailability was evaluated; Not tested,,N,1,1,,BAO_0000218
10738,Rattus norvegicus,Intermediate,CHEMBL620459,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10739,Rattus norvegicus,Intermediate,CHEMBL620460,,,50597,,A,,Oral bioavailability in rat by oral dosing,,N,1,1,,BAO_0000218
10740,Rattus norvegicus,Intermediate,CHEMBL620461,,,50597,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,1,1,,BAO_0000218
10741,Rattus norvegicus,Intermediate,CHEMBL620462,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley),,N,1,1,,BAO_0000218
10742,Rattus norvegicus,Intermediate,CHEMBL620463,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10743,Rattus norvegicus,Intermediate,CHEMBL620464,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,1,1,,BAO_0000218
10744,Rattus norvegicus,Intermediate,CHEMBL620465,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,1,1,,BAO_0000218
10745,Rattus norvegicus,Intermediate,CHEMBL620466,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,N,1,1,,BAO_0000218
10746,Rattus norvegicus,Intermediate,CHEMBL620467,,,50597,,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,N,1,1,,BAO_0000218
10747,Rattus norvegicus,Intermediate,CHEMBL620468,,,50597,,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,N,1,1,,BAO_0000218
10748,Rattus norvegicus,Intermediate,CHEMBL620469,,,50597,,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,N,1,1,,BAO_0000218
10749,Rattus norvegicus,Intermediate,CHEMBL620470,,,50597,,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,N,1,1,,BAO_0000218
10750,Rattus norvegicus,Intermediate,CHEMBL620471,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10751,Rattus norvegicus,Intermediate,CHEMBL620472,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10752,Rattus norvegicus,Intermediate,CHEMBL620473,,,50597,,A,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,N,1,1,,BAO_0000218
10753,Rattus norvegicus,Intermediate,CHEMBL620474,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10754,Rattus norvegicus,Intermediate,CHEMBL620475,,,50597,,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,N,1,1,,BAO_0000218
10755,Rattus norvegicus,Intermediate,CHEMBL620476,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10756,Rattus norvegicus,Intermediate,CHEMBL620477,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10757,Rattus norvegicus,Intermediate,CHEMBL620478,,,50597,,A,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,N,1,1,,BAO_0000218
10758,Rattus norvegicus,Intermediate,CHEMBL618768,,,50597,,A,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,N,1,1,,BAO_0000218
10759,Rattus norvegicus,Intermediate,CHEMBL618769,,,50597,,A,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,N,1,1,,BAO_0000218
10760,Rattus norvegicus,Intermediate,CHEMBL618770,,,50597,,A,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,N,1,1,,BAO_0000218
10761,Rattus norvegicus,Intermediate,CHEMBL618771,,,50597,,A,,Oral bioavailability (dose 20 mg/kg p.o.),,N,1,1,,BAO_0000218
10762,Rattus norvegicus,Intermediate,CHEMBL618772,,,50597,,A,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,N,1,1,,BAO_0000218
10763,Rattus norvegicus,Intermediate,CHEMBL618773,,,50597,,A,,Oral bioavailability in rat at 10 mg/kg of the compound,,N,1,1,,BAO_0000218
10764,Rattus norvegicus,Intermediate,CHEMBL875842,,,50597,,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,1,1,,BAO_0000218
10765,Rattus norvegicus,Intermediate,CHEMBL618774,,,50597,,A,,Bioavailability in rat (dose 3 mg/kg i.v.),,N,1,1,,BAO_0000218
10766,Rattus norvegicus,Intermediate,CHEMBL618775,,,50597,,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,1,1,,BAO_0000218
10767,Rattus norvegicus,Intermediate,CHEMBL618776,,,50597,,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,1,1,,BAO_0000218
10768,Rattus norvegicus,Intermediate,CHEMBL618777,,,50597,,A,,Percent bioavailability (F) in rats after iv administration,,N,1,1,,BAO_0000218
10769,Rattus norvegicus,Intermediate,CHEMBL618778,,,50597,,A,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,N,1,1,,BAO_0000218
10770,Rattus norvegicus,Intermediate,CHEMBL618779,,,50597,,A,,Bioavailability in rat (dose 5 uM/kg p.o.),,N,1,1,,BAO_0000218
10771,Rattus norvegicus,Intermediate,CHEMBL618780,,,50597,,A,,Oral bioavailability,,N,1,1,,BAO_0000218
10772,Rattus norvegicus,Intermediate,CHEMBL618781,,,50597,,A,,Bioavailability in rat (dose 2 mg/kg p.o.),,N,1,1,,BAO_0000218
10773,Rattus norvegicus,Intermediate,CHEMBL618782,,,50597,,A,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,N,1,1,,BAO_0000218
10774,Rattus norvegicus,Intermediate,CHEMBL618783,,,50597,,A,,Oral bioavailability in rat (dose 20 mg/kg),,N,1,1,,BAO_0000218
10775,Rattus norvegicus,Intermediate,CHEMBL618784,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10776,Rattus norvegicus,Intermediate,CHEMBL618785,,,50597,,A,,Percent oral bioavailability evaluated in rat,,N,1,1,,BAO_0000218
10777,Rattus norvegicus,Intermediate,CHEMBL618786,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10778,Rattus norvegicus,Intermediate,CHEMBL618787,,,50597,,A,,Percent oral bioavailability in rat; Not determined,,N,1,1,,BAO_0000218
10779,Rattus norvegicus,Intermediate,CHEMBL618788,,,50597,,A,,Oral bioavailability in rat,,N,1,1,,BAO_0000218
10780,Rattus norvegicus,Intermediate,CHEMBL618789,,,50597,,A,,Bioavailability in rat,,N,1,1,,BAO_0000218
10781,Rattus norvegicus,Intermediate,CHEMBL618790,,,50597,,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,N,1,1,,BAO_0000218
10782,Rattus norvegicus,Intermediate,CHEMBL618791,,,50597,,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,N,1,1,,BAO_0000218
10783,Rattus norvegicus,Intermediate,CHEMBL875843,,,50597,,A,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,N,1,1,,BAO_0000218
10784,Rattus norvegicus,Intermediate,CHEMBL618792,,,50597,,A,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,N,1,1,,BAO_0000218
10785,Rattus norvegicus,Intermediate,CHEMBL623395,,,50597,,A,,Cmax at a dose of 30 mg/kg in rat,,N,1,1,,BAO_0000218
10786,Simiiformes,Autocuration,CHEMBL623396,,,22224,,A,,Cmax in monkeys at a dose of 1 mg/kg,,U,0,1,,BAO_0000218
10787,Rattus norvegicus,Intermediate,CHEMBL623397,,,50597,,A,,Cmax in rat,,N,1,1,,BAO_0000218
10788,Rattus norvegicus,Intermediate,CHEMBL623398,,,50597,,A,,Cmax in rats at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
10789,Mus musculus,Intermediate,CHEMBL623399,,,50594,,A,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,N,1,1,,BAO_0000218
10790,,Autocuration,CHEMBL623400,,,22224,,A,,"Cmax value at a dose of 12.7 uM/kg, po",,U,0,1,,BAO_0000218
10791,,Autocuration,CHEMBL623401,,,22224,,A,,"Cmax value at a dose of 6.3 uM/kg, iv",,U,0,1,,BAO_0000218
10792,,Autocuration,CHEMBL623402,,,22224,,A,,"Cmax value at a dose of 7.1 uM/kg, iv",,U,0,1,,BAO_0000218
10793,,Autocuration,CHEMBL623403,,,22224,,A,,Cmax value of compound was determined after 1 hr,,U,0,1,,BAO_0000218
10794,,Autocuration,CHEMBL623404,,,22224,,A,,Cmax value of the compound,,U,0,1,,BAO_0000218
10795,Rattus norvegicus,Intermediate,CHEMBL625997,,,50597,,A,,Cmax value administered intraintestinal in rats.,,N,1,1,,BAO_0000218
10796,Rattus norvegicus,Intermediate,CHEMBL625998,,,50597,,A,,Cmax value administered perorally was determined in rat; Not determined,,N,1,1,,BAO_0000218
10797,,Autocuration,CHEMBL625999,,,22224,,A,,Cmax value at the dose of 2.3 mg/kg,,U,0,1,,BAO_0000218
10798,,Autocuration,CHEMBL626000,,,22224,,A,,Cmax value at the dose of 5 mg/kg,,U,0,1,,BAO_0000218
10799,,Autocuration,CHEMBL626001,,,22224,,A,,Cmax value in the period of 8 hr after dosing. ,,U,0,1,,BAO_0000218
10800,,Autocuration,CHEMBL626002,,,22224,,A,,Cmax value at a oral dose of 20 mg/kg; Not tested,,U,0,1,,BAO_0000218
10801,,Autocuration,CHEMBL626003,,,22224,,A,,Cmax value at a oral dose of 20 mg/kg,,U,0,1,,BAO_0000218
10802,Rattus norvegicus,Intermediate,CHEMBL626004,,,50597,,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,1,1,,BAO_0000218
10803,Cavia porcellus,Intermediate,CHEMBL626005,,,50512,,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,N,1,1,,BAO_0000218
10804,Rattus norvegicus,Intermediate,CHEMBL626006,,,50597,,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,N,1,1,,BAO_0000218
10805,Rattus norvegicus,Intermediate,CHEMBL626007,,,50597,1969.0,A,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,N,1,1,,BAO_0000218
10806,Mus musculus,Intermediate,CHEMBL626008,,,50594,1969.0,A,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,N,1,1,,BAO_0000218
10807,Canis lupus familiaris,Intermediate,CHEMBL626009,,,50588,2107.0,A,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,N,1,1,,BAO_0000218
10808,Canis lupus familiaris,Intermediate,CHEMBL626010,,,50588,,A,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,N,1,1,,BAO_0000218
10809,Mus musculus,Intermediate,CHEMBL626011,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,N,1,1,,BAO_0000218
10810,Mus musculus,Intermediate,CHEMBL626012,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,N,1,1,,BAO_0000218
10811,Mus musculus,Intermediate,CHEMBL626013,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,N,1,1,,BAO_0000218
10812,Mus musculus,Intermediate,CHEMBL626014,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,N,1,1,,BAO_0000218
10813,Mus musculus,Intermediate,CHEMBL877496,,,50594,178.0,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,N,1,1,,BAO_0000218
10814,Canis lupus familiaris,Intermediate,CHEMBL626015,,,50588,,F,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,N,1,1,,BAO_0000218
10815,Canis lupus familiaris,Intermediate,CHEMBL626016,,,50588,,F,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,N,1,1,,BAO_0000218
10816,Canis lupus familiaris,Intermediate,CHEMBL626017,,,50588,,F,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,N,1,1,,BAO_0000218
10817,Canis lupus familiaris,Intermediate,CHEMBL626018,,,50588,1969.0,A,,Bioavailability as maximal plasma concentration in dogs,,N,1,1,,BAO_0000218
10818,Canis lupus familiaris,Intermediate,CHEMBL626692,,,50588,1969.0,A,,Bioavailability as maximal plasma concentration in dogs,,N,1,1,,BAO_0000218
10819,Rattus norvegicus,Intermediate,CHEMBL626693,,,50597,1969.0,A,,Bioavailability as maximal plasma concentration in rats,,N,1,1,,BAO_0000218
10820,Rattus norvegicus,Autocuration,CHEMBL626694,,,22224,1969.0,A,,Bioavailability as maximal plasma concentration in rats,,U,0,1,,BAO_0000218
10821,Canis lupus familiaris,Intermediate,CHEMBL626695,,,50588,178.0,A,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,1,1,,BAO_0000218
10822,Canis lupus familiaris,Intermediate,CHEMBL626696,,,50588,178.0,A,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,1,1,,BAO_0000218
10823,Canis lupus familiaris,Intermediate,CHEMBL626697,,,50588,178.0,A,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,1,1,,BAO_0000218
10824,Canis lupus familiaris,Intermediate,CHEMBL626859,,,50588,178.0,A,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,N,1,1,,BAO_0000218
10825,Canis lupus familiaris,Intermediate,CHEMBL626860,,,50588,178.0,A,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,1,1,,BAO_0000218
10826,Canis lupus familiaris,Intermediate,CHEMBL626861,,,50588,178.0,A,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,1,1,,BAO_0000218
10827,Rattus norvegicus,Intermediate,CHEMBL626296,,,50597,,A,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,1,1,,BAO_0000218
10828,,Autocuration,CHEMBL626297,,,22224,,A,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,U,0,1,,BAO_0000218
10829,,Autocuration,CHEMBL626298,,,22224,1969.0,A,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,U,0,1,,BAO_0000218
10830,Rattus norvegicus,Intermediate,CHEMBL626299,,,50597,1969.0,A,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,N,1,1,,BAO_0000218
10831,Rattus norvegicus,Intermediate,CHEMBL626300,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,N,1,1,,BAO_0000218
10832,Rattus norvegicus,Intermediate,CHEMBL626301,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,N,1,1,,BAO_0000218
10833,Rattus norvegicus,Intermediate,CHEMBL626962,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,N,1,1,,BAO_0000218
10834,Rattus norvegicus,Intermediate,CHEMBL626963,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,N,1,1,,BAO_0000218
10835,Rattus norvegicus,Intermediate,CHEMBL626964,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,N,1,1,,BAO_0000218
10836,Macaca fascicularis,Intermediate,CHEMBL626965,,,100710,1969.0,A,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,N,1,1,,BAO_0000218
10837,Mus musculus,Intermediate,CHEMBL626966,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10838,Mus musculus,Intermediate,CHEMBL626967,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10839,Macaca fascicularis,Intermediate,CHEMBL626968,,,100710,1969.0,A,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,N,1,1,,BAO_0000218
10840,Rattus norvegicus,Intermediate,CHEMBL626969,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,N,1,1,,BAO_0000218
10841,Rattus norvegicus,Intermediate,CHEMBL627126,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,N,1,1,,BAO_0000218
10842,Rattus norvegicus,Intermediate,CHEMBL631276,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,N,1,1,,BAO_0000218
10843,Rattus norvegicus,Intermediate,CHEMBL631277,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,N,1,1,,BAO_0000218
10844,Rattus norvegicus,Intermediate,CHEMBL631278,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,N,1,1,,BAO_0000218
10845,Rattus norvegicus,Intermediate,CHEMBL874457,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,N,1,1,,BAO_0000218
10846,Rattus norvegicus,Intermediate,CHEMBL631279,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,N,1,1,,BAO_0000218
10847,Rattus norvegicus,Intermediate,CHEMBL631280,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,N,1,1,,BAO_0000218
10848,Rattus norvegicus,Intermediate,CHEMBL631281,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,N,1,1,,BAO_0000218
10849,Rattus norvegicus,Intermediate,CHEMBL631968,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,N,1,1,,BAO_0000218
10850,Rattus norvegicus,Intermediate,CHEMBL631969,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,N,1,1,,BAO_0000218
10851,Rattus norvegicus,Intermediate,CHEMBL631970,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,N,1,1,,BAO_0000218
10852,Rattus norvegicus,Intermediate,CHEMBL631971,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,N,1,1,,BAO_0000218
10853,Rattus norvegicus,Intermediate,CHEMBL631972,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,N,1,1,,BAO_0000218
10854,Rattus norvegicus,Intermediate,CHEMBL630435,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,N,1,1,,BAO_0000218
10855,Rattus norvegicus,Intermediate,CHEMBL630436,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,N,1,1,,BAO_0000218
10856,Rattus norvegicus,Intermediate,CHEMBL630437,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,N,1,1,,BAO_0000218
10857,Rattus norvegicus,Intermediate,CHEMBL630438,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,N,1,1,,BAO_0000218
10858,Rattus norvegicus,Intermediate,CHEMBL630439,,,50597,948.0,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,N,1,1,,BAO_0000218
10859,Rattus norvegicus,Intermediate,CHEMBL630440,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,N,1,1,,BAO_0000218
10860,Rattus norvegicus,Intermediate,CHEMBL630441,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,N,1,1,,BAO_0000218
10861,Rattus norvegicus,Intermediate,CHEMBL630442,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,N,1,1,,BAO_0000218
10862,Rattus norvegicus,Intermediate,CHEMBL625234,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,N,1,1,,BAO_0000218
10863,Rattus norvegicus,Intermediate,CHEMBL625235,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,N,1,1,,BAO_0000218
10864,Rattus norvegicus,Intermediate,CHEMBL625236,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,N,1,1,,BAO_0000218
10865,Rattus norvegicus,Intermediate,CHEMBL625237,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,N,1,1,,BAO_0000218
10866,Rattus norvegicus,Intermediate,CHEMBL626125,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,N,1,1,,BAO_0000218
10867,Rattus norvegicus,Intermediate,CHEMBL626126,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,N,1,1,,BAO_0000218
10868,Rattus norvegicus,Intermediate,CHEMBL626127,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,N,1,1,,BAO_0000218
10869,Rattus norvegicus,Intermediate,CHEMBL626128,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,N,1,1,,BAO_0000218
10870,Rattus norvegicus,Intermediate,CHEMBL626129,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,N,1,1,,BAO_0000218
10871,Rattus norvegicus,Intermediate,CHEMBL626130,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,N,1,1,,BAO_0000218
10872,Rattus norvegicus,Intermediate,CHEMBL626131,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,N,1,1,,BAO_0000218
10873,Rattus norvegicus,Intermediate,CHEMBL626132,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,N,1,1,,BAO_0000218
10874,Rattus norvegicus,Intermediate,CHEMBL626752,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,N,1,1,,BAO_0000218
10875,Rattus norvegicus,Intermediate,CHEMBL626753,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,N,1,1,,BAO_0000218
10876,Rattus norvegicus,Intermediate,CHEMBL626754,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,N,1,1,,BAO_0000218
10877,Rattus norvegicus,Intermediate,CHEMBL626755,,,50597,2113.0,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,N,1,1,,BAO_0000218
10878,Rattus norvegicus,Intermediate,CHEMBL626756,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,N,1,1,,BAO_0000218
10879,Rattus norvegicus,Intermediate,CHEMBL626757,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,N,1,1,,BAO_0000218
10880,Rattus norvegicus,Intermediate,CHEMBL626758,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,N,1,1,,BAO_0000218
10881,Rattus norvegicus,Intermediate,CHEMBL626759,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,N,1,1,,BAO_0000218
10882,Rattus norvegicus,Intermediate,CHEMBL626760,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,N,1,1,,BAO_0000218
10883,Canis lupus familiaris,Intermediate,CHEMBL626394,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10884,Canis lupus familiaris,Intermediate,CHEMBL626395,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,N,1,1,,BAO_0000218
10885,Canis lupus familiaris,Intermediate,CHEMBL626396,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
10886,Canis lupus familiaris,Intermediate,CHEMBL626397,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
10887,Canis lupus familiaris,Intermediate,CHEMBL626398,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
10888,Canis lupus familiaris,Intermediate,CHEMBL626399,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10889,Rattus norvegicus,Intermediate,CHEMBL874653,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,N,1,1,,BAO_0000218
10890,Rattus norvegicus,Intermediate,CHEMBL626400,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10891,Rattus norvegicus,Intermediate,CHEMBL626401,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
10892,Rattus norvegicus,Intermediate,CHEMBL626402,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
10893,Rattus norvegicus,Intermediate,CHEMBL626403,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
10894,Rattus norvegicus,Intermediate,CHEMBL626404,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10895,Rattus norvegicus,Intermediate,CHEMBL626405,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,N,1,1,,BAO_0000218
10896,Rattus norvegicus,Intermediate,CHEMBL625529,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10897,Rattus norvegicus,Intermediate,CHEMBL625530,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
10898,Rattus norvegicus,Intermediate,CHEMBL625531,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
10899,Rattus norvegicus,Intermediate,CHEMBL625532,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
10900,Rattus norvegicus,Intermediate,CHEMBL625533,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10901,Rattus norvegicus,Intermediate,CHEMBL875474,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,N,1,1,,BAO_0000218
10902,Rattus norvegicus,Intermediate,CHEMBL625534,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10903,Rattus norvegicus,Intermediate,CHEMBL625535,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
10904,Rattus norvegicus,Intermediate,CHEMBL625536,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
10905,Rattus norvegicus,Intermediate,CHEMBL625537,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
10906,Rattus norvegicus,Intermediate,CHEMBL625538,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10907,Rattus norvegicus,Intermediate,CHEMBL625539,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,N,1,1,,BAO_0000218
10908,Rattus norvegicus,Intermediate,CHEMBL625540,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10909,Rattus norvegicus,Intermediate,CHEMBL625541,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
10910,Rattus norvegicus,Intermediate,CHEMBL625542,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
10911,Rattus norvegicus,Intermediate,CHEMBL625543,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
10912,Rattus norvegicus,Intermediate,CHEMBL625544,,,50597,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
10913,Canis lupus familiaris,Intermediate,CHEMBL625545,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,N,1,1,,BAO_0000218
10914,Canis lupus familiaris,Intermediate,CHEMBL625546,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
10915,Canis lupus familiaris,Intermediate,CHEMBL625547,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,N,1,1,,BAO_0000218
10916,Canis lupus familiaris,Intermediate,CHEMBL625548,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10917,Canis lupus familiaris,Intermediate,CHEMBL625549,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10918,Canis lupus familiaris,Intermediate,CHEMBL625550,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
10919,Canis lupus familiaris,Intermediate,CHEMBL625551,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10920,Canis lupus familiaris,Intermediate,CHEMBL875475,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10921,Canis lupus familiaris,Intermediate,CHEMBL625552,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10922,Canis lupus familiaris,Intermediate,CHEMBL625553,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
10923,Canis lupus familiaris,Intermediate,CHEMBL625554,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
10924,Canis lupus familiaris,Intermediate,CHEMBL625555,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
10925,Canis lupus familiaris,Intermediate,CHEMBL625556,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
10926,Canis lupus familiaris,Intermediate,CHEMBL624986,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,N,1,1,,BAO_0000218
10927,Canis lupus familiaris,Intermediate,CHEMBL624987,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
10928,Canis lupus familiaris,Intermediate,CHEMBL624988,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
10929,Canis lupus familiaris,Intermediate,CHEMBL624989,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,N,1,1,,BAO_0000218
10930,Canis lupus familiaris,Intermediate,CHEMBL624990,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,N,1,1,,BAO_0000218
10931,Canis lupus familiaris,Intermediate,CHEMBL874391,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,N,1,1,,BAO_0000218
10932,Canis lupus familiaris,Intermediate,CHEMBL624991,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,N,1,1,,BAO_0000218
10933,Canis lupus familiaris,Intermediate,CHEMBL624992,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,N,1,1,,BAO_0000218
10934,Canis lupus familiaris,Intermediate,CHEMBL624993,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,N,1,1,,BAO_0000218
10935,Canis lupus familiaris,Intermediate,CHEMBL624994,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,N,1,1,,BAO_0000218
10936,Canis lupus familiaris,Intermediate,CHEMBL624995,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,N,1,1,,BAO_0000218
10937,Canis lupus familiaris,Intermediate,CHEMBL624996,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,N,1,1,,BAO_0000218
10938,Canis lupus familiaris,Intermediate,CHEMBL624997,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,N,1,1,,BAO_0000218
10939,Canis lupus familiaris,Intermediate,CHEMBL624998,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,N,1,1,,BAO_0000218
10940,Canis lupus familiaris,Intermediate,CHEMBL624999,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,N,1,1,,BAO_0000218
10941,Canis lupus familiaris,Intermediate,CHEMBL882955,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,N,1,1,,BAO_0000218
10942,Canis lupus familiaris,Intermediate,CHEMBL625000,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,N,1,1,,BAO_0000218
10943,Canis lupus familiaris,Intermediate,CHEMBL625001,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,N,1,1,,BAO_0000218
10944,Canis lupus familiaris,Intermediate,CHEMBL625089,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,N,1,1,,BAO_0000218
10945,Canis lupus familiaris,Intermediate,CHEMBL625090,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,N,1,1,,BAO_0000218
10946,Canis lupus familiaris,Intermediate,CHEMBL625091,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,N,1,1,,BAO_0000218
10947,Canis lupus familiaris,Intermediate,CHEMBL625092,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,N,1,1,,BAO_0000218
10948,Canis lupus familiaris,Intermediate,CHEMBL625093,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,N,1,1,,BAO_0000218
10949,Canis lupus familiaris,Intermediate,CHEMBL625094,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,N,1,1,,BAO_0000218
10950,Canis lupus familiaris,Intermediate,CHEMBL625095,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,N,1,1,,BAO_0000218
10951,Canis lupus familiaris,Intermediate,CHEMBL625096,,,50588,,A,,Compound was evaluated for its bioavailability in the dogs,,N,1,1,,BAO_0000218
10952,Rattus norvegicus,Intermediate,CHEMBL625097,,,50597,,A,,Compound was evaluated for its bioavailability in the rats,,N,1,1,,BAO_0000218
10953,,Autocuration,CHEMBL882956,,,22224,,A,,Compound was evaluated for oral bioavailability,,U,0,1,,BAO_0000218
10954,Rattus norvegicus,Intermediate,CHEMBL625098,,,50597,,A,,Compound was evaluated for percentage of Oral bioavailability in rats,,N,1,1,,BAO_0000218
10955,Cavia porcellus,Autocuration,CHEMBL625099,,,22224,,A,,Bioavailability in guinea pig,,U,0,1,,BAO_0000218
10956,Rattus norvegicus,Intermediate,CHEMBL625100,,,50597,,A,,Compound was evaluated for the oral bioavailability in rat,,N,1,1,,BAO_0000218
10957,Canis lupus familiaris,Intermediate,CHEMBL625101,,,50588,,A,,Compound was evaluated for the oral bioavailability in dog,,N,1,1,,BAO_0000218
10958,Rattus norvegicus,Intermediate,CHEMBL874396,,,50597,,A,,Compound was evaluated for the oral bioavailability in rat,,N,1,1,,BAO_0000218
10959,Canis lupus familiaris,Autocuration,CHEMBL625102,,,22224,,F,,Bioavailability in dog (dosed i.v.),,U,0,1,,BAO_0000218
10960,Canis lupus familiaris,Intermediate,CHEMBL625103,,,50588,,A,,Compound was tested for in vivo bioavailability in dog,,N,1,1,,BAO_0000218
10961,Cricetinae,Intermediate,CHEMBL625104,,,100712,,A,,Compound was tested for in vivo bioavailability in hamsters,,N,1,1,,BAO_0000218
10962,Simiiformes,Autocuration,CHEMBL625105,,,22224,,A,,Compound was tested for in vivo bioavailability in monkey,,U,0,1,,BAO_0000218
10963,Rattus norvegicus,Intermediate,CHEMBL625106,,,50597,,A,,Compound was tested for in vivo bioavailability in rat,,N,1,1,,BAO_0000218
10964,Mus musculus,Autocuration,CHEMBL625107,,,22224,,A,,Oral bioavailability in mouse,,U,0,1,,BAO_0000218
10965,Mus musculus,Intermediate,CHEMBL625108,,,50594,,A,,Compound was tested for percent of oral bioavailability in mice; 56-74,,N,1,1,,BAO_0000218
10966,Mus musculus,Autocuration,CHEMBL625109,,,22224,,A,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,U,0,1,,BAO_0000218
10967,Macaca fascicularis,Autocuration,CHEMBL625110,,,22224,,A,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,U,0,1,,BAO_0000218
10968,Macaca fascicularis,Autocuration,CHEMBL625111,,,22224,,A,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,U,0,1,,BAO_0000218
10969,Mus musculus,Intermediate,CHEMBL625112,,,50594,,A,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,N,1,1,,BAO_0000218
10970,Mus musculus,Intermediate,CHEMBL875334,,,50594,,A,,Oral bioavailability in nude mice,,N,1,1,,BAO_0000218
10971,Primates,Autocuration,CHEMBL628617,,,22224,,A,,Bioavailability in monkey (i.d. dosing),,U,0,1,,BAO_0000218
10972,Rattus norvegicus,Autocuration,CHEMBL628618,,,22224,,A,,Bioavailability in rat,,U,0,1,,BAO_0000218
10973,,Autocuration,CHEMBL628619,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,U,0,1,,BAO_0000218
10974,,Autocuration,CHEMBL628620,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,U,0,1,,BAO_0000218
10975,Macaca fascicularis,Intermediate,CHEMBL628621,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,1,1,,BAO_0000218
10976,Macaca fascicularis,Intermediate,CHEMBL628622,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,1,1,,BAO_0000218
10977,Macaca fascicularis,Intermediate,CHEMBL628623,,,100710,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,1,1,,BAO_0000218
10978,Macaca fascicularis,Intermediate,CHEMBL628624,,,100710,1969.0,A,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,N,1,1,,BAO_0000218
10979,Mus musculus,Intermediate,CHEMBL628625,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10980,Macaca fascicularis,Intermediate,CHEMBL628626,,,100710,1969.0,A,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,N,1,1,,BAO_0000218
10981,Mus musculus,Intermediate,CHEMBL627041,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10982,Mus musculus,Intermediate,CHEMBL627042,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10983,Mus musculus,Intermediate,CHEMBL627043,,,50594,1969.0,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,1,1,,BAO_0000218
10984,,Autocuration,CHEMBL627044,,,22224,1969.0,A,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,U,0,1,,BAO_0000218
10985,Mus musculus,Intermediate,CHEMBL627045,,,50594,1969.0,A,,Cmax in mouse plasma,,N,1,1,,BAO_0000218
10986,,Autocuration,CHEMBL627046,,,22224,1969.0,A,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,U,0,1,,BAO_0000218
10987,Rattus norvegicus,Intermediate,CHEMBL627047,,,50597,1969.0,A,,Maximal plasma concentration in rat,,N,1,1,,BAO_0000218
10988,Rattus norvegicus,Intermediate,CHEMBL627048,,,50597,1969.0,A,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,N,1,1,,BAO_0000218
10989,Rattus norvegicus,Intermediate,CHEMBL627049,,,50597,,A,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,N,1,1,,BAO_0000218
10990,Rattus norvegicus,Intermediate,CHEMBL627050,,,50597,,A,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,N,1,1,,BAO_0000218
10991,Rattus norvegicus,Intermediate,CHEMBL627051,,,50597,,A,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,N,1,1,,BAO_0000218
10992,Rattus norvegicus,Intermediate,CHEMBL627052,,,50597,,A,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,N,1,1,,BAO_0000218
10993,Rattus norvegicus,Intermediate,CHEMBL627053,,,50597,,A,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,N,1,1,,BAO_0000218
10994,Rattus norvegicus,Intermediate,CHEMBL627054,,,50597,,A,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,N,1,1,,BAO_0000218
10995,Mus musculus,Intermediate,CHEMBL627055,,,50594,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
10996,Mus musculus,Intermediate,CHEMBL627056,,,50594,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
10997,Mus musculus,Intermediate,CHEMBL627057,,,50594,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,1,1,,BAO_0000218
10998,Mus musculus,Intermediate,CHEMBL627058,,,50594,,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
10999,Mus musculus,Intermediate,CHEMBL626211,,,50594,,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,1,1,,BAO_0000218
11000,,Autocuration,CHEMBL626212,,,22224,,A,,Maximum Concentration of the compound.,,U,0,1,,BAO_0000218
11001,Canis lupus familiaris,Intermediate,CHEMBL626213,,,50588,,A,,Maximum Concentration was measured after iv administration into Beagle dog,,N,1,1,,BAO_0000218
11002,Canis lupus familiaris,Intermediate,CHEMBL626214,,,50588,,A,,Maximum Concentration was measured after iv administration into Beagle dog.,,N,1,1,,BAO_0000218
11003,Canis lupus familiaris,Intermediate,CHEMBL626215,,,50588,,A,,Maximum Concentration was measured after po administration into Beagle dog,,N,1,1,,BAO_0000218
11004,Canis lupus familiaris,Intermediate,CHEMBL626216,,,50588,,A,,Maximum Concentration was measured after po administration into Beagle dog.,,N,1,1,,BAO_0000218
11005,,Autocuration,CHEMBL626217,,,22224,178.0,A,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,U,0,1,,BAO_0000218
11006,,Autocuration,CHEMBL626218,,,22224,178.0,A,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,U,0,1,,BAO_0000218
11007,,Autocuration,CHEMBL626219,,,22224,178.0,A,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,U,0,1,,BAO_0000218
11008,,Autocuration,CHEMBL626220,,,22224,178.0,A,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,U,0,1,,BAO_0000218
11009,,Autocuration,CHEMBL626221,,,22224,178.0,A,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,U,0,1,,BAO_0000218
11010,,Autocuration,CHEMBL626222,,,22224,178.0,A,,Maximum blood level reached at dose of 10.6 uM/kg orally,,U,0,1,,BAO_0000218
11011,Cavia porcellus,Intermediate,CHEMBL626223,,,50512,,A,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,N,1,1,,BAO_0000218
11012,Cavia porcellus,Intermediate,CHEMBL626224,,,50512,,A,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,N,1,1,,BAO_0000218
11013,Rattus norvegicus,Intermediate,CHEMBL626225,,,50597,955.0,A,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11014,Rattus norvegicus,Intermediate,CHEMBL626226,,,50597,955.0,A,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11015,Rattus norvegicus,Intermediate,CHEMBL626227,,,50597,955.0,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,N,1,1,,BAO_0000218
11016,Rattus norvegicus,Intermediate,CHEMBL626228,,,50597,955.0,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11017,Rattus norvegicus,Intermediate,CHEMBL626229,,,50597,,A,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11018,Rattus norvegicus,Intermediate,CHEMBL626921,,,50597,,A,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11019,Rattus norvegicus,Intermediate,CHEMBL876793,,,50597,,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,N,1,1,,BAO_0000218
11020,Rattus norvegicus,Intermediate,CHEMBL625309,,,50597,,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
11021,Bacillus subtilis,Intermediate,CHEMBL625310,,,50278,,A,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,1,1,,BAO_0000218
11022,Simiiformes,Autocuration,CHEMBL625311,,,22224,,A,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,U,0,1,,BAO_0000218
11023,Rattus norvegicus,Intermediate,CHEMBL625312,,,50597,,A,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,N,1,1,,BAO_0000218
11024,,Autocuration,CHEMBL625313,,,22224,,A,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,U,0,1,,BAO_0000218
11025,Mus musculus,Intermediate,CHEMBL625314,,,50594,,A,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,N,1,1,,BAO_0000218
11026,Rattus norvegicus,Intermediate,CHEMBL625315,,,50597,,A,,Maximum concentration in male rats after iv administration of 20 mg/kg,,N,1,1,,BAO_0000218
11027,Rattus norvegicus,Intermediate,CHEMBL625316,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,N,1,1,,BAO_0000218
11028,Rattus norvegicus,Intermediate,CHEMBL625317,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,N,1,1,,BAO_0000218
11029,Rattus norvegicus,Intermediate,CHEMBL625318,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,N,1,1,,BAO_0000218
11030,Rattus norvegicus,Intermediate,CHEMBL625319,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,N,1,1,,BAO_0000218
11031,Rattus norvegicus,Intermediate,CHEMBL625320,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,N,1,1,,BAO_0000218
11032,Rattus norvegicus,Intermediate,CHEMBL625321,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,N,1,1,,BAO_0000218
11033,Rattus norvegicus,Intermediate,CHEMBL625322,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,N,1,1,,BAO_0000218
11034,Rattus norvegicus,Intermediate,CHEMBL876801,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,N,1,1,,BAO_0000218
11035,Rattus norvegicus,Intermediate,CHEMBL625323,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,N,1,1,,BAO_0000218
11036,Rattus norvegicus,Intermediate,CHEMBL625324,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,N,1,1,,BAO_0000218
11037,Rattus norvegicus,Intermediate,CHEMBL625325,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,N,1,1,,BAO_0000218
11038,Rattus norvegicus,Intermediate,CHEMBL625326,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,N,1,1,,BAO_0000218
11039,Rattus norvegicus,Intermediate,CHEMBL625327,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,N,1,1,,BAO_0000218
11040,Rattus norvegicus,Intermediate,CHEMBL625328,,,50597,2107.0,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,N,1,1,,BAO_0000218
11041,Rattus norvegicus,Intermediate,CHEMBL625329,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,N,1,1,,BAO_0000218
11042,Rattus norvegicus,Intermediate,CHEMBL625330,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,N,1,1,,BAO_0000218
11043,Rattus norvegicus,Intermediate,CHEMBL627774,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,N,1,1,,BAO_0000218
11044,Rattus norvegicus,Intermediate,CHEMBL627775,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,N,1,1,,BAO_0000218
11045,Rattus norvegicus,Intermediate,CHEMBL627949,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,N,1,1,,BAO_0000218
11046,Rattus norvegicus,Intermediate,CHEMBL627950,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,N,1,1,,BAO_0000218
11047,Rattus norvegicus,Intermediate,CHEMBL627951,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,N,1,1,,BAO_0000218
11048,Rattus norvegicus,Intermediate,CHEMBL627952,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,N,1,1,,BAO_0000218
11049,Rattus norvegicus,Intermediate,CHEMBL627953,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,N,1,1,,BAO_0000218
11050,Rattus norvegicus,Intermediate,CHEMBL627954,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,N,1,1,,BAO_0000218
11051,Rattus norvegicus,Intermediate,CHEMBL627955,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,N,1,1,,BAO_0000218
11052,Rattus norvegicus,Intermediate,CHEMBL627956,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,N,1,1,,BAO_0000218
11053,Rattus norvegicus,Intermediate,CHEMBL876802,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,N,1,1,,BAO_0000218
11054,Rattus norvegicus,Intermediate,CHEMBL627957,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,N,1,1,,BAO_0000218
11055,Rattus norvegicus,Intermediate,CHEMBL627958,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,N,1,1,,BAO_0000218
11056,Rattus norvegicus,Intermediate,CHEMBL627959,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,N,1,1,,BAO_0000218
11057,Rattus norvegicus,Intermediate,CHEMBL627960,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,N,1,1,,BAO_0000218
11058,Rattus norvegicus,Intermediate,CHEMBL627961,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,N,1,1,,BAO_0000218
11059,Rattus norvegicus,Intermediate,CHEMBL627962,,,50597,2048.0,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,N,1,1,,BAO_0000218
11060,Rattus norvegicus,Intermediate,CHEMBL627963,,,50597,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11061,Rattus norvegicus,Intermediate,CHEMBL624759,,,50597,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11062,Rattus norvegicus,Intermediate,CHEMBL624760,,,50597,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11063,Rattus norvegicus,Intermediate,CHEMBL624761,,,50597,,A,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11064,Rattus norvegicus,Intermediate,CHEMBL877607,,,50597,,A,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11065,Rattus norvegicus,Intermediate,CHEMBL624762,,,50597,2107.0,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11066,Rattus norvegicus,Intermediate,CHEMBL624763,,,50597,2107.0,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11067,Rattus norvegicus,Intermediate,CHEMBL624764,,,50597,2107.0,A,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11068,Rattus norvegicus,Intermediate,CHEMBL624765,,,50597,2107.0,A,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11069,Rattus norvegicus,Intermediate,CHEMBL624766,,,50597,2107.0,A,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11070,Canis lupus familiaris,Intermediate,CHEMBL624767,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11071,Canis lupus familiaris,Intermediate,CHEMBL624768,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,N,1,1,,BAO_0000218
11072,Canis lupus familiaris,Intermediate,CHEMBL624769,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11073,Canis lupus familiaris,Intermediate,CHEMBL624770,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
11074,Canis lupus familiaris,Intermediate,CHEMBL624771,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
11075,Canis lupus familiaris,Intermediate,CHEMBL624772,,,50588,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11076,Rattus norvegicus,Intermediate,CHEMBL624773,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,N,1,1,,BAO_0000218
11077,Rattus norvegicus,Intermediate,CHEMBL624774,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11078,Rattus norvegicus,Intermediate,CHEMBL624775,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
11079,Rattus norvegicus,Intermediate,CHEMBL624776,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
11080,Rattus norvegicus,Intermediate,CHEMBL624777,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
11081,Rattus norvegicus,Intermediate,CHEMBL624778,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11082,Rattus norvegicus,Intermediate,CHEMBL624779,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,N,1,1,,BAO_0000218
11083,Rattus norvegicus,Intermediate,CHEMBL624780,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
11084,Rattus norvegicus,Intermediate,CHEMBL624781,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
11085,Rattus norvegicus,Intermediate,CHEMBL877608,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11086,Rattus norvegicus,Intermediate,CHEMBL624782,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
11087,Rattus norvegicus,Intermediate,CHEMBL624783,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11088,Rattus norvegicus,Intermediate,CHEMBL624784,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,N,1,1,,BAO_0000218
11089,Rattus norvegicus,Intermediate,CHEMBL624785,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11090,Rattus norvegicus,Intermediate,CHEMBL624786,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
11091,Rattus norvegicus,Intermediate,CHEMBL624787,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
11092,Rattus norvegicus,Intermediate,CHEMBL628676,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11093,Rattus norvegicus,Intermediate,CHEMBL621842,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,N,1,1,,BAO_0000218
11094,Rattus norvegicus,Intermediate,CHEMBL621843,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11095,Rattus norvegicus,Intermediate,CHEMBL623873,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
11096,Rattus norvegicus,Intermediate,CHEMBL623874,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
11097,Rattus norvegicus,Intermediate,CHEMBL623875,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
11098,Rattus norvegicus,Intermediate,CHEMBL623876,,,50597,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
11099,Canis lupus familiaris,Intermediate,CHEMBL623877,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,N,1,1,,BAO_0000218
11100,Canis lupus familiaris,Intermediate,CHEMBL623878,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11101,Canis lupus familiaris,Intermediate,CHEMBL623879,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,N,1,1,,BAO_0000218
11102,Canis lupus familiaris,Intermediate,CHEMBL623880,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11103,Canis lupus familiaris,Intermediate,CHEMBL623881,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11104,Canis lupus familiaris,Intermediate,CHEMBL623957,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11105,Canis lupus familiaris,Intermediate,CHEMBL623958,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11106,Canis lupus familiaris,Intermediate,CHEMBL623959,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11107,Canis lupus familiaris,Intermediate,CHEMBL623960,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11108,Canis lupus familiaris,Intermediate,CHEMBL623961,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11109,Canis lupus familiaris,Intermediate,CHEMBL623962,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
11110,Canis lupus familiaris,Intermediate,CHEMBL624676,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
11111,Canis lupus familiaris,Intermediate,CHEMBL624677,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11112,Canis lupus familiaris,Intermediate,CHEMBL624678,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,N,1,1,,BAO_0000218
11113,Canis lupus familiaris,Intermediate,CHEMBL624679,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11114,Canis lupus familiaris,Intermediate,CHEMBL624680,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
11115,,Autocuration,CHEMBL624849,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,U,0,1,,BAO_0000218
11116,,Autocuration,CHEMBL624850,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,U,0,1,,BAO_0000218
11117,,Autocuration,CHEMBL874399,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,U,0,1,,BAO_0000218
11118,,Autocuration,CHEMBL624851,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,U,0,1,,BAO_0000218
11119,,Autocuration,CHEMBL624852,,,22224,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,U,0,1,,BAO_0000218
11120,Rattus norvegicus,Autocuration,CHEMBL624853,,,22224,,A,,Oral bioavailability in rat (dose 10 mg/kg),,U,0,1,,BAO_0000218
11121,Rattus norvegicus,Autocuration,CHEMBL624854,,,22224,,A,,Oral bioavailability in rat (Sprague-Dawley),,U,0,1,,BAO_0000218
11122,Rattus norvegicus,Autocuration,CHEMBL624855,,,22224,,A,,Oral bioavailability in rat,,U,0,1,,BAO_0000218
11123,Rattus norvegicus,Autocuration,CHEMBL624856,,,22224,,A,,Oral bioavailability in rats was determined in vivo,,U,0,1,,BAO_0000218
11124,Canis lupus familiaris,Autocuration,CHEMBL882957,,,22224,,A,,Oral bioavailability in dog,,U,0,1,,BAO_0000218
11125,Simiiformes,Autocuration,CHEMBL624857,,,22224,,A,,Oral bioavailability of compound in monkey,,U,0,1,,BAO_0000218
11126,Rattus norvegicus,Intermediate,CHEMBL622202,,,50597,,A,,Oral bioavailability of compound in rat,,N,1,1,,BAO_0000218
11127,Rattus norvegicus,Autocuration,CHEMBL622203,,,22224,,A,,Bioavailability in rat of PMEA prodrug,,U,0,1,,BAO_0000218
11128,Rattus norvegicus,Intermediate,CHEMBL625522,,,50597,,A,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,N,1,1,,BAO_0000218
11129,Macaca mulatta,Autocuration,CHEMBL622868,,,22224,,A,,Serum conc at 3 hours following 25 mg/kg dose,,U,0,1,,BAO_0000218
11130,Macaca mulatta,Autocuration,CHEMBL622869,,,22224,1088.0,A,,Urine conc 0-5 hours following 25 mg/kg dose,,U,0,1,,BAO_0000218
11131,Macaca mulatta,Autocuration,CHEMBL622870,,,22224,1088.0,A,,Urine conc 0-24 hours following 25 mg/kg dose,,U,0,1,,BAO_0000218
11132,Chlorocebus aethiops,Autocuration,CHEMBL622871,,,22224,,A,,Oral bioavailability in African green monkeys; 20-25,,U,0,1,,BAO_0000218
11133,Macaca fascicularis,Intermediate,CHEMBL620560,,,100710,,A,,Oral bioavailability in cynomolgus monkey.,,N,1,1,,BAO_0000218
11134,Canis lupus familiaris,Autocuration,CHEMBL620561,,,22224,,A,,Oral bioavailability in dog,,U,0,1,,BAO_0000218
11135,Canis lupus familiaris,Intermediate,CHEMBL620562,,,50588,,A,,Oral bioavailability in dog at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11136,Cricetinae,Intermediate,CHEMBL620563,,,100712,,A,,Oral bioavailability in hamster at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11137,Rattus norvegicus,Intermediate,CHEMBL620564,,,50597,,A,,Oral bioavailability in rat at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11138,Rattus norvegicus,Autocuration,CHEMBL872265,,,22224,,A,,Oral bioavailability in rat,,U,0,1,,BAO_0000218
11139,Rattus norvegicus,Autocuration,CHEMBL620565,,,22224,,A,,Oral bioavailability in rat,,U,0,1,,BAO_0000218
11140,Eutheria,Autocuration,CHEMBL620566,,,22224,,A,,Oral bioavailability,,U,0,1,,BAO_0000218
11141,,Autocuration,CHEMBL620567,,,22224,,A,,Oral bioavailability was determined; range 49-102%,,U,0,1,,BAO_0000218
11142,Canis lupus familiaris,Intermediate,CHEMBL620568,,,50588,,A,,Oral bioavailability was determined in dogs,,N,1,1,,BAO_0000218
11143,Rattus norvegicus,Autocuration,CHEMBL620569,,,22224,,A,,Oral bioavailability in rat,,U,0,1,,BAO_0000218
11144,Eutheria,Autocuration,CHEMBL620570,,,22224,,A,,Oral bioavailability,,U,0,1,,BAO_0000218
11145,,Autocuration,CHEMBL620571,,,22224,,A,,Oral bioavailability was determined; Not orally available,,U,0,1,,BAO_0000218
11146,Mus musculus,Intermediate,CHEMBL620572,,,50594,,A,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,N,1,1,,BAO_0000218
11147,Mus musculus,Autocuration,CHEMBL620573,,,22224,,A,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,U,0,1,,BAO_0000218
11148,Mus musculus,Autocuration,CHEMBL620574,,,22224,,A,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,U,0,1,,BAO_0000218
11149,Macaca mulatta,Autocuration,CHEMBL620575,,,22224,,A,,Oral bioavailability in Rhesus monkey,,U,0,1,,BAO_0000218
11150,Canis lupus familiaris,Autocuration,CHEMBL620576,,,22224,,A,,Oral bioavailability in dog (female mongrel),,U,0,1,,BAO_0000218
11151,,Autocuration,CHEMBL875846,,,22224,,A,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,U,0,1,,BAO_0000218
11152,Canis lupus familiaris,Autocuration,CHEMBL620577,,,22224,,A,,Oral bioavailability in dog,,U,0,1,,BAO_0000218
11153,,Autocuration,CHEMBL620578,,,22224,,A,,Percentage Bioavailability was evaluated.,,U,0,1,,BAO_0000218
11154,Rattus norvegicus,Autocuration,CHEMBL620579,,,22224,,A,,Bioavailability in rat administered i.d.,,U,0,1,,BAO_0000218
11155,Eutheria,Autocuration,CHEMBL621248,,,22224,,A,,Bioavailability,,U,0,1,,BAO_0000218
11156,Canis lupus familiaris,Autocuration,CHEMBL625390,,,22224,,A,,Bioavailability in dog (male Beagle) i.v. administration,,U,0,1,,BAO_0000218
11157,Rattus norvegicus,Autocuration,CHEMBL625391,,,22224,,A,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,U,0,1,,BAO_0000218
11158,Primates,Autocuration,CHEMBL872266,,,22224,,A,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,U,0,1,,BAO_0000218
11159,Rattus norvegicus,Autocuration,CHEMBL625392,,,22224,,A,,Oral bioavailability in rat (Sprague-Dawley) (male),,U,0,1,,BAO_0000218
11160,Rattus norvegicus,Intermediate,CHEMBL625393,,,50597,,A,,The oral bioavailability was measured on rats after oral administration,,N,1,1,,BAO_0000218
11161,Rattus norvegicus,Intermediate,CHEMBL625394,,,50597,,A,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
11162,Macaca mulatta,Intermediate,CHEMBL625395,,,50797,,A,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,1,1,,BAO_0000218
11163,Rattus norvegicus,Autocuration,CHEMBL625396,,,22224,,A,,Bioavailability in rat (dose 10 mg/kg i.d.),,U,0,1,,BAO_0000218
11164,Canis lupus familiaris,Autocuration,CHEMBL625397,,,22224,,A,,Bioavailability in dog (male Beagle) i.v. administration,,U,0,1,,BAO_0000218
11165,Mus musculus,Intermediate,CHEMBL625398,,,50594,,A,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11166,Mus musculus,Intermediate,CHEMBL625399,,,50594,178.0,A,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11167,Mus musculus,Intermediate,CHEMBL626074,,,50594,2037.0,A,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11168,Mus musculus,Intermediate,CHEMBL626075,,,50594,,A,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11169,Rattus norvegicus,Intermediate,CHEMBL626076,,,50597,1969.0,A,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,1,1,,BAO_0000218
11170,Macaca mulatta,Intermediate,CHEMBL626077,,,50797,1969.0,A,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,1,1,,BAO_0000218
11171,Rattus norvegicus,Intermediate,CHEMBL626078,,,50597,178.0,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,N,1,1,,BAO_0000218
11172,,Autocuration,CHEMBL625846,,,22224,178.0,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,U,0,1,,BAO_0000218
11173,,Autocuration,CHEMBL625847,,,22224,178.0,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,U,0,1,,BAO_0000218
11174,Rattus norvegicus,Expert,CHEMBL625848,,,50597,,A,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,N,1,1,,BAO_0000218
11175,Rattus norvegicus,Intermediate,CHEMBL625849,,,50597,1969.0,A,,Maximum concentration of compound in plasma administered orally to rats,,N,1,1,,BAO_0000218
11176,Canis lupus familiaris,Intermediate,CHEMBL626023,,,50588,1969.0,A,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,N,1,1,,BAO_0000218
11177,Canis lupus familiaris,Intermediate,CHEMBL626024,,,50588,1969.0,A,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,N,1,1,,BAO_0000218
11178,Canis lupus familiaris,Intermediate,CHEMBL626025,,,50588,1969.0,A,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,N,1,1,,BAO_0000218
11179,,Autocuration,CHEMBL626026,,,22224,,A,,Maximum concentration after 10 mg/kg by oral administration,,U,0,1,,BAO_0000218
11180,,Autocuration,CHEMBL626027,,,22224,,A,,Maximum concentration at a dose of 1.5 mg/kg,,U,0,1,,BAO_0000218
11181,,Autocuration,CHEMBL626028,,,22224,,A,,Maximum concentration at a dose of 2.0 mg/kg,,U,0,1,,BAO_0000218
11182,Canis lupus familiaris,Intermediate,CHEMBL626029,,,50588,1969.0,A,,Maximum concentration in dog plasma,,N,1,1,,BAO_0000218
11183,,Autocuration,CHEMBL626030,,,22224,1969.0,A,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,U,0,1,,BAO_0000218
11184,,Autocuration,CHEMBL626031,,,22224,1969.0,A,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,U,0,1,,BAO_0000218
11185,,Autocuration,CHEMBL626032,,,22224,1969.0,A,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,U,0,1,,BAO_0000218
11186,,Autocuration,CHEMBL626033,,,22224,1969.0,A,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,U,0,1,,BAO_0000218
11187,,Autocuration,CHEMBL626034,,,22224,1969.0,A,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,U,0,1,,BAO_0000218
11188,Canis lupus familiaris,Intermediate,CHEMBL626035,,,50588,1969.0,A,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,N,1,1,,BAO_0000218
11189,,Autocuration,CHEMBL626036,,,22224,1969.0,A,,Maximum concentration in plasma at Tmax,,U,0,1,,BAO_0000218
11190,Canis lupus familiaris,Expert,CHEMBL626037,,,50588,1969.0,A,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11191,Cricetinae,Intermediate,CHEMBL626038,,,100712,1969.0,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11192,Rattus norvegicus,Intermediate,CHEMBL626039,,,50597,1969.0,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11193,Rattus norvegicus,Intermediate,CHEMBL626040,,,50597,1969.0,A,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,N,1,1,,BAO_0000218
11194,Oryctolagus cuniculus,Intermediate,CHEMBL626041,,,50592,1969.0,A,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,N,1,1,,BAO_0000218
11195,,Autocuration,CHEMBL626042,,,22224,,A,,Maximum concentration was calculated,,U,0,1,,BAO_0000218
11196,,Autocuration,CHEMBL626043,,,22224,,A,,Maximum concentration was calculated.,,U,0,1,,BAO_0000218
11197,,Autocuration,CHEMBL626044,,,22224,,A,,Maximum concentration at a peroral dose of 10 mg/kg,,U,0,1,,BAO_0000218
11198,,Autocuration,CHEMBL626045,,,22224,,A,,Maximum concentration of the drug at 10 uM/dg administered perorally,,U,0,1,,BAO_0000218
11199,,Autocuration,CHEMBL626046,,,22224,,A,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,U,0,1,,BAO_0000218
11200,Canis lupus familiaris,Intermediate,CHEMBL626047,,,50588,1969.0,A,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,N,1,1,,BAO_0000218
11201,Cricetinae,Intermediate,CHEMBL626048,,,100712,1969.0,A,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,N,1,1,,BAO_0000218
11202,Rattus norvegicus,Intermediate,CHEMBL626049,,,50597,1969.0,A,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,N,1,1,,BAO_0000218
11203,Rattus norvegicus,Intermediate,CHEMBL626050,,,50597,1969.0,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,N,1,1,,BAO_0000218
11204,Canis lupus familiaris,Intermediate,CHEMBL874541,,,50588,1969.0,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,N,1,1,,BAO_0000218
11205,Cricetinae,Intermediate,CHEMBL622826,,,100712,1969.0,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,N,1,1,,BAO_0000218
11206,Cricetinae,Intermediate,CHEMBL622827,,,100712,1969.0,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,N,1,1,,BAO_0000218
11207,Rattus norvegicus,Intermediate,CHEMBL622828,,,50597,1969.0,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,N,1,1,,BAO_0000218
11208,Rattus norvegicus,Intermediate,CHEMBL622829,,,50597,1969.0,A,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,N,1,1,,BAO_0000218
11209,Rattus norvegicus,Intermediate,CHEMBL876806,,,50597,,A,,Maximum concentration reached following intravenous administration in male rat,,N,1,1,,BAO_0000218
11210,Canis lupus familiaris,Intermediate,CHEMBL622830,,,50588,,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,N,1,1,,BAO_0000218
11211,Rattus norvegicus,Intermediate,CHEMBL622831,,,50597,,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,N,1,1,,BAO_0000218
11212,Canis lupus familiaris,Intermediate,CHEMBL626794,,,50588,,A,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,N,1,1,,BAO_0000218
11213,Rattus norvegicus,Intermediate,CHEMBL626795,,,50597,,A,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
11214,Rattus norvegicus,Intermediate,CHEMBL626796,,,50597,,A,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
11215,Rattus norvegicus,Intermediate,CHEMBL626797,,,50597,,A,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
11216,Rattus norvegicus,Intermediate,CHEMBL626798,,,50597,,A,,Maximum drug concentration is determined after oral dosing in rats.,,N,1,1,,BAO_0000218
11217,Canis lupus familiaris,Intermediate,CHEMBL626799,,,50588,,A,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,N,1,1,,BAO_0000218
11218,Canis lupus familiaris,Intermediate,CHEMBL626800,,,50588,,A,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,N,1,1,,BAO_0000218
11219,,Autocuration,CHEMBL626801,,,22224,1969.0,A,,Maximum plasma concentration,,U,0,1,,BAO_0000218
11220,Rattus norvegicus,Intermediate,CHEMBL876816,,,50597,1969.0,A,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,N,1,1,,BAO_0000218
11221,Rattus norvegicus,Intermediate,CHEMBL626802,,,50597,1969.0,A,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,N,1,1,,BAO_0000218
11222,Canis lupus familiaris,Intermediate,CHEMBL626803,,,50588,1969.0,A,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,N,1,1,,BAO_0000218
11223,,Autocuration,CHEMBL626804,,,22224,1969.0,A,,Maximum plasma concentration following oral administration of 30 umol/kg,,U,0,1,,BAO_0000218
11224,Rattus norvegicus,Intermediate,CHEMBL626805,,,50597,1969.0,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,N,1,1,,BAO_0000218
11225,Rattus norvegicus,Intermediate,CHEMBL626309,,,50597,1969.0,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11226,Rattus norvegicus,Intermediate,CHEMBL626310,,,50597,1969.0,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11227,Rattus norvegicus,Intermediate,CHEMBL626311,,,50597,1969.0,A,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11228,Rattus norvegicus,Intermediate,CHEMBL626312,,,50597,1969.0,A,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11229,Rattus norvegicus,Intermediate,CHEMBL626313,,,50597,995.0,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11230,Rattus norvegicus,Intermediate,CHEMBL626314,,,50597,995.0,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11231,Rattus norvegicus,Intermediate,CHEMBL626315,,,50597,995.0,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11232,Rattus norvegicus,Intermediate,CHEMBL626316,,,50597,995.0,A,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11233,Rattus norvegicus,Intermediate,CHEMBL626317,,,50597,995.0,A,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1,1,,BAO_0000218
11234,Rattus norvegicus,Intermediate,CHEMBL626318,,,50597,,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11235,Rattus norvegicus,Intermediate,CHEMBL626319,,,50597,,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11236,Rattus norvegicus,Intermediate,CHEMBL626320,,,50597,,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11237,Rattus norvegicus,Intermediate,CHEMBL875053,,,50597,,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11238,Rattus norvegicus,Intermediate,CHEMBL626321,,,50597,,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11239,Rattus norvegicus,Intermediate,CHEMBL626322,,,50597,,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11240,Rattus norvegicus,Intermediate,CHEMBL626323,,,50597,,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11241,Rattus norvegicus,Intermediate,CHEMBL626324,,,50597,,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11242,Rattus norvegicus,Intermediate,CHEMBL626325,,,50597,,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11243,Rattus norvegicus,Intermediate,CHEMBL626326,,,50597,,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11244,Rattus norvegicus,Intermediate,CHEMBL626327,,,50597,,A,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,N,1,1,,BAO_0000218
11245,Rattus norvegicus,Intermediate,CHEMBL626328,,,50597,,A,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,N,1,1,,BAO_0000218
11246,Rattus norvegicus,Intermediate,CHEMBL626329,,,50597,178.0,A,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11247,Rattus norvegicus,Intermediate,CHEMBL626330,,,50597,178.0,A,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11248,Rattus norvegicus,Intermediate,CHEMBL626331,,,50597,178.0,A,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11249,Rattus norvegicus,Intermediate,CHEMBL626332,,,50597,178.0,A,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11250,Rattus norvegicus,Intermediate,CHEMBL626333,,,50597,178.0,A,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11251,Rattus norvegicus,Intermediate,CHEMBL626334,,,50597,178.0,A,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11252,Rattus norvegicus,Intermediate,CHEMBL626335,,,50597,178.0,A,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11253,Rattus norvegicus,Intermediate,CHEMBL624798,,,50597,178.0,A,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11254,Rattus norvegicus,Intermediate,CHEMBL624799,,,50597,955.0,A,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11255,Rattus norvegicus,Intermediate,CHEMBL624800,,,50597,955.0,A,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11256,Rattus norvegicus,Intermediate,CHEMBL624801,,,50597,955.0,A,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11257,Rattus norvegicus,Intermediate,CHEMBL624802,,,50597,955.0,A,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11258,Rattus norvegicus,Intermediate,CHEMBL624803,,,50597,955.0,A,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11259,Rattus norvegicus,Intermediate,CHEMBL624804,,,50597,955.0,A,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11260,Rattus norvegicus,Intermediate,CHEMBL624805,,,50597,955.0,A,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11261,Rattus norvegicus,Intermediate,CHEMBL624806,,,50597,955.0,A,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,N,1,1,,BAO_0000218
11262,Rattus norvegicus,Intermediate,CHEMBL624807,,,50597,,A,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11263,Rattus norvegicus,Intermediate,CHEMBL624808,,,50597,,A,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11264,Rattus norvegicus,Intermediate,CHEMBL624809,,,50597,,A,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11265,Rattus norvegicus,Intermediate,CHEMBL624810,,,50597,,A,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11266,Rattus norvegicus,Intermediate,CHEMBL877618,,,50597,,A,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11267,Rattus norvegicus,Intermediate,CHEMBL624811,,,50597,,A,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11268,Rattus norvegicus,Intermediate,CHEMBL624812,,,50597,,A,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11269,Rattus norvegicus,Intermediate,CHEMBL624813,,,50597,,A,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11270,Rattus norvegicus,Intermediate,CHEMBL624814,,,50597,,A,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11271,Rattus norvegicus,Intermediate,CHEMBL624815,,,50597,,A,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11272,Rattus norvegicus,Intermediate,CHEMBL624816,,,50597,,A,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11273,Rattus norvegicus,Intermediate,CHEMBL624817,,,50597,,A,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11274,Canis lupus familiaris,Intermediate,CHEMBL624818,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11275,Canis lupus familiaris,Intermediate,CHEMBL624819,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,N,1,1,,BAO_0000218
11276,Canis lupus familiaris,Intermediate,CHEMBL624820,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
11277,Canis lupus familiaris,Intermediate,CHEMBL624821,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
11278,Canis lupus familiaris,Intermediate,CHEMBL624822,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
11279,Canis lupus familiaris,Intermediate,CHEMBL624823,,,50588,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
11280,Escherichia coli,Intermediate,CHEMBL624824,,,50212,,A,,Observed diffusion coefficient in organic solvent for Escherichia coli,,N,1,1,,BAO_0000218
11281,Rattus norvegicus,Intermediate,CHEMBL624825,,,50597,178.0,A,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11282,Rattus norvegicus,Intermediate,CHEMBL624826,,,50597,178.0,A,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11283,Rattus norvegicus,Intermediate,CHEMBL876817,,,50597,2081.0,A,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11284,Rattus norvegicus,Intermediate,CHEMBL624827,,,50597,2081.0,A,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11285,Rattus norvegicus,Intermediate,CHEMBL624828,,,50597,,A,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11286,Rattus norvegicus,Intermediate,CHEMBL624829,,,50597,,A,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11287,Rattus norvegicus,Intermediate,CHEMBL624830,,,50597,2107.0,A,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11288,Rattus norvegicus,Intermediate,CHEMBL624831,,,50597,2107.0,A,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11289,Rattus norvegicus,Intermediate,CHEMBL624832,,,50597,2081.0,A,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11290,Rattus norvegicus,Intermediate,CHEMBL624833,,,50597,2081.0,A,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11291,Rattus norvegicus,Intermediate,CHEMBL624834,,,50597,,A,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11292,Rattus norvegicus,Intermediate,CHEMBL624835,,,50597,,A,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11293,Rattus norvegicus,Intermediate,CHEMBL624836,,,50597,2106.0,A,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,1,1,,BAO_0000218
11294,Rattus norvegicus,Intermediate,CHEMBL624837,,,50597,2106.0,A,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,1,1,,BAO_0000218
11295,Rattus norvegicus,Intermediate,CHEMBL624838,,,50597,178.0,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11296,Rattus norvegicus,Intermediate,CHEMBL622188,,,50597,178.0,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,N,1,1,,BAO_0000218
11297,Rattus norvegicus,Intermediate,CHEMBL622189,,,50597,948.0,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11298,Rattus norvegicus,Intermediate,CHEMBL622190,,,50597,948.0,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,N,1,1,,BAO_0000218
11299,Rattus norvegicus,Intermediate,CHEMBL625170,,,50597,948.0,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,N,1,1,,BAO_0000218
11300,Rattus norvegicus,Intermediate,CHEMBL625171,,,50597,2113.0,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11301,Rattus norvegicus,Intermediate,CHEMBL625172,,,50597,2113.0,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11302,Rattus norvegicus,Intermediate,CHEMBL625173,,,50597,2113.0,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,N,1,1,,BAO_0000218
11303,Rattus norvegicus,Intermediate,CHEMBL625174,,,50597,2107.0,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11304,Rattus norvegicus,Intermediate,CHEMBL625175,,,50597,2107.0,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,N,1,1,,BAO_0000218
11305,Rattus norvegicus,Intermediate,CHEMBL625176,,,50597,2107.0,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,N,1,1,,BAO_0000218
11306,Rattus norvegicus,Intermediate,CHEMBL625177,,,50597,2048.0,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11307,Rattus norvegicus,Intermediate,CHEMBL625178,,,50597,2048.0,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,N,1,1,,BAO_0000218
11308,Rattus norvegicus,Intermediate,CHEMBL625179,,,50597,2048.0,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,N,1,1,,BAO_0000218
11309,Rattus norvegicus,Intermediate,CHEMBL625180,,,50597,2048.0,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,1,1,,BAO_0000218
11310,,Autocuration,CHEMBL625181,,,22224,,A,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,U,0,1,,BAO_0000218
11311,Mus musculus,Intermediate,CHEMBL625182,,,50594,1088.0,A,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,N,1,1,,BAO_0000218
11312,Rattus norvegicus,Intermediate,CHEMBL625183,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11313,Rattus norvegicus,Intermediate,CHEMBL875848,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11314,Rattus norvegicus,Intermediate,CHEMBL622260,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11315,Rattus norvegicus,Intermediate,CHEMBL622261,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11316,Rattus norvegicus,Intermediate,CHEMBL622262,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11317,Rattus norvegicus,Intermediate,CHEMBL622263,,,50597,2113.0,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11318,Rattus norvegicus,Intermediate,CHEMBL622418,,,50597,2113.0,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11319,Rattus norvegicus,Intermediate,CHEMBL622419,,,50597,2107.0,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11320,Mus musculus,Intermediate,CHEMBL623388,,,50594,,A,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11321,Mus musculus,Intermediate,CHEMBL623389,,,50594,2107.0,A,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11322,Mus musculus,Intermediate,CHEMBL623390,,,50594,,A,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11323,Mus musculus,Intermediate,CHEMBL623391,,,50594,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11324,Mus musculus,Intermediate,CHEMBL623392,,,50594,178.0,A,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11325,Mus musculus,Intermediate,CHEMBL623393,,,50594,2037.0,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11326,Mus musculus,Intermediate,CHEMBL623394,,,50594,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11327,Mus musculus,Intermediate,CHEMBL618885,,,50594,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11328,Mus musculus,Intermediate,CHEMBL618886,,,50594,2107.0,A,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11329,Mus musculus,Intermediate,CHEMBL618887,,,50594,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11330,Mus musculus,Intermediate,CHEMBL619535,,,50594,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11331,Mus musculus,Intermediate,CHEMBL619536,,,50594,178.0,A,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11332,Mus musculus,Intermediate,CHEMBL619537,,,50594,2037.0,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11333,Mus musculus,Intermediate,CHEMBL619705,,,50594,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11334,Mus musculus,Intermediate,CHEMBL619706,,,50594,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11335,Mus musculus,Intermediate,CHEMBL619707,,,50594,2107.0,A,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11336,Mus musculus,Intermediate,CHEMBL619708,,,50594,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11337,Mus musculus,Intermediate,CHEMBL625219,,,50594,,A,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11338,Mus musculus,Intermediate,CHEMBL625220,,,50594,178.0,A,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11339,Mus musculus,Intermediate,CHEMBL625221,,,50594,2037.0,A,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11340,Mus musculus,Intermediate,CHEMBL625222,,,50594,,A,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11341,Mus musculus,Intermediate,CHEMBL625223,,,50594,,A,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11342,Mus musculus,Intermediate,CHEMBL625224,,,50594,2107.0,A,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11343,Mus musculus,Intermediate,CHEMBL625225,,,50594,,A,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,1,1,,BAO_0000218
11344,Rattus norvegicus,Intermediate,CHEMBL625226,,,50597,178.0,A,,Biodistribution in Rat blood after 24 hours of iv administration,,N,1,1,,BAO_0000218
11345,Rattus norvegicus,Intermediate,CHEMBL625227,,,50597,178.0,A,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11346,Rattus norvegicus,Intermediate,CHEMBL625228,,,50597,178.0,A,,Biodistribution in Rat blood after 30 minutes of iv administration,,N,1,1,,BAO_0000218
11347,Rattus norvegicus,Intermediate,CHEMBL875354,,,50597,178.0,A,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11348,Rattus norvegicus,Intermediate,CHEMBL625229,,,50597,178.0,A,,Biodistribution in Rat blood after 5 minutes of iv administration,,N,1,1,,BAO_0000218
11349,Rattus norvegicus,Intermediate,CHEMBL625230,,,50597,178.0,A,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11350,Rattus norvegicus,Intermediate,CHEMBL625231,,,50597,948.0,A,,Biodistribution in Rat heart after 24 hours of iv administration,,N,1,1,,BAO_0000218
11351,Rattus norvegicus,Intermediate,CHEMBL625900,,,50597,948.0,A,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11352,Rattus norvegicus,Intermediate,CHEMBL625901,,,50597,948.0,A,,Biodistribution in Rat heart after 30 minutes of iv administration,,N,1,1,,BAO_0000218
11353,Rattus norvegicus,Intermediate,CHEMBL625902,,,50597,948.0,A,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11354,Rattus norvegicus,Intermediate,CHEMBL625903,,,50597,948.0,A,,Biodistribution in Rat heart after 5 minutes of iv administration,,N,1,1,,BAO_0000218
11355,Rattus norvegicus,Intermediate,CHEMBL625904,,,50597,948.0,A,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11356,Rattus norvegicus,Intermediate,CHEMBL625905,,,50597,2107.0,A,,Biodistribution in Rat liver after 24 hours of iv administration,,N,1,1,,BAO_0000218
11357,Rattus norvegicus,Intermediate,CHEMBL627861,,,50597,2107.0,A,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11358,Rattus norvegicus,Intermediate,CHEMBL627862,,,50597,2107.0,A,,Biodistribution in Rat liver after 30 minutes of iv administration,,N,1,1,,BAO_0000218
11359,Rattus norvegicus,Intermediate,CHEMBL627863,,,50597,2107.0,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11360,Rattus norvegicus,Intermediate,CHEMBL627769,,,50597,2107.0,A,,Biodistribution in Rat liver after 30 minutes of iv administration,,N,1,1,,BAO_0000218
11361,Canis lupus familiaris,Intermediate,CHEMBL627770,,,50588,1969.0,A,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,1,1,,BAO_0000218
11362,Macaca fascicularis,Intermediate,CHEMBL627771,,,100710,,A,,Cmax in cynomolgus monkey (PO dose),,N,1,1,,BAO_0000218
11363,Rattus norvegicus,Intermediate,CHEMBL627772,,,50597,,A,,Cmax in rat (PO dose),,N,1,1,,BAO_0000218
11364,Rattus norvegicus,Intermediate,CHEMBL627773,,,50597,,A,,Cmax in rat (PO dose),,N,1,1,,BAO_0000218
11365,Rattus norvegicus,Intermediate,CHEMBL621922,,,50597,1969.0,A,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,N,1,1,,BAO_0000218
11366,Rattus norvegicus,Intermediate,CHEMBL621923,,,50597,1969.0,A,,Cmax in rat plasma after oral dose (10 mg/kg),,N,1,1,,BAO_0000218
11367,,Autocuration,CHEMBL621924,,,22224,1969.0,A,,Cmax in plasma after oral dose (10 mg/kg),,U,0,1,,BAO_0000218
11368,Canis lupus familiaris,Intermediate,CHEMBL621925,,,50588,1969.0,A,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,N,1,1,,BAO_0000218
11369,Simiiformes,Autocuration,CHEMBL621926,,,22224,1969.0,A,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,U,0,1,,BAO_0000218
11370,Oryctolagus cuniculus,Intermediate,CHEMBL621927,,,50592,1969.0,A,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,N,1,1,,BAO_0000218
11371,Rattus norvegicus,Intermediate,CHEMBL621928,,,50597,1969.0,A,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,N,1,1,,BAO_0000218
11372,Rattus norvegicus,Intermediate,CHEMBL621929,,,50597,1969.0,A,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,N,1,1,,BAO_0000218
11373,Mus musculus,Intermediate,CHEMBL621930,,,50594,1969.0,A,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,N,1,1,,BAO_0000218
11374,Rattus norvegicus,Intermediate,CHEMBL621931,,,50597,1969.0,A,,Maximum plasma concentration after oral dosing in rat,,N,1,1,,BAO_0000218
11375,,Autocuration,CHEMBL621932,,,22224,1969.0,A,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11376,,Autocuration,CHEMBL621933,,,22224,1969.0,A,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11377,Canis lupus familiaris,Intermediate,CHEMBL621934,,,50588,1969.0,A,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,N,1,1,,BAO_0000218
11378,Canis lupus familiaris,Intermediate,CHEMBL621935,,,50588,1969.0,A,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,N,1,1,,BAO_0000218
11379,Rattus norvegicus,Intermediate,CHEMBL621936,,,50597,1969.0,A,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,N,1,1,,BAO_0000218
11380,,Autocuration,CHEMBL621937,,,22224,1969.0,A,,Maximum plasma concentration was determined,,U,0,1,,BAO_0000218
11381,,Autocuration,CHEMBL621938,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11382,,Autocuration,CHEMBL621939,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11383,,Autocuration,CHEMBL621940,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11384,,Autocuration,CHEMBL621941,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11385,,Autocuration,CHEMBL621942,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11386,,Autocuration,CHEMBL626178,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11387,,Autocuration,CHEMBL626179,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11388,,Autocuration,CHEMBL626180,,,22224,1969.0,A,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11389,Rattus norvegicus,Intermediate,CHEMBL626181,,,50597,1969.0,A,,Plasma Cmax in rat (PO dose),,N,1,1,,BAO_0000218
11390,Rattus norvegicus,Intermediate,CHEMBL626182,,,50597,,A,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,N,1,1,,BAO_0000218
11391,Rattus norvegicus,Intermediate,CHEMBL626183,,,50597,,A,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,N,1,1,,BAO_0000218
11392,Rattus norvegicus,Intermediate,CHEMBL626184,,,50597,,A,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,N,1,1,,BAO_0000218
11393,Rattus norvegicus,Intermediate,CHEMBL626185,,,50597,,A,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,N,1,1,,BAO_0000218
11394,Canis lupus familiaris,Intermediate,CHEMBL626186,,,50588,1969.0,A,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,N,1,1,,BAO_0000218
11395,Canis lupus familiaris,Intermediate,CHEMBL877589,,,50588,1969.0,A,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,N,1,1,,BAO_0000218
11396,,Autocuration,CHEMBL626187,,,22224,,A,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,U,0,1,,BAO_0000218
11397,,Autocuration,CHEMBL626188,,,22224,,A,,Maximum concentration of the drug at 20 uM/dg administered perorally,,U,0,1,,BAO_0000218
11398,,Autocuration,CHEMBL626189,,,22224,,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,U,0,1,,BAO_0000218
11399,,Autocuration,CHEMBL626855,,,22224,178.0,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11400,,Autocuration,CHEMBL623781,,,22224,178.0,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11401,,Autocuration,CHEMBL623782,,,22224,178.0,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11402,Rattus norvegicus,Intermediate,CHEMBL623783,,,50597,1969.0,A,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,N,1,1,,BAO_0000218
11403,Canis lupus familiaris,Intermediate,CHEMBL623784,,,50588,1969.0,A,,Cmax in dog plasma after 1mg/kg oral dose,,N,1,1,,BAO_0000218
11404,Canis lupus familiaris,Intermediate,CHEMBL623785,,,50588,1969.0,A,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,N,1,1,,BAO_0000218
11405,Rattus norvegicus,Intermediate,CHEMBL623786,,,50597,1969.0,A,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,N,1,1,,BAO_0000218
11406,Rattus norvegicus,Intermediate,CHEMBL623787,,,50597,,A,,Oral maximum concentration in rat,,N,1,1,,BAO_0000218
11407,Rattus norvegicus,Intermediate,CHEMBL623788,,,50597,,A,,Oral maximum concentration in rat,,N,1,1,,BAO_0000218
11408,Mus musculus,Intermediate,CHEMBL623789,,,50594,1969.0,A,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,N,1,1,,BAO_0000218
11409,Mus musculus,Intermediate,CHEMBL623790,,,50594,178.0,A,,Peak concentration in blood after intravenous administration to mice,,N,1,1,,BAO_0000218
11410,Mus musculus,Intermediate,CHEMBL623791,,,50594,178.0,A,,Peak concentration in blood after peroral administration to mice,,N,1,1,,BAO_0000218
11411,Rattus norvegicus,Intermediate,CHEMBL623792,,,50597,1969.0,A,,Peak concentration in rat plasma was determined,,N,1,1,,BAO_0000218
11412,Simiiformes,Autocuration,CHEMBL623793,,,22224,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,0,1,,BAO_0000218
11413,Mus musculus,Intermediate,CHEMBL623794,,,50594,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,1,1,,BAO_0000218
11414,Rattus norvegicus,Intermediate,CHEMBL623795,,,50597,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,N,1,1,,BAO_0000218
11415,Rattus norvegicus,Intermediate,CHEMBL623796,,,50597,,A,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11416,Rattus norvegicus,Intermediate,CHEMBL623797,,,50597,,A,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11417,Rattus norvegicus,Intermediate,CHEMBL623798,,,50597,,A,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11418,Rattus norvegicus,Intermediate,CHEMBL623799,,,50597,,A,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11419,Rattus norvegicus,Intermediate,CHEMBL624490,,,50597,160.0,A,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11420,Rattus norvegicus,Intermediate,CHEMBL624491,,,50597,160.0,A,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11421,Rattus norvegicus,Intermediate,CHEMBL624492,,,50597,160.0,A,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11422,Rattus norvegicus,Intermediate,CHEMBL624493,,,50597,160.0,A,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11423,Rattus norvegicus,Intermediate,CHEMBL877595,,,50597,160.0,A,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11424,Rattus norvegicus,Intermediate,CHEMBL624494,,,50597,160.0,A,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11425,Rattus norvegicus,Intermediate,CHEMBL624495,,,50597,160.0,A,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11426,Rattus norvegicus,Intermediate,CHEMBL624681,,,50597,160.0,A,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11427,Rattus norvegicus,Intermediate,CHEMBL624682,,,50597,,A,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11428,Rattus norvegicus,Intermediate,CHEMBL624683,,,50597,,A,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11429,Rattus norvegicus,Intermediate,CHEMBL624684,,,50597,,A,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11430,Rattus norvegicus,Intermediate,CHEMBL624685,,,50597,,A,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11431,Rattus norvegicus,Intermediate,CHEMBL624686,,,50597,,A,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11432,Rattus norvegicus,Intermediate,CHEMBL624687,,,50597,,A,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11433,Rattus norvegicus,Intermediate,CHEMBL624688,,,50597,,A,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11434,Rattus norvegicus,Intermediate,CHEMBL627161,,,50597,,A,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11435,Rattus norvegicus,Intermediate,CHEMBL622127,,,50597,,A,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11436,Rattus norvegicus,Intermediate,CHEMBL622128,,,50597,,A,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11437,Rattus norvegicus,Intermediate,CHEMBL874384,,,50597,,A,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11438,Rattus norvegicus,Intermediate,CHEMBL624898,,,50597,,A,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11439,Rattus norvegicus,Intermediate,CHEMBL624899,,,50597,,A,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11440,Rattus norvegicus,Intermediate,CHEMBL624900,,,50597,,A,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11441,Rattus norvegicus,Intermediate,CHEMBL624901,,,50597,,A,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11442,Rattus norvegicus,Intermediate,CHEMBL624902,,,50597,,A,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11443,Rattus norvegicus,Intermediate,CHEMBL624903,,,50597,,A,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11444,Rattus norvegicus,Intermediate,CHEMBL624904,,,50597,,A,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11445,Rattus norvegicus,Intermediate,CHEMBL624905,,,50597,,A,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11446,Rattus norvegicus,Intermediate,CHEMBL624906,,,50597,,A,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11447,Rattus norvegicus,Intermediate,CHEMBL624907,,,50597,,A,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11448,Rattus norvegicus,Intermediate,CHEMBL624908,,,50597,,A,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11449,Rattus norvegicus,Intermediate,CHEMBL624909,,,50597,,A,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11450,Rattus norvegicus,Intermediate,CHEMBL624910,,,50597,,A,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11451,Rattus norvegicus,Intermediate,CHEMBL624911,,,50597,2385.0,A,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11452,Rattus norvegicus,Intermediate,CHEMBL874388,,,50597,2385.0,A,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11453,Rattus norvegicus,Intermediate,CHEMBL624912,,,50597,2385.0,A,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11454,Rattus norvegicus,Intermediate,CHEMBL622930,,,50597,2385.0,A,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11455,Rattus norvegicus,Intermediate,CHEMBL623121,,,50597,2385.0,A,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11456,Rattus norvegicus,Intermediate,CHEMBL623122,,,50597,2385.0,A,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11457,Rattus norvegicus,Intermediate,CHEMBL623123,,,50597,2385.0,A,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11458,Rattus norvegicus,Intermediate,CHEMBL623124,,,50597,2385.0,A,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11459,Rattus norvegicus,Intermediate,CHEMBL623125,,,50597,,A,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11460,Rattus norvegicus,Intermediate,CHEMBL623126,,,50597,,A,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11461,Rattus norvegicus,Intermediate,CHEMBL623127,,,50597,,A,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11462,Rattus norvegicus,Intermediate,CHEMBL623128,,,50597,,A,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11463,Rattus norvegicus,Intermediate,CHEMBL623129,,,50597,,A,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11464,Rattus norvegicus,Intermediate,CHEMBL623130,,,50597,,A,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11465,Rattus norvegicus,Intermediate,CHEMBL623131,,,50597,,A,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11466,Rattus norvegicus,Intermediate,CHEMBL623132,,,50597,,A,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11467,Rattus norvegicus,Intermediate,CHEMBL623133,,,50597,2107.0,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11468,Rattus norvegicus,Intermediate,CHEMBL623134,,,50597,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11469,Rattus norvegicus,Intermediate,CHEMBL874389,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11470,Rattus norvegicus,Intermediate,CHEMBL623135,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11471,Rattus norvegicus,Intermediate,CHEMBL623136,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11472,Rattus norvegicus,Intermediate,CHEMBL623137,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11473,Rattus norvegicus,Intermediate,CHEMBL623138,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11474,Rattus norvegicus,Intermediate,CHEMBL623139,,,50597,2113.0,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11475,Rattus norvegicus,Intermediate,CHEMBL623140,,,50597,2113.0,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11476,Rattus norvegicus,Intermediate,CHEMBL623141,,,50597,2107.0,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11477,Rattus norvegicus,Intermediate,CHEMBL623142,,,50597,2107.0,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11478,Rattus norvegicus,Intermediate,CHEMBL623143,,,50597,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11479,Mus musculus,Intermediate,CHEMBL623144,,,50594,1088.0,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,N,1,1,,BAO_0000218
11480,Rattus norvegicus,Intermediate,CHEMBL623405,,,50597,1088.0,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,N,1,1,,BAO_0000218
11481,Rattus norvegicus,Intermediate,CHEMBL624074,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11482,Rattus norvegicus,Intermediate,CHEMBL624075,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11483,Rattus norvegicus,Intermediate,CHEMBL624076,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11484,Rattus norvegicus,Intermediate,CHEMBL624077,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11485,Rattus norvegicus,Intermediate,CHEMBL624078,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11486,Rattus norvegicus,Intermediate,CHEMBL624079,,,50597,2113.0,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11487,Rattus norvegicus,Intermediate,CHEMBL624261,,,50597,2113.0,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11488,Rattus norvegicus,Intermediate,CHEMBL624262,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11489,Rattus norvegicus,Intermediate,CHEMBL624263,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11490,Rattus norvegicus,Intermediate,CHEMBL624264,,,50597,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11491,Rattus norvegicus,Intermediate,CHEMBL624265,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11492,Rattus norvegicus,Intermediate,CHEMBL624266,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11493,Rattus norvegicus,Intermediate,CHEMBL624267,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11494,Rattus norvegicus,Intermediate,CHEMBL624268,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11495,Rattus norvegicus,Intermediate,CHEMBL875227,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11496,Rattus norvegicus,Intermediate,CHEMBL624269,,,50597,2113.0,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11497,Rattus norvegicus,Intermediate,CHEMBL624270,,,50597,2113.0,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11498,Rattus norvegicus,Intermediate,CHEMBL624271,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,1,1,,BAO_0000218
11499,Rattus norvegicus,Intermediate,CHEMBL624272,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11500,Rattus norvegicus,Intermediate,CHEMBL624273,,,50597,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,1,1,,BAO_0000218
11501,Rattus norvegicus,Intermediate,CHEMBL624274,,,50597,1088.0,A,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11502,Rattus norvegicus,Intermediate,CHEMBL624275,,,50597,1088.0,A,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11503,Rattus norvegicus,Intermediate,CHEMBL624276,,,50597,1088.0,A,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11504,Rattus norvegicus,Intermediate,CHEMBL624277,,,50597,1088.0,A,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,N,1,1,,BAO_0000218
11505,,Autocuration,CHEMBL624278,,,22224,,A,,% dose converted to 2-amino-5-chlorophenyl sulfate,,U,0,1,,BAO_0000019
11506,,Autocuration,CHEMBL624279,,,22224,,A,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,U,0,1,,BAO_0000019
11507,Rattus norvegicus,Intermediate,CHEMBL624280,,,50597,1988.0,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,1,1,,BAO_0000218
11508,Rattus norvegicus,Intermediate,CHEMBL624281,,,50597,1988.0,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,1,1,,BAO_0000218
11509,Rattus norvegicus,Intermediate,CHEMBL622933,,,50597,1988.0,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,1,1,,BAO_0000218
11510,Rattus norvegicus,Intermediate,CHEMBL622934,,,50597,1988.0,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,1,1,,BAO_0000218
11511,Rattus norvegicus,Intermediate,CHEMBL622935,,,50597,2107.0,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11512,Rattus norvegicus,Intermediate,CHEMBL622936,,,50597,2107.0,A,,Biodistribution in Rat liver after 5 minutes of iv administration,,N,1,1,,BAO_0000218
11513,Rattus norvegicus,Intermediate,CHEMBL875228,,,50597,2107.0,A,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11514,Rattus norvegicus,Intermediate,CHEMBL622937,,,50597,2048.0,A,,Biodistribution in Rat lung after 24 hours of iv administration,,N,1,1,,BAO_0000218
11515,Rattus norvegicus,Intermediate,CHEMBL622938,,,50597,2048.0,A,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11516,Rattus norvegicus,Intermediate,CHEMBL619736,,,50597,2048.0,A,,Biodistribution in Rat lung after 30 minutes of iv administration,,N,1,1,,BAO_0000218
11517,Rattus norvegicus,Intermediate,CHEMBL625117,,,50597,2048.0,A,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11518,Rattus norvegicus,Intermediate,CHEMBL625118,,,50597,2048.0,A,,Biodistribution in Rat lung after 5 minutes of iv administration,,N,1,1,,BAO_0000218
11519,Rattus norvegicus,Intermediate,CHEMBL625119,,,50597,2048.0,A,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,N,1,1,,BAO_0000218
11520,Rattus norvegicus,Intermediate,CHEMBL625120,,,50597,2037.0,A,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,N,1,1,,BAO_0000218
11521,Rattus norvegicus,Intermediate,CHEMBL625121,,,50597,,A,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,N,1,1,,BAO_0000218
11522,Rattus norvegicus,Intermediate,CHEMBL625122,,,50597,10000006.0,A,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,N,1,1,,BAO_0000218
11523,Rattus norvegicus,Intermediate,CHEMBL622204,,,50597,178.0,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11524,Rattus norvegicus,Intermediate,CHEMBL877503,,,50597,178.0,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11525,Rattus norvegicus,Intermediate,CHEMBL627127,,,50597,178.0,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11526,,Autocuration,CHEMBL627128,,,22224,10000000.0,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,U,0,1,,BAO_0000218
11527,,Autocuration,CHEMBL627129,,,22224,10000000.0,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,U,0,1,,BAO_0000218
11528,,Autocuration,CHEMBL627130,,,22224,10000000.0,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,U,0,1,,BAO_0000218
11529,Rattus norvegicus,Intermediate,CHEMBL627131,,,50597,955.0,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11530,Rattus norvegicus,Intermediate,CHEMBL627132,,,50597,955.0,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11531,Rattus norvegicus,Intermediate,CHEMBL627133,,,50597,955.0,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11532,Rattus norvegicus,Intermediate,CHEMBL627134,,,50597,2037.0,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11533,Rattus norvegicus,Intermediate,CHEMBL627135,,,50597,2037.0,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11534,Rattus norvegicus,Intermediate,CHEMBL627136,,,50597,2037.0,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11535,Rattus norvegicus,Intermediate,CHEMBL628435,,,50597,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11536,Rattus norvegicus,Intermediate,CHEMBL628436,,,50597,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11537,Rattus norvegicus,Intermediate,CHEMBL628437,,,50597,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11538,Rattus norvegicus,Intermediate,CHEMBL628438,,,50597,948.0,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11539,Rattus norvegicus,Intermediate,CHEMBL628439,,,50597,948.0,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11540,Rattus norvegicus,Intermediate,CHEMBL628440,,,50597,948.0,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11541,Rattus norvegicus,Intermediate,CHEMBL628441,,,50597,10000000.0,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11542,Rattus norvegicus,Intermediate,CHEMBL628442,,,50597,10000000.0,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11543,Rattus norvegicus,Intermediate,CHEMBL628443,,,50597,10000000.0,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11544,Rattus norvegicus,Intermediate,CHEMBL628444,,,50597,2113.0,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11545,Rattus norvegicus,Intermediate,CHEMBL628445,,,50597,2113.0,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11546,Rattus norvegicus,Intermediate,CHEMBL877504,,,50597,2113.0,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11547,Rattus norvegicus,Intermediate,CHEMBL628446,,,50597,2107.0,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11548,Rattus norvegicus,Intermediate,CHEMBL626874,,,50597,2107.0,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11549,Rattus norvegicus,Intermediate,CHEMBL626875,,,50597,2107.0,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11550,Rattus norvegicus,Intermediate,CHEMBL626876,,,50597,2048.0,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11551,Rattus norvegicus,Intermediate,CHEMBL626877,,,50597,2048.0,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11552,Rattus norvegicus,Intermediate,CHEMBL626878,,,50597,2048.0,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11553,Rattus norvegicus,Intermediate,CHEMBL626879,,,50597,2385.0,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11554,Simiiformes,Autocuration,CHEMBL626880,,,22224,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,0,1,,BAO_0000218
11555,Mus musculus,Intermediate,CHEMBL626881,,,50594,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,1,1,,BAO_0000218
11556,Rattus norvegicus,Intermediate,CHEMBL626882,,,50597,1969.0,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,N,1,1,,BAO_0000218
11557,Canis lupus familiaris,Intermediate,CHEMBL626883,,,50588,1969.0,A,,Peak plasma concentration was measured in dogs,,N,1,1,,BAO_0000218
11558,Rattus norvegicus,Intermediate,CHEMBL626884,,,50597,,A,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
11559,Rattus norvegicus,Intermediate,CHEMBL626885,,,50597,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,1,1,,BAO_0000218
11560,Rattus norvegicus,Intermediate,CHEMBL626886,,,50597,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,1,1,,BAO_0000218
11561,Rattus norvegicus,Intermediate,CHEMBL626887,,,50597,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,1,1,,BAO_0000218
11562,Rattus norvegicus,Intermediate,CHEMBL626888,,,50597,,A,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
11563,Canis lupus familiaris,Intermediate,CHEMBL626889,,,50588,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,N,1,1,,BAO_0000218
11564,Simiiformes,Autocuration,CHEMBL626761,,,22224,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,U,0,1,,BAO_0000218
11565,Canis lupus familiaris,Intermediate,CHEMBL626762,,,50588,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,N,1,1,,BAO_0000218
11566,Canis lupus familiaris,Intermediate,CHEMBL626763,,,50588,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,N,1,1,,BAO_0000218
11567,Rattus norvegicus,Intermediate,CHEMBL626764,,,50597,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,N,1,1,,BAO_0000218
11568,Rattus norvegicus,Intermediate,CHEMBL626765,,,50597,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,N,1,1,,BAO_0000218
11569,Canis lupus familiaris,Intermediate,CHEMBL626766,,,50588,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,N,1,1,,BAO_0000218
11570,Rattus norvegicus,Intermediate,CHEMBL626767,,,50597,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,N,1,1,,BAO_0000218
11571,Rattus norvegicus,Intermediate,CHEMBL626768,,,50597,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,N,1,1,,BAO_0000218
11572,Canis lupus familiaris,Intermediate,CHEMBL626769,,,50588,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,N,1,1,,BAO_0000218
11573,Canis lupus familiaris,Intermediate,CHEMBL874463,,,50588,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,N,1,1,,BAO_0000218
11574,Simiiformes,Autocuration,CHEMBL626770,,,22224,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,U,0,1,,BAO_0000218
11575,Simiiformes,Autocuration,CHEMBL626771,,,22224,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,U,0,1,,BAO_0000218
11576,Rattus norvegicus,Intermediate,CHEMBL626772,,,50597,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,N,1,1,,BAO_0000218
11577,Macaca fascicularis,Intermediate,CHEMBL626773,,,100710,,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,1,1,,BAO_0000218
11578,Mus musculus,Intermediate,CHEMBL626774,,,50594,,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,N,1,1,,BAO_0000218
11579,Canis lupus familiaris,Intermediate,CHEMBL626775,,,50588,,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,1,1,,BAO_0000218
11580,Canis lupus familiaris,Intermediate,CHEMBL626776,,,50588,,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,1,1,,BAO_0000218
11581,Rattus norvegicus,Intermediate,CHEMBL626777,,,50597,,A,,Maximum concentration (Cmax) in rat when administered orally,,N,1,1,,BAO_0000218
11582,Simiiformes,Autocuration,CHEMBL626778,,,22224,1969.0,A,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,U,0,1,,BAO_0000218
11583,Rattus norvegicus,Autocuration,CHEMBL626779,,,22224,,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,U,0,1,,BAO_0000218
11584,Rattus norvegicus,Autocuration,CHEMBL626780,,,22224,,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,U,0,1,,BAO_0000218
11585,,Autocuration,CHEMBL626781,,,22224,1969.0,A,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,U,0,1,,BAO_0000218
11586,Rattus norvegicus,Intermediate,CHEMBL632164,,,50597,,A,,Pharmacokinetic profile Cmax was evaluated in rats,,N,1,1,,BAO_0000218
11587,Canis lupus familiaris,Intermediate,CHEMBL632165,,,50588,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,N,1,1,,BAO_0000218
11588,Mus musculus,Intermediate,CHEMBL632166,,,50594,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,N,1,1,,BAO_0000218
11589,Canis lupus familiaris,Intermediate,CHEMBL632167,,,50588,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,N,1,1,,BAO_0000218
11590,Mus musculus,Intermediate,CHEMBL632168,,,50594,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,N,1,1,,BAO_0000218
11591,Rattus norvegicus,Autocuration,CHEMBL632169,,,22224,1969.0,A,,Cmax in rat plasma,,U,0,1,,BAO_0000218
11592,Canis lupus familiaris,Intermediate,CHEMBL632170,,,50588,1969.0,A,,Cmax in dog plasma after 30mg/kg oral dose,,N,1,1,,BAO_0000218
11593,Rattus norvegicus,Intermediate,CHEMBL632171,,,50597,1969.0,A,,Cmax in rat plasma after 30mg/kg oral dose,,N,1,1,,BAO_0000218
11594,Rattus norvegicus,Intermediate,CHEMBL632172,,,50597,1969.0,A,,Plasma level in rats at 30 mg/kg,,N,1,1,,BAO_0000218
11595,Mus musculus,Intermediate,CHEMBL632173,,,50594,1969.0,A,,Tested for maximum plasma concentration in mice,,N,1,1,,BAO_0000218
11596,Rattus norvegicus,Intermediate,CHEMBL632174,,,50597,,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
11597,Rattus norvegicus,Intermediate,CHEMBL632175,,,50597,,A,,The Cmax values in female wistar rats.,,N,1,1,,BAO_0000218
11598,Canis lupus familiaris,Intermediate,CHEMBL632176,,,50588,1969.0,A,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
11599,Rattus norvegicus,Intermediate,CHEMBL632177,,,50597,1969.0,A,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
11600,Rattus norvegicus,Intermediate,CHEMBL632178,,,50597,1969.0,A,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,N,1,1,,BAO_0000218
11601,Rattus norvegicus,Intermediate,CHEMBL632179,,,50597,,A,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,1,1,,BAO_0000218
11602,Rattus norvegicus,Intermediate,CHEMBL632180,,,50597,178.0,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,N,1,1,,BAO_0000218
11603,Rattus norvegicus,Intermediate,CHEMBL632181,,,50597,178.0,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,N,1,1,,BAO_0000218
11604,Rattus norvegicus,Intermediate,CHEMBL632182,,,50597,178.0,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,N,1,1,,BAO_0000218
11605,Mus musculus,Autocuration,CHEMBL632183,,,22224,178.0,A,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,U,0,1,,BAO_0000218
11606,Canis lupus familiaris,Intermediate,CHEMBL632184,,,50588,,A,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,N,1,1,,BAO_0000218
11607,Rattus norvegicus,Intermediate,CHEMBL874470,,,50597,,A,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,N,1,1,,BAO_0000218
11608,Rattus norvegicus,Intermediate,CHEMBL631302,,,50597,,A,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11609,Rattus norvegicus,Intermediate,CHEMBL631303,,,50597,,A,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11610,Rattus norvegicus,Intermediate,CHEMBL631304,,,50597,,A,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11611,Rattus norvegicus,Intermediate,CHEMBL631305,,,50597,,A,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11612,Rattus norvegicus,Intermediate,CHEMBL631306,,,50597,,A,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11613,Rattus norvegicus,Intermediate,CHEMBL631307,,,50597,,A,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11614,Rattus norvegicus,Intermediate,CHEMBL631308,,,50597,,A,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11615,Rattus norvegicus,Intermediate,CHEMBL625557,,,50597,,A,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11616,Rattus norvegicus,Intermediate,CHEMBL625558,,,50597,2106.0,A,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11617,Rattus norvegicus,Intermediate,CHEMBL625559,,,50597,2106.0,A,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11618,Rattus norvegicus,Intermediate,CHEMBL625560,,,50597,2106.0,A,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11619,Rattus norvegicus,Intermediate,CHEMBL625561,,,50597,2106.0,A,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11620,Rattus norvegicus,Intermediate,CHEMBL625562,,,50597,2106.0,A,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11621,Rattus norvegicus,Intermediate,CHEMBL875320,,,50597,2106.0,A,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11622,Rattus norvegicus,Intermediate,CHEMBL625563,,,50597,2106.0,A,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11623,Rattus norvegicus,Intermediate,CHEMBL625564,,,50597,2106.0,A,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11624,Rattus norvegicus,Intermediate,CHEMBL625565,,,50597,995.0,A,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11625,Rattus norvegicus,Intermediate,CHEMBL625566,,,50597,995.0,A,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11626,Rattus norvegicus,Intermediate,CHEMBL625567,,,50597,995.0,A,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11627,Rattus norvegicus,Intermediate,CHEMBL625568,,,50597,995.0,A,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11628,Rattus norvegicus,Intermediate,CHEMBL628217,,,50597,995.0,A,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11629,Rattus norvegicus,Intermediate,CHEMBL628218,,,50597,995.0,A,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11630,Rattus norvegicus,Intermediate,CHEMBL628219,,,50597,995.0,A,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11631,Rattus norvegicus,Intermediate,CHEMBL628220,,,50597,995.0,A,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,N,1,1,,BAO_0000218
11632,,Autocuration,CHEMBL628221,,,22224,,A,,Distribution in the blood after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11633,,Autocuration,CHEMBL628222,,,22224,,A,,Distribution in the blood after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11634,,Autocuration,CHEMBL628223,,,22224,,A,,Distribution in the blood after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11635,,Autocuration,CHEMBL628224,,,22224,,A,,Distribution in the blood after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11636,,Autocuration,CHEMBL628225,,,22224,,A,,Distribution in the blood after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11637,,Autocuration,CHEMBL628226,,,22224,,A,,Distribution in the blood after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11638,,Autocuration,CHEMBL628227,,,22224,,A,,Distribution in the bone after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11639,,Autocuration,CHEMBL875481,,,22224,,A,,Distribution in the bone after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11640,,Autocuration,CHEMBL628228,,,22224,,A,,Distribution in the bone after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11641,,Autocuration,CHEMBL628229,,,22224,,A,,Distribution in the bone after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11642,,Autocuration,CHEMBL628230,,,22224,,A,,Distribution in the bone after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11643,,Autocuration,CHEMBL628231,,,22224,,A,,Distribution in the bone after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11644,,Autocuration,CHEMBL628232,,,22224,,A,,Distribution in the heart after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11645,,Autocuration,CHEMBL628233,,,22224,,A,,Distribution in the heart after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11646,,Autocuration,CHEMBL628234,,,22224,,A,,Distribution in the heart after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11647,,Autocuration,CHEMBL628235,,,22224,,A,,Distribution in the heart after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11648,,Autocuration,CHEMBL628236,,,22224,,A,,Distribution in the heart after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11649,,Autocuration,CHEMBL628237,,,22224,,A,,Distribution in the heart after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11650,,Autocuration,CHEMBL628238,,,22224,,A,,Distribution in the kidneys after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11651,,Autocuration,CHEMBL628239,,,22224,,A,,Distribution in the kidneys after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11652,,Autocuration,CHEMBL628240,,,22224,,A,,Distribution in the kidneys after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11653,,Autocuration,CHEMBL628241,,,22224,,A,,Distribution in the kidneys after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11654,,Autocuration,CHEMBL628242,,,22224,,A,,Distribution in the kidneys after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11655,,Autocuration,CHEMBL875482,,,22224,,A,,Distribution in the kidneys after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11656,,Autocuration,CHEMBL628243,,,22224,,A,,Distribution in the liver after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11657,,Autocuration,CHEMBL628244,,,22224,,A,,Distribution in the liver after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11658,,Autocuration,CHEMBL628245,,,22224,,A,,Distribution in the liver after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11659,,Autocuration,CHEMBL628246,,,22224,,A,,Distribution in the liver after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11660,,Autocuration,CHEMBL628247,,,22224,,A,,Distribution in the liver after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11661,,Autocuration,CHEMBL628248,,,22224,,A,,Distribution in the liver after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11662,,Autocuration,CHEMBL628249,,,22224,,A,,Distribution in the lung after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11663,Mus musculus,Intermediate,CHEMBL625452,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,N,1,1,,BAO_0000218
11664,Mus musculus,Intermediate,CHEMBL625453,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,N,1,1,,BAO_0000218
11665,Mus musculus,Intermediate,CHEMBL625454,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,N,1,1,,BAO_0000218
11666,Mus musculus,Intermediate,CHEMBL623844,,,50594,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,N,1,1,,BAO_0000218
11667,Rattus norvegicus,Intermediate,CHEMBL623845,,,50597,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,1,1,,BAO_0000218
11668,Rattus norvegicus,Intermediate,CHEMBL623846,,,50597,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,1,1,,BAO_0000218
11669,,Autocuration,CHEMBL623847,,,22224,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,U,0,1,,BAO_0000218
11670,Macaca fascicularis,Intermediate,CHEMBL623848,,,100710,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,1,1,,BAO_0000218
11671,Macaca fascicularis,Intermediate,CHEMBL623849,,,100710,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,1,1,,BAO_0000218
11672,Macaca fascicularis,Intermediate,CHEMBL623850,,,100710,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,1,1,,BAO_0000218
11673,Macaca fascicularis,Intermediate,CHEMBL623851,,,100710,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,1,1,,BAO_0000218
11674,Simiiformes,Autocuration,CHEMBL623852,,,22224,,A,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,0,1,,BAO_0000218
11675,Mustela putorius furo,Intermediate,CHEMBL624551,,,50506,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,1,1,,BAO_0000218
11676,Mustela putorius furo,Intermediate,CHEMBL624552,,,50506,,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,1,1,,BAO_0000218
11677,Simiiformes,Autocuration,CHEMBL624553,,,22224,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,0,1,,BAO_0000218
11678,Simiiformes,Autocuration,CHEMBL624554,,,22224,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,U,0,1,,BAO_0000218
11679,Rattus norvegicus,Intermediate,CHEMBL624555,,,50597,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,1,1,,BAO_0000218
11680,Rattus norvegicus,Intermediate,CHEMBL624741,,,50597,,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,1,1,,BAO_0000218
11681,Canis lupus familiaris,Intermediate,CHEMBL624742,,,50588,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,N,1,1,,BAO_0000218
11682,Cricetinae,Intermediate,CHEMBL624743,,,100712,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,N,1,1,,BAO_0000218
11683,Rattus norvegicus,Intermediate,CHEMBL877606,,,50597,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,N,1,1,,BAO_0000218
11684,,Autocuration,CHEMBL624744,,,22224,,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,U,0,1,,BAO_0000218
11685,,Autocuration,CHEMBL624745,,,22224,178.0,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11686,,Autocuration,CHEMBL624746,,,22224,178.0,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11687,,Autocuration,CHEMBL624747,,,22224,178.0,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,0,1,,BAO_0000218
11688,,Autocuration,CHEMBL624748,,,22224,,A,,Oral absorption expressed as Area under curve was determined,,U,0,1,,BAO_0000019
11689,Canis lupus familiaris,Intermediate,CHEMBL622504,,,50588,,A,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,N,1,1,,BAO_0000218
11690,Canis lupus familiaris,Intermediate,CHEMBL622505,,,50588,,A,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,N,1,1,,BAO_0000218
11691,Cricetinae,Intermediate,CHEMBL622506,,,100712,,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,1,1,,BAO_0000218
11692,Cricetinae,Intermediate,CHEMBL622507,,,100712,,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,1,1,,BAO_0000218
11693,Rattus norvegicus,Intermediate,CHEMBL622508,,,50597,,A,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,N,1,1,,BAO_0000218
11694,,Autocuration,CHEMBL622509,,,22224,,A,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,U,0,1,,BAO_0000019
11695,Rattus norvegicus,Intermediate,CHEMBL622510,,,50597,,A,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
11696,Rattus norvegicus,Intermediate,CHEMBL622511,,,50597,,A,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,N,1,1,,BAO_0000218
11697,Macaca fascicularis,Intermediate,CHEMBL622512,,,100710,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,1,1,,BAO_0000218
11698,Macaca fascicularis,Intermediate,CHEMBL622513,,,100710,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,1,1,,BAO_0000218
11699,Macaca fascicularis,Intermediate,CHEMBL622514,,,100710,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,N,1,1,,BAO_0000218
11700,Canis lupus familiaris,Intermediate,CHEMBL622515,,,50588,,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,1,1,,BAO_0000218
11701,Canis lupus familiaris,Intermediate,CHEMBL622516,,,50588,,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,N,1,1,,BAO_0000218
11702,Rattus norvegicus,Intermediate,CHEMBL622517,,,50597,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,1,1,,BAO_0000218
11703,Rattus norvegicus,Intermediate,CHEMBL622518,,,50597,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,N,1,1,,BAO_0000218
11704,Rattus norvegicus,Intermediate,CHEMBL622519,,,50597,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,N,1,1,,BAO_0000218
11705,Rattus norvegicus,Intermediate,CHEMBL622520,,,50597,2385.0,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11706,Rattus norvegicus,Intermediate,CHEMBL622521,,,50597,2385.0,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11707,Mus musculus,Intermediate,CHEMBL625113,,,50594,14.0,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11708,Rattus norvegicus,Intermediate,CHEMBL625114,,,50597,14.0,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11709,Rattus norvegicus,Intermediate,CHEMBL874397,,,50597,14.0,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11710,Rattus norvegicus,Intermediate,CHEMBL625115,,,50597,2106.0,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11711,Rattus norvegicus,Intermediate,CHEMBL625116,,,50597,2106.0,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11712,Rattus norvegicus,Intermediate,CHEMBL623932,,,50597,2106.0,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11713,Rattus norvegicus,Intermediate,CHEMBL623933,,,50597,2435.0,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11714,Rattus norvegicus,Intermediate,CHEMBL623934,,,50597,2435.0,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11715,Rattus norvegicus,Intermediate,CHEMBL623935,,,50597,2435.0,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11716,Rattus norvegicus,Intermediate,CHEMBL623936,,,50597,2046.0,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,1,1,,BAO_0000218
11717,Rattus norvegicus,Intermediate,CHEMBL623937,,,50597,2046.0,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,1,1,,BAO_0000218
11718,Rattus norvegicus,Intermediate,CHEMBL623938,,,50597,2046.0,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,1,1,,BAO_0000218
11719,Mus musculus,Intermediate,CHEMBL623939,,,50594,,A,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11720,Mus musculus,Intermediate,CHEMBL623940,,,50594,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,1,1,,BAO_0000218
11721,Mus musculus,Intermediate,CHEMBL623941,,,50594,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,1,1,,BAO_0000218
11722,Mus musculus,Intermediate,CHEMBL627216,,,50594,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11723,Mus musculus,Intermediate,CHEMBL623942,,,50594,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11724,Mus musculus,Intermediate,CHEMBL618793,,,50594,955.0,A,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11725,Mus musculus,Intermediate,CHEMBL618794,,,50594,955.0,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11726,Mus musculus,Intermediate,CHEMBL618795,,,50594,955.0,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11727,Mus musculus,Intermediate,CHEMBL618796,,,50594,,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11728,Mus musculus,Intermediate,CHEMBL618797,,,50594,,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11729,Mus musculus,Intermediate,CHEMBL618798,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,1,1,,BAO_0000218
11730,Mus musculus,Intermediate,CHEMBL618799,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11731,Mus musculus,Intermediate,CHEMBL618800,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,1,1,,BAO_0000218
11732,Mus musculus,Intermediate,CHEMBL618801,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,1,1,,BAO_0000218
11733,Mus musculus,Intermediate,CHEMBL618802,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11734,Mus musculus,Intermediate,CHEMBL618803,,,50594,2113.0,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11735,Mus musculus,Intermediate,CHEMBL618804,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,1,1,,BAO_0000218
11736,Mus musculus,Intermediate,CHEMBL618805,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11737,Mus musculus,Intermediate,CHEMBL618806,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,1,1,,BAO_0000218
11738,Mus musculus,Intermediate,CHEMBL618807,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,1,1,,BAO_0000218
11739,Mus musculus,Intermediate,CHEMBL618808,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11740,Mus musculus,Intermediate,CHEMBL618809,,,50594,2107.0,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11741,Mus musculus,Intermediate,CHEMBL618810,,,50594,2385.0,A,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11742,Mus musculus,Intermediate,CHEMBL618811,,,50594,2385.0,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,1,1,,BAO_0000218
11743,Mus musculus,Intermediate,CHEMBL875844,,,50594,2385.0,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,1,1,,BAO_0000218
11744,Mus musculus,Intermediate,CHEMBL618812,,,50594,2385.0,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11745,Mus musculus,Intermediate,CHEMBL618813,,,50594,2385.0,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11746,Mus musculus,Intermediate,CHEMBL618814,,,50594,,A,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11747,Mus musculus,Intermediate,CHEMBL618815,,,50594,,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11748,Mus musculus,Intermediate,CHEMBL618816,,,50594,,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11749,Mus musculus,Intermediate,CHEMBL618817,,,50594,,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11750,Mus musculus,Intermediate,CHEMBL620544,,,50594,,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11751,Rattus norvegicus,Intermediate,CHEMBL626230,,,50597,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,N,1,1,,BAO_0000218
11752,Rattus norvegicus,Intermediate,CHEMBL626231,,,50597,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,N,1,1,,BAO_0000218
11753,Rattus norvegicus,Intermediate,CHEMBL626232,,,50597,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,N,1,1,,BAO_0000218
11754,Canis lupus familiaris,Intermediate,CHEMBL626233,,,50588,1969.0,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,N,1,1,,BAO_0000218
11755,Rattus norvegicus,Intermediate,CHEMBL626234,,,50597,1969.0,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,N,1,1,,BAO_0000218
11756,Rattus norvegicus,Intermediate,CHEMBL875341,,,50597,1969.0,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,N,1,1,,BAO_0000218
11757,Homo sapiens,Intermediate,CHEMBL626235,,,50587,1969.0,A,,The maximum plasma concentration (100 mg/kg) administered orally in human,,N,1,1,,BAO_0000218
11758,Callithrix,Autocuration,CHEMBL626236,,,22224,1969.0,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,U,0,1,,BAO_0000218
11759,Simiiformes,Autocuration,CHEMBL626237,,,22224,1969.0,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,U,0,1,,BAO_0000218
11760,Canis lupus familiaris,Intermediate,CHEMBL626238,,,50588,1969.0,A,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,N,1,1,,BAO_0000218
11761,Homo sapiens,Intermediate,CHEMBL622412,,,50587,1969.0,A,,The maximum plasma concentration (200 mg/kg) administered orally in human,,N,1,1,,BAO_0000218
11762,Rattus norvegicus,Intermediate,CHEMBL623114,,,50597,1969.0,A,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,N,1,1,,BAO_0000218
11763,Callithrix,Autocuration,CHEMBL623115,,,22224,1969.0,A,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,U,0,1,,BAO_0000218
11764,Simiiformes,Autocuration,CHEMBL623116,,,22224,1969.0,A,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,U,0,1,,BAO_0000218
11765,Canis lupus familiaris,Autocuration,CHEMBL623117,,,22224,1969.0,A,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,U,0,1,,BAO_0000218
11766,Homo sapiens,Intermediate,CHEMBL623118,,,50587,1969.0,A,,The maximum plasma concentration (400 mg/kg) administered orally in human,,N,1,1,,BAO_0000218
11767,Rattus norvegicus,Intermediate,CHEMBL623119,,,50597,1969.0,A,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,N,1,1,,BAO_0000218
11768,Rattus norvegicus,Intermediate,CHEMBL623120,,,50597,1969.0,A,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,N,1,1,,BAO_0000218
11769,Homo sapiens,Intermediate,CHEMBL623286,,,50587,1969.0,A,,The maximum plasma concentration (800 mg/kg) administered orally in human,,N,1,1,,BAO_0000218
11770,Rattus norvegicus,Intermediate,CHEMBL623287,,,50597,1969.0,A,,The maximum plasma concentration was measured on rats,,N,1,1,,BAO_0000218
11771,Rattus norvegicus,Intermediate,CHEMBL623288,,,50597,1969.0,A,,The maximum plasma concentration was measured on rats after oral administration,,N,1,1,,BAO_0000218
11772,Rattus norvegicus,Intermediate,CHEMBL623289,,,50597,1969.0,A,,Plasma drug Cmax in rat (PO dose),,N,1,1,,BAO_0000218
11773,,Autocuration,CHEMBL623290,,,22224,,A,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,U,0,1,,BAO_0000218
11774,Canis lupus familiaris,Intermediate,CHEMBL623291,,,50588,1969.0,A,,maximum Plasma concentration in Dog was determined after Peroral administration,,N,1,1,,BAO_0000218
11775,Rattus norvegicus,Intermediate,CHEMBL623292,,,50597,1969.0,A,,maximum Plasma concentration in Rats was determined after Peroral administration,,N,1,1,,BAO_0000218
11776,Canis lupus familiaris,Intermediate,CHEMBL623293,,,50588,1969.0,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,1,1,,BAO_0000218
11777,Simiiformes,Autocuration,CHEMBL623294,,,22224,1969.0,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,0,1,,BAO_0000218
11778,Rattus norvegicus,Intermediate,CHEMBL623295,,,50597,1969.0,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,1,1,,BAO_0000218
11779,Mus musculus,Intermediate,CHEMBL623296,,,50594,,A,,maximum concentration was measured when administered through oral route in mice,,N,1,1,,BAO_0000218
11780,Mus musculus,Intermediate,CHEMBL875349,,,50594,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,N,1,1,,BAO_0000218
11781,Simiiformes,Autocuration,CHEMBL623297,,,22224,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,U,0,1,,BAO_0000019
11782,Simiiformes,Autocuration,CHEMBL623298,,,22224,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,U,0,1,,BAO_0000019
11783,Simiiformes,Autocuration,CHEMBL623299,,,22224,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,U,0,1,,BAO_0000019
11784,Rattus norvegicus,Intermediate,CHEMBL623300,,,50597,,A,,Pharmacokinetic parameter was evaluated in rats,,N,1,1,,BAO_0000218
11785,Mus musculus,Intermediate,CHEMBL623301,,,50594,,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,1,1,,BAO_0000218
11786,Mus musculus,Intermediate,CHEMBL623302,,,50594,,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,N,1,1,,BAO_0000218
11787,Mus musculus,Intermediate,CHEMBL623303,,,50594,,A,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,1,1,,BAO_0000218
11788,Mus musculus,Intermediate,CHEMBL623304,,,50594,,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,N,1,1,,BAO_0000218
11789,Mus musculus,Intermediate,CHEMBL623305,,,50594,,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,N,1,1,,BAO_0000218
11790,Rattus norvegicus,Intermediate,CHEMBL623306,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,N,1,1,,BAO_0000218
11791,Rattus norvegicus,Intermediate,CHEMBL623307,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,N,1,1,,BAO_0000218
11792,Rattus norvegicus,Intermediate,CHEMBL623308,,,50597,1969.0,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,N,1,1,,BAO_0000218
11793,Mus musculus,Intermediate,CHEMBL623309,,,50594,1969.0,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,N,1,1,,BAO_0000218
11794,Mus musculus,Intermediate,CHEMBL623310,,,50594,,A,,Plasma Concentration after 120 min of oral administration to mice,,N,1,1,,BAO_0000218
11795,Mus musculus,Intermediate,CHEMBL623311,,,50594,,A,,Plasma Concentration after 30 min of oral administration to mice,,N,1,1,,BAO_0000218
11796,Macaca fascicularis,Intermediate,CHEMBL623312,,,100710,,A,,Plasma Concentration after 60 min of oral administration to mice,,N,1,1,,BAO_0000218
11797,Mus musculus,Intermediate,CHEMBL875350,,,50594,,A,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,N,1,1,,BAO_0000218
11798,Mus musculus,Intermediate,CHEMBL628635,,,50594,,A,,Plasma Concentration after 90 min of oral administration to mice,,N,1,1,,BAO_0000218
11799,Rattus norvegicus,Intermediate,CHEMBL628636,,,50597,,A,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11800,Rattus norvegicus,Intermediate,CHEMBL628637,,,50597,,A,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11801,Rattus norvegicus,Intermediate,CHEMBL628058,,,50597,,A,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,N,1,1,,BAO_0000218
11802,Rattus norvegicus,Intermediate,CHEMBL628059,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,N,1,1,,BAO_0000218
11803,Rattus norvegicus,Intermediate,CHEMBL628060,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,N,1,1,,BAO_0000218
11804,,Autocuration,CHEMBL628061,,,22224,,A,,Distribution in the lung after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11805,,Autocuration,CHEMBL628062,,,22224,,A,,Distribution in the lung after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11806,,Autocuration,CHEMBL628063,,,22224,,A,,Distribution in the lung after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11807,,Autocuration,CHEMBL628064,,,22224,,A,,Distribution in the lung after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11808,,Autocuration,CHEMBL628065,,,22224,,A,,Distribution in the lung after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11809,,Autocuration,CHEMBL628066,,,22224,2385.0,A,,Distribution in the muscle after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11810,,Autocuration,CHEMBL628067,,,22224,2385.0,A,,Distribution in the muscle after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11811,Mus musculus,Intermediate,CHEMBL874646,,,50594,2385.0,A,,Distribution in the muscle after 30 min of intravenous administration,,N,1,1,,BAO_0000218
11812,,Autocuration,CHEMBL628068,,,22224,2385.0,A,,Distribution in the muscle after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11813,,Autocuration,CHEMBL628069,,,22224,2385.0,A,,Distribution in the muscle after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11814,,Autocuration,CHEMBL628070,,,22224,2385.0,A,,Distribution in the muscle after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11815,,Autocuration,CHEMBL628071,,,22224,2106.0,A,,Distribution in the spleen after 120 min of intravenous administration,,U,0,1,,BAO_0000019
11816,,Autocuration,CHEMBL628072,,,22224,2106.0,A,,Distribution in the spleen after 15 min of intravenous administration,,U,0,1,,BAO_0000019
11817,,Autocuration,CHEMBL628073,,,22224,2106.0,A,,Distribution in the spleen after 30 min of intravenous administration,,U,0,1,,BAO_0000019
11818,,Autocuration,CHEMBL628074,,,22224,2106.0,A,,Distribution in the spleen after 5 min of intravenous administration,,U,0,1,,BAO_0000019
11819,,Autocuration,CHEMBL628075,,,22224,2106.0,A,,Distribution in the spleen after 60 min of intravenous administration,,U,0,1,,BAO_0000019
11820,,Autocuration,CHEMBL628076,,,22224,2106.0,A,,Distribution in the spleen after 90 min of intravenous administration,,U,0,1,,BAO_0000019
11821,Rattus norvegicus,Intermediate,CHEMBL628077,,,50597,1235.0,A,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11822,Rattus norvegicus,Intermediate,CHEMBL628078,,,50597,178.0,A,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11823,Rattus norvegicus,Intermediate,CHEMBL628079,,,50597,2107.0,A,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11824,Rattus norvegicus,Intermediate,CHEMBL628080,,,50597,992.0,A,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11825,Rattus norvegicus,Intermediate,CHEMBL628081,,,50597,2046.0,A,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11826,Rattus norvegicus,Intermediate,CHEMBL628082,,,50597,1235.0,A,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11827,Rattus norvegicus,Intermediate,CHEMBL874647,,,50597,178.0,A,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11828,Rattus norvegicus,Intermediate,CHEMBL626406,,,50597,2107.0,A,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11829,Rattus norvegicus,Intermediate,CHEMBL626407,,,50597,992.0,A,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11830,Rattus norvegicus,Intermediate,CHEMBL626408,,,50597,2046.0,A,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,N,1,1,,BAO_0000218
11831,Rattus norvegicus,Intermediate,CHEMBL626409,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,N,1,1,,BAO_0000218
11832,Rattus norvegicus,Intermediate,CHEMBL626410,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,N,1,1,,BAO_0000218
11833,Rattus norvegicus,Intermediate,CHEMBL626411,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,N,1,1,,BAO_0000218
11834,Rattus norvegicus,Intermediate,CHEMBL626412,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,N,1,1,,BAO_0000218
11835,Rattus norvegicus,Intermediate,CHEMBL626413,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,N,1,1,,BAO_0000218
11836,Rattus norvegicus,Intermediate,CHEMBL626414,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,N,1,1,,BAO_0000218
11837,Rattus norvegicus,Intermediate,CHEMBL626415,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,N,1,1,,BAO_0000218
11838,Rattus norvegicus,Intermediate,CHEMBL626416,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,N,1,1,,BAO_0000218
11839,Rattus norvegicus,Intermediate,CHEMBL627062,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,N,1,1,,BAO_0000218
11840,Rattus norvegicus,Intermediate,CHEMBL627063,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,N,1,1,,BAO_0000218
11841,Rattus norvegicus,Intermediate,CHEMBL627064,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,N,1,1,,BAO_0000218
11842,Rattus norvegicus,Intermediate,CHEMBL627227,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,N,1,1,,BAO_0000218
11843,Rattus norvegicus,Intermediate,CHEMBL627228,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,N,1,1,,BAO_0000218
11844,Rattus norvegicus,Intermediate,CHEMBL627229,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,N,1,1,,BAO_0000218
11845,Rattus norvegicus,Intermediate,CHEMBL625792,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,N,1,1,,BAO_0000218
11846,Rattus norvegicus,Intermediate,CHEMBL625793,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,N,1,1,,BAO_0000218
11847,Rattus norvegicus,Intermediate,CHEMBL625794,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,N,1,1,,BAO_0000218
11848,Rattus norvegicus,Intermediate,CHEMBL625795,,,50597,178.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,N,1,1,,BAO_0000218
11849,Mus musculus,Intermediate,CHEMBL625796,,,50594,,A,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,N,1,1,,BAO_0000218
11850,Canis lupus familiaris,Intermediate,CHEMBL625797,,,50588,,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,1,1,,BAO_0000218
11851,Canis lupus familiaris,Intermediate,CHEMBL625798,,,50588,,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,1,1,,BAO_0000218
11852,,Autocuration,CHEMBL875613,,,22224,,A,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11853,,Autocuration,CHEMBL625799,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11854,,Autocuration,CHEMBL625800,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11855,,Autocuration,CHEMBL625801,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11856,,Autocuration,CHEMBL625802,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11857,,Autocuration,CHEMBL625803,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11858,,Autocuration,CHEMBL625804,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,U,0,1,,BAO_0000019
11859,,Autocuration,CHEMBL622530,,,22224,,A,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,U,0,1,,BAO_0000218
11860,Mus musculus,Intermediate,CHEMBL622531,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,N,1,1,,BAO_0000218
11861,Mus musculus,Intermediate,CHEMBL622532,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,1,1,,BAO_0000218
11862,Mus musculus,Intermediate,CHEMBL623176,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11863,Mus musculus,Intermediate,CHEMBL623177,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,1,1,,BAO_0000218
11864,Mus musculus,Intermediate,CHEMBL623178,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,1,1,,BAO_0000218
11865,Mus musculus,Intermediate,CHEMBL623179,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,N,1,1,,BAO_0000218
11866,Mus musculus,Intermediate,CHEMBL623180,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,1,1,,BAO_0000218
11867,Mus musculus,Intermediate,CHEMBL623181,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11868,Mus musculus,Intermediate,CHEMBL624131,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11869,Mus musculus,Intermediate,CHEMBL624132,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,N,1,1,,BAO_0000218
11870,Mus musculus,Intermediate,CHEMBL624133,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11871,Mus musculus,Intermediate,CHEMBL624846,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,N,1,1,,BAO_0000218
11872,Mus musculus,Intermediate,CHEMBL624847,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11873,Mus musculus,Intermediate,CHEMBL624848,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11874,Mus musculus,Intermediate,CHEMBL625012,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,1,1,,BAO_0000218
11875,Mus musculus,Intermediate,CHEMBL625013,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11876,Mus musculus,Intermediate,CHEMBL625014,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,N,1,1,,BAO_0000218
11877,Mus musculus,Intermediate,CHEMBL625015,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,N,1,1,,BAO_0000218
11878,Mus musculus,Intermediate,CHEMBL625016,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11879,Mus musculus,Intermediate,CHEMBL625017,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,N,1,1,,BAO_0000218
11880,Mus musculus,Intermediate,CHEMBL625018,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11881,Mus musculus,Intermediate,CHEMBL625019,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11882,Mus musculus,Intermediate,CHEMBL625020,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
11883,Mus musculus,Intermediate,CHEMBL625021,,,50594,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,N,1,1,,BAO_0000218
11884,Rattus norvegicus,Intermediate,CHEMBL625022,,,50597,,A,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
11885,Mus musculus,Intermediate,CHEMBL625023,,,50594,,A,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,N,1,1,,BAO_0000218
11886,Macaca fascicularis,Intermediate,CHEMBL625024,,,100710,,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,N,1,1,,BAO_0000218
11887,Macaca fascicularis,Intermediate,CHEMBL627626,,,100710,,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,1,1,,BAO_0000218
11888,,Autocuration,CHEMBL627627,,,22224,955.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,0,1,,BAO_0000218
11889,,Autocuration,CHEMBL627628,,,22224,1977.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,U,0,1,,BAO_0000218
11890,,Autocuration,CHEMBL627629,,,22224,955.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,0,1,,BAO_0000218
11891,,Autocuration,CHEMBL627630,,,22224,1977.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,U,0,1,,BAO_0000218
11892,,Autocuration,CHEMBL627631,,,22224,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,U,0,1,,BAO_0000019
11893,,Autocuration,CHEMBL629515,,,22224,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,U,0,1,,BAO_0000218
11894,Mus musculus,Intermediate,CHEMBL629516,,,50594,2106.0,A,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11895,Mus musculus,Intermediate,CHEMBL629517,,,50594,2106.0,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11896,Mus musculus,Intermediate,CHEMBL629518,,,50594,2106.0,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11897,Mus musculus,Intermediate,CHEMBL877499,,,50594,,A,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,1,1,,BAO_0000218
11898,Mus musculus,Intermediate,CHEMBL629519,,,50594,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,1,1,,BAO_0000218
11899,Mus musculus,Intermediate,CHEMBL629520,,,50594,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,1,1,,BAO_0000218
11900,Mus musculus,Intermediate,CHEMBL629521,,,50594,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,1,1,,BAO_0000218
11901,Mus musculus,Intermediate,CHEMBL629522,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,N,1,1,,BAO_0000218
11902,Mus musculus,Intermediate,CHEMBL629523,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,N,1,1,,BAO_0000218
11903,Mus musculus,Intermediate,CHEMBL629524,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,N,1,1,,BAO_0000218
11904,Mus musculus,Intermediate,CHEMBL629525,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,N,1,1,,BAO_0000218
11905,Mus musculus,Intermediate,CHEMBL629526,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,N,1,1,,BAO_0000218
11906,Mus musculus,Intermediate,CHEMBL629527,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,N,1,1,,BAO_0000218
11907,Mus musculus,Intermediate,CHEMBL629528,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,N,1,1,,BAO_0000218
11908,Mus musculus,Intermediate,CHEMBL629529,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,N,1,1,,BAO_0000218
11909,Mus musculus,Intermediate,CHEMBL629530,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,N,1,1,,BAO_0000218
11910,Mus musculus,Intermediate,CHEMBL629531,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,N,1,1,,BAO_0000218
11911,Mus musculus,Intermediate,CHEMBL628656,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,N,1,1,,BAO_0000218
11912,Mus musculus,Intermediate,CHEMBL628657,,,50594,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,N,1,1,,BAO_0000218
11913,Rattus norvegicus,Intermediate,CHEMBL628658,,,50597,,A,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11914,Rattus norvegicus,Intermediate,CHEMBL628659,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11915,Rattus norvegicus,Intermediate,CHEMBL877500,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11916,Rattus norvegicus,Intermediate,CHEMBL628660,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11917,Rattus norvegicus,Intermediate,CHEMBL628661,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11918,Rattus norvegicus,Intermediate,CHEMBL628662,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11919,Rattus norvegicus,Intermediate,CHEMBL628663,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11920,Rattus norvegicus,Intermediate,CHEMBL628664,,,50597,,A,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11921,Rattus norvegicus,Intermediate,CHEMBL628665,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11922,Rattus norvegicus,Intermediate,CHEMBL628666,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11923,Rattus norvegicus,Intermediate,CHEMBL628667,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11924,Rattus norvegicus,Intermediate,CHEMBL628668,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11925,Rattus norvegicus,Intermediate,CHEMBL628669,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11926,Rattus norvegicus,Intermediate,CHEMBL628670,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11927,Rattus norvegicus,Intermediate,CHEMBL628671,,,50597,178.0,A,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11928,Rattus norvegicus,Intermediate,CHEMBL628672,,,50597,10000001.0,A,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11929,Rattus norvegicus,Intermediate,CHEMBL630300,,,50597,10000001.0,A,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11930,Rattus norvegicus,Intermediate,CHEMBL629787,,,50597,10000001.0,A,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11931,Rattus norvegicus,Intermediate,CHEMBL629788,,,50597,10000001.0,A,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11932,Rattus norvegicus,Intermediate,CHEMBL629789,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11933,Rattus norvegicus,Intermediate,CHEMBL629790,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11934,Rattus norvegicus,Intermediate,CHEMBL629791,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11935,Rattus norvegicus,Intermediate,CHEMBL629792,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11936,Rattus norvegicus,Intermediate,CHEMBL629793,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11937,Rattus norvegicus,Intermediate,CHEMBL629794,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
11938,Rattus norvegicus,Intermediate,CHEMBL874459,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,N,1,1,,BAO_0000218
11939,Rattus norvegicus,Intermediate,CHEMBL629795,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,N,1,1,,BAO_0000218
11940,Rattus norvegicus,Intermediate,CHEMBL629796,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,N,1,1,,BAO_0000218
11941,Rattus norvegicus,Intermediate,CHEMBL629797,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,N,1,1,,BAO_0000218
11942,Rattus norvegicus,Intermediate,CHEMBL629798,,,50597,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,N,1,1,,BAO_0000218
11943,Rattus norvegicus,Intermediate,CHEMBL629799,,,50597,2369.0,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11944,Rattus norvegicus,Intermediate,CHEMBL629800,,,50597,2369.0,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11945,Rattus norvegicus,Intermediate,CHEMBL629801,,,50597,2369.0,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11946,Rattus norvegicus,Intermediate,CHEMBL629802,,,50597,2369.0,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,N,1,1,,BAO_0000218
11947,Rattus norvegicus,Intermediate,CHEMBL629803,,,50597,2369.0,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11948,Rattus norvegicus,Intermediate,CHEMBL629804,,,50597,178.0,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11949,Rattus norvegicus,Intermediate,CHEMBL629805,,,50597,178.0,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11950,Rattus norvegicus,Intermediate,CHEMBL629806,,,50597,178.0,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11951,Rattus norvegicus,Intermediate,CHEMBL629807,,,50597,178.0,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11952,Rattus norvegicus,Intermediate,CHEMBL629808,,,50597,178.0,A,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11953,Rattus norvegicus,Intermediate,CHEMBL629809,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11954,Rattus norvegicus,Intermediate,CHEMBL629810,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11955,Rattus norvegicus,Intermediate,CHEMBL629811,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11956,Rattus norvegicus,Intermediate,CHEMBL629812,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11957,Rattus norvegicus,Intermediate,CHEMBL629813,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11958,Rattus norvegicus,Intermediate,CHEMBL874460,,,50597,955.0,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11959,Rattus norvegicus,Intermediate,CHEMBL629814,,,50597,,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11960,Rattus norvegicus,Intermediate,CHEMBL629815,,,50597,,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11961,Rattus norvegicus,Intermediate,CHEMBL629816,,,50597,,A,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11962,Rattus norvegicus,Intermediate,CHEMBL629817,,,50597,,A,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11963,Rattus norvegicus,Intermediate,CHEMBL626643,,,50597,2113.0,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11964,Rattus norvegicus,Intermediate,CHEMBL626644,,,50597,2113.0,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11965,Rattus norvegicus,Intermediate,CHEMBL626806,,,50597,2113.0,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11966,Rattus norvegicus,Intermediate,CHEMBL626807,,,50597,2113.0,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11967,Rattus norvegicus,Intermediate,CHEMBL627261,,,50597,2107.0,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11968,Rattus norvegicus,Intermediate,CHEMBL627262,,,50597,2107.0,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11969,Rattus norvegicus,Intermediate,CHEMBL627263,,,50597,2107.0,A,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11970,Rattus norvegicus,Intermediate,CHEMBL627264,,,50597,2107.0,A,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11971,Rattus norvegicus,Intermediate,CHEMBL627265,,,50597,2048.0,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11972,Rattus norvegicus,Intermediate,CHEMBL627266,,,50597,2048.0,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11973,Rattus norvegicus,Intermediate,CHEMBL627267,,,50597,2048.0,A,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11974,Rattus norvegicus,Intermediate,CHEMBL627268,,,50597,2048.0,A,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11975,Rattus norvegicus,Intermediate,CHEMBL627269,,,50597,2385.0,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11976,Rattus norvegicus,Intermediate,CHEMBL627270,,,50597,2385.0,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
11977,Rattus norvegicus,Intermediate,CHEMBL627271,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,N,1,1,,BAO_0000218
11978,Rattus norvegicus,Intermediate,CHEMBL627946,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,N,1,1,,BAO_0000218
11979,Rattus norvegicus,Intermediate,CHEMBL875472,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,N,1,1,,BAO_0000218
11980,Rattus norvegicus,Intermediate,CHEMBL627947,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,N,1,1,,BAO_0000218
11981,Rattus norvegicus,Intermediate,CHEMBL627948,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,N,1,1,,BAO_0000218
11982,Rattus norvegicus,Intermediate,CHEMBL628113,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,N,1,1,,BAO_0000218
11983,Rattus norvegicus,Intermediate,CHEMBL628114,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,N,1,1,,BAO_0000218
11984,Rattus norvegicus,Intermediate,CHEMBL628115,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,N,1,1,,BAO_0000218
11985,Rattus norvegicus,Intermediate,CHEMBL628116,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,N,1,1,,BAO_0000218
11986,Rattus norvegicus,Intermediate,CHEMBL628117,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,N,1,1,,BAO_0000218
11987,Rattus norvegicus,Intermediate,CHEMBL628118,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,N,1,1,,BAO_0000218
11988,Rattus norvegicus,Intermediate,CHEMBL628119,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,N,1,1,,BAO_0000218
11989,Rattus norvegicus,Intermediate,CHEMBL628120,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,N,1,1,,BAO_0000218
11990,Rattus norvegicus,Intermediate,CHEMBL628121,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,N,1,1,,BAO_0000218
11991,Rattus norvegicus,Intermediate,CHEMBL628122,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,N,1,1,,BAO_0000218
11992,Rattus norvegicus,Intermediate,CHEMBL627297,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,N,1,1,,BAO_0000218
11993,Rattus norvegicus,Intermediate,CHEMBL627298,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,N,1,1,,BAO_0000218
11994,Rattus norvegicus,Intermediate,CHEMBL627299,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,N,1,1,,BAO_0000218
11995,Rattus norvegicus,Intermediate,CHEMBL627300,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,N,1,1,,BAO_0000218
11996,Rattus norvegicus,Intermediate,CHEMBL627301,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,N,1,1,,BAO_0000218
11997,Rattus norvegicus,Intermediate,CHEMBL627302,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,N,1,1,,BAO_0000218
11998,Rattus norvegicus,Intermediate,CHEMBL627303,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,N,1,1,,BAO_0000218
11999,Rattus norvegicus,Intermediate,CHEMBL627304,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,N,1,1,,BAO_0000218
12000,Rattus norvegicus,Intermediate,CHEMBL627305,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,N,1,1,,BAO_0000218
12001,Rattus norvegicus,Intermediate,CHEMBL627306,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,1,1,,BAO_0000218
12002,Rattus norvegicus,Intermediate,CHEMBL623982,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,N,1,1,,BAO_0000218
12003,Rattus norvegicus,Intermediate,CHEMBL623983,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,N,1,1,,BAO_0000218
12004,Rattus norvegicus,Intermediate,CHEMBL623984,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,N,1,1,,BAO_0000218
12005,Rattus norvegicus,Intermediate,CHEMBL623985,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,N,1,1,,BAO_0000218
12006,Rattus norvegicus,Intermediate,CHEMBL623986,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,N,1,1,,BAO_0000218
12007,Rattus norvegicus,Intermediate,CHEMBL623987,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,N,1,1,,BAO_0000218
12008,Rattus norvegicus,Intermediate,CHEMBL623988,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,N,1,1,,BAO_0000218
12009,Rattus norvegicus,Intermediate,CHEMBL623989,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,N,1,1,,BAO_0000218
12010,Rattus norvegicus,Intermediate,CHEMBL622215,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,N,1,1,,BAO_0000218
12011,Rattus norvegicus,Intermediate,CHEMBL622216,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,N,1,1,,BAO_0000218
12012,Rattus norvegicus,Intermediate,CHEMBL877481,,,50597,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,N,1,1,,BAO_0000218
12013,,Autocuration,CHEMBL622217,,,22224,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,U,0,1,,BAO_0000218
12014,Mus musculus,Intermediate,CHEMBL622218,,,50594,,A,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,1,1,,BAO_0000218
12015,Rattus norvegicus,Intermediate,CHEMBL622219,,,50597,,A,,Pharmacokinetic profile AUC was evaluated in rats,,N,1,1,,BAO_0000218
12016,,Autocuration,CHEMBL622220,,,22224,,A,,Pharmacokinetic property (Area under curve),,U,0,1,,BAO_0000019
12017,Canis lupus familiaris,Intermediate,CHEMBL622221,,,50588,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,N,1,1,,BAO_0000218
12018,Mus musculus,Intermediate,CHEMBL622222,,,50594,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,N,1,1,,BAO_0000218
12019,Canis lupus familiaris,Intermediate,CHEMBL622223,,,50588,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,N,1,1,,BAO_0000218
12020,Mus musculus,Intermediate,CHEMBL622224,,,50594,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,N,1,1,,BAO_0000218
12021,,Autocuration,CHEMBL622225,,,22224,,A,,Plasma concentration (AUC) was determined,,U,0,1,,BAO_0000019
12022,,Autocuration,CHEMBL622226,,,22224,,A,,Plasma concentration (AUC) was determined; Not detectable,,U,0,1,,BAO_0000019
12023,Cavia porcellus,Intermediate,CHEMBL624154,,,50512,,A,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,N,1,1,,BAO_0000218
12024,Rattus norvegicus,Intermediate,CHEMBL624155,,,50597,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,N,1,1,,BAO_0000218
12025,Rattus norvegicus,Intermediate,CHEMBL624156,,,50597,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,1,1,,BAO_0000218
12026,Rattus norvegicus,Intermediate,CHEMBL624157,,,50597,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,N,1,1,,BAO_0000218
12027,Rattus norvegicus,Intermediate,CHEMBL624158,,,50597,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,N,1,1,,BAO_0000218
12028,Rattus norvegicus,Intermediate,CHEMBL624159,,,50597,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,N,1,1,,BAO_0000218
12029,Rattus norvegicus,Intermediate,CHEMBL624160,,,50597,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,N,1,1,,BAO_0000218
12030,Rattus norvegicus,Intermediate,CHEMBL624161,,,50597,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,N,1,1,,BAO_0000218
12031,Rattus norvegicus,Intermediate,CHEMBL624162,,,50597,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,N,1,1,,BAO_0000218
12032,Canis lupus familiaris,Intermediate,CHEMBL624163,,,50588,,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,N,1,1,,BAO_0000218
12033,Rattus norvegicus,Intermediate,CHEMBL624164,,,50597,,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
12034,Rattus norvegicus,Intermediate,CHEMBL624165,,,50597,,A,,The AUC(0-infinity) values in female wistar rats.,,N,1,1,,BAO_0000218
12035,Rattus norvegicus,Intermediate,CHEMBL624166,,,50597,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
12036,Rattus norvegicus,Intermediate,CHEMBL624167,,,50597,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,N,1,1,,BAO_0000218
12037,Rattus norvegicus,Intermediate,CHEMBL624168,,,50597,,A,,The AUC(0-t)values in female wistar rats.,,N,1,1,,BAO_0000218
12038,Rattus norvegicus,Intermediate,CHEMBL624169,,,50597,,A,,The Area under the concentration time curve of compound was measured on rats,,N,1,1,,BAO_0000218
12039,Homo sapiens,Intermediate,CHEMBL624170,,,50587,,A,,The area under curve (100 mg/kg) administered orally in humans,,N,1,1,,BAO_0000218
12040,Callithrix,Autocuration,CHEMBL624171,,,22224,,A,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,U,0,1,,BAO_0000218
12041,Simiiformes,Autocuration,CHEMBL624172,,,22224,,A,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,U,0,1,,BAO_0000218
12042,Canis lupus familiaris,Intermediate,CHEMBL624173,,,50588,,A,,The area under curve (15 mg/kg) administered intravenously in dog,,N,1,1,,BAO_0000218
12043,Homo sapiens,Intermediate,CHEMBL877488,,,50587,,A,,The area under curve (200 mg/kg) administered orally in humans,,N,1,1,,BAO_0000218
12044,Rattus norvegicus,Intermediate,CHEMBL624174,,,50597,,A,,The area under curve (25 mg/kg) administered intravenously in rat,,N,1,1,,BAO_0000218
12045,Callithrix,Autocuration,CHEMBL624175,,,22224,,A,,The area under curve (25 mg/kg) administered orally in marmoset,,U,0,1,,BAO_0000218
12046,Simiiformes,Autocuration,CHEMBL624176,,,22224,,A,,The area under curve (25 mg/kg) administered orally in monkey,,U,0,1,,BAO_0000218
12047,Canis lupus familiaris,Intermediate,CHEMBL624177,,,50588,,A,,The area under curve (30 mg/kg) administered orally in dog,,N,1,1,,BAO_0000218
12048,Homo sapiens,Intermediate,CHEMBL624178,,,50587,,A,,The area under curve (400 mg/kg) administered orally in humans,,N,1,1,,BAO_0000218
12049,Rattus norvegicus,Intermediate,CHEMBL624179,,,50597,,A,,The area under curve (50 mg/kg) administered orally in fasted rat,,N,1,1,,BAO_0000218
12050,Rattus norvegicus,Intermediate,CHEMBL627689,,,50597,,A,,The area under curve (50 mg/kg) administered orally in rat,,N,1,1,,BAO_0000218
12051,Homo sapiens,Intermediate,CHEMBL627690,,,50587,,A,,The area under curve (800 mg/kg) administered orally in humans,,N,1,1,,BAO_0000218
12052,,Autocuration,CHEMBL627691,,,22224,,A,,The compound was evaluated for area under the curve,,U,0,1,,BAO_0000019
12053,Callithrix,Autocuration,CHEMBL627692,,,22224,,A,,The compound was evaluated for area under the curve in marmosets,,U,0,1,,BAO_0000019
12054,Callithrix,Autocuration,CHEMBL627693,,,22224,,A,,The compound was evaluated for area under the curve in marmosets,,U,0,1,,BAO_0000019
12055,Rattus norvegicus,Intermediate,CHEMBL627694,,,50597,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,1,1,,BAO_0000218
12056,Rattus norvegicus,Intermediate,CHEMBL627695,,,50597,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,N,1,1,,BAO_0000218
12057,,Autocuration,CHEMBL627696,,,22224,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,U,0,1,,BAO_0000218
12058,Rattus norvegicus,Intermediate,CHEMBL627697,,,50597,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,1,1,,BAO_0000218
12059,Rattus norvegicus,Intermediate,CHEMBL627698,,,50597,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,1,1,,BAO_0000218
12060,Rattus norvegicus,Intermediate,CHEMBL627699,,,50597,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,N,1,1,,BAO_0000218
12061,Rattus norvegicus,Intermediate,CHEMBL627700,,,50597,,A,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,N,1,1,,BAO_0000218
12062,Rattus norvegicus,Intermediate,CHEMBL627701,,,50597,,A,,Total drug exposure is determined after oral dosing in rats.,,N,1,1,,BAO_0000218
12063,,Autocuration,CHEMBL627702,,,22224,,A,,Total drug exposure (5 mg/kg) when administered intravenously,,U,0,1,,BAO_0000218
12064,,Autocuration,CHEMBL627703,,,22224,,A,,Total drug exposure (5 mg/kg) when administered orally,,U,0,1,,BAO_0000218
12065,Simiiformes,Autocuration,CHEMBL626873,,,22224,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,0,1,,BAO_0000218
12066,Rattus norvegicus,Intermediate,CHEMBL629583,,,50597,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,1,1,,BAO_0000218
12067,Canis lupus familiaris,Intermediate,CHEMBL629584,,,50588,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,1,1,,BAO_0000218
12068,Canis lupus familiaris,Intermediate,CHEMBL629585,,,50588,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,1,1,,BAO_0000218
12069,Rattus norvegicus,Intermediate,CHEMBL629586,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12070,Rattus norvegicus,Intermediate,CHEMBL629587,,,50597,955.0,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12071,Rattus norvegicus,Intermediate,CHEMBL629588,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12072,Rattus norvegicus,Intermediate,CHEMBL629589,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12073,Rattus norvegicus,Intermediate,CHEMBL629590,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12074,Rattus norvegicus,Intermediate,CHEMBL629591,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12075,Rattus norvegicus,Intermediate,CHEMBL629592,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12076,Rattus norvegicus,Intermediate,CHEMBL629593,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12077,Rattus norvegicus,Intermediate,CHEMBL629594,,,50597,,A,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12078,Rattus norvegicus,Intermediate,CHEMBL629595,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12079,Rattus norvegicus,Intermediate,CHEMBL630290,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12080,Rattus norvegicus,Intermediate,CHEMBL627137,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12081,Rattus norvegicus,Intermediate,CHEMBL627138,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12082,Rattus norvegicus,Intermediate,CHEMBL627139,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12083,Rattus norvegicus,Intermediate,CHEMBL627140,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12084,Rattus norvegicus,Intermediate,CHEMBL627141,,,50597,948.0,A,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12085,Rattus norvegicus,Intermediate,CHEMBL627142,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12086,Rattus norvegicus,Intermediate,CHEMBL627143,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12087,Rattus norvegicus,Intermediate,CHEMBL874449,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12088,Rattus norvegicus,Intermediate,CHEMBL627144,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12089,Rattus norvegicus,Intermediate,CHEMBL627145,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12090,Rattus norvegicus,Intermediate,CHEMBL627146,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12091,Rattus norvegicus,Intermediate,CHEMBL627147,,,50597,2113.0,A,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12092,Rattus norvegicus,Intermediate,CHEMBL627148,,,50597,2107.0,A,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12093,Rattus norvegicus,Intermediate,CHEMBL627149,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12094,Rattus norvegicus,Intermediate,CHEMBL632160,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12095,Rattus norvegicus,Intermediate,CHEMBL632161,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12096,Rattus norvegicus,Intermediate,CHEMBL632162,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12097,Rattus norvegicus,Intermediate,CHEMBL632163,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12098,Rattus norvegicus,Intermediate,CHEMBL874469,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12099,Rattus norvegicus,Intermediate,CHEMBL627182,,,50597,2048.0,A,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12100,Rattus norvegicus,Intermediate,CHEMBL627183,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12101,Rattus norvegicus,Intermediate,CHEMBL627184,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12102,Rattus norvegicus,Intermediate,CHEMBL627185,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12103,Rattus norvegicus,Intermediate,CHEMBL627186,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12104,Rattus norvegicus,Intermediate,CHEMBL627187,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12105,Rattus norvegicus,Intermediate,CHEMBL627188,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12106,Rattus norvegicus,Intermediate,CHEMBL627189,,,50597,2385.0,A,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12107,Rattus norvegicus,Intermediate,CHEMBL627190,,,50597,,A,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12108,Rattus norvegicus,Intermediate,CHEMBL627191,,,50597,2107.0,A,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12109,Rattus norvegicus,Intermediate,CHEMBL627192,,,50597,2107.0,A,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12110,Rattus norvegicus,Intermediate,CHEMBL627193,,,50597,2107.0,A,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12111,Rattus norvegicus,Intermediate,CHEMBL874590,,,50597,2385.0,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12112,Rattus norvegicus,Intermediate,CHEMBL627194,,,50597,2385.0,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12113,Rattus norvegicus,Intermediate,CHEMBL627195,,,50597,2385.0,A,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12114,Rattus norvegicus,Intermediate,CHEMBL627196,,,50597,992.0,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12115,Rattus norvegicus,Intermediate,CHEMBL627197,,,50597,992.0,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12116,Rattus norvegicus,Intermediate,CHEMBL627198,,,50597,992.0,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12117,Rattus norvegicus,Intermediate,CHEMBL627199,,,50597,992.0,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,N,1,1,,BAO_0000218
12118,Rattus norvegicus,Intermediate,CHEMBL627200,,,50597,992.0,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12119,Rattus norvegicus,Intermediate,CHEMBL627201,,,50597,1969.0,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12120,Rattus norvegicus,Intermediate,CHEMBL627202,,,50597,1969.0,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12121,Rattus norvegicus,Intermediate,CHEMBL627203,,,50597,1969.0,A,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12122,Rattus norvegicus,Intermediate,CHEMBL627204,,,50597,1969.0,A,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12123,Rattus norvegicus,Intermediate,CHEMBL627205,,,50597,2106.0,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12124,Rattus norvegicus,Intermediate,CHEMBL627206,,,50597,2106.0,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12125,Rattus norvegicus,Intermediate,CHEMBL627207,,,50597,2106.0,A,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12126,Rattus norvegicus,Intermediate,CHEMBL627208,,,50597,2106.0,A,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12127,Rattus norvegicus,Intermediate,CHEMBL627209,,,50597,2046.0,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12128,Rattus norvegicus,Intermediate,CHEMBL627210,,,50597,2046.0,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12129,Rattus norvegicus,Intermediate,CHEMBL627211,,,50597,2046.0,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12130,Rattus norvegicus,Intermediate,CHEMBL627212,,,50597,2046.0,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12131,Rattus norvegicus,Intermediate,CHEMBL627213,,,50597,995.0,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12132,Rattus norvegicus,Intermediate,CHEMBL626599,,,50597,995.0,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12133,Rattus norvegicus,Intermediate,CHEMBL626600,,,50597,995.0,A,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12134,Rattus norvegicus,Intermediate,CHEMBL626601,,,50597,995.0,A,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,1,1,,BAO_0000218
12135,,Autocuration,CHEMBL627484,,,22224,,A,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,U,0,1,,BAO_0000019
12136,Macaca fascicularis,Intermediate,CHEMBL627485,,,100710,1969.0,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,N,1,1,,BAO_0000218
12137,Macaca fascicularis,Intermediate,CHEMBL628147,,,100710,1969.0,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,N,1,1,,BAO_0000218
12138,Macaca fascicularis,Intermediate,CHEMBL628148,,,100710,1969.0,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,N,1,1,,BAO_0000218
12139,Canis lupus familiaris,Intermediate,CHEMBL628149,,,50588,1969.0,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,N,1,1,,BAO_0000218
12140,Canis lupus familiaris,Intermediate,CHEMBL628150,,,50588,1969.0,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,N,1,1,,BAO_0000218
12141,Canis lupus familiaris,Intermediate,CHEMBL628318,,,50588,1969.0,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,N,1,1,,BAO_0000218
12142,Canis lupus familiaris,Intermediate,CHEMBL628319,,,50588,1969.0,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,N,1,1,,BAO_0000218
12143,Canis lupus familiaris,Intermediate,CHEMBL875609,,,50588,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,1,1,,BAO_0000218
12144,,Autocuration,CHEMBL628320,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,U,0,1,,BAO_0000019
12145,,Autocuration,CHEMBL628321,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,U,0,1,,BAO_0000019
12146,,Autocuration,CHEMBL628322,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,U,0,1,,BAO_0000019
12147,,Autocuration,CHEMBL628323,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,U,0,1,,BAO_0000019
12148,,Autocuration,CHEMBL628324,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,U,0,1,,BAO_0000019
12149,,Autocuration,CHEMBL628325,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,U,0,1,,BAO_0000019
12150,,Autocuration,CHEMBL628326,,,22224,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,U,0,1,,BAO_0000019
12151,Canis lupus familiaris,Intermediate,CHEMBL628327,,,50588,1236.0,A,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12152,Canis lupus familiaris,Intermediate,CHEMBL628328,,,50588,1236.0,A,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,N,1,1,,BAO_0000218
12153,Canis lupus familiaris,Intermediate,CHEMBL628329,,,50588,178.0,A,,"Concentration of compound in blood of dog 1, after administering intravenously",,N,1,1,,BAO_0000218
12154,Rattus norvegicus,Intermediate,CHEMBL628330,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,N,1,1,,BAO_0000218
12155,Rattus norvegicus,Intermediate,CHEMBL628331,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,N,1,1,,BAO_0000218
12156,Rattus norvegicus,Intermediate,CHEMBL628332,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,N,1,1,,BAO_0000218
12157,Rattus norvegicus,Intermediate,CHEMBL628333,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,N,1,1,,BAO_0000218
12158,Rattus norvegicus,Intermediate,CHEMBL628334,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,N,1,1,,BAO_0000218
12159,Rattus norvegicus,Intermediate,CHEMBL628335,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,N,1,1,,BAO_0000218
12160,Rattus norvegicus,Intermediate,CHEMBL628336,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,N,1,1,,BAO_0000218
12161,Rattus norvegicus,Intermediate,CHEMBL628337,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,1,1,,BAO_0000218
12162,Rattus norvegicus,Intermediate,CHEMBL628338,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,N,1,1,,BAO_0000218
12163,Rattus norvegicus,Intermediate,CHEMBL875610,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,N,1,1,,BAO_0000218
12164,Rattus norvegicus,Intermediate,CHEMBL628339,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,N,1,1,,BAO_0000218
12165,Rattus norvegicus,Intermediate,CHEMBL628340,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,N,1,1,,BAO_0000218
12166,Rattus norvegicus,Intermediate,CHEMBL628341,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,N,1,1,,BAO_0000218
12167,Rattus norvegicus,Intermediate,CHEMBL622214,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,N,1,1,,BAO_0000218
12168,Rattus norvegicus,Intermediate,CHEMBL623167,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,N,1,1,,BAO_0000218
12169,Rattus norvegicus,Intermediate,CHEMBL623168,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,N,1,1,,BAO_0000218
12170,Rattus norvegicus,Intermediate,CHEMBL623169,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,N,1,1,,BAO_0000218
12171,Rattus norvegicus,Intermediate,CHEMBL623170,,,50597,2107.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,N,1,1,,BAO_0000218
12172,Rattus norvegicus,Intermediate,CHEMBL627224,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,N,1,1,,BAO_0000218
12173,Rattus norvegicus,Intermediate,CHEMBL875634,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,N,1,1,,BAO_0000218
12174,Rattus norvegicus,Intermediate,CHEMBL627225,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,N,1,1,,BAO_0000218
12175,Rattus norvegicus,Intermediate,CHEMBL627226,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,N,1,1,,BAO_0000218
12176,Rattus norvegicus,Intermediate,CHEMBL626083,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,N,1,1,,BAO_0000218
12177,Rattus norvegicus,Intermediate,CHEMBL626084,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,N,1,1,,BAO_0000218
12178,Rattus norvegicus,Intermediate,CHEMBL626085,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,N,1,1,,BAO_0000218
12179,Rattus norvegicus,Intermediate,CHEMBL626086,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,N,1,1,,BAO_0000218
12180,Rattus norvegicus,Intermediate,CHEMBL626087,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,N,1,1,,BAO_0000218
12181,Rattus norvegicus,Intermediate,CHEMBL626088,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,N,1,1,,BAO_0000218
12182,Rattus norvegicus,Intermediate,CHEMBL626089,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,N,1,1,,BAO_0000218
12183,Rattus norvegicus,Intermediate,CHEMBL626090,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,N,1,1,,BAO_0000218
12184,Rattus norvegicus,Intermediate,CHEMBL626091,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,N,1,1,,BAO_0000218
12185,Rattus norvegicus,Intermediate,CHEMBL626092,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,N,1,1,,BAO_0000218
12186,Rattus norvegicus,Intermediate,CHEMBL626093,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,N,1,1,,BAO_0000218
12187,Rattus norvegicus,Intermediate,CHEMBL626094,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,N,1,1,,BAO_0000218
12188,Rattus norvegicus,Intermediate,CHEMBL626095,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,N,1,1,,BAO_0000218
12189,Rattus norvegicus,Intermediate,CHEMBL626096,,,50597,2048.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,N,1,1,,BAO_0000218
12190,Simiiformes,Autocuration,CHEMBL626097,,,22224,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,0,1,,BAO_0000218
12191,Rattus norvegicus,Intermediate,CHEMBL626098,,,50597,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,1,1,,BAO_0000218
12192,,Autocuration,CHEMBL626099,,,22224,1969.0,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,U,0,1,,BAO_0000218
12193,,Autocuration,CHEMBL626100,,,22224,1969.0,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,U,0,1,,BAO_0000218
12194,Canis lupus familiaris,Intermediate,CHEMBL626101,,,50588,1969.0,A,,AUC 0-inf in dog,,N,1,1,,BAO_0000218
12195,Cavia porcellus,Intermediate,CHEMBL626102,,,50512,1969.0,A,,AUC 0-inf in guinea pig,,N,1,1,,BAO_0000218
12196,Canis lupus familiaris,Intermediate,CHEMBL626103,,,50588,1969.0,A,,AUC 0-t in dog,,N,1,1,,BAO_0000218
12197,Cavia porcellus,Intermediate,CHEMBL628391,,,50512,1969.0,A,,AUC 0-t in guinea pig,,N,1,1,,BAO_0000218
12198,Rattus norvegicus,Intermediate,CHEMBL628392,,,50597,,A,,The compound was tested for brain to plasma partition in rat,,N,1,1,,BAO_0000218
12199,Rattus norvegicus,Intermediate,CHEMBL628393,,,50597,,A,,The compound was tested for brain to plasma partition in rat.,,N,1,1,,BAO_0000218
12200,,Autocuration,CHEMBL628394,,,22224,178.0,A,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,U,0,1,,BAO_0000019
12201,Canis lupus familiaris,Intermediate,CHEMBL628395,,,50588,,A,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12202,Simiiformes,Autocuration,CHEMBL628396,,,22224,,A,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,0,1,,BAO_0000218
12203,Oryctolagus cuniculus,Intermediate,CHEMBL628397,,,50592,,A,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12204,Rattus norvegicus,Intermediate,CHEMBL628398,,,50597,,A,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12205,Macaca mulatta,Intermediate,CHEMBL628399,,,50797,,A,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,1,1,,BAO_0000218
12206,Canis lupus familiaris,Intermediate,CHEMBL628400,,,50588,,A,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
12207,Rattus norvegicus,Intermediate,CHEMBL874907,,,50597,,A,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
12208,,Autocuration,CHEMBL628401,,,22224,,A,,Area under curve of the compound was determined,,U,0,1,,BAO_0000019
12209,Simiiformes,Autocuration,CHEMBL628402,,,22224,1969.0,A,,AUC in monkeys at a dose of 1 mg/kg,,U,0,1,,BAO_0000218
12210,Rattus norvegicus,Intermediate,CHEMBL628403,,,50597,1969.0,A,,AUC in rats at a dose of 1 mg/kg,,N,1,1,,BAO_0000218
12211,,Autocuration,CHEMBL628404,,,22224,,A,,Compound was evaluated for the overall absorbance loss at pH of 2,,U,0,1,,BAO_0000019
12212,,Autocuration,CHEMBL628405,,,22224,,A,,Compound was evaluated for the overall absorbance loss at pH of 4,,U,0,1,,BAO_0000019
12213,,Autocuration,CHEMBL628406,,,22224,,A,,Compound was evaluated for the overall absorbance loss at pH of 7,,U,0,1,,BAO_0000019
12214,Rattus norvegicus,Intermediate,CHEMBL628407,,,50597,,A,,Compound was evaluated for its absorption in the rats,,N,1,1,,BAO_0000218
12215,Rattus norvegicus,Intermediate,CHEMBL628408,,,50597,1088.0,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,1,1,,BAO_0000218
12216,Rattus norvegicus,Intermediate,CHEMBL629171,,,50597,1088.0,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,N,1,1,,BAO_0000218
12217,Rattus norvegicus,Intermediate,CHEMBL629172,,,50597,1088.0,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,1,1,,BAO_0000218
12218,Rattus norvegicus,Intermediate,CHEMBL629173,,,50597,1088.0,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,N,1,1,,BAO_0000218
12219,Rattus norvegicus,Intermediate,CHEMBL629174,,,50597,,A,,In vitro percent permeability into rat ileum,,N,1,1,,BAO_0000218
12220,Rattus norvegicus,Intermediate,CHEMBL629175,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 10-17,,N,1,1,,BAO_0000218
12221,Rattus norvegicus,Intermediate,CHEMBL629176,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 10-18,,N,1,1,,BAO_0000218
12222,Rattus norvegicus,Intermediate,CHEMBL629177,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 10-19,,N,1,1,,BAO_0000218
12223,Rattus norvegicus,Intermediate,CHEMBL629178,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 12-15,,N,1,1,,BAO_0000218
12224,Rattus norvegicus,Intermediate,CHEMBL631869,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 13-19,,N,1,1,,BAO_0000218
12225,Rattus norvegicus,Intermediate,CHEMBL631870,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 14-17,,N,1,1,,BAO_0000218
12226,Rattus norvegicus,Intermediate,CHEMBL631871,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 15-18,,N,1,1,,BAO_0000218
12227,Rattus norvegicus,Intermediate,CHEMBL631872,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 2-5,,N,1,1,,BAO_0000218
12228,,Autocuration,CHEMBL875775,,,22224,2116.0,A,,In vitro percent permeability into rat ileum; Range is 23-42,,U,0,1,,BAO_0000221
12229,Rattus norvegicus,Intermediate,CHEMBL631873,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 28-36,,N,1,1,,BAO_0000218
12230,Rattus norvegicus,Intermediate,CHEMBL631874,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 29-35,,N,1,1,,BAO_0000218
12231,Rattus norvegicus,Intermediate,CHEMBL631875,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 46-66,,N,1,1,,BAO_0000218
12232,Rattus norvegicus,Intermediate,CHEMBL631876,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 50-68,,N,1,1,,BAO_0000218
12233,Rattus norvegicus,Intermediate,CHEMBL631877,,,50597,,A,,In vitro percent permeability into rat ileum; Range is 78-81,,N,1,1,,BAO_0000218
12234,Rattus norvegicus,Intermediate,CHEMBL631878,,,50597,,A,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,N,1,1,,BAO_0000218
12235,Rattus norvegicus,Intermediate,CHEMBL631879,,,50597,,A,,In vitro percent permeability into rat ileum; nd indicates not detected,,N,1,1,,BAO_0000218
12236,Rattus norvegicus,Intermediate,CHEMBL631880,,,50597,,A,,In vitro percent permeability into rat ileum; nt indicates not detected,,N,1,1,,BAO_0000218
12237,Rattus norvegicus,Intermediate,CHEMBL631881,,,50597,,A,,In vitro percent permeability into rat ileum; nt indicates not tested,,N,1,1,,BAO_0000218
12238,Rattus norvegicus,Intermediate,CHEMBL631882,,,50597,,A,,Compound was tested for oral absorption in bile-duct cannulated rats,,N,1,1,,BAO_0000218
12239,Rattus norvegicus,Intermediate,CHEMBL630749,,,50597,,A,,Compound was tested for oral absorption in bile-duct cannulated rats.,,N,1,1,,BAO_0000218
12240,Homo sapiens,Intermediate,CHEMBL630750,,,50587,,A,,Oral absorption using Caco-2 cell monolayers.,,N,1,1,,BAO_0000218
12241,Homo sapiens,Intermediate,CHEMBL630253,,,50587,,A,,Percent of the drug absorbed after administration to humans was determined,,N,1,1,,BAO_0000218
12242,Rattus norvegicus,Intermediate,CHEMBL630254,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,1,1,,BAO_0000218
12243,Rattus norvegicus,Intermediate,CHEMBL630255,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,1,1,,BAO_0000218
12244,Rattus norvegicus,Intermediate,CHEMBL630256,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,1,1,,BAO_0000218
12245,Rattus norvegicus,Intermediate,CHEMBL875781,,,50597,2107.0,A,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12246,Rattus norvegicus,Intermediate,CHEMBL630257,,,50597,2107.0,A,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12247,Rattus norvegicus,Intermediate,CHEMBL630258,,,50597,2107.0,A,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,1,1,,BAO_0000218
12248,Rattus norvegicus,Intermediate,CHEMBL630259,,,50597,,A,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,N,1,1,,BAO_0000218
12249,Rattus norvegicus,Intermediate,CHEMBL630260,,,50597,2435.0,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,N,1,1,,BAO_0000218
12250,Rattus norvegicus,Intermediate,CHEMBL630261,,,50597,2435.0,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,N,1,1,,BAO_0000218
12251,Rattus norvegicus,Intermediate,CHEMBL630262,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,N,1,1,,BAO_0000218
12252,Rattus norvegicus,Intermediate,CHEMBL630263,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,N,1,1,,BAO_0000218
12253,Rattus norvegicus,Intermediate,CHEMBL630264,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,N,1,1,,BAO_0000218
12254,Rattus norvegicus,Intermediate,CHEMBL630265,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,N,1,1,,BAO_0000218
12255,Rattus norvegicus,Intermediate,CHEMBL630266,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,N,1,1,,BAO_0000218
12256,Rattus norvegicus,Intermediate,CHEMBL630267,,,50597,2113.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,N,1,1,,BAO_0000218
12257,Rattus norvegicus,Intermediate,CHEMBL630268,,,50597,2113.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,N,1,1,,BAO_0000218
12258,Rattus norvegicus,Intermediate,CHEMBL630269,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,N,1,1,,BAO_0000218
12259,Rattus norvegicus,Intermediate,CHEMBL630270,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,N,1,1,,BAO_0000218
12260,Rattus norvegicus,Intermediate,CHEMBL630141,,,50597,2048.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,N,1,1,,BAO_0000218
12261,Rattus norvegicus,Intermediate,CHEMBL630142,,,50597,2048.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,N,1,1,,BAO_0000218
12262,Rattus norvegicus,Intermediate,CHEMBL630143,,,50597,2385.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,N,1,1,,BAO_0000218
12263,Rattus norvegicus,Intermediate,CHEMBL630144,,,50597,2385.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,N,1,1,,BAO_0000218
12264,Rattus norvegicus,Intermediate,CHEMBL630145,,,50597,2367.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,N,1,1,,BAO_0000218
12265,Rattus norvegicus,Intermediate,CHEMBL630146,,,50597,2367.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,N,1,1,,BAO_0000218
12266,Rattus norvegicus,Intermediate,CHEMBL630147,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,N,1,1,,BAO_0000218
12267,Rattus norvegicus,Intermediate,CHEMBL630148,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,N,1,1,,BAO_0000218
12268,Rattus norvegicus,Intermediate,CHEMBL630149,,,50597,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,N,1,1,,BAO_0000218
12269,Rattus norvegicus,Intermediate,CHEMBL630150,,,50597,2106.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,N,1,1,,BAO_0000218
12270,Rattus norvegicus,Intermediate,CHEMBL630151,,,50597,2106.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,N,1,1,,BAO_0000218
12271,Rattus norvegicus,Intermediate,CHEMBL632031,,,50597,2046.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,N,1,1,,BAO_0000218
12272,Rattus norvegicus,Intermediate,CHEMBL632032,,,50597,2046.0,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,N,1,1,,BAO_0000218
12273,Rattus norvegicus,Intermediate,CHEMBL632033,,,50597,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,N,1,1,,BAO_0000218
12274,Rattus norvegicus,Intermediate,CHEMBL632034,,,50597,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,N,1,1,,BAO_0000218
12275,Rattus norvegicus,Intermediate,CHEMBL632035,,,50597,2385.0,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,N,1,1,,BAO_0000218
12276,Rattus norvegicus,Intermediate,CHEMBL632036,,,50597,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,N,1,1,,BAO_0000218
12277,Rattus norvegicus,Intermediate,CHEMBL632037,,,50597,2046.0,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,N,1,1,,BAO_0000218
12278,Rattus norvegicus,Intermediate,CHEMBL632038,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,1,1,,BAO_0000218
12279,Rattus norvegicus,Intermediate,CHEMBL632039,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12280,Rattus norvegicus,Intermediate,CHEMBL632040,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12281,Rattus norvegicus,Intermediate,CHEMBL632041,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,1,1,,BAO_0000218
12282,Canis lupus familiaris,Intermediate,CHEMBL632042,,,50588,178.0,A,,"Concentration of compound in blood of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12283,Canis lupus familiaris,Intermediate,CHEMBL632043,,,50588,,A,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,N,1,1,,BAO_0000218
12284,Canis lupus familiaris,Intermediate,CHEMBL632044,,,50588,,A,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12285,Canis lupus familiaris,Intermediate,CHEMBL632045,,,50588,2107.0,A,,"Concentration of compound in liver of dog 1, after administering intravenously",,N,1,1,,BAO_0000218
12286,Canis lupus familiaris,Intermediate,CHEMBL632046,,,50588,2107.0,A,,"Concentration of compound in liver of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12287,Canis lupus familiaris,Intermediate,CHEMBL632047,,,50588,2048.0,A,,"Concentration of compound in lung of dog 1, after administering intravenously",,N,1,1,,BAO_0000218
12288,Canis lupus familiaris,Intermediate,CHEMBL632048,,,50588,2048.0,A,,"Concentration of compound in lung of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12289,Canis lupus familiaris,Intermediate,CHEMBL632049,,,50588,2385.0,A,,"Concentration of compound in muscle of dog 1, after administering intravenously",,N,1,1,,BAO_0000218
12290,Canis lupus familiaris,Intermediate,CHEMBL876418,,,50588,2385.0,A,,"Concentration of compound in muscle of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12291,Canis lupus familiaris,Intermediate,CHEMBL632050,,,50588,2106.0,A,,"Concentration of compound in spleen of dog 1,after administering intravenously",,N,1,1,,BAO_0000218
12292,Canis lupus familiaris,Intermediate,CHEMBL632051,,,50588,2106.0,A,,"Concentration of compound in spleen of dog 2, after administering intravenously",,N,1,1,,BAO_0000218
12293,,Autocuration,CHEMBL632052,,,22224,,F,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,U,0,1,,BAO_0000218
12294,,Autocuration,CHEMBL632053,,,22224,,F,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,U,0,1,,BAO_0000218
12295,,Autocuration,CHEMBL632054,,,22224,,A,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,0,1,,BAO_0000218
12296,,Autocuration,CHEMBL632055,,,22224,,F,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,0,1,,BAO_0000218
12297,,Autocuration,CHEMBL631181,,,22224,,F,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,U,0,1,,BAO_0000218
12298,,Autocuration,CHEMBL631182,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,U,0,1,,BAO_0000218
12299,,Autocuration,CHEMBL631183,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,0,1,,BAO_0000218
12300,,Autocuration,CHEMBL631184,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12301,,Autocuration,CHEMBL629774,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12302,,Autocuration,CHEMBL629775,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12303,,Autocuration,CHEMBL876549,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12304,,Autocuration,CHEMBL628172,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12305,,Autocuration,CHEMBL628173,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12306,,Autocuration,CHEMBL628174,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,U,0,1,,BAO_0000218
12307,,Autocuration,CHEMBL628175,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,U,0,1,,BAO_0000218
12308,,Autocuration,CHEMBL628176,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12309,,Autocuration,CHEMBL628177,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12310,,Autocuration,CHEMBL628178,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12311,,Autocuration,CHEMBL628179,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12312,,Autocuration,CHEMBL628180,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,0,1,,BAO_0000218
12313,,Autocuration,CHEMBL628181,,,22224,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,U,0,1,,BAO_0000218
12314,,Autocuration,CHEMBL628182,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12315,,Autocuration,CHEMBL628183,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12316,,Autocuration,CHEMBL628184,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,U,0,1,,BAO_0000218
12317,,Autocuration,CHEMBL628185,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12318,,Autocuration,CHEMBL875617,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12319,,Autocuration,CHEMBL628186,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,0,1,,BAO_0000218
12320,,Autocuration,CHEMBL628187,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12321,,Autocuration,CHEMBL628188,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12322,,Autocuration,CHEMBL628189,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12323,,Autocuration,CHEMBL628190,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,U,0,1,,BAO_0000218
12324,,Autocuration,CHEMBL628191,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12325,,Autocuration,CHEMBL626513,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,U,0,1,,BAO_0000218
12326,Rattus norvegicus,Intermediate,CHEMBL626514,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,N,1,1,,BAO_0000218
12327,Rattus norvegicus,Intermediate,CHEMBL626515,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,N,1,1,,BAO_0000218
12328,Rattus norvegicus,Intermediate,CHEMBL626516,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,N,1,1,,BAO_0000218
12329,Rattus norvegicus,Intermediate,CHEMBL626517,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,N,1,1,,BAO_0000218
12330,Rattus norvegicus,Intermediate,CHEMBL626518,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,N,1,1,,BAO_0000218
12331,Rattus norvegicus,Intermediate,CHEMBL626519,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,N,1,1,,BAO_0000218
12332,Rattus norvegicus,Intermediate,CHEMBL626520,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,N,1,1,,BAO_0000218
12333,Rattus norvegicus,Intermediate,CHEMBL626521,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,N,1,1,,BAO_0000218
12334,Rattus norvegicus,Intermediate,CHEMBL626522,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,N,1,1,,BAO_0000218
12335,Rattus norvegicus,Intermediate,CHEMBL626523,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,N,1,1,,BAO_0000218
12336,Rattus norvegicus,Intermediate,CHEMBL626524,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,N,1,1,,BAO_0000218
12337,Rattus norvegicus,Intermediate,CHEMBL626688,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,N,1,1,,BAO_0000218
12338,Rattus norvegicus,Intermediate,CHEMBL626689,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,N,1,1,,BAO_0000218
12339,Rattus norvegicus,Intermediate,CHEMBL626690,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,N,1,1,,BAO_0000218
12340,Rattus norvegicus,Intermediate,CHEMBL626691,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,N,1,1,,BAO_0000218
12341,Rattus norvegicus,Intermediate,CHEMBL627319,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,N,1,1,,BAO_0000218
12342,Rattus norvegicus,Intermediate,CHEMBL624052,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,N,1,1,,BAO_0000218
12343,Rattus norvegicus,Intermediate,CHEMBL624053,,,50597,2046.0,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,N,1,1,,BAO_0000218
12344,Rattus norvegicus,Intermediate,CHEMBL624054,,,50597,,A,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12345,Rattus norvegicus,Intermediate,CHEMBL624055,,,50597,,A,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12346,Rattus norvegicus,Intermediate,CHEMBL624056,,,50597,,A,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12347,Rattus norvegicus,Intermediate,CHEMBL624057,,,50597,995.0,A,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12348,Rattus norvegicus,Intermediate,CHEMBL622281,,,50597,995.0,A,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12349,Rattus norvegicus,Intermediate,CHEMBL622282,,,50597,995.0,A,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12350,Rattus norvegicus,Intermediate,CHEMBL622283,,,50597,995.0,A,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12351,Rattus norvegicus,Intermediate,CHEMBL622284,,,50597,995.0,A,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12352,Rattus norvegicus,Intermediate,CHEMBL622285,,,50597,995.0,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12353,Rattus norvegicus,Intermediate,CHEMBL622286,,,50597,995.0,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,1,1,,BAO_0000218
12354,,Autocuration,CHEMBL622287,,,22224,,P,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,U,0,1,,BAO_0000100
12355,Mus musculus,Intermediate,CHEMBL622288,,,50594,,A,,Partition coefficient (logD7.4),,N,1,1,,BAO_0000218
12356,Mus musculus,Intermediate,CHEMBL622289,,,50594,,A,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,1,1,,BAO_0000218
12357,Mus musculus,Intermediate,CHEMBL622290,,,50594,955.0,A,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,1,1,,BAO_0000218
12358,Mus musculus,Intermediate,CHEMBL622291,,,50594,,A,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,1,1,,BAO_0000218
12359,Mus musculus,Intermediate,CHEMBL622292,,,50594,955.0,A,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,1,1,,BAO_0000218
12360,Mus musculus,Intermediate,CHEMBL622293,,,50594,,A,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,1,1,,BAO_0000218
12361,Mus musculus,Intermediate,CHEMBL622294,,,50594,955.0,A,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,1,1,,BAO_0000218
12362,Mus musculus,Intermediate,CHEMBL622295,,,50594,,A,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,1,1,,BAO_0000218
12363,Rattus norvegicus,Intermediate,CHEMBL622296,,,50597,955.0,A,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,1,1,,BAO_0000218
12364,Rattus norvegicus,Intermediate,CHEMBL874409,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,N,1,1,,BAO_0000218
12365,Rattus norvegicus,Intermediate,CHEMBL622297,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,1,1,,BAO_0000218
12366,Rattus norvegicus,Intermediate,CHEMBL622298,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,1,1,,BAO_0000218
12367,Rattus norvegicus,Intermediate,CHEMBL622299,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,1,1,,BAO_0000218
12368,Rattus norvegicus,Intermediate,CHEMBL622300,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,1,1,,BAO_0000218
12369,Rattus norvegicus,Intermediate,CHEMBL622301,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,1,1,,BAO_0000218
12370,Rattus norvegicus,Intermediate,CHEMBL622302,,,50597,1969.0,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,1,1,,BAO_0000218
12371,Rattus norvegicus,Intermediate,CHEMBL622303,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,1,1,,BAO_0000218
12372,Rattus norvegicus,Intermediate,CHEMBL622304,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,1,1,,BAO_0000218
12373,Rattus norvegicus,Intermediate,CHEMBL622305,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,N,1,1,,BAO_0000218
12374,Rattus norvegicus,Intermediate,CHEMBL622306,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,1,1,,BAO_0000218
12375,Rattus norvegicus,Intermediate,CHEMBL626864,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,N,1,1,,BAO_0000218
12376,Rattus norvegicus,Intermediate,CHEMBL626865,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,1,1,,BAO_0000218
12377,Rattus norvegicus,Intermediate,CHEMBL626866,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,N,1,1,,BAO_0000218
12378,Rattus norvegicus,Intermediate,CHEMBL626867,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,1,1,,BAO_0000218
12379,Rattus norvegicus,Intermediate,CHEMBL626868,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,1,1,,BAO_0000218
12380,Rattus norvegicus,Intermediate,CHEMBL626869,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,N,1,1,,BAO_0000218
12381,Rattus norvegicus,Intermediate,CHEMBL626870,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,1,1,,BAO_0000218
12382,Rattus norvegicus,Intermediate,CHEMBL626871,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,N,1,1,,BAO_0000218
12383,Rattus norvegicus,Intermediate,CHEMBL626872,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,1,1,,BAO_0000218
12384,Rattus norvegicus,Intermediate,CHEMBL632185,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,1,1,,BAO_0000218
12385,Rattus norvegicus,Intermediate,CHEMBL632186,,,50597,1969.0,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,N,1,1,,BAO_0000218
12386,,Autocuration,CHEMBL629310,,,22224,,A,,Amount of acetic acid produced by the compound,,U,0,1,,BAO_0000019
12387,,Autocuration,CHEMBL629311,,,22224,,A,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,U,0,1,,BAO_0000019
12388,Rattus norvegicus,Intermediate,CHEMBL629312,,,50597,,A,,Log of (Cbrain/Cblood) in rats,,N,1,1,,BAO_0000218
12389,,Autocuration,CHEMBL629313,,,22224,,A,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,0,1,,BAO_0000221
12390,,Autocuration,CHEMBL629314,,,22224,,A,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000221
12391,,Autocuration,CHEMBL629315,,,22224,,A,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,0,1,,BAO_0000221
12392,,Autocuration,CHEMBL629316,,,22224,,B,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,U,0,1,,BAO_0000219
12393,,Autocuration,CHEMBL629317,,,22224,,A,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000221
12394,,Autocuration,CHEMBL629318,,,22224,,A,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12395,,Autocuration,CHEMBL877497,,,22224,,A,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12396,,Autocuration,CHEMBL629319,,,22224,,A,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12397,,Autocuration,CHEMBL629320,,,22224,,A,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12398,,Autocuration,CHEMBL629496,,,22224,,A,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12399,,Autocuration,CHEMBL629497,,,22224,,A,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12400,,Autocuration,CHEMBL629498,,,22224,,A,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12401,,Autocuration,CHEMBL629499,,,22224,,A,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12402,,Autocuration,CHEMBL629500,,,22224,,A,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12403,,Autocuration,CHEMBL629501,,,22224,,A,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12404,,Autocuration,CHEMBL629502,,,22224,,A,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,U,0,1,,BAO_0000019
12405,,Autocuration,CHEMBL629503,,,22224,,F,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,U,0,1,,BAO_0000218
12406,Canis lupus familiaris,Intermediate,CHEMBL629504,,,50588,,A,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,N,1,1,,BAO_0000218
12407,,Autocuration,CHEMBL629505,,,22224,,A,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,U,0,1,,BAO_0000019
12408,,Autocuration,CHEMBL629506,,,22224,,A,,Compound was evaluated for total body clearance,,U,0,1,,BAO_0000019
12409,,Autocuration,CHEMBL629507,,,22224,,A,,Compound was evaluated for volume of distribution at steady state,,U,0,1,,BAO_0000019
12410,,Autocuration,CHEMBL877498,,,22224,,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,U,0,1,,BAO_0000019
12411,,Autocuration,CHEMBL629508,,,22224,,A,,Percentage of the diamine which is monoprotonated at pH 7.4,,U,0,1,,BAO_0000019
12412,,Autocuration,CHEMBL629509,,,22224,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,U,0,1,,BAO_0000019
12413,Rattus norvegicus,Intermediate,CHEMBL629510,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12414,Rattus norvegicus,Intermediate,CHEMBL629511,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,1,1,,BAO_0000218
12415,Rattus norvegicus,Intermediate,CHEMBL629512,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12416,Rattus norvegicus,Intermediate,CHEMBL629513,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12417,Rattus norvegicus,Intermediate,CHEMBL629514,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,1,1,,BAO_0000218
12418,Rattus norvegicus,Intermediate,CHEMBL628447,,,50597,178.0,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12419,Rattus norvegicus,Intermediate,CHEMBL628448,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,1,1,,BAO_0000218
12420,Rattus norvegicus,Intermediate,CHEMBL628449,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12421,Rattus norvegicus,Intermediate,CHEMBL631119,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12422,Rattus norvegicus,Intermediate,CHEMBL631120,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,1,1,,BAO_0000218
12423,Rattus norvegicus,Intermediate,CHEMBL631121,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12424,Rattus norvegicus,Intermediate,CHEMBL874458,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,N,1,1,,BAO_0000218
12425,Rattus norvegicus,Intermediate,CHEMBL631122,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12426,Rattus norvegicus,Intermediate,CHEMBL631123,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12427,Rattus norvegicus,Intermediate,CHEMBL631124,,,50597,178.0,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12428,Rattus norvegicus,Intermediate,CHEMBL631125,,,50597,178.0,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,1,1,,BAO_0000218
12429,Rattus norvegicus,Intermediate,CHEMBL631290,,,50597,178.0,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12430,Rattus norvegicus,Intermediate,CHEMBL631291,,,50597,178.0,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12431,Rattus norvegicus,Intermediate,CHEMBL631292,,,50597,178.0,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12432,Rattus norvegicus,Intermediate,CHEMBL631293,,,50597,178.0,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,1,1,,BAO_0000218
12433,Rattus norvegicus,Intermediate,CHEMBL631294,,,50597,178.0,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,1,1,,BAO_0000218
12434,Rattus norvegicus,Intermediate,CHEMBL631295,,,50597,178.0,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,1,1,,BAO_0000218
12435,Rattus norvegicus,Intermediate,CHEMBL631296,,,50597,178.0,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,1,1,,BAO_0000218
12436,Rattus norvegicus,Intermediate,CHEMBL631297,,,50597,178.0,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,1,1,,BAO_0000218
12437,,Autocuration,CHEMBL631298,,,22224,,A,,Maximum biodistribution (Bmax) was determined.,,U,0,1,,BAO_0000218
12438,Mus musculus,Intermediate,CHEMBL631299,,,50594,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,N,1,1,,BAO_0000218
12439,Mus musculus,Intermediate,CHEMBL631300,,,50594,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,N,1,1,,BAO_0000218
12440,Mus musculus,Intermediate,CHEMBL631301,,,50594,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,N,1,1,,BAO_0000218
12441,Mus musculus,Intermediate,CHEMBL630291,,,50594,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,N,1,1,,BAO_0000218
12442,,Autocuration,CHEMBL630292,,,22224,,A,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,0,1,,BAO_0000218
12443,,Autocuration,CHEMBL630293,,,22224,,A,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,U,0,1,,BAO_0000218
12444,,Autocuration,CHEMBL630294,,,22224,,A,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12445,,Autocuration,CHEMBL630295,,,22224,,A,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,U,0,1,,BAO_0000218
12446,,Autocuration,CHEMBL630296,,,22224,,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,U,0,1,,BAO_0000218
12447,,Autocuration,CHEMBL626782,,,22224,,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12448,,Autocuration,CHEMBL626783,,,22224,,A,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12449,,Autocuration,CHEMBL626784,,,22224,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,0,1,,BAO_0000218
12450,,Autocuration,CHEMBL626785,,,22224,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,U,0,1,,BAO_0000218
12451,,Autocuration,CHEMBL626786,,,22224,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12452,,Autocuration,CHEMBL626787,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12453,,Autocuration,CHEMBL626788,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,0,1,,BAO_0000218
12454,,Autocuration,CHEMBL625927,,,22224,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12455,Rattus norvegicus,Intermediate,CHEMBL625928,,,50597,178.0,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12456,Rattus norvegicus,Intermediate,CHEMBL625929,,,50597,178.0,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12457,Rattus norvegicus,Intermediate,CHEMBL625930,,,50597,178.0,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,1,1,,BAO_0000218
12458,Rattus norvegicus,Intermediate,CHEMBL625931,,,50597,178.0,A,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,N,1,1,,BAO_0000218
12459,Rattus norvegicus,Intermediate,CHEMBL627230,,,50597,178.0,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,N,1,1,,BAO_0000218
12460,Rattus norvegicus,Intermediate,CHEMBL627231,,,50597,178.0,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12461,Rattus norvegicus,Intermediate,CHEMBL627232,,,50597,178.0,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12462,Rattus norvegicus,Intermediate,CHEMBL627233,,,50597,178.0,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,1,1,,BAO_0000218
12463,Rattus norvegicus,Intermediate,CHEMBL875470,,,50597,178.0,A,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12464,Rattus norvegicus,Intermediate,CHEMBL627234,,,50597,178.0,A,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12465,Rattus norvegicus,Intermediate,CHEMBL627235,,,50597,178.0,A,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12466,Rattus norvegicus,Intermediate,CHEMBL627236,,,50597,178.0,A,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12467,Rattus norvegicus,Intermediate,CHEMBL627237,,,50597,178.0,A,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12468,Rattus norvegicus,Intermediate,CHEMBL627238,,,50597,178.0,A,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12469,Rattus norvegicus,Intermediate,CHEMBL627239,,,50597,178.0,A,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12470,Rattus norvegicus,Intermediate,CHEMBL627240,,,50597,178.0,A,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12471,Rattus norvegicus,Intermediate,CHEMBL627241,,,50597,178.0,A,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12472,Rattus norvegicus,Intermediate,CHEMBL627242,,,50597,178.0,A,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12473,Rattus norvegicus,Intermediate,CHEMBL627243,,,50597,178.0,A,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,N,1,1,,BAO_0000218
12474,Rattus norvegicus,Intermediate,CHEMBL627244,,,50597,178.0,A,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12475,Rattus norvegicus,Intermediate,CHEMBL627245,,,50597,178.0,A,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12476,Rattus norvegicus,Intermediate,CHEMBL627246,,,50597,178.0,A,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12477,Rattus norvegicus,Intermediate,CHEMBL627247,,,50597,178.0,A,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12478,Rattus norvegicus,Intermediate,CHEMBL627248,,,50597,178.0,A,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12479,Rattus norvegicus,Intermediate,CHEMBL627249,,,50597,178.0,A,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12480,Rattus norvegicus,Intermediate,CHEMBL625569,,,50597,178.0,A,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12481,Rattus norvegicus,Intermediate,CHEMBL625570,,,50597,178.0,A,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12482,Rattus norvegicus,Intermediate,CHEMBL625571,,,50597,178.0,A,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12483,Rattus norvegicus,Intermediate,CHEMBL625572,,,50597,178.0,A,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12484,Rattus norvegicus,Intermediate,CHEMBL625573,,,50597,178.0,A,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12485,Rattus norvegicus,Intermediate,CHEMBL625574,,,50597,178.0,A,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,N,1,1,,BAO_0000218
12486,Rattus norvegicus,Intermediate,CHEMBL626245,,,50597,178.0,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,1,1,,BAO_0000218
12487,Rattus norvegicus,Intermediate,CHEMBL626246,,,50597,178.0,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12488,,Autocuration,CHEMBL626247,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12489,,Autocuration,CHEMBL626248,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12490,,Autocuration,CHEMBL626249,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,0,1,,BAO_0000218
12491,,Autocuration,CHEMBL626420,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12492,,Autocuration,CHEMBL626421,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,0,1,,BAO_0000218
12493,,Autocuration,CHEMBL626422,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12494,,Autocuration,CHEMBL626423,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12495,,Autocuration,CHEMBL626424,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12496,Canis lupus familiaris,Intermediate,CHEMBL626425,,,50588,,A,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,N,1,1,,BAO_0000218
12497,Rattus norvegicus,Intermediate,CHEMBL875476,,,50597,,A,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,N,1,1,,BAO_0000218
12498,Macaca fascicularis,Intermediate,CHEMBL626426,,,100710,,A,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,N,1,1,,BAO_0000218
12499,,Autocuration,CHEMBL626427,,,22224,,P,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,0,1,,BAO_0000100
12500,,Autocuration,CHEMBL626428,,,22224,,P,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,0,1,,BAO_0000100
12501,,Autocuration,CHEMBL626429,,,22224,,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,U,0,1,,BAO_0000019
12502,,Autocuration,CHEMBL625025,,,22224,1088.0,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,U,0,1,,BAO_0000019
12503,Rattus norvegicus,Intermediate,CHEMBL625026,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12504,Rattus norvegicus,Intermediate,CHEMBL625027,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12505,Rattus norvegicus,Intermediate,CHEMBL874410,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12506,Rattus norvegicus,Intermediate,CHEMBL625028,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12507,Rattus norvegicus,Intermediate,CHEMBL625029,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12508,Rattus norvegicus,Intermediate,CHEMBL625030,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12509,Rattus norvegicus,Intermediate,CHEMBL625031,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12510,Rattus norvegicus,Intermediate,CHEMBL625032,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12511,Rattus norvegicus,Intermediate,CHEMBL625033,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12512,Rattus norvegicus,Intermediate,CHEMBL625034,,,50597,178.0,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12513,Rattus norvegicus,Intermediate,CHEMBL624872,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12514,Rattus norvegicus,Intermediate,CHEMBL624873,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12515,Rattus norvegicus,Intermediate,CHEMBL624874,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12516,Rattus norvegicus,Intermediate,CHEMBL624875,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12517,Rattus norvegicus,Intermediate,CHEMBL624876,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12518,Rattus norvegicus,Intermediate,CHEMBL624877,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12519,Rattus norvegicus,Intermediate,CHEMBL624878,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12520,Rattus norvegicus,Intermediate,CHEMBL624879,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12521,Rattus norvegicus,Intermediate,CHEMBL624880,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12522,Rattus norvegicus,Intermediate,CHEMBL624881,,,50597,948.0,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12523,Rattus norvegicus,Intermediate,CHEMBL624882,,,50597,948.0,A,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,N,1,1,,BAO_0000218
12524,Rattus norvegicus,Intermediate,CHEMBL624883,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12525,Rattus norvegicus,Intermediate,CHEMBL624884,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12526,Rattus norvegicus,Intermediate,CHEMBL624885,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12527,Rattus norvegicus,Intermediate,CHEMBL624886,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12528,Rattus norvegicus,Intermediate,CHEMBL624887,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12529,Rattus norvegicus,Intermediate,CHEMBL624888,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12530,Rattus norvegicus,Intermediate,CHEMBL624889,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12531,Rattus norvegicus,Intermediate,CHEMBL624890,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12532,Rattus norvegicus,Intermediate,CHEMBL621964,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12533,Rattus norvegicus,Intermediate,CHEMBL621965,,,50597,2113.0,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12534,Rattus norvegicus,Intermediate,CHEMBL621966,,,50597,2107.0,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12535,Rattus norvegicus,Intermediate,CHEMBL621967,,,50597,2107.0,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12536,Rattus norvegicus,Intermediate,CHEMBL622164,,,50597,2107.0,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12537,,Autocuration,CHEMBL623097,,,22224,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,U,0,1,,BAO_0000019
12538,,Autocuration,CHEMBL623098,,,22224,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,U,0,1,,BAO_0000019
12539,,Autocuration,CHEMBL623099,,,22224,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,U,0,1,,BAO_0000019
12540,,Autocuration,CHEMBL623100,,,22224,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,U,0,1,,BAO_0000019
12541,Rattus norvegicus,Intermediate,CHEMBL628673,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,N,1,1,,BAO_0000218
12542,Rattus norvegicus,Intermediate,CHEMBL628674,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,N,1,1,,BAO_0000218
12543,Rattus norvegicus,Intermediate,CHEMBL628675,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,N,1,1,,BAO_0000218
12544,Rattus norvegicus,Intermediate,CHEMBL627644,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,N,1,1,,BAO_0000218
12545,Rattus norvegicus,Intermediate,CHEMBL627645,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,N,1,1,,BAO_0000218
12546,Rattus norvegicus,Intermediate,CHEMBL627646,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,N,1,1,,BAO_0000218
12547,Rattus norvegicus,Intermediate,CHEMBL627647,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,N,1,1,,BAO_0000218
12548,Rattus norvegicus,Intermediate,CHEMBL627648,,,50597,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,N,1,1,,BAO_0000218
12549,Rattus norvegicus,Intermediate,CHEMBL627649,,,50597,,A,,Free level in rat plasma,,N,1,1,,BAO_0000218
12550,,Autocuration,CHEMBL628313,,,22224,,A,,Level reaching in blood plasma of rat or human was determined,,U,0,1,,BAO_0000019
12551,Rattus norvegicus,Intermediate,CHEMBL628314,,,50597,,A,,Log (Cbrain/Cblood) in rats,,N,1,1,,BAO_0000218
12552,,Autocuration,CHEMBL628315,,,22224,,A,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,U,0,1,,BAO_0000019
12553,,Autocuration,CHEMBL628316,,,22224,,A,,Mean percentage of compound transport through membrane; expressed as membrane transport,,U,0,1,,BAO_0000019
12554,,Autocuration,CHEMBL628317,,,22224,,A,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,U,0,1,,BAO_0000218
12555,,Autocuration,CHEMBL628473,,,22224,,A,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,U,0,1,,BAO_0000019
12556,,Autocuration,CHEMBL628474,,,22224,,A,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,U,0,1,,BAO_0000019
12557,,Autocuration,CHEMBL628475,,,22224,,A,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,U,0,1,,BAO_0000019
12558,,Autocuration,CHEMBL628476,,,22224,,A,,Net water uptake by a carrier mediated transport (%cm) mechanism,,U,0,1,,BAO_0000019
12559,Simiiformes,Autocuration,CHEMBL628477,,,22224,,A,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,0,1,,BAO_0000218
12560,Mustela putorius furo,Intermediate,CHEMBL628478,,,50506,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,1,1,,BAO_0000218
12561,Mustela putorius furo,Intermediate,CHEMBL628479,,,50506,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,1,1,,BAO_0000218
12562,Simiiformes,Autocuration,CHEMBL628480,,,22224,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,0,1,,BAO_0000218
12563,Simiiformes,Autocuration,CHEMBL628481,,,22224,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,U,0,1,,BAO_0000218
12564,Rattus norvegicus,Intermediate,CHEMBL628482,,,50597,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,1,1,,BAO_0000218
12565,Rattus norvegicus,Intermediate,CHEMBL628483,,,50597,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,1,1,,BAO_0000218
12566,Rattus norvegicus,Intermediate,CHEMBL628484,,,50597,1969.0,A,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,1,1,,BAO_0000218
12567,Rattus norvegicus,Intermediate,CHEMBL628485,,,50597,1969.0,A,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1,1,,BAO_0000218
12568,Macaca fascicularis,Intermediate,CHEMBL628486,,,100710,1969.0,A,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,N,1,1,,BAO_0000218
12569,Homo sapiens,Intermediate,CHEMBL628487,,,50587,1969.0,A,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,N,1,1,,BAO_0000218
12570,Rattus norvegicus,Intermediate,CHEMBL628488,,,50597,1969.0,A,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,1,1,,BAO_0000218
12571,Rattus norvegicus,Intermediate,CHEMBL628489,,,50597,1969.0,A,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1,1,,BAO_0000218
12572,Rattus norvegicus,Intermediate,CHEMBL628490,,,50597,1969.0,A,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1,1,,BAO_0000218
12573,Macaca fascicularis,Intermediate,CHEMBL628491,,,100710,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,1,1,,BAO_0000218
12574,Macaca fascicularis,Intermediate,CHEMBL877507,,,100710,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,1,1,,BAO_0000218
12575,,Autocuration,CHEMBL628492,,,22224,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,U,0,1,,BAO_0000218
12576,Simiiformes,Autocuration,CHEMBL628493,,,22224,,A,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,U,0,1,,BAO_0000019
12577,Simiiformes,Autocuration,CHEMBL628494,,,22224,,A,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,U,0,1,,BAO_0000019
12578,Simiiformes,Autocuration,CHEMBL628495,,,22224,,A,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,U,0,1,,BAO_0000019
12579,Homo sapiens,Intermediate,CHEMBL628496,,,50587,,A,,Permeability in Caco-2 assay at 10E-6,,N,1,1,,BAO_0000218
12580,,Autocuration,CHEMBL628497,,,22224,955.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,0,1,,BAO_0000218
12581,,Autocuration,CHEMBL628498,,,22224,955.0,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,0,1,,BAO_0000218
12582,,Autocuration,CHEMBL628499,,,22224,,A,,Plasma protein binding was determined,,U,0,1,,BAO_0000019
12583,,Autocuration,CHEMBL627656,,,22224,,A,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12584,,Autocuration,CHEMBL627657,,,22224,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,0,1,,BAO_0000218
12585,,Autocuration,CHEMBL626808,,,22224,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,U,0,1,,BAO_0000218
12586,,Autocuration,CHEMBL626809,,,22224,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12587,,Autocuration,CHEMBL626810,,,22224,,A,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12588,,Autocuration,CHEMBL626811,,,22224,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,0,1,,BAO_0000218
12589,,Autocuration,CHEMBL874465,,,22224,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,U,0,1,,BAO_0000218
12590,,Autocuration,CHEMBL626812,,,22224,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12591,,Autocuration,CHEMBL626813,,,22224,,A,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12592,,Autocuration,CHEMBL626814,,,22224,,A,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,U,0,1,,BAO_0000218
12593,,Autocuration,CHEMBL626815,,,22224,,A,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,U,0,1,,BAO_0000019
12594,,Autocuration,CHEMBL628566,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
12595,,Autocuration,CHEMBL628567,,,22229,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,0,1,,BAO_0000100
12596,,Autocuration,CHEMBL628568,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12597,Canis lupus familiaris,Intermediate,CHEMBL628569,,,50588,,A,,C max in dog,,N,1,1,,BAO_0000218
12598,Cavia porcellus,Intermediate,CHEMBL628570,,,50512,,A,,C max in guinea pig,,N,1,1,,BAO_0000218
12599,,Autocuration,CHEMBL628571,,,22224,,A,,C max value was evaluated,,U,0,1,,BAO_0000218
12600,,Autocuration,CHEMBL628572,,,22224,,A,,Cmax value after oral dose of 0.1 mg//kg,,U,0,1,,BAO_0000218
12601,,Autocuration,CHEMBL628573,,,22224,,A,,Cmax value after oral dose of 0.3 mg/kg,,U,0,1,,BAO_0000218
12602,,Autocuration,CHEMBL628574,,,22224,,A,,Cmax value after oral dose of 1 mg/kg,,U,0,1,,BAO_0000218
12603,,Autocuration,CHEMBL628575,,,22224,,A,,Cmax value after oral dose of 10 mg/kg,,U,0,1,,BAO_0000218
12604,,Autocuration,CHEMBL628576,,,22224,,A,,Cmax value after oral dose of 23.4 mg/kg,,U,0,1,,BAO_0000218
12605,,Autocuration,CHEMBL628577,,,22224,,A,,Cmax value after oral dose of 3 mg/kg,,U,0,1,,BAO_0000218
12606,,Autocuration,CHEMBL628578,,,22224,,A,,Cmax value after oral dose of 3.87 mg/kg,,U,0,1,,BAO_0000218
12607,Canis lupus familiaris,Intermediate,CHEMBL874466,,,50588,,A,,Cmax value in female Beagle dogs,,N,1,1,,BAO_0000218
12608,Rattus norvegicus,Intermediate,CHEMBL628579,,,50597,,A,,Cmax value in male rats,,N,1,1,,BAO_0000218
12609,Rattus norvegicus,Intermediate,CHEMBL628580,,,50597,1969.0,A,,Cmax value in rat plasma when administered 20 mg/kg perorally,,N,1,1,,BAO_0000218
12610,Canis lupus familiaris,Intermediate,CHEMBL628581,,,50588,1969.0,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,1,1,,BAO_0000218
12611,Canis lupus familiaris,Intermediate,CHEMBL628582,,,50588,1969.0,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,1,1,,BAO_0000218
12612,Canis lupus familiaris,Intermediate,CHEMBL628583,,,50588,,A,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12613,Simiiformes,Autocuration,CHEMBL625782,,,22224,,A,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,U,0,1,,BAO_0000218
12614,Oryctolagus cuniculus,Intermediate,CHEMBL625783,,,50592,,A,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12615,Rattus norvegicus,Intermediate,CHEMBL625784,,,50597,,A,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12616,Macaca mulatta,Intermediate,CHEMBL625785,,,50797,1969.0,A,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,1,1,,BAO_0000218
12617,Rattus norvegicus,Intermediate,CHEMBL625786,,,50597,,A,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,N,1,1,,BAO_0000218
12618,,Autocuration,CHEMBL874467,,,22224,,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,U,0,1,,BAO_0000019
12619,Canis lupus familiaris,Intermediate,CHEMBL625787,,,50588,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,1,1,,BAO_0000218
12620,Human immunodeficiency virus,Intermediate,CHEMBL625964,,,50677,,A,,cytotoxicity against HIV protease enzyme.,,N,1,1,,BAO_0000218
12621,Mus musculus,Intermediate,CHEMBL625965,,,50594,,A,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,N,1,1,,BAO_0000218
12622,Mus musculus,Intermediate,CHEMBL625966,,,50594,,A,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,N,1,1,,BAO_0000218
12623,Canis lupus familiaris,Intermediate,CHEMBL625967,,,50588,1969.0,A,,The plasma clearance in dog.,,N,1,1,,BAO_0000218
12624,Rattus norvegicus,Intermediate,CHEMBL625968,,,50597,1969.0,A,,The plasma clearance in rat.,,N,1,1,,BAO_0000218
12625,Rattus norvegicus,Intermediate,CHEMBL625969,,,50597,1969.0,A,,Clearance from plasma in male Sprague-Dawley rats,,N,1,1,,BAO_0000218
12626,Macaca fascicularis,Intermediate,CHEMBL625970,,,100710,1969.0,A,,Clearance from plasma in male cynomolgus monkeys,,N,1,1,,BAO_0000218
12627,Canis lupus familiaris,Intermediate,CHEMBL625971,,,50588,1969.0,A,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,N,1,1,,BAO_0000218
12628,Canis lupus familiaris,Intermediate,CHEMBL625972,,,50588,1969.0,A,,Clearance of compound in dog plasma,,N,1,1,,BAO_0000218
12629,Homo sapiens,Intermediate,CHEMBL625973,,,50587,1969.0,A,,Clearance of compound in human plasma,,N,1,1,,BAO_0000218
12630,Canis lupus familiaris,Intermediate,CHEMBL625974,,,50588,,A,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,N,1,1,,BAO_0000218
12631,Canis lupus familiaris,Intermediate,CHEMBL625975,,,50588,,A,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,N,1,1,,BAO_0000218
12632,Canis lupus familiaris,Intermediate,CHEMBL625976,,,50588,1969.0,A,,"Clearance (10 mg/kg, intravenously) in dog plasma",,N,1,1,,BAO_0000218
12633,Canis lupus familiaris,Intermediate,CHEMBL625977,,,50588,,A,,Clearance value in dog,,N,1,1,,BAO_0000218
12634,Cavia porcellus,Intermediate,CHEMBL625978,,,50512,,A,,Clearance value in guinea pig,,N,1,1,,BAO_0000218
12635,Rattus norvegicus,Intermediate,CHEMBL874468,,,50597,,A,,Clearance values in rats after iv administration.,,N,1,1,,BAO_0000218
12636,,Autocuration,CHEMBL625421,,,22224,1969.0,A,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,U,0,1,,BAO_0000218
12637,Oryctolagus cuniculus,Intermediate,CHEMBL625422,,,50592,,A,,In vivo clearance (5 mg/kg) was determined in rabbits,,N,1,1,,BAO_0000218
12638,Rattus norvegicus,Intermediate,CHEMBL625423,,,50597,,A,,Plasma Clearance rate was determined for the compound in rats,,N,1,1,,BAO_0000218
12639,Saimiri,Autocuration,CHEMBL625424,,,22224,,A,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,U,0,1,,BAO_0000218
12640,Rattus norvegicus,Intermediate,CHEMBL625425,,,50597,,A,,Plasma clearance in rat,,N,1,1,,BAO_0000218
12641,,Autocuration,CHEMBL625426,,,22224,,A,,Plasma clearance of the compound,,U,0,1,,BAO_0000218
12642,Cavia porcellus,Intermediate,CHEMBL625427,,,50512,,A,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,N,1,1,,BAO_0000218
12643,Cavia porcellus,Intermediate,CHEMBL625428,,,50512,,A,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,N,1,1,,BAO_0000218
12644,,Autocuration,CHEMBL625429,,,22224,,A,,Plasma clearance was determined,,U,0,1,,BAO_0000218
12645,Canis lupus familiaris,Intermediate,CHEMBL625430,,,50588,,A,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,N,1,1,,BAO_0000218
12646,Rattus norvegicus,Intermediate,CHEMBL625431,,,50597,,A,,Plasma clearance rate was determined for the compound in rats,,N,1,1,,BAO_0000218
12647,Saimiri,Autocuration,CHEMBL627307,,,22224,,A,,Plasma clearance rate was determined for the compound in squirrel monkeys,,U,0,1,,BAO_0000218
12648,,Autocuration,CHEMBL627308,,,22224,,A,,Slow clearance (CL) was determined,,U,0,1,,BAO_0000218
12649,,Autocuration,CHEMBL627309,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12650,,Autocuration,CHEMBL627310,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,0,1,,BAO_0000218
12651,,Autocuration,CHEMBL627311,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,0,1,,BAO_0000218
12652,,Autocuration,CHEMBL627312,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12653,,Autocuration,CHEMBL627313,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,0,1,,BAO_0000218
12654,,Autocuration,CHEMBL627314,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12655,,Autocuration,CHEMBL627315,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12656,,Autocuration,CHEMBL627316,,,22224,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12657,,Autocuration,CHEMBL627317,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,0,1,,BAO_0000218
12658,,Autocuration,CHEMBL627318,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12659,,Autocuration,CHEMBL627999,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,0,1,,BAO_0000218
12660,,Autocuration,CHEMBL628000,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,0,1,,BAO_0000218
12661,,Autocuration,CHEMBL628001,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,0,1,,BAO_0000218
12662,,Autocuration,CHEMBL628002,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12663,,Autocuration,CHEMBL625610,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12664,,Autocuration,CHEMBL625611,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12665,,Autocuration,CHEMBL625612,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,0,1,,BAO_0000218
12666,,Autocuration,CHEMBL625613,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,0,1,,BAO_0000218
12667,,Autocuration,CHEMBL875479,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,0,1,,BAO_0000218
12668,,Autocuration,CHEMBL625614,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,0,1,,BAO_0000218
12669,,Autocuration,CHEMBL625615,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,0,1,,BAO_0000218
12670,,Autocuration,CHEMBL626302,,,22224,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,0,1,,BAO_0000218
12671,Rattus norvegicus,Intermediate,CHEMBL626303,,,50597,178.0,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12672,Rattus norvegicus,Intermediate,CHEMBL627420,,,50597,178.0,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,1,1,,BAO_0000218
12673,Rattus norvegicus,Intermediate,CHEMBL627421,,,50597,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,N,1,1,,BAO_0000218
12674,Rattus norvegicus,Intermediate,CHEMBL625695,,,50597,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,N,1,1,,BAO_0000218
12675,Rattus norvegicus,Intermediate,CHEMBL625696,,,50597,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,N,1,1,,BAO_0000218
12676,Mus musculus,Intermediate,CHEMBL875606,,,50594,955.0,A,,Distribution of compound in mice brain was measured after 1 hr,,N,1,1,,BAO_0000218
12677,Mus musculus,Intermediate,CHEMBL625697,,,50594,955.0,A,,Distribution of compound in mice brain was measured after 24 hr r,,N,1,1,,BAO_0000218
12678,Mus musculus,Intermediate,CHEMBL625698,,,50594,955.0,A,,Distribution of compound in mice brain was measured after 2 hr,,N,1,1,,BAO_0000218
12679,Mus musculus,Intermediate,CHEMBL625699,,,50594,955.0,A,,Distribution of compound in mice brain was measured after 3 hr,,N,1,1,,BAO_0000218
12680,Mus musculus,Intermediate,CHEMBL625700,,,50594,955.0,A,,Distribution of compound in mice brain was measured after 6 hr,,N,1,1,,BAO_0000218
12681,Mus musculus,Intermediate,CHEMBL625701,,,50594,,A,,Distribution of compound in mice liver was measured after 1 hr,,N,1,1,,BAO_0000218
12682,Mus musculus,Intermediate,CHEMBL625702,,,50594,,A,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,N,1,1,,BAO_0000218
12683,Mus musculus,Intermediate,CHEMBL625703,,,50594,,A,,Distribution of compound in mice liver was measured after 2 hr,,N,1,1,,BAO_0000218
12684,Mus musculus,Intermediate,CHEMBL625704,,,50594,,A,,Distribution of compound in mice liver was measured after 3 hr,,N,1,1,,BAO_0000218
12685,Mus musculus,Intermediate,CHEMBL625705,,,50594,,A,,Distribution of compound in mice liver was measured after 6 hr,,N,1,1,,BAO_0000218
12686,Canis lupus familiaris,Intermediate,CHEMBL625706,,,50588,1236.0,A,,Distribution in dog adrenal medulla 30 min after administration.,,N,1,1,,BAO_0000218
12687,Canis lupus familiaris,Intermediate,CHEMBL625707,,,50588,1236.0,A,,Distribution in dog adrenal medulla 72 hours after administration.,,N,1,1,,BAO_0000218
12688,Canis lupus familiaris,Intermediate,CHEMBL625708,,,50588,,A,,Distribution in female dog Ovary 24 hours after administration.,,N,1,1,,BAO_0000218
12689,Canis lupus familiaris,Intermediate,CHEMBL625709,,,50588,,A,,Distribution in female dog Ovary 72 hours after administration.,,N,1,1,,BAO_0000218
12690,Canis lupus familiaris,Intermediate,CHEMBL624180,,,50588,,A,,Distribution in female dog adipose 24 hours after administration.,,N,1,1,,BAO_0000218
12691,Canis lupus familiaris,Intermediate,CHEMBL624181,,,50588,,A,,Distribution in female dog adipose 72 hours after administration.,,N,1,1,,BAO_0000218
12692,Canis lupus familiaris,Intermediate,CHEMBL624182,,,50588,1235.0,A,,Distribution in female dog adrenal cortex 72 hours after administration.,,N,1,1,,BAO_0000218
12693,Canis lupus familiaris,Intermediate,CHEMBL624183,,,50588,1235.0,A,,Distribution in female dog adrenal cortex 72 hours after administration.,,N,1,1,,BAO_0000218
12694,Rattus norvegicus,Intermediate,CHEMBL624184,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12695,Rattus norvegicus,Intermediate,CHEMBL877489,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12696,Rattus norvegicus,Intermediate,CHEMBL624185,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12697,Rattus norvegicus,Intermediate,CHEMBL624186,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12698,Rattus norvegicus,Intermediate,CHEMBL624187,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12699,Rattus norvegicus,Intermediate,CHEMBL624188,,,50597,2107.0,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12700,Rattus norvegicus,Intermediate,CHEMBL624189,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12701,Rattus norvegicus,Intermediate,CHEMBL624190,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12702,Rattus norvegicus,Intermediate,CHEMBL624191,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12703,Rattus norvegicus,Intermediate,CHEMBL624192,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12704,Rattus norvegicus,Intermediate,CHEMBL624193,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12705,Rattus norvegicus,Intermediate,CHEMBL624194,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12706,Rattus norvegicus,Intermediate,CHEMBL624891,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12707,Rattus norvegicus,Intermediate,CHEMBL624892,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12708,Rattus norvegicus,Intermediate,CHEMBL624893,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12709,Rattus norvegicus,Intermediate,CHEMBL627632,,,50597,2048.0,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12710,Rattus norvegicus,Intermediate,CHEMBL627633,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12711,Rattus norvegicus,Intermediate,CHEMBL627634,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12712,Rattus norvegicus,Intermediate,CHEMBL627635,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12713,Rattus norvegicus,Intermediate,CHEMBL627636,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12714,Rattus norvegicus,Intermediate,CHEMBL626816,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12715,Rattus norvegicus,Intermediate,CHEMBL626817,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12716,Rattus norvegicus,Intermediate,CHEMBL626818,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12717,Rattus norvegicus,Intermediate,CHEMBL626819,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12718,Rattus norvegicus,Intermediate,CHEMBL626820,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12719,Rattus norvegicus,Intermediate,CHEMBL626821,,,50597,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12720,Rattus norvegicus,Intermediate,CHEMBL626822,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12721,Rattus norvegicus,Intermediate,CHEMBL626823,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12722,Rattus norvegicus,Intermediate,CHEMBL626824,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12723,Rattus norvegicus,Intermediate,CHEMBL626825,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12724,Rattus norvegicus,Intermediate,CHEMBL626826,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12725,Rattus norvegicus,Intermediate,CHEMBL626827,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12726,Rattus norvegicus,Intermediate,CHEMBL626828,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12727,Rattus norvegicus,Intermediate,CHEMBL626829,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12728,Rattus norvegicus,Intermediate,CHEMBL626830,,,50597,2046.0,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12729,Rattus norvegicus,Intermediate,CHEMBL627150,,,50597,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12730,Rattus norvegicus,Intermediate,CHEMBL627151,,,50597,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12731,Rattus norvegicus,Intermediate,CHEMBL627152,,,50597,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,1,1,,BAO_0000218
12732,Rattus norvegicus,Intermediate,CHEMBL627153,,,50597,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12733,,Autocuration,CHEMBL627154,,,22224,,A,,Rate of acetate production by the compound was determined,,U,0,1,,BAO_0000019
12734,,Autocuration,CHEMBL627155,,,22224,,A,,Rate of acetate production by the compound was determined; Not determined,,U,0,1,,BAO_0000019
12735,,Autocuration,CHEMBL627156,,,22224,,A,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,U,0,1,,BAO_0000019
12736,,Autocuration,CHEMBL627157,,,22224,,A,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,U,0,1,,BAO_0000019
12737,Oryctolagus cuniculus,Intermediate,CHEMBL627158,,,50592,,A,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,1,1,,BAO_0000218
12738,Oryctolagus cuniculus,Intermediate,CHEMBL627159,,,50592,1969.0,A,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,1,1,,BAO_0000218
12739,Mus musculus,Intermediate,CHEMBL627160,,,50594,,A,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1,1,,BAO_0000218
12740,Rattus norvegicus,Intermediate,CHEMBL628540,,,50597,,A,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1,1,,BAO_0000218
12741,Rattus norvegicus,Intermediate,CHEMBL628541,,,50597,1969.0,A,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1,1,,BAO_0000218
12742,Rattus norvegicus,Intermediate,CHEMBL628542,,,50597,1969.0,A,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1,1,,BAO_0000218
12743,,Autocuration,CHEMBL628543,,,22229,,P,,Solubility after at a pH 1.2,,U,0,1,,BAO_0000100
12744,,Autocuration,CHEMBL628544,,,22229,,P,,Solubility after at pH 1.2,,U,0,1,,BAO_0000100
12745,,Autocuration,CHEMBL628545,,,22229,,P,,Solubility after injection of water,,U,0,1,,BAO_0000100
12746,,Autocuration,CHEMBL628546,,,22224,,A,,Statistical significance of IC 50 values; Expressed as R value,,U,0,1,,BAO_0000019
12747,,Autocuration,CHEMBL874455,,,22224,,A,,Systemic availability with respect to methyldopa was determined,,U,0,1,,BAO_0000019
12748,Rattus norvegicus,Intermediate,CHEMBL628547,,,50597,,A,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,N,1,1,,BAO_0000218
12749,Rattus norvegicus,Intermediate,CHEMBL628548,,,50597,1969.0,A,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,N,1,1,,BAO_0000218
12750,Oryctolagus cuniculus,Intermediate,CHEMBL628549,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12751,Oryctolagus cuniculus,Intermediate,CHEMBL628550,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12752,Oryctolagus cuniculus,Intermediate,CHEMBL628551,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,N,1,1,,BAO_0000218
12753,Oryctolagus cuniculus,Intermediate,CHEMBL628552,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,N,1,1,,BAO_0000218
12754,Oryctolagus cuniculus,Intermediate,CHEMBL628553,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,N,1,1,,BAO_0000218
12755,Oryctolagus cuniculus,Intermediate,CHEMBL628554,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,N,1,1,,BAO_0000218
12756,Oryctolagus cuniculus,Intermediate,CHEMBL628555,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,N,1,1,,BAO_0000218
12757,Oryctolagus cuniculus,Intermediate,CHEMBL628556,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,N,1,1,,BAO_0000218
12758,Oryctolagus cuniculus,Intermediate,CHEMBL628557,,,50592,2113.0,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12759,Oryctolagus cuniculus,Intermediate,CHEMBL628558,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12760,Oryctolagus cuniculus,Intermediate,CHEMBL628559,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,N,1,1,,BAO_0000218
12761,Oryctolagus cuniculus,Intermediate,CHEMBL628560,,,50592,1988.0,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12762,Oryctolagus cuniculus,Intermediate,CHEMBL874456,,,50592,1088.0,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,N,1,1,,BAO_0000218
12763,Oryctolagus cuniculus,Intermediate,CHEMBL628561,,,50592,1988.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,N,1,1,,BAO_0000218
12764,Oryctolagus cuniculus,Intermediate,CHEMBL628562,,,50592,1988.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,N,1,1,,BAO_0000218
12765,Oryctolagus cuniculus,Intermediate,CHEMBL628563,,,50592,1088.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,N,1,1,,BAO_0000218
12766,Oryctolagus cuniculus,Intermediate,CHEMBL628564,,,50592,1088.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,N,1,1,,BAO_0000218
12767,Oryctolagus cuniculus,Intermediate,CHEMBL628565,,,50592,1088.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,N,1,1,,BAO_0000218
12768,Oryctolagus cuniculus,Intermediate,CHEMBL631248,,,50592,1088.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,N,1,1,,BAO_0000218
12769,Oryctolagus cuniculus,Intermediate,CHEMBL631249,,,50592,1088.0,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,N,1,1,,BAO_0000218
12770,Oryctolagus cuniculus,Intermediate,CHEMBL627214,,,50592,2113.0,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12771,Oryctolagus cuniculus,Intermediate,CHEMBL874591,,,50592,1988.0,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12772,Oryctolagus cuniculus,Intermediate,CHEMBL627215,,,50592,1988.0,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,N,1,1,,BAO_0000218
12773,Oryctolagus cuniculus,Intermediate,CHEMBL625471,,,50592,1988.0,A,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,N,1,1,,BAO_0000218
12774,Oryctolagus cuniculus,Intermediate,CHEMBL625472,,,50592,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,N,1,1,,BAO_0000218
12775,Oryctolagus cuniculus,Intermediate,CHEMBL625473,,,50592,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,N,1,1,,BAO_0000218
12776,Canis lupus familiaris,Intermediate,CHEMBL625474,,,50588,,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,N,1,1,,BAO_0000218
12777,Canis lupus familiaris,Intermediate,CHEMBL625475,,,50588,,A,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,N,1,1,,BAO_0000218
12778,Rattus norvegicus,Intermediate,CHEMBL625476,,,50597,,A,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,N,1,1,,BAO_0000218
12779,Rattus norvegicus,Intermediate,CHEMBL625477,,,50597,,A,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,N,1,1,,BAO_0000218
12780,Rattus norvegicus,Intermediate,CHEMBL625478,,,50597,,A,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,N,1,1,,BAO_0000218
12781,Rattus norvegicus,Intermediate,CHEMBL625479,,,50597,,A,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,N,1,1,,BAO_0000218
12782,Rattus norvegicus,Intermediate,CHEMBL625480,,,50597,,A,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,N,1,1,,BAO_0000218
12783,Rattus norvegicus,Intermediate,CHEMBL625481,,,50597,1969.0,A,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,N,1,1,,BAO_0000218
12784,Rattus norvegicus,Intermediate,CHEMBL625482,,,50597,,A,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,N,1,1,,BAO_0000218
12785,Rattus norvegicus,Intermediate,CHEMBL625483,,,50597,,A,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,N,1,1,,BAO_0000218
12786,Rattus norvegicus,Intermediate,CHEMBL625484,,,50597,,A,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,N,1,1,,BAO_0000218
12787,Rattus norvegicus,Intermediate,CHEMBL625485,,,50597,,A,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,N,1,1,,BAO_0000218
12788,Canis lupus familiaris,Intermediate,CHEMBL625486,,,50588,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,N,1,1,,BAO_0000218
12789,Rattus norvegicus,Intermediate,CHEMBL625487,,,50597,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
12790,Rattus norvegicus,Intermediate,CHEMBL625488,,,50597,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
12791,Rattus norvegicus,Intermediate,CHEMBL625489,,,50597,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
12792,Rattus norvegicus,Intermediate,CHEMBL625490,,,50597,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
12793,Canis lupus familiaris,Intermediate,CHEMBL625491,,,50588,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,N,1,1,,BAO_0000218
12794,Rattus norvegicus,Intermediate,CHEMBL625492,,,50597,1969.0,A,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,N,1,1,,BAO_0000218
12795,Homo sapiens,Intermediate,CHEMBL625493,,,50587,1969.0,A,,plasma clearance in human,,N,1,1,,BAO_0000218
12796,Rattus norvegicus,Intermediate,CHEMBL625494,,,50597,,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,1,1,,BAO_0000218
12797,Rattus norvegicus,Intermediate,CHEMBL625495,,,50597,,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,1,1,,BAO_0000218
12798,Rattus norvegicus,Intermediate,CHEMBL625496,,,50597,,A,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,1,1,,BAO_0000218
12799,,Autocuration,CHEMBL625497,,,22229,,P,,1-Octanol/water partition coefficient measured at 7.4,,U,0,1,,BAO_0000100
12800,,Autocuration,CHEMBL625498,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12801,,Autocuration,CHEMBL625499,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
12802,,Autocuration,CHEMBL625500,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12803,,Autocuration,CHEMBL625501,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12804,,Autocuration,CHEMBL625502,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12805,,Autocuration,CHEMBL625503,,,22229,,P,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,U,0,1,,BAO_0000100
12806,,Autocuration,CHEMBL625504,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12807,,Autocuration,CHEMBL625505,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12808,,Autocuration,CHEMBL625506,,,22229,,P,,Calculated partition coefficient of the compound,,U,0,1,,BAO_0000100
12809,,Autocuration,CHEMBL625507,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
12810,,Autocuration,CHEMBL625508,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12811,,Autocuration,CHEMBL625509,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12812,,Autocuration,CHEMBL625510,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12813,,Autocuration,CHEMBL883125,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12814,,Autocuration,CHEMBL625511,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12815,,Autocuration,CHEMBL874650,,,22224,,A,,Partition coefficient of the compound,,U,0,1,,BAO_0000019
12816,,Autocuration,CHEMBL625512,,,22224,,A,,Partition coefficient of the compound,,U,0,1,,BAO_0000019
12817,,Autocuration,CHEMBL625513,,,22224,,A,,Partition coefficient of compound was determined,,U,0,1,,BAO_0000019
12818,,Autocuration,CHEMBL625514,,,22224,,A,,Partition coefficient was determined,,U,0,1,,BAO_0000019
12819,,Autocuration,CHEMBL625515,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12820,,Autocuration,CHEMBL625516,,,22229,,P,,partition coefficient of compound was determined,,U,0,1,,BAO_0000100
12821,Canis lupus familiaris,Intermediate,CHEMBL625517,,,50588,,A,,The total body administered intravenously in dog,,N,1,1,,BAO_0000218
12822,Rattus norvegicus,Intermediate,CHEMBL625518,,,50597,,A,,The total body administered intravenously in rats,,N,1,1,,BAO_0000218
12823,Mus musculus,Intermediate,CHEMBL625519,,,50594,,A,,Time taken for the administration to female NIH mice weighing 25-30 g.,,N,1,1,,BAO_0000218
12824,,Autocuration,CHEMBL625520,,,22224,,A,,Time taken for the administration,,U,0,1,,BAO_0000019
12825,Canis lupus familiaris,Intermediate,CHEMBL874651,,,50588,,A,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12826,Simiiformes,Autocuration,CHEMBL625521,,,22224,,A,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,0,1,,BAO_0000218
12827,Oryctolagus cuniculus,Intermediate,CHEMBL623171,,,50592,,A,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12828,Rattus norvegicus,Intermediate,CHEMBL623853,,,50597,,A,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,N,1,1,,BAO_0000218
12829,,Autocuration,CHEMBL623854,,,22224,,A,,Plasma clearance for the compound was determined.,,U,0,1,,BAO_0000019
12830,,Autocuration,CHEMBL874405,,,22224,,P,,CLog P value of the compound,,U,0,1,,BAO_0000100
12831,,Autocuration,CHEMBL623855,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12832,,Autocuration,CHEMBL623856,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12833,,Autocuration,CHEMBL623857,,,22224,,P,,ClogP value of the compound; nd ='no data',,U,0,1,,BAO_0000100
12834,,Autocuration,CHEMBL623858,,,22224,,P,,ClogP value of the compound; nd ='not determined',,U,0,1,,BAO_0000100
12835,,Autocuration,CHEMBL623859,,,22224,,P,,CLog P was determined,,U,0,1,,BAO_0000100
12836,,Autocuration,CHEMBL839829,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12837,,Autocuration,CHEMBL623860,,,22224,,A,,CLogP was calculated,,U,0,1,,BAO_0000019
12838,,Autocuration,CHEMBL623861,,,22224,,A,,CLogP value was determined,,U,0,1,,BAO_0000019
12839,,Autocuration,CHEMBL623862,,,22224,,A,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,U,0,1,,BAO_0000019
12840,,Autocuration,CHEMBL874406,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12841,,Autocuration,CHEMBL623863,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12842,,Autocuration,CHEMBL624021,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12843,Canis lupus familiaris,Intermediate,CHEMBL624022,,,50588,1236.0,A,,Distribution in female dog adrenal medulla 24 hours after administration.,,N,1,1,,BAO_0000218
12844,Canis lupus familiaris,Intermediate,CHEMBL624023,,,50588,1236.0,A,,Distribution in female dog adrenal medulla 72 hours after administration.,,N,1,1,,BAO_0000218
12845,Canis lupus familiaris,Intermediate,CHEMBL624024,,,50588,,A,,Distribution in female dog bile 24 hours after administration.,,N,1,1,,BAO_0000218
12846,Canis lupus familiaris,Intermediate,CHEMBL624025,,,50588,,A,,Distribution in female dog bile 72 hr after administration.,,N,1,1,,BAO_0000218
12847,Canis lupus familiaris,Intermediate,CHEMBL624026,,,50588,,A,,Distribution in female dog blood 24 hours after administration.,,N,1,1,,BAO_0000218
12848,Canis lupus familiaris,Intermediate,CHEMBL624027,,,50588,,A,,Distribution in female dog blood 72 hours after administration.,,N,1,1,,BAO_0000218
12849,Canis lupus familiaris,Intermediate,CHEMBL624028,,,50588,,A,,Distribution in female dog heart 24 hours after administration.,,N,1,1,,BAO_0000218
12850,Canis lupus familiaris,Intermediate,CHEMBL624029,,,50588,,A,,Distribution in female dog heart 72 hours after administration.,,N,1,1,,BAO_0000218
12851,Canis lupus familiaris,Intermediate,CHEMBL624030,,,50588,,A,,Distribution in female dog kidney 24 hours after administration.,,N,1,1,,BAO_0000218
12852,Canis lupus familiaris,Intermediate,CHEMBL624031,,,50588,,A,,Distribution in female dog kidney 72 hours after administration.,,N,1,1,,BAO_0000218
12853,Canis lupus familiaris,Intermediate,CHEMBL624032,,,50588,160.0,A,,Distribution in female dog large intestine 24 hours after administration.,,N,1,1,,BAO_0000218
12854,Canis lupus familiaris,Intermediate,CHEMBL874407,,,50588,160.0,A,,Distribution in female dog large intestine 72 hours after administration.,,N,1,1,,BAO_0000218
12855,Canis lupus familiaris,Intermediate,CHEMBL624033,,,50588,,A,,Distribution in female dog liver 24 hours after administration.,,N,1,1,,BAO_0000218
12856,Canis lupus familiaris,Intermediate,CHEMBL624034,,,50588,,A,,Distribution in female dog liver 72 hours after administration.,,N,1,1,,BAO_0000218
12857,Canis lupus familiaris,Intermediate,CHEMBL624035,,,50588,,A,,Distribution in female dog lung 24 hours after administration.,,N,1,1,,BAO_0000218
12858,Canis lupus familiaris,Intermediate,CHEMBL624036,,,50588,,A,,Distribution in female dog lung 72 hours after administration.,,N,1,1,,BAO_0000218
12859,Canis lupus familiaris,Intermediate,CHEMBL624037,,,50588,2385.0,A,,Distribution in female dog muscle 24 hours after administration.,,N,1,1,,BAO_0000218
12860,Canis lupus familiaris,Intermediate,CHEMBL624038,,,50588,2385.0,A,,Distribution in female dog muscle 72 hours after administration.,,N,1,1,,BAO_0000218
12861,Canis lupus familiaris,Intermediate,CHEMBL624039,,,50588,,A,,Distribution in female dog pancreas 24 hours after administration.,,N,1,1,,BAO_0000218
12862,Canis lupus familiaris,Intermediate,CHEMBL624040,,,50588,,A,,Distribution in female dog pancreas 72 hours after administration.,,N,1,1,,BAO_0000218
12863,Canis lupus familiaris,Intermediate,CHEMBL624041,,,50588,160.0,A,,Distribution in female dog small intestine 24 hours after administration.,,N,1,1,,BAO_0000218
12864,Canis lupus familiaris,Intermediate,CHEMBL624042,,,50588,160.0,A,,Distribution in female dog small intestine 72 hours after administration.,,N,1,1,,BAO_0000218
12865,Canis lupus familiaris,Intermediate,CHEMBL624043,,,50588,2106.0,A,,Distribution in female dog spleen 24 hours after administration.,,N,1,1,,BAO_0000218
12866,Canis lupus familiaris,Intermediate,CHEMBL624044,,,50588,2106.0,A,,Distribution in female dog spleen 72 hours after administration.,,N,1,1,,BAO_0000218
12867,Canis lupus familiaris,Intermediate,CHEMBL624045,,,50588,945.0,A,,Distribution in female dog stomach 24 hours after administration.,,N,1,1,,BAO_0000218
12868,Canis lupus familiaris,Intermediate,CHEMBL624046,,,50588,945.0,A,,Distribution in female dog stomach 72 hours after administration.,,N,1,1,,BAO_0000218
12869,Canis lupus familiaris,Intermediate,CHEMBL624047,,,50588,2046.0,A,,Distribution in female dog thyroid 24 hours after administration.,,N,1,1,,BAO_0000218
12870,Canis lupus familiaris,Intermediate,CHEMBL624048,,,50588,2046.0,A,,Distribution in female dog thyroid 72 hours after administration.,,N,1,1,,BAO_0000218
12871,Canis lupus familiaris,Intermediate,CHEMBL874408,,,50588,1088.0,A,,Distribution in female dog urine 24 hours after administration.,,N,1,1,,BAO_0000218
12872,Canis lupus familiaris,Intermediate,CHEMBL624049,,,50588,1088.0,A,,Distribution in female dog urine 72 hr after administration.,,N,1,1,,BAO_0000218
12873,,Autocuration,CHEMBL624050,,,22224,1969.0,A,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,U,0,1,,BAO_0000218
12874,,Autocuration,CHEMBL624051,,,22224,,A,,Plasma concentration at 7 hr after intravenous dosing,,U,0,1,,BAO_0000019
12875,Rattus norvegicus,Intermediate,CHEMBL623278,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,N,1,1,,BAO_0000218
12876,Rattus norvegicus,Intermediate,CHEMBL623279,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,N,1,1,,BAO_0000218
12877,Rattus norvegicus,Intermediate,CHEMBL623280,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,N,1,1,,BAO_0000218
12878,Rattus norvegicus,Intermediate,CHEMBL623963,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,N,1,1,,BAO_0000218
12879,Rattus norvegicus,Intermediate,CHEMBL623964,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,N,1,1,,BAO_0000218
12880,Rattus norvegicus,Intermediate,CHEMBL623965,,,50597,,A,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,N,1,1,,BAO_0000218
12881,Rattus norvegicus,Intermediate,CHEMBL623966,,,50597,,A,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,N,1,1,,BAO_0000218
12882,Rattus norvegicus,Intermediate,CHEMBL874415,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,N,1,1,,BAO_0000218
12883,Rattus norvegicus,Intermediate,CHEMBL623967,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,N,1,1,,BAO_0000218
12884,Rattus norvegicus,Intermediate,CHEMBL623968,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,N,1,1,,BAO_0000218
12885,Rattus norvegicus,Intermediate,CHEMBL623969,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,N,1,1,,BAO_0000218
12886,Rattus norvegicus,Intermediate,CHEMBL628409,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,N,1,1,,BAO_0000218
12887,Rattus norvegicus,Intermediate,CHEMBL628410,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,N,1,1,,BAO_0000218
12888,Rattus norvegicus,Intermediate,CHEMBL628411,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,N,1,1,,BAO_0000218
12889,Rattus norvegicus,Intermediate,CHEMBL628412,,,50597,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,N,1,1,,BAO_0000218
12890,,Autocuration,CHEMBL628413,,,22224,,A,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,U,0,1,,BAO_0000019
12891,,Autocuration,CHEMBL628414,,,22224,1969.0,A,,The concentration in plasmat; Not determined,,U,0,1,,BAO_0000019
12892,Rattus norvegicus,Intermediate,CHEMBL628415,,,50597,,A,,Tissue level at 10 mg/kg/po in wistar rats in blood,,N,1,1,,BAO_0000218
12893,Rattus norvegicus,Intermediate,CHEMBL628416,,,50597,,A,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,N,1,1,,BAO_0000218
12894,Rattus norvegicus,Intermediate,CHEMBL628417,,,50597,,A,,Tissue level at 10 mg/kg/po in wistar rats in heart,,N,1,1,,BAO_0000218
12895,Rattus norvegicus,Intermediate,CHEMBL874908,,,50597,2107.0,A,,Tissue level at 10 mg/kg/po in wistar rats in liver,,N,1,1,,BAO_0000218
12896,Rattus norvegicus,Intermediate,CHEMBL628418,,,50597,,A,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,N,1,1,,BAO_0000218
12897,Rattus norvegicus,Intermediate,CHEMBL628419,,,50597,2385.0,A,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,N,1,1,,BAO_0000218
12898,Rattus norvegicus,Intermediate,CHEMBL628420,,,50597,,A,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,N,1,1,,BAO_0000218
12899,,Autocuration,CHEMBL628421,,,22224,,A,,Water solubility at 37 degree C.,,U,0,1,,BAO_0000019
12900,,Autocuration,CHEMBL626726,,,22229,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,0,1,,BAO_0000100
12901,,Autocuration,CHEMBL626727,,,22229,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,0,1,,BAO_0000100
12902,Rattus norvegicus,Intermediate,CHEMBL626728,,,50597,178.0,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12903,Rattus norvegicus,Intermediate,CHEMBL626729,,,50597,178.0,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12904,Rattus norvegicus,Intermediate,CHEMBL626730,,,50597,178.0,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12905,Rattus norvegicus,Intermediate,CHEMBL626731,,,50597,178.0,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12906,Rattus norvegicus,Intermediate,CHEMBL626732,,,50597,178.0,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12907,Rattus norvegicus,Intermediate,CHEMBL626733,,,50597,948.0,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12908,Rattus norvegicus,Intermediate,CHEMBL626734,,,50597,948.0,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12909,Rattus norvegicus,Intermediate,CHEMBL626735,,,50597,948.0,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12910,Rattus norvegicus,Intermediate,CHEMBL874909,,,50597,948.0,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12911,Rattus norvegicus,Intermediate,CHEMBL626736,,,50597,948.0,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12912,Rattus norvegicus,Intermediate,CHEMBL626737,,,50597,2113.0,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12913,Rattus norvegicus,Intermediate,CHEMBL630999,,,50597,2113.0,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12914,Rattus norvegicus,Intermediate,CHEMBL631000,,,50597,2113.0,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12915,Rattus norvegicus,Intermediate,CHEMBL631001,,,50597,2113.0,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12916,Rattus norvegicus,Intermediate,CHEMBL631002,,,50597,2113.0,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12917,Rattus norvegicus,Intermediate,CHEMBL631003,,,50597,2107.0,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12918,Rattus norvegicus,Intermediate,CHEMBL631004,,,50597,2107.0,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12919,Rattus norvegicus,Intermediate,CHEMBL631005,,,50597,2107.0,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12920,Rattus norvegicus,Intermediate,CHEMBL631006,,,50597,2107.0,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12921,Rattus norvegicus,Intermediate,CHEMBL631007,,,50597,2107.0,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12922,Rattus norvegicus,Intermediate,CHEMBL631008,,,50597,2048.0,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12923,Rattus norvegicus,Intermediate,CHEMBL631009,,,50597,2048.0,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12924,Rattus norvegicus,Intermediate,CHEMBL631010,,,50597,2048.0,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12925,Rattus norvegicus,Intermediate,CHEMBL631011,,,50597,2048.0,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12926,Rattus norvegicus,Intermediate,CHEMBL631012,,,50597,2048.0,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12927,Rattus norvegicus,Intermediate,CHEMBL630271,,,50597,2046.0,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12928,Rattus norvegicus,Intermediate,CHEMBL630272,,,50597,2046.0,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12929,Rattus norvegicus,Intermediate,CHEMBL630273,,,50597,2046.0,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12930,Rattus norvegicus,Intermediate,CHEMBL630274,,,50597,2046.0,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12931,Rattus norvegicus,Intermediate,CHEMBL630275,,,50597,2046.0,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12932,Rattus norvegicus,Intermediate,CHEMBL875782,,,50597,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12933,Rattus norvegicus,Intermediate,CHEMBL630276,,,50597,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12934,Rattus norvegicus,Intermediate,CHEMBL630277,,,50597,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12935,Rattus norvegicus,Intermediate,CHEMBL630278,,,50597,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12936,Rattus norvegicus,Intermediate,CHEMBL630279,,,50597,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,N,1,1,,BAO_0000218
12937,,Autocuration,CHEMBL630280,,,22224,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,U,0,1,,BAO_0000019
12938,,Autocuration,CHEMBL630281,,,22224,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,0,1,,BAO_0000019
12939,Oryctolagus cuniculus,Intermediate,CHEMBL630282,,,50592,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,N,1,1,,BAO_0000218
12940,Oryctolagus cuniculus,Intermediate,CHEMBL630283,,,50592,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,N,1,1,,BAO_0000218
12941,,Autocuration,CHEMBL630284,,,22224,,A,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,U,0,1,,BAO_0000019
12942,,Autocuration,CHEMBL630285,,,22224,,A,,Alkylating activity was determined,,U,0,1,,BAO_0000019
12943,,Autocuration,CHEMBL630286,,,22224,,A,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,U,0,1,,BAO_0000251
12944,Oryctolagus cuniculus,Intermediate,CHEMBL630069,,,50592,,A,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,N,1,1,,BAO_0000218
12945,Oryctolagus cuniculus,Intermediate,CHEMBL630070,,,50592,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,N,1,1,,BAO_0000218
12946,Oryctolagus cuniculus,Intermediate,CHEMBL630071,,,50592,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,N,1,1,,BAO_0000218
12947,Oryctolagus cuniculus,Intermediate,CHEMBL630072,,,50592,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,N,1,1,,BAO_0000218
12948,Oryctolagus cuniculus,Intermediate,CHEMBL875110,,,50592,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,N,1,1,,BAO_0000218
12949,Rattus norvegicus,Intermediate,CHEMBL630073,,,50597,,A,,Compound was tested for antidiuretic activity in rats,,N,1,1,,BAO_0000218
12950,,Autocuration,CHEMBL630074,,,22224,,A,,Compound was tested for inactivation kinetic values,,U,0,1,,BAO_0000019
12951,,Autocuration,CHEMBL630075,,,22224,,A,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,U,0,1,,BAO_0000218
12952,,Autocuration,CHEMBL630076,,,22224,,A,,Dissociation rate calculated from the first-order equation using the t1/2 value,,U,0,1,,BAO_0000019
12953,,Autocuration,CHEMBL630077,,,22229,,P,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,U,0,1,,BAO_0000100
12954,,Autocuration,CHEMBL630078,,,22229,,P,,Aqueous solubility was measured,,U,0,1,,BAO_0000100
12955,,Autocuration,CHEMBL630079,,,22229,,P,,Aqueous solubility was measured at a pH 4,,U,0,1,,BAO_0000100
12956,,Autocuration,CHEMBL630080,,,22229,,P,,Aqueous solubility (pH 7),,U,0,1,,BAO_0000100
12957,,Autocuration,CHEMBL630081,,,22229,,P,,Aqueous solubility was measured at a pH 9,,U,0,1,,BAO_0000100
12958,,Autocuration,CHEMBL630082,,,22224,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,U,0,1,,BAO_0000019
12959,,Autocuration,CHEMBL630083,,,22224,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,0,1,,BAO_0000019
12960,,Autocuration,CHEMBL630084,,,22224,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,0,1,,BAO_0000019
12961,,Autocuration,CHEMBL629198,,,22229,,P,,Aqueous solubility of the compound,,U,0,1,,BAO_0000100
12962,,Autocuration,CHEMBL629199,,,22229,,P,,Aqueous solubility at 37 degree Celsius at pH 7.38,,U,0,1,,BAO_0000100
12963,,Autocuration,CHEMBL629200,,,22229,,P,,Aqueous solubility in pH 7.4 phosphate buffer,,U,0,1,,BAO_0000100
12964,Canis lupus familiaris,Intermediate,CHEMBL629201,,,50588,,A,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,N,1,1,,BAO_0000218
12965,Canis lupus familiaris,Intermediate,CHEMBL629202,,,50588,,A,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,N,1,1,,BAO_0000218
12966,Homo sapiens,Intermediate,CHEMBL875111,,,50587,,A,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,N,1,1,,BAO_0000218
12967,Homo sapiens,Intermediate,CHEMBL629203,,,50587,,A,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,N,1,1,,BAO_0000218
12968,Homo sapiens,Intermediate,CHEMBL629204,,,50587,,A,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,N,1,1,,BAO_0000218
12969,Homo sapiens,Intermediate,CHEMBL629205,,,50587,,A,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,N,1,1,,BAO_0000218
12970,Homo sapiens,Intermediate,CHEMBL629206,,,50587,,A,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,N,1,1,,BAO_0000218
12971,,Autocuration,CHEMBL631185,,,22224,,A,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,U,0,1,,BAO_0000019
12972,Rattus norvegicus,Intermediate,CHEMBL631186,,,50597,,A,,Compound was evaluated for the average bile flow rat in rats,,N,1,1,,BAO_0000218
12973,Oryctolagus cuniculus,Intermediate,CHEMBL631187,,,50592,,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,1,1,,BAO_0000218
12974,Oryctolagus cuniculus,Intermediate,CHEMBL631188,,,50592,,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,1,1,,BAO_0000218
12975,,Autocuration,CHEMBL876419,,,22224,,A,,Average half life period was determined,,U,0,1,,BAO_0000019
12976,,Autocuration,CHEMBL631189,,,22224,,A,,Average half life period was determined,,U,0,1,,BAO_0000019
12977,Human herpesvirus 1,Intermediate,CHEMBL631190,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,1,1,,BAO_0000218
12978,Human herpesvirus 1,Intermediate,CHEMBL631191,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,1,1,,BAO_0000218
12979,Human herpesvirus 1,Intermediate,CHEMBL631192,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,N,1,1,,BAO_0000218
12980,Human herpesvirus 1,Intermediate,CHEMBL632400,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,N,1,1,,BAO_0000218
12981,Human herpesvirus 1,Intermediate,CHEMBL630564,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,1,1,,BAO_0000218
12982,Human herpesvirus 1,Intermediate,CHEMBL630565,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,1,1,,BAO_0000218
12983,Human herpesvirus 1,Intermediate,CHEMBL630566,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,N,1,1,,BAO_0000218
12984,Human herpesvirus 1,Intermediate,CHEMBL631229,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,N,1,1,,BAO_0000218
12985,Human herpesvirus 1,Intermediate,CHEMBL631230,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,N,1,1,,BAO_0000218
12986,,Autocuration,CHEMBL876428,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12987,,Autocuration,CHEMBL631231,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12988,,Autocuration,CHEMBL631232,,,22229,,P,,Calculated partition coefficient (clogP) (MacLogP),,U,0,1,,BAO_0000100
12989,,Autocuration,CHEMBL631233,,,22224,,A,,Hydrophilicity was determined,,U,0,1,,BAO_0000019
12990,,Autocuration,CHEMBL631234,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12991,,Autocuration,CHEMBL883126,,,22224,,A,,Increased absorption was determined,,U,0,1,,BAO_0000019
12992,,Autocuration,CHEMBL631235,,,22224,,P,,Lipophilicity value was evaluated,,U,0,1,,BAO_0000100
12993,,Autocuration,CHEMBL631236,,,22224,,P,,Log P value of the compound.,,U,0,1,,BAO_0000100
12994,,Autocuration,CHEMBL631237,,,22224,,A,,Partition coefficient of compound was determined,,U,0,1,,BAO_0000019
12995,,Autocuration,CHEMBL631238,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12996,,Autocuration,CHEMBL876429,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
12997,,Autocuration,CHEMBL631414,,,22224,,A,,Partition coefficient was measured by medchem software; Not calculated,,U,0,1,,BAO_0000019
12998,,Autocuration,CHEMBL631415,,,22224,,P,,Partition coefficient was measured by octanol-water using standard shake-flask method,,U,0,1,,BAO_0000100
12999,,Autocuration,CHEMBL631416,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13000,,Autocuration,CHEMBL631417,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
13001,,Autocuration,CHEMBL631418,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13002,,Autocuration,CHEMBL631419,,,22229,,P,,The Octanol/Water partition coefficient CLogP,,U,0,1,,BAO_0000100
13003,,Autocuration,CHEMBL631420,,,22224,,A,,The pharmacokinetic parameter C Log p was reported,,U,0,1,,BAO_0000019
13004,,Autocuration,CHEMBL631421,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13005,,Autocuration,CHEMBL631422,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13006,,Autocuration,CHEMBL631423,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13007,Rattus norvegicus,Intermediate,CHEMBL876430,,,50597,1969.0,A,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
13008,Rattus norvegicus,Intermediate,CHEMBL631424,,,50597,1969.0,A,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
13009,Canis lupus familiaris,Intermediate,CHEMBL631425,,,50588,1969.0,A,,Compound was administered intravenously in dog to evaluate plasma clearance values,,N,1,1,,BAO_0000218
13010,Simiiformes,Autocuration,CHEMBL631426,,,22224,1969.0,A,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,U,0,1,,BAO_0000218
13011,Mus musculus,Intermediate,CHEMBL631427,,,50594,1969.0,A,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,N,1,1,,BAO_0000218
13012,Canis lupus familiaris,Intermediate,CHEMBL631428,,,50588,1969.0,A,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,N,1,1,,BAO_0000218
13013,Macaca mulatta,Intermediate,CHEMBL631429,,,50797,2107.0,A,,Intrinsic clearance in Rhesus liver microsome,Microsomes,N,1,1,,BAO_0000218
13014,Canis lupus familiaris,Intermediate,CHEMBL631430,,,50588,2107.0,A,,Intrinsic clearance in dog liver microsome,Microsomes,N,1,1,,BAO_0000218
13015,Rattus norvegicus,Intermediate,CHEMBL631431,,,50597,2107.0,A,,Intrinsic clearance in rat liver microsome,Microsomes,N,1,1,,BAO_0000218
13016,Macaca mulatta,Intermediate,CHEMBL631432,,,50797,1969.0,A,,Low plasma clearance was calculated in rhesus monkey,,N,1,1,,BAO_0000218
13017,Canis lupus familiaris,Intermediate,CHEMBL631433,,,50588,,A,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,N,1,1,,BAO_0000218
13018,,Autocuration,CHEMBL631434,,,22224,,A,,Plasma clearance after intravenous dose of 0.3 mg/kg,,U,0,1,,BAO_0000218
13019,,Autocuration,CHEMBL631435,,,22224,,A,,Plasma clearance after intravenous dose of 1 mg/kg,,U,0,1,,BAO_0000218
13020,,Autocuration,CHEMBL631436,,,22224,,A,,Plasma clearance after intravenous dose of 3 mg/kg,,U,0,1,,BAO_0000218
13021,,Autocuration,CHEMBL631437,,,22224,,A,,Plasma clearance after intravenous dose of 3.87 mg/kg,,U,0,1,,BAO_0000218
13022,Rattus norvegicus,Intermediate,CHEMBL631438,,,50597,,A,,Plasma clearance after peroral administration at 10 mpk in Rat,,N,1,1,,BAO_0000218
13023,Macaca mulatta,Intermediate,CHEMBL876431,,,50797,,A,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,N,1,1,,BAO_0000218
13024,Canis lupus familiaris,Intermediate,CHEMBL631439,,,50588,,A,,Plasma clearance after peroral administration at 10 mpk in dog,,N,1,1,,BAO_0000218
13025,Rattus norvegicus,Intermediate,CHEMBL631440,,,50597,,A,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,N,1,1,,BAO_0000218
13026,,Autocuration,CHEMBL631441,,,22224,,A,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,U,0,1,,BAO_0000019
13027,,Autocuration,CHEMBL631442,,,22224,,A,,Critical Micellar concentration was determined,,U,0,1,,BAO_0000019
13028,,Autocuration,CHEMBL626525,,,22224,,A,,Critical Micellar concentration of the compound. was determined,,U,0,1,,BAO_0000019
13029,,Autocuration,CHEMBL627168,,,22224,,A,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,U,0,1,,BAO_0000019
13030,,Autocuration,CHEMBL875618,,,22224,,A,,Critical micellar concentration was measured in water by the dye solubilization method,,U,0,1,,BAO_0000019
13031,,Autocuration,CHEMBL626612,,,22224,,B,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,U,0,1,,BAO_0000019
13032,,Autocuration,CHEMBL626613,,,22224,,A,,CMR value (relative to BAY K 8644),,U,0,1,,BAO_0000019
13033,,Autocuration,CHEMBL626614,,,22224,,A,,Carbamoylating activity was determined,,U,0,1,,BAO_0000019
13034,Simiiformes,Autocuration,CHEMBL626615,,,22224,,A,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,U,0,1,,BAO_0000218
13035,,Autocuration,CHEMBL626616,,,22224,,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,U,0,1,,BAO_0000019
13036,,Autocuration,CHEMBL626617,,,22224,,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,U,0,1,,BAO_0000019
13037,Canis lupus familiaris,Intermediate,CHEMBL626618,,,50588,1969.0,A,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,N,1,1,,BAO_0000218
13038,Rattus norvegicus,Intermediate,CHEMBL626619,,,50597,1969.0,A,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,N,1,1,,BAO_0000218
13039,Canis lupus familiaris,Intermediate,CHEMBL626620,,,50588,,A,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,N,1,1,,BAO_0000218
13040,Rattus norvegicus,Intermediate,CHEMBL626621,,,50597,,A,,"Clearance rate at 5.5 mg/kg, iv, in rat",,N,1,1,,BAO_0000218
13041,Macaca fascicularis,Intermediate,CHEMBL626622,,,100710,,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,1,1,,BAO_0000218
13042,Macaca fascicularis,Intermediate,CHEMBL626623,,,100710,,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,1,1,,BAO_0000218
13043,Canis lupus familiaris,Intermediate,CHEMBL626624,,,50588,,A,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,1,1,,BAO_0000218
13044,Rattus norvegicus,Intermediate,CHEMBL626625,,,50597,,A,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,1,1,,BAO_0000218
13045,Rattus norvegicus,Intermediate,CHEMBL626626,,,50597,2107.0,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,1,1,,BAO_0000218
13046,,Autocuration,CHEMBL626627,,,22224,,A,,Tested for the total clearance of the compound,,U,0,1,,BAO_0000218
13047,Canis lupus familiaris,Intermediate,CHEMBL626628,,,50588,,A,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
13048,,Autocuration,CHEMBL626629,,,22224,,A,,Total body clearance was determined,,U,0,1,,BAO_0000218
13049,Rattus norvegicus,Intermediate,CHEMBL626630,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,1,1,,BAO_0000218
13050,Rattus norvegicus,Intermediate,CHEMBL626631,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,1,1,,BAO_0000218
13051,,Autocuration,CHEMBL626632,,,22229,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,0,1,,BAO_0000100
13052,,Autocuration,CHEMBL626633,,,22229,,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,0,1,,BAO_0000100
13053,,Autocuration,CHEMBL626634,,,22229,,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,U,0,1,,BAO_0000100
13054,,Autocuration,CHEMBL626635,,,22229,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,0,1,,BAO_0000100
13055,,Autocuration,CHEMBL626636,,,22229,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,0,1,,BAO_0000100
13056,,Autocuration,CHEMBL626637,,,22229,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,0,1,,BAO_0000100
13057,Pneumocystis carinii,Intermediate,CHEMBL626638,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,N,1,1,,BAO_0000218
13058,Pneumocystis carinii,Intermediate,CHEMBL626639,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,N,1,1,,BAO_0000218
13059,Pneumocystis carinii,Intermediate,CHEMBL626640,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,N,1,1,,BAO_0000218
13060,Pneumocystis carinii,Intermediate,CHEMBL626641,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,N,1,1,,BAO_0000218
13061,Pneumocystis carinii,Intermediate,CHEMBL627272,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,N,1,1,,BAO_0000218
13062,Pneumocystis carinii,Intermediate,CHEMBL627273,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,N,1,1,,BAO_0000218
13063,Pneumocystis carinii,Intermediate,CHEMBL627441,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,N,1,1,,BAO_0000218
13064,Pneumocystis carinii,Intermediate,CHEMBL628355,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,N,1,1,,BAO_0000218
13065,Pneumocystis carinii,Intermediate,CHEMBL628356,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,N,1,1,,BAO_0000218
13066,Pneumocystis carinii,Intermediate,CHEMBL628357,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,N,1,1,,BAO_0000218
13067,Pneumocystis carinii,Intermediate,CHEMBL628358,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,N,1,1,,BAO_0000218
13068,Pneumocystis carinii,Intermediate,CHEMBL622307,,,50339,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,N,1,1,,BAO_0000218
13069,,Autocuration,CHEMBL622527,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,U,0,1,,BAO_0000019
13070,,Autocuration,CHEMBL622528,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,U,0,1,,BAO_0000019
13071,,Autocuration,CHEMBL622529,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,U,0,1,,BAO_0000019
13072,,Autocuration,CHEMBL622992,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,U,0,1,,BAO_0000019
13073,,Autocuration,CHEMBL622993,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,U,0,1,,BAO_0000019
13074,,Autocuration,CHEMBL622994,,,22224,,A,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,U,0,1,,BAO_0000019
13075,Rattus norvegicus,Intermediate,CHEMBL622995,,,50597,,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,N,1,1,,BAO_0000218
13076,Rattus norvegicus,Intermediate,CHEMBL622996,,,50597,,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,N,1,1,,BAO_0000218
13077,Rattus norvegicus,Intermediate,CHEMBL622997,,,50597,,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,N,1,1,,BAO_0000218
13078,Rattus norvegicus,Intermediate,CHEMBL622998,,,50597,,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,N,1,1,,BAO_0000218
13079,,Autocuration,CHEMBL622999,,,22224,,A,,Cp max following ip administration at 1 mg/kg,,U,0,1,,BAO_0000218
13080,,Autocuration,CHEMBL623000,,,22224,1969.0,A,,Maximum concentration in plasma was reported at 0.5 hour,,U,0,1,,BAO_0000218
13081,,Autocuration,CHEMBL623001,,,22224,1969.0,A,,Maximum concentration in plasma was reported at 2 hour,,U,0,1,,BAO_0000218
13082,Mus musculus,Intermediate,CHEMBL623002,,,50594,,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,N,1,1,,BAO_0000218
13083,,Autocuration,CHEMBL623003,,,22229,,P,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,U,0,1,,BAO_0000100
13084,,Autocuration,CHEMBL623004,,,22224,,A,,Steady state concentration was evaluated,,U,0,1,,BAO_0000019
13085,,Autocuration,CHEMBL623005,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
13086,,Autocuration,CHEMBL623006,,,22224,,A,,Partition coefficient (logD7.4),,U,0,1,,BAO_0000019
13087,Rattus norvegicus,Intermediate,CHEMBL623007,,,50597,2107.0,A,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,N,1,1,,BAO_0000218
13088,Rattus norvegicus,Intermediate,CHEMBL623008,,,50597,10000001.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,N,1,1,,BAO_0000218
13089,Rattus norvegicus,Intermediate,CHEMBL876654,,,50597,2037.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,1,1,,BAO_0000218
13090,Rattus norvegicus,Intermediate,CHEMBL623009,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,N,1,1,,BAO_0000218
13091,Rattus norvegicus,Intermediate,CHEMBL623010,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,N,1,1,,BAO_0000218
13092,Rattus norvegicus,Intermediate,CHEMBL623011,,,50597,948.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,N,1,1,,BAO_0000218
13093,Rattus norvegicus,Intermediate,CHEMBL623012,,,50597,160.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,N,1,1,,BAO_0000218
13094,,Autocuration,CHEMBL623013,,,22224,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,U,0,1,,BAO_0000019
13095,,Autocuration,CHEMBL623014,,,22224,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,0,1,,BAO_0000019
13096,,Autocuration,CHEMBL623015,,,22224,1088.0,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,U,0,1,,BAO_0000019
13097,,Autocuration,CHEMBL623016,,,22224,1088.0,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,U,0,1,,BAO_0000019
13098,,Autocuration,CHEMBL624858,,,22224,1088.0,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,U,0,1,,BAO_0000019
13099,Rattus norvegicus,Intermediate,CHEMBL624859,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,N,1,1,,BAO_0000218
13100,Rattus norvegicus,Intermediate,CHEMBL624860,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,1,1,,BAO_0000218
13101,Rattus norvegicus,Intermediate,CHEMBL624861,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,1,1,,BAO_0000218
13102,Rattus norvegicus,Intermediate,CHEMBL624862,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,N,1,1,,BAO_0000218
13103,Rattus norvegicus,Intermediate,CHEMBL624863,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,N,1,1,,BAO_0000218
13104,Rattus norvegicus,Intermediate,CHEMBL876655,,,50597,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,1,1,,BAO_0000218
13105,Canis lupus familiaris,Intermediate,CHEMBL624864,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,1,1,,BAO_0000218
13106,Canis lupus familiaris,Intermediate,CHEMBL624865,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,1,1,,BAO_0000218
13107,Canis lupus familiaris,Intermediate,CHEMBL624866,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,1,1,,BAO_0000218
13108,Canis lupus familiaris,Expert,CHEMBL624867,,,50588,,F,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,N,1,1,,BAO_0000218
13109,Canis lupus familiaris,Intermediate,CHEMBL624868,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,1,1,,BAO_0000218
13110,Canis lupus familiaris,Intermediate,CHEMBL628450,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,N,1,1,,BAO_0000218
13111,Canis lupus familiaris,Intermediate,CHEMBL628451,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,1,1,,BAO_0000218
13112,Canis lupus familiaris,Intermediate,CHEMBL628452,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,1,1,,BAO_0000218
13113,Canis lupus familiaris,Intermediate,CHEMBL628453,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,1,1,,BAO_0000218
13114,Canis lupus familiaris,Intermediate,CHEMBL628454,,,50588,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,N,1,1,,BAO_0000218
13115,Canis lupus familiaris,Intermediate,CHEMBL628455,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,1,1,,BAO_0000218
13116,Canis lupus familiaris,Intermediate,CHEMBL628456,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,1,1,,BAO_0000218
13117,Canis lupus familiaris,Intermediate,CHEMBL628457,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,1,1,,BAO_0000218
13118,Canis lupus familiaris,Intermediate,CHEMBL877505,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,N,1,1,,BAO_0000218
13119,Canis lupus familiaris,Intermediate,CHEMBL628458,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,N,1,1,,BAO_0000218
13120,Canis lupus familiaris,Intermediate,CHEMBL628459,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,1,1,,BAO_0000218
13121,Canis lupus familiaris,Intermediate,CHEMBL628460,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,1,1,,BAO_0000218
13122,Canis lupus familiaris,Intermediate,CHEMBL628461,,,50588,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,1,1,,BAO_0000218
13123,,Autocuration,CHEMBL628462,,,22224,,B,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,U,0,1,,BAO_0000218
13124,Canis lupus familiaris,Intermediate,CHEMBL628463,,,50588,,A,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,1,1,,BAO_0000218
13125,Rattus norvegicus,Expert,CHEMBL625666,,,50597,,F,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,N,1,1,,BAO_0000218
13126,,Autocuration,CHEMBL625667,,,22224,,B,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,U,0,1,,BAO_0000218
13127,Rattus norvegicus,Expert,CHEMBL625668,,,50597,,A,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,1,1,,BAO_0000218
13128,Rattus norvegicus,Intermediate,CHEMBL625669,,,50597,,A,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,1,1,,BAO_0000218
13129,,Autocuration,CHEMBL625670,,,22224,,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,U,0,1,,BAO_0000019
13130,Rattus norvegicus,Intermediate,CHEMBL625671,,,50597,,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,N,1,1,,BAO_0000218
13131,Human herpesvirus 1,Intermediate,CHEMBL625672,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,N,1,1,,BAO_0000218
13132,Human herpesvirus 1,Intermediate,CHEMBL625673,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,N,1,1,,BAO_0000218
13133,Human herpesvirus 1,Intermediate,CHEMBL625674,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,N,1,1,,BAO_0000218
13134,Human herpesvirus 1,Intermediate,CHEMBL625675,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,N,1,1,,BAO_0000218
13135,Human herpesvirus 1,Intermediate,CHEMBL627637,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,1,1,,BAO_0000218
13136,Human herpesvirus 1,Intermediate,CHEMBL627638,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,N,1,1,,BAO_0000218
13137,Human herpesvirus 1,Intermediate,CHEMBL627639,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,N,1,1,,BAO_0000218
13138,Human herpesvirus 1,Intermediate,CHEMBL627640,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,N,1,1,,BAO_0000218
13139,Human herpesvirus 1,Intermediate,CHEMBL627641,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,N,1,1,,BAO_0000218
13140,Human herpesvirus 1,Intermediate,CHEMBL627642,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,1,1,,BAO_0000218
13141,Human herpesvirus 1,Intermediate,CHEMBL877506,,,50602,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,1,1,,BAO_0000218
13142,Mus musculus,Intermediate,CHEMBL627275,,,50594,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,1,1,,BAO_0000218
13143,Mustela putorius furo,Intermediate,CHEMBL627643,,,50506,,A,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,N,1,1,,BAO_0000218
13144,Mustela putorius furo,Intermediate,CHEMBL631246,,,50506,,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,1,1,,BAO_0000218
13145,Mustela putorius furo,Intermediate,CHEMBL631247,,,50506,,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,1,1,,BAO_0000218
13146,Mustela putorius furo,Intermediate,CHEMBL629532,,,50506,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,1,1,,BAO_0000218
13147,Mustela putorius furo,Intermediate,CHEMBL629533,,,50506,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,N,1,1,,BAO_0000218
13148,Mustela putorius furo,Intermediate,CHEMBL629534,,,50506,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,1,1,,BAO_0000218
13149,Mustela putorius furo,Intermediate,CHEMBL629535,,,50506,,A,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,N,1,1,,BAO_0000218
13150,,Autocuration,CHEMBL625932,,,22224,,A,,Pharmacokinetic parameter :drug bound to plasma was reported,,U,0,1,,BAO_0000019
13151,,Autocuration,CHEMBL625933,,,22224,,A,,compound was evaluated for drug bound in plasma,,U,0,1,,BAO_0000019
13152,Rattus norvegicus,Intermediate,CHEMBL625934,,,50597,,A,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,N,1,1,,BAO_0000218
13153,Eutheria,Autocuration,CHEMBL625935,,,22224,,A,,Bioavailability,,U,0,1,,BAO_0000218
13154,Rattus norvegicus,Intermediate,CHEMBL625936,,,50597,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,N,1,1,,BAO_0000218
13155,Rattus norvegicus,Intermediate,CHEMBL625937,,,50597,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,N,1,1,,BAO_0000218
13156,Canis lupus familiaris,Intermediate,CHEMBL625938,,,50588,,A,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,1,1,,BAO_0000218
13157,Rattus norvegicus,Intermediate,CHEMBL625939,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,N,1,1,,BAO_0000218
13158,Rattus norvegicus,Intermediate,CHEMBL625940,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,N,1,1,,BAO_0000218
13159,Rattus norvegicus,Intermediate,CHEMBL874464,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,N,1,1,,BAO_0000218
13160,Rattus norvegicus,Intermediate,CHEMBL625941,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,N,1,1,,BAO_0000218
13161,Rattus norvegicus,Intermediate,CHEMBL625942,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,N,1,1,,BAO_0000218
13162,Rattus norvegicus,Intermediate,CHEMBL625943,,,50597,1970.0,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,N,1,1,,BAO_0000218
13163,Homo sapiens,Intermediate,CHEMBL625944,,,50587,1977.0,A,,In vitro protein binding in human serum at 5 ug/ml,,N,1,1,,BAO_0000218
13164,,Autocuration,CHEMBL625945,,,22224,,A,,Serum protein binding ability was measured,,U,0,1,,BAO_0000019
13165,,Autocuration,CHEMBL625946,,,22224,,A,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,U,0,1,,BAO_0000019
13166,Canis lupus familiaris,Autocuration,CHEMBL625947,,,22224,,A,,Oral bioavailability in dog,,U,0,1,,BAO_0000218
13167,Rattus norvegicus,Intermediate,CHEMBL625948,,,50597,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,N,1,1,,BAO_0000218
13168,,Autocuration,CHEMBL625949,,,22224,,A,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,U,0,1,,BAO_0000218
13169,,Autocuration,CHEMBL625950,,,22224,,A,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,U,0,1,,BAO_0000218
13170,Eutheria,Autocuration,CHEMBL625951,,,22224,,A,,Oral bioavailability (dose 15 mg/kg i.v.),,U,0,1,,BAO_0000218
13171,,Autocuration,CHEMBL625952,,,22224,,A,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,U,0,1,,BAO_0000218
13172,,Autocuration,CHEMBL625953,,,22224,,A,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,U,0,1,,BAO_0000218
13173,,Autocuration,CHEMBL625954,,,22224,,A,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,U,0,1,,BAO_0000218
13174,,Autocuration,CHEMBL882959,,,22224,,A,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,U,0,1,,BAO_0000218
13175,Canis lupus familiaris,Intermediate,CHEMBL625955,,,50588,,A,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,N,1,1,,BAO_0000218
13176,Mustela putorius furo,Autocuration,CHEMBL625956,,,22224,,A,,Bioavailability in ferret,,U,0,1,,BAO_0000218
13177,Macaca fascicularis,Intermediate,CHEMBL625957,,,100710,,A,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,N,1,1,,BAO_0000218
13178,Rattus norvegicus,Intermediate,CHEMBL625958,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,1,1,,BAO_0000218
13179,Rattus norvegicus,Intermediate,CHEMBL625959,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,1,1,,BAO_0000218
13180,Rattus norvegicus,Intermediate,CHEMBL626642,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,1,1,,BAO_0000218
13181,Rattus norvegicus,Intermediate,CHEMBL631330,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,1,1,,BAO_0000218
13182,Rattus norvegicus,Intermediate,CHEMBL631331,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,1,1,,BAO_0000218
13183,Rattus norvegicus,Intermediate,CHEMBL631332,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,1,1,,BAO_0000218
13184,Rattus norvegicus,Intermediate,CHEMBL631333,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,1,1,,BAO_0000218
13185,Rattus norvegicus,Intermediate,CHEMBL632018,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,1,1,,BAO_0000218
13186,Rattus norvegicus,Intermediate,CHEMBL632019,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,1,1,,BAO_0000218
13187,Rattus norvegicus,Intermediate,CHEMBL632020,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,1,1,,BAO_0000218
13188,Rattus norvegicus,Intermediate,CHEMBL632021,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,1,1,,BAO_0000218
13189,Rattus norvegicus,Intermediate,CHEMBL632022,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,1,1,,BAO_0000218
13190,Rattus norvegicus,Intermediate,CHEMBL632023,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,1,1,,BAO_0000218
13191,Rattus norvegicus,Intermediate,CHEMBL632024,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,1,1,,BAO_0000218
13192,Rattus norvegicus,Intermediate,CHEMBL874472,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,1,1,,BAO_0000218
13193,Rattus norvegicus,Intermediate,CHEMBL632025,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,1,1,,BAO_0000218
13194,Rattus norvegicus,Intermediate,CHEMBL632026,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,1,1,,BAO_0000218
13195,Rattus norvegicus,Intermediate,CHEMBL632027,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,1,1,,BAO_0000218
13196,Rattus norvegicus,Intermediate,CHEMBL632028,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,1,1,,BAO_0000218
13197,Rattus norvegicus,Intermediate,CHEMBL626430,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,1,1,,BAO_0000218
13198,Rattus norvegicus,Intermediate,CHEMBL626431,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,1,1,,BAO_0000218
13199,Rattus norvegicus,Intermediate,CHEMBL626432,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,1,1,,BAO_0000218
13200,Rattus norvegicus,Intermediate,CHEMBL626433,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,1,1,,BAO_0000218
13201,Rattus norvegicus,Intermediate,CHEMBL626434,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,1,1,,BAO_0000218
13202,Rattus norvegicus,Intermediate,CHEMBL627280,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,1,1,,BAO_0000218
13203,Rattus norvegicus,Intermediate,CHEMBL627281,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,1,1,,BAO_0000218
13204,Rattus norvegicus,Intermediate,CHEMBL627282,,,50597,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,1,1,,BAO_0000218
13205,,Autocuration,CHEMBL627283,,,22224,,A,,Total body clearance was measured at given dose,,U,0,1,,BAO_0000019
13206,,Autocuration,CHEMBL627284,,,22224,,A,,Total body clearance was measured at given dose.,,U,0,1,,BAO_0000218
13207,Rattus norvegicus,Intermediate,CHEMBL627285,,,50597,,A,,Metabolic clearance from the body in rat,,N,1,1,,BAO_0000218
13208,,Autocuration,CHEMBL627286,,,22224,,A,,Renal clearance from the body,,U,0,1,,BAO_0000218
13209,Rattus norvegicus,Intermediate,CHEMBL875477,,,50597,,A,,Renal clearance from the body in rat,,N,1,1,,BAO_0000218
13210,Rattus norvegicus,Intermediate,CHEMBL627287,,,50597,,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,N,1,1,,BAO_0000218
13211,Canis lupus familiaris,Intermediate,CHEMBL627288,,,50588,,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,N,1,1,,BAO_0000218
13212,Rattus norvegicus,Intermediate,CHEMBL627289,,,50597,,A,,Total clearance from the body in rat,,N,1,1,,BAO_0000218
13213,Rattus norvegicus,Intermediate,CHEMBL627290,,,50597,1969.0,A,,Clearance into cortex from rat plasma or PBS,,N,1,1,,BAO_0000218
13214,,Autocuration,CHEMBL627291,,,22224,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,U,0,1,,BAO_0000218
13215,,Autocuration,CHEMBL627292,,,22224,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,U,0,1,,BAO_0000218
13216,,Autocuration,CHEMBL627293,,,22224,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,U,0,1,,BAO_0000218
13217,,Autocuration,CHEMBL627294,,,22224,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,U,0,1,,BAO_0000218
13218,,Autocuration,CHEMBL875478,,,22224,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,U,0,1,,BAO_0000218
13219,,Autocuration,CHEMBL627295,,,22224,,A,,Clearance was determined,,U,0,1,,BAO_0000218
13220,Mus musculus,Intermediate,CHEMBL627296,,,50594,,A,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,N,1,1,,BAO_0000218
13221,Oryctolagus cuniculus,Intermediate,CHEMBL626119,,,50592,,A,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,N,1,1,,BAO_0000218
13222,Rattus norvegicus,Intermediate,CHEMBL626120,,,50597,,A,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,N,1,1,,BAO_0000218
13223,Rattus norvegicus,Intermediate,CHEMBL626121,,,50597,,A,,Clearance in rat after iv dose (100 ug/kg),,N,1,1,,BAO_0000218
13224,Cavia porcellus,Autocuration,CHEMBL626122,,,22224,,A,,Clearance in guinea pig,,U,0,1,,BAO_0000218
13225,Rattus norvegicus,Intermediate,CHEMBL626123,,,50597,,A,,Compound was evaluated for clearance in rat,,N,1,1,,BAO_0000218
13226,Canis lupus familiaris,Intermediate,CHEMBL623456,,,50588,,A,,Compound was evaluated for the clearance in dog,,N,1,1,,BAO_0000218
13227,Rattus norvegicus,Intermediate,CHEMBL623457,,,50597,,A,,Compound was evaluated for the clearance in rat,,N,1,1,,BAO_0000218
13228,Rattus norvegicus,Intermediate,CHEMBL623458,,,50597,,A,,Compound was tested in vivo for clearance after iv administration in the rat,,N,1,1,,BAO_0000218
13229,,Autocuration,CHEMBL623459,,,22224,,A,,IV clearance determined at an iv dose of 14 mg/kg,,U,0,1,,BAO_0000218
13230,,Autocuration,CHEMBL875484,,,22224,,A,,IV clearance determined at an iv dose of 15.2 mg/kg,,U,0,1,,BAO_0000218
13231,,Autocuration,CHEMBL623460,,,22224,,A,,IV clearance determined at an iv dose of 15 mg/kg,,U,0,1,,BAO_0000218
13232,,Autocuration,CHEMBL623461,,,22224,,A,,IV clearance determined at an peroral dose of 30 mg/kg.,,U,0,1,,BAO_0000218
13233,,Autocuration,CHEMBL623462,,,22224,,A,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,U,0,1,,BAO_0000218
13234,,Autocuration,CHEMBL627386,,,22224,,A,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,U,0,1,,BAO_0000218
13235,Rattus norvegicus,Intermediate,CHEMBL627387,,,50597,2113.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,N,1,1,,BAO_0000218
13236,Rattus norvegicus,Intermediate,CHEMBL627388,,,50597,2107.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,N,1,1,,BAO_0000218
13237,Rattus norvegicus,Intermediate,CHEMBL627389,,,50597,2048.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,N,1,1,,BAO_0000218
13238,Rattus norvegicus,Intermediate,CHEMBL627390,,,50597,2385.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,N,1,1,,BAO_0000218
13239,Rattus norvegicus,Intermediate,CHEMBL627391,,,50597,1969.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,N,1,1,,BAO_0000218
13240,Rattus norvegicus,Intermediate,CHEMBL627392,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,1,1,,BAO_0000218
13241,Rattus norvegicus,Intermediate,CHEMBL627393,,,50597,2106.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,N,1,1,,BAO_0000218
13242,Rattus norvegicus,Intermediate,CHEMBL627394,,,50597,3126.0,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,N,1,1,,BAO_0000218
13243,Rattus norvegicus,Intermediate,CHEMBL627395,,,50597,10000001.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,N,1,1,,BAO_0000218
13244,Rattus norvegicus,Intermediate,CHEMBL875485,,,50597,2037.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,1,1,,BAO_0000218
13245,Rattus norvegicus,Intermediate,CHEMBL627396,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,N,1,1,,BAO_0000218
13246,Rattus norvegicus,Intermediate,CHEMBL627397,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,N,1,1,,BAO_0000218
13247,Rattus norvegicus,Intermediate,CHEMBL627398,,,50597,948.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,N,1,1,,BAO_0000218
13248,Rattus norvegicus,Intermediate,CHEMBL627399,,,50597,10000001.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,N,1,1,,BAO_0000218
13249,Rattus norvegicus,Intermediate,CHEMBL627400,,,50597,2113.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,N,1,1,,BAO_0000218
13250,Rattus norvegicus,Intermediate,CHEMBL627401,,,50597,2107.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,N,1,1,,BAO_0000218
13251,Rattus norvegicus,Intermediate,CHEMBL627402,,,50597,2048.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,N,1,1,,BAO_0000218
13252,Rattus norvegicus,Intermediate,CHEMBL627403,,,50597,2385.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,N,1,1,,BAO_0000218
13253,Rattus norvegicus,Intermediate,CHEMBL627404,,,50597,1969.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,N,1,1,,BAO_0000218
13254,Rattus norvegicus,Intermediate,CHEMBL623101,,,50597,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,1,1,,BAO_0000218
13255,Rattus norvegicus,Intermediate,CHEMBL877480,,,50597,2106.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,N,1,1,,BAO_0000218
13256,Rattus norvegicus,Intermediate,CHEMBL623102,,,50597,3126.0,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,N,1,1,,BAO_0000218
13257,Rattus norvegicus,Intermediate,CHEMBL623103,,,50597,10000001.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,N,1,1,,BAO_0000218
13258,Rattus norvegicus,Intermediate,CHEMBL623104,,,50597,2037.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,1,1,,BAO_0000218
13259,Rattus norvegicus,Intermediate,CHEMBL623105,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,N,1,1,,BAO_0000218
13260,Rattus norvegicus,Intermediate,CHEMBL623106,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,N,1,1,,BAO_0000218
13261,Rattus norvegicus,Intermediate,CHEMBL623107,,,50597,948.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,N,1,1,,BAO_0000218
13262,Rattus norvegicus,Intermediate,CHEMBL623108,,,50597,160.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,N,1,1,,BAO_0000218
13263,Rattus norvegicus,Intermediate,CHEMBL623109,,,50597,2113.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,N,1,1,,BAO_0000218
13264,Rattus norvegicus,Intermediate,CHEMBL623110,,,50597,2107.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,N,1,1,,BAO_0000218
13265,Rattus norvegicus,Intermediate,CHEMBL623111,,,50597,2048.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,N,1,1,,BAO_0000218
13266,Rattus norvegicus,Intermediate,CHEMBL625060,,,50597,2385.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,N,1,1,,BAO_0000218
13267,Rattus norvegicus,Intermediate,CHEMBL625061,,,50597,1969.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,N,1,1,,BAO_0000218
13268,Rattus norvegicus,Intermediate,CHEMBL625062,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,1,1,,BAO_0000218
13269,Rattus norvegicus,Intermediate,CHEMBL625063,,,50597,2106.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,N,1,1,,BAO_0000218
13270,Rattus norvegicus,Intermediate,CHEMBL625064,,,50597,3126.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,N,1,1,,BAO_0000218
13271,Rattus norvegicus,Intermediate,CHEMBL625065,,,50597,10000001.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,N,1,1,,BAO_0000218
13272,Rattus norvegicus,Intermediate,CHEMBL625066,,,50597,2037.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,1,1,,BAO_0000218
13273,Rattus norvegicus,Intermediate,CHEMBL625067,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,N,1,1,,BAO_0000218
13274,Rattus norvegicus,Intermediate,CHEMBL625068,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,N,1,1,,BAO_0000218
13275,Rattus norvegicus,Intermediate,CHEMBL622159,,,50597,948.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,N,1,1,,BAO_0000218
13276,Rattus norvegicus,Intermediate,CHEMBL622160,,,50597,160.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,N,1,1,,BAO_0000218
13277,Rattus norvegicus,Intermediate,CHEMBL622161,,,50597,2113.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,N,1,1,,BAO_0000218
13278,Rattus norvegicus,Intermediate,CHEMBL622162,,,50597,2048.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,N,1,1,,BAO_0000218
13279,Rattus norvegicus,Intermediate,CHEMBL622163,,,50597,2385.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,N,1,1,,BAO_0000218
13280,Rattus norvegicus,Intermediate,CHEMBL622313,,,50597,1969.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,N,1,1,,BAO_0000218
13281,Rattus norvegicus,Intermediate,CHEMBL622314,,,50597,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,1,1,,BAO_0000218
13282,Rattus norvegicus,Intermediate,CHEMBL622315,,,50597,2106.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,N,1,1,,BAO_0000218
13283,Rattus norvegicus,Intermediate,CHEMBL622316,,,50597,3126.0,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,N,1,1,,BAO_0000218
13284,Escherichia coli,Intermediate,CHEMBL877486,,,50212,,A,,Normal diffusion coefficient in water for Escherichia coli,,N,1,1,,BAO_0000218
13285,,Autocuration,CHEMBL622317,,,22224,,A,,Average max percent decrease in RVR (renal vascular resistance) was determined,,U,0,1,,BAO_0000019
13286,,Autocuration,CHEMBL622318,,,22224,,A,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,U,0,1,,BAO_0000019
13287,,Autocuration,CHEMBL622319,,,22224,,A,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,U,0,1,,BAO_0000019
13288,,Autocuration,CHEMBL622320,,,22224,,A,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,U,0,1,,BAO_0000019
13289,,Autocuration,CHEMBL622321,,,22224,,A,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,U,0,1,,BAO_0000019
13290,,Autocuration,CHEMBL622322,,,22224,,A,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,U,0,1,,BAO_0000019
13291,,Autocuration,CHEMBL622323,,,22224,,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,U,0,1,,BAO_0000019
13292,Rattus norvegicus,Intermediate,CHEMBL622324,,,50597,,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,N,1,1,,BAO_0000218
13293,Canis lupus familiaris,Intermediate,CHEMBL622325,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,1,1,,BAO_0000218
13294,Canis lupus familiaris,Intermediate,CHEMBL622326,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1,1,,BAO_0000218
13295,Canis lupus familiaris,Intermediate,CHEMBL877487,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,N,1,1,,BAO_0000218
13296,Canis lupus familiaris,Intermediate,CHEMBL622327,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1,1,,BAO_0000218
13297,Canis lupus familiaris,Intermediate,CHEMBL622328,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,N,1,1,,BAO_0000218
13298,Canis lupus familiaris,Intermediate,CHEMBL622329,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,1,1,,BAO_0000218
13299,Canis lupus familiaris,Intermediate,CHEMBL622330,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13300,Canis lupus familiaris,Intermediate,CHEMBL622331,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,1,1,,BAO_0000218
13301,Canis lupus familiaris,Intermediate,CHEMBL622332,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1,1,,BAO_0000218
13302,Canis lupus familiaris,Intermediate,CHEMBL622333,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,N,1,1,,BAO_0000218
13303,Simiiformes,Autocuration,CHEMBL627658,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,0,1,,BAO_0000218
13304,Simiiformes,Autocuration,CHEMBL630428,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,0,1,,BAO_0000218
13305,Simiiformes,Autocuration,CHEMBL630429,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,0,1,,BAO_0000218
13306,Simiiformes,Autocuration,CHEMBL630430,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,U,0,1,,BAO_0000218
13307,Simiiformes,Autocuration,CHEMBL630431,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,U,0,1,,BAO_0000218
13308,Rattus norvegicus,Intermediate,CHEMBL630432,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13309,Rattus norvegicus,Intermediate,CHEMBL630433,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,1,1,,BAO_0000218
13310,Rattus norvegicus,Intermediate,CHEMBL630434,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,1,1,,BAO_0000218
13311,Rattus norvegicus,Intermediate,CHEMBL629372,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,1,1,,BAO_0000218
13312,Rattus norvegicus,Intermediate,CHEMBL629553,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,N,1,1,,BAO_0000218
13313,Rattus norvegicus,Intermediate,CHEMBL629554,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,1,1,,BAO_0000218
13314,Rattus norvegicus,Intermediate,CHEMBL874447,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,1,1,,BAO_0000218
13315,Rattus norvegicus,Intermediate,CHEMBL629555,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,1,1,,BAO_0000218
13316,Rattus norvegicus,Intermediate,CHEMBL629556,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,1,1,,BAO_0000218
13317,Rattus norvegicus,Intermediate,CHEMBL629557,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,N,1,1,,BAO_0000218
13318,Rattus norvegicus,Intermediate,CHEMBL629558,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,1,1,,BAO_0000218
13319,Rattus norvegicus,Intermediate,CHEMBL629559,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,1,1,,BAO_0000218
13320,Rattus norvegicus,Intermediate,CHEMBL629560,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,1,1,,BAO_0000218
13321,Canis lupus familiaris,Intermediate,CHEMBL629561,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,1,1,,BAO_0000218
13322,Canis lupus familiaris,Intermediate,CHEMBL629562,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13323,Canis lupus familiaris,Intermediate,CHEMBL629563,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,1,1,,BAO_0000218
13324,Canis lupus familiaris,Intermediate,CHEMBL629564,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1,1,,BAO_0000218
13325,Canis lupus familiaris,Intermediate,CHEMBL629565,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,1,1,,BAO_0000218
13326,Canis lupus familiaris,Intermediate,CHEMBL629566,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1,1,,BAO_0000218
13327,Canis lupus familiaris,Intermediate,CHEMBL629567,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1,1,,BAO_0000218
13328,Canis lupus familiaris,Intermediate,CHEMBL629568,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,1,1,,BAO_0000218
13329,Canis lupus familiaris,Intermediate,CHEMBL629569,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,N,1,1,,BAO_0000218
13330,Canis lupus familiaris,Intermediate,CHEMBL629570,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,1,1,,BAO_0000218
13331,Simiiformes,Autocuration,CHEMBL629571,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,0,1,,BAO_0000218
13332,Rattus norvegicus,Autocuration,CHEMBL629572,,,22224,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,0,1,,BAO_0000218
13333,Rattus norvegicus,Autocuration,CHEMBL629573,,,22224,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,0,1,,BAO_0000218
13334,Eutheria,Autocuration,CHEMBL629574,,,22224,,A,,Bioavailability (dose 20 mg/kg),,U,0,1,,BAO_0000218
13335,Canis lupus familiaris,Autocuration,CHEMBL629575,,,22224,,A,,Bioavailability in dog,,U,0,1,,BAO_0000218
13336,Rattus norvegicus,Autocuration,CHEMBL874448,,,22224,,A,,Bioavailability in rat (Sprague-Dawley) (male),,U,0,1,,BAO_0000218
13337,Primates,Autocuration,CHEMBL629576,,,22224,,A,,Bioavailability in monkey (dose 10 mg/kg i.d.),,U,0,1,,BAO_0000218
13338,Rattus norvegicus,Autocuration,CHEMBL629577,,,22224,,A,,Bioavailability in rat,,U,0,1,,BAO_0000218
13339,Rattus norvegicus,Autocuration,CHEMBL629578,,,22224,,A,,Bioavailability in rat,,U,0,1,,BAO_0000218
13340,Canis lupus familiaris,Autocuration,CHEMBL629579,,,22224,,A,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,U,0,1,,BAO_0000218
13341,Canis lupus familiaris,Autocuration,CHEMBL882958,,,22224,,A,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,U,0,1,,BAO_0000218
13342,Pan troglodytes,Intermediate,CHEMBL629580,,,50505,,A,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,N,1,1,,BAO_0000218
13343,Eutheria,Autocuration,CHEMBL629581,,,22224,,A,,Bioavailability,,U,0,1,,BAO_0000218
13344,Saimiri,Autocuration,CHEMBL629582,,,22224,,A,,Bioavailability in squirrel monkey,,U,0,1,,BAO_0000218
13345,Canis lupus familiaris,Intermediate,CHEMBL628522,,,50588,,A,,Bioavailability was evaluated in dog,,N,1,1,,BAO_0000218
13346,Cricetinae,Intermediate,CHEMBL625432,,,100712,,A,,Bioavailability was evaluated in hamster,,N,1,1,,BAO_0000218
13347,Rattus norvegicus,Autocuration,CHEMBL625433,,,22224,,A,,Bioavailability in rat,,U,0,1,,BAO_0000218
13348,Rattus norvegicus,Intermediate,CHEMBL625434,,,50597,1969.0,A,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
13349,Rattus norvegicus,Intermediate,CHEMBL625435,,,50597,1969.0,A,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,N,1,1,,BAO_0000218
13350,Rattus norvegicus,Autocuration,CHEMBL625436,,,22224,,A,,Bioavailability in rat (dose 10 mg/kg p.o.),,U,0,1,,BAO_0000218
13351,Macaca fascicularis,Intermediate,CHEMBL874588,,,100710,,A,,Bioavailability was measured in cynomolgus monkeys.,,N,1,1,,BAO_0000218
13352,Mus musculus,Intermediate,CHEMBL625437,,,50594,,A,,Bioavailability was measured in nude mice.,,N,1,1,,BAO_0000218
13353,Mustela putorius furo,Autocuration,CHEMBL625438,,,22224,,A,,Bioavailability in ferret (dose 10 mg/kg i.d.),,U,0,1,,BAO_0000218
13354,Simiiformes,Autocuration,CHEMBL625439,,,22224,,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,U,0,1,,BAO_0000218
13355,Simiiformes,Autocuration,CHEMBL625440,,,22224,,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,U,0,1,,BAO_0000218
13356,Simiiformes,Autocuration,CHEMBL625441,,,22224,,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,U,0,1,,BAO_0000218
13357,Rattus norvegicus,Autocuration,CHEMBL625442,,,22224,,A,,Bioavailability in rat (dose 10 mg/kg i.d.),,U,0,1,,BAO_0000218
13358,Rattus norvegicus,Intermediate,CHEMBL625443,,,50597,,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,1,1,,BAO_0000218
13359,,Autocuration,CHEMBL625444,,,22224,,A,,Bioavailability was determined; extremely poor,,U,0,1,,BAO_0000218
13360,Mus musculus,Intermediate,CHEMBL625445,,,50594,,A,,% bioavailability in mice after oral administration of prodrug,,N,1,1,,BAO_0000218
13361,Canis lupus familiaris,Intermediate,CHEMBL625446,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,N,1,1,,BAO_0000218
13362,Canis lupus familiaris,Intermediate,CHEMBL882960,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,N,1,1,,BAO_0000218
13363,Canis lupus familiaris,Intermediate,CHEMBL625447,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,N,1,1,,BAO_0000218
13364,Canis lupus familiaris,Intermediate,CHEMBL625448,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,N,1,1,,BAO_0000218
13365,Canis lupus familiaris,Intermediate,CHEMBL625449,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,N,1,1,,BAO_0000218
13366,Canis lupus familiaris,Intermediate,CHEMBL874589,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,N,1,1,,BAO_0000218
13367,Canis lupus familiaris,Intermediate,CHEMBL625450,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,N,1,1,,BAO_0000218
13368,Canis lupus familiaris,Intermediate,CHEMBL625451,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,N,1,1,,BAO_0000218
13369,Canis lupus familiaris,Intermediate,CHEMBL626584,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,N,1,1,,BAO_0000218
13370,Canis lupus familiaris,Intermediate,CHEMBL626585,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,N,1,1,,BAO_0000218
13371,Canis lupus familiaris,Intermediate,CHEMBL626586,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,N,1,1,,BAO_0000218
13372,Canis lupus familiaris,Intermediate,CHEMBL626587,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,N,1,1,,BAO_0000218
13373,Canis lupus familiaris,Intermediate,CHEMBL626588,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,N,1,1,,BAO_0000218
13374,Canis lupus familiaris,Intermediate,CHEMBL626589,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,N,1,1,,BAO_0000218
13375,Canis lupus familiaris,Intermediate,CHEMBL626590,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,N,1,1,,BAO_0000218
13376,Canis lupus familiaris,Intermediate,CHEMBL626591,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,N,1,1,,BAO_0000218
13377,Canis lupus familiaris,Intermediate,CHEMBL627181,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,N,1,1,,BAO_0000218
13378,Canis lupus familiaris,Intermediate,CHEMBL628083,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,N,1,1,,BAO_0000218
13379,,Autocuration,CHEMBL628084,,,22224,,A,,IV clearance determined at an peroral dose of 15 mg/kg.,,U,0,1,,BAO_0000218
13380,Hymenolepis nana,Expert,CHEMBL628085,,,50064,,F,,Mouse oral clearance was measured against Hymenolepiasis nana.,,N,1,1,,BAO_0000218
13381,Heligmosomoides polygyrus,Expert,CHEMBL628086,,,50545,,F,,Mouse oral clearance was measured against Nematospiroides dubius,,N,1,1,,BAO_0000218
13382,,Autocuration,CHEMBL628087,,,22224,,F,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,U,0,1,,BAO_0000218
13383,Mus musculus,Intermediate,CHEMBL628088,,,50594,,A,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,N,1,1,,BAO_0000218
13384,,Autocuration,CHEMBL628089,,,22224,,B,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,U,0,1,,BAO_0000218
13385,,Autocuration,CHEMBL628090,,,22224,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13386,,Autocuration,CHEMBL628091,,,22224,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13387,,Autocuration,CHEMBL628092,,,22224,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13388,,Autocuration,CHEMBL628093,,,22224,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13389,,Autocuration,CHEMBL875607,,,22224,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13390,,Autocuration,CHEMBL625710,,,22224,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13391,,Autocuration,CHEMBL625711,,,22224,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13392,,Autocuration,CHEMBL625712,,,22224,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13393,,Autocuration,CHEMBL625713,,,22224,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,U,0,1,,BAO_0000218
13394,Canis lupus familiaris,Intermediate,CHEMBL625714,,,50588,,A,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,N,1,1,,BAO_0000218
13395,Macaca mulatta,Intermediate,CHEMBL625715,,,50797,,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,N,1,1,,BAO_0000218
13396,Rattus norvegicus,Intermediate,CHEMBL625716,,,50597,,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,N,1,1,,BAO_0000218
13397,Rattus norvegicus,Intermediate,CHEMBL625717,,,50597,,A,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,N,1,1,,BAO_0000218
13398,Rattus norvegicus,Intermediate,CHEMBL625718,,,50597,,A,,Plasma clearance was determined for the compound in rats,,N,1,1,,BAO_0000218
13399,Rattus norvegicus,Intermediate,CHEMBL625719,,,50597,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,N,1,1,,BAO_0000218
13400,Rattus norvegicus,Intermediate,CHEMBL625720,,,50597,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,N,1,1,,BAO_0000218
13401,Rattus norvegicus,Intermediate,CHEMBL625721,,,50597,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,N,1,1,,BAO_0000218
13402,Rattus norvegicus,Intermediate,CHEMBL625722,,,50597,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,N,1,1,,BAO_0000218
13403,Rattus norvegicus,Intermediate,CHEMBL625723,,,50597,,A,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,1,1,,BAO_0000218
13404,Heligmosomoides polygyrus,Intermediate,CHEMBL625724,,,50545,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,N,1,1,,BAO_0000218
13405,Heligmosomoides polygyrus,Intermediate,CHEMBL625725,,,50545,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,N,1,1,,BAO_0000218
13406,Heligmosomoides polygyrus,Intermediate,CHEMBL625726,,,50545,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,N,1,1,,BAO_0000218
13407,Heligmosomoides polygyrus,Intermediate,CHEMBL875608,,,50545,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,N,1,1,,BAO_0000218
13408,Heligmosomoides polygyrus,Intermediate,CHEMBL625727,,,50545,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,N,1,1,,BAO_0000218
13409,Rattus norvegicus,Autocuration,CHEMBL625728,,,22224,1088.0,A,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,U,0,1,,BAO_0000218
13410,Rattus norvegicus,Autocuration,CHEMBL625729,,,22224,,A,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,0,1,,BAO_0000218
13411,Rattus norvegicus,Autocuration,CHEMBL625730,,,22224,,A,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,U,0,1,,BAO_0000218
13412,Rattus norvegicus,Autocuration,CHEMBL625731,,,22224,1088.0,A,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,0,1,,BAO_0000218
13413,Rattus norvegicus,Autocuration,CHEMBL626417,,,22224,1088.0,A,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,U,0,1,,BAO_0000218
13414,Homo sapiens,Intermediate,CHEMBL626418,,,50587,1088.0,A,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,N,1,1,,BAO_0000218
13415,Canis lupus familiaris,Intermediate,CHEMBL626419,,,50588,1088.0,A,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,N,1,1,,BAO_0000218
13416,Canis lupus familiaris,Intermediate,CHEMBL626592,,,50588,1969.0,A,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,N,1,1,,BAO_0000218
13417,Rattus norvegicus,Intermediate,CHEMBL626593,,,50597,1969.0,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,1,1,,BAO_0000218
13418,Rattus norvegicus,Intermediate,CHEMBL626594,,,50597,,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,1,1,,BAO_0000218
13419,Canis lupus familiaris,Intermediate,CHEMBL625035,,,50588,,A,,Clearance rate in dogs,,N,1,1,,BAO_0000218
13420,,Autocuration,CHEMBL625036,,,22224,,A,,Compound was measured for intrinsic clearance,,U,0,1,,BAO_0000019
13421,,Autocuration,CHEMBL625037,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13422,,Autocuration,CHEMBL625038,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13423,,Autocuration,CHEMBL625039,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13424,,Autocuration,CHEMBL625040,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13425,,Autocuration,CHEMBL625041,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13426,,Autocuration,CHEMBL625042,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13427,,Autocuration,CHEMBL874411,,,22224,,A,,Partition coefficient of the compound,,U,0,1,,BAO_0000019
13428,,Autocuration,CHEMBL625043,,,22224,,A,,Permeability,,U,0,1,,BAO_0000019
13429,,Autocuration,CHEMBL625044,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13430,,Autocuration,CHEMBL625045,,,22224,,A,,Partition coefficient (logD),,U,0,1,,BAO_0000019
13431,,Autocuration,CHEMBL625046,,,22229,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,0,1,,BAO_0000100
13432,,Autocuration,CHEMBL625047,,,22229,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,0,1,,BAO_0000100
13433,,Autocuration,CHEMBL625048,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13434,,Autocuration,CHEMBL625049,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13435,,Autocuration,CHEMBL625050,,,22229,,P,,Calculated logarithm of partition coefficient (P) was determined,,U,0,1,,BAO_0000100
13436,,Autocuration,CHEMBL625051,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13437,,Autocuration,CHEMBL874412,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13438,,Autocuration,CHEMBL625052,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13439,,Autocuration,CHEMBL625053,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13440,,Autocuration,CHEMBL623250,,,22224,,A,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,U,0,1,,BAO_0000019
13441,,Autocuration,CHEMBL623251,,,22224,,A,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,U,0,1,,BAO_0000019
13442,,Autocuration,CHEMBL623252,,,22224,,A,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,U,0,1,,BAO_0000019
13443,,Autocuration,CHEMBL623253,,,22224,,A,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,U,0,1,,BAO_0000019
13444,,Autocuration,CHEMBL623254,,,22224,,A,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,U,0,1,,BAO_0000019
13445,,Autocuration,CHEMBL623255,,,22224,,A,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,U,0,1,,BAO_0000019
13446,,Autocuration,CHEMBL626831,,,22224,,A,,Percent degradation of compound at a pH of 1 over a 18 hr period,,U,0,1,,BAO_0000019
13447,,Autocuration,CHEMBL877494,,,22224,,A,,Percent degradation of compound at pH of 1 over an 18 hr period,,U,0,1,,BAO_0000019
13448,,Autocuration,CHEMBL626832,,,22224,,A,,Delta Logarithm of Partition Coefficient value was determined.,,U,0,1,,BAO_0000019
13449,,Autocuration,CHEMBL626833,,,22224,,A,,Delta logPoct-cyc,,U,0,1,,BAO_0000019
13450,,Autocuration,CHEMBL626834,,,22224,,P,,Lipophilicity estimated on reversed phase TLC,,U,0,1,,BAO_0000100
13451,,Autocuration,CHEMBL626835,,,22224,,A,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,U,0,1,,BAO_0000019
13452,,Autocuration,CHEMBL626836,,,22224,,A,,Delta logPoct-cyc,,U,0,1,,BAO_0000019
13453,,Autocuration,CHEMBL626837,,,22229,,P,,Change in logarithm of partition coefficient of the compound,,U,0,1,,BAO_0000100
13454,,Autocuration,CHEMBL626838,,,22224,,A,,Delta logD (pH 6.5),,U,0,1,,BAO_0000019
13455,,Autocuration,CHEMBL626839,,,22224,,P,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,U,0,1,,BAO_0000100
13456,,Autocuration,CHEMBL626840,,,22224,,A,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,U,0,1,,BAO_0000019
13457,,Autocuration,CHEMBL626841,,,22224,,A,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,U,0,1,,BAO_0000019
13458,,Autocuration,CHEMBL626842,,,22224,,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,U,0,1,,BAO_0000219
13459,,Autocuration,CHEMBL626843,,,22224,,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,U,0,1,,BAO_0000219
13460,Rattus norvegicus,Intermediate,CHEMBL626844,,,50597,,A,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,N,1,1,,BAO_0000218
13461,Rattus norvegicus,Intermediate,CHEMBL877495,,,50597,,A,,Amount of deuterium retained was reported after normal workup in rats,,N,1,1,,BAO_0000218
13462,Rattus norvegicus,Intermediate,CHEMBL626845,,,50597,,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,N,1,1,,BAO_0000218
13463,Rattus norvegicus,Intermediate,CHEMBL626846,,,50597,,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,N,1,1,,BAO_0000218
13464,Rattus norvegicus,Intermediate,CHEMBL626847,,,50597,,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,1,1,,BAO_0000218
13465,Rattus norvegicus,Intermediate,CHEMBL628677,,,50597,,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,1,1,,BAO_0000218
13466,Rattus norvegicus,Intermediate,CHEMBL628678,,,50597,,A,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,N,1,1,,BAO_0000218
13467,,Autocuration,CHEMBL628679,,,22224,,A,,Compound was subjected to electrochemical oxidation,,U,0,1,,BAO_0000019
13468,,Autocuration,CHEMBL628680,,,22224,,A,,Compound was subjected to photochemical oxidation,,U,0,1,,BAO_0000019
13469,,Autocuration,CHEMBL628681,,,22224,,A,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,U,0,1,,BAO_0000019
13470,,Autocuration,CHEMBL628682,,,22224,,A,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,U,0,1,,BAO_0000019
13471,,Autocuration,CHEMBL628683,,,22224,,A,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,U,0,1,,BAO_0000019
13472,Rattus norvegicus,Intermediate,CHEMBL628684,,,50597,,A,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,N,1,1,,BAO_0000218
13473,,Autocuration,CHEMBL877501,,,22229,,P,,Dissociation constant (pKa),,U,0,1,,BAO_0000100
13474,,Autocuration,CHEMBL628685,,,22224,,P,,Dissociation constant value of the compound; ND means not determined.,,U,0,1,,BAO_0000100
13475,Rattus norvegicus,Intermediate,CHEMBL628686,,,50597,178.0,A,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13476,Rattus norvegicus,Intermediate,CHEMBL628687,,,50597,178.0,A,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13477,Rattus norvegicus,Intermediate,CHEMBL628688,,,50597,,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13478,Rattus norvegicus,Intermediate,CHEMBL628689,,,50597,,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13479,Rattus norvegicus,Intermediate,CHEMBL628690,,,50597,2107.0,A,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13480,Rattus norvegicus,Intermediate,CHEMBL629363,,,50597,2107.0,A,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13481,Rattus norvegicus,Intermediate,CHEMBL629364,,,50597,2106.0,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13482,Rattus norvegicus,Intermediate,CHEMBL629365,,,50597,2106.0,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13483,Rattus norvegicus,Intermediate,CHEMBL629366,,,50597,,A,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13484,Rattus norvegicus,Intermediate,CHEMBL629367,,,50597,1088.0,A,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,N,1,1,,BAO_0000218
13485,Rattus norvegicus,Intermediate,CHEMBL629368,,,50597,1988.0,A,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13486,Rattus norvegicus,Intermediate,CHEMBL877502,,,50597,1088.0,A,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,1,1,,BAO_0000218
13487,Mus musculus,Intermediate,CHEMBL629369,,,50594,2037.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,N,1,1,,BAO_0000218
13488,Mus musculus,Intermediate,CHEMBL629370,,,50594,955.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,N,1,1,,BAO_0000218
13489,Simiiformes,Autocuration,CHEMBL629371,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,U,0,1,,BAO_0000218
13490,Simiiformes,Autocuration,CHEMBL626276,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,0,1,,BAO_0000218
13491,Simiiformes,Autocuration,CHEMBL626277,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,0,1,,BAO_0000218
13492,Simiiformes,Autocuration,CHEMBL631250,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,0,1,,BAO_0000218
13493,Rattus norvegicus,Intermediate,CHEMBL631251,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13494,Rattus norvegicus,Intermediate,CHEMBL631252,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,1,1,,BAO_0000218
13495,Rattus norvegicus,Intermediate,CHEMBL631253,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,N,1,1,,BAO_0000218
13496,Rattus norvegicus,Intermediate,CHEMBL631254,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,1,1,,BAO_0000218
13497,Rattus norvegicus,Intermediate,CHEMBL631255,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,1,1,,BAO_0000218
13498,Rattus norvegicus,Intermediate,CHEMBL631256,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,1,1,,BAO_0000218
13499,Rattus norvegicus,Intermediate,CHEMBL631257,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,1,1,,BAO_0000218
13500,Rattus norvegicus,Intermediate,CHEMBL628009,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,N,1,1,,BAO_0000218
13501,Rattus norvegicus,Intermediate,CHEMBL628010,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,1,1,,BAO_0000218
13502,Rattus norvegicus,Intermediate,CHEMBL628011,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,1,1,,BAO_0000218
13503,Rattus norvegicus,Intermediate,CHEMBL628012,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,N,1,1,,BAO_0000218
13504,Rattus norvegicus,Intermediate,CHEMBL628013,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,1,1,,BAO_0000218
13505,Rattus norvegicus,Intermediate,CHEMBL628014,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,1,1,,BAO_0000218
13506,Canis lupus familiaris,Intermediate,CHEMBL628015,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,N,1,1,,BAO_0000218
13507,Canis lupus familiaris,Intermediate,CHEMBL628016,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13508,Canis lupus familiaris,Intermediate,CHEMBL874461,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,N,1,1,,BAO_0000218
13509,Canis lupus familiaris,Intermediate,CHEMBL628017,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1,1,,BAO_0000218
13510,Canis lupus familiaris,Intermediate,CHEMBL628018,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,1,1,,BAO_0000218
13511,Canis lupus familiaris,Intermediate,CHEMBL628019,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1,1,,BAO_0000218
13512,Canis lupus familiaris,Intermediate,CHEMBL628020,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1,1,,BAO_0000218
13513,Canis lupus familiaris,Intermediate,CHEMBL628021,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,1,1,,BAO_0000218
13514,Canis lupus familiaris,Intermediate,CHEMBL628022,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,1,1,,BAO_0000218
13515,Canis lupus familiaris,Intermediate,CHEMBL628023,,,50588,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,1,1,,BAO_0000218
13516,Simiiformes,Autocuration,CHEMBL628024,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,0,1,,BAO_0000218
13517,Simiiformes,Autocuration,CHEMBL628025,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,0,1,,BAO_0000218
13518,Simiiformes,Autocuration,CHEMBL628026,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,0,1,,BAO_0000218
13519,Simiiformes,Autocuration,CHEMBL628027,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,0,1,,BAO_0000218
13520,Simiiformes,Autocuration,CHEMBL628028,,,22224,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,0,1,,BAO_0000218
13521,Rattus norvegicus,Intermediate,CHEMBL628029,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1,1,,BAO_0000218
13522,Rattus norvegicus,Intermediate,CHEMBL628030,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,N,1,1,,BAO_0000218
13523,Rattus norvegicus,Intermediate,CHEMBL628031,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,1,1,,BAO_0000218
13524,Rattus norvegicus,Intermediate,CHEMBL628032,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,N,1,1,,BAO_0000218
13525,Rattus norvegicus,Intermediate,CHEMBL628033,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,1,1,,BAO_0000218
13526,Rattus norvegicus,Intermediate,CHEMBL628034,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,N,1,1,,BAO_0000218
13527,Rattus norvegicus,Intermediate,CHEMBL628035,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,1,1,,BAO_0000218
13528,Rattus norvegicus,Intermediate,CHEMBL628036,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,N,1,1,,BAO_0000218
13529,Rattus norvegicus,Intermediate,CHEMBL874462,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,1,1,,BAO_0000218
13530,Canis lupus familiaris,Intermediate,CHEMBL628037,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,N,1,1,,BAO_0000218
13531,Canis lupus familiaris,Intermediate,CHEMBL628123,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,N,1,1,,BAO_0000218
13532,Canis lupus familiaris,Intermediate,CHEMBL628124,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,N,1,1,,BAO_0000218
13533,Canis lupus familiaris,Intermediate,CHEMBL628125,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,N,1,1,,BAO_0000218
13534,Canis lupus familiaris,Intermediate,CHEMBL628126,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,N,1,1,,BAO_0000218
13535,Canis lupus familiaris,Intermediate,CHEMBL628127,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,N,1,1,,BAO_0000218
13536,Canis lupus familiaris,Intermediate,CHEMBL628128,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,N,1,1,,BAO_0000218
13537,Canis lupus familiaris,Intermediate,CHEMBL628129,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,N,1,1,,BAO_0000218
13538,Canis lupus familiaris,Intermediate,CHEMBL628130,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,N,1,1,,BAO_0000218
13539,Canis lupus familiaris,Intermediate,CHEMBL628131,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,N,1,1,,BAO_0000218
13540,Canis lupus familiaris,Intermediate,CHEMBL628132,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,N,1,1,,BAO_0000218
13541,Canis lupus familiaris,Intermediate,CHEMBL628133,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,N,1,1,,BAO_0000218
13542,Canis lupus familiaris,Intermediate,CHEMBL628134,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,N,1,1,,BAO_0000218
13543,Canis lupus familiaris,Intermediate,CHEMBL628135,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,N,1,1,,BAO_0000218
13544,Canis lupus familiaris,Intermediate,CHEMBL628136,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,N,1,1,,BAO_0000218
13545,Canis lupus familiaris,Intermediate,CHEMBL628137,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,N,1,1,,BAO_0000218
13546,Canis lupus familiaris,Intermediate,CHEMBL628138,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,N,1,1,,BAO_0000218
13547,Canis lupus familiaris,Intermediate,CHEMBL628139,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,N,1,1,,BAO_0000218
13548,Canis lupus familiaris,Intermediate,CHEMBL628140,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,N,1,1,,BAO_0000218
13549,Canis lupus familiaris,Intermediate,CHEMBL628141,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,N,1,1,,BAO_0000218
13550,Canis lupus familiaris,Intermediate,CHEMBL628142,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,N,1,1,,BAO_0000218
13551,Canis lupus familiaris,Intermediate,CHEMBL628143,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,N,1,1,,BAO_0000218
13552,Canis lupus familiaris,Intermediate,CHEMBL628144,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,N,1,1,,BAO_0000218
13553,Canis lupus familiaris,Intermediate,CHEMBL628145,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,N,1,1,,BAO_0000218
13554,Canis lupus familiaris,Intermediate,CHEMBL628146,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,N,1,1,,BAO_0000218
13555,Canis lupus familiaris,Intermediate,CHEMBL625355,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,N,1,1,,BAO_0000218
13556,Canis lupus familiaris,Intermediate,CHEMBL625356,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,N,1,1,,BAO_0000218
13557,Canis lupus familiaris,Intermediate,CHEMBL625357,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,N,1,1,,BAO_0000218
13558,Canis lupus familiaris,Intermediate,CHEMBL625527,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,N,1,1,,BAO_0000218
13559,Canis lupus familiaris,Intermediate,CHEMBL875473,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,N,1,1,,BAO_0000218
13560,Canis lupus familiaris,Intermediate,CHEMBL625528,,,50588,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,N,1,1,,BAO_0000218
13561,Rattus norvegicus,Intermediate,CHEMBL626304,,,50597,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,N,1,1,,BAO_0000218
13562,Canis lupus familiaris,Intermediate,CHEMBL624138,,,50588,1637.0,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,N,1,1,,BAO_0000218
13563,,Autocuration,CHEMBL624139,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13564,,Autocuration,CHEMBL624140,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13565,,Autocuration,CHEMBL624141,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13566,,Autocuration,CHEMBL624142,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13567,,Autocuration,CHEMBL624143,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13568,,Autocuration,CHEMBL624144,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13569,,Autocuration,CHEMBL624145,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13570,,Autocuration,CHEMBL624146,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13571,,Autocuration,CHEMBL624147,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13572,,Autocuration,CHEMBL883123,,,22229,,P,,Calculated partition coefficient (clogP) (MacLogP),,U,0,1,,BAO_0000100
13573,,Autocuration,CHEMBL624148,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
13574,,Autocuration,CHEMBL874416,,,22224,,A,,Kinetic parameter was determined,,U,0,1,,BAO_0000019
13575,,Autocuration,CHEMBL624149,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13576,,Autocuration,CHEMBL624150,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13577,,Autocuration,CHEMBL624151,,,22224,,P,,Lipophilicity was determined,,U,0,1,,BAO_0000100
13578,,Autocuration,CHEMBL624152,,,22224,,P,,Lipophilicity was determined,,U,0,1,,BAO_0000100
13579,,Autocuration,CHEMBL622139,,,22224,,P,,Lipophilicity was determined,,U,0,1,,BAO_0000100
13580,,Autocuration,CHEMBL622140,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13581,,Autocuration,CHEMBL622141,,,22224,,P,,Lipophilicity was determined,,U,0,1,,BAO_0000100
13582,,Autocuration,CHEMBL622142,,,22224,,P,,Lipophilicity in octanol-water,,U,0,1,,BAO_0000100
13583,,Autocuration,CHEMBL622143,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13584,,Autocuration,CHEMBL622144,,,22229,,P,,Octanol-water partition coefficient was determined,,U,0,1,,BAO_0000100
13585,,Autocuration,CHEMBL877473,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
13586,,Autocuration,CHEMBL622145,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13587,,Autocuration,CHEMBL622146,,,22224,,A,,Partition coefficient was determined; ND means not determined,,U,0,1,,BAO_0000019
13588,,Autocuration,CHEMBL622147,,,22229,,P,,Calculated partition coefficient (clogP),,U,0,1,,BAO_0000100
13589,,Autocuration,CHEMBL622148,,,22224,,A,,Partition coefficient of the compound,,U,0,1,,BAO_0000019
13590,,Autocuration,CHEMBL883124,,,22224,,A,,Permeability was determined,,U,0,1,,BAO_0000019
13591,,Autocuration,CHEMBL622149,,,22229,,P,,The compound was evaluated for the partition coefficient,,U,0,1,,BAO_0000100
13592,,Autocuration,CHEMBL622150,,,22224,,A,,Partition coefficient (logP),,U,0,1,,BAO_0000019
13593,,Autocuration,CHEMBL622151,,,22224,,P,,The lipophilicity was reported,,U,0,1,,BAO_0000100
13594,,Autocuration,CHEMBL622152,,,22229,,P,,logarithm of the octanol-water partition coefficient for the compound,,U,0,1,,BAO_0000100
13595,,Autocuration,CHEMBL622153,,,22224,,A,,Clogp value was determined,,U,0,1,,BAO_0000019
13596,,Autocuration,CHEMBL877474,,,22224,,A,,Clp at a dose of 1.5 mg/kg,,U,0,1,,BAO_0000218
13597,,Autocuration,CHEMBL622154,,,22224,,A,,Clp at a dose of 2.0 mg/kg,,U,0,1,,BAO_0000218
13598,,Autocuration,CHEMBL622155,,,22224,1969.0,A,,"Clp, plasma clearance at a dose of 10 mg/kg",,U,0,1,,BAO_0000218
13599,,Autocuration,CHEMBL622156,,,22224,1969.0,A,,"Clp, plasma clearance at a dose of 50 mg/kg",,U,0,1,,BAO_0000218
13600,Rattus norvegicus,Intermediate,CHEMBL622157,,,50597,1969.0,A,,Compound was tested for plasma clearance in rat,,N,1,1,,BAO_0000218
13601,Rattus norvegicus,Intermediate,CHEMBL622158,,,50597,1969.0,A,,Compound was tested for plasma clearance in rat; Not determined,,N,1,1,,BAO_0000218
13602,Rattus norvegicus,Intermediate,CHEMBL622807,,,50597,,A,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,N,1,1,,BAO_0000218
13603,Macaca mulatta,Intermediate,CHEMBL622808,,,50797,,A,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,N,1,1,,BAO_0000218
13604,,Autocuration,CHEMBL622809,,,22224,,A,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,U,0,1,,BAO_0000218
13605,,Autocuration,CHEMBL622810,,,22224,,A,,Plasma clearance determined,,U,0,1,,BAO_0000218
13606,Cricetinae,Intermediate,CHEMBL876653,,,100712,,A,,Plasma clearance after iv administration at 3 mg/kg in hamster,,N,1,1,,BAO_0000218
13607,Cricetinae,Intermediate,CHEMBL622811,,,100712,,A,,Plasma clearance after iv administration at 4 mg/kg in hamster,,N,1,1,,BAO_0000218
13608,Rattus norvegicus,Intermediate,CHEMBL622986,,,50597,,A,,Rate of clearance in rat was determined,,N,1,1,,BAO_0000218
13609,Rattus norvegicus,Intermediate,CHEMBL622987,,,50597,1969.0,A,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,N,1,1,,BAO_0000218
13610,Rattus norvegicus,Intermediate,CHEMBL622988,,,50597,1969.0,A,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,N,1,1,,BAO_0000218
13611,Rattus norvegicus,Intermediate,CHEMBL622989,,,50597,1969.0,A,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,1,1,,BAO_0000218
13612,Rattus norvegicus,Intermediate,CHEMBL622990,,,50597,1969.0,A,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,1,1,,BAO_0000218
13613,Simiiformes,Autocuration,CHEMBL622991,,,22224,1969.0,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,0,1,,BAO_0000218
13614,Rattus norvegicus,Intermediate,CHEMBL622227,,,50597,1969.0,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,1,1,,BAO_0000218
13615,Canis lupus familiaris,Intermediate,CHEMBL622228,,,50588,1969.0,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,1,1,,BAO_0000218
13616,Rattus norvegicus,Intermediate,CHEMBL622229,,,50597,,A,,Clpl value in rat,,N,1,1,,BAO_0000218
13617,Cavia porcellus,Intermediate,CHEMBL622230,,,50512,,A,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,N,1,1,,BAO_0000218
13618,Rattus norvegicus,Intermediate,CHEMBL622231,,,50597,,A,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,N,1,1,,BAO_0000218
13619,Macaca fascicularis,Intermediate,CHEMBL622232,,,100710,,A,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,N,1,1,,BAO_0000218
13620,,Autocuration,CHEMBL622233,,,22224,,A,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,U,0,1,,BAO_0000218
13621,,Autocuration,CHEMBL622234,,,22224,,A,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,U,0,1,,BAO_0000218
13622,,Autocuration,CHEMBL622235,,,22224,,A,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,U,0,1,,BAO_0000218
13623,,Autocuration,CHEMBL622236,,,22224,,A,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,U,0,1,,BAO_0000218
13624,,Autocuration,CHEMBL622237,,,22224,,A,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,U,0,1,,BAO_0000218
13625,,Autocuration,CHEMBL877482,,,22224,,A,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,U,0,1,,BAO_0000218
13626,,Autocuration,CHEMBL622238,,,22224,,A,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,U,0,1,,BAO_0000218
13627,,Autocuration,CHEMBL622239,,,22224,,A,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,U,0,1,,BAO_0000218
13628,,Autocuration,CHEMBL622240,,,22224,178.0,A,,Cmax was calculated as maximum concentration reached in the blood,,U,0,1,,BAO_0000218
13629,,Autocuration,CHEMBL622241,,,22224,178.0,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,U,0,1,,BAO_0000218
13630,Rattus norvegicus,Intermediate,CHEMBL631013,,,50597,,A,,Cmax was determine after peroral administration at 10 mpk in Rat,,N,1,1,,BAO_0000218
13631,Macaca mulatta,Intermediate,CHEMBL631014,,,50797,,A,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,N,1,1,,BAO_0000218
13632,Canis lupus familiaris,Intermediate,CHEMBL631015,,,50588,,A,,Cmax was determine after peroral administration at 10 mpk in dog,,N,1,1,,BAO_0000218
13633,Rattus norvegicus,Intermediate,CHEMBL631016,,,50597,,A,,Cmax was determine after peroral administration at 160 mpk in Rat,,N,1,1,,BAO_0000218
13634,Rattus norvegicus,Intermediate,CHEMBL631017,,,50597,,A,,Cmax was determine after peroral administration at 20 mpk in Rat,,N,1,1,,BAO_0000218
13635,Rattus norvegicus,Intermediate,CHEMBL631018,,,50597,,A,,Cmax was determine after peroral administration at 50 mpk in Rat,,N,1,1,,BAO_0000218
13636,,Autocuration,CHEMBL631019,,,22224,,A,,Cmax was determined,,U,0,1,,BAO_0000218
13637,Mus musculus,Intermediate,CHEMBL875761,,,50594,955.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,N,1,1,,BAO_0000218
13638,Mus musculus,Intermediate,CHEMBL631020,,,50594,955.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,N,1,1,,BAO_0000218
13639,Mus musculus,Intermediate,CHEMBL631669,,,50594,955.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,N,1,1,,BAO_0000218
13640,Mus musculus,Intermediate,CHEMBL631670,,,50594,955.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,N,1,1,,BAO_0000218
13641,Mus musculus,Intermediate,CHEMBL631671,,,50594,2435.0,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,N,1,1,,BAO_0000218
13642,Rattus norvegicus,Intermediate,CHEMBL631672,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,N,1,1,,BAO_0000218
13643,Rattus norvegicus,Intermediate,CHEMBL631673,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,N,1,1,,BAO_0000218
13644,Rattus norvegicus,Intermediate,CHEMBL631856,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,N,1,1,,BAO_0000218
13645,Rattus norvegicus,Intermediate,CHEMBL631857,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,N,1,1,,BAO_0000218
13646,Rattus norvegicus,Intermediate,CHEMBL631858,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,N,1,1,,BAO_0000218
13647,Rattus norvegicus,Intermediate,CHEMBL631859,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,N,1,1,,BAO_0000218
13648,Rattus norvegicus,Intermediate,CHEMBL631860,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,N,1,1,,BAO_0000218
13649,Rattus norvegicus,Intermediate,CHEMBL631861,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,N,1,1,,BAO_0000218
13650,Rattus norvegicus,Intermediate,CHEMBL631862,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,N,1,1,,BAO_0000218
13651,Rattus norvegicus,Intermediate,CHEMBL631863,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,N,1,1,,BAO_0000218
13652,Rattus norvegicus,Intermediate,CHEMBL631864,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,N,1,1,,BAO_0000218
13653,Rattus norvegicus,Intermediate,CHEMBL631865,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,N,1,1,,BAO_0000218
13654,Rattus norvegicus,Intermediate,CHEMBL631866,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,N,1,1,,BAO_0000218
13655,Rattus norvegicus,Intermediate,CHEMBL629360,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,N,1,1,,BAO_0000218
13656,Rattus norvegicus,Intermediate,CHEMBL629361,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,N,1,1,,BAO_0000218
13657,Rattus norvegicus,Intermediate,CHEMBL629362,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,N,1,1,,BAO_0000218
13658,Rattus norvegicus,Intermediate,CHEMBL630740,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,N,1,1,,BAO_0000218
13659,Rattus norvegicus,Intermediate,CHEMBL630741,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,N,1,1,,BAO_0000218
13660,Rattus norvegicus,Intermediate,CHEMBL630742,,,50597,178.0,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,N,1,1,,BAO_0000218
13661,Rattus norvegicus,Intermediate,CHEMBL630743,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,N,1,1,,BAO_0000218
13662,Rattus norvegicus,Intermediate,CHEMBL630744,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,N,1,1,,BAO_0000218
13663,Rattus norvegicus,Intermediate,CHEMBL630745,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,N,1,1,,BAO_0000218
13664,Rattus norvegicus,Intermediate,CHEMBL630746,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,N,1,1,,BAO_0000218
13665,Rattus norvegicus,Intermediate,CHEMBL630747,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,N,1,1,,BAO_0000218
13666,Rattus norvegicus,Intermediate,CHEMBL630748,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,N,1,1,,BAO_0000218
13667,Rattus norvegicus,Intermediate,CHEMBL632056,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,N,1,1,,BAO_0000218
13668,Rattus norvegicus,Intermediate,CHEMBL632057,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,N,1,1,,BAO_0000218
13669,Rattus norvegicus,Intermediate,CHEMBL632058,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,N,1,1,,BAO_0000218
13670,Rattus norvegicus,Intermediate,CHEMBL632059,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,N,1,1,,BAO_0000218
13671,Rattus norvegicus,Intermediate,CHEMBL632060,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,N,1,1,,BAO_0000218
13672,Rattus norvegicus,Intermediate,CHEMBL632061,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,N,1,1,,BAO_0000218
13673,Rattus norvegicus,Intermediate,CHEMBL629207,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,N,1,1,,BAO_0000218
13674,Rattus norvegicus,Intermediate,CHEMBL629208,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,N,1,1,,BAO_0000218
13675,Rattus norvegicus,Intermediate,CHEMBL629209,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,N,1,1,,BAO_0000218
13676,Rattus norvegicus,Intermediate,CHEMBL629210,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,N,1,1,,BAO_0000218
13677,Rattus norvegicus,Intermediate,CHEMBL629211,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,N,1,1,,BAO_0000218
13678,Rattus norvegicus,Intermediate,CHEMBL629212,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,N,1,1,,BAO_0000218
13679,Rattus norvegicus,Intermediate,CHEMBL629213,,,50597,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,N,1,1,,BAO_0000218
13680,Rattus norvegicus,Intermediate,CHEMBL629214,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,1,1,,BAO_0000218
13681,Rattus norvegicus,Intermediate,CHEMBL629215,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,N,1,1,,BAO_0000218
13682,Rattus norvegicus,Intermediate,CHEMBL635154,,,50597,1088.0,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,N,1,1,,BAO_0000218
13683,Rattus norvegicus,Intermediate,CHEMBL629216,,,50597,,A,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
13684,Rattus norvegicus,Intermediate,CHEMBL629217,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,N,1,1,,BAO_0000218
13685,Rattus norvegicus,Intermediate,CHEMBL629218,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13686,Rattus norvegicus,Intermediate,CHEMBL629219,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
13687,Rattus norvegicus,Intermediate,CHEMBL629220,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
13688,Rattus norvegicus,Intermediate,CHEMBL629221,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
13689,Rattus norvegicus,Intermediate,CHEMBL631127,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13690,Rattus norvegicus,Intermediate,CHEMBL631128,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,N,1,1,,BAO_0000218
13691,Rattus norvegicus,Intermediate,CHEMBL631129,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13692,Rattus norvegicus,Intermediate,CHEMBL631130,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
13693,Rattus norvegicus,Intermediate,CHEMBL631131,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
13694,Rattus norvegicus,Intermediate,CHEMBL631132,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
13695,Rattus norvegicus,Intermediate,CHEMBL631133,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13696,Rattus norvegicus,Intermediate,CHEMBL631134,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,N,1,1,,BAO_0000218
13697,Rattus norvegicus,Intermediate,CHEMBL875120,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13698,Rattus norvegicus,Intermediate,CHEMBL631135,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
13699,Rattus norvegicus,Intermediate,CHEMBL631136,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
13700,Rattus norvegicus,Intermediate,CHEMBL631137,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
13701,Rattus norvegicus,Intermediate,CHEMBL631138,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13702,Rattus norvegicus,Intermediate,CHEMBL631139,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,N,1,1,,BAO_0000218
13703,Rattus norvegicus,Intermediate,CHEMBL631140,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13704,Rattus norvegicus,Intermediate,CHEMBL631141,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,1,1,,BAO_0000218
13705,Rattus norvegicus,Intermediate,CHEMBL631142,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,1,1,,BAO_0000218
13706,Rattus norvegicus,Intermediate,CHEMBL631143,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,1,1,,BAO_0000218
13707,Rattus norvegicus,Intermediate,CHEMBL631144,,,50597,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,1,1,,BAO_0000218
13708,Canis lupus familiaris,Intermediate,CHEMBL631145,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,N,1,1,,BAO_0000218
13709,Canis lupus familiaris,Intermediate,CHEMBL631146,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
13710,Canis lupus familiaris,Intermediate,CHEMBL631147,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,N,1,1,,BAO_0000218
13711,Canis lupus familiaris,Intermediate,CHEMBL631148,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13712,Canis lupus familiaris,Intermediate,CHEMBL631149,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13713,Canis lupus familiaris,Intermediate,CHEMBL631150,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
13714,Canis lupus familiaris,Intermediate,CHEMBL631151,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13715,Canis lupus familiaris,Intermediate,CHEMBL631152,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13716,Canis lupus familiaris,Intermediate,CHEMBL631443,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13717,Canis lupus familiaris,Intermediate,CHEMBL631444,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
13718,Canis lupus familiaris,Intermediate,CHEMBL631445,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
13719,Canis lupus familiaris,Intermediate,CHEMBL631446,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,1,1,,BAO_0000218
13720,Canis lupus familiaris,Intermediate,CHEMBL631447,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,N,1,1,,BAO_0000218
13721,Canis lupus familiaris,Intermediate,CHEMBL631448,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,1,1,,BAO_0000218
13722,Canis lupus familiaris,Intermediate,CHEMBL631449,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,N,1,1,,BAO_0000218
13723,Canis lupus familiaris,Intermediate,CHEMBL631450,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,1,1,,BAO_0000218
13724,Canis lupus familiaris,Intermediate,CHEMBL629724,,,50588,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,1,1,,BAO_0000218
13725,Mus musculus,Intermediate,CHEMBL629725,,,50594,14.0,A,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13726,Mus musculus,Intermediate,CHEMBL629726,,,50594,14.0,A,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13727,Mus musculus,Intermediate,CHEMBL629727,,,50594,2106.0,A,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13728,Mus musculus,Intermediate,CHEMBL630404,,,50594,2106.0,A,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13729,Mus musculus,Intermediate,CHEMBL630405,,,50594,2106.0,A,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13730,Mus musculus,Intermediate,CHEMBL630406,,,50594,2106.0,A,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13731,Mus musculus,Intermediate,CHEMBL630407,,,50594,945.0,A,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13732,Mus musculus,Intermediate,CHEMBL630573,,,50594,945.0,A,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13733,Mus musculus,Intermediate,CHEMBL630574,,,50594,945.0,A,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13734,Mus musculus,Intermediate,CHEMBL630575,,,50594,945.0,A,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13735,Mus musculus,Intermediate,CHEMBL630576,,,50594,,A,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13736,Mus musculus,Intermediate,CHEMBL630577,,,50594,,A,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13737,Mus musculus,Intermediate,CHEMBL630578,,,50594,,A,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13738,Mus musculus,Intermediate,CHEMBL630579,,,50594,,A,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,1,1,,BAO_0000218
13739,Mus musculus,Intermediate,CHEMBL630580,,,50594,2113.0,A,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,N,1,1,,BAO_0000218
13740,Mus musculus,Intermediate,CHEMBL630581,,,50594,2113.0,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,N,1,1,,BAO_0000218
13741,Mus musculus,Intermediate,CHEMBL630582,,,50594,2113.0,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,N,1,1,,BAO_0000218
13742,Mus musculus,Intermediate,CHEMBL630583,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,N,1,1,,BAO_0000218
13743,Mus musculus,Intermediate,CHEMBL630584,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,N,1,1,,BAO_0000218
13744,Mus musculus,Intermediate,CHEMBL630585,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,N,1,1,,BAO_0000218
13745,Mus musculus,Intermediate,CHEMBL630586,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,N,1,1,,BAO_0000218
13746,Mus musculus,Intermediate,CHEMBL630587,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,N,1,1,,BAO_0000218
13747,Mus musculus,Intermediate,CHEMBL630588,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,N,1,1,,BAO_0000218
13748,Mus musculus,Intermediate,CHEMBL630589,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,N,1,1,,BAO_0000218
13749,Mus musculus,Intermediate,CHEMBL630590,,,50594,,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,N,1,1,,BAO_0000218
13750,,Autocuration,CHEMBL630591,,,22224,1988.0,A,,Removal of 238-Plutonium(IV) in feces at 24 h,,U,0,1,,BAO_0000019
13751,,Autocuration,CHEMBL630592,,,22224,1988.0,A,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,U,0,1,,BAO_0000019
13752,,Autocuration,CHEMBL630593,,,22224,,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,U,0,1,,BAO_0000019
13753,,Autocuration,CHEMBL630594,,,22224,,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,U,0,1,,BAO_0000019
13754,,Autocuration,CHEMBL630595,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,U,0,1,,BAO_0000019
13755,,Autocuration,CHEMBL630596,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,U,0,1,,BAO_0000019
13756,,Autocuration,CHEMBL630597,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,U,0,1,,BAO_0000019
13757,,Autocuration,CHEMBL630598,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,U,0,1,,BAO_0000019
13758,,Autocuration,CHEMBL630599,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,U,0,1,,BAO_0000019
13759,,Autocuration,CHEMBL630600,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,U,0,1,,BAO_0000019
13760,,Autocuration,CHEMBL630601,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,U,0,1,,BAO_0000019
13761,,Autocuration,CHEMBL630602,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,U,0,1,,BAO_0000019
13762,,Autocuration,CHEMBL630603,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,U,0,1,,BAO_0000019
13763,,Autocuration,CHEMBL630604,,,22224,1088.0,A,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,U,0,1,,BAO_0000019
13764,Rattus norvegicus,Intermediate,CHEMBL624869,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13765,Rattus norvegicus,Intermediate,CHEMBL624870,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13766,Rattus norvegicus,Intermediate,CHEMBL623189,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13767,Rattus norvegicus,Intermediate,CHEMBL623190,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13768,Rattus norvegicus,Intermediate,CHEMBL623191,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13769,Rattus norvegicus,Intermediate,CHEMBL623192,,,50597,,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13770,Rattus norvegicus,Intermediate,CHEMBL623193,,,50597,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13771,Rattus norvegicus,Intermediate,CHEMBL623194,,,50597,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13772,Rattus norvegicus,Intermediate,CHEMBL623195,,,50597,,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13773,Rattus norvegicus,Intermediate,CHEMBL623196,,,50597,,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13774,Rattus norvegicus,Intermediate,CHEMBL623197,,,50597,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,N,1,1,,BAO_0000218
13775,Rattus norvegicus,Intermediate,CHEMBL623198,,,50597,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13776,Rattus norvegicus,Intermediate,CHEMBL623199,,,50597,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,1,1,,BAO_0000218
13777,Rattus norvegicus,Intermediate,CHEMBL623200,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13778,Rattus norvegicus,Intermediate,CHEMBL623201,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13779,Rattus norvegicus,Intermediate,CHEMBL623202,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13780,Rattus norvegicus,Intermediate,CHEMBL623203,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13781,Rattus norvegicus,Intermediate,CHEMBL623204,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13782,Rattus norvegicus,Intermediate,CHEMBL623205,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,N,1,1,,BAO_0000218
13783,Rattus norvegicus,Intermediate,CHEMBL623206,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13784,Rattus norvegicus,Intermediate,CHEMBL623207,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,N,1,1,,BAO_0000218
13785,Rattus norvegicus,Intermediate,CHEMBL623208,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,N,1,1,,BAO_0000218
13786,Rattus norvegicus,Intermediate,CHEMBL623209,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13787,Rattus norvegicus,Intermediate,CHEMBL623210,,,50597,2385.0,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,1,1,,BAO_0000218
13788,Rattus norvegicus,Intermediate,CHEMBL623211,,,50597,,A,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13789,Rattus norvegicus,Intermediate,CHEMBL623212,,,50597,995.0,A,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,1,1,,BAO_0000218
13790,,Autocuration,CHEMBL623213,,,22224,,A,,Tested in vitro for intrinsic activity relative to quinpirole,,U,0,1,,BAO_0000019
13791,,Autocuration,CHEMBL623214,,,22224,,A,,"Relative ion enhancement, determined in pulsed ultrafiltration",,U,0,1,,BAO_0000019
13792,,Autocuration,CHEMBL623215,,,22224,,A,,% ionization at the pH 7.4 at 37 degree Centigrade,,U,0,1,,BAO_0000019
13793,,Autocuration,CHEMBL623216,,,22224,,A,,Percentage ionization was measured,,U,0,1,,BAO_0000019
13794,Bos taurus,Intermediate,CHEMBL623217,,,50591,,A,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,N,1,1,,BAO_0000218
13795,,Autocuration,CHEMBL623218,,,22224,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,U,0,1,,BAO_0000019
13796,,Autocuration,CHEMBL623913,,,22224,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,U,0,1,,BAO_0000019
13797,,Autocuration,CHEMBL623914,,,22224,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,U,0,1,,BAO_0000019
13798,,Autocuration,CHEMBL623915,,,22229,,P,,Compound was evaluated for the partition coefficient in octanol/water,,U,0,1,,BAO_0000100
13799,,Autocuration,CHEMBL624080,,,22229,,P,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,U,0,1,,BAO_0000100
13800,,Autocuration,CHEMBL624081,,,22224,,A,,Equilibrium constant measured by the pulse radiolysis at pH 7,,U,0,1,,BAO_0000019
13801,Homo sapiens,Intermediate,CHEMBL624082,,,50587,,A,,In vitro hydrolytic rate constant determined in human blood,,N,1,1,,BAO_0000218
13802,Homo sapiens,Intermediate,CHEMBL625054,,,50587,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,N,1,1,,BAO_0000218
13803,,Autocuration,CHEMBL877485,,,22224,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,U,0,1,,BAO_0000019
13804,Mus musculus,Intermediate,CHEMBL625055,,,50594,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,N,1,1,,BAO_0000218
13805,Mus musculus,Intermediate,CHEMBL625056,,,50594,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,N,1,1,,BAO_0000218
13806,Homo sapiens,Intermediate,CHEMBL625057,,,50587,,A,,In vitro oxidation of compound in presence of human plasma,,N,1,1,,BAO_0000218
13807,,Autocuration,CHEMBL625058,,,22224,,A,,In vitro oxidation of compound in presence of hydrogen peroxide,,U,0,1,,BAO_0000019
13808,Mus musculus,Intermediate,CHEMBL625059,,,50594,,A,,In vitro oxidation of compound in presence of mouse brain homogenate,,N,1,1,,BAO_0000218
13809,Mus musculus,Intermediate,CHEMBL629536,,,50594,,A,,In vitro oxidation of compound in presence of mouse liver homogenate,,N,1,1,,BAO_0000218
13810,Rattus norvegicus,Intermediate,CHEMBL629537,,,50597,,A,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,1,1,,BAO_0000218
13811,Rattus norvegicus,Intermediate,CHEMBL629538,,,50597,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,1,1,,BAO_0000218
13812,Rattus norvegicus,Intermediate,CHEMBL629539,,,50597,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,1,1,,BAO_0000218
13813,Rattus norvegicus,Intermediate,CHEMBL874445,,,50597,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,1,1,,BAO_0000218
13814,Rattus norvegicus,Intermediate,CHEMBL629540,,,50597,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,1,1,,BAO_0000218
13815,Rattus norvegicus,Intermediate,CHEMBL629541,,,50597,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,1,1,,BAO_0000218
13816,Rattus norvegicus,Intermediate,CHEMBL629542,,,50597,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,1,1,,BAO_0000218
13817,Rattus norvegicus,Intermediate,CHEMBL630243,,,50597,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,1,1,,BAO_0000218
13818,Rattus norvegicus,Intermediate,CHEMBL630244,,,50597,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,1,1,,BAO_0000218
13819,Rattus norvegicus,Intermediate,CHEMBL630245,,,50597,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,1,1,,BAO_0000218
13820,Rattus norvegicus,Intermediate,CHEMBL630246,,,50597,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,1,1,,BAO_0000218
13821,Rattus norvegicus,Intermediate,CHEMBL630247,,,50597,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,1,1,,BAO_0000218
13822,Rattus norvegicus,Intermediate,CHEMBL630248,,,50597,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,1,1,,BAO_0000218
13823,Rattus norvegicus,Intermediate,CHEMBL630249,,,50597,178.0,A,,Biodistribution in rat blood at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13824,Rattus norvegicus,Intermediate,CHEMBL630250,,,50597,178.0,A,,Biodistribution in rat blood at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13825,Rattus norvegicus,Intermediate,CHEMBL630251,,,50597,178.0,A,,Biodistribution in rat blood at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13826,Rattus norvegicus,Intermediate,CHEMBL630252,,,50597,178.0,A,,Biodistribution in rat blood at 3 hr after dose administration.,,N,1,1,,BAO_0000218
13827,Rattus norvegicus,Intermediate,CHEMBL630408,,,50597,178.0,A,,Biodistribution in rat blood at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13828,Rattus norvegicus,Intermediate,CHEMBL630409,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13829,Rattus norvegicus,Intermediate,CHEMBL874446,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13830,Rattus norvegicus,Intermediate,CHEMBL630410,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13831,Rattus norvegicus,Intermediate,CHEMBL630411,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13832,Rattus norvegicus,Intermediate,CHEMBL630412,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13833,Rattus norvegicus,Intermediate,CHEMBL630413,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13834,Rattus norvegicus,Intermediate,CHEMBL630414,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,N,1,1,,BAO_0000218
13835,Rattus norvegicus,Intermediate,CHEMBL630415,,,50597,2037.0,A,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13836,Rattus norvegicus,Intermediate,CHEMBL630416,,,50597,,A,,Biodistribution in rat cortex at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13837,Rattus norvegicus,Intermediate,CHEMBL630417,,,50597,,A,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13838,Rattus norvegicus,Intermediate,CHEMBL630418,,,50597,,A,,Biodistribution in rat cortex at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13839,Rattus norvegicus,Intermediate,CHEMBL630419,,,50597,,A,,Biodistribution in rat cortex at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13840,Rattus norvegicus,Intermediate,CHEMBL630420,,,50597,,A,,Biodistribution in rat cortex at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13841,Rattus norvegicus,Intermediate,CHEMBL630421,,,50597,,A,,Biodistribution in rat cortex at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13842,Rattus norvegicus,Intermediate,CHEMBL630422,,,50597,,A,,Biodistribution in rat cortex at 3 hr after dose administration.,,N,1,1,,BAO_0000218
13843,Rattus norvegicus,Intermediate,CHEMBL630423,,,50597,,A,,Biodistribution in rat cortex at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13844,Rattus norvegicus,Intermediate,CHEMBL630424,,,50597,948.0,A,,Biodistribution in rat heart at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13845,Rattus norvegicus,Intermediate,CHEMBL630425,,,50597,948.0,A,,Biodistribution in rat heart at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13846,Rattus norvegicus,Intermediate,CHEMBL629462,,,50597,948.0,A,,Biodistribution in rat heart at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13847,Rattus norvegicus,Intermediate,CHEMBL630426,,,50597,948.0,A,,Biodistribution in rat heart at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13848,Rattus norvegicus,Intermediate,CHEMBL630427,,,50597,948.0,A,,Biodistribution in rat heart at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13849,Rattus norvegicus,Intermediate,CHEMBL625877,,,50597,948.0,A,,Biodistribution in rat heart at 3 hr after dose administration.,,N,1,1,,BAO_0000218
13850,Rattus norvegicus,Intermediate,CHEMBL625878,,,50597,948.0,A,,Biodistribution in rat heart at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13851,Rattus norvegicus,Intermediate,CHEMBL625879,,,50597,10000000.0,A,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13852,Rattus norvegicus,Intermediate,CHEMBL625880,,,50597,10000000.0,A,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13853,Rattus norvegicus,Intermediate,CHEMBL625881,,,50597,10000000.0,A,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13854,Rattus norvegicus,Intermediate,CHEMBL625882,,,50597,10000000.0,A,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13855,Rattus norvegicus,Intermediate,CHEMBL625883,,,50597,10000000.0,A,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13856,Rattus norvegicus,Intermediate,CHEMBL625884,,,50597,2113.0,A,,Biodistribution in rat kidney at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13857,Rattus norvegicus,Intermediate,CHEMBL625885,,,50597,2113.0,A,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13858,Rattus norvegicus,Intermediate,CHEMBL628649,,,50597,2113.0,A,,Biodistribution in rat kidney at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13859,Rattus norvegicus,Intermediate,CHEMBL628650,,,50597,2113.0,A,,Biodistribution in rat kidney at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13860,Rattus norvegicus,Intermediate,CHEMBL628651,,,50597,2113.0,A,,Biodistribution in rat kidney at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13861,Rattus norvegicus,Intermediate,CHEMBL628652,,,50597,2113.0,A,,Biodistribution in rat kidney at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13862,Rattus norvegicus,Intermediate,CHEMBL628653,,,50597,2113.0,A,,Biodistribution in rat kidney at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13863,Rattus norvegicus,Intermediate,CHEMBL628654,,,50597,2107.0,A,,Biodistribution in rat liver at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13864,Rattus norvegicus,Intermediate,CHEMBL628655,,,50597,2107.0,A,,Biodistribution in rat liver at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13865,Rattus norvegicus,Intermediate,CHEMBL625238,,,50597,2107.0,A,,Biodistribution in rat liver at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13866,Rattus norvegicus,Intermediate,CHEMBL625239,,,50597,2107.0,A,,Biodistribution in rat liver at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13867,Rattus norvegicus,Intermediate,CHEMBL625240,,,50597,2107.0,A,,Biodistribution in rat liver at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13868,Rattus norvegicus,Intermediate,CHEMBL625241,,,50597,2107.0,A,,Biodistribution in rat liver at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13869,Rattus norvegicus,Intermediate,CHEMBL625242,,,50597,2107.0,A,,Biodistribution in rat liver at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
13870,Rattus norvegicus,Intermediate,CHEMBL874587,,,50597,2048.0,A,,Biodistribution in rat lung at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
13871,Rattus norvegicus,Intermediate,CHEMBL625405,,,50597,2048.0,A,,Biodistribution in rat lung at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
13872,Rattus norvegicus,Intermediate,CHEMBL625406,,,50597,2048.0,A,,Biodistribution in rat lung at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
13873,Rattus norvegicus,Intermediate,CHEMBL625407,,,50597,2048.0,A,,Biodistribution in rat lung at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
13874,Rattus norvegicus,Intermediate,CHEMBL625408,,,50597,2048.0,A,,Biodistribution in rat lung at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
13875,Rattus norvegicus,Intermediate,CHEMBL625409,,,50597,2048.0,A,,Biodistribution in rat lung at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
13876,Rattus norvegicus,Intermediate,CHEMBL625410,,,50597,1515.0,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,N,1,1,,BAO_0000218
13877,Rattus norvegicus,Intermediate,CHEMBL625411,,,50597,1515.0,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,N,1,1,,BAO_0000218
13878,Rattus norvegicus,Intermediate,CHEMBL625412,,,50597,1515.0,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,N,1,1,,BAO_0000218
13879,Rattus norvegicus,Intermediate,CHEMBL625413,,,50597,1515.0,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,N,1,1,,BAO_0000218
13880,Rattus norvegicus,Intermediate,CHEMBL625414,,,50597,1515.0,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,N,1,1,,BAO_0000218
13881,Rattus norvegicus,Intermediate,CHEMBL625415,,,50597,1515.0,A,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,1,1,,BAO_0000218
13882,Rattus norvegicus,Intermediate,CHEMBL625416,,,50597,1515.0,A,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,1,1,,BAO_0000218
13883,Rattus norvegicus,Intermediate,CHEMBL625417,,,50597,1088.0,A,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,N,1,1,,BAO_0000218
13884,Rattus norvegicus,Intermediate,CHEMBL625418,,,50597,1988.0,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,N,1,1,,BAO_0000218
13885,Rattus norvegicus,Intermediate,CHEMBL625419,,,50597,1088.0,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,N,1,1,,BAO_0000218
13886,Rattus norvegicus,Intermediate,CHEMBL625420,,,50597,,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,N,1,1,,BAO_0000218
13887,Rattus norvegicus,Intermediate,CHEMBL626996,,,50597,,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,N,1,1,,BAO_0000218
13888,Rattus norvegicus,Intermediate,CHEMBL626997,,,50597,1988.0,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,N,1,1,,BAO_0000218
13889,Rattus norvegicus,Intermediate,CHEMBL626998,,,50597,1088.0,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,N,1,1,,BAO_0000218
13890,Rattus norvegicus,Intermediate,CHEMBL626999,,,50597,,A,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,N,1,1,,BAO_0000218
13891,Mus musculus,Intermediate,CHEMBL627000,,,50594,,A,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,N,1,1,,BAO_0000218
13892,Mus musculus,Intermediate,CHEMBL627001,,,50594,,A,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,N,1,1,,BAO_0000218
13893,Mus musculus,Intermediate,CHEMBL627002,,,50594,,A,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,N,1,1,,BAO_0000218
13894,Mus musculus,Intermediate,CHEMBL627003,,,50594,,A,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,N,1,1,,BAO_0000218
13895,Mus musculus,Intermediate,CHEMBL627004,,,50594,1088.0,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,N,1,1,,BAO_0000218
13896,Mus musculus,Intermediate,CHEMBL627005,,,50594,1088.0,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,N,1,1,,BAO_0000218
13897,Mus musculus,Intermediate,CHEMBL874594,,,50594,1088.0,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,N,1,1,,BAO_0000218
13898,Mus musculus,Intermediate,CHEMBL627006,,,50594,1088.0,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,N,1,1,,BAO_0000218
13899,Mus musculus,Intermediate,CHEMBL627007,,,50594,1088.0,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,N,1,1,,BAO_0000218
13900,Mus musculus,Intermediate,CHEMBL627884,,,50594,1088.0,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,N,1,1,,BAO_0000218
13901,Mus musculus,Intermediate,CHEMBL627885,,,50594,1088.0,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,N,1,1,,BAO_0000218
13902,Mus musculus,Intermediate,CHEMBL627886,,,50594,1088.0,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,N,1,1,,BAO_0000218
13903,Mus musculus,Intermediate,CHEMBL627887,,,50594,1088.0,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,N,1,1,,BAO_0000218
13904,Mus musculus,Intermediate,CHEMBL627888,,,50594,1088.0,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,N,1,1,,BAO_0000218
13905,Mus musculus,Intermediate,CHEMBL628057,,,50594,1088.0,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,N,1,1,,BAO_0000218
13906,Mus musculus,Intermediate,CHEMBL627405,,,50594,1088.0,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,N,1,1,,BAO_0000218
13907,Canis lupus familiaris,Intermediate,CHEMBL627406,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1,1,,BAO_0000218
13908,Canis lupus familiaris,Intermediate,CHEMBL627407,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1,1,,BAO_0000218
13909,Canis lupus familiaris,Intermediate,CHEMBL627408,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1,1,,BAO_0000218
13910,Canis lupus familiaris,Intermediate,CHEMBL627409,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1,1,,BAO_0000218
13911,Canis lupus familiaris,Intermediate,CHEMBL875486,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1,1,,BAO_0000218
13912,Canis lupus familiaris,Intermediate,CHEMBL627410,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
13913,Canis lupus familiaris,Intermediate,CHEMBL627411,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1,1,,BAO_0000218
13914,Canis lupus familiaris,Intermediate,CHEMBL627412,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1,1,,BAO_0000218
13915,Canis lupus familiaris,Intermediate,CHEMBL627413,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1,1,,BAO_0000218
13916,Canis lupus familiaris,Intermediate,CHEMBL627414,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1,1,,BAO_0000218
13917,Canis lupus familiaris,Intermediate,CHEMBL627415,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
13918,Canis lupus familiaris,Intermediate,CHEMBL627416,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,1,1,,BAO_0000218
13919,Canis lupus familiaris,Intermediate,CHEMBL627417,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
13920,Canis lupus familiaris,Intermediate,CHEMBL627418,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
13921,Canis lupus familiaris,Intermediate,CHEMBL627419,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
13922,Canis lupus familiaris,Intermediate,CHEMBL627320,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,1,1,,BAO_0000218
13923,Canis lupus familiaris,Intermediate,CHEMBL627321,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,1,1,,BAO_0000218
13924,Rattus norvegicus,Intermediate,CHEMBL627322,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13925,Rattus norvegicus,Intermediate,CHEMBL627323,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13926,Rattus norvegicus,Intermediate,CHEMBL627491,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13927,Rattus norvegicus,Intermediate,CHEMBL627492,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13928,Rattus norvegicus,Intermediate,CHEMBL627493,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13929,Rattus norvegicus,Intermediate,CHEMBL627494,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13930,Rattus norvegicus,Intermediate,CHEMBL627495,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13931,Rattus norvegicus,Intermediate,CHEMBL627496,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13932,Rattus norvegicus,Intermediate,CHEMBL627497,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13933,Rattus norvegicus,Intermediate,CHEMBL627498,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13934,Rattus norvegicus,Intermediate,CHEMBL627499,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13935,Rattus norvegicus,Intermediate,CHEMBL627500,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13936,Rattus norvegicus,Intermediate,CHEMBL627501,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13937,Rattus norvegicus,Intermediate,CHEMBL625616,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13938,Rattus norvegicus,Intermediate,CHEMBL625617,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13939,Rattus norvegicus,Intermediate,CHEMBL625618,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13940,Rattus norvegicus,Intermediate,CHEMBL625619,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13941,Rattus norvegicus,Intermediate,CHEMBL625620,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13942,Rattus norvegicus,Intermediate,CHEMBL625621,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13943,Rattus norvegicus,Intermediate,CHEMBL625622,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13944,Rattus norvegicus,Intermediate,CHEMBL625788,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13945,Rattus norvegicus,Intermediate,CHEMBL625789,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13946,Rattus norvegicus,Intermediate,CHEMBL625790,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13947,Rattus norvegicus,Intermediate,CHEMBL625791,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13948,Rattus norvegicus,Intermediate,CHEMBL622334,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13949,Rattus norvegicus,Intermediate,CHEMBL622335,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13950,Rattus norvegicus,Intermediate,CHEMBL622336,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13951,Rattus norvegicus,Intermediate,CHEMBL622337,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13952,Rattus norvegicus,Intermediate,CHEMBL622338,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13953,Rattus norvegicus,Intermediate,CHEMBL622339,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13954,Rattus norvegicus,Intermediate,CHEMBL624153,,,50597,,A,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13955,Rattus norvegicus,Intermediate,CHEMBL628430,,,50597,,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13956,Rattus norvegicus,Intermediate,CHEMBL628431,,,50597,,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
13957,Rattus norvegicus,Intermediate,CHEMBL628432,,,50597,,A,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13958,Rattus norvegicus,Intermediate,CHEMBL628433,,,50597,,A,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
13959,Rattus norvegicus,Intermediate,CHEMBL628434,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
13960,Rattus norvegicus,Intermediate,CHEMBL626789,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
13961,Rattus norvegicus,Intermediate,CHEMBL626790,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,N,1,1,,BAO_0000218
13962,Rattus norvegicus,Intermediate,CHEMBL626791,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
13963,Rattus norvegicus,Intermediate,CHEMBL626792,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
13964,Rattus norvegicus,Intermediate,CHEMBL626793,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
13965,Rattus norvegicus,Intermediate,CHEMBL627436,,,50597,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,1,1,,BAO_0000218
13966,Rattus norvegicus,Intermediate,CHEMBL627437,,,50597,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,1,1,,BAO_0000218
13967,Rattus norvegicus,Intermediate,CHEMBL627438,,,50597,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,1,1,,BAO_0000218
13968,Rattus norvegicus,Intermediate,CHEMBL627439,,,50597,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,1,1,,BAO_0000218
13969,Rattus norvegicus,Intermediate,CHEMBL627440,,,50597,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,1,1,,BAO_0000218
13970,Rattus norvegicus,Intermediate,CHEMBL627602,,,50597,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,1,1,,BAO_0000218
13971,Rattus norvegicus,Intermediate,CHEMBL627603,,,50597,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,1,1,,BAO_0000218
13972,Rattus norvegicus,Intermediate,CHEMBL627604,,,50597,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,1,1,,BAO_0000218
13973,Rattus norvegicus,Intermediate,CHEMBL627605,,,50597,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,1,1,,BAO_0000218
13974,Rattus norvegicus,Intermediate,CHEMBL627606,,,50597,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,1,1,,BAO_0000218
13975,Rattus norvegicus,Intermediate,CHEMBL627607,,,50597,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,1,1,,BAO_0000218
13976,Rattus norvegicus,Intermediate,CHEMBL627608,,,50597,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,1,1,,BAO_0000218
13977,Rattus norvegicus,Intermediate,CHEMBL627609,,,50597,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,1,1,,BAO_0000218
13978,Rattus norvegicus,Intermediate,CHEMBL627610,,,50597,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,1,1,,BAO_0000218
13979,Rattus norvegicus,Intermediate,CHEMBL627611,,,50597,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,1,1,,BAO_0000218
13980,Rattus norvegicus,Intermediate,CHEMBL627612,,,50597,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,1,1,,BAO_0000218
13981,,Autocuration,CHEMBL627613,,,22229,,P,,Octanol:water partition coefficient is evaluated,,U,0,1,,BAO_0000100
13982,,Autocuration,CHEMBL627614,,,22224,,P,,Partition coefficient in 1-octanol/water system,,U,0,1,,BAO_0000100
13983,,Autocuration,CHEMBL627615,,,22224,,P,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,U,0,1,,BAO_0000100
13984,,Autocuration,CHEMBL627616,,,22224,,P,,Partition coefficient in octanol/water system was determined,,U,0,1,,BAO_0000100
13985,,Autocuration,CHEMBL627617,,,22224,,P,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,U,0,1,,BAO_0000100
13986,,Autocuration,CHEMBL627618,,,22224,,A,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,U,0,1,,BAO_0000019
13987,,Autocuration,CHEMBL627619,,,22224,,A,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,U,0,1,,BAO_0000019
13988,,Autocuration,CHEMBL627620,,,22224,,A,,Pseudo-first-order rate constant of the compound,,U,0,1,,BAO_0000019
13989,,Autocuration,CHEMBL627621,,,22224,,A,,Pseudo-first-order rate constant with 1-min time point,,U,0,1,,BAO_0000019
13990,,Autocuration,CHEMBL627622,,,22224,,A,,Pseudo-first-order rate constant without 1-min time point,,U,0,1,,BAO_0000019
13991,,Autocuration,CHEMBL627623,,,22224,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,U,0,1,,BAO_0000019
13992,,Autocuration,CHEMBL627624,,,22224,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,U,0,1,,BAO_0000019
13993,,Autocuration,CHEMBL627625,,,22224,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,U,0,1,,BAO_0000019
13994,,Autocuration,CHEMBL628523,,,22224,,A,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,U,0,1,,BAO_0000019
13995,,Autocuration,CHEMBL628524,,,22224,,A,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,U,0,1,,BAO_0000019
13996,,Autocuration,CHEMBL628525,,,22224,,A,,The efflux rate constant of the compound,,U,0,1,,BAO_0000019
13997,,Autocuration,CHEMBL625732,,,22224,,A,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,0,1,,BAO_0000019
13998,,Autocuration,CHEMBL625733,,,22224,,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,0,1,,BAO_0000019
13999,,Autocuration,CHEMBL625734,,,22224,,F,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,0,1,,BAO_0000019
14000,,Autocuration,CHEMBL625913,,,22224,,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,U,0,1,,BAO_0000019
14001,,Autocuration,CHEMBL625914,,,22224,,A,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,U,0,1,,BAO_0000019
14002,,Autocuration,CHEMBL625915,,,22224,,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,U,0,1,,BAO_0000019
14003,,Autocuration,CHEMBL625916,,,22224,,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,U,0,1,,BAO_0000019
14004,,Autocuration,CHEMBL625917,,,22224,,A,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,U,0,1,,BAO_0000019
14005,,Autocuration,CHEMBL625918,,,22224,,A,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14006,,Autocuration,CHEMBL625919,,,22224,,A,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14007,,Autocuration,CHEMBL625920,,,22224,,A,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14008,,Autocuration,CHEMBL874453,,,22224,,A,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14009,,Autocuration,CHEMBL625921,,,22224,,A,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14010,,Autocuration,CHEMBL625922,,,22224,,A,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,U,0,1,,BAO_0000019
14011,,Autocuration,CHEMBL625923,,,22224,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14012,,Autocuration,CHEMBL625924,,,22224,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14013,,Autocuration,CHEMBL625925,,,22224,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14014,,Autocuration,CHEMBL625926,,,22224,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14015,Rattus norvegicus,Intermediate,CHEMBL627704,,,50597,2048.0,A,,Biodistribution in rat lung at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
14016,Rattus norvegicus,Intermediate,CHEMBL627705,,,50597,,A,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
14017,Rattus norvegicus,Intermediate,CHEMBL627706,,,50597,,A,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
14018,Rattus norvegicus,Intermediate,CHEMBL627707,,,50597,,A,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
14019,Rattus norvegicus,Intermediate,CHEMBL627708,,,50597,,A,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
14020,Rattus norvegicus,Intermediate,CHEMBL628361,,,50597,,A,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
14021,Rattus norvegicus,Intermediate,CHEMBL628362,,,50597,,A,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
14022,Rattus norvegicus,Intermediate,CHEMBL628363,,,50597,2435.0,A,,Biodistribution in rat striatum at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
14023,Rattus norvegicus,Intermediate,CHEMBL628364,,,50597,2435.0,A,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
14024,Rattus norvegicus,Intermediate,CHEMBL628365,,,50597,2435.0,A,,Biodistribution in rat striatum at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
14025,Rattus norvegicus,Intermediate,CHEMBL874454,,,50597,2435.0,A,,Biodistribution in rat striatum at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
14026,Rattus norvegicus,Intermediate,CHEMBL628531,,,50597,2435.0,A,,Biodistribution in rat striatum at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
14027,Rattus norvegicus,Intermediate,CHEMBL628532,,,50597,2435.0,A,,Biodistribution in rat striatum at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
14028,Rattus norvegicus,Intermediate,CHEMBL628533,,,50597,2435.0,A,,Biodistribution in rat striatum at 3 hr after dose administration.,,N,1,1,,BAO_0000218
14029,Rattus norvegicus,Intermediate,CHEMBL628534,,,50597,2435.0,A,,Biodistribution in rat striatum at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
14030,Rattus norvegicus,Intermediate,CHEMBL628535,,,50597,2046.0,A,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,N,1,1,,BAO_0000218
14031,Rattus norvegicus,Intermediate,CHEMBL628536,,,50597,2046.0,A,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
14032,Rattus norvegicus,Intermediate,CHEMBL628537,,,50597,2046.0,A,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
14033,Rattus norvegicus,Intermediate,CHEMBL628538,,,50597,2046.0,A,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
14034,Rattus norvegicus,Intermediate,CHEMBL628539,,,50597,2046.0,A,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
14035,Rattus norvegicus,Intermediate,CHEMBL630297,,,50597,2046.0,A,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
14036,Rattus norvegicus,Intermediate,CHEMBL630298,,,50597,2046.0,A,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
14037,Rattus norvegicus,Intermediate,CHEMBL630299,,,50597,955.0,A,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,N,1,1,,BAO_0000218
14038,Rattus norvegicus,Intermediate,CHEMBL628094,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,N,1,1,,BAO_0000218
14039,Rattus norvegicus,Intermediate,CHEMBL628095,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,N,1,1,,BAO_0000218
14040,Rattus norvegicus,Intermediate,CHEMBL874648,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,N,1,1,,BAO_0000218
14041,Rattus norvegicus,Intermediate,CHEMBL628096,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,N,1,1,,BAO_0000218
14042,Rattus norvegicus,Intermediate,CHEMBL628097,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,N,1,1,,BAO_0000218
14043,Rattus norvegicus,Intermediate,CHEMBL628098,,,50597,955.0,A,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,N,1,1,,BAO_0000218
14044,,Autocuration,CHEMBL628099,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,U,0,1,,BAO_0000019
14045,,Autocuration,CHEMBL628100,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,0,1,,BAO_0000019
14046,,Autocuration,CHEMBL628101,,,22224,,A,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,U,0,1,,BAO_0000019
14047,,Autocuration,CHEMBL628102,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,U,0,1,,BAO_0000019
14048,,Autocuration,CHEMBL628103,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,U,0,1,,BAO_0000019
14049,,Autocuration,CHEMBL628104,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,0,1,,BAO_0000019
14050,,Autocuration,CHEMBL628105,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,U,0,1,,BAO_0000019
14051,,Autocuration,CHEMBL628106,,,22224,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,U,0,1,,BAO_0000019
14052,Rattus norvegicus,Intermediate,CHEMBL628107,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,N,1,1,,BAO_0000218
14053,,Autocuration,CHEMBL628108,,,22224,1088.0,F,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,U,0,1,,BAO_0000218
14054,Rattus norvegicus,Intermediate,CHEMBL628109,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,N,1,1,,BAO_0000218
14055,,Autocuration,CHEMBL625299,,,22224,1088.0,F,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,U,0,1,,BAO_0000218
14056,Rattus norvegicus,Intermediate,CHEMBL625300,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,N,1,1,,BAO_0000218
14057,Rattus norvegicus,Intermediate,CHEMBL625301,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,N,1,1,,BAO_0000218
14058,Rattus norvegicus,Intermediate,CHEMBL625302,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,N,1,1,,BAO_0000218
14059,Rattus norvegicus,Intermediate,CHEMBL874649,,,50597,1088.0,A,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,N,1,1,,BAO_0000218
14060,Rattus norvegicus,Intermediate,CHEMBL625303,,,50597,,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,N,1,1,,BAO_0000218
14061,Rattus norvegicus,Intermediate,CHEMBL625463,,,50597,,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,N,1,1,,BAO_0000218
14062,Homo sapiens,Intermediate,CHEMBL625464,,,50587,2107.0,A,,In vitro metabolism in human liver microsomes,,N,1,1,,BAO_0000218
14063,Homo sapiens,Intermediate,CHEMBL625465,,,50587,,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,N,1,1,,BAO_0000218
14064,Canis lupus familiaris,Intermediate,CHEMBL625466,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,1,1,,BAO_0000218
14065,Canis lupus familiaris,Intermediate,CHEMBL625467,,,50588,1088.0,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14066,Rattus norvegicus,Intermediate,CHEMBL625468,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,1,1,,BAO_0000218
14067,Rattus norvegicus,Intermediate,CHEMBL625469,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1,1,,BAO_0000218
14068,Rattus norvegicus,Intermediate,CHEMBL625470,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1,1,,BAO_0000218
14069,Rattus norvegicus,Intermediate,CHEMBL632418,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1,1,,BAO_0000218
14070,Rattus norvegicus,Intermediate,CHEMBL627250,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14071,Rattus norvegicus,Intermediate,CHEMBL627251,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1,1,,BAO_0000218
14072,Rattus norvegicus,Intermediate,CHEMBL627252,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1,1,,BAO_0000218
14073,Rattus norvegicus,Intermediate,CHEMBL627253,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1,1,,BAO_0000218
14074,Rattus norvegicus,Intermediate,CHEMBL627254,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1,1,,BAO_0000218
14075,Rattus norvegicus,Intermediate,CHEMBL875471,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14076,Rattus norvegicus,Intermediate,CHEMBL627255,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1,1,,BAO_0000218
14077,Rattus norvegicus,Intermediate,CHEMBL627256,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14078,Rattus norvegicus,Intermediate,CHEMBL627257,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1,1,,BAO_0000218
14079,Rattus norvegicus,Intermediate,CHEMBL627258,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14080,Rattus norvegicus,Intermediate,CHEMBL627259,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1,1,,BAO_0000218
14081,Rattus norvegicus,Intermediate,CHEMBL627260,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14082,Rattus norvegicus,Intermediate,CHEMBL623256,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1,1,,BAO_0000218
14083,Rattus norvegicus,Intermediate,CHEMBL874413,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14084,Rattus norvegicus,Intermediate,CHEMBL623257,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1,1,,BAO_0000218
14085,Rattus norvegicus,Intermediate,CHEMBL623258,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14086,Rattus norvegicus,Intermediate,CHEMBL623259,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1,1,,BAO_0000218
14087,Rattus norvegicus,Intermediate,CHEMBL623260,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1,1,,BAO_0000218
14088,Rattus norvegicus,Intermediate,CHEMBL623261,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14089,Rattus norvegicus,Intermediate,CHEMBL623262,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1,1,,BAO_0000218
14090,Rattus norvegicus,Intermediate,CHEMBL623263,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1,1,,BAO_0000218
14091,Rattus norvegicus,Intermediate,CHEMBL623264,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14092,Rattus norvegicus,Intermediate,CHEMBL623265,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,1,1,,BAO_0000218
14093,Rattus norvegicus,Intermediate,CHEMBL623266,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14094,Rattus norvegicus,Intermediate,CHEMBL623267,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1,1,,BAO_0000218
14095,Rattus norvegicus,Intermediate,CHEMBL623268,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1,1,,BAO_0000218
14096,Rattus norvegicus,Intermediate,CHEMBL623269,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
14097,Rattus norvegicus,Intermediate,CHEMBL623270,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
14098,Rattus norvegicus,Intermediate,CHEMBL623271,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14099,Rattus norvegicus,Intermediate,CHEMBL623272,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1,1,,BAO_0000218
14100,Rattus norvegicus,Intermediate,CHEMBL623273,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14101,Rattus norvegicus,Intermediate,CHEMBL623274,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1,1,,BAO_0000218
14102,Rattus norvegicus,Intermediate,CHEMBL874414,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14103,Rattus norvegicus,Intermediate,CHEMBL623275,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1,1,,BAO_0000218
14104,Rattus norvegicus,Intermediate,CHEMBL629150,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1,1,,BAO_0000218
14105,Rattus norvegicus,Intermediate,CHEMBL623276,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14106,Rattus norvegicus,Intermediate,CHEMBL623277,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14107,Rattus norvegicus,Intermediate,CHEMBL623112,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1,1,,BAO_0000218
14108,Rattus norvegicus,Intermediate,CHEMBL623113,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1,1,,BAO_0000218
14109,Rattus norvegicus,Intermediate,CHEMBL623800,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14110,Rattus norvegicus,Intermediate,CHEMBL623801,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14111,Rattus norvegicus,Intermediate,CHEMBL623802,,,50597,2106.0,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,1,1,,BAO_0000218
14112,Rattus norvegicus,Intermediate,CHEMBL623803,,,50597,995.0,A,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14113,Rattus norvegicus,Intermediate,CHEMBL623970,,,50597,995.0,A,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14114,Rattus norvegicus,Intermediate,CHEMBL623971,,,50597,995.0,A,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14115,Rattus norvegicus,Intermediate,CHEMBL623972,,,50597,178.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14116,Rattus norvegicus,Intermediate,CHEMBL623973,,,50597,178.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14117,Rattus norvegicus,Intermediate,CHEMBL623974,,,50597,178.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14118,Rattus norvegicus,Intermediate,CHEMBL623975,,,50597,178.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14119,Rattus norvegicus,Intermediate,CHEMBL623976,,,50597,955.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14120,Rattus norvegicus,Intermediate,CHEMBL623977,,,50597,955.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14121,Rattus norvegicus,Intermediate,CHEMBL623978,,,50597,955.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14122,Rattus norvegicus,Intermediate,CHEMBL623979,,,50597,955.0,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14123,Rattus norvegicus,Intermediate,CHEMBL623980,,,50597,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14124,Rattus norvegicus,Intermediate,CHEMBL623981,,,50597,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14125,Rattus norvegicus,Intermediate,CHEMBL626278,,,50597,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14126,Rattus norvegicus,Intermediate,CHEMBL626279,,,50597,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,N,1,1,,BAO_0000218
14127,Mus musculus,Intermediate,CHEMBL626280,,,50594,,A,,Biodistribution in mice bladder plus excreted urine was determined,,N,1,1,,BAO_0000218
14128,Mus musculus,Intermediate,CHEMBL626281,,,50594,,A,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,N,1,1,,BAO_0000218
14129,Mus musculus,Intermediate,CHEMBL626282,,,50594,,A,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,N,1,1,,BAO_0000218
14130,Mus musculus,Intermediate,CHEMBL626283,,,50594,,A,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,N,1,1,,BAO_0000218
14131,Mus musculus,Intermediate,CHEMBL626284,,,50594,,A,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,N,1,1,,BAO_0000218
14132,Mus musculus,Intermediate,CHEMBL626285,,,50594,955.0,A,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,N,1,1,,BAO_0000218
14133,Mus musculus,Intermediate,CHEMBL626286,,,50594,955.0,A,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,N,1,1,,BAO_0000218
14134,Mus musculus,Intermediate,CHEMBL626287,,,50594,955.0,A,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,N,1,1,,BAO_0000218
14135,Mus musculus,Intermediate,CHEMBL626288,,,50594,955.0,A,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,N,1,1,,BAO_0000218
14136,Mus musculus,Intermediate,CHEMBL626289,,,50594,,A,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,N,1,1,,BAO_0000218
14137,Mus musculus,Intermediate,CHEMBL626290,,,50594,,A,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,N,1,1,,BAO_0000218
14138,Mus musculus,Intermediate,CHEMBL626291,,,50594,,A,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,N,1,1,,BAO_0000218
14139,Mus musculus,Intermediate,CHEMBL839888,,,50594,,A,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,N,1,1,,BAO_0000218
14140,Mus musculus,Intermediate,CHEMBL626292,,,50594,160.0,A,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,N,1,1,,BAO_0000218
14141,Mus musculus,Intermediate,CHEMBL626293,,,50594,160.0,A,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,N,1,1,,BAO_0000218
14142,Mus musculus,Intermediate,CHEMBL626294,,,50594,160.0,A,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,N,1,1,,BAO_0000218
14143,Mus musculus,Intermediate,CHEMBL626295,,,50594,160.0,A,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,N,1,1,,BAO_0000218
14144,Mus musculus,Intermediate,CHEMBL627659,,,50594,2107.0,A,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,N,1,1,,BAO_0000218
14145,Mus musculus,Intermediate,CHEMBL627660,,,50594,2107.0,A,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,N,1,1,,BAO_0000218
14146,Mus musculus,Intermediate,CHEMBL627661,,,50594,2107.0,A,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,N,1,1,,BAO_0000218
14147,Mus musculus,Intermediate,CHEMBL627662,,,50594,2107.0,A,,Biodistribution in mice liver at 60 minutes of post injection,,N,1,1,,BAO_0000218
14148,Mus musculus,Intermediate,CHEMBL627663,,,50594,2048.0,A,,Biodistribution in mice lungs at 10 min of post injection,,N,1,1,,BAO_0000218
14149,Mus musculus,Intermediate,CHEMBL627664,,,50594,,A,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,N,1,1,,BAO_0000218
14150,Mus musculus,Intermediate,CHEMBL627665,,,50594,,A,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,N,1,1,,BAO_0000218
14151,Mus musculus,Intermediate,CHEMBL627666,,,50594,2048.0,A,,Biodistribution in mice lungs at 60 min of post injection,,N,1,1,,BAO_0000218
14152,Mus musculus,Intermediate,CHEMBL627667,,,50594,2106.0,A,,Percentage biodistribution in mouse spleen,,N,1,1,,BAO_0000218
14153,Mus musculus,Intermediate,CHEMBL627668,,,50594,945.0,A,,Percentage biodistribution in mouse stomach,,N,1,1,,BAO_0000218
14154,Mus musculus,Intermediate,CHEMBL627669,,,50594,1088.0,A,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,N,1,1,,BAO_0000218
14155,,Autocuration,CHEMBL627670,,,22224,1255.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,U,0,1,,BAO_0000218
14156,,Autocuration,CHEMBL627671,,,22224,178.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,U,0,1,,BAO_0000218
14157,,Autocuration,CHEMBL627672,,,22224,1474.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,U,0,1,,BAO_0000218
14158,,Autocuration,CHEMBL627673,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,U,0,1,,BAO_0000218
14159,,Autocuration,CHEMBL627674,,,22224,2113.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,U,0,1,,BAO_0000218
14160,,Autocuration,CHEMBL627675,,,22224,2107.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,U,0,1,,BAO_0000218
14161,,Autocuration,CHEMBL627676,,,22224,2048.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,U,0,1,,BAO_0000218
14162,,Autocuration,CHEMBL627677,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,U,0,1,,BAO_0000218
14163,,Autocuration,CHEMBL627678,,,22224,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
14164,Rattus norvegicus,Intermediate,CHEMBL627679,,,50597,1977.0,A,,Affinity for protein binding expressed as association constant in fresh rat serum,,N,1,1,,BAO_0000218
14165,,Autocuration,CHEMBL627680,,,22224,,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,0,1,,BAO_0000019
14166,,Autocuration,CHEMBL627681,,,22224,,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,0,1,,BAO_0000019
14167,,Autocuration,CHEMBL627682,,,22224,,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,0,1,,BAO_0000019
14168,,Autocuration,CHEMBL627683,,,22224,,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,0,1,,BAO_0000019
14169,,Autocuration,CHEMBL627684,,,22224,,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,U,0,1,,BAO_0000019
14170,,Autocuration,CHEMBL874441,,,22224,,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,0,1,,BAO_0000019
14171,,Autocuration,CHEMBL627685,,,22224,,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,U,0,1,,BAO_0000019
14172,,Autocuration,CHEMBL627686,,,22224,,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,0,1,,BAO_0000019
14173,,Autocuration,CHEMBL627687,,,22224,,A,,Apparent rate constant Koff for inactivation of dTMP synthase.,,U,0,1,,BAO_0000019
14174,,Autocuration,CHEMBL627688,,,22224,,A,,The irreversible inhibitor activity by second order rate equation.,,U,0,1,,BAO_0000019
14175,Rattus norvegicus,Intermediate,CHEMBL628038,,,50597,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,N,1,1,,BAO_0000218
14176,Rattus norvegicus,Intermediate,CHEMBL628039,,,50597,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,N,1,1,,BAO_0000218
14177,Rattus norvegicus,Intermediate,CHEMBL628040,,,50597,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,N,1,1,,BAO_0000218
14178,,Autocuration,CHEMBL628041,,,22224,,A,,Dissociation rate calculated from the first-order equation using t1/2 value,,U,0,1,,BAO_0000019
14179,,Autocuration,CHEMBL630226,,,22224,,A,,The compound was tested for Binding constant against DNA,,U,0,1,,BAO_0000019
14180,,Autocuration,CHEMBL628042,,,22224,,A,,First order rate constant for cyclization of the compound,,U,0,1,,BAO_0000019
14181,,Autocuration,CHEMBL625232,,,22224,,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,0,1,,BAO_0000019
14182,,Autocuration,CHEMBL625233,,,22224,,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,0,1,,BAO_0000019
14183,,Autocuration,CHEMBL625979,,,22224,,A,,Hydrolysis rate constant was determined,,U,0,1,,BAO_0000019
14184,,Autocuration,CHEMBL625980,,,22224,,A,,Observed first order rate constant,,U,0,1,,BAO_0000019
14185,,Autocuration,CHEMBL625981,,,22224,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,0,1,,BAO_0000019
14186,,Autocuration,CHEMBL625982,,,22224,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,0,1,,BAO_0000019
14187,,Autocuration,CHEMBL625983,,,22224,,A,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,U,0,1,,BAO_0000019
14188,,Autocuration,CHEMBL625984,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14189,,Autocuration,CHEMBL625985,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14190,,Autocuration,CHEMBL625986,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14191,,Autocuration,CHEMBL625987,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14192,,Autocuration,CHEMBL625988,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14193,,Autocuration,CHEMBL625989,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14194,,Autocuration,CHEMBL625990,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14195,,Autocuration,CHEMBL625991,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14196,,Autocuration,CHEMBL625992,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14197,,Autocuration,CHEMBL625993,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14198,,Autocuration,CHEMBL631973,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14199,,Autocuration,CHEMBL632143,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14200,,Autocuration,CHEMBL632144,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14201,,Autocuration,CHEMBL632145,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14202,,Autocuration,CHEMBL632146,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14203,,Autocuration,CHEMBL632147,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14204,,Autocuration,CHEMBL632148,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14205,,Autocuration,CHEMBL632149,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14206,,Autocuration,CHEMBL632150,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14207,,Autocuration,CHEMBL632151,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14208,Homo sapiens,Intermediate,CHEMBL632152,,,50587,,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,N,1,1,,BAO_0000218
14209,Homo sapiens,Intermediate,CHEMBL632153,,,50587,,A,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,1,1,,BAO_0000218
14210,Homo sapiens,Intermediate,CHEMBL632154,,,50587,,A,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,1,1,,BAO_0000218
14211,Human herpesvirus 1,Intermediate,CHEMBL632155,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14212,Human herpesvirus 1,Intermediate,CHEMBL632156,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,N,1,1,,BAO_0000218
14213,Human herpesvirus 1,Intermediate,CHEMBL632157,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14214,Human herpesvirus 1,Intermediate,CHEMBL632158,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14215,Human herpesvirus 1,Intermediate,CHEMBL632159,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,N,1,1,,BAO_0000218
14216,Human herpesvirus 1,Intermediate,CHEMBL626305,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14217,Human herpesvirus 1,Intermediate,CHEMBL626306,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,N,1,1,,BAO_0000218
14218,Human herpesvirus 1,Intermediate,CHEMBL626307,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14219,Human herpesvirus 1,Intermediate,CHEMBL626308,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14220,Human herpesvirus 1,Intermediate,CHEMBL626479,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14221,Human herpesvirus 1,Intermediate,CHEMBL626480,,,50602,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,N,1,1,,BAO_0000218
14222,,Autocuration,CHEMBL626481,,,22229,,P,,Calculated partition coefficient (clogP) (MlogP),,U,0,1,,BAO_0000100
14223,,Autocuration,CHEMBL626482,,,22224,,A,,Equipotent potent ratio relative to carbachol (nicotinic activity),,U,0,1,,BAO_0000019
14224,Canis lupus familiaris,Intermediate,CHEMBL626483,,,50588,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,N,1,1,,BAO_0000218
14225,Canis lupus familiaris,Intermediate,CHEMBL626484,,,50588,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,N,1,1,,BAO_0000218
14226,,Autocuration,CHEMBL626485,,,22229,,P,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,U,0,1,,BAO_0000100
14227,,Autocuration,CHEMBL626486,,,22229,,P,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,U,0,1,,BAO_0000100
14228,,Autocuration,CHEMBL626487,,,22229,,P,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,U,0,1,,BAO_0000100
14229,Canis lupus familiaris,Intermediate,CHEMBL626488,,,50588,1969.0,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,1,1,,BAO_0000218
14230,Rattus norvegicus,Intermediate,CHEMBL626489,,,50597,1977.0,A,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,N,1,1,,BAO_0000218
14231,,Autocuration,CHEMBL626490,,,22224,,A,,Area under the MAP curve measured over 5 min; ND means Not determined,,U,0,1,,BAO_0000019
14232,,Autocuration,CHEMBL626491,,,22224,,P,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,U,0,1,,BAO_0000100
14233,,Autocuration,CHEMBL626492,,,22229,,P,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,U,0,1,,BAO_0000100
14234,,Autocuration,CHEMBL626493,,,22224,,A,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,U,0,1,,BAO_0000019
14235,Rattus norvegicus,Intermediate,CHEMBL626494,,,50597,,A,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,N,1,1,,BAO_0000218
14236,,Autocuration,CHEMBL626495,,,22224,,A,,Half life after oral tested,,U,0,1,,BAO_0000218
14237,Rattus norvegicus,Intermediate,CHEMBL626496,,,50597,1969.0,A,,Half life was determined in plasma of rat; NT indicates not tested,,N,1,1,,BAO_0000218
14238,Rattus norvegicus,Intermediate,CHEMBL626497,,,50597,,A,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,N,1,1,,BAO_0000218
14239,,Autocuration,CHEMBL626498,,,22224,,A,,Oral bioavailability after oral tested,,U,0,1,,BAO_0000218
14240,Rattus norvegicus,Intermediate,CHEMBL626499,,,50597,,A,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,N,1,1,,BAO_0000218
14241,Rattus norvegicus,Intermediate,CHEMBL626500,,,50597,,A,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,N,1,1,,BAO_0000218
14242,Rattus norvegicus,Intermediate,CHEMBL626501,,,50597,1969.0,A,,half life was determined in plasma of rat; NT indicates not tested,,N,1,1,,BAO_0000218
14243,Rattus norvegicus,Intermediate,CHEMBL626502,,,50597,1969.0,A,,half life was determined in plasma of rat; NT means not tested,,N,1,1,,BAO_0000218
14244,Rattus norvegicus,Intermediate,CHEMBL626503,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,N,1,1,,BAO_0000218
14245,Rattus norvegicus,Intermediate,CHEMBL626504,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,N,1,1,,BAO_0000218
14246,Rattus norvegicus,Intermediate,CHEMBL626505,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,N,1,1,,BAO_0000218
14247,Rattus norvegicus,Intermediate,CHEMBL626506,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,N,1,1,,BAO_0000218
14248,Rattus norvegicus,Intermediate,CHEMBL626507,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,N,1,1,,BAO_0000218
14249,Rattus norvegicus,Intermediate,CHEMBL626508,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,N,1,1,,BAO_0000218
14250,Rattus norvegicus,Intermediate,CHEMBL626509,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,N,1,1,,BAO_0000218
14251,Rattus norvegicus,Intermediate,CHEMBL875480,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,N,1,1,,BAO_0000218
14252,Rattus norvegicus,Intermediate,CHEMBL626510,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,N,1,1,,BAO_0000218
14253,Rattus norvegicus,Intermediate,CHEMBL626511,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,N,1,1,,BAO_0000218
14254,Rattus norvegicus,Intermediate,CHEMBL626512,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,N,1,1,,BAO_0000218
14255,Rattus norvegicus,Intermediate,CHEMBL628208,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,N,1,1,,BAO_0000218
14256,Rattus norvegicus,Intermediate,CHEMBL628209,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,N,1,1,,BAO_0000218
14257,Rattus norvegicus,Intermediate,CHEMBL628210,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,N,1,1,,BAO_0000218
14258,Rattus norvegicus,Intermediate,CHEMBL628211,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,N,1,1,,BAO_0000218
14259,Rattus norvegicus,Intermediate,CHEMBL628212,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,N,1,1,,BAO_0000218
14260,Rattus norvegicus,Intermediate,CHEMBL628213,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,N,1,1,,BAO_0000218
14261,Rattus norvegicus,Intermediate,CHEMBL628214,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14262,Rattus norvegicus,Intermediate,CHEMBL628215,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14263,Rattus norvegicus,Intermediate,CHEMBL628216,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14264,Rattus norvegicus,Intermediate,CHEMBL626595,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14265,Rattus norvegicus,Intermediate,CHEMBL626596,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14266,Rattus norvegicus,Intermediate,CHEMBL626597,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14267,Rattus norvegicus,Intermediate,CHEMBL626598,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14268,Rattus norvegicus,Intermediate,CHEMBL622242,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14269,Rattus norvegicus,Intermediate,CHEMBL622243,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14270,Rattus norvegicus,Intermediate,CHEMBL622244,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14271,Rattus norvegicus,Intermediate,CHEMBL622245,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14272,Rattus norvegicus,Intermediate,CHEMBL622246,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14273,Rattus norvegicus,Intermediate,CHEMBL622247,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1,1,,BAO_0000218
14274,Rattus norvegicus,Intermediate,CHEMBL622248,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14275,Rattus norvegicus,Intermediate,CHEMBL877483,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14276,Rattus norvegicus,Intermediate,CHEMBL622249,,,50597,1088.0,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14277,Canis lupus familiaris,Intermediate,CHEMBL622250,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14278,Canis lupus familiaris,Intermediate,CHEMBL622251,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1,1,,BAO_0000218
14279,Canis lupus familiaris,Intermediate,CHEMBL622252,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14280,Canis lupus familiaris,Intermediate,CHEMBL622253,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1,1,,BAO_0000218
14281,Canis lupus familiaris,Intermediate,CHEMBL622254,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1,1,,BAO_0000218
14282,Canis lupus familiaris,Intermediate,CHEMBL622255,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14283,Canis lupus familiaris,Intermediate,CHEMBL622256,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14284,Canis lupus familiaris,Intermediate,CHEMBL622257,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1,1,,BAO_0000218
14285,Canis lupus familiaris,Intermediate,CHEMBL622258,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1,1,,BAO_0000218
14286,Canis lupus familiaris,Intermediate,CHEMBL622259,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1,1,,BAO_0000218
14287,Canis lupus familiaris,Intermediate,CHEMBL622927,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14288,Canis lupus familiaris,Intermediate,CHEMBL622928,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
14289,Canis lupus familiaris,Intermediate,CHEMBL622929,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
14290,Canis lupus familiaris,Intermediate,CHEMBL623182,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,1,1,,BAO_0000218
14291,Canis lupus familiaris,Intermediate,CHEMBL623183,,,50588,1088.0,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14292,Rattus norvegicus,Intermediate,CHEMBL623184,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1,1,,BAO_0000218
14293,Rattus norvegicus,Intermediate,CHEMBL623185,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1,1,,BAO_0000218
14294,Rattus norvegicus,Intermediate,CHEMBL877484,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1,1,,BAO_0000218
14295,Rattus norvegicus,Intermediate,CHEMBL627274,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14296,Rattus norvegicus,Intermediate,CHEMBL623186,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1,1,,BAO_0000218
14297,Rattus norvegicus,Intermediate,CHEMBL623187,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1,1,,BAO_0000218
14298,Rattus norvegicus,Intermediate,CHEMBL623188,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1,1,,BAO_0000218
14299,Rattus norvegicus,Intermediate,CHEMBL628055,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1,1,,BAO_0000218
14300,Rattus norvegicus,Intermediate,CHEMBL628056,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14301,Rattus norvegicus,Intermediate,CHEMBL628200,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1,1,,BAO_0000218
14302,Rattus norvegicus,Intermediate,CHEMBL628201,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14303,Rattus norvegicus,Intermediate,CHEMBL628202,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1,1,,BAO_0000218
14304,Rattus norvegicus,Intermediate,CHEMBL628203,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14305,Rattus norvegicus,Intermediate,CHEMBL628204,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1,1,,BAO_0000218
14306,Rattus norvegicus,Intermediate,CHEMBL628205,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14307,Rattus norvegicus,Intermediate,CHEMBL628206,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1,1,,BAO_0000218
14308,,Autocuration,CHEMBL628207,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,U,0,1,,BAO_0000218
14309,,Autocuration,CHEMBL627220,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,U,0,1,,BAO_0000218
14310,,Autocuration,CHEMBL627221,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,U,0,1,,BAO_0000218
14311,,Autocuration,CHEMBL627222,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,U,0,1,,BAO_0000218
14312,,Autocuration,CHEMBL627223,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,U,0,1,,BAO_0000218
14313,,Autocuration,CHEMBL632062,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,U,0,1,,BAO_0000218
14314,,Autocuration,CHEMBL632063,,,22224,2106.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,U,0,1,,BAO_0000218
14315,,Autocuration,CHEMBL632064,,,22224,1255.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,U,0,1,,BAO_0000218
14316,,Autocuration,CHEMBL632065,,,22224,178.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,U,0,1,,BAO_0000218
14317,,Autocuration,CHEMBL632066,,,22224,1474.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,U,0,1,,BAO_0000218
14318,,Autocuration,CHEMBL632067,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,U,0,1,,BAO_0000218
14319,,Autocuration,CHEMBL629188,,,22224,2113.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,U,0,1,,BAO_0000218
14320,,Autocuration,CHEMBL629189,,,22224,2107.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,U,0,1,,BAO_0000218
14321,,Autocuration,CHEMBL629190,,,22224,2048.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,U,0,1,,BAO_0000218
14322,,Autocuration,CHEMBL629191,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,U,0,1,,BAO_0000218
14323,,Autocuration,CHEMBL629192,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,U,0,1,,BAO_0000218
14324,,Autocuration,CHEMBL629193,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,U,0,1,,BAO_0000218
14325,,Autocuration,CHEMBL629194,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,U,0,1,,BAO_0000218
14326,,Autocuration,CHEMBL629195,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,U,0,1,,BAO_0000218
14327,,Autocuration,CHEMBL629373,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,U,0,1,,BAO_0000218
14328,,Autocuration,CHEMBL629374,,,22224,2106.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,U,0,1,,BAO_0000218
14329,,Autocuration,CHEMBL629375,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,U,0,1,,BAO_0000218
14330,,Autocuration,CHEMBL629376,,,22224,1255.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,U,0,1,,BAO_0000218
14331,,Autocuration,CHEMBL629377,,,22224,178.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,U,0,1,,BAO_0000218
14332,,Autocuration,CHEMBL629378,,,22224,1474.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,U,0,1,,BAO_0000218
14333,,Autocuration,CHEMBL629379,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,U,0,1,,BAO_0000218
14334,,Autocuration,CHEMBL629151,,,22224,2113.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,U,0,1,,BAO_0000218
14335,,Autocuration,CHEMBL629152,,,22224,2107.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,U,0,1,,BAO_0000218
14336,,Autocuration,CHEMBL629153,,,22224,2048.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,U,0,1,,BAO_0000218
14337,,Autocuration,CHEMBL629154,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,U,0,1,,BAO_0000218
14338,,Autocuration,CHEMBL629155,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,U,0,1,,BAO_0000218
14339,,Autocuration,CHEMBL629156,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,U,0,1,,BAO_0000218
14340,,Autocuration,CHEMBL629157,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,U,0,1,,BAO_0000218
14341,,Autocuration,CHEMBL629158,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,U,0,1,,BAO_0000218
14342,,Autocuration,CHEMBL629159,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,U,0,1,,BAO_0000218
14343,,Autocuration,CHEMBL629160,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,U,0,1,,BAO_0000218
14344,,Autocuration,CHEMBL629161,,,22224,2106.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,U,0,1,,BAO_0000218
14345,,Autocuration,CHEMBL629162,,,22224,1255.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,U,0,1,,BAO_0000218
14346,,Autocuration,CHEMBL629163,,,22224,178.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,U,0,1,,BAO_0000218
14347,,Autocuration,CHEMBL629164,,,22224,1474.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,U,0,1,,BAO_0000218
14348,,Autocuration,CHEMBL629165,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,U,0,1,,BAO_0000218
14349,,Autocuration,CHEMBL629166,,,22224,2107.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,U,0,1,,BAO_0000218
14350,,Autocuration,CHEMBL629167,,,22224,2048.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,U,0,1,,BAO_0000218
14351,,Autocuration,CHEMBL629168,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,U,0,1,,BAO_0000218
14352,,Autocuration,CHEMBL629169,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,U,0,1,,BAO_0000019
14353,,Autocuration,CHEMBL629170,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,U,0,1,,BAO_0000019
14354,,Autocuration,CHEMBL631153,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,U,0,1,,BAO_0000019
14355,,Autocuration,CHEMBL875121,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,U,0,1,,BAO_0000019
14356,,Autocuration,CHEMBL631154,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,U,0,1,,BAO_0000019
14357,,Autocuration,CHEMBL631155,,,22224,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,U,0,1,,BAO_0000019
14358,,Autocuration,CHEMBL631156,,,22224,,A,,Hydrolysis rate constant was determined,,U,0,1,,BAO_0000019
14359,,Autocuration,CHEMBL631157,,,22224,,A,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,U,0,1,,BAO_0000019
14360,,Autocuration,CHEMBL631158,,,22224,,A,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,0,1,,BAO_0000019
14361,,Autocuration,CHEMBL631159,,,22224,,A,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,0,1,,BAO_0000019
14362,,Autocuration,CHEMBL631160,,,22224,,A,,Observed second order rate constant,,U,0,1,,BAO_0000019
14363,,Autocuration,CHEMBL631161,,,22224,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,0,1,,BAO_0000019
14364,,Autocuration,CHEMBL631162,,,22224,,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,0,1,,BAO_0000019
14365,,Autocuration,CHEMBL630313,,,22224,,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,0,1,,BAO_0000019
14366,,Autocuration,CHEMBL630314,,,22224,,A,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,0,1,,BAO_0000019
14367,,Autocuration,CHEMBL630315,,,22224,,A,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,0,1,,BAO_0000019
14368,,Autocuration,CHEMBL630316,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14369,,Autocuration,CHEMBL630986,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14370,,Autocuration,CHEMBL630987,,,22224,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14371,,Autocuration,CHEMBL630988,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14372,,Autocuration,CHEMBL630989,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14373,,Autocuration,CHEMBL630990,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14374,,Autocuration,CHEMBL630991,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14375,,Autocuration,CHEMBL630992,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14376,,Autocuration,CHEMBL630993,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14377,,Autocuration,CHEMBL630994,,,22224,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,0,1,,BAO_0000019
14378,Rattus norvegicus,Intermediate,CHEMBL630995,,,50597,,A,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,N,1,1,,BAO_0000218
14379,,Autocuration,CHEMBL629252,,,22224,,A,,Association constant for compound at 31 degree C was determined,,U,0,1,,BAO_0000019
14380,,Autocuration,CHEMBL629253,,,22224,,A,,Calculated antagonist equilibrium dissociation constant of the compound,,U,0,1,,BAO_0000019
14381,,Autocuration,CHEMBL629944,,,22224,,A,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,U,0,1,,BAO_0000019
14382,Cavia porcellus,Intermediate,CHEMBL629945,,,50512,3126.0,A,,Dissociation constants vs LTE4 on guinea pig trachea,,N,1,1,,BAO_0000218
14383,,Autocuration,CHEMBL629946,,,22224,,A,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,U,0,1,,BAO_0000019
14384,,Autocuration,CHEMBL629947,,,22224,,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,U,0,1,,BAO_0000019
14385,,Autocuration,CHEMBL629948,,,22224,,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,U,0,1,,BAO_0000019
14386,,Autocuration,CHEMBL856024,,,22224,,A,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,U,0,1,,BAO_0000019
14387,,Autocuration,CHEMBL629949,,,22224,,A,,Affinity constant KD value was derived from TMP,,U,0,1,,BAO_0000019
14388,,Autocuration,CHEMBL629950,,,22224,,A,,Apparent dissociation (binding) rate constant was evaluated,,U,0,1,,BAO_0000019
14389,,Autocuration,CHEMBL630127,,,22224,,P,,Dissociation constant (KD) of the compound,,U,0,1,,BAO_0000100
14390,,Autocuration,CHEMBL630128,,,22224,,P,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,U,0,1,,BAO_0000100
14391,,Autocuration,CHEMBL630129,,,22224,,P,,Dissociation constant from ESR titration experiments,,U,0,1,,BAO_0000100
14392,,Autocuration,CHEMBL630130,,,22224,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,U,0,1,,BAO_0000019
14393,,Autocuration,CHEMBL875234,,,22224,,P,,Dissociation constant was evaluated.,,U,0,1,,BAO_0000100
14394,,Autocuration,CHEMBL630131,,,22224,,P,,Dissociation constant was reported,,U,0,1,,BAO_0000100
14395,Rattus norvegicus,Intermediate,CHEMBL630132,,,50597,,A,,Dissociation constant was determined in rat pituitary cells.,,N,1,1,,BAO_0000218
14396,,Autocuration,CHEMBL630133,,,22224,,A,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,U,0,1,,BAO_0000019
14397,,Autocuration,CHEMBL630134,,,22224,,A,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,U,0,1,,BAO_0000019
14398,,Autocuration,CHEMBL630135,,,22224,,A,,Equilibrium dissociation constant of the compound,,U,0,1,,BAO_0000019
14399,,Autocuration,CHEMBL630136,,,22224,,A,,Equilibrium dissociation constant was determined,,U,0,1,,BAO_0000019
14400,,Autocuration,CHEMBL630137,,,22224,,A,,Kinetic constant KD was evaluated,,U,0,1,,BAO_0000019
14401,,Autocuration,CHEMBL630138,,,22224,,A,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,U,0,1,,BAO_0000019
14402,,Autocuration,CHEMBL630139,,,22224,,A,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,U,0,1,,BAO_0000019
14403,,Autocuration,CHEMBL630140,,,22224,,A,,Rate constant for hydrolysis in aqueous acetone.,,U,0,1,,BAO_0000019
14404,,Autocuration,CHEMBL875235,,,22224,,A,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,U,0,1,,BAO_0000019
14405,Rattus norvegicus,Intermediate,CHEMBL876439,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,N,1,1,,BAO_0000218
14406,Rattus norvegicus,Intermediate,CHEMBL630605,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,N,1,1,,BAO_0000218
14407,Rattus norvegicus,Intermediate,CHEMBL630606,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,N,1,1,,BAO_0000218
14408,Rattus norvegicus,Intermediate,CHEMBL630607,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,N,1,1,,BAO_0000218
14409,Rattus norvegicus,Intermediate,CHEMBL630608,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,N,1,1,,BAO_0000218
14410,Rattus norvegicus,Intermediate,CHEMBL630609,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,N,1,1,,BAO_0000218
14411,Rattus norvegicus,Intermediate,CHEMBL630610,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,N,1,1,,BAO_0000218
14412,Rattus norvegicus,Intermediate,CHEMBL630611,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,N,1,1,,BAO_0000218
14413,Rattus norvegicus,Intermediate,CHEMBL629552,,,50597,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,N,1,1,,BAO_0000218
14414,Rattus norvegicus,Intermediate,CHEMBL629733,,,50597,,A,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,1,1,,BAO_0000218
14415,Rattus norvegicus,Intermediate,CHEMBL629734,,,50597,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,1,1,,BAO_0000218
14416,Rattus norvegicus,Intermediate,CHEMBL629735,,,50597,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,1,1,,BAO_0000218
14417,Rattus norvegicus,Intermediate,CHEMBL629736,,,50597,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,1,1,,BAO_0000218
14418,Rattus norvegicus,Intermediate,CHEMBL629737,,,50597,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,1,1,,BAO_0000218
14419,Rattus norvegicus,Intermediate,CHEMBL629738,,,50597,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,1,1,,BAO_0000218
14420,Rattus norvegicus,Intermediate,CHEMBL629739,,,50597,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,1,1,,BAO_0000218
14421,Rattus norvegicus,Intermediate,CHEMBL629740,,,50597,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,1,1,,BAO_0000218
14422,Rattus norvegicus,Intermediate,CHEMBL629741,,,50597,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,1,1,,BAO_0000218
14423,Rattus norvegicus,Intermediate,CHEMBL629742,,,50597,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,1,1,,BAO_0000218
14424,Rattus norvegicus,Intermediate,CHEMBL629743,,,50597,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,1,1,,BAO_0000218
14425,Rattus norvegicus,Intermediate,CHEMBL629744,,,50597,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,1,1,,BAO_0000218
14426,Rattus norvegicus,Intermediate,CHEMBL629745,,,50597,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,1,1,,BAO_0000218
14427,Rattus norvegicus,Intermediate,CHEMBL629746,,,50597,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,1,1,,BAO_0000218
14428,Rattus norvegicus,Intermediate,CHEMBL629747,,,50597,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,1,1,,BAO_0000218
14429,Rattus norvegicus,Intermediate,CHEMBL629748,,,50597,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,1,1,,BAO_0000218
14430,Rattus norvegicus,Intermediate,CHEMBL629749,,,50597,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,1,1,,BAO_0000218
14431,Rattus norvegicus,Intermediate,CHEMBL629750,,,50597,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,1,1,,BAO_0000218
14432,Rattus norvegicus,Intermediate,CHEMBL629751,,,50597,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,1,1,,BAO_0000218
14433,Rattus norvegicus,Intermediate,CHEMBL629752,,,50597,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,1,1,,BAO_0000218
14434,Rattus norvegicus,Intermediate,CHEMBL629753,,,50597,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,1,1,,BAO_0000218
14435,Rattus norvegicus,Intermediate,CHEMBL629754,,,50597,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,1,1,,BAO_0000218
14436,Rattus norvegicus,Intermediate,CHEMBL629755,,,50597,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,1,1,,BAO_0000218
14437,Rattus norvegicus,Intermediate,CHEMBL629756,,,50597,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,1,1,,BAO_0000218
14438,Rattus norvegicus,Intermediate,CHEMBL629757,,,50597,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,1,1,,BAO_0000218
14439,Rattus norvegicus,Intermediate,CHEMBL629758,,,50597,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,1,1,,BAO_0000218
14440,Rattus norvegicus,Intermediate,CHEMBL629759,,,50597,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,1,1,,BAO_0000218
14441,Rattus norvegicus,Intermediate,CHEMBL629760,,,50597,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,1,1,,BAO_0000218
14442,Rattus norvegicus,Intermediate,CHEMBL876443,,,50597,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,1,1,,BAO_0000218
14443,Canis lupus familiaris,Intermediate,CHEMBL629761,,,50588,,A,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,1,1,,BAO_0000218
14444,Canis lupus familiaris,Intermediate,CHEMBL629762,,,50588,,A,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,N,1,1,,BAO_0000218
14445,Mus musculus,Intermediate,CHEMBL629763,,,50594,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,1,1,,BAO_0000218
14446,Mus musculus,Intermediate,CHEMBL629764,,,50594,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,1,1,,BAO_0000218
14447,Mus musculus,Intermediate,CHEMBL629765,,,50594,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,1,1,,BAO_0000218
14448,Mus musculus,Intermediate,CHEMBL629766,,,50594,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,N,1,1,,BAO_0000218
14449,Mus musculus,Intermediate,CHEMBL629767,,,50594,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,1,1,,BAO_0000218
14450,Canis lupus familiaris,Intermediate,CHEMBL629768,,,50588,,A,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,N,1,1,,BAO_0000218
14451,Mus musculus,Intermediate,CHEMBL629769,,,50594,,A,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,N,1,1,,BAO_0000218
14452,Canis lupus familiaris,Intermediate,CHEMBL629770,,,50588,,A,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,1,1,,BAO_0000218
14453,Canis lupus familiaris,Intermediate,CHEMBL629771,,,50588,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,N,1,1,,BAO_0000218
14454,Mus musculus,Intermediate,CHEMBL629772,,,50594,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,1,1,,BAO_0000218
14455,Mus musculus,Intermediate,CHEMBL629773,,,50594,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,1,1,,BAO_0000218
14456,Mus musculus,Intermediate,CHEMBL625455,,,50594,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,1,1,,BAO_0000218
14457,Mus musculus,Intermediate,CHEMBL625456,,,50594,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,N,1,1,,BAO_0000218
14458,Mus musculus,Intermediate,CHEMBL625457,,,50594,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,N,1,1,,BAO_0000218
14459,Rattus norvegicus,Intermediate,CHEMBL625458,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14460,Rattus norvegicus,Intermediate,CHEMBL625459,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1,1,,BAO_0000218
14461,Rattus norvegicus,Intermediate,CHEMBL875483,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14462,Rattus norvegicus,Intermediate,CHEMBL634779,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1,1,,BAO_0000218
14463,Rattus norvegicus,Intermediate,CHEMBL625460,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1,1,,BAO_0000218
14464,Rattus norvegicus,Intermediate,CHEMBL626117,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14465,Rattus norvegicus,Intermediate,CHEMBL626118,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1,1,,BAO_0000218
14466,Rattus norvegicus,Intermediate,CHEMBL628342,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1,1,,BAO_0000218
14467,Rattus norvegicus,Intermediate,CHEMBL628343,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14468,Rattus norvegicus,Intermediate,CHEMBL628344,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,1,1,,BAO_0000218
14469,Rattus norvegicus,Intermediate,CHEMBL628345,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14470,Rattus norvegicus,Intermediate,CHEMBL628346,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1,1,,BAO_0000218
14471,Rattus norvegicus,Intermediate,CHEMBL628347,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1,1,,BAO_0000218
14472,Rattus norvegicus,Intermediate,CHEMBL628348,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
14473,Rattus norvegicus,Intermediate,CHEMBL628349,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
14474,Rattus norvegicus,Intermediate,CHEMBL875611,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14475,Rattus norvegicus,Intermediate,CHEMBL628350,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1,1,,BAO_0000218
14476,Rattus norvegicus,Intermediate,CHEMBL628351,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14477,Rattus norvegicus,Intermediate,CHEMBL628352,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1,1,,BAO_0000218
14478,Rattus norvegicus,Intermediate,CHEMBL628353,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14479,Rattus norvegicus,Intermediate,CHEMBL628354,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1,1,,BAO_0000218
14480,Rattus norvegicus,Intermediate,CHEMBL626667,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1,1,,BAO_0000218
14481,Rattus norvegicus,Intermediate,CHEMBL626668,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14482,Rattus norvegicus,Intermediate,CHEMBL626669,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14483,Rattus norvegicus,Intermediate,CHEMBL626670,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1,1,,BAO_0000218
14484,Rattus norvegicus,Intermediate,CHEMBL626671,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1,1,,BAO_0000218
14485,Rattus norvegicus,Intermediate,CHEMBL626672,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14486,Rattus norvegicus,Intermediate,CHEMBL626673,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14487,Rattus norvegicus,Intermediate,CHEMBL626674,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14488,Rattus norvegicus,Intermediate,CHEMBL626675,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14489,Rattus norvegicus,Intermediate,CHEMBL626676,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14490,Rattus norvegicus,Intermediate,CHEMBL626677,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,N,1,1,,BAO_0000218
14491,Rattus norvegicus,Intermediate,CHEMBL626678,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14492,Rattus norvegicus,Intermediate,CHEMBL626679,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14493,Rattus norvegicus,Intermediate,CHEMBL875612,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14494,Rattus norvegicus,Intermediate,CHEMBL626680,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14495,Rattus norvegicus,Intermediate,CHEMBL626681,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14496,Rattus norvegicus,Intermediate,CHEMBL626682,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14497,Rattus norvegicus,Intermediate,CHEMBL626683,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14498,Rattus norvegicus,Intermediate,CHEMBL626684,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14499,Rattus norvegicus,Intermediate,CHEMBL626685,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14500,Rattus norvegicus,Intermediate,CHEMBL626686,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14501,Rattus norvegicus,Intermediate,CHEMBL626687,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14502,Rattus norvegicus,Intermediate,CHEMBL624978,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1,1,,BAO_0000218
14503,Rattus norvegicus,Intermediate,CHEMBL624979,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14504,Rattus norvegicus,Intermediate,CHEMBL624980,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14505,Rattus norvegicus,Intermediate,CHEMBL624981,,,50597,1088.0,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14506,Canis lupus familiaris,Intermediate,CHEMBL624982,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14507,,Autocuration,CHEMBL627564,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,U,0,1,,BAO_0000218
14508,,Autocuration,CHEMBL627565,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,U,0,1,,BAO_0000218
14509,,Autocuration,CHEMBL627566,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,U,0,1,,BAO_0000218
14510,,Autocuration,CHEMBL627567,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,U,0,1,,BAO_0000218
14511,,Autocuration,CHEMBL627568,,,22224,2106.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,U,0,1,,BAO_0000218
14512,,Autocuration,CHEMBL627569,,,22224,2113.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,U,0,1,,BAO_0000218
14513,,Autocuration,CHEMBL627570,,,22224,1255.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,U,0,1,,BAO_0000218
14514,,Autocuration,CHEMBL627571,,,22224,178.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,U,0,1,,BAO_0000218
14515,,Autocuration,CHEMBL627572,,,22224,1474.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,U,0,1,,BAO_0000218
14516,,Autocuration,CHEMBL627573,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,U,0,1,,BAO_0000218
14517,,Autocuration,CHEMBL627574,,,22224,2113.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,U,0,1,,BAO_0000218
14518,,Autocuration,CHEMBL627575,,,22224,2107.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,U,0,1,,BAO_0000218
14519,,Autocuration,CHEMBL627576,,,22224,2048.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,U,0,1,,BAO_0000218
14520,,Autocuration,CHEMBL627577,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,U,0,1,,BAO_0000218
14521,,Autocuration,CHEMBL627578,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,U,0,1,,BAO_0000218
14522,,Autocuration,CHEMBL627579,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,U,0,1,,BAO_0000218
14523,,Autocuration,CHEMBL627580,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,U,0,1,,BAO_0000218
14524,,Autocuration,CHEMBL627581,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,U,0,1,,BAO_0000218
14525,,Autocuration,CHEMBL627582,,,22224,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,U,0,1,,BAO_0000218
14526,,Autocuration,CHEMBL627583,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,U,0,1,,BAO_0000218
14527,,Autocuration,CHEMBL627584,,,22224,2106.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,U,0,1,,BAO_0000218
14528,,Autocuration,CHEMBL627585,,,22224,2367.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,U,0,1,,BAO_0000218
14529,,Autocuration,CHEMBL627586,,,22224,2385.0,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,U,0,1,,BAO_0000218
14530,Rattus norvegicus,Intermediate,CHEMBL627587,,,50597,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,N,1,1,,BAO_0000218
14531,Rattus norvegicus,Intermediate,CHEMBL627588,,,50597,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14532,Rattus norvegicus,Intermediate,CHEMBL628250,,,50597,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,N,1,1,,BAO_0000218
14533,Rattus norvegicus,Intermediate,CHEMBL628251,,,50597,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14534,Rattus norvegicus,Intermediate,CHEMBL628252,,,50597,10000000.0,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,N,1,1,,BAO_0000218
14535,Rattus norvegicus,Intermediate,CHEMBL628253,,,50597,10000000.0,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14536,Rattus norvegicus,Intermediate,CHEMBL628254,,,50597,1898.0,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,N,1,1,,BAO_0000218
14537,Rattus norvegicus,Intermediate,CHEMBL877493,,,50597,1898.0,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14538,Rattus norvegicus,Intermediate,CHEMBL628255,,,50597,,A,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14539,Rattus norvegicus,Intermediate,CHEMBL628256,,,50597,,A,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14540,Rattus norvegicus,Intermediate,CHEMBL628257,,,50597,10000000.0,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14541,Rattus norvegicus,Intermediate,CHEMBL628258,,,50597,1898.0,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14542,Rattus norvegicus,Intermediate,CHEMBL628259,,,50597,,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14543,Rattus norvegicus,Intermediate,CHEMBL628429,,,50597,,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14544,Rattus norvegicus,Intermediate,CHEMBL626862,,,50597,10000000.0,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,1,1,,BAO_0000218
14545,Rattus norvegicus,Intermediate,CHEMBL626863,,,50597,1898.0,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,N,1,1,,BAO_0000218
14546,Rattus norvegicus,Intermediate,CHEMBL625886,,,50597,2037.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,N,1,1,,BAO_0000218
14547,Rattus norvegicus,Intermediate,CHEMBL625887,,,50597,2037.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,N,1,1,,BAO_0000218
14548,Rattus norvegicus,Intermediate,CHEMBL625888,,,50597,,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,N,1,1,,BAO_0000218
14549,Rattus norvegicus,Intermediate,CHEMBL625889,,,50597,,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,N,1,1,,BAO_0000218
14550,Rattus norvegicus,Intermediate,CHEMBL625890,,,50597,10000000.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,N,1,1,,BAO_0000218
14551,Rattus norvegicus,Intermediate,CHEMBL625891,,,50597,10000000.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,N,1,1,,BAO_0000218
14552,Rattus norvegicus,Intermediate,CHEMBL625892,,,50597,1898.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,N,1,1,,BAO_0000218
14553,Rattus norvegicus,Intermediate,CHEMBL625893,,,50597,1898.0,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,N,1,1,,BAO_0000218
14554,Rattus norvegicus,Intermediate,CHEMBL625894,,,50597,2037.0,A,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,N,1,1,,BAO_0000218
14555,Rattus norvegicus,Intermediate,CHEMBL625895,,,50597,,A,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,N,1,1,,BAO_0000218
14556,,Autocuration,CHEMBL625896,,,22224,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,0,1,,BAO_0000019
14557,,Autocuration,CHEMBL625897,,,22224,,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,U,0,1,,BAO_0000019
14558,,Autocuration,CHEMBL625898,,,22224,,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,0,1,,BAO_0000019
14559,,Autocuration,CHEMBL625899,,,22224,,A,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,0,1,,BAO_0000019
14560,,Autocuration,CHEMBL626124,,,22224,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,0,1,,BAO_0000019
14561,Escherichia coli,Intermediate,CHEMBL628500,,,50212,,A,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,N,1,1,,BAO_0000218
14562,Rattus norvegicus,Intermediate,CHEMBL857856,,,50597,,A,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,N,1,1,,BAO_0000218
14563,Rattus norvegicus,Intermediate,CHEMBL628501,,,50597,,A,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,N,1,1,,BAO_0000218
14564,,Autocuration,CHEMBL628502,,,22224,,A,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,U,0,1,,BAO_0000019
14565,,Autocuration,CHEMBL628503,,,22224,,A,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,U,0,1,,BAO_0000019
14566,,Autocuration,CHEMBL628504,,,22224,,A,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,U,0,1,,BAO_0000019
14567,,Autocuration,CHEMBL628505,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,0,1,,BAO_0000019
14568,,Autocuration,CHEMBL874452,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,U,0,1,,BAO_0000019
14569,,Autocuration,CHEMBL628506,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,U,0,1,,BAO_0000019
14570,,Autocuration,CHEMBL628507,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,0,1,,BAO_0000019
14571,,Autocuration,CHEMBL628508,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,U,0,1,,BAO_0000019
14572,,Autocuration,CHEMBL628509,,,22224,,A,,Michaelis constant (KM) was evaluated,,U,0,1,,BAO_0000019
14573,,Autocuration,CHEMBL628510,,,22224,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,0,1,,BAO_0000019
14574,,Autocuration,CHEMBL628511,,,22224,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,U,0,1,,BAO_0000019
14575,,Autocuration,CHEMBL628512,,,22224,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,U,0,1,,BAO_0000019
14576,,Autocuration,CHEMBL628513,,,22224,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,U,0,1,,BAO_0000019
14577,,Autocuration,CHEMBL628514,,,22224,,B,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,U,0,1,,BAO_0000019
14578,,Autocuration,CHEMBL628515,,,22224,,A,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,U,0,1,,BAO_0000019
14579,,Autocuration,CHEMBL628516,,,22224,,A,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,U,0,1,,BAO_0000019
14580,,Autocuration,CHEMBL628517,,,22224,,A,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,0,1,,BAO_0000019
14581,,Autocuration,CHEMBL628518,,,22224,,A,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,0,1,,BAO_0000019
14582,,Autocuration,CHEMBL628519,,,22224,,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,U,0,1,,BAO_0000019
14583,,Autocuration,CHEMBL628520,,,22224,,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,U,0,1,,BAO_0000019
14584,,Autocuration,CHEMBL628521,,,22224,,A,,Binding constant was determined,,U,0,1,,BAO_0000019
14585,,Autocuration,CHEMBL630443,,,22224,,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,U,0,1,,BAO_0000019
14586,,Autocuration,CHEMBL630444,,,22224,,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,U,0,1,,BAO_0000019
14587,,Autocuration,CHEMBL857732,,,22224,,A,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,U,0,1,,BAO_0000019
14588,,Autocuration,CHEMBL630445,,,22224,,P,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,U,0,1,,BAO_0000100
14589,,Autocuration,CHEMBL630446,,,22224,,A,,Catalytic rate constant of the compound,,U,0,1,,BAO_0000019
14590,,Autocuration,CHEMBL630447,,,22224,,B,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,U,0,1,,BAO_0000019
14591,,Autocuration,CHEMBL630448,,,22224,,A,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,U,0,1,,BAO_0000019
14592,,Autocuration,CHEMBL630449,,,22224,,A,,Catalytic rate constant against phospholipase A2 was determined,,U,0,1,,BAO_0000019
14593,,Autocuration,CHEMBL630450,,,22224,,A,,"Compound was evaluated for catalytic constant, Kcat",,U,0,1,,BAO_0000019
14594,,Autocuration,CHEMBL630451,,,22224,,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,U,0,1,,BAO_0000019
14595,,Autocuration,CHEMBL630452,,,22224,,A,,Kcat calculated from 0.693/T1/2,,U,0,1,,BAO_0000019
14596,,Autocuration,CHEMBL630453,,,22224,,A,,Kcat was determined,,U,0,1,,BAO_0000019
14597,,Autocuration,CHEMBL630454,,,22224,,A,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,U,0,1,,BAO_0000019
14598,,Autocuration,CHEMBL630455,,,22224,,A,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,U,0,1,,BAO_0000019
14599,,Autocuration,CHEMBL631487,,,22224,,A,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,U,0,1,,BAO_0000019
14600,,Autocuration,CHEMBL631488,,,22224,,A,,Kcat value was determined,,U,0,1,,BAO_0000019
14601,,Autocuration,CHEMBL876440,,,22224,,A,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,U,0,1,,BAO_0000019
14602,,Autocuration,CHEMBL631489,,,22224,,A,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,U,0,1,,BAO_0000019
14603,,Autocuration,CHEMBL857742,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,0,1,,BAO_0000019
14604,,Autocuration,CHEMBL631490,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,0,1,,BAO_0000019
14605,,Autocuration,CHEMBL631491,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,U,0,1,,BAO_0000019
14606,,Autocuration,CHEMBL631492,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,0,1,,BAO_0000019
14607,,Autocuration,CHEMBL631493,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,0,1,,BAO_0000019
14608,,Autocuration,CHEMBL631494,,,22224,,A,,Kinetic parameter for rate of conversion to PABA was determined,,U,0,1,,BAO_0000019
14609,,Autocuration,CHEMBL631495,,,22224,,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,0,1,,BAO_0000019
14610,Rattus norvegicus,Intermediate,CHEMBL631496,,,50597,1988.0,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,1,1,,BAO_0000218
14611,Rattus norvegicus,Intermediate,CHEMBL631497,,,50597,1088.0,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,1,1,,BAO_0000218
14612,Rattus norvegicus,Intermediate,CHEMBL631498,,,50597,1088.0,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,1,1,,BAO_0000218
14613,Rattus norvegicus,Intermediate,CHEMBL629776,,,50597,1088.0,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,1,1,,BAO_0000218
14614,Rattus norvegicus,Intermediate,CHEMBL629777,,,50597,1088.0,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,1,1,,BAO_0000218
14615,Rattus norvegicus,Intermediate,CHEMBL629778,,,50597,1088.0,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,1,1,,BAO_0000218
14616,Rattus norvegicus,Intermediate,CHEMBL630456,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,N,1,1,,BAO_0000218
14617,Rattus norvegicus,Intermediate,CHEMBL630457,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,N,1,1,,BAO_0000218
14618,Rattus norvegicus,Intermediate,CHEMBL630458,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,N,1,1,,BAO_0000218
14619,Rattus norvegicus,Intermediate,CHEMBL630459,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,N,1,1,,BAO_0000218
14620,Rattus norvegicus,Intermediate,CHEMBL630460,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,N,1,1,,BAO_0000218
14621,Rattus norvegicus,Intermediate,CHEMBL876550,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,N,1,1,,BAO_0000218
14622,Rattus norvegicus,Intermediate,CHEMBL630461,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,N,1,1,,BAO_0000218
14623,Rattus norvegicus,Intermediate,CHEMBL630462,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,N,1,1,,BAO_0000218
14624,Rattus norvegicus,Intermediate,CHEMBL630463,,,50597,,A,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,N,1,1,,BAO_0000218
14625,Rattus norvegicus,Intermediate,CHEMBL630464,,,50597,,A,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,N,1,1,,BAO_0000218
14626,Rattus norvegicus,Intermediate,CHEMBL630465,,,50597,,A,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,N,1,1,,BAO_0000218
14627,Rattus norvegicus,Intermediate,CHEMBL630466,,,50597,,A,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,N,1,1,,BAO_0000218
14628,Rattus norvegicus,Intermediate,CHEMBL630467,,,50597,,A,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,N,1,1,,BAO_0000218
14629,Rattus norvegicus,Intermediate,CHEMBL630633,,,50597,,A,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,N,1,1,,BAO_0000218
14630,Rattus norvegicus,Intermediate,CHEMBL630634,,,50597,,A,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,N,1,1,,BAO_0000218
14631,Rattus norvegicus,Intermediate,CHEMBL630635,,,50597,,A,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,N,1,1,,BAO_0000218
14632,Rattus norvegicus,Intermediate,CHEMBL630636,,,50597,,A,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,N,1,1,,BAO_0000218
14633,Rattus norvegicus,Intermediate,CHEMBL630637,,,50597,,A,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,N,1,1,,BAO_0000218
14634,Oryctolagus cuniculus,Intermediate,CHEMBL630638,,,50592,1988.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,1,1,,BAO_0000218
14635,Oryctolagus cuniculus,Intermediate,CHEMBL630639,,,50592,1988.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,1,1,,BAO_0000218
14636,Oryctolagus cuniculus,Intermediate,CHEMBL630640,,,50592,1988.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,1,1,,BAO_0000218
14637,Oryctolagus cuniculus,Intermediate,CHEMBL876551,,,50592,1988.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,1,1,,BAO_0000218
14638,Oryctolagus cuniculus,Intermediate,CHEMBL630641,,,50592,1088.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,N,1,1,,BAO_0000218
14639,Oryctolagus cuniculus,Intermediate,CHEMBL630642,,,50592,1088.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,1,1,,BAO_0000218
14640,Oryctolagus cuniculus,Intermediate,CHEMBL630643,,,50592,1088.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,1,1,,BAO_0000218
14641,Oryctolagus cuniculus,Intermediate,CHEMBL630644,,,50592,1088.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,1,1,,BAO_0000218
14642,Oryctolagus cuniculus,Intermediate,CHEMBL630645,,,50592,1088.0,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,1,1,,BAO_0000218
14643,Oryctolagus cuniculus,Intermediate,CHEMBL625599,,,50592,1988.0,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,1,1,,BAO_0000218
14644,Oryctolagus cuniculus,Intermediate,CHEMBL625600,,,50592,1988.0,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,1,1,,BAO_0000218
14645,Oryctolagus cuniculus,Intermediate,CHEMBL625601,,,50592,1988.0,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,1,1,,BAO_0000218
14646,Oryctolagus cuniculus,Intermediate,CHEMBL625602,,,50592,1988.0,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,1,1,,BAO_0000218
14647,Oryctolagus cuniculus,Intermediate,CHEMBL627470,,,50592,1088.0,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,N,1,1,,BAO_0000218
14648,Oryctolagus cuniculus,Intermediate,CHEMBL627471,,,50592,1088.0,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,1,1,,BAO_0000218
14649,Oryctolagus cuniculus,Intermediate,CHEMBL627472,,,50592,1088.0,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,1,1,,BAO_0000218
14650,Oryctolagus cuniculus,Intermediate,CHEMBL627473,,,50592,1088.0,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,1,1,,BAO_0000218
14651,Oryctolagus cuniculus,Intermediate,CHEMBL627474,,,50592,1088.0,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,1,1,,BAO_0000218
14652,Rattus norvegicus,Intermediate,CHEMBL627475,,,50597,178.0,A,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14653,Rattus norvegicus,Intermediate,CHEMBL627476,,,50597,178.0,A,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14654,Canis lupus familiaris,Intermediate,CHEMBL627477,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14655,Canis lupus familiaris,Intermediate,CHEMBL627478,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1,1,,BAO_0000218
14656,Canis lupus familiaris,Intermediate,CHEMBL627479,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14657,Canis lupus familiaris,Intermediate,CHEMBL627480,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1,1,,BAO_0000218
14658,Canis lupus familiaris,Intermediate,CHEMBL627481,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1,1,,BAO_0000218
14659,Canis lupus familiaris,Intermediate,CHEMBL627482,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14660,Canis lupus familiaris,Intermediate,CHEMBL627483,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1,1,,BAO_0000218
14661,Canis lupus familiaris,Intermediate,CHEMBL875636,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1,1,,BAO_0000218
14662,Canis lupus familiaris,Intermediate,CHEMBL625764,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1,1,,BAO_0000218
14663,Canis lupus familiaris,Intermediate,CHEMBL625765,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14664,Canis lupus familiaris,Intermediate,CHEMBL625766,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,1,1,,BAO_0000218
14665,Canis lupus familiaris,Intermediate,CHEMBL625767,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
14666,Canis lupus familiaris,Intermediate,CHEMBL625768,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
14667,Canis lupus familiaris,Intermediate,CHEMBL625769,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14668,Canis lupus familiaris,Intermediate,CHEMBL625770,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14669,Canis lupus familiaris,Intermediate,CHEMBL625771,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14670,Canis lupus familiaris,Intermediate,CHEMBL625772,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,N,1,1,,BAO_0000218
14671,Canis lupus familiaris,Intermediate,CHEMBL625773,,,50588,1088.0,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14672,Rattus norvegicus,Intermediate,CHEMBL625774,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,1,1,,BAO_0000218
14673,Rattus norvegicus,Intermediate,CHEMBL625775,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1,1,,BAO_0000218
14674,Rattus norvegicus,Intermediate,CHEMBL625776,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1,1,,BAO_0000218
14675,Rattus norvegicus,Intermediate,CHEMBL625777,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1,1,,BAO_0000218
14676,Rattus norvegicus,Intermediate,CHEMBL625778,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14677,Rattus norvegicus,Intermediate,CHEMBL625779,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1,1,,BAO_0000218
14678,Rattus norvegicus,Intermediate,CHEMBL625780,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1,1,,BAO_0000218
14679,Rattus norvegicus,Intermediate,CHEMBL625781,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1,1,,BAO_0000218
14680,Rattus norvegicus,Intermediate,CHEMBL875637,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1,1,,BAO_0000218
14681,Rattus norvegicus,Intermediate,CHEMBL626473,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14682,Rattus norvegicus,Intermediate,CHEMBL626474,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1,1,,BAO_0000218
14683,Rattus norvegicus,Intermediate,CHEMBL626475,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14684,Rattus norvegicus,Intermediate,CHEMBL626476,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1,1,,BAO_0000218
14685,Rattus norvegicus,Intermediate,CHEMBL634397,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14686,Rattus norvegicus,Intermediate,CHEMBL626477,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1,1,,BAO_0000218
14687,Rattus norvegicus,Intermediate,CHEMBL631069,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14688,Rattus norvegicus,Intermediate,CHEMBL631070,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1,1,,BAO_0000218
14689,Rattus norvegicus,Intermediate,CHEMBL631071,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14690,Rattus norvegicus,Intermediate,CHEMBL631072,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1,1,,BAO_0000218
14691,Rattus norvegicus,Intermediate,CHEMBL631073,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14692,Rattus norvegicus,Intermediate,CHEMBL631074,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1,1,,BAO_0000218
14693,Rattus norvegicus,Intermediate,CHEMBL631075,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1,1,,BAO_0000218
14694,Rattus norvegicus,Intermediate,CHEMBL631725,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14695,Rattus norvegicus,Intermediate,CHEMBL631726,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1,1,,BAO_0000218
14696,Rattus norvegicus,Intermediate,CHEMBL631727,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1,1,,BAO_0000218
14697,Rattus norvegicus,Intermediate,CHEMBL631728,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14698,Rattus norvegicus,Intermediate,CHEMBL631729,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14699,Rattus norvegicus,Intermediate,CHEMBL631730,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1,1,,BAO_0000218
14700,Rattus norvegicus,Intermediate,CHEMBL631731,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1,1,,BAO_0000218
14701,Rattus norvegicus,Intermediate,CHEMBL631910,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1,1,,BAO_0000218
14702,Rattus norvegicus,Intermediate,CHEMBL631911,,,50597,10000000.0,A,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,N,1,1,,BAO_0000218
14703,Rattus norvegicus,Intermediate,CHEMBL631912,,,50597,1898.0,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,N,1,1,,BAO_0000218
14704,Rattus norvegicus,Intermediate,CHEMBL631913,,,50597,1898.0,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,N,1,1,,BAO_0000218
14705,Rattus norvegicus,Intermediate,CHEMBL631914,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14706,Rattus norvegicus,Intermediate,CHEMBL631915,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14707,Rattus norvegicus,Intermediate,CHEMBL875778,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14708,Rattus norvegicus,Intermediate,CHEMBL631916,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14709,Rattus norvegicus,Intermediate,CHEMBL631917,,,50597,178.0,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14710,Rattus norvegicus,Intermediate,CHEMBL631918,,,50597,178.0,A,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14711,Rattus norvegicus,Intermediate,CHEMBL631919,,,50597,178.0,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14712,Rattus norvegicus,Intermediate,CHEMBL631920,,,50597,178.0,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14713,Rattus norvegicus,Intermediate,CHEMBL631921,,,50597,178.0,A,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14714,Rattus norvegicus,Intermediate,CHEMBL631922,,,50597,178.0,A,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14715,Rattus norvegicus,Intermediate,CHEMBL631923,,,50597,178.0,A,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14716,Rattus norvegicus,Intermediate,CHEMBL631924,,,50597,,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14717,Rattus norvegicus,Intermediate,CHEMBL630234,,,50597,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14718,Rattus norvegicus,Intermediate,CHEMBL630235,,,50597,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14719,Rattus norvegicus,Intermediate,CHEMBL630236,,,50597,,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14720,Rattus norvegicus,Intermediate,CHEMBL630237,,,50597,,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14721,Rattus norvegicus,Intermediate,CHEMBL630238,,,50597,,A,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14722,Rattus norvegicus,Intermediate,CHEMBL630239,,,50597,,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14723,Rattus norvegicus,Intermediate,CHEMBL630303,,,50597,,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14724,Rattus norvegicus,Intermediate,CHEMBL630304,,,50597,,A,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14725,Rattus norvegicus,Intermediate,CHEMBL630305,,,50597,,A,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14726,Rattus norvegicus,Intermediate,CHEMBL630306,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14727,Rattus norvegicus,Intermediate,CHEMBL630307,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14728,Rattus norvegicus,Intermediate,CHEMBL630308,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14729,Rattus norvegicus,Intermediate,CHEMBL630309,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14730,Rattus norvegicus,Intermediate,CHEMBL629309,,,50597,2113.0,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14731,Rattus norvegicus,Intermediate,CHEMBL629993,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14732,Rattus norvegicus,Intermediate,CHEMBL629994,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14733,Rattus norvegicus,Intermediate,CHEMBL629995,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14734,Rattus norvegicus,Intermediate,CHEMBL631993,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14735,Rattus norvegicus,Intermediate,CHEMBL631994,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14736,Rattus norvegicus,Intermediate,CHEMBL631995,,,50597,2113.0,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14737,Rattus norvegicus,Intermediate,CHEMBL631996,,,50597,2107.0,A,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14738,Rattus norvegicus,Intermediate,CHEMBL631997,,,50597,2107.0,A,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14739,Rattus norvegicus,Intermediate,CHEMBL631998,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14740,Rattus norvegicus,Intermediate,CHEMBL631999,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14741,Rattus norvegicus,Intermediate,CHEMBL632000,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14742,Rattus norvegicus,Intermediate,CHEMBL632001,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14743,Rattus norvegicus,Intermediate,CHEMBL874424,,,50597,2107.0,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14744,Rattus norvegicus,Intermediate,CHEMBL632002,,,50597,2107.0,A,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14745,Rattus norvegicus,Intermediate,CHEMBL632003,,,50597,2107.0,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14746,,Autocuration,CHEMBL632004,,,22224,,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,0,1,,BAO_0000019
14747,,Autocuration,CHEMBL632005,,,22224,,A,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,U,0,1,,BAO_0000019
14748,,Autocuration,CHEMBL632006,,,22224,,A,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,U,0,1,,BAO_0000019
14749,,Autocuration,CHEMBL632007,,,22224,,A,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,U,0,1,,BAO_0000019
14750,,Autocuration,CHEMBL632008,,,22224,,A,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,U,0,1,,BAO_0000019
14751,,Autocuration,CHEMBL632009,,,22224,,A,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,U,0,1,,BAO_0000019
14752,,Autocuration,CHEMBL632010,,,22224,,A,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,U,0,1,,BAO_0000019
14753,,Autocuration,CHEMBL857750,,,22224,,A,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,U,0,1,,BAO_0000019
14754,,Autocuration,CHEMBL632011,,,22224,,A,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,U,0,1,,BAO_0000019
14755,,Autocuration,CHEMBL632012,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14756,,Autocuration,CHEMBL632013,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14757,,Autocuration,CHEMBL632014,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14758,,Autocuration,CHEMBL629622,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14759,,Autocuration,CHEMBL629623,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14760,,Autocuration,CHEMBL629624,,,22224,,A,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,U,0,1,,BAO_0000019
14761,,Autocuration,CHEMBL629625,,,22224,,A,,Ratio of Kcat to that of Km was determined,,U,0,1,,BAO_0000019
14762,,Autocuration,CHEMBL629626,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,0,1,,BAO_0000019
14763,,Autocuration,CHEMBL629627,,,22224,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,0,1,,BAO_0000019
14764,,Autocuration,CHEMBL629628,,,22224,,A,,"Compound was evaluated for constant, Kd",,U,0,1,,BAO_0000019
14765,,Autocuration,CHEMBL629629,,,22224,,A,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,U,0,1,,BAO_0000019
14766,,Autocuration,CHEMBL629630,,,22224,,A,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,U,0,1,,BAO_0000019
14767,,Autocuration,CHEMBL856030,,,22224,,A,,Dissociation Constant of compound determined,,U,0,1,,BAO_0000019
14768,,Autocuration,CHEMBL629631,,,22224,,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,U,0,1,,BAO_0000019
14769,,Autocuration,CHEMBL629632,,,22224,,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,U,0,1,,BAO_0000019
14770,,Autocuration,CHEMBL629633,,,22224,,P,,Dissociation constant of compound with Fructose was determined,,U,0,1,,BAO_0000100
14771,,Autocuration,CHEMBL629634,,,22224,,P,,Dissociation constant of compound with Fructose was determined; Not determined,,U,0,1,,BAO_0000100
14772,,Autocuration,CHEMBL629635,,,22224,,P,,Dissociation constant of compound with Lactulose was determined,,U,0,1,,BAO_0000100
14773,,Autocuration,CHEMBL629636,,,22224,,P,,Dissociation constant of compound with Lactulose was determined; Not determined,,U,0,1,,BAO_0000100
14774,,Autocuration,CHEMBL629637,,,22224,,P,,Dissociation constant of the Compound,,U,0,1,,BAO_0000100
14775,,Autocuration,CHEMBL629638,,,22224,,P,,Dissociation constant by non-linear regression analysis,,U,0,1,,BAO_0000100
14776,,Autocuration,CHEMBL629639,,,22224,,P,,Dissociation constant was determined,,U,0,1,,BAO_0000100
14777,,Autocuration,CHEMBL629640,,,22224,,P,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,U,0,1,,BAO_0000100
14778,,Autocuration,CHEMBL629641,,,22224,,P,,Dissociation constant was determined,,U,0,1,,BAO_0000100
14779,,Autocuration,CHEMBL631344,,,22224,,P,,Dissociation constant was determined,,U,0,1,,BAO_0000100
14780,Rattus norvegicus,Intermediate,CHEMBL631345,,,50597,2385.0,A,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,N,1,1,,BAO_0000218
14781,,Autocuration,CHEMBL631346,,,22224,,A,,The dissociation constant determined by fluorescence displacement assay,,U,0,1,,BAO_0000019
14782,,Autocuration,CHEMBL631524,,,22224,,A,,kd value surface plasmon resonance (SPR) method,,U,0,1,,BAO_0000019
14783,Rattus norvegicus,Intermediate,CHEMBL631525,,,50597,2385.0,A,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,N,1,1,,BAO_0000218
14784,,Autocuration,CHEMBL631526,,,22224,,F,,First dissociation constant of the binding of compound to V30M TTR,,U,0,1,,BAO_0000019
14785,,Autocuration,CHEMBL631527,,,22224,,F,,Second dissociation constant of the binding of compound to V30M TTR,,U,0,1,,BAO_0000019
14786,,Autocuration,CHEMBL631528,,,22224,,A,,"Compound was evaluated for equilibrium constant, Ke",,U,0,1,,BAO_0000019
14787,,Autocuration,CHEMBL631529,,,22224,1898.0,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,U,0,1,,BAO_0000019
14788,,Autocuration,CHEMBL631530,,,22224,1898.0,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,U,0,1,,BAO_0000019
14789,,Autocuration,CHEMBL631531,,,22224,,A,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,U,0,1,,BAO_0000019
14790,,Autocuration,CHEMBL631532,,,22224,,A,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,U,0,1,,BAO_0000019
14791,,Autocuration,CHEMBL631533,,,22224,,A,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,U,0,1,,BAO_0000019
14792,Mus musculus,Intermediate,CHEMBL876552,,,50594,,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,1,1,,BAO_0000218
14793,Mus musculus,Intermediate,CHEMBL631534,,,50594,,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,1,1,,BAO_0000218
14794,Mus musculus,Intermediate,CHEMBL631535,,,50594,,A,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,1,1,,BAO_0000218
14795,Mus musculus,Intermediate,CHEMBL631536,,,50594,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,1,1,,BAO_0000218
14796,Mus musculus,Intermediate,CHEMBL631537,,,50594,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,N,1,1,,BAO_0000218
14797,Mus musculus,Intermediate,CHEMBL631538,,,50594,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,1,1,,BAO_0000218
14798,Mus musculus,Intermediate,CHEMBL631539,,,50594,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,N,1,1,,BAO_0000218
14799,Mus musculus,Intermediate,CHEMBL631540,,,50594,,A,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,1,1,,BAO_0000218
14800,Rattus norvegicus,Intermediate,CHEMBL625637,,,50597,,A,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
14801,Rattus norvegicus,Intermediate,CHEMBL625638,,,50597,,A,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,1,1,,BAO_0000218
14802,Rattus norvegicus,Intermediate,CHEMBL625639,,,50597,,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,1,1,,BAO_0000218
14803,Rattus norvegicus,Intermediate,CHEMBL625640,,,50597,955.0,A,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14804,Rattus norvegicus,Intermediate,CHEMBL625641,,,50597,955.0,A,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14805,Rattus norvegicus,Intermediate,CHEMBL625642,,,50597,948.0,A,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14806,Rattus norvegicus,Intermediate,CHEMBL625643,,,50597,948.0,A,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14807,Rattus norvegicus,Intermediate,CHEMBL625644,,,50597,2113.0,A,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14808,Rattus norvegicus,Intermediate,CHEMBL625645,,,50597,2113.0,A,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14809,Rattus norvegicus,Intermediate,CHEMBL625646,,,50597,2107.0,A,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14810,Rattus norvegicus,Intermediate,CHEMBL625647,,,50597,2107.0,A,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14811,Rattus norvegicus,Intermediate,CHEMBL625648,,,50597,2048.0,A,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14812,Rattus norvegicus,Intermediate,CHEMBL625649,,,50597,2048.0,A,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14813,Rattus norvegicus,Intermediate,CHEMBL625650,,,50597,2385.0,A,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14814,Rattus norvegicus,Intermediate,CHEMBL625651,,,50597,2385.0,A,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14815,Rattus norvegicus,Intermediate,CHEMBL625652,,,50597,14.0,A,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14816,Rattus norvegicus,Intermediate,CHEMBL625653,,,50597,14.0,A,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14817,Rattus norvegicus,Intermediate,CHEMBL625654,,,50597,2106.0,A,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14818,Rattus norvegicus,Intermediate,CHEMBL625655,,,50597,2106.0,A,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,1,1,,BAO_0000218
14819,Rattus norvegicus,Intermediate,CHEMBL625656,,,50597,178.0,A,,Biodistribution of Compound in rat blood after 15 minutes of administration,,N,1,1,,BAO_0000218
14820,Rattus norvegicus,Intermediate,CHEMBL625657,,,50597,178.0,A,,Biodistribution of Compound in rat blood after 2 minutes of administration,,N,1,1,,BAO_0000218
14821,Rattus norvegicus,Intermediate,CHEMBL625658,,,50597,955.0,A,,Biodistribution of Compound in rat brain after 15 minutes of administration,,N,1,1,,BAO_0000218
14822,Rattus norvegicus,Intermediate,CHEMBL625659,,,50597,955.0,A,,Biodistribution of Compound in rat brain after 2 minutes of administration,,N,1,1,,BAO_0000218
14823,Rattus norvegicus,Intermediate,CHEMBL625660,,,50597,948.0,A,,Biodistribution of Compound in rat heart after 15 minutes of administration,,N,1,1,,BAO_0000218
14824,Rattus norvegicus,Intermediate,CHEMBL625661,,,50597,948.0,A,,Biodistribution of Compound in rat heart after 2 minutes of administration,,N,1,1,,BAO_0000218
14825,Rattus norvegicus,Intermediate,CHEMBL625662,,,50597,2107.0,A,,Biodistribution of Compound in rat liver after 15 minutes of administration,,N,1,1,,BAO_0000218
14826,Rattus norvegicus,Intermediate,CHEMBL625663,,,50597,2107.0,A,,Biodistribution of Compound in rat liver after 2 minutes of administration,,N,1,1,,BAO_0000218
14827,Rattus norvegicus,Intermediate,CHEMBL875621,,,50597,2048.0,A,,Biodistribution of Compound in rat lung after 15 minutes of administration,,N,1,1,,BAO_0000218
14828,Rattus norvegicus,Intermediate,CHEMBL628382,,,50597,2048.0,A,,Biodistribution of Compound in rat lung after 2 minutes of administration,,N,1,1,,BAO_0000218
14829,Rattus norvegicus,Intermediate,CHEMBL628383,,,50597,2385.0,A,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,N,1,1,,BAO_0000218
14830,Rattus norvegicus,Intermediate,CHEMBL628384,,,50597,2385.0,A,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,N,1,1,,BAO_0000218
14831,Rattus norvegicus,Intermediate,CHEMBL628385,,,50597,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,N,1,1,,BAO_0000218
14832,Rattus norvegicus,Intermediate,CHEMBL875753,,,50597,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,N,1,1,,BAO_0000218
14833,Rattus norvegicus,Intermediate,CHEMBL628386,,,50597,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,N,1,1,,BAO_0000218
14834,Rattus norvegicus,Intermediate,CHEMBL628387,,,50597,,A,,Organ distribution in rat blood 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14835,Rattus norvegicus,Intermediate,CHEMBL628388,,,50597,,A,,Organ distribution in rat blood 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14836,Rattus norvegicus,Intermediate,CHEMBL628389,,,50597,,A,,Organ distribution in rat blood 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14837,Rattus norvegicus,Intermediate,CHEMBL632756,,,50597,,A,,Organ distribution in rat blood 30 min after intravenous injection,,N,1,1,,BAO_0000218
14838,Rattus norvegicus,Intermediate,CHEMBL628390,,,50597,,A,,Organ distribution in rat brain 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14839,Rattus norvegicus,Intermediate,CHEMBL631811,,,50597,,A,,Organ distribution in rat brain 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14840,Rattus norvegicus,Intermediate,CHEMBL631812,,,50597,,A,,Organ distribution in rat brain 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14841,Rattus norvegicus,Intermediate,CHEMBL631813,,,50597,,A,,Organ distribution in rat heart 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14842,Rattus norvegicus,Intermediate,CHEMBL631814,,,50597,,A,,Organ distribution in rat heart 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14843,Rattus norvegicus,Intermediate,CHEMBL631815,,,50597,,A,,Organ distribution in rat heart 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14844,Rattus norvegicus,Intermediate,CHEMBL631816,,,50597,,A,,Organ distribution in rat kidney 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14845,Rattus norvegicus,Intermediate,CHEMBL875758,,,50597,,A,,Organ distribution in rat kidney 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14846,Rattus norvegicus,Intermediate,CHEMBL631817,,,50597,,A,,Organ distribution in rat kidney 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14847,Rattus norvegicus,Intermediate,CHEMBL631818,,,50597,2107.0,A,,Organ distribution in rat liver 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14848,Rattus norvegicus,Intermediate,CHEMBL631819,,,50597,2107.0,A,,Organ distribution in rat liver 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14849,Rattus norvegicus,Intermediate,CHEMBL631820,,,50597,2107.0,A,,Organ distribution in rat liver 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14850,Rattus norvegicus,Intermediate,CHEMBL631821,,,50597,,A,,Organ distribution in rat lung 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14851,Rattus norvegicus,Intermediate,CHEMBL631822,,,50597,,A,,Organ distribution in rat lung 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14852,Rattus norvegicus,Intermediate,CHEMBL631823,,,50597,,A,,Organ distribution in rat lung 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14853,Rattus norvegicus,Intermediate,CHEMBL631824,,,50597,2385.0,A,,Organ distribution in rat muscle 2 minutes after intravenous injection,,N,1,1,,BAO_0000218
14854,Rattus norvegicus,Intermediate,CHEMBL631825,,,50597,2385.0,A,,Organ distribution in rat muscle 2 hr after intravenous injection,,N,1,1,,BAO_0000218
14855,Rattus norvegicus,Intermediate,CHEMBL631826,,,50597,2385.0,A,,Organ distribution in rat muscle 30 minutes after intravenous injection,,N,1,1,,BAO_0000218
14856,Mus musculus,Intermediate,CHEMBL631827,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,N,1,1,,BAO_0000218
14857,Mus musculus,Intermediate,CHEMBL631828,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,N,1,1,,BAO_0000218
14858,Mus musculus,Intermediate,CHEMBL631829,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,N,1,1,,BAO_0000218
14859,Rattus norvegicus,Intermediate,CHEMBL875759,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1,1,,BAO_0000218
14860,Rattus norvegicus,Intermediate,CHEMBL631830,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,N,1,1,,BAO_0000218
14861,Rattus norvegicus,Intermediate,CHEMBL631831,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1,1,,BAO_0000218
14862,Rattus norvegicus,Intermediate,CHEMBL631832,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14863,Rattus norvegicus,Intermediate,CHEMBL631833,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1,1,,BAO_0000218
14864,Rattus norvegicus,Intermediate,CHEMBL631834,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14865,Rattus norvegicus,Intermediate,CHEMBL631835,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1,1,,BAO_0000218
14866,Rattus norvegicus,Intermediate,CHEMBL631836,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1,1,,BAO_0000218
14867,Rattus norvegicus,Intermediate,CHEMBL631837,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14868,Rattus norvegicus,Intermediate,CHEMBL631838,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14869,Rattus norvegicus,Intermediate,CHEMBL631839,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1,1,,BAO_0000218
14870,Rattus norvegicus,Intermediate,CHEMBL631840,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1,1,,BAO_0000218
14871,Rattus norvegicus,Intermediate,CHEMBL631841,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14872,Rattus norvegicus,Intermediate,CHEMBL631842,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14873,Rattus norvegicus,Intermediate,CHEMBL631843,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1,1,,BAO_0000218
14874,Rattus norvegicus,Intermediate,CHEMBL631844,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14875,Rattus norvegicus,Intermediate,CHEMBL631845,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14876,Rattus norvegicus,Intermediate,CHEMBL631846,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14877,Rattus norvegicus,Intermediate,CHEMBL875760,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14878,Rattus norvegicus,Intermediate,CHEMBL632199,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1,1,,BAO_0000218
14879,Rattus norvegicus,Intermediate,CHEMBL631847,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14880,Rattus norvegicus,Intermediate,CHEMBL631848,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1,1,,BAO_0000218
14881,Rattus norvegicus,Intermediate,CHEMBL628707,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1,1,,BAO_0000218
14882,Rattus norvegicus,Intermediate,CHEMBL628708,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14883,Rattus norvegicus,Intermediate,CHEMBL628709,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1,1,,BAO_0000218
14884,Rattus norvegicus,Intermediate,CHEMBL628710,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14885,Rattus norvegicus,Intermediate,CHEMBL628711,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1,1,,BAO_0000218
14886,Rattus norvegicus,Intermediate,CHEMBL628712,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1,1,,BAO_0000218
14887,Rattus norvegicus,Intermediate,CHEMBL628713,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1,1,,BAO_0000218
14888,Rattus norvegicus,Intermediate,CHEMBL628714,,,50597,1088.0,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1,1,,BAO_0000218
14889,Rattus norvegicus,Intermediate,CHEMBL628715,,,50597,,A,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,N,1,1,,BAO_0000218
14890,,Autocuration,CHEMBL629179,,,22224,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,U,0,1,,BAO_0000019
14891,,Autocuration,CHEMBL629180,,,22224,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,U,0,1,,BAO_0000019
14892,,Autocuration,CHEMBL875108,,,22224,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,U,0,1,,BAO_0000019
14893,,Autocuration,CHEMBL629181,,,22224,1235.0,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14894,,Autocuration,CHEMBL629182,,,22224,1235.0,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14895,,Autocuration,CHEMBL629183,,,22224,,A,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14896,,Autocuration,CHEMBL629184,,,22224,,A,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14897,,Autocuration,CHEMBL629185,,,22224,1235.0,A,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14898,,Autocuration,CHEMBL629186,,,22224,1235.0,A,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14899,,Autocuration,CHEMBL629187,,,22224,,A,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14900,,Autocuration,CHEMBL629887,,,22224,,A,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14901,,Autocuration,CHEMBL629888,,,22224,,A,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14902,,Autocuration,CHEMBL629889,,,22224,,A,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14903,,Autocuration,CHEMBL629890,,,22224,1235.0,A,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14904,,Autocuration,CHEMBL629891,,,22224,,A,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14905,,Autocuration,CHEMBL629892,,,22224,,A,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14906,,Autocuration,CHEMBL629893,,,22224,1235.0,A,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14907,,Autocuration,CHEMBL629894,,,22224,,A,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14908,,Autocuration,CHEMBL629895,,,22224,,A,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,0,1,,BAO_0000019
14909,Canis lupus familiaris,Autocuration,CHEMBL875109,,,22224,,A,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,U,0,1,,BAO_0000218
14910,Macaca fascicularis,Autocuration,CHEMBL629896,,,22224,,A,,Absolute bioavailability in male cynomolgus monkeys,,U,0,1,,BAO_0000218
14911,Rattus norvegicus,Autocuration,CHEMBL629897,,,22224,,A,,Absolute bioavailability in maleSprague-Dawley rats,,U,0,1,,BAO_0000218
14912,Rattus norvegicus,Intermediate,CHEMBL629898,,,50597,2107.0,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14913,Rattus norvegicus,Intermediate,CHEMBL630057,,,50597,2107.0,A,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14914,Rattus norvegicus,Intermediate,CHEMBL630058,,,50597,2107.0,A,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14915,Rattus norvegicus,Intermediate,CHEMBL630059,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14916,Rattus norvegicus,Intermediate,CHEMBL630060,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14917,Rattus norvegicus,Intermediate,CHEMBL630061,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14918,Rattus norvegicus,Intermediate,CHEMBL630062,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14919,Rattus norvegicus,Intermediate,CHEMBL630063,,,50597,2048.0,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14920,Rattus norvegicus,Intermediate,CHEMBL630064,,,50597,2048.0,A,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14921,Rattus norvegicus,Intermediate,CHEMBL630065,,,50597,2048.0,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14922,Rattus norvegicus,Intermediate,CHEMBL630066,,,50597,2048.0,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14923,Rattus norvegicus,Intermediate,CHEMBL630067,,,50597,2048.0,A,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14924,Rattus norvegicus,Intermediate,CHEMBL630068,,,50597,2048.0,A,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14925,Rattus norvegicus,Intermediate,CHEMBL631113,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14926,Rattus norvegicus,Intermediate,CHEMBL631114,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14927,Rattus norvegicus,Intermediate,CHEMBL631115,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14928,Rattus norvegicus,Intermediate,CHEMBL631116,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14929,Rattus norvegicus,Intermediate,CHEMBL630528,,,50597,2385.0,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14930,Rattus norvegicus,Intermediate,CHEMBL630529,,,50597,2385.0,A,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14931,Rattus norvegicus,Intermediate,CHEMBL630530,,,50597,2385.0,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14932,Rattus norvegicus,Intermediate,CHEMBL630531,,,50597,2385.0,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14933,Rattus norvegicus,Intermediate,CHEMBL630532,,,50597,2385.0,A,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14934,Rattus norvegicus,Intermediate,CHEMBL630533,,,50597,2385.0,A,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14935,Mus musculus,Intermediate,CHEMBL630534,,,50594,178.0,A,,Biodistribution in normal mice blood after 120 hr,,N,1,1,,BAO_0000218
14936,Mus musculus,Intermediate,CHEMBL630535,,,50594,178.0,A,,Biodistribution in normal mice blood after 24 hr,,N,1,1,,BAO_0000218
14937,Mus musculus,Intermediate,CHEMBL630536,,,50594,178.0,A,,Biodistribution in normal mice blood after 4 hr,,N,1,1,,BAO_0000218
14938,Mus musculus,Intermediate,CHEMBL630537,,,50594,10000001.0,A,,Biodistribution in normal mice bone after 120 hr,,N,1,1,,BAO_0000218
14939,Mus musculus,Intermediate,CHEMBL630538,,,50594,10000001.0,A,,Biodistribution in normal mice bone after 24 hr,,N,1,1,,BAO_0000218
14940,Mus musculus,Intermediate,CHEMBL630539,,,50594,10000001.0,A,,Biodistribution in normal mice bone after 4 hr,,N,1,1,,BAO_0000218
14941,Mus musculus,Intermediate,CHEMBL630540,,,50594,948.0,A,,Biodistribution in normal mice heart after 120 hr,,N,1,1,,BAO_0000218
14942,Mus musculus,Intermediate,CHEMBL630541,,,50594,948.0,A,,Biodistribution in normal mice heart after 24 hr,,N,1,1,,BAO_0000218
14943,Mus musculus,Intermediate,CHEMBL630542,,,50594,948.0,A,,Biodistribution in normal mice heart after 4 hr,,N,1,1,,BAO_0000218
14944,Mus musculus,Intermediate,CHEMBL630543,,,50594,2113.0,A,,Biodistribution in normal mice kidney after 120 hr,,N,1,1,,BAO_0000218
14945,Mus musculus,Intermediate,CHEMBL630544,,,50594,2113.0,A,,Biodistribution in normal mice kidney after 24 hr,,N,1,1,,BAO_0000218
14946,Mus musculus,Intermediate,CHEMBL630545,,,50594,2113.0,A,,Biodistribution in normal mice kidney after 4 hr,,N,1,1,,BAO_0000218
14947,Mus musculus,Intermediate,CHEMBL630546,,,50594,2107.0,A,,Biodistribution in normal mice liver after 120 hr,,N,1,1,,BAO_0000218
14948,Mus musculus,Intermediate,CHEMBL630547,,,50594,2107.0,A,,Biodistribution in normal mice liver after 24 hr,,N,1,1,,BAO_0000218
14949,Mus musculus,Intermediate,CHEMBL630548,,,50594,2107.0,A,,Biodistribution in normal mice liver after 4 hr,,N,1,1,,BAO_0000218
14950,Mus musculus,Intermediate,CHEMBL630549,,,50594,2106.0,A,,Biodistribution in normal mice spleen after 120 hr,,N,1,1,,BAO_0000218
14951,Mus musculus,Intermediate,CHEMBL630550,,,50594,2106.0,A,,Biodistribution in normal mice spleen after 24 hr,,N,1,1,,BAO_0000218
14952,Mus musculus,Intermediate,CHEMBL876426,,,50594,2106.0,A,,Biodistribution in normal mice spleen after 4 hr,,N,1,1,,BAO_0000218
14953,Rattus norvegicus,Intermediate,CHEMBL630551,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14954,Rattus norvegicus,Intermediate,CHEMBL630552,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14955,Rattus norvegicus,Intermediate,CHEMBL630553,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14956,Rattus norvegicus,Intermediate,CHEMBL630554,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14957,Rattus norvegicus,Intermediate,CHEMBL630555,,,50597,2106.0,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14958,Rattus norvegicus,Intermediate,CHEMBL630556,,,50597,2106.0,A,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14959,Rattus norvegicus,Intermediate,CHEMBL630557,,,50597,2106.0,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14960,Rattus norvegicus,Intermediate,CHEMBL630558,,,50597,2106.0,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,1,1,,BAO_0000218
14961,Rattus norvegicus,Intermediate,CHEMBL630559,,,50597,2106.0,A,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14962,Rattus norvegicus,Intermediate,CHEMBL630560,,,50597,2106.0,A,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14963,Rattus norvegicus,Intermediate,CHEMBL876427,,,50597,2046.0,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,1,1,,BAO_0000218
14964,Rattus norvegicus,Intermediate,CHEMBL630561,,,50597,,A,,The Kel values in female wistar rats.,,N,1,1,,BAO_0000218
14965,,Autocuration,CHEMBL630562,,,22224,,A,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,U,0,1,,BAO_0000019
14966,,Autocuration,CHEMBL630563,,,22224,,A,,Hydrolysis rate constant of the compound,,U,0,1,,BAO_0000019
14967,,Autocuration,CHEMBL629673,,,22229,,P,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,U,0,1,,BAO_0000100
14968,,Autocuration,CHEMBL629674,,,22224,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,U,0,1,,BAO_0000019
14969,,Autocuration,CHEMBL629675,,,22224,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,U,0,1,,BAO_0000019
14970,,Autocuration,CHEMBL629676,,,22224,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,U,0,1,,BAO_0000019
14971,,Autocuration,CHEMBL629677,,,22224,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,U,0,1,,BAO_0000019
14972,,Autocuration,CHEMBL629678,,,22224,,A,,Apparent inactivation rate constant was evaluated,,U,0,1,,BAO_0000019
14973,,Autocuration,CHEMBL629679,,,22224,,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,U,0,1,,BAO_0000019
14974,,Autocuration,CHEMBL629680,,,22224,,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,U,0,1,,BAO_0000019
14975,,Autocuration,CHEMBL629681,,,22224,,A,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,U,0,1,,BAO_0000019
14976,,Autocuration,CHEMBL629682,,,22224,,A,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,U,0,1,,BAO_0000019
14977,,Autocuration,CHEMBL629683,,,22224,,A,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,U,0,1,,BAO_0000019
14978,,Autocuration,CHEMBL629684,,,22224,,F,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,U,0,1,,BAO_0000019
14979,,Autocuration,CHEMBL629685,,,22224,,P,,Dissociation constant was determined,,U,0,1,,BAO_0000100
14980,,Autocuration,CHEMBL629686,,,22224,,P,,Dissociation constant was determined,,U,0,1,,BAO_0000100
14981,,Autocuration,CHEMBL872932,,,22224,,P,,Dissociation constant at pH 7.4,,U,0,1,,BAO_0000100
14982,,Autocuration,CHEMBL629687,,,22224,,P,,Dissociation constant in presence of 1 mM dithiothreitol,,U,0,1,,BAO_0000100
14983,,Autocuration,CHEMBL872931,,,22224,,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,0,1,,BAO_0000019
14984,,Autocuration,CHEMBL628151,,,22224,,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,0,1,,BAO_0000019
14985,,Autocuration,CHEMBL628152,,,22224,,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,0,1,,BAO_0000019
14986,,Autocuration,CHEMBL628153,,,22224,,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,0,1,,BAO_0000019
14987,,Autocuration,CHEMBL628154,,,22224,,A,,Kinetic constant for aromatization of androstenedione,,U,0,1,,BAO_0000019
14988,,Autocuration,CHEMBL628155,,,22224,,A,,Kinetic constant for aromatization of testosterone,,U,0,1,,BAO_0000019
14989,,Autocuration,CHEMBL628156,,,22224,,A,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,U,0,1,,BAO_0000019
14990,,Autocuration,CHEMBL628157,,,22224,,A,,Local inhibition constant was determined,,U,0,1,,BAO_0000019
14991,Saccharomyces cerevisiae,Intermediate,CHEMBL857533,,,50347,,A,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,N,1,1,,BAO_0000218
14992,,Autocuration,CHEMBL628158,,,22224,,P,,Dissociation constant value of the compound,,U,0,1,,BAO_0000100
14993,,Autocuration,CHEMBL628159,,,22224,964.0,A,,In vitro permeability through cornea without epithelium,,U,0,1,,BAO_0000019
14994,,Autocuration,CHEMBL875616,,,22224,964.0,A,,In vitro permeability through intact cornea,,U,0,1,,BAO_0000019
14995,Oryctolagus cuniculus,Intermediate,CHEMBL628160,,,50592,964.0,A,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,N,1,1,,BAO_0000218
14996,,Autocuration,CHEMBL628161,,,22224,,A,,Rate of enzyme inactivation for the compound was determined,,U,0,1,,BAO_0000019
14997,,Autocuration,CHEMBL628162,,,22224,964.0,A,,In vitro permeability through cornea without epithelium,,U,0,1,,BAO_0000019
14998,,Autocuration,CHEMBL628163,,,22224,964.0,A,,In vitro permeability through intact cornea,,U,0,1,,BAO_0000019
14999,,Autocuration,CHEMBL628164,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15000,,Autocuration,CHEMBL628165,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15001,,Autocuration,CHEMBL628166,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15002,,Autocuration,CHEMBL628167,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15003,,Autocuration,CHEMBL628168,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15004,,Autocuration,CHEMBL628169,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15005,,Autocuration,CHEMBL628170,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15006,,Autocuration,CHEMBL628171,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15007,,Autocuration,CHEMBL627434,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15008,,Autocuration,CHEMBL627435,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15009,,Autocuration,CHEMBL628110,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15010,,Autocuration,CHEMBL628111,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15011,,Autocuration,CHEMBL628112,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15012,,Autocuration,CHEMBL628260,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15013,,Autocuration,CHEMBL628261,,,22224,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,0,1,,BAO_0000019
15014,Mus musculus,Intermediate,CHEMBL628262,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,N,1,1,,BAO_0000218
15015,Homo sapiens,Intermediate,CHEMBL628263,,,50587,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,N,1,1,,BAO_0000218
15016,Mus musculus,Intermediate,CHEMBL628264,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,N,1,1,,BAO_0000218
15017,Mus musculus,Intermediate,CHEMBL628265,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,N,1,1,,BAO_0000218
15018,Mus musculus,Intermediate,CHEMBL628266,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,N,1,1,,BAO_0000218
15019,Mus musculus,Intermediate,CHEMBL628267,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,N,1,1,,BAO_0000218
15020,Mus musculus,Intermediate,CHEMBL628268,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,N,1,1,,BAO_0000218
15021,Mus musculus,Intermediate,CHEMBL628269,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,N,1,1,,BAO_0000218
15022,Mus musculus,Intermediate,CHEMBL628270,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,N,1,1,,BAO_0000218
15023,Mus musculus,Intermediate,CHEMBL628271,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,N,1,1,,BAO_0000218
15024,Mus musculus,Intermediate,CHEMBL628272,,,50594,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,N,1,1,,BAO_0000218
1,,Autocuration,CHEMBL615117,,,12052,,B,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,,H,8,1,,BAO_0000019
2,,Autocuration,CHEMBL615118,,,22226,,F,,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,,U,0,1,,BAO_0000219
3,,Autocuration,CHEMBL615119,,,22226,,B,,,,U,0,1,,BAO_0000019
4,Bos taurus,Autocuration,CHEMBL615120,,,104729,,B,,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,,H,4,1,,BAO_0000249
5,Homo sapiens,Intermediate,CHEMBL615121,163.0,,80001,,F,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,N,1,1,,BAO_0000219
6,Homo sapiens,Intermediate,CHEMBL615122,163.0,,80001,,F,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,N,1,1,,BAO_0000219
7,Mus musculus,Intermediate,CHEMBL615123,163.0,,80001,,F,,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,,N,1,1,,BAO_0000219
8,Homo sapiens,Expert,CHEMBL615124,163.0,,80001,,F,,In vitro cell cytotoxicity was determined against 143B cell line,,N,1,1,,BAO_0000219
9,Homo sapiens,Intermediate,CHEMBL615125,163.0,,80001,,F,,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,,N,1,1,,BAO_0000219
10,Homo sapiens,Intermediate,CHEMBL615126,163.0,,80001,,F,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,N,1,1,,BAO_0000219
11,Homo sapiens,Intermediate,CHEMBL615127,163.0,,80001,,F,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,N,1,1,,BAO_0000219
12,Homo sapiens,Expert,CHEMBL615128,163.0,,80001,,F,,In vitro cell cytotoxicity was determined against 143B-LTK cell line,,N,1,1,,BAO_0000219
13,Staphylococcus aureus,Intermediate,CHEMBL857900,,,50185,,F,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,1,1,,BAO_0000218
14,Staphylococcus aureus,Intermediate,CHEMBL615129,,,50185,,F,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,1,1,,BAO_0000218
15,Staphylococcus aureus,Intermediate,CHEMBL615130,,,50185,,F,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,1,1,,BAO_0000218
16,Staphylococcus aureus,Intermediate,CHEMBL615131,,,50185,,F,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,1,1,,BAO_0000218
17,Rattus norvegicus,Expert,CHEMBL884521,,,100122,,A,,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,,D,9,1,,BAO_0000357
18,,Autocuration,CHEMBL615132,,,12054,,B,,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,H,8,1,,BAO_0000357
19,,Autocuration,CHEMBL615133,,,12054,,B,,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,H,8,1,,BAO_0000019
20,,Autocuration,CHEMBL615134,,,12054,,B,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,H,8,1,,BAO_0000357
21,,Autocuration,CHEMBL615135,,,12054,,B,,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,H,8,1,,BAO_0000357
22,,Autocuration,CHEMBL615136,,,12054,,B,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,H,8,1,,BAO_0000357
23,,Autocuration,CHEMBL615137,,,12054,,B,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,H,8,1,,BAO_0000357
24,,Autocuration,CHEMBL615138,,,12054,,B,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,H,8,1,,BAO_0000357
25,,Autocuration,CHEMBL836324,,,22226,,B,,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",,U,0,1,,BAO_0000219
26,Oryctolagus cuniculus,Autocuration,CHEMBL615139,,,12054,,B,,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,,H,8,1,,BAO_0000357
27,Oryctolagus cuniculus,Autocuration,CHEMBL615140,,,12054,,B,,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),,H,8,1,,BAO_0000357
28,,Autocuration,CHEMBL615141,,,12426,,B,,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,,H,8,1,,BAO_0000219
29,soya bean,Autocuration,CHEMBL615142,,,12054,,B,,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,,H,8,1,,BAO_0000357
30,Glycine max,Autocuration,CHEMBL615143,,,12054,,B,,Inhibitory activity against soybean 15-lipoxygenase was evaluated,,H,8,1,,BAO_0000357
31,Glycine max,Autocuration,CHEMBL615144,,,12054,,B,,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,,H,8,1,,BAO_0000357
32,Glycine max,Autocuration,CHEMBL872867,,,12054,,B,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,,H,8,1,,BAO_0000357
33,Glycine max,Autocuration,CHEMBL615145,,,12054,,B,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,,H,8,1,,BAO_0000357
34,Glycine max,Autocuration,CHEMBL615146,,,12054,,B,,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,,H,8,1,,BAO_0000357
35,Glycine max,Autocuration,CHEMBL615147,,,12054,,B,,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,,H,8,1,,BAO_0000357
36,Rattus norvegicus,Autocuration,CHEMBL615148,,,22226,,A,,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,,U,0,1,,BAO_0000019
37,Escherichia coli,Autocuration,CHEMBL615149,,,22226,,B,,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,,U,0,1,,BAO_0000019
38,,Autocuration,CHEMBL615150,,,22226,,B,,Dissociation constant with dimeric 16S rRNA RNA construct B,,U,0,1,,BAO_0000019
39,,Intermediate,CHEMBL615151,,,22222,,B,,Dissociation constant towards 16S rRNA construct A,,M,3,1,,BAO_0000225
40,,Intermediate,CHEMBL615152,,,22222,,B,,Dissociation constant towards 16S rRNA construct B,,M,3,1,,BAO_0000225
41,Escherichia coli,Expert,CHEMBL615153,,,100263,,B,,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,,M,3,1,,BAO_0000225
42,Escherichia coli,Expert,CHEMBL615154,,,100263,,B,,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,,M,3,1,,BAO_0000225
43,,Autocuration,CHEMBL615155,,,13053,,B,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,8,1,,BAO_0000019
44,,Autocuration,CHEMBL615156,,,13053,,B,,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,8,1,,BAO_0000019
45,Homo sapiens,Autocuration,CHEMBL615157,,,20001,,B,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,H,8,1,,BAO_0000019
46,Homo sapiens,Autocuration,CHEMBL615158,,,20001,,B,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,H,8,1,,BAO_0000019
47,Rattus norvegicus,Expert,CHEMBL615159,,,12971,,B,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,D,9,1,,BAO_0000019
48,Rattus norvegicus,Expert,CHEMBL615172,,,12971,,B,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,D,9,1,,BAO_0000019
49,Rattus norvegicus,Expert,CHEMBL615173,,,12971,,B,,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,D,9,1,,BAO_0000019
50,Rattus norvegicus,Expert,CHEMBL615174,,,12971,,B,,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,D,9,1,,BAO_0000019
51,,Autocuration,CHEMBL884518,,,13053,,B,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,8,1,,BAO_0000019
52,,Autocuration,CHEMBL615175,,,11512,,B,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),,H,8,1,,BAO_0000357
53,,Autocuration,CHEMBL615176,,,11512,,B,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,,H,8,1,,BAO_0000357
54,,Autocuration,CHEMBL615177,,,11512,,B,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,,H,8,1,,BAO_0000357
55,Rattus norvegicus,Autocuration,CHEMBL615178,,,104740,,B,,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,Membranes,D,5,1,,BAO_0000249
56,Homo sapiens,Intermediate,CHEMBL615179,506.0,,80002,,F,,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,,N,1,1,,BAO_0000219
57,Rattus norvegicus,Autocuration,CHEMBL615180,,,104835,,F,,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,,D,7,1,,BAO_0000219
58,Rattus norvegicus,Autocuration,CHEMBL615181,,,104821,,F,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,,D,7,1,,BAO_0000219
59,Rattus norvegicus,Autocuration,CHEMBL615182,,,104848,,F,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,,D,7,1,,BAO_0000219
60,Homo sapiens,Expert,CHEMBL615183,506.0,,80002,,F,,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,,N,1,1,,BAO_0000219
61,Homo sapiens,Intermediate,CHEMBL615184,506.0,,80002,,F,,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,,N,1,1,,BAO_0000219
62,Homo sapiens,Intermediate,CHEMBL615185,506.0,,80002,,F,,Cytotoxic activity against human ovarian cancer (1A9) cell line,,N,1,1,,BAO_0000219
63,Homo sapiens,Intermediate,CHEMBL615186,506.0,,80002,,F,,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,,N,1,1,,BAO_0000219
64,Homo sapiens,Intermediate,CHEMBL615187,506.0,,80002,,F,,Effective dose of compound against replication of 1A9 cell line was evaluated,,N,1,1,,BAO_0000219
65,Homo sapiens,Expert,CHEMBL885343,506.0,,80002,,F,,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,,N,1,1,,BAO_0000219
66,Homo sapiens,Intermediate,CHEMBL615188,506.0,,80002,,F,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),,N,1,1,,BAO_0000219
67,Homo sapiens,Intermediate,CHEMBL615189,506.0,,80002,,F,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,,N,1,1,,BAO_0000219
68,Homo sapiens,Intermediate,CHEMBL615190,506.0,,80002,,F,,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,,N,1,1,,BAO_0000219
69,Homo sapiens,Intermediate,CHEMBL615191,506.0,,80002,,F,,Inhibitory activity against Taxol resistant 1A9 cell lines,,N,1,1,,BAO_0000219
70,Homo sapiens,Expert,CHEMBL615192,506.0,,80002,,F,,Cytotoxicity against human ovarian cancer (1A9) cell lines.,,N,1,1,,BAO_0000219
71,Homo sapiens,Expert,CHEMBL827083,506.0,,80002,,F,,Percentage inhibition of human ovarian cancer (1A9) cell lines.,,N,1,1,,BAO_0000219
72,Homo sapiens,Expert,CHEMBL615193,506.0,,80002,,F,,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,,N,1,1,,BAO_0000219
73,Homo sapiens,Intermediate,CHEMBL615194,506.0,,80002,,F,,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,,N,1,1,,BAO_0000219
74,Homo sapiens,Intermediate,CHEMBL615195,506.0,,80002,,F,,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,,N,1,1,,BAO_0000219
75,Homo sapiens,Intermediate,CHEMBL615196,506.0,,80002,,F,,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,,N,1,1,,BAO_0000219
76,Homo sapiens,Intermediate,CHEMBL615197,503.0,,81072,,F,,Inhibitory concentration against Jurkat cells,,N,1,1,,BAO_0000219
77,,Intermediate,CHEMBL615198,,,22226,,F,,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,,U,0,1,,BAO_0000019
78,Rattus norvegicus,Expert,CHEMBL615199,,,100121,,A,,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,,D,9,1,,BAO_0000357
79,,Expert,CHEMBL615200,,,11231,,B,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,H,8,1,,BAO_0000357
80,,Expert,CHEMBL615201,,,11231,,B,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,H,8,1,,BAO_0000357
81,,Expert,CHEMBL615202,,,11231,,B,,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",,H,8,1,,BAO_0000357
82,Candida albicans,Autocuration,CHEMBL615203,,,11231,,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",Microsomes,H,8,1,,BAO_0000251
83,Candida albicans,Autocuration,CHEMBL615204,,,11231,,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",Microsomes,H,8,1,,BAO_0000251
84,Saccharomyces cerevisiae,Autocuration,CHEMBL615205,,,11231,,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",Microsomes,H,8,1,,BAO_0000251
85,Saccharomyces cerevisiae,Autocuration,CHEMBL615206,,,11231,,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",Microsomes,H,8,1,,BAO_0000251
86,Sus scrofa,Autocuration,CHEMBL615207,,,12083,2107.0,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",Microsomes,H,8,1,,BAO_0000251
87,Rattus norvegicus,Autocuration,CHEMBL827084,,,11231,,B,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",,H,8,1,,BAO_0000019
88,Rattus norvegicus,Autocuration,CHEMBL615208,,,11231,,B,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",,H,8,1,,BAO_0000019
89,Rattus norvegicus,Autocuration,CHEMBL615209,,,11231,,B,,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",,H,8,1,,BAO_0000019
90,Rattus norvegicus,Autocuration,CHEMBL615210,,,12083,2107.0,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",Microsomes,D,9,1,,BAO_0000251
91,Rattus norvegicus,Autocuration,CHEMBL615211,,,12083,2107.0,B,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,D,9,1,,BAO_0000251
92,Rattus norvegicus,Autocuration,CHEMBL615212,,,12083,2107.0,B,,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,D,9,1,,BAO_0000251
93,,Expert,CHEMBL615213,,,11377,,B,,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,H,8,1,,BAO_0000357
94,,Expert,CHEMBL615273,,,11377,,B,,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,H,8,1,,BAO_0000357
95,Homo sapiens,Expert,CHEMBL615274,726.0,,81020,,F,,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,N,1,1,,BAO_0000219
96,Homo sapiens,Intermediate,CHEMBL615275,726.0,,81020,,F,,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,,N,1,1,,BAO_0000219
97,Homo sapiens,Intermediate,CHEMBL615276,726.0,,81020,,F,,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,,N,1,1,,BAO_0000219
98,Homo sapiens,Intermediate,CHEMBL615277,726.0,,81020,,F,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,,N,1,1,,BAO_0000219
99,Homo sapiens,Intermediate,CHEMBL615326,726.0,,81020,,F,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,,N,1,1,,BAO_0000219
100,Hepatitis B virus,Expert,CHEMBL883130,,,50606,,F,,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,N,1,1,,BAO_0000218
101,Homo sapiens,Intermediate,CHEMBL884519,726.0,,81020,,F,,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,,N,1,1,,BAO_0000219
102,Homo sapiens,Intermediate,CHEMBL615327,726.0,,81020,,F,,Concentration required to inhibit 50% of 2.2.15 cell line,,N,1,1,,BAO_0000219
103,Homo sapiens,Intermediate,CHEMBL615328,726.0,,81020,,A,,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,,N,1,1,,BAO_0000219
104,Homo sapiens,Intermediate,CHEMBL615329,,,50587,,F,,Cytotoxic activity of compound against uninfected 2.2.15 cells.,,N,1,1,,BAO_0000218
105,Homo sapiens,Intermediate,CHEMBL615330,,,50587,,F,,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,,N,1,1,,BAO_0000218
106,Hepatitis B virus,Expert,CHEMBL615331,,,50606,,F,,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",,N,1,1,,BAO_0000218
107,Homo sapiens,Intermediate,CHEMBL615332,,,50587,,F,,In vitro anti-HBV activity in 2.2.15 cells,,N,1,1,,BAO_0000218
108,Homo sapiens,Intermediate,CHEMBL615333,,,50587,,F,,In vitro anti-HBV activity in 2.2.15 cells; Not determined,,N,1,1,,BAO_0000218
109,Homo sapiens,Intermediate,CHEMBL615334,,,50587,,F,,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,,N,1,1,,BAO_0000218
110,Homo sapiens,Intermediate,CHEMBL615335,,,50587,,F,,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,,N,1,1,,BAO_0000218
111,Homo sapiens,Intermediate,CHEMBL615336,,,50587,,F,,Cytotoxicity in 2.2.15 cells,,N,1,1,,BAO_0000218
112,Homo sapiens,Intermediate,CHEMBL615337,,,50587,,F,,Cytotoxicity in 2.2.15 cells; Not determined,,N,1,1,,BAO_0000218
113,Homo sapiens,Intermediate,CHEMBL615338,,,50587,,F,,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,,N,1,1,,BAO_0000218
114,Homo sapiens,Intermediate,CHEMBL615339,,,50587,,F,,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,,N,1,1,,BAO_0000218
115,Homo sapiens,Intermediate,CHEMBL615340,,,50587,,F,,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,,N,1,1,,BAO_0000218
116,Homo sapiens,Intermediate,CHEMBL615341,726.0,,81020,,F,,Antiviral activity against HBV was determined in 2.215 cell line,,N,1,1,,BAO_0000219
117,Homo sapiens,Autocuration,CHEMBL615342,,,22226,,B,,Inhibition of 20-HETE synthesis in human renal microsomes,Microsomes,U,0,1,,BAO_0000251
118,,Autocuration,CHEMBL615343,,,22226,,B,,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,,U,0,1,,BAO_0000019
119,Homo sapiens,Intermediate,CHEMBL615344,388.0,,80612,,F,,Inhibitory concentration against 2008 (ovarian) cells,,N,1,1,,BAO_0000219
120,Homo sapiens,Intermediate,CHEMBL615345,388.0,,80612,,F,,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,,N,1,1,,BAO_0000219
121,Homo sapiens,Intermediate,CHEMBL615346,388.0,,80612,,F,,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),,N,1,1,,BAO_0000219
122,Homo sapiens,Intermediate,CHEMBL615347,388.0,,80612,,F,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,,N,1,1,,BAO_0000219
123,Homo sapiens,Intermediate,CHEMBL615348,388.0,,80612,,F,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,,N,1,1,,BAO_0000219
124,Homo sapiens,Intermediate,CHEMBL827085,561.0,,80613,,F,,In vitro inhibition of 2008/R ovarian cancer cell line,,N,1,1,,BAO_0000219
125,Homo sapiens,Intermediate,CHEMBL615349,561.0,,80613,,F,,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,,N,1,1,,BAO_0000219
126,Homo sapiens,Intermediate,CHEMBL615350,389.0,,80614,,F,,In vitro inhibition of 2008/S ovarian cancer cell line,,N,1,1,,BAO_0000219
127,Homo sapiens,Intermediate,CHEMBL615351,389.0,,80614,,F,,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,,N,1,1,,BAO_0000219
128,Homo sapiens,Expert,CHEMBL615352,,,100256,,B,,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,,S,2,1,,BAO_0000220
129,Homo sapiens,Intermediate,CHEMBL615353,,,100256,,B,,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,,S,2,1,,BAO_0000220
130,,Expert,CHEMBL615354,,,100256,,B,,Inhibition of chymotrypsin-like activity of 20S proteasome,,S,2,1,,BAO_0000220
131,,Expert,CHEMBL615355,,,100256,,B,,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,S,2,1,,BAO_0000220
132,,Intermediate,CHEMBL615356,,,100256,,B,,Inhibitory activity against 20S proteosome,,S,2,1,,BAO_0000220
133,Homo sapiens,Autocuration,CHEMBL615357,,,22226,,B,,Compound was tested for inhibitory activity against tryptase,,U,0,1,,BAO_0000019
134,Homo sapiens,Intermediate,CHEMBL615358,726.0,,81020,,F,,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,,N,1,1,,BAO_0000219
135,Homo sapiens,Intermediate,CHEMBL827086,726.0,,81020,,F,,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,,N,1,1,,BAO_0000219
136,,Autocuration,CHEMBL615359,,,22226,,B,,Compound was tested for the inhibition of Alpha-glucosidase,,U,0,1,,BAO_0000019
137,,Autocuration,CHEMBL615360,,,235,,B,,Inhibitory concentration against human neutrophil elastase (HNE),,H,8,1,,BAO_0000357
138,Rattus norvegicus,Autocuration,CHEMBL615361,,,22226,948.0,F,,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,,U,0,1,,BAO_0000218
139,,Autocuration,CHEMBL615362,,,19640,,F,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,H,8,1,,BAO_0000019
140,,Expert,CHEMBL615363,,,19640,,F,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,H,8,1,,BAO_0000019
141,,Autocuration,CHEMBL615364,,,19640,,B,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,H,8,1,,BAO_0000357
142,,Expert,CHEMBL615365,,,19640,,F,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,H,8,1,,BAO_0000019
143,Mus musculus,Intermediate,CHEMBL615366,524.0,,80360,,F,,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,,N,1,1,,BAO_0000219
144,Mus musculus,Intermediate,CHEMBL615367,524.0,,80360,,F,,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,,N,1,1,,BAO_0000219
145,Homo sapiens,Intermediate,CHEMBL615368,554.0,,80384,,F,,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,,N,1,1,,BAO_0000219
146,Ovis aries,Autocuration,CHEMBL615369,,,22226,,F,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,,U,0,1,,BAO_0000019
147,Ovis aries,Autocuration,CHEMBL615370,,,22226,,F,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,,U,0,1,,BAO_0000019
148,,Autocuration,CHEMBL615673,,,191,,B,,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,H,8,1,,BAO_0000357
149,Homo sapiens,Autocuration,CHEMBL615674,,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,,U,0,1,,BAO_0000019
150,Homo sapiens,Autocuration,CHEMBL615675,,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,,U,0,1,,BAO_0000019
151,Homo sapiens,Autocuration,CHEMBL615676,635.0,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,,U,0,1,,BAO_0000219
152,Homo sapiens,Autocuration,CHEMBL615677,635.0,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,,U,0,1,,BAO_0000219
153,Homo sapiens,Autocuration,CHEMBL615678,635.0,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,,U,0,1,,BAO_0000219
154,Homo sapiens,Autocuration,CHEMBL615679,635.0,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,,U,0,1,,BAO_0000219
155,Homo sapiens,Autocuration,CHEMBL615680,,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,,U,0,1,,BAO_0000019
156,Homo sapiens,Autocuration,CHEMBL615681,,,22226,,F,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,,U,0,1,,BAO_0000019
157,,Autocuration,CHEMBL857972,,,104290,,B,,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,H,6,1,,BAO_0000249
158,Streptococcus pyogenes,Intermediate,CHEMBL857899,,,50264,,F,,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,,N,1,1,,BAO_0000218
159,Human herpesvirus 3,Intermediate,CHEMBL615371,,,50527,,F,,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),,N,1,1,,BAO_0000218
160,vericilla zoster virus,Expert,CHEMBL615372,468.0,,50527,,F,,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,,N,1,1,,BAO_0000218
161,vericilla zoster virus,Intermediate,CHEMBL615373,,,50527,,F,,Antiviral activity against 07/1 strain of VZV; ND: No data,,N,1,1,,BAO_0000218
162,vericilla zoster virus,Intermediate,CHEMBL615374,,,50527,,F,,Antiviral activity against 07/1 strain of VZV; ND=No data,,N,1,1,,BAO_0000218
163,escherichia cloac,Intermediate,CHEMBL615375,,,50145,,F,,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",,N,1,1,,BAO_0000218
164,,Autocuration,CHEMBL615376,,,22226,,B,,Ratio of Ki at A2 to Ki at A1 receptors,,U,0,1,,BAO_0000019
165,Candida albicans,Expert,CHEMBL615377,,,11143,,B,,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",,H,8,1,,BAO_0000249
166,Candida glabrata CBS 138,Expert,CHEMBL615378,,,18077,,B,,"Inhibition of 1,3-beta-glucan synthase",,H,8,1,,BAO_0000357
167,Homo sapiens,Intermediate,CHEMBL615379,832.0,,80609,,F,,Inhibition of growth of 1-87 human tumor cell line,,N,1,1,,BAO_0000219
168,Rattus norvegicus,Expert,CHEMBL615380,,,12166,,B,,Inhibition of 1-lipoxygenase (LOX)in RBL cells,,D,9,1,,BAO_0000219
169,Glycine max,Autocuration,CHEMBL615381,,,100171,,B,,Inhibitory activity against soybean 1-lipoxygenase (SLO),,D,9,1,,BAO_0000357
170,Glycine max,Autocuration,CHEMBL615382,,,100171,,B,,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,,D,9,1,,BAO_0000357
171,Glycine max,Autocuration,CHEMBL615383,,,100171,,B,,% inhibition against soybean 1-lipoxygenase (SLO),,D,9,1,,BAO_0000357
172,Glycine max,Autocuration,CHEMBL615384,,,100171,,B,,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,,D,9,1,,BAO_0000357
173,Glycine max,Autocuration,CHEMBL615385,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,,D,9,1,,BAO_0000357
174,Glycine max,Autocuration,CHEMBL615386,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,,D,9,1,,BAO_0000357
175,Glycine max,Autocuration,CHEMBL615387,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,,D,9,1,,BAO_0000357
176,Glycine max,Autocuration,CHEMBL615388,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,,D,9,1,,BAO_0000357
177,Glycine max,Autocuration,CHEMBL615214,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,,D,9,1,,BAO_0000357
178,Glycine max,Autocuration,CHEMBL827087,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,,D,9,1,,BAO_0000357
179,Glycine max,Autocuration,CHEMBL615215,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,,D,9,1,,BAO_0000357
180,Glycine max,Autocuration,CHEMBL615216,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,,D,9,1,,BAO_0000357
181,Glycine max,Autocuration,CHEMBL615217,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,,D,9,1,,BAO_0000357
182,Glycine max,Autocuration,CHEMBL615218,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,,D,9,1,,BAO_0000357
183,Glycine max,Autocuration,CHEMBL615219,,,100171,,B,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,,D,9,1,,BAO_0000357
184,Mus musculus,Autocuration,CHEMBL615220,,,22226,,B,,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,,U,0,1,,BAO_0000019
185,Mus musculus,Intermediate,CHEMBL615221,294.0,,80049,,F,,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),,N,1,1,,BAO_0000219
186,,Intermediate,CHEMBL615222,,,22226,,F,,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,,U,0,1,,BAO_0000019
187,,Autocuration,CHEMBL615223,,,11489,,B,,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,H,8,1,,BAO_0000357
188,,Autocuration,CHEMBL615224,,,11862,,B,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,H,8,1,,BAO_0000357
189,,Autocuration,CHEMBL615225,,,11862,,B,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,H,8,1,,BAO_0000357
190,,Autocuration,CHEMBL615226,,,11489,,B,,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,H,8,1,,BAO_0000357
191,,Autocuration,CHEMBL615227,,,11862,,B,,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,H,8,1,,BAO_0000357
192,Bos taurus,Expert,CHEMBL615228,,,12347,,F,,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,,D,9,1,,BAO_0000019
193,Rattus norvegicus,Expert,CHEMBL615229,,,100120,,B,,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,,D,9,1,,BAO_0000357
194,Rattus norvegicus,Expert,CHEMBL615230,,,100120,2369.0,B,,Inhibition of 11 beta-hydroxylase from rat adrenal gland,,D,9,1,,BAO_0000357
195,Rattus norvegicus,Expert,CHEMBL615231,,,100120,,B,,Inhibition of rat adrenal 11-beta-hydroxylase,,D,9,1,,BAO_0000357
196,Rattus norvegicus,Expert,CHEMBL884520,,,100120,,B,,Inhibition of rat adrenal 11-beta-hydroxylase,,D,9,1,,BAO_0000357
197,Rattus norvegicus,Expert,CHEMBL615232,,,100120,,B,,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,,D,9,1,,BAO_0000357
198,,Autocuration,CHEMBL615233,,,10328,,B,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,H,8,1,,BAO_0000019
199,,Autocuration,CHEMBL827088,,,11490,,B,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,H,8,1,,BAO_0000357
200,,Autocuration,CHEMBL615234,,,11490,,B,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,H,8,1,,BAO_0000357
201,,Autocuration,CHEMBL615235,,,11134,,F,,Compound was tested for the percent of inhibition against 12-LO at 10 uM,,H,8,1,,BAO_0000019
202,,Autocuration,CHEMBL615236,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,8,1,,BAO_0000019
203,,Autocuration,CHEMBL615237,,,11134,,B,,Compound was tested in vitro for inhibition of 12-LO human platelet,,H,8,1,,BAO_0000019
204,,Autocuration,CHEMBL615238,,,11134,,F,,Inhibitory concentration against human platelet 12-lipoxygenase,,H,8,1,,BAO_0000019
205,,Autocuration,CHEMBL615239,,,11134,,B,,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,H,8,1,,BAO_0000019
206,Homo sapiens,Autocuration,CHEMBL615240,,,11134,,F,,Inhibitory concentration against human platelet 12-lipoxygenase,,D,9,1,,BAO_0000019
207,,Expert,CHEMBL615241,,,11835,,B,,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,H,8,1,,BAO_0000019
208,,Expert,CHEMBL615242,,,11601,,B,,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,H,8,1,,BAO_0000357
209,,Autocuration,CHEMBL615243,,,11134,,B,,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,H,8,1,,BAO_0000019
210,,Autocuration,CHEMBL615244,,,11134,,B,,Inhibitory activity against human platelet 12-lipoxygenase,,H,8,1,,BAO_0000019
211,,Autocuration,CHEMBL615245,,,11134,,B,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,,H,8,1,,BAO_0000019
212,,Autocuration,CHEMBL615246,,,11134,,B,,% inhibition against human platelet 12-lipoxygenase (12-HLO),,H,8,1,,BAO_0000019
213,,Autocuration,CHEMBL615247,,,11134,,B,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,,H,8,1,,BAO_0000019
214,,Autocuration,CHEMBL615248,,,11134,,B,,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,H,8,1,,BAO_0000019
215,,Autocuration,CHEMBL615249,,,11601,,B,,Inhibitory activity towards porcine 12-lipoxygenase,,H,8,1,,BAO_0000357
216,,Autocuration,CHEMBL615250,,,11601,,B,,Tested for inhibition against porcine 12-LO,,H,8,1,,BAO_0000357
217,,Autocuration,CHEMBL615251,,,12052,,B,,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,,H,8,1,,BAO_0000019
218,,Autocuration,CHEMBL615252,,,12052,,B,,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,,H,8,1,,BAO_0000019
219,,Expert,CHEMBL828340,,,12052,,B,,In vitro inhibition of rat platelet 12-lipoxygenase,,H,8,1,,BAO_0000019
220,,Autocuration,CHEMBL615253,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,8,1,,BAO_0000019
221,,Autocuration,CHEMBL615254,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,,H,8,1,,BAO_0000019
222,,Autocuration,CHEMBL615255,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,,H,8,1,,BAO_0000019
223,,Autocuration,CHEMBL615256,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,8,1,,BAO_0000019
224,,Autocuration,CHEMBL615257,,,12052,,B,,In vitro inhibitory activity against rat platelet 12-lipoxygenase,,H,8,1,,BAO_0000019
225,,Autocuration,CHEMBL615258,,,12052,,B,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,,H,8,1,,BAO_0000019
226,Homo sapiens,Intermediate,CHEMBL615259,621.0,,80007,,F,,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,,N,1,1,,BAO_0000219
227,Homo sapiens,Expert,CHEMBL615260,621.0,,80007,,F,,In vitro antitumor activity against 41M cell line.,,N,1,1,,BAO_0000219
228,Homo sapiens,Intermediate,CHEMBL615261,621.0,,80007,,F,,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,,N,1,1,,BAO_0000219
229,Homo sapiens,Intermediate,CHEMBL615262,621.0,,80007,,F,,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,,N,1,1,,BAO_0000219
230,Homo sapiens,Expert,CHEMBL615263,621.0,,80007,,F,,In vitro antitumor activity against 41McisR cell line.,,N,1,1,,BAO_0000219
231,Homo sapiens,Expert,CHEMBL838393,621.0,,80007,,F,,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,,N,1,1,,BAO_0000219
232,Homo sapiens,Intermediate,CHEMBL615264,621.0,,80007,,F,,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,,N,1,1,,BAO_0000219
233,Homo sapiens,Expert,CHEMBL615265,,,84,,B,,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),,D,9,1,,BAO_0000357
234,Homo sapiens,Expert,CHEMBL615266,,,68,,B,,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,D,9,1,,BAO_0000357
235,,Expert,CHEMBL615267,,,68,,B,,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,H,8,1,,BAO_0000357
236,,Expert,CHEMBL615268,,,10201,,B,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,,H,8,1,,BAO_0000357
237,,Expert,CHEMBL615269,,,10201,,B,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,H,8,1,,BAO_0000357
238,,Expert,CHEMBL615270,,,10201,,B,,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,,H,8,1,,BAO_0000357
239,,Autocuration,CHEMBL615271,,,12220,,B,,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,H,8,1,,BAO_0000357
240,Escherichia coli,Autocuration,CHEMBL615272,,,11303,,B,,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,H,8,1,,BAO_0000357
241,Escherichia coli,Autocuration,CHEMBL615103,,,11303,,B,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,H,8,1,,BAO_0000357
242,Escherichia coli,Autocuration,CHEMBL615104,,,11303,,B,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",,H,8,1,,BAO_0000357
243,,Autocuration,CHEMBL615105,,,12220,,B,,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,H,8,1,,BAO_0000357
244,,Autocuration,CHEMBL872866,,,12220,,B,,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",,H,8,1,,BAO_0000357
245,Sus scrofa,Autocuration,CHEMBL615106,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,8,1,,BAO_0000357
246,Sus scrofa,Autocuration,CHEMBL615107,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",,H,8,1,,BAO_0000019
247,Sus scrofa,Autocuration,CHEMBL615108,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",,H,8,1,,BAO_0000357
248,Sus scrofa,Autocuration,CHEMBL615109,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",,H,8,1,,BAO_0000357
249,Sus scrofa,Autocuration,CHEMBL615110,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,8,1,,BAO_0000357
250,Sus scrofa,Autocuration,CHEMBL840105,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,H,8,1,,BAO_0000019
251,Sus scrofa,Autocuration,CHEMBL615111,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",,H,8,1,,BAO_0000019
252,Sus scrofa,Autocuration,CHEMBL615112,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",,H,8,1,,BAO_0000019
253,Sus scrofa,Autocuration,CHEMBL615113,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",,H,8,1,,BAO_0000019
254,Sus scrofa,Autocuration,CHEMBL615114,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",,H,8,1,,BAO_0000019
255,Sus scrofa,Autocuration,CHEMBL615115,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,8,1,,BAO_0000357
256,Sus scrofa,Autocuration,CHEMBL615116,,,11303,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,H,8,1,,BAO_0000019
257,,Autocuration,CHEMBL615698,,,11303,,B,,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",,H,8,1,,BAO_0000357
258,Sus scrofa,Autocuration,CHEMBL615699,,,22226,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",,U,0,1,,BAO_0000019
259,Sus scrofa,Autocuration,CHEMBL615700,,,22226,,B,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",,U,0,1,,BAO_0000019
260,Saccharomyces cerevisiae,Expert,CHEMBL615701,,,100249,,B,,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,,H,8,1,,BAO_0000357
261,Rattus norvegicus,Autocuration,CHEMBL615702,,,22226,,B,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,U,0,1,,BAO_0000019
262,Rattus norvegicus,Autocuration,CHEMBL615703,,,22226,,B,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,U,0,1,,BAO_0000019
263,Rattus norvegicus,Autocuration,CHEMBL615704,,,22226,,B,,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",,U,0,1,,BAO_0000019
264,,Autocuration,CHEMBL615705,,,104698,,F,,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,H,6,1,,BAO_0000019
265,,Autocuration,CHEMBL615706,,,104698,,F,,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,H,6,1,,BAO_0000019
266,Cavia porcellus,Intermediate,CHEMBL615707,,,20033,2116.0,F,,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,,D,9,1,,BAO_0000221
267,,Expert,CHEMBL615708,,,10623,,F,,Stimulatory activity of intragastric pressure was tested in the rat,,H,8,1,,BAO_0000019
268,,Autocuration,CHEMBL615709,,,121,,B,,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,,H,8,1,,BAO_0000357
269,Rattus norvegicus,Autocuration,CHEMBL615710,,,22226,,F,,Dose to reduce neuronal firing against 5-HT cells in rats (iv),,U,0,1,,BAO_0000218
270,,Autocuration,CHEMBL615711,,,12688,,F,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,H,8,1,,BAO_0000019
271,Homo sapiens,Expert,CHEMBL615712,,,121,,B,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,,D,9,1,,BAO_0000357
272,Homo sapiens,Expert,CHEMBL836325,,,121,,B,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,,D,9,1,,BAO_0000357
273,,Autocuration,CHEMBL615713,,,12198,,F,,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,H,8,1,,BAO_0000019
274,,Autocuration,CHEMBL615714,,,12198,,B,,Inhibition constant of high-affinity 5-HT uptake,,H,8,1,,BAO_0000357
275,,Autocuration,CHEMBL615715,,,12198,,F,,Michaelis-Menten constant was reported for high affinity transport of 5-HT,,H,8,1,,BAO_0000019
276,,Autocuration,CHEMBL615716,,,12198,,F,,Maximum rate was determined for high affinity transport of 5-HT,,H,8,1,,BAO_0000019
277,,Autocuration,CHEMBL615717,,,104714,,F,,Compound was tested for agonistic activity against 5-HT uptake,,H,4,1,,BAO_0000019
278,,Expert,CHEMBL881818,,,10577,,B,,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,,H,8,1,,BAO_0000019
279,Bos taurus,Expert,CHEMBL884540,,,105,,B,,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,,H,8,1,,BAO_0000357
280,Rattus norvegicus,Autocuration,CHEMBL615718,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,D,5,1,,BAO_0000224
281,,Autocuration,CHEMBL615719,,,104744,,B,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,,H,4,1,,BAO_0000224
282,,Autocuration,CHEMBL615720,,,104744,,B,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,Membranes,H,4,1,,BAO_0000249
283,,Autocuration,CHEMBL615721,,,104744,,B,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,Membranes,H,4,1,,BAO_0000249
284,,Autocuration,CHEMBL615722,,,104744,,B,,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,4,1,,BAO_0000019
285,,Autocuration,CHEMBL615723,,,51,,F,,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,,H,8,1,,BAO_0000019
286,,Autocuration,CHEMBL615724,,,51,10000000.0,B,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
287,,Autocuration,CHEMBL615725,,,51,10000000.0,B,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
288,,Autocuration,CHEMBL615726,,,51,10000000.0,B,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
289,,Autocuration,CHEMBL615727,,,10576,,F,,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,H,8,1,,BAO_0000218
290,Cavia porcellus,Intermediate,CHEMBL615728,,,105570,,F,,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,,D,9,1,,BAO_0000019
291,,Autocuration,CHEMBL857971,449.0,,279,,B,,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
292,,Autocuration,CHEMBL615729,,,107,,B,,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
293,Rattus norvegicus,Expert,CHEMBL615730,,,12687,,F,,Efficacy against 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000019
294,,Expert,CHEMBL615731,,,12687,,F,,Intrinsic activity towards 5-HT2A receptor of rat tail artery,,H,8,1,,BAO_0000019
295,,Expert,CHEMBL615732,,,12687,,F,,Relative potency towards 5-HT2A receptor of rat tail artery,,H,8,1,,BAO_0000019
296,,Expert,CHEMBL615733,,,12687,,F,,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,,H,8,1,,BAO_0000019
297,,Expert,CHEMBL615734,,,12687,,F,,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,H,8,1,,BAO_0000019
298,,Autocuration,CHEMBL615735,,,12687,,F,,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,H,8,1,,BAO_0000019
299,,Expert,CHEMBL615736,,,12687,,F,,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,H,8,1,,BAO_0000019
300,Cavia porcellus,Intermediate,CHEMBL615737,,,20033,2116.0,F,,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,D,9,1,,BAO_0000221
301,Cavia porcellus,Intermediate,CHEMBL615738,,,20033,2116.0,F,,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),,D,9,1,,BAO_0000221
302,Cavia porcellus,Intermediate,CHEMBL615739,,,20033,2116.0,F,,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,D,9,1,,BAO_0000221
303,,Autocuration,CHEMBL615278,,,10623,,B,,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,,H,8,1,,BAO_0000357
304,Rattus norvegicus,Expert,CHEMBL615279,,,10623,,F,,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,D,9,1,,BAO_0000019
305,,Expert,CHEMBL615280,,,168,,B,,Binding affinity against 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
306,Gallus gallus,Autocuration,CHEMBL615281,,,22226,,B,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,,U,0,1,,BAO_0000019
307,Homo sapiens,Autocuration,CHEMBL615282,,,22226,,F,,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,,U,0,1,,BAO_0000019
308,Homo sapiens,Autocuration,CHEMBL615283,,,22226,,F,,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,,U,0,1,,BAO_0000019
309,Homo sapiens,Autocuration,CHEMBL615284,649.0,,80156,,B,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,,N,1,1,,BAO_0000219
310,Homo sapiens,Autocuration,CHEMBL615285,,,22226,,B,,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,,U,0,1,,BAO_0000019
311,Homo sapiens,Autocuration,CHEMBL615286,,,22226,,B,,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,,U,0,1,,BAO_0000019
312,Homo sapiens,Autocuration,CHEMBL615287,,,104703,,B,,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,,D,7,1,,BAO_0000219
313,,Intermediate,CHEMBL615288,,,100256,,F,,Chymotryptic inhibitory activity against 26S proteasome,,S,2,1,,BAO_0000220
314,,Intermediate,CHEMBL615289,,,100256,,B,,Inhibitory activity against 26S proteasome degradation of IkB,,S,2,1,,BAO_0000220
315,Homo sapiens,Intermediate,CHEMBL615290,478.0,,81034,,F,,In vitro inhibition of 2780/DOX ovarian cancer cell line,,N,1,1,,BAO_0000219
316,Homo sapiens,Intermediate,CHEMBL884522,478.0,,81034,,F,,In vitro inhibition of 2780/S ovarian cancer cell line,,N,1,1,,BAO_0000219
317,Homo sapiens,Autocuration,CHEMBL615291,,,22226,,F,,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,,U,0,1,,BAO_0000019
318,,Intermediate,CHEMBL615292,,,22222,,B,,Association constant for binding to AATT 28-mer AATT hairpin,,M,3,1,,BAO_0000225
319,,Intermediate,CHEMBL615293,,,22222,,B,,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,M,3,1,,BAO_0000225
320,,Intermediate,CHEMBL615294,,,22222,,B,,Reaction Rate Parameter for 28-mer AATT hairpin,,M,3,1,,BAO_0000225
321,,Intermediate,CHEMBL615295,,,22222,,B,,Reaction Rate Parameter for 28-mer AATT hairpin,,M,3,1,,BAO_0000225
322,Homo sapiens,Autocuration,CHEMBL825021,,,22226,,F,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),,U,0,1,,BAO_0000019
323,Homo sapiens,Autocuration,CHEMBL615296,,,22226,,F,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),,U,0,1,,BAO_0000019
324,Homo sapiens,Autocuration,CHEMBL615297,,,22226,,F,,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,,U,0,1,,BAO_0000019
325,Cricetulus griseus,Autocuration,CHEMBL615298,,,22226,,F,,Cytotoxicity against cell line 2SC/20 determined by MTT test,,U,0,1,,BAO_0000019
326,Cricetulus griseus,Autocuration,CHEMBL615299,,,22226,,F,,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,,U,0,1,,BAO_0000019
327,Cricetulus griseus,Autocuration,CHEMBL615300,,,22226,,F,,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,,U,0,1,,BAO_0000019
328,,Autocuration,CHEMBL615301,,,241,,B,,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,,H,8,1,,BAO_0000357
329,Homo sapiens,Expert,CHEMBL615302,,,241,,B,,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,,D,9,1,,BAO_0000357
330,Rattus norvegicus,Autocuration,CHEMBL615303,,,22226,,B,,Selectivity ratio of ID50 in liver and heart,,U,0,1,,BAO_0000019
331,,Autocuration,CHEMBL615304,,,12132,,B,,"Selectivity, ratio of relative ID50 in liver and heart",,H,8,1,,BAO_0000019
332,,Autocuration,CHEMBL615305,,,12132,,B,,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,H,8,1,,BAO_0000019
333,,Autocuration,CHEMBL615306,,,12132,,B,,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000218
334,,Autocuration,CHEMBL615307,,,12132,,B,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000218
335,,Autocuration,CHEMBL615308,,,12132,,B,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000218
336,,Autocuration,CHEMBL615309,,,12132,,F,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000218
337,,Autocuration,CHEMBL615310,,,22226,,B,,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",,U,0,1,,BAO_0000019
338,,Autocuration,CHEMBL615311,,,12132,,B,,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,H,8,1,,BAO_0000019
339,Homo sapiens,Autocuration,CHEMBL615312,,,22226,,B,,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",,U,0,1,,BAO_0000019
340,,Autocuration,CHEMBL615313,,,12132,,B,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,H,8,1,,BAO_0000019
341,,Autocuration,CHEMBL615314,,,12132,,F,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,H,8,1,,BAO_0000019
342,,Autocuration,CHEMBL615315,,,12132,,B,,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000019
343,Rattus norvegicus,Autocuration,CHEMBL615316,,,22226,,B,,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",,U,0,1,,BAO_0000218
344,,Autocuration,CHEMBL615317,,,12132,,B,,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,,H,8,1,,BAO_0000218
345,,Autocuration,CHEMBL615318,,,12132,,B,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000218
346,Rattus norvegicus,Autocuration,CHEMBL615319,,,22226,,B,,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",,U,0,1,,BAO_0000218
347,,Autocuration,CHEMBL615320,,,12132,,B,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000019
348,,Autocuration,CHEMBL615321,,,12132,,F,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,H,8,1,,BAO_0000019
349,Rattus norvegicus,Autocuration,CHEMBL615322,,,22226,,B,,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",,U,0,1,,BAO_0000019
350,Escherichia coli,Autocuration,CHEMBL615323,,,19690,,B,,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,H,8,1,,BAO_0000357
351,Escherichia coli,Autocuration,CHEMBL615407,,,19690,,B,,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,H,8,1,,BAO_0000357
352,Escherichia coli,Autocuration,CHEMBL857267,,,19690,,B,,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,H,8,1,,BAO_0000357
353,Escherichia coli,Autocuration,CHEMBL615408,,,19690,,B,,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,H,8,1,,BAO_0000357
354,,Autocuration,CHEMBL615409,,,19690,,B,,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,H,8,1,,BAO_0000357
355,,Autocuration,CHEMBL615410,,,19690,,B,,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,H,8,1,,BAO_0000357
356,,Autocuration,CHEMBL615411,,,19690,,B,,Inhibition constant against 3-dehydroquinate synthase,,H,8,1,,BAO_0000357
357,,Autocuration,CHEMBL615412,,,19690,,B,,Association rate constant against 3-dehydroquinate synthase,,H,8,1,,BAO_0000357
358,,Autocuration,CHEMBL615413,,,19690,,B,,Rate constant against 3-dehydroquinate synthase,,H,8,1,,BAO_0000357
359,,Autocuration,CHEMBL615414,,,22226,,B,,Inhibitory activity against fuc-TVII,,U,0,1,,BAO_0000019
360,Rattus norvegicus,Autocuration,CHEMBL615415,,,12236,2107.0,B,,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
361,Rattus norvegicus,Autocuration,CHEMBL615416,,,12236,2107.0,B,,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
362,Rattus norvegicus,Autocuration,CHEMBL615417,,,12236,2107.0,B,,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
363,Rattus norvegicus,Autocuration,CHEMBL615418,,,12236,2107.0,B,,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
364,Rattus norvegicus,Autocuration,CHEMBL615419,,,12236,2107.0,B,,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
365,Rattus norvegicus,Autocuration,CHEMBL615420,,,12236,2107.0,B,,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,Microsomes,D,9,1,,BAO_0000251
366,Rattus norvegicus,Autocuration,CHEMBL615421,,,12236,2107.0,B,,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,Microsomes,D,9,1,,BAO_0000251
367,Rattus norvegicus,Autocuration,CHEMBL615422,,,12236,2107.0,B,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,Microsomes,D,9,1,,BAO_0000251
368,Rattus norvegicus,Autocuration,CHEMBL615423,,,12236,2107.0,B,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,Microsomes,D,9,1,,BAO_0000251
369,Rattus norvegicus,Autocuration,CHEMBL872868,,,12236,2107.0,B,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,Microsomes,D,9,1,,BAO_0000251
370,Rattus norvegicus,Autocuration,CHEMBL615424,,,12236,2107.0,B,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,Microsomes,D,9,1,,BAO_0000251
371,,Autocuration,CHEMBL825022,,,104832,,B,,Inhibitory activity against 3-phosphoglycerate kinase.,,H,4,1,,BAO_0000224
372,,Autocuration,CHEMBL615425,,,104832,,B,,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,,H,4,1,,BAO_0000224
373,,Autocuration,CHEMBL615426,,,104832,,B,,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,H,4,1,,BAO_0000224
374,Homo sapiens,Expert,CHEMBL615427,,,10612,,B,,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,,D,9,1,,BAO_0000357
375,Homo sapiens,Intermediate,CHEMBL615428,844.0,,80616,,F,,Cytotoxicity on 3677 melanoma cells,,N,1,1,,BAO_0000219
376,Homo sapiens,Intermediate,CHEMBL615429,844.0,,80616,,F,,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,,N,1,1,,BAO_0000219
377,Mus musculus,Intermediate,CHEMBL615430,700.0,,80617,,F,,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,,N,1,1,,BAO_0000219
378,Homo sapiens,Intermediate,CHEMBL615431,,,22226,,F,,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,,U,0,1,,BAO_0000019
379,,Autocuration,CHEMBL615432,798.0,,22226,,F,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,,U,0,1,,BAO_0000218
380,,Autocuration,CHEMBL615433,798.0,,22226,,F,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,,U,0,1,,BAO_0000218
381,Human rhinovirus 14,Expert,CHEMBL615434,,,12464,,F,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,,D,9,1,,BAO_0000019
382,Human rhinovirus sp.,Intermediate,CHEMBL615435,,,50085,,F,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,,N,1,1,,BAO_0000218
383,human rhinovirus type 14,Intermediate,CHEMBL615436,,,50679,,F,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,,N,1,1,,BAO_0000218
384,human rhinovirus type 14,Intermediate,CHEMBL615437,,,50679,,F,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,,N,1,1,,BAO_0000218
385,Human rhinovirus 14,Expert,CHEMBL615438,,,12464,,F,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,9,1,,BAO_0000019
386,Human rhinovirus 14,Expert,CHEMBL615439,,,12464,,F,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,9,1,,BAO_0000019
387,Human rhinovirus 14,Expert,CHEMBL615440,,,12464,,F,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,9,1,,BAO_0000019
388,Human rhinovirus 14,Expert,CHEMBL615441,,,12464,,F,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,,D,9,1,,BAO_0000019
389,Enterovirus,Intermediate,CHEMBL615641,,,50665,,F,,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,,N,1,1,,BAO_0000218
390,Enterovirus,Intermediate,CHEMBL872065,,,50665,,F,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,,N,1,1,,BAO_0000218
391,Enterovirus,Intermediate,CHEMBL825023,,,50665,,F,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,,N,1,1,,BAO_0000218
392,Enterovirus,Intermediate,CHEMBL615642,,,50665,,F,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,,N,1,1,,BAO_0000218
393,Human rhinovirus B,Expert,CHEMBL615643,,,12464,,B,,Inhibition of human rhinovirus 3C protease,,H,8,1,,BAO_0000357
394,Homo sapiens,Autocuration,CHEMBL615644,,,22226,,B,,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,,U,0,1,,BAO_0000019
395,Mus musculus,Intermediate,CHEMBL615645,833.0,,80619,,F,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),,N,1,1,,BAO_0000218
396,Mus musculus,Intermediate,CHEMBL615646,833.0,,80619,,F,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),,N,1,1,,BAO_0000218
397,Mus musculus,Intermediate,CHEMBL615647,833.0,,80619,,F,,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),,N,1,1,,BAO_0000218
398,Mus musculus,Intermediate,CHEMBL615648,833.0,,80619,,F,,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),,N,1,1,,BAO_0000218
399,Mus musculus,Intermediate,CHEMBL615649,833.0,,80619,,F,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,,N,1,1,,BAO_0000218
400,Mus musculus,Intermediate,CHEMBL615650,833.0,,80619,,F,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,,N,1,1,,BAO_0000218
401,Mus musculus,Intermediate,CHEMBL615651,847.0,,80620,,F,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,N,1,1,,BAO_0000218
402,Mus musculus,Intermediate,CHEMBL615652,847.0,,80620,,F,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,N,1,1,,BAO_0000218
403,Mus musculus,Expert,CHEMBL615653,847.0,,80620,,F,,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,,N,1,1,,BAO_0000218
404,Mus musculus,Intermediate,CHEMBL615654,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,,N,1,1,,BAO_0000219
405,Mus musculus,Intermediate,CHEMBL615655,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,,N,1,1,,BAO_0000219
406,Mus musculus,Intermediate,CHEMBL825024,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,,N,1,1,,BAO_0000219
407,Mus musculus,Intermediate,CHEMBL615656,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,,N,1,1,,BAO_0000219
408,Mus musculus,Intermediate,CHEMBL615657,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,,N,1,1,,BAO_0000219
409,Mus musculus,Intermediate,CHEMBL615658,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,,N,1,1,,BAO_0000219
410,Mus musculus,Intermediate,CHEMBL615659,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,,N,1,1,,BAO_0000219
411,Mus musculus,Intermediate,CHEMBL615660,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,,N,1,1,,BAO_0000219
412,Mus musculus,Intermediate,CHEMBL615661,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,N,1,1,,BAO_0000219
413,Mus musculus,Intermediate,CHEMBL615662,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,,N,1,1,,BAO_0000219
414,Mus musculus,Intermediate,CHEMBL615663,847.0,,80620,,F,,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,,N,1,1,,BAO_0000219
415,Mus musculus,Intermediate,CHEMBL615664,847.0,,80620,,F,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,,N,1,1,,BAO_0000219
416,Mus musculus,Intermediate,CHEMBL615665,847.0,,80620,,F,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,,N,1,1,,BAO_0000219
417,Mus musculus,Intermediate,CHEMBL615666,847.0,,80620,,F,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,N,1,1,,BAO_0000219
418,Mus musculus,Intermediate,CHEMBL615667,847.0,,80620,,F,,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,,N,1,1,,BAO_0000219
419,Mus musculus,Intermediate,CHEMBL615668,847.0,,80620,,F,,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,,N,1,1,,BAO_0000219
420,Mus musculus,Intermediate,CHEMBL615669,847.0,,80620,,F,,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,,N,1,1,,BAO_0000219
421,Mus musculus,Intermediate,CHEMBL615670,847.0,,80620,,F,,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,,N,1,1,,BAO_0000219
422,Mus musculus,Intermediate,CHEMBL836739,847.0,,80620,,F,,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,,N,1,1,,BAO_0000219
423,Mus musculus,Intermediate,CHEMBL615671,847.0,,80620,,F,,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,,N,1,1,,BAO_0000219
424,Mus musculus,Intermediate,CHEMBL615672,847.0,,80620,,F,,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,,N,1,1,,BAO_0000219
425,Mus musculus,Intermediate,CHEMBL615791,847.0,,80620,,F,,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,,N,1,1,,BAO_0000219
426,Mus musculus,Intermediate,CHEMBL615792,847.0,,80620,,F,,spermine levels in 3LL cells after the treatment of 1 uM of Compound,,N,1,1,,BAO_0000219
427,Mus musculus,Intermediate,CHEMBL615793,847.0,,80620,,F,,spermine levels in 3LL cells after the treatment of 10 uM of Compound,,N,1,1,,BAO_0000219
428,Mus musculus,Intermediate,CHEMBL615794,847.0,,80620,,F,,spermine levels in 3LL cells after the treatment of 250 uM of Compound,,N,1,1,,BAO_0000219
429,Mus musculus,Intermediate,CHEMBL615795,847.0,,80620,,F,,spermine levels in 3LL cells after the treatment of 50 uM of Compound,,N,1,1,,BAO_0000219
430,Homo sapiens,Intermediate,CHEMBL615590,971.0,,80621,,F,,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,,N,1,1,,BAO_0000219
431,,Autocuration,CHEMBL615591,,,22226,,F,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,,U,0,1,,BAO_0000218
432,,Autocuration,CHEMBL615592,,,22226,,F,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,,U,0,1,,BAO_0000218
433,,Autocuration,CHEMBL615593,,,22226,,F,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,U,0,1,,BAO_0000218
434,,Autocuration,CHEMBL615594,,,22226,,F,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,U,0,1,,BAO_0000218
435,Mus musculus,Intermediate,CHEMBL615595,723.0,,80951,,F,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,N,1,1,,BAO_0000219
436,Mus musculus,Intermediate,CHEMBL615596,723.0,,80951,,F,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,N,1,1,,BAO_0000219
437,,Expert,CHEMBL615597,723.0,,11169,,F,,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,,H,8,1,,BAO_0000219
438,Mus musculus,Intermediate,CHEMBL615598,723.0,,80951,,F,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,,N,1,1,,BAO_0000219
439,Mus musculus,Intermediate,CHEMBL615599,723.0,,80951,,F,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,,N,1,1,,BAO_0000219
440,Mus musculus,Expert,CHEMBL615600,723.0,,80951,,F,,Effective dose against murine 3T3 fibroblasts cells,,N,1,1,,BAO_0000219
441,Mus musculus,Expert,CHEMBL615601,723.0,,80951,,F,,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,,N,1,1,,BAO_0000219
442,Mus musculus,Expert,CHEMBL615602,723.0,,80951,,F,,Cytotoxic effect on 3T3 cells,,N,1,1,,BAO_0000219
443,Mus musculus,Expert,CHEMBL615603,723.0,,80951,,F,,Cytotoxic effect on 3T3 cells,,N,1,1,,BAO_0000219
444,Mus musculus,Intermediate,CHEMBL615604,723.0,,80951,,F,,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,,N,1,1,,BAO_0000219
445,Mus musculus,Intermediate,CHEMBL615605,723.0,,80951,,F,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,N,1,1,,BAO_0000219
446,Mus musculus,Intermediate,CHEMBL615606,723.0,,80951,,F,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,,N,1,1,,BAO_0000219
447,Mus musculus,Expert,CHEMBL884526,723.0,,80951,,F,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,,N,1,1,,BAO_0000219
448,Mus musculus,Expert,CHEMBL615607,723.0,,80951,,F,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,,N,1,1,,BAO_0000219
449,Mus musculus,Intermediate,CHEMBL615608,723.0,,80951,,F,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,,N,1,1,,BAO_0000219
450,Mus musculus,Expert,CHEMBL615609,723.0,,80951,,F,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,,N,1,1,,BAO_0000219
451,Mus musculus,Expert,CHEMBL615682,723.0,,80951,,F,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,,N,1,1,,BAO_0000219
452,Mus musculus,Intermediate,CHEMBL615683,723.0,,80951,,F,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,,N,1,1,,BAO_0000219
453,Mus musculus,Expert,CHEMBL615684,723.0,,80951,,F,,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,,N,1,1,,BAO_0000218
454,Mus musculus,Autocuration,CHEMBL615685,,,104860,,F,,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,,D,7,1,,BAO_0000219
455,Mus musculus,Expert,CHEMBL615686,723.0,,80951,,F,,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,,N,1,1,,BAO_0000219
456,Mus musculus,Intermediate,CHEMBL615687,723.0,,80951,,F,,Inhibitory activity against 3T3 cell line,,N,1,1,,BAO_0000219
457,Mus musculus,Intermediate,CHEMBL884523,723.0,,80951,,F,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,,N,1,1,,BAO_0000219
458,,Expert,CHEMBL615688,,,11169,,F,,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,,H,8,1,,BAO_0000019
459,Mus musculus,Intermediate,CHEMBL615689,723.0,,80951,,F,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,,N,1,1,,BAO_0000219
460,Mus musculus,Intermediate,CHEMBL615690,723.0,,80951,,F,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,,N,1,1,,BAO_0000219
461,,Expert,CHEMBL615691,,,11169,,F,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,,H,8,1,,BAO_0000019
462,,Expert,CHEMBL615692,,,11169,,F,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,,H,8,1,,BAO_0000019
463,Mus musculus,Intermediate,CHEMBL615693,723.0,,80951,,F,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,N,1,1,,BAO_0000219
464,Mus musculus,Expert,CHEMBL615324,723.0,,80951,,F,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,,N,1,1,,BAO_0000219
465,Homo sapiens,Expert,CHEMBL615325,723.0,,9,,F,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,,D,9,1,,BAO_0000219
466,Homo sapiens,Expert,CHEMBL615490,723.0,,9,,F,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),,D,9,1,,BAO_0000219
467,Homo sapiens,Expert,CHEMBL615491,723.0,,188,,F,,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,,D,9,1,,BAO_0000219
468,Homo sapiens,Expert,CHEMBL615492,723.0,,188,,F,,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),,D,9,1,,BAO_0000219
469,Mus musculus,Intermediate,CHEMBL615493,723.0,,80951,,F,,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,,N,1,1,,BAO_0000219
470,Mus musculus,Intermediate,CHEMBL615494,723.0,,80951,,F,,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,,N,1,1,,BAO_0000219
471,Mus musculus,Intermediate,CHEMBL615495,723.0,,80951,,F,,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,,N,1,1,,BAO_0000219
472,Mus musculus,Intermediate,CHEMBL615496,723.0,,80951,,F,,Inhibitory concentration was calculated on 3T3 cells by using growth assay,,N,1,1,,BAO_0000219
473,Mus musculus,Intermediate,CHEMBL615497,723.0,,80951,,F,,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,,N,1,1,,BAO_0000219
474,Mus musculus,Expert,CHEMBL615498,723.0,,80951,,F,,Inhibition of Swiss 3T3 mouse fibroblast proliferation,,N,1,1,,BAO_0000219
475,Mus musculus,Intermediate,CHEMBL615499,723.0,,80951,,A,,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,,N,1,1,,BAO_0000219
476,Mus musculus,Expert,CHEMBL835522,723.0,,80951,,F,,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,,N,1,1,,BAO_0000219
477,Mus musculus,Intermediate,CHEMBL615500,723.0,,80951,,F,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,,N,1,1,,BAO_0000219
478,Mus musculus,Intermediate,CHEMBL615501,723.0,,80951,,F,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,1,1,,BAO_0000219
479,Mus musculus,Intermediate,CHEMBL615502,723.0,,80951,,F,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,1,1,,BAO_0000219
480,Mus musculus,Intermediate,CHEMBL615503,723.0,,80951,,F,,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,1,1,,BAO_0000219
481,Mus musculus,Intermediate,CHEMBL615504,723.0,,80951,,F,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,1,1,,BAO_0000219
482,Mus musculus,Intermediate,CHEMBL615505,723.0,,80951,,F,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,1,1,,BAO_0000219
483,Mus musculus,Expert,CHEMBL615506,723.0,,80951,,F,,Inhibition of swiss 3T3 mouse fibroblast proliferation,,N,1,1,,BAO_0000219
484,Mus musculus,Intermediate,CHEMBL615507,723.0,,80951,,F,,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,,N,1,1,,BAO_0000219
485,,Intermediate,CHEMBL615508,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,1,1,,BAO_0000218
486,Mus musculus,Intermediate,CHEMBL615509,620.0,,80006,,F,,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,,N,1,1,,BAO_0000219
487,Mus musculus,Intermediate,CHEMBL615510,620.0,,80006,,F,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,,N,1,1,,BAO_0000219
488,Mus musculus,Intermediate,CHEMBL615511,620.0,,80006,,F,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,,N,1,1,,BAO_0000219
489,Mus musculus,Intermediate,CHEMBL615512,620.0,,80006,,F,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,,N,1,1,,BAO_0000219
490,Mus musculus,Intermediate,CHEMBL615513,620.0,,80006,,F,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",,N,1,1,,BAO_0000218
491,Mus musculus,Intermediate,CHEMBL615514,620.0,,80006,,F,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",,N,1,1,,BAO_0000218
492,,Intermediate,CHEMBL615515,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,,N,1,1,,BAO_0000219
493,,Intermediate,CHEMBL615516,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,N,1,1,,BAO_0000219
494,,Intermediate,CHEMBL615517,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,1,1,,BAO_0000219
495,,Intermediate,CHEMBL615518,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,N,1,1,,BAO_0000219
496,,Intermediate,CHEMBL615519,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,1,1,,BAO_0000219
497,,Intermediate,CHEMBL615520,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,,N,1,1,,BAO_0000218
498,,Intermediate,CHEMBL615521,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,,N,1,1,,BAO_0000218
499,,Intermediate,CHEMBL615522,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,N,1,1,,BAO_0000218
500,,Intermediate,CHEMBL615523,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,1,1,,BAO_0000218
501,,Expert,CHEMBL615524,620.0,,80006,,F,,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,N,1,1,,BAO_0000218
502,,Expert,CHEMBL615525,620.0,,80006,,F,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,1,1,,BAO_0000218
503,,Intermediate,CHEMBL615526,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,N,1,1,,BAO_0000218
504,,Intermediate,CHEMBL615527,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,1,1,,BAO_0000218
505,,Intermediate,CHEMBL615528,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,,N,1,1,,BAO_0000218
506,,Expert,CHEMBL615529,620.0,,80006,,F,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,1,1,,BAO_0000218
507,,Expert,CHEMBL615530,620.0,,80006,,F,,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,1,1,,BAO_0000218
508,,Expert,CHEMBL615531,620.0,,80006,,F,,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,N,1,1,,BAO_0000218
509,,Intermediate,CHEMBL615532,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,N,1,1,,BAO_0000219
510,,Intermediate,CHEMBL615533,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,1,1,,BAO_0000219
511,,Intermediate,CHEMBL615534,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,N,1,1,,BAO_0000219
512,,Intermediate,CHEMBL615535,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,N,1,1,,BAO_0000218
513,,Intermediate,CHEMBL615536,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,1,1,,BAO_0000218
514,,Intermediate,CHEMBL615537,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,1,1,,BAO_0000218
515,,Intermediate,CHEMBL615538,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,1,1,,BAO_0000218
516,,Intermediate,CHEMBL836166,620.0,,80006,,F,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,N,1,1,,BAO_0000218
517,,Expert,CHEMBL615539,620.0,,11214,,F,,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,,H,8,1,,BAO_0000219
518,Mus musculus,Intermediate,CHEMBL615540,620.0,,80006,,F,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,,N,1,1,,BAO_0000219
519,,Expert,CHEMBL615541,620.0,,11214,,F,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,,H,8,1,,BAO_0000219
520,Mus musculus,Expert,CHEMBL615542,620.0,,80006,,F,,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,,N,1,1,,BAO_0000219
521,Mus musculus,Intermediate,CHEMBL615543,620.0,,80006,,F,,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,,N,1,1,,BAO_0000219
522,Mus musculus,Expert,CHEMBL615544,620.0,,80006,,F,,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,,N,1,1,,BAO_0000219
523,Mus musculus,Expert,CHEMBL615545,620.0,,80006,,F,,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,N,1,1,,BAO_0000219
524,Mus musculus,Expert,CHEMBL615546,620.0,,80006,,F,,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,N,1,1,,BAO_0000219
525,Mus musculus,Expert,CHEMBL615547,620.0,,80006,,F,,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,,N,1,1,,BAO_0000219
526,Mus musculus,Expert,CHEMBL615548,620.0,,80006,,F,,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,,N,1,1,,BAO_0000219
527,Mus musculus,Expert,CHEMBL615549,620.0,,80006,,F,,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,,N,1,1,,BAO_0000219
528,Mus musculus,Expert,CHEMBL615550,620.0,,80006,,F,,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,,N,1,1,,BAO_0000219
529,Rattus norvegicus,Intermediate,CHEMBL615551,1118.0,,80622,,F,,Inhibitory activity against rat fibroblast (3Y1) cell line,,N,1,1,,BAO_0000219
530,Rattus norvegicus,Expert,CHEMBL615552,1118.0,,80622,,F,,Mean concentration causing inhibition of cell growth in 3Y1 cells.,,N,1,1,,BAO_0000219
531,Rattus norvegicus,Expert,CHEMBL615553,1118.0,,80622,,F,,Cytotoxicity in 3Y1 cells.,,N,1,1,,BAO_0000219
532,Rattus norvegicus,Expert,CHEMBL615554,1118.0,,80622,,F,,Cytostatic effect in 3Y1 cells.,,N,1,1,,BAO_0000219
533,Rattus norvegicus,Intermediate,CHEMBL615555,1118.0,,80622,,F,,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",,N,1,1,,BAO_0000219
534,Rattus norvegicus,Expert,CHEMBL615556,1118.0,,80622,,F,,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,,N,1,1,,BAO_0000219
535,,Autocuration,CHEMBL615557,,,22226,,B,,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,,U,0,1,,BAO_0000019
536,,Autocuration,CHEMBL615558,,,22226,,B,,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,U,0,1,,BAO_0000019
537,,Autocuration,CHEMBL872066,,,22226,,B,,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,U,0,1,,BAO_0000019
538,Sus scrofa,Expert,CHEMBL615559,,,11607,,B,,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,,D,9,1,,BAO_0000019
539,,Autocuration,CHEMBL615560,,,11607,,B,,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,H,8,1,,BAO_0000019
540,,Autocuration,CHEMBL615561,,,11607,,B,,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,H,8,1,,BAO_0000019
541,,Expert,CHEMBL857062,,,11607,,B,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,H,8,1,,BAO_0000019
542,,Expert,CHEMBL615562,,,11607,,B,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,H,8,1,,BAO_0000019
543,,Autocuration,CHEMBL615563,,,11607,,B,,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,H,8,1,,BAO_0000019
544,,Autocuration,CHEMBL615564,,,11607,,B,,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,H,8,1,,BAO_0000357
545,,Autocuration,CHEMBL615565,,,11607,,B,,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,H,8,1,,BAO_0000019
546,,Autocuration,CHEMBL615566,,,11607,,B,,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,H,8,1,,BAO_0000019
547,Sus scrofa,Expert,CHEMBL615567,,,11607,,B,,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,,D,9,1,,BAO_0000019
548,,Autocuration,CHEMBL615568,,,11607,,B,,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,H,8,1,,BAO_0000019
549,,Autocuration,CHEMBL615569,,,11607,,B,,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,H,8,1,,BAO_0000357
550,,Autocuration,CHEMBL615570,,,11607,,B,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,H,8,1,,BAO_0000019
551,,Autocuration,CHEMBL615571,,,11607,,B,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,H,8,1,,BAO_0000019
552,,Autocuration,CHEMBL615572,,,104733,,B,,Binding affinity against melatonin (MT1) receptor (pC1),,H,4,1,,BAO_0000224
553,,Autocuration,CHEMBL615573,,,22226,,B,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,U,0,1,,BAO_0000019
554,,Autocuration,CHEMBL615574,,,22226,,B,,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,,U,0,1,,BAO_0000019
555,,Autocuration,CHEMBL615575,,,22226,,B,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,,U,0,1,,BAO_0000019
556,,Autocuration,CHEMBL615576,,,10619,,B,,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,,H,8,1,,BAO_0000357
557,,Autocuration,CHEMBL615577,,,10619,,B,,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
558,,Autocuration,CHEMBL615578,,,51,10000000.0,B,,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,,H,8,1,,BAO_0000221
559,,Expert,CHEMBL615579,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
560,,Expert,CHEMBL615580,,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
561,,Expert,CHEMBL615581,,,51,,B,,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,,H,8,1,,BAO_0000019
562,,Autocuration,CHEMBL615582,,,51,10000000.0,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,8,1,,BAO_0000221
563,,Autocuration,CHEMBL615583,,,51,10000000.0,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,8,1,,BAO_0000221
564,,Autocuration,CHEMBL615584,,,51,10000000.0,B,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
565,,Autocuration,CHEMBL833691,,,51,10000000.0,B,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
566,,Autocuration,CHEMBL615585,,,51,10000000.0,B,,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
567,,Autocuration,CHEMBL615586,,,51,10000000.0,B,,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
568,,Autocuration,CHEMBL884524,,,51,10000000.0,B,,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
569,,Autocuration,CHEMBL615587,,,51,10000000.0,B,,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,8,1,,BAO_0000221
570,,Autocuration,CHEMBL615588,,,51,10000000.0,B,,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000221
571,Rattus norvegicus,Expert,CHEMBL615589,,,10576,,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,Membranes,D,9,1,,BAO_0000249
572,Bos taurus,Expert,CHEMBL615442,,,51,10000000.0,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,,H,8,1,,BAO_0000221
573,,Autocuration,CHEMBL615443,,,51,10000000.0,B,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,H,8,1,,BAO_0000221
574,,Autocuration,CHEMBL615444,,,51,10000000.0,B,,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,H,8,1,,BAO_0000221
575,,Expert,CHEMBL615445,,,51,10000000.0,B,,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,,H,8,1,,BAO_0000221
576,,Autocuration,CHEMBL615446,,,51,10000000.0,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,H,8,1,,BAO_0000221
577,,Autocuration,CHEMBL615447,449.0,,51,,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,,H,8,1,,BAO_0000219
578,,Expert,CHEMBL615448,,,51,10000000.0,B,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,8,1,,BAO_0000221
579,,Expert,CHEMBL615449,,,51,10000000.0,B,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,8,1,,BAO_0000221
580,,Autocuration,CHEMBL615450,449.0,,51,,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,8,1,,BAO_0000219
581,,Expert,CHEMBL615451,,,51,10000000.0,B,,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000221
582,,Autocuration,CHEMBL615452,,,51,,B,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,H,8,1,,BAO_0000357
583,,Autocuration,CHEMBL615453,,,51,10000000.0,B,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
584,,Autocuration,CHEMBL615454,,,51,10000000.0,B,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
585,,Autocuration,CHEMBL615455,,,51,10000000.0,B,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
586,,Autocuration,CHEMBL615456,,,51,10000000.0,B,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
587,,Autocuration,CHEMBL615457,,,51,10000000.0,B,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
588,,Expert,CHEMBL615458,,,51,10000000.0,B,,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,,H,8,1,,BAO_0000218
589,,Expert,CHEMBL615459,,,51,10000000.0,B,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
590,Homo sapiens,Expert,CHEMBL615460,449.0,,51,,B,,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",,D,9,1,,BAO_0000219
591,Cavia porcellus,Autocuration,CHEMBL615461,,,51,,F,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,,H,8,1,,BAO_0000019
592,Cavia porcellus,Autocuration,CHEMBL615462,,,51,,F,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,,H,8,1,,BAO_0000019
593,Cavia porcellus,Autocuration,CHEMBL615463,,,51,10000000.0,F,,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,,H,8,1,,BAO_0000221
594,Cavia porcellus,Autocuration,CHEMBL615464,,,51,2116.0,B,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,H,8,1,,BAO_0000221
595,Cavia porcellus,Autocuration,CHEMBL615465,,,51,2116.0,B,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,8,1,,BAO_0000221
596,Cavia porcellus,Autocuration,CHEMBL615466,,,51,2116.0,B,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,H,8,1,,BAO_0000221
597,Cavia porcellus,Autocuration,CHEMBL615467,,,51,2116.0,B,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,8,1,,BAO_0000221
598,Cavia porcellus,Autocuration,CHEMBL615468,,,51,2116.0,B,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,8,1,,BAO_0000221
599,Cavia porcellus,Autocuration,CHEMBL615469,,,51,2116.0,B,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,,H,8,1,,BAO_0000221
600,Cavia porcellus,Autocuration,CHEMBL615470,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
601,Cavia porcellus,Autocuration,CHEMBL615471,,,51,,B,,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
602,Cavia porcellus,Autocuration,CHEMBL615472,,,51,,B,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
603,Cavia porcellus,Autocuration,CHEMBL883242,,,106,10000000.0,B,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,H,8,1,,BAO_0000221
604,Cavia porcellus,Autocuration,CHEMBL615473,,,106,10000000.0,F,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,H,8,1,,BAO_0000221
605,Cricetulus griseus,Autocuration,CHEMBL615474,449.0,,11863,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,H,8,1,,BAO_0000218
606,,Autocuration,CHEMBL615475,,,51,,B,,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
607,,Autocuration,CHEMBL615476,308.0,,51,,F,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,,H,8,1,,BAO_0000219
608,,Autocuration,CHEMBL615477,308.0,,51,,F,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,,H,8,1,,BAO_0000219
609,,Autocuration,CHEMBL615478,,,51,,F,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
610,,Autocuration,CHEMBL615160,449.0,,51,,F,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
611,,Expert,CHEMBL615161,449.0,,51,,F,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
612,,Autocuration,CHEMBL615162,449.0,,51,,F,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,,H,8,1,,BAO_0000219
613,,Autocuration,CHEMBL615163,449.0,,51,,F,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,,H,8,1,,BAO_0000219
614,,Expert,CHEMBL615164,449.0,,51,,B,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
615,,Expert,CHEMBL615165,449.0,,51,,B,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
616,,Autocuration,CHEMBL615166,449.0,,51,,B,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,,H,8,1,,BAO_0000219
617,,Autocuration,CHEMBL615167,,,51,,F,,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,H,8,1,,BAO_0000219
618,Homo sapiens,Expert,CHEMBL615168,308.0,,51,,B,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,D,9,1,,BAO_0000219
619,Homo sapiens,Expert,CHEMBL615169,308.0,,51,,B,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,,D,9,1,,BAO_0000219
620,Homo sapiens,Expert,CHEMBL615170,449.0,,51,,B,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000219
621,Homo sapiens,Expert,CHEMBL615171,449.0,,51,,B,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,,D,9,1,,BAO_0000219
622,,Autocuration,CHEMBL615694,,,51,,F,,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
623,,Autocuration,CHEMBL615695,,,51,,F,,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
624,,Autocuration,CHEMBL615696,,,51,,F,,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000019
625,,Autocuration,CHEMBL615697,449.0,,51,,F,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,8,1,,BAO_0000219
626,Homo sapiens,Expert,CHEMBL859410,449.0,,51,,F,,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,D,9,1,,BAO_0000219
627,,Autocuration,CHEMBL615841,449.0,,51,,F,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,H,8,1,,BAO_0000219
628,Homo sapiens,Expert,CHEMBL615842,449.0,,51,,F,,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,D,9,1,,BAO_0000219
629,,Autocuration,CHEMBL835003,449.0,,51,,F,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,8,1,,BAO_0000219
630,,Autocuration,CHEMBL615843,449.0,,51,,F,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,H,8,1,,BAO_0000219
631,Homo sapiens,Expert,CHEMBL615979,449.0,,51,,F,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,D,9,1,,BAO_0000219
632,,Autocuration,CHEMBL615980,449.0,,51,,F,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,H,8,1,,BAO_0000219
633,Homo sapiens,Expert,CHEMBL615981,449.0,,51,,F,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,D,9,1,,BAO_0000219
634,Homo sapiens,Expert,CHEMBL615982,,,51,,F,,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,D,9,1,,BAO_0000019
635,Homo sapiens,Expert,CHEMBL615983,,,51,,F,,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,9,1,,BAO_0000019
636,Homo sapiens,Expert,CHEMBL615984,,,51,,F,,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",,D,9,1,,BAO_0000019
637,Homo sapiens,Expert,CHEMBL615985,,,51,,F,,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",,D,9,1,,BAO_0000019
638,,Autocuration,CHEMBL615986,449.0,,51,,F,,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,8,1,,BAO_0000219
639,,Autocuration,CHEMBL615987,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,8,1,,BAO_0000219
640,,Autocuration,CHEMBL615988,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,H,8,1,,BAO_0000219
641,,Expert,CHEMBL615989,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,8,1,,BAO_0000219
642,,Autocuration,CHEMBL615990,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,H,8,1,,BAO_0000219
643,,Autocuration,CHEMBL615991,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,,H,8,1,,BAO_0000219
644,,Autocuration,CHEMBL615992,449.0,,51,,F,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,8,1,,BAO_0000219
645,,Autocuration,CHEMBL615993,449.0,,51,,F,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,,H,8,1,,BAO_0000219
646,,Expert,CHEMBL615994,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,8,1,,BAO_0000219
647,,Autocuration,CHEMBL615995,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,,H,8,1,,BAO_0000219
648,,Autocuration,CHEMBL615996,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,8,1,,BAO_0000219
649,,Autocuration,CHEMBL615997,449.0,,51,,F,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,H,8,1,,BAO_0000219
650,,Autocuration,CHEMBL615998,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,8,1,,BAO_0000019
651,,Autocuration,CHEMBL615999,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,8,1,,BAO_0000019
652,,Autocuration,CHEMBL616000,,,51,,F,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,H,8,1,,BAO_0000019
653,,Autocuration,CHEMBL616001,722.0,,51,,F,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,8,1,,BAO_0000219
654,Homo sapiens,Expert,CHEMBL616002,,,51,,F,,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",,D,9,1,,BAO_0000019
655,,Expert,CHEMBL616003,,,51,,F,,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",,H,8,1,,BAO_0000019
656,Homo sapiens,Expert,CHEMBL616004,,,51,,F,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000019
657,Homo sapiens,Expert,CHEMBL616005,,,51,,F,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,,D,9,1,,BAO_0000019
658,,Autocuration,CHEMBL616006,,,51,,F,,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,8,1,,BAO_0000019
659,,Expert,CHEMBL616007,,,51,,F,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",,H,8,1,,BAO_0000019
660,,Autocuration,CHEMBL616008,,,51,,F,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,8,1,,BAO_0000019
661,,Autocuration,CHEMBL616009,,,51,,F,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,8,1,,BAO_0000019
662,,Expert,CHEMBL616010,,,51,,F,,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",,H,8,1,,BAO_0000019
663,Homo sapiens,Expert,CHEMBL616011,,,51,,F,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",,D,9,1,,BAO_0000019
664,Homo sapiens,Expert,CHEMBL615740,,,51,,F,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",,D,9,1,,BAO_0000019
665,,Autocuration,CHEMBL615741,,,51,,F,,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000019
666,,Expert,CHEMBL615742,,,51,,F,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,H,8,1,,BAO_0000019
667,,Autocuration,CHEMBL615743,,,51,,F,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",,H,8,1,,BAO_0000019
668,,Autocuration,CHEMBL615744,449.0,,51,,F,,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,H,8,1,,BAO_0000219
669,,Expert,CHEMBL615745,449.0,,51,,F,,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,,H,8,1,,BAO_0000219
670,,Autocuration,CHEMBL615746,,,51,,B,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
671,,Autocuration,CHEMBL615747,,,51,,B,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
672,,Autocuration,CHEMBL615748,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,8,1,,BAO_0000019
673,,Autocuration,CHEMBL615749,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",,H,8,1,,BAO_0000019
674,,Autocuration,CHEMBL615750,,,51,,F,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,H,8,1,,BAO_0000019
675,Homo sapiens,Expert,CHEMBL616259,,,51,,F,,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000019
676,,Autocuration,CHEMBL616260,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,8,1,,BAO_0000019
677,Homo sapiens,Expert,CHEMBL616261,,,51,,F,,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,,D,9,1,,BAO_0000019
678,Homo sapiens,Expert,CHEMBL616262,,,51,,F,,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,9,1,,BAO_0000019
679,Homo sapiens,Expert,CHEMBL616263,,,51,,F,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,D,9,1,,BAO_0000019
680,Homo sapiens,Expert,CHEMBL616264,,,51,,F,,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,,D,9,1,,BAO_0000019
681,Homo sapiens,Expert,CHEMBL616265,,,51,,F,,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,,D,9,1,,BAO_0000019
682,Homo sapiens,Expert,CHEMBL616266,,,51,,F,,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,9,1,,BAO_0000019
683,Homo sapiens,Expert,CHEMBL616267,,,51,,F,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,D,9,1,,BAO_0000019
684,Homo sapiens,Expert,CHEMBL616268,,,51,,F,,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,,D,9,1,,BAO_0000019
685,Homo sapiens,Expert,CHEMBL616269,,,51,,B,,Inhibition of human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
686,,Autocuration,CHEMBL884528,449.0,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
687,,Expert,CHEMBL616270,722.0,,105,,B,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,,D,9,1,,BAO_0000219
688,,Autocuration,CHEMBL616271,449.0,,51,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
689,,Autocuration,CHEMBL616272,449.0,,51,,F,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
690,,Expert,CHEMBL616273,,,51,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,,H,8,1,,BAO_0000357
691,Homo sapiens,Expert,CHEMBL616274,,,51,,B,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
692,,Autocuration,CHEMBL616275,449.0,,51,,B,,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
693,,Autocuration,CHEMBL616276,449.0,,51,,B,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
694,Rattus norvegicus,Autocuration,CHEMBL616277,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,U,0,1,,BAO_0000218
695,Rattus norvegicus,Autocuration,CHEMBL616278,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,,U,0,1,,BAO_0000218
696,Rattus norvegicus,Autocuration,CHEMBL616279,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,,U,0,1,,BAO_0000218
697,Rattus norvegicus,Autocuration,CHEMBL616280,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,U,0,1,,BAO_0000218
698,Rattus norvegicus,Autocuration,CHEMBL616281,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,,U,0,1,,BAO_0000218
699,Rattus norvegicus,Autocuration,CHEMBL616282,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,U,0,1,,BAO_0000218
700,Rattus norvegicus,Autocuration,CHEMBL616283,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,,U,0,1,,BAO_0000218
701,Rattus norvegicus,Autocuration,CHEMBL616284,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,,U,0,1,,BAO_0000218
702,Rattus norvegicus,Autocuration,CHEMBL616285,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,,U,0,1,,BAO_0000218
703,Rattus norvegicus,Autocuration,CHEMBL616286,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,,U,0,1,,BAO_0000218
704,Rattus norvegicus,Autocuration,CHEMBL616287,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,,U,0,1,,BAO_0000218
705,Rattus norvegicus,Autocuration,CHEMBL616288,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,,U,0,1,,BAO_0000218
706,Rattus norvegicus,Autocuration,CHEMBL616289,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,,U,0,1,,BAO_0000218
707,Rattus norvegicus,Autocuration,CHEMBL615610,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,,U,0,1,,BAO_0000218
708,Rattus norvegicus,Autocuration,CHEMBL615611,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,,U,0,1,,BAO_0000218
709,Rattus norvegicus,Autocuration,CHEMBL615612,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,,U,0,1,,BAO_0000218
710,Rattus norvegicus,Autocuration,CHEMBL615613,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,,U,0,1,,BAO_0000218
711,Rattus norvegicus,Autocuration,CHEMBL615614,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,,U,0,1,,BAO_0000218
712,Rattus norvegicus,Autocuration,CHEMBL615615,,,22226,,F,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,U,0,1,,BAO_0000218
713,,Autocuration,CHEMBL615616,,,105093,,B,,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,,H,4,1,,BAO_0000019
714,,Autocuration,CHEMBL615617,,,11923,1898.0,B,,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,,H,8,1,,BAO_0000249
715,,Autocuration,CHEMBL615618,,,10577,,B,,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,H,8,1,,BAO_0000019
716,,Autocuration,CHEMBL615619,,,10577,,B,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,,H,8,1,,BAO_0000019
717,,Expert,CHEMBL615620,,,10577,,B,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,H,8,1,,BAO_0000019
718,,Autocuration,CHEMBL615621,,,55,,B,,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",,H,8,1,,BAO_0000357
719,,Autocuration,CHEMBL615622,,,55,,B,,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,H,8,1,,BAO_0000357
720,,Autocuration,CHEMBL615623,,,12166,,F,,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,H,8,1,,BAO_0000019
721,,Autocuration,CHEMBL615624,,,12166,,F,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,8,1,,BAO_0000019
722,,Autocuration,CHEMBL615625,,,12166,,F,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,8,1,,BAO_0000019
723,,Autocuration,CHEMBL767045,,,12166,,F,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,8,1,,BAO_0000019
724,Cavia porcellus,Autocuration,CHEMBL615626,,,55,,F,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,,H,8,1,,BAO_0000019
725,Cavia porcellus,Autocuration,CHEMBL615627,,,55,,F,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,,H,8,1,,BAO_0000019
726,Cavia porcellus,Autocuration,CHEMBL615628,,,55,,B,,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,,H,8,1,,BAO_0000019
727,Cavia porcellus,Autocuration,CHEMBL615629,,,55,,B,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,,H,8,1,,BAO_0000357
728,Homo sapiens,Expert,CHEMBL615630,,,55,,B,,Inhibitory concentration against 5-lipoxygenase from human whole blood,,D,9,1,,BAO_0000357
729,,Autocuration,CHEMBL615631,,,55,,B,,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,H,8,1,,BAO_0000219
730,,Autocuration,CHEMBL615632,,,17087,,F,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,H,8,1,,BAO_0000218
731,,Autocuration,CHEMBL615633,,,17087,,B,,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,,H,8,1,,BAO_0000357
732,,Autocuration,CHEMBL615634,,,17087,,F,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,H,8,1,,BAO_0000218
733,Sus scrofa,Expert,CHEMBL615635,,,55,,B,,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,,H,8,1,,BAO_0000019
734,,Expert,CHEMBL615636,,,12166,,B,,In vitro inhibition of rat 5-Lipoxygenase,,H,8,1,,BAO_0000357
735,Rattus norvegicus,Expert,CHEMBL615637,,,12166,,B,,Inhibitory activity against 5-Lipoxygenase,,D,9,1,,BAO_0000357
736,,Expert,CHEMBL615638,702.0,,12166,,B,,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,,H,8,1,,BAO_0000219
737,,Autocuration,CHEMBL615639,702.0,,12166,,B,,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),,H,8,1,,BAO_0000219
738,,Autocuration,CHEMBL615640,702.0,,12166,,B,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,,H,8,1,,BAO_0000219
739,,Autocuration,CHEMBL615796,,,12166,,B,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,H,8,1,,BAO_0000019
740,,Autocuration,CHEMBL615845,,,12166,,B,,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,H,8,1,,BAO_0000219
741,,Autocuration,CHEMBL615846,,,12166,,B,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,H,8,1,,BAO_0000357
742,,Autocuration,CHEMBL615847,702.0,,12166,,B,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,,H,8,1,,BAO_0000219
743,,Autocuration,CHEMBL615848,,,12166,,B,,The compound was tested for inhibition of isolated 5-Lipoxygenase,,H,8,1,,BAO_0000357
744,Rattus norvegicus,Autocuration,CHEMBL615849,,,22226,,B,,Ratio of IC50 against 5-LO and COX,,U,0,1,,BAO_0000019
745,,Autocuration,CHEMBL615850,,,12166,,B,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,H,8,1,,BAO_0000357
746,,Autocuration,CHEMBL615851,,,12166,,B,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,H,8,1,,BAO_0000357
747,,Autocuration,CHEMBL615852,,,12166,,B,,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,,H,8,1,,BAO_0000219
748,,Autocuration,CHEMBL615853,,,12166,,F,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,H,8,1,,BAO_0000019
749,,Autocuration,CHEMBL884527,,,120,2367.0,B,,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,H,8,1,,BAO_0000357
750,Columba livia,Autocuration,CHEMBL872871,,,22226,,B,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,,U,0,1,,BAO_0000019
751,Columba livia,Autocuration,CHEMBL615854,,,22226,,B,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,,U,0,1,,BAO_0000019
752,Columba livia,Autocuration,CHEMBL767046,,,22226,,B,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,,U,0,1,,BAO_0000019
753,,Autocuration,CHEMBL615855,,,10732,,B,,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,,H,8,1,,BAO_0000357
754,Rattus norvegicus,Expert,CHEMBL615856,,,12198,,F,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,,D,9,1,,BAO_0000019
755,Rattus norvegicus,Expert,CHEMBL615857,,,12198,,F,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,D,9,1,,BAO_0000019
756,Rattus norvegicus,Expert,CHEMBL615858,,,12198,,F,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,D,9,1,,BAO_0000019
757,,Expert,CHEMBL615859,,,10576,10000000.0,B,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,H,8,1,,BAO_0000221
758,,Autocuration,CHEMBL615860,,,51,,B,,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,H,8,1,,BAO_0000357
759,Oryctolagus cuniculus,Autocuration,CHEMBL615861,,,22226,,B,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,U,0,1,,BAO_0000019
760,Oryctolagus cuniculus,Autocuration,CHEMBL615862,,,22226,,B,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,U,0,1,,BAO_0000019
761,Oryctolagus cuniculus,Autocuration,CHEMBL615863,,,22226,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,,U,0,1,,BAO_0000019
762,Oryctolagus cuniculus,Autocuration,CHEMBL615864,,,22226,,B,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,U,0,1,,BAO_0000019
763,,Autocuration,CHEMBL615865,,,104744,10000000.0,B,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,4,1,,BAO_0000221
764,,Autocuration,CHEMBL615866,,,104744,10000000.0,B,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,4,1,,BAO_0000221
765,,Autocuration,CHEMBL615867,,,104744,10000000.0,B,,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,4,1,,BAO_0000221
766,,Autocuration,CHEMBL615868,,,104744,,B,,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,Membranes,H,4,1,,BAO_0000249
767,Rattus norvegicus,Autocuration,CHEMBL615869,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,,D,5,1,,BAO_0000249
768,Rattus norvegicus,Autocuration,CHEMBL615870,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,,D,5,1,,BAO_0000019
769,Rattus norvegicus,Autocuration,CHEMBL615871,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,,D,5,1,,BAO_0000019
770,,Autocuration,CHEMBL615872,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,,H,4,1,,BAO_0000224
771,,Autocuration,CHEMBL833492,,,104744,10000000.0,B,,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,,H,4,1,,BAO_0000221
772,,Autocuration,CHEMBL615873,,,104744,10000000.0,B,,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,,H,4,1,,BAO_0000221
773,,Autocuration,CHEMBL615479,,,104744,,B,,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,H,4,1,,BAO_0000224
774,,Autocuration,CHEMBL615480,,,104744,,B,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,H,4,1,,BAO_0000019
775,Rattus norvegicus,Autocuration,CHEMBL615481,,,104744,,B,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,,D,5,1,,BAO_0000249
776,,Autocuration,CHEMBL872869,,,104744,,B,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,4,1,,BAO_0000019
777,,Autocuration,CHEMBL615482,,,104744,,B,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,4,1,,BAO_0000019
778,,Autocuration,CHEMBL615483,,,104744,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,4,1,,BAO_0000221
779,,Autocuration,CHEMBL615484,,,104744,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,4,1,,BAO_0000221
780,,Autocuration,CHEMBL615485,,,104744,,B,,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,,H,4,1,,BAO_0000019
781,Rattus norvegicus,Autocuration,CHEMBL615486,,,104744,,B,,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,,D,5,1,,BAO_0000224
782,,Autocuration,CHEMBL615487,,,104744,,B,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,,H,4,1,,BAO_0000224
783,,Autocuration,CHEMBL615488,,,104744,,B,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,4,1,,BAO_0000224
784,,Autocuration,CHEMBL615489,,,104744,,B,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,4,1,,BAO_0000224
785,,Autocuration,CHEMBL615389,,,104744,,B,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,4,1,,BAO_0000224
786,,Autocuration,CHEMBL615390,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,H,4,1,,BAO_0000019
787,,Autocuration,CHEMBL615391,,,104744,,B,,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,H,4,1,,BAO_0000019
788,,Autocuration,CHEMBL615392,,,104744,,B,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,H,4,1,,BAO_0000224
789,Rattus norvegicus,Autocuration,CHEMBL615393,,,22226,,B,,Affinity for 5-hydroxytryptamine 1 receptor,,U,0,1,,BAO_0000019
790,,Autocuration,CHEMBL615394,,,104744,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,,H,4,1,,BAO_0000221
791,,Autocuration,CHEMBL615395,,,104744,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,4,1,,BAO_0000221
792,,Autocuration,CHEMBL615396,,,104744,,B,,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,H,4,1,,BAO_0000224
793,,Autocuration,CHEMBL615397,,,104744,955.0,B,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,,H,4,1,,BAO_0000221
794,,Autocuration,CHEMBL615398,,,104744,,B,,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,4,1,,BAO_0000019
795,Rattus norvegicus,Autocuration,CHEMBL615399,,,22226,,B,,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,,U,0,1,,BAO_0000019
796,,Autocuration,CHEMBL615400,,,104744,,B,,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,H,4,1,,BAO_0000019
797,Rattus norvegicus,Autocuration,CHEMBL615401,,,104744,,B,,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,,D,5,1,,BAO_0000019
798,Rattus norvegicus,Autocuration,CHEMBL615402,,,22226,,B,,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,,U,0,1,,BAO_0000019
799,,Autocuration,CHEMBL615403,,,104744,,B,,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,H,4,1,,BAO_0000019
800,,Autocuration,CHEMBL615404,,,104744,955.0,B,,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,H,4,1,,BAO_0000221
801,,Autocuration,CHEMBL615781,,,104744,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,,H,4,1,,BAO_0000019
802,,Autocuration,CHEMBL615782,,,104744,955.0,B,,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,,H,4,1,,BAO_0000220
803,,Autocuration,CHEMBL615783,,,104744,955.0,B,,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,,H,4,1,,BAO_0000221
804,,Autocuration,CHEMBL873481,,,22226,,B,,Compound was tested for binding affinity against 5-HT1 receptor,,U,0,1,,BAO_0000019
805,,Autocuration,CHEMBL615784,,,22226,,B,,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,,U,0,1,,BAO_0000019
806,,Expert,CHEMBL615785,,,10576,,B,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,H,8,1,,BAO_0000357
807,,Autocuration,CHEMBL615786,,,10576,,F,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000249
808,,Autocuration,CHEMBL615787,,,10576,,F,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,H,8,1,,BAO_0000218
809,,Autocuration,CHEMBL615788,,,10576,,F,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,H,8,1,,BAO_0000218
810,,Autocuration,CHEMBL767044,,,10576,,F,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
811,,Autocuration,CHEMBL615789,,,10576,,F,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,H,8,1,,BAO_0000218
812,,Autocuration,CHEMBL615790,,,10576,,F,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,H,8,1,,BAO_0000218
813,,Autocuration,CHEMBL615813,,,10576,,F,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,,H,8,1,,BAO_0000019
814,,Autocuration,CHEMBL615814,,,10576,,F,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,H,8,1,,BAO_0000219
815,,Expert,CHEMBL615815,,,51,,F,,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,,H,8,1,,BAO_0000219
816,,Autocuration,CHEMBL615816,,,10576,,F,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,H,8,1,,BAO_0000219
817,,Expert,CHEMBL615817,,,10576,,B,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,H,8,1,,BAO_0000249
818,,Autocuration,CHEMBL615818,,,10576,10000000.0,B,,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,H,8,1,,BAO_0000221
819,,Autocuration,CHEMBL615819,,,10576,10000000.0,B,,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,H,8,1,,BAO_0000221
820,,Expert,CHEMBL615820,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,Membranes,H,8,1,,BAO_0000249
821,Rattus norvegicus,Expert,CHEMBL615821,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,,D,9,1,,BAO_0000221
822,Rattus norvegicus,Expert,CHEMBL615822,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,D,9,1,,BAO_0000221
823,,Expert,CHEMBL615823,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
824,Rattus norvegicus,Expert,CHEMBL615824,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,,D,9,1,,BAO_0000221
825,Rattus norvegicus,Expert,CHEMBL615825,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,D,9,1,,BAO_0000221
826,,Expert,CHEMBL615826,,,10576,,B,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
827,,Expert,CHEMBL615827,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000249
828,,Expert,CHEMBL615828,,,10576,10000000.0,B,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000249
829,,Expert,CHEMBL615829,,,10576,10000000.0,B,,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
830,,Autocuration,CHEMBL615830,,,10576,10000000.0,B,,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
831,,Expert,CHEMBL615831,,,10576,10000000.0,B,,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,,H,8,1,,BAO_0000221
832,,Autocuration,CHEMBL615832,,,10576,,B,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
833,,Autocuration,CHEMBL615833,,,10576,,B,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,,H,8,1,,BAO_0000019
834,,Autocuration,CHEMBL615834,,,10576,10000000.0,B,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,,H,8,1,,BAO_0000221
835,,Intermediate,CHEMBL615835,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,,H,8,1,,BAO_0000249
836,,Autocuration,CHEMBL615836,,,10576,10000000.0,B,,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,,H,8,1,,BAO_0000249
837,Rattus norvegicus,Expert,CHEMBL615837,,,10576,,B,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,,D,9,1,,BAO_0000019
838,Rattus norvegicus,Expert,CHEMBL615838,,,10576,,B,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,,D,9,1,,BAO_0000019
839,,Expert,CHEMBL615839,,,10576,,B,,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",,H,8,1,,BAO_0000249
840,,Autocuration,CHEMBL884525,,,10576,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,,H,8,1,,BAO_0000019
841,,Autocuration,CHEMBL615840,,,10576,,B,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,H,8,1,,BAO_0000249
842,,Expert,CHEMBL615405,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
843,,Expert,CHEMBL615406,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,8,1,,BAO_0000019
844,,Expert,CHEMBL615900,,,10576,10000000.0,B,,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,H,8,1,,BAO_0000221
845,,Expert,CHEMBL615901,,,10576,10000000.0,B,,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,,H,8,1,,BAO_0000221
846,,Expert,CHEMBL615902,,,10576,,B,,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,,H,8,1,,BAO_0000357
847,,Autocuration,CHEMBL615903,,,10576,10000000.0,B,,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,H,8,1,,BAO_0000221
848,,Autocuration,CHEMBL615904,,,10576,,B,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,,H,8,1,,BAO_0000357
849,,Expert,CHEMBL615905,,,10576,,B,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,H,8,1,,BAO_0000357
850,,Autocuration,CHEMBL615906,,,10576,,B,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,H,8,1,,BAO_0000019
851,,Autocuration,CHEMBL615907,,,10576,,F,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,H,8,1,,BAO_0000019
852,,Expert,CHEMBL615908,,,10576,,B,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,8,1,,BAO_0000019
853,,Autocuration,CHEMBL615909,,,10576,10000000.0,B,,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,H,8,1,,BAO_0000221
854,,Autocuration,CHEMBL615910,,,10576,,B,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,H,8,1,,BAO_0000019
855,,Autocuration,CHEMBL615911,,,10576,,B,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",,H,8,1,,BAO_0000019
856,,Autocuration,CHEMBL615912,,,10576,,B,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",,H,8,1,,BAO_0000019
857,,Expert,CHEMBL615913,,,10576,,B,,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000019
858,,Expert,CHEMBL615914,,,10576,,B,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000357
859,,Autocuration,CHEMBL615915,,,10576,10000000.0,B,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,H,8,1,,BAO_0000221
860,,Autocuration,CHEMBL615916,,,10576,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,H,8,1,,BAO_0000357
861,,Expert,CHEMBL615917,,,10576,,B,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,,H,8,1,,BAO_0000357
862,,Expert,CHEMBL615918,,,10576,,B,,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
863,,Expert,CHEMBL615919,,,10576,10000000.0,B,,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,,H,8,1,,BAO_0000249
864,Rattus norvegicus,Expert,CHEMBL615920,,,10576,10000000.0,B,,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,D,9,1,,BAO_0000221
865,,Autocuration,CHEMBL615921,,,10576,,B,,Inhibition concentration against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
866,,Expert,CHEMBL615922,,,10576,,B,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),,H,8,1,,BAO_0000357
867,Rattus norvegicus,Expert,CHEMBL881290,,,10576,,F,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,D,9,1,,BAO_0000249
868,,Autocuration,CHEMBL615923,,,10576,10000000.0,B,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,H,8,1,,BAO_0000221
869,,Autocuration,CHEMBL615924,,,10576,10000000.0,F,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
870,,Autocuration,CHEMBL615925,,,10576,10000000.0,F,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
871,Rattus norvegicus,Expert,CHEMBL615926,,,10576,,B,,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
872,Rattus norvegicus,Expert,CHEMBL615927,,,10576,,B,,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000019
873,,Autocuration,CHEMBL615928,,,10576,10000000.0,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,8,1,,BAO_0000221
874,Rattus norvegicus,Expert,CHEMBL615929,,,10576,,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,,D,9,1,,BAO_0000357
875,,Autocuration,CHEMBL615930,,,10576,10000000.0,B,,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
876,,Autocuration,CHEMBL615931,449.0,,51,,B,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,8,1,,BAO_0000219
877,,Autocuration,CHEMBL615932,449.0,,51,,F,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
878,,Autocuration,CHEMBL615933,449.0,,51,,F,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
879,,Autocuration,CHEMBL615934,,,51,,B,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
880,,Autocuration,CHEMBL615935,,,51,,B,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,,H,8,1,,BAO_0000357
881,,Autocuration,CHEMBL615936,,,51,,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,8,1,,BAO_0000019
882,,Autocuration,CHEMBL615937,449.0,,51,,B,,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,,H,8,1,,BAO_0000219
883,,Autocuration,CHEMBL615938,,,51,,B,,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
884,,Autocuration,CHEMBL615797,,,51,,B,,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
885,,Autocuration,CHEMBL615798,,,51,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
886,,Autocuration,CHEMBL872870,,,51,,B,,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,,H,8,1,,BAO_0000357
887,,Autocuration,CHEMBL615799,,,51,,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,,H,8,1,,BAO_0000357
888,,Autocuration,CHEMBL615800,,,51,,B,,Percent binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
889,,Autocuration,CHEMBL615801,722.0,,51,,F,,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,8,1,,BAO_0000219
890,,Autocuration,CHEMBL615802,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,H,8,1,,BAO_0000019
891,,Autocuration,CHEMBL615803,,,51,,B,,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,H,8,1,,BAO_0000357
892,,Expert,CHEMBL835002,,,51,,F,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,H,8,1,,BAO_0000019
893,,Autocuration,CHEMBL615804,,,51,,F,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",,H,8,1,,BAO_0000019
894,,Expert,CHEMBL615805,308.0,,51,,B,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
895,,Autocuration,CHEMBL615806,449.0,,51,,B,,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000219
896,Homo sapiens,Expert,CHEMBL615807,,,51,,B,,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,,D,9,1,,BAO_0000357
897,,Autocuration,CHEMBL615808,,,51,,B,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,H,8,1,,BAO_0000357
898,Homo sapiens,Expert,CHEMBL615809,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
899,,Autocuration,CHEMBL615810,308.0,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,,H,8,1,,BAO_0000219
900,,Autocuration,CHEMBL615811,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
901,,Autocuration,CHEMBL615812,449.0,,51,,B,,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,,H,8,1,,BAO_0000219
902,,Autocuration,CHEMBL615751,449.0,,51,,B,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,8,1,,BAO_0000219
903,,Autocuration,CHEMBL615752,,,51,,B,,Binding affinity against human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
904,,Expert,CHEMBL615753,449.0,,51,,B,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,,H,8,1,,BAO_0000219
905,,Autocuration,CHEMBL615754,449.0,,51,,B,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,,H,8,1,,BAO_0000219
906,,Autocuration,CHEMBL615755,,,51,,B,,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
907,Homo sapiens,Expert,CHEMBL615756,449.0,,51,,B,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,D,9,1,,BAO_0000219
908,,Autocuration,CHEMBL615757,,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000019
909,,Autocuration,CHEMBL615758,,,51,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
910,,Expert,CHEMBL615759,,,51,,B,,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,H,8,1,,BAO_0000357
911,,Autocuration,CHEMBL615760,,,51,,B,,Binding affinity towards human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
912,,Expert,CHEMBL615761,308.0,,51,,B,,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,,H,8,1,,BAO_0000219
913,,Autocuration,CHEMBL872104,,,51,,B,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,,H,8,1,,BAO_0000357
914,,Autocuration,CHEMBL615762,,,51,,B,,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
915,,Autocuration,CHEMBL615763,,,51,,B,,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
916,,Autocuration,CHEMBL615764,,,51,,B,,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
917,,Autocuration,CHEMBL615765,1167.0,,51,,B,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),,H,8,1,,BAO_0000219
918,,Autocuration,CHEMBL615766,,,51,,B,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,H,8,1,,BAO_0000019
919,,Autocuration,CHEMBL615767,,,51,,B,,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
920,,Expert,CHEMBL615768,,,51,,B,,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
921,,Autocuration,CHEMBL615769,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
922,,Expert,CHEMBL615770,,,51,,B,,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,H,8,1,,BAO_0000357
923,,Autocuration,CHEMBL615771,,,51,,B,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
924,,Expert,CHEMBL615772,,,51,,B,,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,,H,8,1,,BAO_0000357
925,,Autocuration,CHEMBL615773,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
926,,Expert,CHEMBL615774,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
927,,Autocuration,CHEMBL615775,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
928,,Autocuration,CHEMBL615776,,,51,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
929,,Expert,CHEMBL615777,,,51,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
930,,Autocuration,CHEMBL615778,,,51,,B,,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,H,8,1,,BAO_0000219
931,Homo sapiens,Expert,CHEMBL615779,,,51,,B,,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,D,9,1,,BAO_0000357
932,,Autocuration,CHEMBL615780,,,51,,B,,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
933,,Autocuration,CHEMBL616298,,,51,,B,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
934,,Autocuration,CHEMBL616299,,,51,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
935,,Autocuration,CHEMBL616300,485.0,,51,,B,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
936,,Expert,CHEMBL616301,485.0,,51,,F,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,,H,8,1,,BAO_0000219
937,,Autocuration,CHEMBL616302,,,51,,B,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
938,,Autocuration,CHEMBL616117,,,51,,B,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,H,8,1,,BAO_0000019
939,,Autocuration,CHEMBL616118,,,51,,B,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,H,8,1,,BAO_0000019
940,,Autocuration,CHEMBL616119,,,51,,B,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,H,8,1,,BAO_0000019
941,Homo sapiens,Expert,CHEMBL616120,308.0,,51,,B,,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,D,9,1,,BAO_0000219
942,,Autocuration,CHEMBL616121,,,51,,B,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
943,,Autocuration,CHEMBL616122,,,51,,B,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,H,8,1,,BAO_0000357
944,,Autocuration,CHEMBL616123,,,51,,B,,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
945,Homo sapiens,Expert,CHEMBL616124,,,51,,B,,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
946,,Expert,CHEMBL616125,,,51,,B,,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,H,8,1,,BAO_0000357
947,Rattus norvegicus,Expert,CHEMBL616126,,,51,,B,,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
948,,Autocuration,CHEMBL616127,449.0,,51,,B,,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000219
949,,Expert,CHEMBL616128,,,51,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
950,,Autocuration,CHEMBL616129,,,51,,B,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,H,8,1,,BAO_0000357
951,,Expert,CHEMBL616130,,,51,,B,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
952,,Autocuration,CHEMBL616131,,,51,,B,,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,H,8,1,,BAO_0000357
953,,Autocuration,CHEMBL616132,308.0,,51,,B,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,,H,8,1,,BAO_0000219
954,Homo sapiens,Expert,CHEMBL616133,308.0,,51,,B,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,,D,9,1,,BAO_0000219
955,,Autocuration,CHEMBL616134,,,51,,B,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
956,,Autocuration,CHEMBL616135,,,51,,B,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,,H,8,1,,BAO_0000357
957,Homo sapiens,Expert,CHEMBL616136,,,51,,B,,Affinity for 5-hydroxytryptamine 1A receptor subtype,,D,9,1,,BAO_0000357
958,,Autocuration,CHEMBL616137,,,51,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,H,8,1,,BAO_0000019
959,,Autocuration,CHEMBL872105,,,51,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,H,8,1,,BAO_0000019
960,,Autocuration,CHEMBL616138,,,51,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,H,8,1,,BAO_0000357
961,Homo sapiens,Expert,CHEMBL616139,,,51,,B,,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
962,,Autocuration,CHEMBL616140,,,51,,F,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",,H,8,1,,BAO_0000019
963,,Expert,CHEMBL616141,,,51,,B,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,H,8,1,,BAO_0000019
964,,Autocuration,CHEMBL616142,,,51,,B,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
965,,Autocuration,CHEMBL616143,,,51,,B,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,,H,8,1,,BAO_0000357
966,,Autocuration,CHEMBL616144,308.0,,51,,B,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,8,1,,BAO_0000219
967,,Autocuration,CHEMBL616145,308.0,,51,,B,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,,H,8,1,,BAO_0000219
968,,Autocuration,CHEMBL616012,308.0,,51,,B,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,8,1,,BAO_0000219
969,,Autocuration,CHEMBL616013,308.0,,51,,B,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,8,1,,BAO_0000219
970,,Autocuration,CHEMBL616014,,,51,,F,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,8,1,,BAO_0000019
971,,Autocuration,CHEMBL616015,,,51,,F,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,8,1,,BAO_0000019
972,,Autocuration,CHEMBL616016,,,51,,F,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,8,1,,BAO_0000019
973,,Autocuration,CHEMBL616017,,,51,,F,,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,,H,8,1,,BAO_0000218
974,,Autocuration,CHEMBL616018,,,51,,B,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,H,8,1,,BAO_0000019
975,,Autocuration,CHEMBL616019,,,51,,F,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,H,8,1,,BAO_0000019
976,,Autocuration,CHEMBL616020,,,51,,F,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,H,8,1,,BAO_0000019
977,,Autocuration,CHEMBL858018,,,51,,B,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
978,,Autocuration,CHEMBL616021,722.0,,51,,F,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,8,1,,BAO_0000219
979,,Expert,CHEMBL616022,,,51,,F,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",,H,8,1,,BAO_0000019
980,,Autocuration,CHEMBL616023,,,51,,F,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",,H,8,1,,BAO_0000019
981,,Autocuration,CHEMBL616024,,,51,,F,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",,H,8,1,,BAO_0000019
982,,Autocuration,CHEMBL616025,,,51,,F,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",,H,8,1,,BAO_0000019
983,,Autocuration,CHEMBL616026,449.0,,51,,F,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,8,1,,BAO_0000219
984,,Autocuration,CHEMBL616027,,,51,,F,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",,H,8,1,,BAO_0000019
985,Homo sapiens,Expert,CHEMBL616028,,,51,,F,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",,D,9,1,,BAO_0000019
986,Homo sapiens,Expert,CHEMBL616029,,,51,,F,,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,,D,9,1,,BAO_0000019
987,,Expert,CHEMBL616030,449.0,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,,H,8,1,,BAO_0000219
988,,Expert,CHEMBL616031,,,51,,B,,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,,H,8,1,,BAO_0000019
989,Homo sapiens,Expert,CHEMBL616032,,,51,,F,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,D,9,1,,BAO_0000019
990,Homo sapiens,Expert,CHEMBL616033,,,51,,F,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,D,9,1,,BAO_0000019
991,,Autocuration,CHEMBL616034,,,51,,F,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,8,1,,BAO_0000019
992,,Autocuration,CHEMBL616035,,,51,,F,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,8,1,,BAO_0000019
993,,Autocuration,CHEMBL616036,,,51,,F,,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
994,,Autocuration,CHEMBL616037,,,51,,F,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,8,1,,BAO_0000019
995,,Autocuration,CHEMBL616038,,,51,,F,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,8,1,,BAO_0000019
996,,Autocuration,CHEMBL616039,,,51,,F,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,8,1,,BAO_0000019
997,,Autocuration,CHEMBL616040,,,51,,F,,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
998,Homo sapiens,Expert,CHEMBL616041,308.0,,51,,F,,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,9,1,,BAO_0000219
999,Homo sapiens,Expert,CHEMBL616042,308.0,,51,,F,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,9,1,,BAO_0000219
1000,Homo sapiens,Expert,CHEMBL616043,308.0,,51,,F,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,9,1,,BAO_0000219
1001,,Autocuration,CHEMBL616044,,,51,,F,,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000019
1002,,Autocuration,CHEMBL616045,,,51,,F,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000019
1003,,Autocuration,CHEMBL616046,722.0,,51,,F,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,8,1,,BAO_0000219
1004,,Autocuration,CHEMBL616047,449.0,,51,,F,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,H,8,1,,BAO_0000219
1005,,Autocuration,CHEMBL616048,449.0,,51,,F,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,H,8,1,,BAO_0000219
1006,Homo sapiens,Expert,CHEMBL616049,449.0,,51,,F,,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),,D,9,1,,BAO_0000219
1007,,Autocuration,CHEMBL616050,449.0,,51,,F,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,H,8,1,,BAO_0000219
1008,,Expert,CHEMBL616051,,,51,,F,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,,H,8,1,,BAO_0000219
1009,,Autocuration,CHEMBL616212,,,51,,F,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,,H,8,1,,BAO_0000219
1010,,Autocuration,CHEMBL616213,,,51,,F,,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000019
1011,,Expert,CHEMBL616214,,,51,,B,,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,,H,8,1,,BAO_0000219
1012,,Expert,CHEMBL616215,,,51,,B,,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,,H,8,1,,BAO_0000219
1013,,Autocuration,CHEMBL616216,,,51,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
1014,,Autocuration,CHEMBL616217,,,51,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,8,1,,BAO_0000019
1015,,Autocuration,CHEMBL616218,,,51,,B,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1016,,Autocuration,CHEMBL616219,,,51,,B,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1017,,Autocuration,CHEMBL616220,,,51,,B,,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1018,Homo sapiens,Expert,CHEMBL833493,,,51,,B,,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1019,,Autocuration,CHEMBL616221,,,51,,B,,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1020,Homo sapiens,Expert,CHEMBL616222,449.0,,51,,B,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,D,9,1,,BAO_0000219
1021,,Autocuration,CHEMBL616223,,,51,,F,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
1022,,Autocuration,CHEMBL616224,,,51,,F,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,,H,8,1,,BAO_0000019
1023,,Expert,CHEMBL616225,,,51,,B,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,,H,8,1,,BAO_0000019
1024,Homo sapiens,Expert,CHEMBL616226,722.0,,51,,B,,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,,D,9,1,,BAO_0000219
1025,,Autocuration,CHEMBL616227,722.0,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,,H,8,1,,BAO_0000219
1026,,Autocuration,CHEMBL616228,722.0,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000219
1027,,Autocuration,CHEMBL616229,722.0,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,H,8,1,,BAO_0000219
1028,,Autocuration,CHEMBL616230,722.0,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,,H,8,1,,BAO_0000219
1029,,Autocuration,CHEMBL616231,722.0,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,,H,8,1,,BAO_0000219
1030,,Autocuration,CHEMBL616232,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1031,,Autocuration,CHEMBL616233,722.0,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,H,8,1,,BAO_0000219
1032,,Autocuration,CHEMBL857973,722.0,,51,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,,H,8,1,,BAO_0000219
1033,,Autocuration,CHEMBL616234,,,51,,B,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,,H,8,1,,BAO_0000219
1034,,Autocuration,CHEMBL616235,,,51,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1035,,Expert,CHEMBL616236,308.0,,51,,B,,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,H,8,1,,BAO_0000219
1036,,Expert,CHEMBL616237,,,51,,B,,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,H,8,1,,BAO_0000019
1037,,Autocuration,CHEMBL616238,722.0,,51,,B,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,,H,8,1,,BAO_0000219
1038,,Autocuration,CHEMBL616239,722.0,,51,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,,H,8,1,,BAO_0000219
1039,,Autocuration,CHEMBL616240,,,51,,B,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,,H,8,1,,BAO_0000219
1040,Homo sapiens,Expert,CHEMBL616241,308.0,,51,,B,,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,,D,9,1,,BAO_0000219
1041,,Autocuration,CHEMBL616242,722.0,,51,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,,H,8,1,,BAO_0000219
1042,,Autocuration,CHEMBL616243,722.0,,51,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000219
1043,,Expert,CHEMBL616244,,,51,,B,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1044,Homo sapiens,Autocuration,CHEMBL616245,,,51,,B,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1045,,Autocuration,CHEMBL616246,,,106,,B,,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,H,8,1,,BAO_0000357
1046,,Autocuration,CHEMBL616247,,,105,,B,,Binding affinity against 5-HT1D receptor,,H,8,1,,BAO_0000357
1047,,Autocuration,CHEMBL616248,,,105,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1048,,Autocuration,CHEMBL616249,,,107,,B,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
1049,Homo sapiens,Autocuration,CHEMBL616250,,,10576,,B,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,H,8,1,,BAO_0000357
1050,,Autocuration,CHEMBL616251,,,51,,B,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1051,,Autocuration,CHEMBL616252,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,,H,8,1,,BAO_0000218
1052,,Autocuration,CHEMBL616253,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,,H,8,1,,BAO_0000218
1053,,Autocuration,CHEMBL616254,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,,H,8,1,,BAO_0000218
1054,Mus musculus,Expert,CHEMBL616255,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,,D,9,1,,BAO_0000218
1055,Mus musculus,Expert,CHEMBL832872,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,,D,9,1,,BAO_0000218
1056,Mus musculus,Expert,CHEMBL616256,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,,D,9,1,,BAO_0000218
1057,Mus musculus,Expert,CHEMBL616257,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,,D,9,1,,BAO_0000218
1058,Mus musculus,Expert,CHEMBL616258,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,,D,9,1,,BAO_0000218
1059,Mus musculus,Expert,CHEMBL616384,,,11863,,F,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,,D,9,1,,BAO_0000218
1060,,Autocuration,CHEMBL616385,,,11863,10000000.0,B,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,H,8,1,,BAO_0000221
1061,,Expert,CHEMBL616386,,,11863,,B,,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,,H,8,1,,BAO_0000357
1062,Mus musculus,Expert,CHEMBL616387,,,11863,10000000.0,B,,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,D,9,1,,BAO_0000221
1063,,Autocuration,CHEMBL616388,,,11863,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,H,8,1,,BAO_0000221
1064,Mus musculus,Expert,CHEMBL616389,,,11863,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,D,9,1,,BAO_0000221
1065,,Autocuration,CHEMBL616390,,,11863,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,H,8,1,,BAO_0000221
1066,,Autocuration,CHEMBL616391,,,11863,,B,,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,,H,8,1,,BAO_0000357
1067,Mus musculus,Expert,CHEMBL616392,,,11863,10000000.0,B,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,D,9,1,,BAO_0000221
1068,Sus scrofa,Autocuration,CHEMBL616393,,,51,,B,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1069,Sus scrofa,Autocuration,CHEMBL616394,,,51,,B,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,,H,8,1,,BAO_0000357
1070,Sus scrofa,Autocuration,CHEMBL616395,,,51,,B,,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,,H,8,1,,BAO_0000019
1071,Sus scrofa,Autocuration,CHEMBL616396,,,51,,B,,Compound was evaluated for the binding affinity at 5- HT1A receptor,,H,8,1,,BAO_0000357
1072,Sus scrofa,Autocuration,CHEMBL872907,,,51,,B,,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,H,8,1,,BAO_0000019
1073,Sus scrofa,Autocuration,CHEMBL616397,,,51,,B,,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,H,8,1,,BAO_0000019
1074,Sus scrofa,Autocuration,CHEMBL616398,,,51,,B,,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,,H,8,1,,BAO_0000019
1075,Sus scrofa,Expert,CHEMBL616399,,,51,,B,,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1076,Sus scrofa,Autocuration,CHEMBL857065,,,51,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
1077,Sus scrofa,Expert,CHEMBL616400,,,51,,B,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,H,8,1,,BAO_0000019
1078,Sus scrofa,Autocuration,CHEMBL616401,,,51,,B,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,H,8,1,,BAO_0000019
1079,,Expert,CHEMBL616402,,,10624,,B,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,,H,8,1,,BAO_0000019
1080,Sus scrofa,Expert,CHEMBL616403,,,51,,B,,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
1081,Sus scrofa,Autocuration,CHEMBL616404,,,51,10000000.0,B,,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,,H,8,1,,BAO_0000221
1082,Sus scrofa,Autocuration,CHEMBL616405,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,,H,8,1,,BAO_0000249
1083,Sus scrofa,Autocuration,CHEMBL616406,,,51,,B,,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,,H,8,1,,BAO_0000019
1084,Sus scrofa,Expert,CHEMBL616407,,,51,,F,,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,,H,8,1,,BAO_0000019
1085,Oryctolagus cuniculus,Autocuration,CHEMBL616408,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,,H,8,1,,BAO_0000019
1086,Rattus norvegicus,Expert,CHEMBL616409,,,10576,,B,,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,,D,9,1,,BAO_0000249
1087,Rattus norvegicus,Expert,CHEMBL616410,,,10576,10000000.0,B,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",,D,9,1,,BAO_0000221
1088,,Autocuration,CHEMBL616411,,,10576,,B,,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,,H,8,1,,BAO_0000357
1089,Rattus norvegicus,Expert,CHEMBL616412,,,10576,,F,,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,D,9,1,,BAO_0000249
1090,Rattus norvegicus,Expert,CHEMBL616413,,,10576,10000000.0,F,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,D,9,1,,BAO_0000249
1091,,Autocuration,CHEMBL616414,,,10576,10000000.0,B,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,8,1,,BAO_0000221
1092,Rattus norvegicus,Expert,CHEMBL616415,,,10576,10000000.0,B,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,,D,9,1,,BAO_0000221
1093,,Autocuration,CHEMBL616416,,,10576,,B,,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,,H,8,1,,BAO_0000019
1094,,Expert,CHEMBL616417,,,10576,,B,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000357
1095,,Autocuration,CHEMBL616418,,,10576,,B,,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,,H,8,1,,BAO_0000357
1096,,Autocuration,CHEMBL616419,,,10576,,B,,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,8,1,,BAO_0000219
1097,,Autocuration,CHEMBL616420,,,10576,,B,,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
1098,,Autocuration,CHEMBL616421,,,10576,,B,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,H,8,1,,BAO_0000249
1099,,Autocuration,CHEMBL616422,,,10576,,B,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,H,8,1,,BAO_0000249
1100,,Expert,CHEMBL616423,,,10576,,B,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,Membranes,H,8,1,,BAO_0000249
1101,Rattus norvegicus,Expert,CHEMBL616424,,,10576,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,,D,9,1,,BAO_0000357
1102,,Expert,CHEMBL616425,,,10576,,B,,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1103,,Expert,CHEMBL616426,,,10576,,B,,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,,H,8,1,,BAO_0000357
1104,,Autocuration,CHEMBL616427,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,,H,8,1,,BAO_0000221
1105,,Autocuration,CHEMBL616428,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,,H,8,1,,BAO_0000221
1106,,Autocuration,CHEMBL616290,,,10576,10000000.0,B,,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1107,Rattus norvegicus,Expert,CHEMBL616052,,,10576,,B,,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1108,,Autocuration,CHEMBL616053,,,10576,,B,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1109,,Autocuration,CHEMBL616054,,,10576,,B,,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000249
1110,,Autocuration,CHEMBL616055,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1111,,Autocuration,CHEMBL616056,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,,H,8,1,,BAO_0000357
1112,,Expert,CHEMBL616057,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,H,8,1,,BAO_0000019
1113,Rattus norvegicus,Expert,CHEMBL616058,,,10576,955.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,D,9,1,,BAO_0000221
1114,,Autocuration,CHEMBL616059,,,10576,955.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,H,8,1,,BAO_0000221
1115,,Autocuration,CHEMBL616060,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000249
1116,Rattus norvegicus,Expert,CHEMBL616061,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,,D,9,1,,BAO_0000221
1117,,Expert,CHEMBL616062,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,,H,8,1,,BAO_0000221
1118,,Autocuration,CHEMBL616063,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000249
1119,,Autocuration,CHEMBL616064,,,10576,2435.0,B,,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,H,8,1,,BAO_0000249
1120,Rattus norvegicus,Expert,CHEMBL616065,,,10576,,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,Membranes,D,9,1,,BAO_0000249
1121,Rattus norvegicus,Expert,CHEMBL616066,,,10576,,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,Membranes,D,9,1,,BAO_0000249
1122,,Autocuration,CHEMBL616067,,,10576,10000000.0,B,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1123,,Autocuration,CHEMBL616068,,,10576,10000000.0,B,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,,H,8,1,,BAO_0000221
1124,,Intermediate,CHEMBL616069,,,10576,10000000.0,B,,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1125,,Expert,CHEMBL616070,,,10576,,B,,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,H,8,1,,BAO_0000249
1126,,Autocuration,CHEMBL616071,,,10576,10000000.0,B,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1127,,Expert,CHEMBL616072,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000221
1128,,Autocuration,CHEMBL616073,,,10576,10000000.0,B,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,,H,8,1,,BAO_0000221
1129,,Autocuration,CHEMBL616074,,,10576,10000000.0,B,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,,H,8,1,,BAO_0000221
1130,,Expert,CHEMBL616075,,,10576,,B,,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,,H,8,1,,BAO_0000019
1131,,Autocuration,CHEMBL616076,,,10576,,B,,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1132,Rattus norvegicus,Expert,CHEMBL616077,,,10576,,B,,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,,D,9,1,,BAO_0000019
1133,Rattus norvegicus,Expert,CHEMBL616078,,,10576,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,,D,9,1,,BAO_0000019
1134,Rattus norvegicus,Expert,CHEMBL616079,,,10576,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,,D,9,1,,BAO_0000019
1135,Rattus norvegicus,Expert,CHEMBL616080,485.0,,10576,,B,,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,D,9,1,,BAO_0000219
1136,,Autocuration,CHEMBL616081,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1137,Rattus norvegicus,Expert,CHEMBL616082,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,,D,9,1,,BAO_0000221
1138,,Autocuration,CHEMBL616083,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,,H,8,1,,BAO_0000221
1139,,Autocuration,CHEMBL616084,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,8,1,,BAO_0000019
1140,,Expert,CHEMBL616085,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,,H,8,1,,BAO_0000019
1141,,Autocuration,CHEMBL616086,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,,H,8,1,,BAO_0000019
1142,,Autocuration,CHEMBL616087,,,10576,10000000.0,B,,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",,H,8,1,,BAO_0000221
1143,,Expert,CHEMBL616088,,,10576,,B,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,,H,8,1,,BAO_0000357
1144,,Autocuration,CHEMBL616089,,,10576,,B,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,,H,8,1,,BAO_0000019
1145,Rattus norvegicus,Expert,CHEMBL616090,,,10576,,B,,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,,D,9,1,,BAO_0000357
1146,,Autocuration,CHEMBL616091,,,10576,,B,,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
1147,,Autocuration,CHEMBL616092,,,10576,2435.0,B,,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",Membranes,H,8,1,,BAO_0000249
1148,,Autocuration,CHEMBL616093,,,10576,,B,,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),,H,8,1,,BAO_0000357
1149,,Autocuration,CHEMBL616094,,,10576,,B,,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),,H,8,1,,BAO_0000218
1150,,Autocuration,CHEMBL616095,,,10576,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,,H,8,1,,BAO_0000221
1151,Rattus norvegicus,Expert,CHEMBL616096,,,10576,,B,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1152,,Expert,CHEMBL616097,,,10576,,B,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,,H,8,1,,BAO_0000249
1153,Rattus norvegicus,Expert,CHEMBL616098,,,10576,,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,Membranes,D,9,1,,BAO_0000249
1154,,Autocuration,CHEMBL616099,,,10576,10000000.0,B,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1155,,Autocuration,CHEMBL616100,,,10576,10000000.0,B,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1156,,Expert,CHEMBL616101,,,10576,,B,,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1157,,Expert,CHEMBL616102,,,10576,,B,,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,,H,8,1,,BAO_0000249
1158,,Autocuration,CHEMBL616103,,,10576,,B,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1159,,Expert,CHEMBL616104,,,10576,,B,,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,,H,8,1,,BAO_0000019
1160,,Expert,CHEMBL616105,,,10576,,B,,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000019
1161,Rattus norvegicus,Expert,CHEMBL616106,,,10576,,B,,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000019
1162,,Autocuration,CHEMBL616107,,,10576,,B,,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,,H,8,1,,BAO_0000019
1163,,Expert,CHEMBL616108,,,10576,,B,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,,H,8,1,,BAO_0000357
1164,,Expert,CHEMBL616109,,,10576,10000000.0,B,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,8,1,,BAO_0000221
1165,,Autocuration,CHEMBL616110,,,10576,,B,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,,H,8,1,,BAO_0000357
1166,,Expert,CHEMBL616111,449.0,,10576,,B,,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,,H,8,1,,BAO_0000219
1167,,Expert,CHEMBL616112,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,,H,8,1,,BAO_0000019
1168,,Autocuration,CHEMBL616113,,,10576,10000000.0,B,,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,,H,8,1,,BAO_0000221
1169,,Autocuration,CHEMBL616114,,,10576,,B,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
1170,,Autocuration,CHEMBL616115,,,10576,,B,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
1171,,Autocuration,CHEMBL616116,,,10576,,B,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1172,,Expert,CHEMBL615844,,,10576,955.0,B,,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1173,,Expert,CHEMBL615939,,,10576,10000000.0,B,,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000221
1174,,Expert,CHEMBL615940,,,10576,,B,,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,,H,8,1,,BAO_0000019
1175,,Expert,CHEMBL615941,,,10576,10000000.0,B,,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,,H,8,1,,BAO_0000221
1176,,Autocuration,CHEMBL615942,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,,H,8,1,,BAO_0000221
1177,,Autocuration,CHEMBL615943,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,H,8,1,,BAO_0000221
1178,,Autocuration,CHEMBL615944,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,,H,8,1,,BAO_0000221
1179,,Autocuration,CHEMBL615945,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,,H,8,1,,BAO_0000221
1180,,Autocuration,CHEMBL615946,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,,H,8,1,,BAO_0000221
1181,,Autocuration,CHEMBL615947,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,,H,8,1,,BAO_0000221
1182,,Autocuration,CHEMBL615948,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,,H,8,1,,BAO_0000221
1183,,Autocuration,CHEMBL615949,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,,H,8,1,,BAO_0000221
1184,,Autocuration,CHEMBL615950,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,,H,8,1,,BAO_0000221
1185,,Autocuration,CHEMBL615951,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,,H,8,1,,BAO_0000221
1186,,Autocuration,CHEMBL615952,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,,H,8,1,,BAO_0000221
1187,,Autocuration,CHEMBL615953,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,,H,8,1,,BAO_0000221
1188,,Autocuration,CHEMBL615954,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,,H,8,1,,BAO_0000221
1189,Rattus norvegicus,Expert,CHEMBL615955,,,10576,10000000.0,B,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,D,9,1,,BAO_0000221
1190,,Autocuration,CHEMBL615956,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,,H,8,1,,BAO_0000221
1191,,Autocuration,CHEMBL615957,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,,H,8,1,,BAO_0000221
1192,,Expert,CHEMBL615958,,,10576,,B,,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,,H,8,1,,BAO_0000019
1193,,Expert,CHEMBL615959,,,10576,,B,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,,H,8,1,,BAO_0000019
1194,,Autocuration,CHEMBL615960,,,10576,,B,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),,H,8,1,,BAO_0000019
1195,,Autocuration,CHEMBL615961,,,10576,,B,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),,H,8,1,,BAO_0000019
1196,,Expert,CHEMBL615962,,,10576,955.0,B,,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,H,8,1,,BAO_0000221
1197,,Expert,CHEMBL615963,,,10576,,B,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,,H,8,1,,BAO_0000019
1198,,Autocuration,CHEMBL615964,,,10576,,B,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,,H,8,1,,BAO_0000019
1199,,Autocuration,CHEMBL615965,,,10576,,B,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,,H,8,1,,BAO_0000019
1200,,Expert,CHEMBL615966,449.0,,10576,,B,,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,,H,8,1,,BAO_0000219
1201,,Expert,CHEMBL615967,,,10576,,B,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,,H,8,1,,BAO_0000249
1202,,Expert,CHEMBL615968,,,10576,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000019
1203,,Autocuration,CHEMBL615969,449.0,,10576,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,H,8,1,,BAO_0000218
1204,,Autocuration,CHEMBL615970,,,10576,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),,H,8,1,,BAO_0000218
1205,Rattus norvegicus,Expert,CHEMBL615971,,,10576,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,,D,9,1,,BAO_0000357
1206,,Expert,CHEMBL615972,,,10576,,B,,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,H,8,1,,BAO_0000249
1207,,Autocuration,CHEMBL615973,,,10576,,B,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,,H,8,1,,BAO_0000249
1208,,Autocuration,CHEMBL615974,,,10576,,B,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,,H,8,1,,BAO_0000249
1209,Homo sapiens,Expert,CHEMBL615975,449.0,,51,,B,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,D,9,1,,BAO_0000219
1210,,Expert,CHEMBL615976,,,10576,,B,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,,H,8,1,,BAO_0000249
1211,Rattus norvegicus,Expert,CHEMBL872106,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,,D,9,1,,BAO_0000221
1212,,Autocuration,CHEMBL615977,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1213,,Autocuration,CHEMBL615978,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,,H,8,1,,BAO_0000357
1214,,Autocuration,CHEMBL616166,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,,H,8,1,,BAO_0000357
1215,,Autocuration,CHEMBL616167,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,,H,8,1,,BAO_0000357
1216,,Autocuration,CHEMBL616168,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,,H,8,1,,BAO_0000357
1217,,Autocuration,CHEMBL616169,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,,H,8,1,,BAO_0000357
1218,,Autocuration,CHEMBL616170,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,,H,8,1,,BAO_0000357
1219,,Autocuration,CHEMBL616171,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,,H,8,1,,BAO_0000357
1220,,Autocuration,CHEMBL616172,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,,H,8,1,,BAO_0000357
1221,,Autocuration,CHEMBL616173,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,,H,8,1,,BAO_0000357
1222,,Autocuration,CHEMBL616174,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,,H,8,1,,BAO_0000357
1223,,Autocuration,CHEMBL616175,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,,H,8,1,,BAO_0000357
1224,,Autocuration,CHEMBL616176,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,,H,8,1,,BAO_0000357
1225,,Autocuration,CHEMBL616177,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,,H,8,1,,BAO_0000357
1226,,Autocuration,CHEMBL616178,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,,H,8,1,,BAO_0000357
1227,,Autocuration,CHEMBL616179,,,10576,,B,,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,,H,8,1,,BAO_0000019
1228,,Autocuration,CHEMBL616180,,,10576,,B,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1229,,Autocuration,CHEMBL616181,,,10576,,B,,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
1230,,Autocuration,CHEMBL616182,,,10576,,B,,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,,H,8,1,,BAO_0000019
1231,,Autocuration,CHEMBL616183,,,10576,10000000.0,B,,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000221
1232,,Expert,CHEMBL615874,,,10576,,B,,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,,H,8,1,,BAO_0000019
1233,Rattus norvegicus,Expert,CHEMBL615875,485.0,,10576,,B,,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,D,9,1,,BAO_0000219
1234,,Autocuration,CHEMBL615876,,,10576,,B,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,,H,8,1,,BAO_0000019
1235,,Autocuration,CHEMBL615877,,,10576,,B,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,,H,8,1,,BAO_0000019
1236,,Autocuration,CHEMBL615878,,,10576,,B,,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),,H,8,1,,BAO_0000357
1237,,Expert,CHEMBL615879,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,,H,8,1,,BAO_0000357
1238,,Expert,CHEMBL615880,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,,H,8,1,,BAO_0000357
1239,,Autocuration,CHEMBL615881,,,10576,,B,,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000019
1240,Rattus norvegicus,Expert,CHEMBL615882,,,10576,,B,,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,D,9,1,,BAO_0000019
1241,,Autocuration,CHEMBL615883,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,,H,8,1,,BAO_0000218
1242,,Autocuration,CHEMBL615884,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),,H,8,1,,BAO_0000218
1243,,Autocuration,CHEMBL615885,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),,H,8,1,,BAO_0000218
1244,,Autocuration,CHEMBL615886,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),,H,8,1,,BAO_0000218
1245,,Autocuration,CHEMBL615887,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),,H,8,1,,BAO_0000218
1246,,Autocuration,CHEMBL615888,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),,H,8,1,,BAO_0000218
1247,,Autocuration,CHEMBL615889,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),,H,8,1,,BAO_0000218
1248,,Autocuration,CHEMBL615890,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),,H,8,1,,BAO_0000218
1249,,Autocuration,CHEMBL615891,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),,H,8,1,,BAO_0000218
1250,,Autocuration,CHEMBL615892,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),,H,8,1,,BAO_0000218
1251,,Autocuration,CHEMBL615893,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),,H,8,1,,BAO_0000218
1252,,Autocuration,CHEMBL615894,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),,H,8,1,,BAO_0000218
1253,,Autocuration,CHEMBL615895,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),,H,8,1,,BAO_0000218
1254,,Autocuration,CHEMBL615896,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),,H,8,1,,BAO_0000218
1255,,Autocuration,CHEMBL615897,,,10576,,F,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,,H,8,1,,BAO_0000218
1256,Rattus norvegicus,Expert,CHEMBL615898,,,10576,,F,,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,D,9,1,,BAO_0000249
1257,,Autocuration,CHEMBL615899,,,10576,,B,,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,,H,8,1,,BAO_0000019
1258,,Autocuration,CHEMBL616291,,,10576,,B,,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,H,8,1,,BAO_0000019
1259,,Autocuration,CHEMBL616292,,,10576,,B,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,,H,8,1,,BAO_0000357
1260,,Autocuration,CHEMBL616293,,,10576,,F,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,H,8,1,,BAO_0000249
1261,,Expert,CHEMBL616294,,,10576,10000000.0,B,,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1262,,Autocuration,CHEMBL616295,,,10576,10000000.0,B,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,H,8,1,,BAO_0000249
1263,,Autocuration,CHEMBL616296,,,10576,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,,H,8,1,,BAO_0000221
1264,,Autocuration,CHEMBL616297,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,H,8,1,,BAO_0000019
1265,,Autocuration,CHEMBL616605,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,,H,8,1,,BAO_0000019
1266,,Autocuration,CHEMBL616606,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,,H,8,1,,BAO_0000019
1267,,Autocuration,CHEMBL616607,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,H,8,1,,BAO_0000019
1268,,Expert,CHEMBL616608,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,H,8,1,,BAO_0000019
1269,,Autocuration,CHEMBL616609,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,,H,8,1,,BAO_0000019
1270,Rattus norvegicus,Expert,CHEMBL616610,,,10576,,F,,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,,D,9,1,,BAO_0000019
1271,,Autocuration,CHEMBL616611,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,H,8,1,,BAO_0000019
1272,,Expert,CHEMBL616612,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,,H,8,1,,BAO_0000019
1273,,Autocuration,CHEMBL616613,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,,H,8,1,,BAO_0000019
1274,,Expert,CHEMBL616614,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,,H,8,1,,BAO_0000019
1275,,Autocuration,CHEMBL616615,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,,H,8,1,,BAO_0000019
1276,,Expert,CHEMBL616616,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,H,8,1,,BAO_0000019
1277,,Autocuration,CHEMBL616617,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,,H,8,1,,BAO_0000019
1278,,Autocuration,CHEMBL616618,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,H,8,1,,BAO_0000019
1279,,Autocuration,CHEMBL616619,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,,H,8,1,,BAO_0000019
1280,,Expert,CHEMBL616620,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,,H,8,1,,BAO_0000019
1281,,Expert,CHEMBL616621,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,H,8,1,,BAO_0000019
1282,,Autocuration,CHEMBL616622,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,,H,8,1,,BAO_0000019
1283,,Expert,CHEMBL616146,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,,H,8,1,,BAO_0000019
1284,,Autocuration,CHEMBL832873,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,,H,8,1,,BAO_0000019
1285,,Autocuration,CHEMBL616147,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,,H,8,1,,BAO_0000019
1286,,Autocuration,CHEMBL872872,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,H,8,1,,BAO_0000019
1287,,Autocuration,CHEMBL616148,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,H,8,1,,BAO_0000019
1288,,Autocuration,CHEMBL616149,,,10576,10000000.0,B,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,,H,8,1,,BAO_0000221
1289,,Expert,CHEMBL616150,,,10576,10000000.0,B,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,,H,8,1,,BAO_0000221
1290,Rattus norvegicus,Expert,CHEMBL616151,,,10576,,B,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,Membranes,D,9,1,,BAO_0000249
1291,,Expert,CHEMBL872873,,,10576,10000000.0,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,,H,8,1,,BAO_0000221
1292,,Autocuration,CHEMBL616670,,,10576,10000000.0,B,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,,H,8,1,,BAO_0000221
1293,,Autocuration,CHEMBL616671,,,10576,10000000.0,B,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,,H,8,1,,BAO_0000221
1294,Rattus norvegicus,Expert,CHEMBL884861,,,10576,,F,,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,D,9,1,,BAO_0000249
1295,,Autocuration,CHEMBL616672,,,10576,,B,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,,H,8,1,,BAO_0000357
1296,,Autocuration,CHEMBL616673,,,10576,,B,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,H,8,1,,BAO_0000019
1297,,Expert,CHEMBL616674,,,10576,,F,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000019
1298,,Autocuration,CHEMBL616675,,,10576,,B,,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,H,8,1,,BAO_0000357
1299,,Autocuration,CHEMBL616676,,,10576,10000000.0,B,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,,H,8,1,,BAO_0000221
1300,,Autocuration,CHEMBL616677,,,10576,10000000.0,B,,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,8,1,,BAO_0000221
1301,,Autocuration,CHEMBL616678,,,10576,10000000.0,B,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,8,1,,BAO_0000221
1302,Rattus norvegicus,Expert,CHEMBL616679,,,10576,,B,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1303,,Expert,CHEMBL616680,,,10576,10000000.0,B,,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,,H,8,1,,BAO_0000221
1304,,Autocuration,CHEMBL616681,,,10576,10000000.0,B,,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1305,,Autocuration,CHEMBL616682,,,10576,10000000.0,B,,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1306,,Autocuration,CHEMBL616683,,,10576,10000000.0,B,,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000221
1307,,Autocuration,CHEMBL616684,,,10576,10000000.0,B,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000221
1308,,Autocuration,CHEMBL616685,,,10576,10000000.0,B,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,,H,8,1,,BAO_0000221
1309,,Autocuration,CHEMBL616686,,,10576,955.0,B,,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,,H,8,1,,BAO_0000221
1310,,Autocuration,CHEMBL616687,,,10576,,B,,Affinity for 5-hydroxytryptamine 1A receptor site,,H,8,1,,BAO_0000357
1311,,Autocuration,CHEMBL616688,,,10576,,B,,Affinity for 5-hydroxytryptamine 1A receptor site,,H,8,1,,BAO_0000357
1312,,Autocuration,CHEMBL616689,,,10576,10000000.0,B,,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,,H,8,1,,BAO_0000221
1313,,Autocuration,CHEMBL616690,,,10576,,B,,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,,H,8,1,,BAO_0000357
1314,,Expert,CHEMBL616691,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1315,Rattus norvegicus,Expert,CHEMBL616692,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,,D,9,1,,BAO_0000221
1316,,Expert,CHEMBL616693,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,,H,8,1,,BAO_0000249
1317,Rattus norvegicus,Expert,CHEMBL616694,,,10576,,B,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,D,9,1,,BAO_0000019
1318,,Autocuration,CHEMBL616695,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,,H,8,1,,BAO_0000221
1319,,Autocuration,CHEMBL616696,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,,H,8,1,,BAO_0000357
1320,,Autocuration,CHEMBL616697,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
1321,,Autocuration,CHEMBL616698,,,10576,,B,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1322,Rattus norvegicus,Expert,CHEMBL616949,,,10576,,B,,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000019
1323,,Autocuration,CHEMBL616950,,,10576,10000000.0,B,,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,,H,8,1,,BAO_0000221
1324,,Autocuration,CHEMBL832875,,,10576,,B,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,H,8,1,,BAO_0000357
1325,,Expert,CHEMBL616951,,,10576,955.0,B,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,8,1,,BAO_0000221
1326,,Expert,CHEMBL616952,,,10576,955.0,B,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,8,1,,BAO_0000221
1327,,Expert,CHEMBL616953,,,10576,,B,,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,,H,8,1,,BAO_0000357
1328,,Autocuration,CHEMBL616954,,,10576,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,,H,8,1,,BAO_0000357
1329,,Autocuration,CHEMBL616955,,,106,,B,,GTPgammaS radioligand binding assay,,H,8,1,,BAO_0000357
1330,,Autocuration,CHEMBL616956,,,106,,B,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,H,8,1,,BAO_0000357
1331,,Autocuration,CHEMBL616957,,,106,,F,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,,H,8,1,,BAO_0000019
1332,,Autocuration,CHEMBL616958,,,106,,F,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,,H,8,1,,BAO_0000019
1333,,Autocuration,CHEMBL616959,,,106,,B,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1334,,Autocuration,CHEMBL616960,,,106,,B,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,H,8,1,,BAO_0000357
1335,,Autocuration,CHEMBL616961,,,106,,F,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,,H,8,1,,BAO_0000019
1336,,Expert,CHEMBL616962,308.0,,106,,B,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000219
1337,,Autocuration,CHEMBL616963,308.0,,106,,B,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,,H,8,1,,BAO_0000219
1338,Homo sapiens,Expert,CHEMBL616524,,,106,,B,,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,,D,9,1,,BAO_0000357
1339,,Autocuration,CHEMBL616525,449.0,,106,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
1340,,Autocuration,CHEMBL872908,,,106,,B,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,,H,8,1,,BAO_0000019
1341,,Autocuration,CHEMBL616526,,,106,,B,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,,H,8,1,,BAO_0000019
1342,Homo sapiens,Expert,CHEMBL616527,,,106,,B,,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1343,,Expert,CHEMBL616528,,,106,,B,,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,H,8,1,,BAO_0000219
1344,,Autocuration,CHEMBL616529,,,106,,B,,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
1345,,Autocuration,CHEMBL616530,,,106,,B,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,,H,8,1,,BAO_0000357
1346,,Expert,CHEMBL616531,,,106,,B,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1347,,Autocuration,CHEMBL616532,,,106,,B,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1348,,Autocuration,CHEMBL616533,,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1349,,Expert,CHEMBL616534,,,106,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1350,,Expert,CHEMBL616535,,,106,,B,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,,H,8,1,,BAO_0000357
1351,,Autocuration,CHEMBL616536,,,106,,B,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,,H,8,1,,BAO_0000357
1352,,Autocuration,CHEMBL616537,,,106,,B,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1353,,Expert,CHEMBL616538,485.0,,106,,F,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,,H,8,1,,BAO_0000219
1354,,Expert,CHEMBL616539,,,106,,F,,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000019
1355,,Expert,CHEMBL616540,,,106,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000019
1356,,Autocuration,CHEMBL616429,,,106,,B,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,H,8,1,,BAO_0000357
1357,,Expert,CHEMBL616430,,,106,,B,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1358,Homo sapiens,Expert,CHEMBL616431,,,106,,B,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,,D,9,1,,BAO_0000219
1359,Homo sapiens,Expert,CHEMBL616432,,,106,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1360,Homo sapiens,Expert,CHEMBL616433,,,106,,B,,Affinity for 5-hydroxytryptamine 1B receptor subtype,,D,9,1,,BAO_0000357
1361,Homo sapiens,Expert,CHEMBL616434,,,106,,B,,Binding affinity for human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1362,,Autocuration,CHEMBL616435,449.0,,106,,B,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,,H,8,1,,BAO_0000219
1363,,Expert,CHEMBL616436,,,106,,B,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,,H,8,1,,BAO_0000019
1364,,Autocuration,CHEMBL616437,308.0,,106,,B,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,H,8,1,,BAO_0000219
1365,,Autocuration,CHEMBL616438,308.0,,106,,B,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,,H,8,1,,BAO_0000219
1366,,Autocuration,CHEMBL616439,308.0,,106,,B,,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,H,8,1,,BAO_0000219
1367,Homo sapiens,Expert,CHEMBL616440,,,106,,B,,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,,D,9,1,,BAO_0000357
1368,,Autocuration,CHEMBL616441,485.0,,106,,B,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,,H,8,1,,BAO_0000219
1369,,Expert,CHEMBL616442,,,106,,B,,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,,H,8,1,,BAO_0000357
1370,,Autocuration,CHEMBL616443,,,106,,B,,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1371,,Expert,CHEMBL616444,485.0,,106,,B,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000219
1372,Homo sapiens,Expert,CHEMBL616445,,,106,,B,,Binding activity against human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1373,Homo sapiens,Expert,CHEMBL616446,,,106,,B,,Binding activity against human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1374,Homo sapiens,Expert,CHEMBL616447,449.0,,106,,B,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,D,9,1,,BAO_0000219
1375,,Autocuration,CHEMBL616448,,,106,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,,H,8,1,,BAO_0000357
1376,,Autocuration,CHEMBL616449,449.0,,106,,B,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,,H,8,1,,BAO_0000219
1377,,Autocuration,CHEMBL616450,449.0,,106,,B,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,,H,8,1,,BAO_0000219
1378,,Autocuration,CHEMBL857974,449.0,,106,,B,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,,H,8,1,,BAO_0000219
1379,,Autocuration,CHEMBL616451,449.0,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
1380,,Autocuration,CHEMBL616452,449.0,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
1381,,Autocuration,CHEMBL616453,449.0,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,,H,8,1,,BAO_0000219
1382,,Autocuration,CHEMBL616454,449.0,,106,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000219
1383,Homo sapiens,Expert,CHEMBL616455,,,106,,B,,Binding affinity for human 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1384,,Autocuration,CHEMBL616456,449.0,,106,,B,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,H,8,1,,BAO_0000219
1385,,Autocuration,CHEMBL616457,,,106,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000357
1386,,Autocuration,CHEMBL616458,449.0,,106,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,H,8,1,,BAO_0000219
1387,,Autocuration,CHEMBL616459,449.0,,106,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
1388,,Expert,CHEMBL616460,,,106,,F,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,,H,8,1,,BAO_0000019
1389,,Expert,CHEMBL616461,,,106,,F,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,,H,8,1,,BAO_0000019
1390,,Autocuration,CHEMBL616462,449.0,,106,,F,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",,H,8,1,,BAO_0000219
1391,,Autocuration,CHEMBL616463,449.0,,106,,F,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",,H,8,1,,BAO_0000219
1392,,Autocuration,CHEMBL616464,,,105,,F,,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",,H,8,1,,BAO_0000019
1393,,Autocuration,CHEMBL616465,449.0,,105,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,,H,8,1,,BAO_0000219
1394,,Autocuration,CHEMBL832874,,,17105,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1395,Oryctolagus cuniculus,Autocuration,CHEMBL616184,,,106,,F,,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,,H,8,1,,BAO_0000019
1396,Oryctolagus cuniculus,Autocuration,CHEMBL616185,,,106,,B,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,,H,8,1,,BAO_0000019
1397,Oryctolagus cuniculus,Intermediate,CHEMBL616186,,,106,,B,,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",,H,8,1,,BAO_0000019
1398,Oryctolagus cuniculus,Autocuration,CHEMBL616187,,,106,,B,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,,H,8,1,,BAO_0000019
1399,,Expert,CHEMBL616188,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1400,,Intermediate,CHEMBL873475,,,10577,,B,,Binding affinity for 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1401,Rattus norvegicus,Expert,CHEMBL616189,,,10577,2435.0,B,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,,D,9,1,,BAO_0000019
1402,,Expert,CHEMBL616190,,,10577,,B,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,H,8,1,,BAO_0000357
1403,,Autocuration,CHEMBL616191,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,,H,8,1,,BAO_0000357
1404,,Autocuration,CHEMBL616192,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,,H,8,1,,BAO_0000357
1405,,Autocuration,CHEMBL616193,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,,H,8,1,,BAO_0000357
1406,,Autocuration,CHEMBL616194,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,,H,8,1,,BAO_0000357
1407,,Autocuration,CHEMBL616195,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,,H,8,1,,BAO_0000357
1408,,Autocuration,CHEMBL616196,,,10576,,B,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,,H,8,1,,BAO_0000357
1409,,Autocuration,CHEMBL616197,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,,H,8,1,,BAO_0000249
1410,,Intermediate,CHEMBL616198,,,10576,,B,,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000019
1411,,Autocuration,CHEMBL616199,,,10576,10000000.0,B,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,H,8,1,,BAO_0000221
1412,,Expert,CHEMBL616200,,,10576,10000000.0,B,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,,H,8,1,,BAO_0000221
1413,,Expert,CHEMBL616201,,,10576,10000000.0,B,,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1414,,Expert,CHEMBL616202,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,H,8,1,,BAO_0000221
1415,,Expert,CHEMBL616203,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,H,8,1,,BAO_0000221
1416,,Expert,CHEMBL616204,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,,H,8,1,,BAO_0000221
1417,,Expert,CHEMBL616205,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,,H,8,1,,BAO_0000221
1418,,Expert,CHEMBL616206,,,10576,10000000.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,,H,8,1,,BAO_0000221
1419,,Expert,CHEMBL616207,,,10576,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,H,8,1,,BAO_0000249
1420,,Autocuration,CHEMBL616208,,,10576,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,,H,8,1,,BAO_0000249
1421,,Autocuration,CHEMBL616209,,,10576,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,,H,8,1,,BAO_0000249
1422,,Expert,CHEMBL616210,,,10576,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,,H,8,1,,BAO_0000357
1423,,Expert,CHEMBL616211,,,10576,10000000.0,B,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,,H,8,1,,BAO_0000221
1424,,Autocuration,CHEMBL616504,,,10576,10000000.0,B,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,,H,8,1,,BAO_0000221
1425,Rattus norvegicus,Expert,CHEMBL616505,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000221
1426,,Autocuration,CHEMBL616506,,,10576,,F,,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000019
1427,,Autocuration,CHEMBL872107,,,10576,10000000.0,B,,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,8,1,,BAO_0000221
1428,Rattus norvegicus,Expert,CHEMBL616507,,,10576,10000000.0,B,,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,,D,9,1,,BAO_0000221
1429,,Autocuration,CHEMBL616303,,,10576,,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,,H,8,1,,BAO_0000249
1430,,Autocuration,CHEMBL616304,,,10576,10000000.0,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,,H,8,1,,BAO_0000221
1431,,Expert,CHEMBL616305,,,10576,10000000.0,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,,H,8,1,,BAO_0000221
1432,,Intermediate,CHEMBL616306,,,10576,10000000.0,F,,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000221
1433,,Autocuration,CHEMBL616307,,,10576,,B,,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1434,Rattus norvegicus,Expert,CHEMBL881829,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,,D,9,1,,BAO_0000221
1435,,Expert,CHEMBL616308,,,10576,,B,,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,,H,8,1,,BAO_0000357
1436,,Autocuration,CHEMBL616309,,,10576,,B,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,,H,8,1,,BAO_0000019
1437,,Expert,CHEMBL616310,,,10576,,B,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,,H,8,1,,BAO_0000019
1438,,Autocuration,CHEMBL616311,449.0,,10576,,B,,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,,H,8,1,,BAO_0000219
1439,,Expert,CHEMBL616312,,,10576,,B,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1440,,Autocuration,CHEMBL616313,,,10576,,B,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,,H,8,1,,BAO_0000357
1441,Rattus norvegicus,Expert,CHEMBL616314,,,10576,10000000.0,B,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000221
1442,,Autocuration,CHEMBL616315,,,10576,10000000.0,B,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1443,,Autocuration,CHEMBL616567,,,10576,10000000.0,B,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,,H,8,1,,BAO_0000221
1444,,Autocuration,CHEMBL616568,,,10576,10000000.0,B,,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,,H,8,1,,BAO_0000221
1445,,Intermediate,CHEMBL616569,,,10576,,B,,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,,H,8,1,,BAO_0000019
1446,,Expert,CHEMBL616570,,,10576,,B,,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,,H,8,1,,BAO_0000357
1447,,Autocuration,CHEMBL616571,,,10576,,B,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,H,8,1,,BAO_0000357
1448,,Autocuration,CHEMBL616572,,,10576,10000000.0,B,,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,,H,8,1,,BAO_0000221
1449,,Expert,CHEMBL616573,,,10576,,B,,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,,H,8,1,,BAO_0000249
1450,Rattus norvegicus,Expert,CHEMBL616574,,,10576,,B,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,,D,9,1,,BAO_0000357
1451,,Expert,CHEMBL616575,,,10576,10000000.0,B,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,,H,8,1,,BAO_0000221
1452,,Autocuration,CHEMBL872108,,,10576,10000000.0,B,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,,H,8,1,,BAO_0000221
1453,,Autocuration,CHEMBL616576,,,10576,,B,,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000357
1454,,Autocuration,CHEMBL616577,,,10576,,B,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,,H,8,1,,BAO_0000249
1455,,Autocuration,CHEMBL616578,,,10576,,B,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,,H,8,1,,BAO_0000249
1456,,Expert,CHEMBL616579,,,10576,,B,,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,,H,8,1,,BAO_0000357
1457,Rattus norvegicus,Expert,CHEMBL616580,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,,D,9,1,,BAO_0000019
1458,,Autocuration,CHEMBL616581,,,10576,,B,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,H,8,1,,BAO_0000019
1459,,Autocuration,CHEMBL616582,,,10576,10000000.0,B,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1460,,Expert,CHEMBL616583,,,10576,10000000.0,B,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,8,1,,BAO_0000221
1461,Rattus norvegicus,Expert,CHEMBL616584,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,,D,9,1,,BAO_0000221
1462,,Expert,CHEMBL616585,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1463,Rattus norvegicus,Expert,CHEMBL616586,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,,D,9,1,,BAO_0000221
1464,,Autocuration,CHEMBL616587,,,10576,10000000.0,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,,H,8,1,,BAO_0000221
1465,,Autocuration,CHEMBL616588,,,10576,10000000.0,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1466,,Autocuration,CHEMBL616589,,,10576,10000000.0,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000221
1467,,Expert,CHEMBL616590,,,10576,10000000.0,B,,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000221
1468,,Expert,CHEMBL616591,449.0,,10576,,B,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",,H,8,1,,BAO_0000219
1469,,Expert,CHEMBL616592,,,10576,,B,,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1470,,Autocuration,CHEMBL616593,,,10576,,B,,The inhibition activity of 5-HT1A at 1 uM,,H,8,1,,BAO_0000357
1471,,Expert,CHEMBL616594,485.0,,10576,,B,,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",,H,8,1,,BAO_0000219
1472,,Expert,CHEMBL616595,,,10576,,B,,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,,H,8,1,,BAO_0000249
1473,,Autocuration,CHEMBL616596,,,10576,,B,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,,H,8,1,,BAO_0000357
1474,,Autocuration,CHEMBL616597,,,10576,10000000.0,B,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,8,1,,BAO_0000221
1475,,Expert,CHEMBL616598,,,10576,10000000.0,B,,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,8,1,,BAO_0000221
1476,Rattus norvegicus,Expert,CHEMBL616599,,,10576,,F,,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,Membranes,D,9,1,,BAO_0000249
1477,Rattus norvegicus,Expert,CHEMBL616600,,,10576,10000000.0,F,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,D,9,1,,BAO_0000249
1478,,Autocuration,CHEMBL616601,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,,H,8,1,,BAO_0000019
1479,,Autocuration,CHEMBL616602,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,,H,8,1,,BAO_0000019
1480,,Autocuration,CHEMBL616603,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,,H,8,1,,BAO_0000019
1481,,Autocuration,CHEMBL616604,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,,H,8,1,,BAO_0000019
1482,,Autocuration,CHEMBL616316,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,,H,8,1,,BAO_0000249
1483,,Autocuration,CHEMBL616317,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,,H,8,1,,BAO_0000249
1484,Rattus norvegicus,Expert,CHEMBL616318,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,,D,9,1,,BAO_0000019
1485,,Autocuration,CHEMBL616319,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,,H,8,1,,BAO_0000221
1486,,Autocuration,CHEMBL616320,,,10576,10000000.0,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,,H,8,1,,BAO_0000221
1487,Rattus norvegicus,Expert,CHEMBL616321,,,10576,10000000.0,B,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,,D,9,1,,BAO_0000221
1488,,Autocuration,CHEMBL616322,,,10576,,F,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,H,8,1,,BAO_0000019
1489,,Autocuration,CHEMBL616323,,,10576,,F,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,,H,8,1,,BAO_0000019
1490,,Autocuration,CHEMBL616324,,,10576,,B,,Ratio of binding affinity to 5-HT 1A and D2 receptor,,H,8,1,,BAO_0000357
1491,,Autocuration,CHEMBL616325,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,H,8,1,,BAO_0000221
1492,,Autocuration,CHEMBL616326,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,H,8,1,,BAO_0000221
1493,,Autocuration,CHEMBL616327,,,10576,10000000.0,B,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,,H,8,1,,BAO_0000221
1494,,Autocuration,CHEMBL616328,,,10576,,B,,Percentage inhibition against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1495,,Autocuration,CHEMBL858110,,,10576,,B,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,H,8,1,,BAO_0000249
1496,,Autocuration,CHEMBL616329,,,10576,,F,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,H,8,1,,BAO_0000249
1497,,Autocuration,CHEMBL616330,,,10576,,B,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,H,8,1,,BAO_0000249
1498,,Autocuration,CHEMBL616331,,,10576,,F,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,H,8,1,,BAO_0000249
1499,,Autocuration,CHEMBL616332,,,10576,,F,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,H,8,1,,BAO_0000249
1500,,Autocuration,CHEMBL857063,,,10576,955.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,8,1,,BAO_0000249
1501,,Autocuration,CHEMBL616333,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,,H,8,1,,BAO_0000019
1502,,Expert,CHEMBL616334,,,10576,,F,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000019
1503,,Autocuration,CHEMBL616335,,,10576,10000000.0,B,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,H,8,1,,BAO_0000221
1504,,Autocuration,CHEMBL616336,,,10576,,B,,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,,H,8,1,,BAO_0000019
1505,,Expert,CHEMBL616337,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000249
1506,,Autocuration,CHEMBL616338,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,,H,8,1,,BAO_0000019
1507,,Autocuration,CHEMBL616339,,,10576,10000000.0,B,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,,H,8,1,,BAO_0000221
1508,,Autocuration,CHEMBL616340,,,10576,10000000.0,B,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,,H,8,1,,BAO_0000221
1509,,Autocuration,CHEMBL616341,,,10576,,B,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
1510,Rattus norvegicus,Expert,CHEMBL616342,,,10576,,B,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1511,Rattus norvegicus,Expert,CHEMBL616343,,,10576,,B,,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,,D,9,1,,BAO_0000019
1512,,Expert,CHEMBL616344,,,10576,,B,,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,,H,8,1,,BAO_0000019
1513,,Expert,CHEMBL616345,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000357
1514,,Expert,CHEMBL616346,,,10576,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,,H,8,1,,BAO_0000019
1515,,Autocuration,CHEMBL616347,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,H,8,1,,BAO_0000221
1516,,Expert,CHEMBL616348,,,10576,,B,,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,,H,8,1,,BAO_0000019
1517,,Expert,CHEMBL616349,,,10576,,B,,Binding affinity at 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1518,Rattus norvegicus,Expert,CHEMBL616152,,,10576,,B,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,Membranes,D,9,1,,BAO_0000249
1519,,Autocuration,CHEMBL616153,,,10576,,B,,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,H,8,1,,BAO_0000249
1520,,Expert,CHEMBL616154,,,10576,,B,,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",,H,8,1,,BAO_0000019
1521,,Autocuration,CHEMBL616155,,,10576,,B,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,8,1,,BAO_0000019
1522,Rattus norvegicus,Expert,CHEMBL616156,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,,D,9,1,,BAO_0000221
1523,Rattus norvegicus,Expert,CHEMBL616157,,,10576,10000000.0,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,,D,9,1,,BAO_0000221
1524,,Autocuration,CHEMBL616158,,,10576,10000000.0,B,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,,H,8,1,,BAO_0000221
1525,,Autocuration,CHEMBL616159,,,10576,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,8,1,,BAO_0000357
1526,,Expert,CHEMBL616160,,,10576,,B,,pKi value against rat 5-hydroxytryptamine 1A receptor.,,H,8,1,,BAO_0000357
1527,,Autocuration,CHEMBL616161,,,10576,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,,H,8,1,,BAO_0000019
1528,,Autocuration,CHEMBL616162,,,10576,,F,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,H,8,1,,BAO_0000019
1529,Rattus norvegicus,Expert,CHEMBL616163,,,12687,,B,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,D,9,1,,BAO_0000357
1530,,Expert,CHEMBL616164,,,10626,,B,,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,H,8,1,,BAO_0000249
1531,,Autocuration,CHEMBL616165,,,10576,955.0,B,,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,,H,8,1,,BAO_0000221
1532,Rattus norvegicus,Autocuration,CHEMBL616355,,,51,,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,,H,8,1,,BAO_0000019
1533,,Autocuration,CHEMBL616356,,,10576,,F,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,H,8,1,,BAO_0000019
1534,,Autocuration,CHEMBL616357,,,10576,955.0,B,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,8,1,,BAO_0000221
1535,,Autocuration,CHEMBL616358,,,10576,,B,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,H,8,1,,BAO_0000019
1536,,Autocuration,CHEMBL616359,,,51,,B,,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1537,,Expert,CHEMBL616360,,,51,,B,,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,,H,8,1,,BAO_0000357
1538,,Expert,CHEMBL616361,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1539,,Autocuration,CHEMBL616362,,,51,,B,,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1540,,Autocuration,CHEMBL616363,,,51,,B,,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,Brain membranes,H,8,1,,BAO_0000249
1541,,Autocuration,CHEMBL616364,,,51,,B,,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,,H,8,1,,BAO_0000357
1542,,Autocuration,CHEMBL616365,,,51,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1543,,Expert,CHEMBL616366,,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1544,,Expert,CHEMBL872906,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1545,,Autocuration,CHEMBL616367,,,51,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,,H,8,1,,BAO_0000357
1546,,Autocuration,CHEMBL616368,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1547,,Autocuration,CHEMBL616369,,,51,,B,,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
1548,Homo sapiens,Expert,CHEMBL616370,,,51,,B,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,,D,9,1,,BAO_0000357
1549,Homo sapiens,Expert,CHEMBL616371,,,51,,B,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,,D,9,1,,BAO_0000357
1550,,Autocuration,CHEMBL616372,449.0,,51,,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,8,1,,BAO_0000219
1551,,Expert,CHEMBL616373,,,51,,B,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,,H,8,1,,BAO_0000219
1552,,Autocuration,CHEMBL616374,,,51,,B,,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000218
1553,,Autocuration,CHEMBL616375,,,51,10000000.0,B,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,8,1,,BAO_0000221
1554,,Autocuration,CHEMBL616376,,,51,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
1555,,Expert,CHEMBL857064,,,51,,B,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,,H,8,1,,BAO_0000357
1556,,Autocuration,CHEMBL616377,,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
1557,,Autocuration,CHEMBL616378,,,51,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,H,8,1,,BAO_0000357
1558,,Autocuration,CHEMBL616379,,,51,,B,,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1559,,Autocuration,CHEMBL616380,,,11863,,B,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1560,,Autocuration,CHEMBL616381,,,11863,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,,H,8,1,,BAO_0000357
1561,,Autocuration,CHEMBL616382,,,11863,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1562,,Autocuration,CHEMBL616383,,,11863,,B,,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,,H,8,1,,BAO_0000357
1563,Mus musculus,Expert,CHEMBL616350,449.0,,11863,,B,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,,D,9,1,,BAO_0000219
1564,,Autocuration,CHEMBL616351,,,11863,,B,,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1565,,Autocuration,CHEMBL616352,,,11863,,B,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,,H,8,1,,BAO_0000357
1566,,Autocuration,CHEMBL616353,,,11863,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1567,,Autocuration,CHEMBL616354,,,11863,,B,,Binding affinity against serotonergic 5-HT1a receptor,,H,8,1,,BAO_0000357
1568,,Autocuration,CHEMBL616508,,,11863,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1569,Mus musculus,Expert,CHEMBL616559,,,11863,,B,,Binding affinity for 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1570,,Autocuration,CHEMBL616560,,,11863,,B,,Binding affinity at 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1571,,Autocuration,CHEMBL616561,,,11863,,B,,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",,H,8,1,,BAO_0000357
1572,,Autocuration,CHEMBL616562,449.0,,11863,,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,8,1,,BAO_0000219
1573,,Autocuration,CHEMBL616563,449.0,,11863,,B,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,8,1,,BAO_0000219
1574,,Autocuration,CHEMBL616564,,,11863,,B,,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1575,,Autocuration,CHEMBL616565,,,11863,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
1576,,Autocuration,CHEMBL616566,,,11863,,B,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000218
1577,,Autocuration,CHEMBL616989,,,11863,,B,,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,,H,8,1,,BAO_0000357
1578,,Autocuration,CHEMBL857975,,,11863,,B,,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1579,Mus musculus,Expert,CHEMBL616990,,,11863,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,D,9,1,,BAO_0000357
1580,,Autocuration,CHEMBL616991,,,11863,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,,H,8,1,,BAO_0000357
1581,,Autocuration,CHEMBL616992,,,11863,,B,,Tested against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1582,,Autocuration,CHEMBL616993,,,11863,,B,,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
1583,Oryctolagus cuniculus,Expert,CHEMBL616994,,,106,,B,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,,H,8,1,,BAO_0000019
1584,Oryctolagus cuniculus,Autocuration,CHEMBL616995,,,106,,B,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,,H,8,1,,BAO_0000019
1585,Gorilla gorilla,Intermediate,CHEMBL616996,722.0,,105571,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,D,9,1,,BAO_0000219
1586,Cavia porcellus,Autocuration,CHEMBL616997,,,106,,F,,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,H,8,1,,BAO_0000218
1587,Cavia porcellus,Autocuration,CHEMBL616998,,,106,,F,,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,H,8,1,,BAO_0000218
1588,Cavia porcellus,Autocuration,CHEMBL616999,,,106,,F,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,,H,8,1,,BAO_0000019
1589,Cavia porcellus,Autocuration,CHEMBL617000,,,106,,F,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,,H,8,1,,BAO_0000019
1590,Cavia porcellus,Autocuration,CHEMBL617001,,,106,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,,H,8,1,,BAO_0000019
1591,Cavia porcellus,Autocuration,CHEMBL858111,,,106,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,,H,8,1,,BAO_0000019
1592,,Autocuration,CHEMBL617002,,,106,,F,,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,,H,8,1,,BAO_0000019
1593,,Autocuration,CHEMBL617003,,,106,,F,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),,H,8,1,,BAO_0000019
1594,,Autocuration,CHEMBL617004,,,106,,F,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),,H,8,1,,BAO_0000019
1595,Homo sapiens,Expert,CHEMBL617005,,,106,,F,,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,,D,9,1,,BAO_0000019
1596,Homo sapiens,Expert,CHEMBL616623,485.0,,106,,F,,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,,D,9,1,,BAO_0000219
1597,,Autocuration,CHEMBL616624,449.0,,106,,F,,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,,H,8,1,,BAO_0000219
1598,,Autocuration,CHEMBL883243,,,106,,B,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1599,,Autocuration,CHEMBL616625,,,106,,F,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,,H,8,1,,BAO_0000019
1600,,Expert,CHEMBL616626,449.0,,106,,F,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",,H,8,1,,BAO_0000219
1601,,Autocuration,CHEMBL616627,449.0,,106,,F,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,,H,8,1,,BAO_0000219
1602,,Autocuration,CHEMBL616628,449.0,,106,,F,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,,H,8,1,,BAO_0000219
1603,,Autocuration,CHEMBL616629,449.0,,106,,F,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,,H,8,1,,BAO_0000219
1604,,Autocuration,CHEMBL616630,449.0,,106,,F,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,,H,8,1,,BAO_0000219
1605,,Expert,CHEMBL616631,,,106,,F,,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",,H,8,1,,BAO_0000019
1606,,Autocuration,CHEMBL616632,,,106,,F,,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",,H,8,1,,BAO_0000019
1607,Homo sapiens,Expert,CHEMBL616633,,,106,,B,,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1608,,Expert,CHEMBL616634,449.0,,106,,B,,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,,H,8,1,,BAO_0000219
1609,,Autocuration,CHEMBL616635,,,106,,B,,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
1610,Homo sapiens,Expert,CHEMBL885358,,,106,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1611,Homo sapiens,Expert,CHEMBL616636,449.0,,106,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,D,9,1,,BAO_0000219
1612,,Expert,CHEMBL616637,449.0,,106,,B,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,,H,8,1,,BAO_0000219
1613,,Autocuration,CHEMBL616638,,,106,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1614,,Expert,CHEMBL616639,449.0,,106,,B,,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
1615,,Expert,CHEMBL616640,449.0,,106,,B,,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,,H,8,1,,BAO_0000219
1616,,Expert,CHEMBL616641,449.0,,106,,B,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
1617,,Expert,CHEMBL616642,449.0,,106,,B,,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,,H,8,1,,BAO_0000219
1618,,Expert,CHEMBL616643,449.0,,106,,B,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,H,8,1,,BAO_0000219
1619,,Autocuration,CHEMBL616644,,,106,,B,,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
1620,,Autocuration,CHEMBL616645,,,106,,B,,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,,H,8,1,,BAO_0000357
1621,Oryctolagus cuniculus,Autocuration,CHEMBL616646,,,105,,F,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,8,1,,BAO_0000019
1622,Oryctolagus cuniculus,Expert,CHEMBL616647,,,105,,F,,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,8,1,,BAO_0000019
1623,,Autocuration,CHEMBL616509,,,105,,B,,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),,H,8,1,,BAO_0000357
1624,,Autocuration,CHEMBL616510,,,105,,B,,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),,H,8,1,,BAO_0000357
1625,,Autocuration,CHEMBL616511,,,105,,B,,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1626,Bos taurus,Expert,CHEMBL616512,,,105,,B,,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,,H,8,1,,BAO_0000357
1627,Bos taurus,Autocuration,CHEMBL616513,,,105,,B,,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,,H,8,1,,BAO_0000357
1628,Bos taurus,Autocuration,CHEMBL616514,,,105,2435.0,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,H,8,1,,BAO_0000019
1629,Bos taurus,Expert,CHEMBL616515,,,105,,B,,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,,H,8,1,,BAO_0000357
1630,Bos taurus,Autocuration,CHEMBL616516,,,105,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,,H,8,1,,BAO_0000019
1631,Bos taurus,Autocuration,CHEMBL616517,,,105,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,H,8,1,,BAO_0000357
1632,Bos taurus,Autocuration,CHEMBL616518,,,105,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,H,8,1,,BAO_0000357
1633,Bos taurus,Autocuration,CHEMBL616519,,,105,,B,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000357
1634,Bos taurus,Autocuration,CHEMBL616520,,,105,,B,,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000357
1635,Bos taurus,Autocuration,CHEMBL616521,,,105,,B,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,,H,8,1,,BAO_0000357
1636,Bos taurus,Autocuration,CHEMBL616522,,,105,,B,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,,H,8,1,,BAO_0000357
1637,Bos taurus,Autocuration,CHEMBL884531,,,105,,B,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,H,8,1,,BAO_0000357
1638,Bos taurus,Autocuration,CHEMBL616523,,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1639,Bos taurus,Autocuration,CHEMBL616731,,,105,2435.0,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,H,8,1,,BAO_0000019
1640,Bos taurus,Autocuration,CHEMBL616732,,,105,,B,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,,H,8,1,,BAO_0000019
1641,Bos taurus,Autocuration,CHEMBL616733,,,105,,B,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,,H,8,1,,BAO_0000357
1642,Bos taurus,Autocuration,CHEMBL616734,,,105,,B,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,H,8,1,,BAO_0000357
1643,Bos taurus,Autocuration,CHEMBL616735,,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,,H,8,1,,BAO_0000249
1644,Bos taurus,Autocuration,CHEMBL616736,,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,,H,8,1,,BAO_0000249
1645,Bos taurus,Expert,CHEMBL616737,,,105,,F,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,8,1,,BAO_0000019
1646,Bos taurus,Autocuration,CHEMBL616738,,,105,,B,,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,,H,8,1,,BAO_0000019
1647,Bos taurus,Expert,CHEMBL616739,,,105,,F,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,8,1,,BAO_0000019
1648,Bos taurus,Expert,CHEMBL616740,,,105,,F,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,8,1,,BAO_0000019
1649,Bos taurus,Expert,CHEMBL616741,,,105,,F,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,8,1,,BAO_0000019
1650,Gorilla gorilla,Autocuration,CHEMBL616742,722.0,,105,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,H,8,1,,BAO_0000219
1651,Cavia porcellus,Intermediate,CHEMBL616743,,,105570,,B,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,,D,9,1,,BAO_0000019
1652,Cavia porcellus,Intermediate,CHEMBL616744,,,105570,,B,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,,D,9,1,,BAO_0000019
1653,Cavia porcellus,Intermediate,CHEMBL616745,,,105570,,F,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,,D,9,1,,BAO_0000019
1654,Cavia porcellus,Intermediate,CHEMBL616746,,,105570,,F,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,9,1,,BAO_0000019
1655,Cavia porcellus,Intermediate,CHEMBL616747,,,105570,,F,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,,D,9,1,,BAO_0000019
1656,Cavia porcellus,Intermediate,CHEMBL616748,,,105570,,F,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,,D,9,1,,BAO_0000019
1657,Cavia porcellus,Intermediate,CHEMBL616648,,,105570,,F,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,,D,9,1,,BAO_0000019
1658,Cavia porcellus,Intermediate,CHEMBL616649,,,105570,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1659,Cavia porcellus,Intermediate,CHEMBL616650,,,105570,,B,,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,,D,9,1,,BAO_0000357
1660,Cavia porcellus,Intermediate,CHEMBL616651,,,105570,,F,,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,9,1,,BAO_0000218
1661,Cavia porcellus,Intermediate,CHEMBL616652,,,105570,,F,,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,9,1,,BAO_0000218
1662,Cavia porcellus,Intermediate,CHEMBL616653,,,105570,,F,,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,9,1,,BAO_0000218
1663,Cavia porcellus,Intermediate,CHEMBL616654,,,105570,,F,,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,,D,9,1,,BAO_0000218
1664,Cavia porcellus,Intermediate,CHEMBL616655,,,105570,,B,,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,,D,9,1,,BAO_0000019
1665,Cavia porcellus,Intermediate,CHEMBL616656,,,105570,,B,,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1666,Cavia porcellus,Autocuration,CHEMBL616657,,,105,,B,,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,,H,8,1,,BAO_0000019
1667,Cavia porcellus,Intermediate,CHEMBL616658,,,105570,2435.0,B,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,,D,9,1,,BAO_0000357
1668,Cavia porcellus,Intermediate,CHEMBL616659,,,105570,,B,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,,D,9,1,,BAO_0000357
1669,,Autocuration,CHEMBL616660,,,51,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1670,,Autocuration,CHEMBL616661,,,106,,B,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,,H,8,1,,BAO_0000357
1671,,Expert,CHEMBL616662,,,105,,F,,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1672,,Autocuration,CHEMBL616663,,,105,,F,,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1673,,Autocuration,CHEMBL616664,,,105,,F,,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1674,Homo sapiens,Expert,CHEMBL881820,449.0,,105,,F,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",,D,9,1,,BAO_0000219
1675,,Autocuration,CHEMBL616665,449.0,,105,,F,,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",,H,8,1,,BAO_0000219
1676,,Expert,CHEMBL616666,449.0,,105,,B,,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000219
1677,,Autocuration,CHEMBL616667,449.0,,105,,B,,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000219
1678,,Expert,CHEMBL616668,449.0,,105,,F,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,H,8,1,,BAO_0000219
1679,Homo sapiens,Expert,CHEMBL616669,449.0,,105,,F,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,D,9,1,,BAO_0000219
1680,,Expert,CHEMBL617040,449.0,,105,,F,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",,H,8,1,,BAO_0000219
1681,,Autocuration,CHEMBL617041,449.0,,105,,F,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",,H,8,1,,BAO_0000219
1682,,Expert,CHEMBL617042,449.0,,105,,F,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",,H,8,1,,BAO_0000219
1683,,Expert,CHEMBL617043,449.0,,105,,F,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",,H,8,1,,BAO_0000219
1684,,Autocuration,CHEMBL617044,,,105,,F,,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1685,,Expert,CHEMBL617045,449.0,,105,,F,,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000219
1686,Homo sapiens,Expert,CHEMBL617046,449.0,,105,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,D,9,1,,BAO_0000219
1687,Homo sapiens,Expert,CHEMBL617047,449.0,,105,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,D,9,1,,BAO_0000219
1688,,Expert,CHEMBL617048,,,105,,F,,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",,H,8,1,,BAO_0000019
1689,,Autocuration,CHEMBL616897,,,105,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",,H,8,1,,BAO_0000019
1690,Homo sapiens,Expert,CHEMBL616898,,,105,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",,D,9,1,,BAO_0000019
1691,Homo sapiens,Expert,CHEMBL858201,449.0,,105,,F,,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,,D,9,1,,BAO_0000219
1692,,Autocuration,CHEMBL616899,,,105,,F,,Intrinsic activity for 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1693,,Autocuration,CHEMBL616900,,,105,,B,,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),,H,8,1,,BAO_0000219
1694,,Expert,CHEMBL616901,449.0,,105,,B,,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,,H,8,1,,BAO_0000219
1695,,Autocuration,CHEMBL616902,,,105,,B,,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
1696,Homo sapiens,Expert,CHEMBL616903,449.0,,105,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,9,1,,BAO_0000219
1697,,Expert,CHEMBL616904,449.0,,105,,B,,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,,H,8,1,,BAO_0000219
1698,,Autocuration,CHEMBL616905,,,105,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1699,,Expert,CHEMBL616906,449.0,,105,,B,,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,,H,8,1,,BAO_0000219
1700,,Expert,CHEMBL616907,449.0,,105,,B,,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
1701,,Expert,CHEMBL616908,449.0,,105,,B,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
1702,Homo sapiens,Expert,CHEMBL616909,449.0,,105,,B,,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,9,1,,BAO_0000219
1703,Homo sapiens,Expert,CHEMBL616910,449.0,,105,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,9,1,,BAO_0000219
1704,,Expert,CHEMBL616911,449.0,,105,,B,,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
1705,,Expert,CHEMBL616912,449.0,,105,,B,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,H,8,1,,BAO_0000219
1706,,Autocuration,CHEMBL616913,,,105,,B,,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
1707,Homo sapiens,Expert,CHEMBL616914,449.0,,105,,B,,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,,D,9,1,,BAO_0000219
1708,,Autocuration,CHEMBL616915,449.0,,105,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
1709,,Autocuration,CHEMBL616916,,,105,,B,,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,,H,8,1,,BAO_0000019
1710,Homo sapiens,Expert,CHEMBL616917,,,105,,B,,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1711,,Autocuration,CHEMBL616918,,,105,,B,,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",,H,8,1,,BAO_0000357
1712,,Expert,CHEMBL616919,,,105,,B,,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,H,8,1,,BAO_0000219
1713,,Autocuration,CHEMBL616920,,,105,,B,,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1714,,Autocuration,CHEMBL872914,,,105,,B,,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
1715,,Autocuration,CHEMBL616921,,,105,,B,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,,H,8,1,,BAO_0000357
1716,,Expert,CHEMBL616922,,,105,,B,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1717,,Autocuration,CHEMBL616923,,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1718,,Expert,CHEMBL616924,,,105,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1719,,Expert,CHEMBL875909,,,105,,B,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,,H,8,1,,BAO_0000357
1720,,Autocuration,CHEMBL616925,,,105,,B,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,,H,8,1,,BAO_0000357
1721,,Autocuration,CHEMBL616926,,,105,,B,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,,H,8,1,,BAO_0000357
1722,,Autocuration,CHEMBL616927,,,105,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1723,,Expert,CHEMBL616928,485.0,,105,,F,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,,H,8,1,,BAO_0000219
1724,Homo sapiens,Expert,CHEMBL616929,,,105,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),,D,9,1,,BAO_0000219
1725,Homo sapiens,Expert,CHEMBL616930,,,105,,B,,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1726,,Expert,CHEMBL616931,,,105,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1727,,Autocuration,CHEMBL616932,,,105,,B,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,H,8,1,,BAO_0000357
1728,,Expert,CHEMBL616933,,,105,,B,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1729,Homo sapiens,Expert,CHEMBL616934,,,105,,B,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,,D,9,1,,BAO_0000219
1730,Homo sapiens,Expert,CHEMBL616935,,,105,,B,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1731,,Autocuration,CHEMBL616936,,,105,,B,,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,,H,8,1,,BAO_0000357
1732,Homo sapiens,Expert,CHEMBL616937,,,105,,B,,Affinity for 5-hydroxytryptamine 1D receptor subtype,,D,9,1,,BAO_0000357
1733,Homo sapiens,Expert,CHEMBL616938,,,105,,B,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1734,,Autocuration,CHEMBL616939,,,105,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1735,,Expert,CHEMBL616940,,,105,,B,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,,H,8,1,,BAO_0000019
1736,Homo sapiens,Expert,CHEMBL616941,,,105,,B,,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,,D,9,1,,BAO_0000357
1737,,Autocuration,CHEMBL616942,485.0,,105,,B,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,,H,8,1,,BAO_0000219
1738,,Autocuration,CHEMBL616943,485.0,,105,,B,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,,H,8,1,,BAO_0000219
1739,,Autocuration,CHEMBL616944,449.0,,104802,,B,,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,,H,4,1,,BAO_0000219
1740,,Autocuration,CHEMBL616945,,,105,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",,H,8,1,,BAO_0000019
1741,,Autocuration,CHEMBL616946,,,105,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
1742,,Autocuration,CHEMBL616947,,,105,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,8,1,,BAO_0000019
1743,,Expert,CHEMBL616948,485.0,,105,,B,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000219
1744,,Autocuration,CHEMBL616851,,,105,,B,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1745,,Autocuration,CHEMBL616852,,,105,,B,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1746,,Autocuration,CHEMBL616853,,,105,,B,,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1747,Homo sapiens,Expert,CHEMBL616854,,,105,,B,,Binding activity against human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1748,Homo sapiens,Expert,CHEMBL616855,449.0,,105,,B,,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,D,9,1,,BAO_0000219
1749,,Autocuration,CHEMBL616856,449.0,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,,H,8,1,,BAO_0000219
1750,,Autocuration,CHEMBL616857,449.0,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
1751,,Autocuration,CHEMBL616858,,,105,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1752,,Autocuration,CHEMBL616859,449.0,,105,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
1753,,Autocuration,CHEMBL616860,449.0,,105,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,,H,8,1,,BAO_0000219
1754,,Autocuration,CHEMBL616861,722.0,,105,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
1755,,Autocuration,CHEMBL616541,722.0,,105,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
1756,,Autocuration,CHEMBL616542,722.0,,105,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,,H,8,1,,BAO_0000219
1757,,Autocuration,CHEMBL616543,449.0,,105,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000219
1758,Homo sapiens,Expert,CHEMBL616544,,,105,,B,,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1759,,Autocuration,CHEMBL616545,449.0,,105,,B,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,,H,8,1,,BAO_0000219
1760,,Autocuration,CHEMBL616546,,,105,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000357
1761,,Autocuration,CHEMBL616547,449.0,,105,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,,H,8,1,,BAO_0000219
1762,,Autocuration,CHEMBL616548,449.0,,105,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
1763,,Expert,CHEMBL616549,,,105,,F,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,,H,8,1,,BAO_0000019
1764,,Expert,CHEMBL616550,,,105,,F,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,,H,8,1,,BAO_0000019
1765,,Autocuration,CHEMBL857066,,,108,,B,,Binding affinity against 5-HT2C receptor,,H,8,1,,BAO_0000357
1766,,Autocuration,CHEMBL616551,,,108,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1767,,Autocuration,CHEMBL616552,,,10577,,B,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,H,8,1,,BAO_0000357
1768,,Autocuration,CHEMBL832876,,,10577,,F,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,H,8,1,,BAO_0000019
1769,,Expert,CHEMBL616553,,,10577,,B,,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",,H,8,1,,BAO_0000019
1770,,Autocuration,CHEMBL616554,,,10577,,B,,Binding affinity towards 5-HT1B was determined,,H,8,1,,BAO_0000357
1771,,Expert,CHEMBL616555,,,10577,,B,,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,,H,8,1,,BAO_0000019
1772,,Expert,CHEMBL616556,,,10577,,B,,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",,H,8,1,,BAO_0000019
1773,,Autocuration,CHEMBL616557,,,10577,,B,,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",,H,8,1,,BAO_0000019
1774,,Expert,CHEMBL616558,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,8,1,,BAO_0000019
1775,Rattus norvegicus,Expert,CHEMBL616749,,,10577,,B,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,,D,9,1,,BAO_0000019
1776,,Autocuration,CHEMBL616750,,,10577,,B,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,H,8,1,,BAO_0000357
1777,,Autocuration,CHEMBL616751,,,10577,,B,,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",,H,8,1,,BAO_0000357
1778,,Autocuration,CHEMBL616752,,,10577,,B,,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,H,8,1,,BAO_0000249
1779,,Autocuration,CHEMBL616753,,,10577,2435.0,B,,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,,H,8,1,,BAO_0000019
1780,Rattus norvegicus,Expert,CHEMBL616754,,,10577,,B,,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1781,,Autocuration,CHEMBL616755,,,10577,,B,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,,H,8,1,,BAO_0000019
1782,,Autocuration,CHEMBL616756,,,10577,2435.0,B,,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,,H,8,1,,BAO_0000019
1783,,Autocuration,CHEMBL616757,,,10577,2435.0,B,,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,,H,8,1,,BAO_0000019
1784,,Autocuration,CHEMBL616758,,,10577,2435.0,B,,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,,H,8,1,,BAO_0000357
1785,,Autocuration,CHEMBL616759,,,10577,,B,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,H,8,1,,BAO_0000249
1786,,Autocuration,CHEMBL616760,,,10577,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,,H,8,1,,BAO_0000357
1787,,Autocuration,CHEMBL616761,,,10577,2435.0,B,,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,,H,8,1,,BAO_0000019
1788,,Autocuration,CHEMBL616762,,,10577,2435.0,B,,Binding affinity against 5-HT1B serotonin receptor in rat striatum,,H,8,1,,BAO_0000019
1789,,Autocuration,CHEMBL616763,,,10577,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,,H,8,1,,BAO_0000019
1790,,Expert,CHEMBL872909,,,10577,,B,,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,,H,8,1,,BAO_0000357
1791,,Autocuration,CHEMBL616764,,,10577,,B,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1792,Rattus norvegicus,Expert,CHEMBL616765,,,10577,,B,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1793,,Autocuration,CHEMBL616766,,,10577,2435.0,B,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,,H,8,1,,BAO_0000357
1794,,Autocuration,CHEMBL616767,,,10577,2435.0,B,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,,H,8,1,,BAO_0000357
1795,,Autocuration,CHEMBL616768,,,10577,,B,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1796,,Autocuration,CHEMBL616769,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1797,,Autocuration,CHEMBL616770,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,,H,8,1,,BAO_0000019
1798,,Autocuration,CHEMBL616771,,,10577,,B,,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,,H,8,1,,BAO_0000019
1799,,Autocuration,CHEMBL616772,,,10577,2435.0,B,,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,,H,8,1,,BAO_0000019
1800,,Expert,CHEMBL616773,,,10577,,B,,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,,H,8,1,,BAO_0000019
1801,,Autocuration,CHEMBL616774,,,10577,,B,,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,,H,8,1,,BAO_0000019
1802,,Autocuration,CHEMBL616775,,,10577,,B,,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1803,,Autocuration,CHEMBL616776,,,10577,,B,,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000249
1804,,Autocuration,CHEMBL616777,,,10577,,B,,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,,H,8,1,,BAO_0000357
1805,,Autocuration,CHEMBL616778,,,10577,,B,,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,,H,8,1,,BAO_0000357
1806,Rattus norvegicus,Expert,CHEMBL616779,,,10577,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,,D,9,1,,BAO_0000249
1807,Rattus norvegicus,Expert,CHEMBL616780,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor,,D,9,1,,BAO_0000357
1808,,Autocuration,CHEMBL616781,,,10577,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,H,8,1,,BAO_0000019
1809,,Autocuration,CHEMBL616782,,,10577,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1810,,Autocuration,CHEMBL616783,,,10577,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
1811,,Expert,CHEMBL616784,,,10577,2435.0,B,,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,,H,8,1,,BAO_0000019
1812,,Autocuration,CHEMBL616785,,,10577,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,,H,8,1,,BAO_0000357
1813,,Autocuration,CHEMBL857067,,,10577,955.0,B,,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,8,1,,BAO_0000249
1814,,Autocuration,CHEMBL616786,,,10577,,B,,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,,H,8,1,,BAO_0000019
1815,,Autocuration,CHEMBL616787,,,10577,955.0,B,,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,8,1,,BAO_0000249
1816,,Autocuration,CHEMBL616788,,,10577,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,,H,8,1,,BAO_0000357
1817,,Autocuration,CHEMBL616789,,,10577,,B,,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1818,Rattus norvegicus,Expert,CHEMBL616790,,,10577,,B,,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,,D,9,1,,BAO_0000019
1819,,Expert,CHEMBL616791,,,10577,,B,,Binding affinity at 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1820,,Autocuration,CHEMBL616792,,,10577,,B,,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,,H,8,1,,BAO_0000019
1821,Rattus norvegicus,Expert,CHEMBL616793,,,10577,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,,D,9,1,,BAO_0000249
1822,,Autocuration,CHEMBL616794,,,10577,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1823,,Autocuration,CHEMBL616795,,,10577,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
1824,,Autocuration,CHEMBL616796,,,104686,,B,,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,,H,4,1,,BAO_0000019
1825,,Autocuration,CHEMBL616797,,,106,,B,,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1826,,Autocuration,CHEMBL616798,,,106,,B,,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,Brain membranes,H,8,1,,BAO_0000249
1827,,Autocuration,CHEMBL616799,,,106,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,,H,8,1,,BAO_0000357
1828,,Autocuration,CHEMBL616800,,,106,,B,,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,,H,8,1,,BAO_0000357
1829,,Autocuration,CHEMBL616801,,,106,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1830,,Autocuration,CHEMBL616802,,,106,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,,H,8,1,,BAO_0000357
1831,,Autocuration,CHEMBL616803,,,106,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,,H,8,1,,BAO_0000357
1832,,Expert,CHEMBL857068,,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,,H,8,1,,BAO_0000357
1833,,Autocuration,CHEMBL616804,,,106,,B,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,,H,8,1,,BAO_0000357
1834,,Autocuration,CHEMBL616805,,,106,,B,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,,H,8,1,,BAO_0000357
1835,,Autocuration,CHEMBL616806,,,106,,B,,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1836,,Autocuration,CHEMBL616807,,,106,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor,,H,8,1,,BAO_0000357
1837,,Autocuration,CHEMBL616808,,,106,,B,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1838,,Autocuration,CHEMBL616809,,,106,,B,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
1839,,Autocuration,CHEMBL616810,,,106,,B,,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,,H,8,1,,BAO_0000357
1840,,Autocuration,CHEMBL616811,,,104802,,B,,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,,H,4,1,,BAO_0000224
1841,Bos taurus,Autocuration,CHEMBL616812,,,108,,B,,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,,H,8,1,,BAO_0000357
1842,Sus scrofa,Autocuration,CHEMBL616813,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
1843,Sus scrofa,Autocuration,CHEMBL616814,,,108,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
1844,Sus scrofa,Autocuration,CHEMBL616815,,,108,,B,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,H,8,1,,BAO_0000357
1845,Sus scrofa,Autocuration,CHEMBL616816,,,108,,B,,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,H,8,1,,BAO_0000357
1846,Sus scrofa,Autocuration,CHEMBL616817,,,108,,B,,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,,H,8,1,,BAO_0000357
1847,Sus scrofa,Autocuration,CHEMBL616818,,,108,,B,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000357
1848,Sus scrofa,Expert,CHEMBL616819,,,108,,B,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,,H,8,1,,BAO_0000357
1849,Sus scrofa,Expert,CHEMBL616820,,,108,,B,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,,H,8,1,,BAO_0000357
1850,Sus scrofa,Expert,CHEMBL616821,,,108,,B,,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000019
1851,Sus scrofa,Autocuration,CHEMBL616822,,,108,,B,,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,,H,8,1,,BAO_0000357
1852,Oryctolagus cuniculus,Autocuration,CHEMBL616823,,,108,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
1853,Rattus norvegicus,Autocuration,CHEMBL616824,,,12689,,B,,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,,D,9,1,,BAO_0000357
1854,Rattus norvegicus,Autocuration,CHEMBL616825,,,12689,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,D,9,1,,BAO_0000357
1855,Rattus norvegicus,Autocuration,CHEMBL616826,,,12689,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,D,9,1,,BAO_0000357
1856,Rattus norvegicus,Expert,CHEMBL616827,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,,D,9,1,,BAO_0000019
1857,Rattus norvegicus,Autocuration,CHEMBL616828,,,12689,,B,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,,D,9,1,,BAO_0000357
1858,Rattus norvegicus,Autocuration,CHEMBL616829,,,12689,,B,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,D,9,1,,BAO_0000357
1859,Rattus norvegicus,Autocuration,CHEMBL616830,,,12689,,B,,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,,D,9,1,,BAO_0000019
1860,Rattus norvegicus,Expert,CHEMBL616831,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 1C receptor,,D,9,1,,BAO_0000357
1861,Rattus norvegicus,Autocuration,CHEMBL616832,,,12689,,B,,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,9,1,,BAO_0000019
1862,Rattus norvegicus,Autocuration,CHEMBL616833,,,12689,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,9,1,,BAO_0000019
1863,Rattus norvegicus,Expert,CHEMBL616834,,,12689,,B,,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,9,1,,BAO_0000019
1864,Rattus norvegicus,Autocuration,CHEMBL829595,,,12689,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,9,1,,BAO_0000019
1865,Rattus norvegicus,Autocuration,CHEMBL616835,,,12689,,B,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,,D,9,1,,BAO_0000357
1866,Rattus norvegicus,Autocuration,CHEMBL872910,,,12689,,B,,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,,D,9,1,,BAO_0000249
1867,,Expert,CHEMBL616836,,,12689,,B,,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
1868,Rattus norvegicus,Autocuration,CHEMBL616837,,,12689,,B,,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,,D,9,1,,BAO_0000357
1869,Rattus norvegicus,Autocuration,CHEMBL616466,,,12689,,B,,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,,D,9,1,,BAO_0000019
1870,Rattus norvegicus,Autocuration,CHEMBL616467,722.0,,12689,,B,,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,,D,9,1,,BAO_0000219
1871,,Autocuration,CHEMBL616468,,,108,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000357
1872,,Autocuration,CHEMBL616469,,,108,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
1873,,Autocuration,CHEMBL616470,,,108,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
1874,,Autocuration,CHEMBL616471,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000357
1875,,Autocuration,CHEMBL616472,,,12689,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000357
1876,,Autocuration,CHEMBL616473,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 1C receptor,,H,8,1,,BAO_0000357
1877,,Autocuration,CHEMBL616474,,,12689,,B,,Binding affinity against serotonergic 5-HT1c receptor,,H,8,1,,BAO_0000357
1878,,Autocuration,CHEMBL616475,,,12689,,B,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,,H,8,1,,BAO_0000357
1879,,Autocuration,CHEMBL616476,,,12689,,B,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,,H,8,1,,BAO_0000357
1880,Oryctolagus cuniculus,Autocuration,CHEMBL616477,,,105,,B,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,8,1,,BAO_0000019
1881,,Autocuration,CHEMBL616478,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,,H,4,1,,BAO_0000224
1882,,Autocuration,CHEMBL616479,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,,H,4,1,,BAO_0000224
1883,,Autocuration,CHEMBL616480,,,104686,,B,,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,,H,4,1,,BAO_0000019
1884,Rattus norvegicus,Autocuration,CHEMBL616481,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,,D,5,1,,BAO_0000019
1885,Rattus norvegicus,Autocuration,CHEMBL616482,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,,D,5,1,,BAO_0000249
1886,Rattus norvegicus,Autocuration,CHEMBL884713,,,104686,955.0,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,,D,5,1,,BAO_0000221
1887,,Autocuration,CHEMBL616483,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,,H,4,1,,BAO_0000224
1888,,Autocuration,CHEMBL616484,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,,H,4,1,,BAO_0000224
1889,,Autocuration,CHEMBL616485,,,104686,,B,,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,,H,4,1,,BAO_0000019
1890,,Autocuration,CHEMBL616486,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,4,1,,BAO_0000224
1891,,Autocuration,CHEMBL616487,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,,H,4,1,,BAO_0000224
1892,,Autocuration,CHEMBL616488,,,104686,,B,,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,H,4,1,,BAO_0000224
1893,,Autocuration,CHEMBL616489,,,104686,,B,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000019
1894,,Autocuration,CHEMBL616490,,,104686,,B,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000019
1895,,Autocuration,CHEMBL616491,,,104686,,B,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,,H,4,1,,BAO_0000019
1896,,Autocuration,CHEMBL616492,,,104686,,B,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,,H,4,1,,BAO_0000019
1897,,Autocuration,CHEMBL616493,,,104686,,B,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000019
1898,,Autocuration,CHEMBL616494,,,104686,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,,H,4,1,,BAO_0000019
1899,,Autocuration,CHEMBL616495,,,104686,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000019
1900,,Autocuration,CHEMBL616496,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,,H,4,1,,BAO_0000019
1901,,Autocuration,CHEMBL616497,,,104686,,B,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000019
1902,,Autocuration,CHEMBL616498,,,104686,,B,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000019
1903,,Autocuration,CHEMBL616499,,,104686,,B,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,,H,4,1,,BAO_0000019
1904,,Autocuration,CHEMBL616500,,,104686,,B,,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,,H,4,1,,BAO_0000019
1905,Rattus norvegicus,Autocuration,CHEMBL616501,,,104686,955.0,B,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,D,5,1,,BAO_0000221
1906,,Autocuration,CHEMBL616502,,,104686,955.0,B,,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,,H,4,1,,BAO_0000221
1907,,Autocuration,CHEMBL884529,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,H,4,1,,BAO_0000249
1908,,Autocuration,CHEMBL616503,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,H,4,1,,BAO_0000249
1909,,Autocuration,CHEMBL616964,,,104686,,B,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
1910,,Autocuration,CHEMBL616965,,,104686,,B,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,H,4,1,,BAO_0000249
1911,,Autocuration,CHEMBL616966,,,104686,,B,,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,,H,4,1,,BAO_0000224
1912,,Autocuration,CHEMBL616967,,,104686,,B,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,4,1,,BAO_0000224
1913,Rattus norvegicus,Autocuration,CHEMBL616968,,,104686,,B,,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
1914,,Autocuration,CHEMBL616969,,,104686,,B,,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,4,1,,BAO_0000224
1915,,Autocuration,CHEMBL884530,,,104686,,B,,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,,H,4,1,,BAO_0000019
1916,,Autocuration,CHEMBL616970,,,104686,,B,,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
1917,,Autocuration,CHEMBL616971,,,104686,,B,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,H,4,1,,BAO_0000224
1918,,Autocuration,CHEMBL616972,,,104686,,B,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,H,4,1,,BAO_0000224
1919,,Autocuration,CHEMBL616973,,,104686,,B,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,,H,4,1,,BAO_0000224
1920,,Autocuration,CHEMBL616974,,,104686,,B,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,,H,4,1,,BAO_0000224
1921,,Autocuration,CHEMBL616975,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,,H,4,1,,BAO_0000019
1922,,Autocuration,CHEMBL616976,,,104686,,B,,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,,H,4,1,,BAO_0000019
1923,,Autocuration,CHEMBL616977,,,104686,,B,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,,H,4,1,,BAO_0000224
1924,,Autocuration,CHEMBL616978,,,104686,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,H,4,1,,BAO_0000224
1925,,Autocuration,CHEMBL616979,,,104686,,B,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,,H,4,1,,BAO_0000224
1926,,Autocuration,CHEMBL616980,,,104686,,B,,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
1927,,Autocuration,CHEMBL616981,,,104686,,B,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,Membranes,H,4,1,,BAO_0000249
1928,,Autocuration,CHEMBL616982,,,104686,,B,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,Membranes,H,4,1,,BAO_0000249
1929,,Autocuration,CHEMBL616983,,,104686,,B,,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,,H,4,1,,BAO_0000224
1930,,Autocuration,CHEMBL616984,,,104686,,B,,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,,H,4,1,,BAO_0000019
1931,Rattus norvegicus,Autocuration,CHEMBL616985,,,104686,,B,,Inhibitory activity against 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
1932,,Autocuration,CHEMBL616986,,,104686,,B,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,H,4,1,,BAO_0000224
1933,,Autocuration,CHEMBL616987,,,104686,,B,,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,H,4,1,,BAO_0000224
1934,,Autocuration,CHEMBL616988,,,104686,,B,,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,,H,4,1,,BAO_0000019
1935,,Autocuration,CHEMBL617243,,,104686,,B,,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,,H,4,1,,BAO_0000019
1936,,Autocuration,CHEMBL617244,,,104686,,B,,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,,H,4,1,,BAO_0000019
1937,Rattus norvegicus,Autocuration,CHEMBL617245,485.0,,104686,,B,,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,5,1,,BAO_0000219
1938,,Autocuration,CHEMBL617246,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,H,4,1,,BAO_0000249
1939,,Autocuration,CHEMBL617546,,,104686,,B,,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),,H,4,1,,BAO_0000224
1940,,Autocuration,CHEMBL617547,,,104686,,B,,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),Brain membranes,H,4,1,,BAO_0000249
1941,,Autocuration,CHEMBL617548,,,104686,,B,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,4,1,,BAO_0000219
1942,,Autocuration,CHEMBL617549,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
1943,,Autocuration,CHEMBL617550,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,H,4,1,,BAO_0000224
1944,,Autocuration,CHEMBL617551,,,104686,,B,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,H,4,1,,BAO_0000224
1945,,Autocuration,CHEMBL617552,,,104686,,B,,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,Membranes,H,4,1,,BAO_0000249
1946,,Autocuration,CHEMBL617553,,,104686,,B,,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,Membranes,H,4,1,,BAO_0000249
1947,,Autocuration,CHEMBL617554,,,104686,1515.0,F,,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,,H,4,1,,BAO_0000019
1948,,Autocuration,CHEMBL617555,,,104686,,B,,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000019
1949,,Autocuration,CHEMBL617556,,,104686,,B,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,H,4,1,,BAO_0000224
1950,,Autocuration,CHEMBL617557,,,10624,,B,,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,H,8,1,,BAO_0000357
1951,,Autocuration,CHEMBL617558,,,10624,,B,,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,H,8,1,,BAO_0000357
1952,,Expert,CHEMBL617559,,,17106,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1953,,Expert,CHEMBL617560,,,17106,,B,,Binding affinity for 5-hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1954,,Autocuration,CHEMBL617561,,,17106,,B,,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,8,1,,BAO_0000249
1955,,Autocuration,CHEMBL617562,,,17106,,B,,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,8,1,,BAO_0000249
1956,,Autocuration,CHEMBL617563,,,17106,2435.0,B,,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,,H,8,1,,BAO_0000357
1957,,Autocuration,CHEMBL617564,,,17106,,F,,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1958,,Expert,CHEMBL617565,,,17106,,B,,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,,H,8,1,,BAO_0000019
1959,,Autocuration,CHEMBL856076,,,17106,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
1960,,Autocuration,CHEMBL617566,,,17106,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
1961,,Expert,CHEMBL875911,,,17106,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,8,1,,BAO_0000019
1962,,Autocuration,CHEMBL617567,,,17106,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,H,8,1,,BAO_0000019
1963,,Autocuration,CHEMBL617568,,,17106,,B,,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,8,1,,BAO_0000249
1964,,Expert,CHEMBL617569,,,17106,,B,,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,,H,8,1,,BAO_0000019
1965,,Expert,CHEMBL617570,,,17106,,B,,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,,H,8,1,,BAO_0000249
1966,,Autocuration,CHEMBL617571,,,17106,,B,,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,,H,8,1,,BAO_0000357
1967,Sus scrofa,Autocuration,CHEMBL617572,,,105,,B,,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,,H,8,1,,BAO_0000357
1968,Oryctolagus cuniculus,Expert,CHEMBL617573,,,105,,B,,The compound was tested for intrinsic activity against 5-HT1D receptor,,H,8,1,,BAO_0000357
1969,Oryctolagus cuniculus,Autocuration,CHEMBL617574,,,105,,B,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
1970,Oryctolagus cuniculus,Expert,CHEMBL617575,,,105,,B,,The compound was tested for binding affinity against 5-HT1D receptor,,H,8,1,,BAO_0000357
1971,,Autocuration,CHEMBL617576,,,10578,,B,,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,,H,8,1,,BAO_0000357
1972,,Autocuration,CHEMBL617577,,,10578,,F,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,,H,8,1,,BAO_0000019
1973,,Autocuration,CHEMBL617578,,,10578,,F,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000019
1974,,Autocuration,CHEMBL617579,,,10578,,B,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1975,,Expert,CHEMBL617580,,,10578,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,8,1,,BAO_0000019
1976,,Autocuration,CHEMBL617581,,,10578,,B,,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000249
1977,,Autocuration,CHEMBL617582,,,10578,,B,,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,,H,8,1,,BAO_0000357
1978,,Expert,CHEMBL617583,,,10578,,B,,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,,H,8,1,,BAO_0000019
1979,,Autocuration,CHEMBL617584,,,105,,B,,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,,H,8,1,,BAO_0000357
1980,,Autocuration,CHEMBL617585,,,105,,B,,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1981,,Autocuration,CHEMBL875912,,,105,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1982,,Autocuration,CHEMBL617586,,,105,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1983,,Autocuration,CHEMBL617587,,,105,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,,H,8,1,,BAO_0000357
1984,,Autocuration,CHEMBL617588,,,105,,B,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,,H,8,1,,BAO_0000357
1985,,Autocuration,CHEMBL857980,,,105,,B,,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1986,,Autocuration,CHEMBL617589,,,105,,B,,Tested against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
1987,,Autocuration,CHEMBL617590,,,105,,B,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
1988,,Autocuration,CHEMBL617591,722.0,,105,,B,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
1989,Homo sapiens,Expert,CHEMBL617592,,,105,,B,,Binding affinity against 5-Hydroxytryptamine 1D receptor,,D,9,1,,BAO_0000357
1990,,Autocuration,CHEMBL617593,,,105,,B,,,,H,8,1,,BAO_0000357
1991,,Autocuration,CHEMBL617594,485.0,,106,,B,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
1992,,Autocuration,CHEMBL617595,485.0,,105,,B,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
1993,,Autocuration,CHEMBL617596,722.0,,105,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,,H,8,1,,BAO_0000219
1994,,Autocuration,CHEMBL617597,722.0,,105,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,H,8,1,,BAO_0000219
1995,,Autocuration,CHEMBL617598,,,105,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
1996,,Autocuration,CHEMBL872916,,,105,,B,,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,,H,8,1,,BAO_0000357
1997,,Expert,CHEMBL617599,,,105,,B,,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,,H,8,1,,BAO_0000357
1998,,Autocuration,CHEMBL617091,,,105,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,,H,8,1,,BAO_0000357
1999,,Expert,CHEMBL617092,485.0,,105,,B,,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",,H,8,1,,BAO_0000219
2000,,Autocuration,CHEMBL617093,485.0,,105,,B,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
2001,,Autocuration,CHEMBL617094,,,105,,F,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,,H,8,1,,BAO_0000019
2002,,Autocuration,CHEMBL617095,,,105,,F,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,8,1,,BAO_0000019
2003,,Autocuration,CHEMBL617096,,,105,,F,,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,8,1,,BAO_0000019
2004,,Autocuration,CHEMBL617097,,,105,,F,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,8,1,,BAO_0000019
2005,,Autocuration,CHEMBL617098,,,105,,F,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,8,1,,BAO_0000019
2006,,Autocuration,CHEMBL617301,,,105,,B,,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2007,,Autocuration,CHEMBL617302,,,105,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2008,,Autocuration,CHEMBL617303,,,105,,B,,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2009,,Expert,CHEMBL617304,,,105,,B,,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2010,,Expert,CHEMBL617305,449.0,,105,,B,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2011,Homo sapiens,Autocuration,CHEMBL617306,,,105,,B,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,,D,9,1,,BAO_0000219
2012,,Autocuration,CHEMBL617307,,,17106,,B,,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,,H,8,1,,BAO_0000357
2013,Oryctolagus cuniculus,Autocuration,CHEMBL617308,,,105,,B,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
2014,,Autocuration,CHEMBL617309,,,105,,B,,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2015,,Autocuration,CHEMBL617310,,,105,,B,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2016,,Autocuration,CHEMBL617311,,,105,,B,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2017,,Autocuration,CHEMBL617312,,,105,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
2018,,Autocuration,CHEMBL617313,,,105,,B,,Affinity against 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2019,,Expert,CHEMBL617314,,,105,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,,H,8,1,,BAO_0000357
2020,,Autocuration,CHEMBL617315,,,106,,F,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,8,1,,BAO_0000019
2021,,Autocuration,CHEMBL617316,722.0,,106,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,,H,8,1,,BAO_0000219
2022,,Autocuration,CHEMBL617317,722.0,,106,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,H,8,1,,BAO_0000219
2023,,Autocuration,CHEMBL617318,449.0,,106,,B,,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2024,,Autocuration,CHEMBL617319,,,106,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
2025,,Expert,CHEMBL617320,,,106,,B,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,9,1,,BAO_0000357
2026,,Expert,CHEMBL617321,,,106,,B,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,9,1,,BAO_0000357
2027,,Expert,CHEMBL617322,,,106,,B,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,9,1,,BAO_0000357
2028,,Autocuration,CHEMBL616862,,,106,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
2029,,Autocuration,CHEMBL616863,,,106,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,,H,8,1,,BAO_0000357
2030,,Autocuration,CHEMBL616864,449.0,,106,,B,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,,H,8,1,,BAO_0000219
2031,,Autocuration,CHEMBL616865,485.0,,106,,B,,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
2032,,Autocuration,CHEMBL616866,485.0,,106,,B,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
2033,,Autocuration,CHEMBL616867,,,106,,F,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,8,1,,BAO_0000019
2034,,Expert,CHEMBL616868,485.0,,106,,B,,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",,H,8,1,,BAO_0000219
2035,,Expert,CHEMBL616869,,,105,,B,,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,,H,8,1,,BAO_0000357
2036,,Expert,CHEMBL616870,449.0,,106,,B,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2037,,Autocuration,CHEMBL616871,485.0,,105,,F,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,,H,8,1,,BAO_0000219
2038,,Autocuration,CHEMBL616872,485.0,,105,,F,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,,H,8,1,,BAO_0000219
2039,,Autocuration,CHEMBL616873,485.0,,105,,F,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,,H,8,1,,BAO_0000219
2040,,Autocuration,CHEMBL616838,485.0,,105,,F,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,,H,8,1,,BAO_0000219
2041,,Autocuration,CHEMBL616839,,,105,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,,H,8,1,,BAO_0000357
2042,Oryctolagus cuniculus,Autocuration,CHEMBL616840,,,106,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
2043,,Autocuration,CHEMBL616841,,,105,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,,H,8,1,,BAO_0000357
2044,,Autocuration,CHEMBL616842,,,105,,B,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2045,,Expert,CHEMBL857976,,,105,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor beta,,H,8,1,,BAO_0000357
2046,,Autocuration,CHEMBL616843,449.0,,10618,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2047,Homo sapiens,Expert,CHEMBL616844,,,10618,,B,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,,D,9,1,,BAO_0000357
2048,,Autocuration,CHEMBL616845,,,10618,,B,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,,H,8,1,,BAO_0000357
2049,Homo sapiens,Expert,CHEMBL616846,,,10618,,B,,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,,D,9,1,,BAO_0000357
2050,,Autocuration,CHEMBL616847,,,10618,,B,,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2051,,Autocuration,CHEMBL616848,,,10618,,B,,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,,H,8,1,,BAO_0000019
2052,,Autocuration,CHEMBL616849,,,10618,,B,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000357
2053,,Autocuration,CHEMBL872911,,,10618,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000357
2054,,Autocuration,CHEMBL616850,,,10618,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000019
2055,Homo sapiens,Expert,CHEMBL616699,449.0,,10618,,B,,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,,D,9,1,,BAO_0000219
2056,,Autocuration,CHEMBL616700,,,10618,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,,H,8,1,,BAO_0000357
2057,,Autocuration,CHEMBL616701,449.0,,10618,,B,,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
2058,,Autocuration,CHEMBL616702,449.0,,10618,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
2059,,Autocuration,CHEMBL616703,449.0,,10618,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,,H,8,1,,BAO_0000219
2060,,Autocuration,CHEMBL616704,,,10618,,B,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,,H,8,1,,BAO_0000357
2061,,Autocuration,CHEMBL616705,449.0,,10618,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000219
2062,,Autocuration,CHEMBL616706,,,10618,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000357
2063,,Autocuration,CHEMBL616707,449.0,,10618,,B,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,,H,8,1,,BAO_0000219
2064,,Autocuration,CHEMBL616708,,,10618,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000357
2065,,Autocuration,CHEMBL616709,,,10618,,B,,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2066,,Autocuration,CHEMBL616710,449.0,,10618,,B,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,,H,8,1,,BAO_0000219
2067,,Autocuration,CHEMBL616711,449.0,,10618,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,,H,8,1,,BAO_0000219
2068,,Autocuration,CHEMBL616712,449.0,,10618,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2069,,Autocuration,CHEMBL616713,,,10618,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,,H,8,1,,BAO_0000357
2070,,Autocuration,CHEMBL616714,,,10618,,B,,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,,H,8,1,,BAO_0000357
2071,,Autocuration,CHEMBL616715,,,10618,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000357
2072,,Autocuration,CHEMBL616716,,,10618,,B,,Binding affinity towards 5-hydroxytryptamine 1E receptor,,H,8,1,,BAO_0000357
2073,,Autocuration,CHEMBL616717,,,279,,F,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",,H,8,1,,BAO_0000019
2074,,Expert,CHEMBL616718,,,279,,F,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",,H,8,1,,BAO_0000019
2075,,Autocuration,CHEMBL875905,,,279,,F,,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000019
2076,,Autocuration,CHEMBL616719,,,279,,F,,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000019
2077,,Expert,CHEMBL616720,,,279,,F,,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",,H,8,1,,BAO_0000019
2078,,Autocuration,CHEMBL616721,,,279,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2079,,Autocuration,CHEMBL616722,449.0,,279,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2080,,Autocuration,CHEMBL616723,,,279,,B,,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
2081,,Autocuration,CHEMBL616724,449.0,,279,,B,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,,H,8,1,,BAO_0000219
2082,,Autocuration,CHEMBL616725,,,279,,B,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,,H,8,1,,BAO_0000357
2083,,Autocuration,CHEMBL616726,,,279,,B,,Binding affinity towards human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2084,,Autocuration,CHEMBL616727,,,279,,B,,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,,H,8,1,,BAO_0000357
2085,,Autocuration,CHEMBL616728,,,279,,B,,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,,H,8,1,,BAO_0000357
2086,,Autocuration,CHEMBL616729,,,279,,B,,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2087,,Expert,CHEMBL616730,,,279,,B,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000019
2088,,Autocuration,CHEMBL617125,,,279,,B,,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2089,,Autocuration,CHEMBL857977,,,279,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,,H,8,1,,BAO_0000357
2090,,Autocuration,CHEMBL617126,449.0,,279,,B,,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
2091,,Autocuration,CHEMBL617127,449.0,,279,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,,H,8,1,,BAO_0000219
2092,,Autocuration,CHEMBL617128,,,279,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2093,,Autocuration,CHEMBL617129,449.0,,279,,B,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,,H,8,1,,BAO_0000219
2094,,Autocuration,CHEMBL617130,,,279,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,,H,8,1,,BAO_0000357
2095,,Autocuration,CHEMBL617131,449.0,,279,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,,H,8,1,,BAO_0000219
2096,,Autocuration,CHEMBL617132,449.0,,279,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2097,,Autocuration,CHEMBL617133,449.0,,279,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2098,,Autocuration,CHEMBL617134,,,279,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,,H,8,1,,BAO_0000357
2099,,Autocuration,CHEMBL617135,,,279,,B,,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,,H,8,1,,BAO_0000357
2100,,Autocuration,CHEMBL617136,,,279,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,,H,8,1,,BAO_0000357
2101,,Autocuration,CHEMBL617137,,,104686,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",,H,4,1,,BAO_0000019
2102,,Autocuration,CHEMBL617138,,,104686,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,H,4,1,,BAO_0000019
2103,,Autocuration,CHEMBL617139,,,104686,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,4,1,,BAO_0000019
2104,,Autocuration,CHEMBL617140,,,12687,,B,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2105,,Autocuration,CHEMBL617141,,,104686,,F,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",,H,4,1,,BAO_0000218
2106,,Autocuration,CHEMBL858112,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2107,,Intermediate,CHEMBL617142,,,17005,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,,H,8,1,,BAO_0000019
2108,Bos taurus,Autocuration,CHEMBL617143,,,22226,,B,,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",,U,0,1,,BAO_0000019
2109,Bos taurus,Autocuration,CHEMBL617144,,,22226,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,,U,0,1,,BAO_0000019
2110,Bos taurus,Autocuration,CHEMBL617145,,,22226,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,,U,0,1,,BAO_0000019
2111,,Autocuration,CHEMBL617146,,,22226,,B,,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,,U,0,1,,BAO_0000019
2112,Cavia porcellus,Autocuration,CHEMBL617147,,,104784,,B,,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,,H,4,1,,BAO_0000019
2113,Cavia porcellus,Autocuration,CHEMBL617148,,,104784,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,,H,4,1,,BAO_0000019
2114,Cavia porcellus,Autocuration,CHEMBL617149,,,104784,,B,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,,H,4,1,,BAO_0000019
2115,,Autocuration,CHEMBL617150,,,104784,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,,H,4,1,,BAO_0000224
2116,,Autocuration,CHEMBL617151,,,104784,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,4,1,,BAO_0000224
2117,,Autocuration,CHEMBL617201,,,104784,,B,,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2118,,Autocuration,CHEMBL617202,,,10209,,B,,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,H,8,1,,BAO_0000357
2119,,Autocuration,CHEMBL617203,,,104826,,B,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,H,4,1,,BAO_0000218
2120,,Autocuration,CHEMBL617204,,,104826,,B,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,H,4,1,,BAO_0000019
2121,,Autocuration,CHEMBL617205,,,104826,,B,,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,,H,4,1,,BAO_0000224
2122,Mus musculus,Autocuration,CHEMBL617206,,,104826,,B,,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,,D,5,1,,BAO_0000019
2123,,Autocuration,CHEMBL617207,,,104826,,B,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,H,4,1,,BAO_0000218
2124,Mus musculus,Autocuration,CHEMBL617208,,,104826,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,,D,5,1,,BAO_0000019
2125,,Autocuration,CHEMBL617209,,,104826,,B,,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2126,,Autocuration,CHEMBL617210,,,104826,,B,,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,,H,4,1,,BAO_0000224
2127,,Autocuration,CHEMBL617211,,,104826,,B,,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,,H,4,1,,BAO_0000224
2128,Mus musculus,Autocuration,CHEMBL617212,,,104826,,B,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,D,5,1,,BAO_0000019
2129,Sus scrofa,Autocuration,CHEMBL617213,,,104784,,B,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,,H,4,1,,BAO_0000224
2130,Sus scrofa,Autocuration,CHEMBL617214,,,104784,,B,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,,H,4,1,,BAO_0000224
2131,,Autocuration,CHEMBL617215,,,22226,,B,,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,U,0,1,,BAO_0000221
2132,,Autocuration,CHEMBL617216,,,22226,,B,,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,U,0,1,,BAO_0000221
2133,Sus scrofa,Autocuration,CHEMBL617217,,,17005,,B,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000357
2134,,Autocuration,CHEMBL617218,,,104686,,B,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000019
2135,,Autocuration,CHEMBL872913,,,104686,,B,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000019
2136,,Autocuration,CHEMBL617219,,,104826,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,,H,4,1,,BAO_0000019
2137,,Autocuration,CHEMBL873482,,,104686,,B,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2138,Rattus norvegicus,Autocuration,CHEMBL617220,,,104686,,B,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,,D,5,1,,BAO_0000019
2139,,Autocuration,CHEMBL617221,,,104686,,B,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,,H,4,1,,BAO_0000019
2140,,Autocuration,CHEMBL617222,,,104686,,B,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,,H,4,1,,BAO_0000019
2141,,Autocuration,CHEMBL875906,,,104686,,F,,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,,H,4,1,,BAO_0000019
2142,,Autocuration,CHEMBL617223,,,104686,,B,,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,,H,4,1,,BAO_0000019
2143,,Autocuration,CHEMBL617224,,,104686,,B,,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2144,Rattus norvegicus,Autocuration,CHEMBL617225,,,104686,,B,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,D,5,1,,BAO_0000224
2145,,Autocuration,CHEMBL617226,,,104686,,B,,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,,H,4,1,,BAO_0000224
2146,,Autocuration,CHEMBL617227,,,104686,,B,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,,H,4,1,,BAO_0000224
2147,,Autocuration,CHEMBL617228,,,104686,,B,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,,H,4,1,,BAO_0000224
2148,,Autocuration,CHEMBL617229,,,104686,,B,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,H,4,1,,BAO_0000224
2149,,Autocuration,CHEMBL617230,,,104686,,B,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,H,4,1,,BAO_0000224
2150,,Autocuration,CHEMBL617231,,,104686,,B,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,H,4,1,,BAO_0000224
2151,,Autocuration,CHEMBL617232,,,104686,,B,,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,,H,4,1,,BAO_0000224
2152,,Autocuration,CHEMBL617233,,,104686,,B,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2153,,Autocuration,CHEMBL617234,,,104686,,B,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,4,1,,BAO_0000224
2154,,Autocuration,CHEMBL617235,,,104686,,F,,Compound was tested for the inhibition of quipazine induced head twitches in rats,,H,4,1,,BAO_0000019
2155,,Autocuration,CHEMBL617236,,,104686,,F,,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,,H,4,1,,BAO_0000019
2156,,Autocuration,CHEMBL617237,,,104686,10000000.0,B,,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,,H,4,1,,BAO_0000221
2157,,Autocuration,CHEMBL617238,,,104686,10000000.0,B,,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,,H,4,1,,BAO_0000221
2158,Rattus norvegicus,Autocuration,CHEMBL617239,,,104686,955.0,B,,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,,D,5,1,,BAO_0000221
2159,,Autocuration,CHEMBL617240,,,104686,,B,,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,,H,4,1,,BAO_0000019
2160,,Autocuration,CHEMBL617241,,,104686,,B,,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,H,4,1,,BAO_0000249
2161,,Autocuration,CHEMBL875907,,,104686,,B,,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,H,4,1,,BAO_0000249
2162,,Autocuration,CHEMBL617242,,,104686,,B,,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,,H,4,1,,BAO_0000019
2163,,Autocuration,CHEMBL617152,,,104686,,F,,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,,H,4,1,,BAO_0000019
2164,Rattus norvegicus,Autocuration,CHEMBL617153,,,104686,955.0,B,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,D,5,1,,BAO_0000221
2165,Rattus norvegicus,Autocuration,CHEMBL617154,,,104686,,B,,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,Membranes,D,5,1,,BAO_0000249
2166,,Autocuration,CHEMBL617155,,,104686,955.0,B,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000221
2167,,Autocuration,CHEMBL617156,,,104686,,F,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,H,4,1,,BAO_0000019
2168,,Autocuration,CHEMBL617157,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2169,,Autocuration,CHEMBL617158,,,104686,,F,,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2170,,Autocuration,CHEMBL617159,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,H,4,1,,BAO_0000019
2171,,Autocuration,CHEMBL617160,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,H,4,1,,BAO_0000019
2172,,Autocuration,CHEMBL858113,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2173,,Autocuration,CHEMBL617247,,,104686,955.0,B,,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,,H,4,1,,BAO_0000220
2174,,Autocuration,CHEMBL617248,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000019
2175,,Autocuration,CHEMBL617249,,,104686,955.0,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,4,1,,BAO_0000249
2176,,Autocuration,CHEMBL617250,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,,H,4,1,,BAO_0000019
2177,,Autocuration,CHEMBL617251,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000019
2178,Rattus norvegicus,Autocuration,CHEMBL617252,,,104686,,B,,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000019
2179,,Autocuration,CHEMBL617006,,,104686,,B,,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,,H,4,1,,BAO_0000019
2180,,Autocuration,CHEMBL617007,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,,H,4,1,,BAO_0000019
2181,,Autocuration,CHEMBL617008,,,104686,,F,,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",,H,4,1,,BAO_0000019
2182,,Autocuration,CHEMBL617009,,,104686,,B,,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,,H,4,1,,BAO_0000019
2183,Rattus norvegicus,Autocuration,CHEMBL617010,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,,D,5,1,,BAO_0000224
2184,Rattus norvegicus,Autocuration,CHEMBL857978,,,104686,,B,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000019
2185,Rattus norvegicus,Autocuration,CHEMBL617011,,,104686,,B,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000019
2186,Rattus norvegicus,Autocuration,CHEMBL617012,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,,D,5,1,,BAO_0000019
2187,,Autocuration,CHEMBL617013,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,,H,4,1,,BAO_0000224
2188,,Autocuration,CHEMBL617014,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,,H,4,1,,BAO_0000249
2189,,Autocuration,CHEMBL617015,,,104686,,B,,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000019
2190,,Autocuration,CHEMBL617016,,,104686,,B,,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,,H,4,1,,BAO_0000019
2191,,Autocuration,CHEMBL617017,,,104686,,B,,pKi value for 5-hydroxytryptamine 2 receptor binding site,,H,4,1,,BAO_0000224
2192,,Autocuration,CHEMBL617018,,,104686,955.0,B,,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,,H,4,1,,BAO_0000221
2193,,Autocuration,CHEMBL617019,,,104686,,F,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,H,4,1,,BAO_0000019
2194,,Autocuration,CHEMBL617020,,,105075,,B,,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2195,,Autocuration,CHEMBL617021,,,105075,,B,,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2196,,Autocuration,CHEMBL617022,,,105075,,B,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2197,,Autocuration,CHEMBL617023,,,105075,,B,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2198,,Autocuration,CHEMBL617024,,,105075,,B,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2199,,Autocuration,CHEMBL617025,,,105075,,B,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2200,,Autocuration,CHEMBL617026,,,105075,,B,,Hill coefficient of compound was determined,,H,4,1,,BAO_0000224
2201,,Autocuration,CHEMBL617027,,,22226,,B,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,,U,0,1,,BAO_0000019
2202,Rattus norvegicus,Autocuration,CHEMBL617028,,,104686,,B,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,,D,5,1,,BAO_0000019
2203,,Expert,CHEMBL617029,,,12687,,B,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,,H,8,1,,BAO_0000019
2204,,Expert,CHEMBL875908,,,12687,,B,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,,H,8,1,,BAO_0000019
2205,,Autocuration,CHEMBL617030,,,12687,,B,,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),,H,8,1,,BAO_0000357
2206,,Autocuration,CHEMBL617031,,,12687,,B,,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),,H,8,1,,BAO_0000019
2207,,Autocuration,CHEMBL617032,,,12687,,B,,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,,H,8,1,,BAO_0000019
2208,Rattus norvegicus,Autocuration,CHEMBL617033,,,104686,,B,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,,D,5,1,,BAO_0000224
2209,,Autocuration,CHEMBL617034,,,104686,,B,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",,H,4,1,,BAO_0000224
2210,,Autocuration,CHEMBL617035,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,,H,4,1,,BAO_0000224
2211,,Autocuration,CHEMBL617036,,,104686,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,4,1,,BAO_0000019
2212,,Autocuration,CHEMBL617037,,,104784,,B,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2213,,Autocuration,CHEMBL617038,,,22226,,B,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,,U,0,1,,BAO_0000219
2214,,Autocuration,CHEMBL617039,,,104784,,B,,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",,H,4,1,,BAO_0000219
2215,,Autocuration,CHEMBL617161,,,104784,,B,,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2216,,Autocuration,CHEMBL617162,,,104784,,B,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2217,,Autocuration,CHEMBL617163,,,104784,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2218,,Autocuration,CHEMBL617164,,,104784,,B,,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2219,,Autocuration,CHEMBL617165,,,104784,,B,,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,Brain membranes,H,4,1,,BAO_0000249
2220,,Autocuration,CHEMBL617166,,,104784,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000224
2221,,Autocuration,CHEMBL617167,,,104784,,B,,Binding affinity towards 5-HT2 receptor,,H,4,1,,BAO_0000224
2222,,Autocuration,CHEMBL872912,,,104784,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2223,,Autocuration,CHEMBL617168,,,104784,,B,,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,,H,4,1,,BAO_0000224
2224,,Autocuration,CHEMBL617169,,,104686,,B,,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,,H,4,1,,BAO_0000224
2225,,Autocuration,CHEMBL617170,,,104784,,B,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2226,,Autocuration,CHEMBL617171,,,104784,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,,H,4,1,,BAO_0000224
2227,,Autocuration,CHEMBL617172,,,104784,,B,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,,H,4,1,,BAO_0000224
2228,,Autocuration,CHEMBL617173,,,104784,,B,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2229,,Autocuration,CHEMBL617174,,,22226,,B,,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,,U,0,1,,BAO_0000019
2230,,Autocuration,CHEMBL617175,,,104784,,B,,5-hydroxytryptamine 2 receptor binding affinity,,H,4,1,,BAO_0000224
2231,,Autocuration,CHEMBL617176,,,17005,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,,H,8,1,,BAO_0000357
2232,,Autocuration,CHEMBL617177,,,17005,,B,,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2233,,Autocuration,CHEMBL617178,,,104784,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,H,4,1,,BAO_0000224
2234,,Autocuration,CHEMBL617179,,,104784,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,,H,4,1,,BAO_0000224
2235,,Autocuration,CHEMBL617180,,,104784,,B,,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,H,4,1,,BAO_0000224
2236,,Autocuration,CHEMBL617181,,,17005,,B,,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,,H,8,1,,BAO_0000357
2237,,Autocuration,CHEMBL617182,,,17005,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000357
2238,,Autocuration,CHEMBL617183,,,17005,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000357
2239,,Autocuration,CHEMBL617184,,,17005,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2240,,Autocuration,CHEMBL617185,,,17005,,B,,Binding affinity against serotonergic 5-HT2 receptor,,H,8,1,,BAO_0000357
2241,,Autocuration,CHEMBL617186,,,17005,,B,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2242,,Autocuration,CHEMBL617187,,,17005,,B,,Compound was evaluated for the binding affinity at 5- HT2 receptor,,H,8,1,,BAO_0000357
2243,,Autocuration,CHEMBL617188,,,17005,,B,,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000357
2244,,Autocuration,CHEMBL617189,,,17005,,B,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000218
2245,Homo sapiens,Autocuration,CHEMBL617190,,,104784,,B,,Inhibitory activity against cloned human 5-HT2 receptor,,D,5,1,,BAO_0000224
2246,Homo sapiens,Autocuration,CHEMBL617191,449.0,,104784,,B,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",,D,5,1,,BAO_0000219
2247,Homo sapiens,Autocuration,CHEMBL617192,449.0,,104784,,B,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",,D,5,1,,BAO_0000219
2248,Homo sapiens,Autocuration,CHEMBL617193,449.0,,104784,,B,,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",,D,5,1,,BAO_0000219
2249,Homo sapiens,Autocuration,CHEMBL617194,449.0,,104784,,B,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",,D,5,1,,BAO_0000219
2250,,Autocuration,CHEMBL617195,,,104784,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2251,,Autocuration,CHEMBL881830,,,104784,,B,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,H,4,1,,BAO_0000224
2252,,Autocuration,CHEMBL617196,,,17005,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,8,1,,BAO_0000357
2253,,Autocuration,CHEMBL617197,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,,H,4,1,,BAO_0000224
2254,,Expert,CHEMBL617198,,,17005,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2255,,Expert,CHEMBL873476,,,17005,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2256,,Expert,CHEMBL617199,,,17005,,B,,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,,H,8,1,,BAO_0000019
2257,Cavia porcellus,Autocuration,CHEMBL617200,,,107,,B,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2258,,Autocuration,CHEMBL617484,,,51,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,8,1,,BAO_0000357
2259,,Autocuration,CHEMBL617485,,,107,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,8,1,,BAO_0000357
2260,,Autocuration,CHEMBL617486,,,51,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,8,1,,BAO_0000357
2261,,Autocuration,CHEMBL858022,,,107,,B,,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2262,,Autocuration,CHEMBL617049,449.0,,107,,B,,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,H,8,1,,BAO_0000219
2263,Homo sapiens,Expert,CHEMBL617050,449.0,,107,,F,,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,,D,9,1,,BAO_0000219
2264,,Autocuration,CHEMBL617051,,,107,,F,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,H,8,1,,BAO_0000219
2265,,Autocuration,CHEMBL617052,,,107,,F,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,,H,8,1,,BAO_0000219
2266,,Autocuration,CHEMBL617053,,,107,,F,,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,H,8,1,,BAO_0000219
2267,,Autocuration,CHEMBL617054,449.0,,107,,B,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",,H,8,1,,BAO_0000219
2268,,Autocuration,CHEMBL617055,449.0,,107,,B,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",,H,8,1,,BAO_0000219
2269,,Autocuration,CHEMBL882924,,,107,,B,,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,,H,8,1,,BAO_0000357
2270,Homo sapiens,Expert,CHEMBL617056,,,107,,B,,Inhibition of human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2271,,Autocuration,CHEMBL617057,449.0,,107,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2272,,Expert,CHEMBL617058,,,107,,B,,Inhibitory concentration against human 5-HT2A receptor in BEK cells,,H,8,1,,BAO_0000219
2273,,Autocuration,CHEMBL617059,,,107,,B,,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
2274,,Autocuration,CHEMBL617060,449.0,,107,,B,,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000219
2275,,Expert,CHEMBL617061,449.0,,107,,B,,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,,H,8,1,,BAO_0000219
2276,,Expert,CHEMBL617062,307.0,,107,,B,,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,,H,8,1,,BAO_0000219
2277,,Expert,CHEMBL617063,449.0,,107,,B,,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2278,,Autocuration,CHEMBL617064,,,107,,F,,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,,H,8,1,,BAO_0000019
2279,,Autocuration,CHEMBL617065,,,107,,F,,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000019
2280,,Autocuration,CHEMBL617066,449.0,,107,,B,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,H,8,1,,BAO_0000219
2281,,Autocuration,CHEMBL617067,449.0,,107,,B,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,,H,8,1,,BAO_0000219
2282,,Autocuration,CHEMBL617068,,,107,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,,H,8,1,,BAO_0000019
2283,,Autocuration,CHEMBL617069,,,107,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,,H,8,1,,BAO_0000019
2284,,Autocuration,CHEMBL617070,,,107,,F,,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2285,,Autocuration,CHEMBL617071,,,107,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,,H,8,1,,BAO_0000357
2286,,Autocuration,CHEMBL872915,,,107,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2287,,Autocuration,CHEMBL617072,,,107,,B,,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,,H,8,1,,BAO_0000357
2288,,Autocuration,CHEMBL617073,,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,,H,8,1,,BAO_0000357
2289,,Autocuration,CHEMBL617074,,,107,,B,,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,,H,8,1,,BAO_0000357
2290,,Expert,CHEMBL617075,449.0,,107,,B,,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2291,,Autocuration,CHEMBL617076,,,107,,B,,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2292,Homo sapiens,Expert,CHEMBL617077,,,107,,B,,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,,D,9,1,,BAO_0000019
2293,,Expert,CHEMBL617078,,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,,H,8,1,,BAO_0000357
2294,Homo sapiens,Expert,CHEMBL617079,,,107,,B,,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2295,,Autocuration,CHEMBL617080,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
2296,,Expert,CHEMBL617081,449.0,,107,,B,,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,,H,8,1,,BAO_0000219
2297,,Expert,CHEMBL617082,,,107,,B,,Binding affinity towards human 5-HT2A receptor in BEK cells,,H,8,1,,BAO_0000219
2298,,Autocuration,CHEMBL617083,,,107,,B,,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2299,,Autocuration,CHEMBL617084,,,107,,B,,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000357
2300,Homo sapiens,Expert,CHEMBL617085,,,107,,B,,Binding affinity for human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2301,,Autocuration,CHEMBL617086,,,107,,B,,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2302,,Autocuration,CHEMBL617087,,,107,,B,,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,,H,8,1,,BAO_0000219
2303,,Autocuration,CHEMBL617088,,,107,,B,,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2304,,Autocuration,CHEMBL617089,,,107,,B,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2305,,Expert,CHEMBL617090,,,107,,B,,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",,H,8,1,,BAO_0000019
2306,,Autocuration,CHEMBL617513,,,107,,B,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2307,,Autocuration,CHEMBL617514,722.0,,107,,B,,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2308,,Autocuration,CHEMBL617515,,,107,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2309,,Autocuration,CHEMBL617516,,,107,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,8,1,,BAO_0000357
2310,Homo sapiens,Expert,CHEMBL617517,,,107,,B,,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,D,9,1,,BAO_0000357
2311,Homo sapiens,Expert,CHEMBL617518,449.0,,107,,B,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,,D,9,1,,BAO_0000219
2312,,Autocuration,CHEMBL617519,,,107,,B,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2313,Homo sapiens,Expert,CHEMBL617520,,,107,,B,,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2314,,Autocuration,CHEMBL617521,,,107,,B,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,,H,8,1,,BAO_0000357
2315,Homo sapiens,Expert,CHEMBL617522,,,107,,B,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2316,,Autocuration,CHEMBL617523,,,107,,B,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2317,,Autocuration,CHEMBL617524,,,107,,B,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2318,,Autocuration,CHEMBL617525,,,104686,,B,,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,,H,4,1,,BAO_0000019
2319,Rattus norvegicus,Autocuration,CHEMBL617526,,,104686,,B,,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,,D,5,1,,BAO_0000019
2320,,Autocuration,CHEMBL617527,,,104686,,B,,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,,H,4,1,,BAO_0000224
2321,,Autocuration,CHEMBL617528,,,104686,,B,,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,H,4,1,,BAO_0000019
2322,,Autocuration,CHEMBL617529,,,104686,,B,,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,H,4,1,,BAO_0000019
2323,,Autocuration,CHEMBL617530,,,104686,,B,,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,,H,4,1,,BAO_0000224
2324,,Autocuration,CHEMBL617531,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,H,4,1,,BAO_0000019
2325,,Autocuration,CHEMBL617532,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,,H,4,1,,BAO_0000019
2326,,Autocuration,CHEMBL617533,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000019
2327,,Autocuration,CHEMBL617534,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,H,4,1,,BAO_0000019
2328,,Autocuration,CHEMBL617535,,,104686,,B,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000224
2329,,Autocuration,CHEMBL617536,,,104686,,B,,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,H,4,1,,BAO_0000224
2330,,Autocuration,CHEMBL617537,,,104686,,B,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2331,,Autocuration,CHEMBL617538,,,104686,,B,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2332,,Autocuration,CHEMBL617539,,,104686,,B,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,4,1,,BAO_0000219
2333,Rattus norvegicus,Autocuration,CHEMBL617540,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
2334,Rattus norvegicus,Autocuration,CHEMBL617541,,,104686,,B,,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,,D,5,1,,BAO_0000224
2335,,Autocuration,CHEMBL617542,,,104686,,B,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2336,,Autocuration,CHEMBL617543,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,,H,4,1,,BAO_0000224
2337,Rattus norvegicus,Autocuration,CHEMBL617544,485.0,,104686,,B,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,5,1,,BAO_0000219
2338,Rattus norvegicus,Autocuration,CHEMBL617545,485.0,,104686,,B,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,5,1,,BAO_0000219
2339,Rattus norvegicus,Autocuration,CHEMBL617413,,,104686,,B,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,,D,5,1,,BAO_0000019
2340,,Autocuration,CHEMBL617414,,,104686,,B,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,,H,4,1,,BAO_0000019
2341,Rattus norvegicus,Autocuration,CHEMBL617415,,,104686,,B,,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,,D,5,1,,BAO_0000019
2342,,Autocuration,CHEMBL617416,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2343,,Autocuration,CHEMBL617417,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,H,4,1,,BAO_0000224
2344,,Autocuration,CHEMBL617418,,,104686,,B,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",,H,4,1,,BAO_0000019
2345,,Autocuration,CHEMBL617419,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,,H,4,1,,BAO_0000019
2346,,Autocuration,CHEMBL617420,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,4,1,,BAO_0000224
2347,Rattus norvegicus,Autocuration,CHEMBL617421,,,104686,,B,,Affinity for 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
2348,,Autocuration,CHEMBL617422,,,104686,,B,,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,,H,4,1,,BAO_0000224
2349,,Autocuration,CHEMBL617423,,,104686,,B,,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,,H,4,1,,BAO_0000019
2350,,Autocuration,CHEMBL617424,,,104686,,B,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,,H,4,1,,BAO_0000019
2351,,Autocuration,CHEMBL617425,,,104686,,B,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,,H,4,1,,BAO_0000019
2352,,Autocuration,CHEMBL617426,,,104686,,B,,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),,H,4,1,,BAO_0000224
2353,,Autocuration,CHEMBL617427,,,104686,,B,,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),,H,4,1,,BAO_0000218
2354,,Autocuration,CHEMBL617428,,,104686,955.0,B,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,,H,4,1,,BAO_0000221
2355,,Autocuration,CHEMBL617429,,,104686,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,,H,4,1,,BAO_0000224
2356,,Autocuration,CHEMBL617430,,,104686,,B,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,H,4,1,,BAO_0000019
2357,,Autocuration,CHEMBL617431,,,104686,,B,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,H,4,1,,BAO_0000019
2358,,Autocuration,CHEMBL617432,,,104686,1870.0,B,,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,,H,4,1,,BAO_0000019
2359,,Autocuration,CHEMBL617433,,,104686,,B,,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2360,,Autocuration,CHEMBL617434,,,104686,,B,,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2361,Rattus norvegicus,Autocuration,CHEMBL617435,,,104686,,B,,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,,D,5,1,,BAO_0000224
2362,,Autocuration,CHEMBL617436,,,104686,,B,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,,H,4,1,,BAO_0000019
2363,Rattus norvegicus,Autocuration,CHEMBL617437,,,104686,2435.0,B,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,,D,5,1,,BAO_0000019
2364,,Autocuration,CHEMBL617438,,,104686,,B,,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,H,4,1,,BAO_0000019
2365,,Autocuration,CHEMBL617439,,,104686,,B,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,4,1,,BAO_0000019
2366,,Autocuration,CHEMBL617440,,,104686,,B,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2367,,Autocuration,CHEMBL617441,,,104686,,B,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2368,Rattus norvegicus,Autocuration,CHEMBL872918,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,,D,5,1,,BAO_0000019
2369,Rattus norvegicus,Autocuration,CHEMBL617442,,,104686,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,,D,5,1,,BAO_0000019
2370,,Autocuration,CHEMBL617443,,,104686,,B,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,H,4,1,,BAO_0000019
2371,,Autocuration,CHEMBL617444,,,104686,,B,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,,H,4,1,,BAO_0000019
2372,,Autocuration,CHEMBL617445,,,104686,,B,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,H,4,1,,BAO_0000019
2373,,Autocuration,CHEMBL617446,,,104686,,B,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,,H,4,1,,BAO_0000019
2374,,Autocuration,CHEMBL617447,,,104686,,B,,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,,H,4,1,,BAO_0000249
2375,,Autocuration,CHEMBL617448,,,104686,,B,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,,H,4,1,,BAO_0000019
2376,,Autocuration,CHEMBL617449,,,104686,,B,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,,H,4,1,,BAO_0000019
2377,,Autocuration,CHEMBL617450,,,104686,,B,,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,,H,4,1,,BAO_0000019
2378,,Autocuration,CHEMBL617451,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,,H,4,1,,BAO_0000019
2379,,Autocuration,CHEMBL617452,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,,H,4,1,,BAO_0000019
2380,,Autocuration,CHEMBL617453,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,,H,4,1,,BAO_0000019
2381,,Autocuration,CHEMBL617660,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,,H,4,1,,BAO_0000019
2382,,Autocuration,CHEMBL617661,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,,H,4,1,,BAO_0000019
2383,,Autocuration,CHEMBL617662,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,,H,4,1,,BAO_0000019
2384,,Autocuration,CHEMBL872919,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,,H,4,1,,BAO_0000019
2385,,Autocuration,CHEMBL617663,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,,H,4,1,,BAO_0000019
2386,,Autocuration,CHEMBL617664,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,,H,4,1,,BAO_0000019
2387,,Autocuration,CHEMBL617665,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,,H,4,1,,BAO_0000019
2388,,Autocuration,CHEMBL617666,,,104686,,B,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,,H,4,1,,BAO_0000019
2389,,Autocuration,CHEMBL617667,,,104686,,B,,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,,H,4,1,,BAO_0000019
2390,,Autocuration,CHEMBL617668,,,104686,,B,,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,,H,4,1,,BAO_0000249
2391,,Autocuration,CHEMBL617669,,,104686,,B,,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,,H,4,1,,BAO_0000249
2392,,Autocuration,CHEMBL617670,,,104686,,B,,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2393,Rattus norvegicus,Autocuration,CHEMBL617671,,,104686,,B,,Inhibitory constant against 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
2394,,Autocuration,CHEMBL617672,,,104686,,B,,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2395,,Autocuration,CHEMBL617673,,,104686,,B,,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,,H,4,1,,BAO_0000019
2396,,Autocuration,CHEMBL617674,,,104686,,B,,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,,H,4,1,,BAO_0000224
2397,,Autocuration,CHEMBL617675,,,104686,,B,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,,H,4,1,,BAO_0000019
2398,,Autocuration,CHEMBL617676,,,104686,,B,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,,H,4,1,,BAO_0000019
2399,,Autocuration,CHEMBL617677,,,104686,,B,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,,H,4,1,,BAO_0000019
2400,,Autocuration,CHEMBL617678,,,104686,,B,,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000019
2401,,Autocuration,CHEMBL617679,,,104686,,B,,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,,H,4,1,,BAO_0000224
2402,,Autocuration,CHEMBL617680,,,104686,,B,,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,,H,4,1,,BAO_0000224
2403,,Autocuration,CHEMBL617681,,,104686,,B,,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,,H,4,1,,BAO_0000019
2404,,Autocuration,CHEMBL617682,,,104686,955.0,B,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,,H,4,1,,BAO_0000221
2405,,Autocuration,CHEMBL617683,,,104686,,B,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,,H,4,1,,BAO_0000224
2406,,Autocuration,CHEMBL617684,,,104686,,B,,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,,H,4,1,,BAO_0000224
2407,Rattus norvegicus,Autocuration,CHEMBL617685,,,104686,,B,,Binding affinity towards 5-hydroxytryptamine 2 receptor,,D,5,1,,BAO_0000224
2408,,Autocuration,CHEMBL617686,,,104686,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,,H,4,1,,BAO_0000019
2409,,Autocuration,CHEMBL617687,,,104686,,B,,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,,H,4,1,,BAO_0000224
2410,,Autocuration,CHEMBL617688,,,104686,,B,,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,H,4,1,,BAO_0000224
2411,,Autocuration,CHEMBL617689,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2412,,Autocuration,CHEMBL617690,,,104686,,F,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,4,1,,BAO_0000019
2413,,Autocuration,CHEMBL617691,,,104686,,F,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,H,4,1,,BAO_0000218
2414,,Autocuration,CHEMBL617692,,,104686,,F,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,H,4,1,,BAO_0000218
2415,,Autocuration,CHEMBL617693,,,104686,,F,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,H,4,1,,BAO_0000218
2416,,Autocuration,CHEMBL617694,,,104686,,F,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,H,4,1,,BAO_0000218
2417,,Expert,CHEMBL857985,,,12687,955.0,B,,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,,H,8,1,,BAO_0000221
2418,Rattus norvegicus,Expert,CHEMBL617695,,,12687,,B,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,9,1,,BAO_0000019
2419,,Autocuration,CHEMBL617696,,,12687,,B,,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,,H,8,1,,BAO_0000019
2420,,Autocuration,CHEMBL617697,,,12687,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000357
2421,Rattus norvegicus,Expert,CHEMBL617257,,,12687,,B,,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,,D,9,1,,BAO_0000019
2422,Rattus norvegicus,Expert,CHEMBL617258,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,D,9,1,,BAO_0000357
2423,,Expert,CHEMBL617259,,,12687,,B,,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,,H,8,1,,BAO_0000019
2424,,Autocuration,CHEMBL617260,,,12687,,B,,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,,H,8,1,,BAO_0000357
2425,Rattus norvegicus,Expert,CHEMBL617261,,,12687,,B,,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2426,,Autocuration,CHEMBL617262,,,12687,,B,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,,H,8,1,,BAO_0000019
2427,,Expert,CHEMBL617263,,,12687,,B,,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,H,8,1,,BAO_0000019
2428,,Autocuration,CHEMBL617264,,,12687,,B,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,,H,8,1,,BAO_0000019
2429,Rattus norvegicus,Expert,CHEMBL617265,,,12687,,B,,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000019
2430,,Autocuration,CHEMBL617266,,,12687,,B,,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,Membranes,H,8,1,,BAO_0000249
2431,,Autocuration,CHEMBL617267,,,12687,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,,H,8,1,,BAO_0000019
2432,,Expert,CHEMBL617268,,,12687,,B,,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,,H,8,1,,BAO_0000019
2433,,Autocuration,CHEMBL617269,449.0,,12687,,B,,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,H,8,1,,BAO_0000219
2434,,Expert,CHEMBL617323,,,12687,,B,,Kinetic inhibition constant evaluated by measuring serotonergic activity,,H,8,1,,BAO_0000357
2435,,Autocuration,CHEMBL617324,,,12687,,B,,Serotonergic activity of the compound.,,H,8,1,,BAO_0000357
2436,,Autocuration,CHEMBL617325,,,12687,,B,,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,,H,8,1,,BAO_0000249
2437,Rattus norvegicus,Expert,CHEMBL617326,,,12687,,B,,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,,D,9,1,,BAO_0000019
2438,,Expert,CHEMBL617327,,,12687,,B,,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,,H,8,1,,BAO_0000249
2439,Rattus norvegicus,Expert,CHEMBL617328,,,12687,,F,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,9,1,,BAO_0000019
2440,Rattus norvegicus,Expert,CHEMBL617329,,,12687,,F,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,9,1,,BAO_0000019
2441,Rattus norvegicus,Expert,CHEMBL617330,,,12687,,F,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,9,1,,BAO_0000019
2442,,Autocuration,CHEMBL617331,,,12687,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2443,,Autocuration,CHEMBL617332,,,12687,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,,H,8,1,,BAO_0000357
2444,,Expert,CHEMBL617333,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2445,,Autocuration,CHEMBL617334,,,107,,B,,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,,H,8,1,,BAO_0000357
2446,,Autocuration,CHEMBL617335,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,,H,8,1,,BAO_0000357
2447,,Autocuration,CHEMBL617336,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,,H,8,1,,BAO_0000357
2448,,Autocuration,CHEMBL617337,,,107,,B,,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,,H,8,1,,BAO_0000357
2449,Homo sapiens,Expert,CHEMBL617338,,,107,,B,,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,,D,9,1,,BAO_0000357
2450,,Autocuration,CHEMBL617339,,,107,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2451,,Expert,CHEMBL617340,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2452,,Autocuration,CHEMBL617341,,,107,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,,H,8,1,,BAO_0000357
2453,,Expert,CHEMBL617342,,,107,,B,,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2454,,Expert,CHEMBL617343,,,107,,B,,Affinity for 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2455,,Expert,CHEMBL617344,723.0,,107,,B,,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,,H,8,1,,BAO_0000219
2456,,Expert,CHEMBL617345,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,H,8,1,,BAO_0000357
2457,,Expert,CHEMBL617346,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,,H,8,1,,BAO_0000357
2458,,Autocuration,CHEMBL617347,,,107,,B,,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2459,,Autocuration,CHEMBL617348,,,107,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000357
2460,,Autocuration,CHEMBL617349,,,107,,B,,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000357
2461,,Autocuration,CHEMBL617350,,,107,,F,,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2462,,Expert,CHEMBL872339,,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,,H,8,1,,BAO_0000357
2463,,Autocuration,CHEMBL617351,,,107,,B,,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000357
2464,,Expert,CHEMBL617352,,,107,,B,,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2465,,Autocuration,CHEMBL617353,,,107,,B,,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2466,,Autocuration,CHEMBL617354,,,107,,B,,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2467,,Autocuration,CHEMBL617355,,,107,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2468,Mus musculus,Expert,CHEMBL617356,449.0,,107,,B,,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,,H,8,1,,BAO_0000219
2469,,Autocuration,CHEMBL617357,,,107,,B,,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2470,,Autocuration,CHEMBL617358,,,107,,B,,Binding affinity at 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2471,,Expert,CHEMBL617359,,,107,,B,,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2472,,Autocuration,CHEMBL617360,,,107,,B,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,,H,8,1,,BAO_0000357
2473,,Autocuration,CHEMBL875913,,,107,,B,,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,,H,8,1,,BAO_0000357
2474,,Autocuration,CHEMBL617361,,,107,,B,,Affinity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2475,Homo sapiens,Expert,CHEMBL617362,,,107,,B,,Binding affinity against 5-Hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2476,,Autocuration,CHEMBL617363,,,107,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,,H,8,1,,BAO_0000357
2477,,Autocuration,CHEMBL617364,,,107,,B,,Tested against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2478,,Autocuration,CHEMBL617365,,,105075,,B,,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,H,4,1,,BAO_0000224
2479,,Autocuration,CHEMBL617366,,,105075,,B,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,,H,4,1,,BAO_0000224
2480,,Autocuration,CHEMBL617367,,,105075,,B,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,,H,4,1,,BAO_0000224
2481,,Autocuration,CHEMBL617368,,,105075,,B,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,H,4,1,,BAO_0000224
2482,,Autocuration,CHEMBL617369,,,107,,B,,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),,H,8,1,,BAO_0000357
2483,Homo sapiens,Expert,CHEMBL617370,722.0,,227,,B,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,,D,9,1,,BAO_0000219
2484,Homo sapiens,Expert,CHEMBL617371,449.0,,227,,F,,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,,D,9,1,,BAO_0000219
2485,,Autocuration,CHEMBL617372,,,227,,B,,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
2486,Homo sapiens,Expert,CHEMBL617373,,,227,,B,,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,,D,9,1,,BAO_0000357
2487,,Autocuration,CHEMBL617374,,,227,,F,,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,,H,8,1,,BAO_0000019
2488,,Autocuration,CHEMBL617375,,,227,,F,,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,,H,8,1,,BAO_0000019
2489,,Autocuration,CHEMBL617376,,,227,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,,H,8,1,,BAO_0000019
2490,,Autocuration,CHEMBL617377,,,227,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,,H,8,1,,BAO_0000019
2491,,Autocuration,CHEMBL617378,,,227,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,,H,8,1,,BAO_0000019
2492,,Autocuration,CHEMBL617379,,,227,,F,,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,H,8,1,,BAO_0000019
2493,,Autocuration,CHEMBL617380,,,227,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,,H,8,1,,BAO_0000357
2494,,Autocuration,CHEMBL617381,,,227,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,,H,8,1,,BAO_0000357
2495,,Autocuration,CHEMBL617382,,,227,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,H,8,1,,BAO_0000357
2496,,Autocuration,CHEMBL617383,,,107,,B,,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2497,,Expert,CHEMBL617384,,,107,,B,,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,,H,8,1,,BAO_0000357
2498,,Expert,CHEMBL617385,,,107,,B,,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,,H,8,1,,BAO_0000357
2499,,Autocuration,CHEMBL617386,,,107,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,,H,8,1,,BAO_0000019
2500,,Autocuration,CHEMBL617387,,,107,,B,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,,H,8,1,,BAO_0000019
2501,,Autocuration,CHEMBL617388,723.0,,107,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,8,1,,BAO_0000219
2502,,Autocuration,CHEMBL617389,449.0,,107,,F,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,H,8,1,,BAO_0000219
2503,Homo sapiens,Expert,CHEMBL617390,449.0,,107,,F,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,9,1,,BAO_0000219
2504,,Autocuration,CHEMBL617391,,,104817,,B,,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,,H,4,1,,BAO_0000224
2505,,Autocuration,CHEMBL617392,,,107,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
2506,,Autocuration,CHEMBL617393,,,107,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
2507,,Autocuration,CHEMBL617394,307.0,,107,,B,,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,H,8,1,,BAO_0000219
2508,,Expert,CHEMBL617395,307.0,,107,,B,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,H,8,1,,BAO_0000219
2509,,Expert,CHEMBL617396,307.0,,107,,B,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,,H,8,1,,BAO_0000219
2510,,Autocuration,CHEMBL617397,307.0,,107,,B,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,,H,8,1,,BAO_0000219
2511,,Autocuration,CHEMBL617398,,,107,,B,,Binding affinity against 5-HT2A receptor,,H,8,1,,BAO_0000357
2512,,Autocuration,CHEMBL617399,,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2513,,Autocuration,CHEMBL617400,722.0,,107,,B,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2514,,Autocuration,CHEMBL617401,722.0,,107,,B,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2515,Homo sapiens,Expert,CHEMBL617402,722.0,,107,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,,D,9,1,,BAO_0000219
2516,Homo sapiens,Expert,CHEMBL617403,722.0,,107,,B,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,9,1,,BAO_0000219
2517,,Expert,CHEMBL617404,,,107,,B,,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,,H,8,1,,BAO_0000357
2518,Homo sapiens,Expert,CHEMBL857981,722.0,,107,,B,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,9,1,,BAO_0000219
2519,Homo sapiens,Expert,CHEMBL617405,722.0,,107,,B,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,9,1,,BAO_0000219
2520,Homo sapiens,Expert,CHEMBL617253,722.0,,107,,B,,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,,D,9,1,,BAO_0000219
2521,,Expert,CHEMBL617254,,,107,,B,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,,H,8,1,,BAO_0000357
2522,,Autocuration,CHEMBL617255,722.0,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2523,,Autocuration,CHEMBL617256,722.0,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2524,,Autocuration,CHEMBL616874,722.0,,107,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2525,Homo sapiens,Expert,CHEMBL616875,722.0,,107,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,,D,9,1,,BAO_0000219
2526,,Expert,CHEMBL616876,722.0,,107,,B,,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2527,,Expert,CHEMBL616877,722.0,,107,,B,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",,H,8,1,,BAO_0000219
2528,Homo sapiens,Expert,CHEMBL616878,722.0,,107,,B,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,,D,9,1,,BAO_0000219
2529,,Expert,CHEMBL616879,722.0,,107,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,,H,8,1,,BAO_0000219
2530,,Expert,CHEMBL616880,722.0,,107,,B,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,,H,8,1,,BAO_0000219
2531,Homo sapiens,Expert,CHEMBL616881,722.0,,107,,B,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,9,1,,BAO_0000219
2532,,Autocuration,CHEMBL616882,723.0,,107,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
2533,,Autocuration,CHEMBL616883,723.0,,107,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,8,1,,BAO_0000219
2534,,Autocuration,CHEMBL616884,723.0,,107,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,8,1,,BAO_0000219
2535,,Autocuration,CHEMBL616885,722.0,,107,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,,H,8,1,,BAO_0000219
2536,,Autocuration,CHEMBL616886,485.0,,107,,B,,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,,H,8,1,,BAO_0000219
2537,,Expert,CHEMBL616887,485.0,,107,,B,,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,,H,8,1,,BAO_0000219
2538,Homo sapiens,Expert,CHEMBL616888,,,107,,B,,Binding affinity for human 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2539,,Autocuration,CHEMBL616889,722.0,,107,,B,,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,,H,8,1,,BAO_0000219
2540,,Autocuration,CHEMBL616890,722.0,,107,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,,H,8,1,,BAO_0000219
2541,Homo sapiens,Expert,CHEMBL616891,449.0,,107,,B,,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,D,9,1,,BAO_0000219
2542,,Autocuration,CHEMBL616892,722.0,,107,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,,H,8,1,,BAO_0000219
2543,,Autocuration,CHEMBL616893,722.0,,107,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",,H,8,1,,BAO_0000219
2544,,Autocuration,CHEMBL616894,723.0,,10620,,F,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,,H,8,1,,BAO_0000219
2545,,Expert,CHEMBL616895,723.0,,107,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,,H,8,1,,BAO_0000219
2546,,Autocuration,CHEMBL616896,,,10620,,F,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2547,,Autocuration,CHEMBL617099,,,10621,,B,,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2548,,Autocuration,CHEMBL617100,,,10621,,B,,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,,H,8,1,,BAO_0000357
2549,Oryctolagus cuniculus,Autocuration,CHEMBL884532,,,107,,B,,Binding affinity against rabbit aorta 5-HT2A receptor,,H,8,1,,BAO_0000357
2550,Oryctolagus cuniculus,Expert,CHEMBL617101,,,107,,B,,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,,H,8,1,,BAO_0000357
2551,Oryctolagus cuniculus,Expert,CHEMBL617102,,,107,,B,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,,H,8,1,,BAO_0000357
2552,Oryctolagus cuniculus,Autocuration,CHEMBL617103,,,107,,B,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
2553,Oryctolagus cuniculus,Expert,CHEMBL617104,,,107,,B,,The compound was tested for binding affinity against 5-HT2A receptor,,H,8,1,,BAO_0000357
2554,,Autocuration,CHEMBL857979,485.0,,10576,,B,,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,,H,8,1,,BAO_0000219
2555,,Autocuration,CHEMBL857502,,,12687,,B,,Binding affinity analysed towards 5-HT 2A in rat jugular vein,,H,8,1,,BAO_0000019
2556,,Autocuration,CHEMBL617105,,,12687,,B,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,H,8,1,,BAO_0000019
2557,,Autocuration,CHEMBL858021,,,12687,945.0,B,,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,,H,8,1,,BAO_0000019
2558,Rattus norvegicus,Expert,CHEMBL875910,,,12687,945.0,B,,Binding affinity for 5-HT 2A in rat stomach fundus,,D,9,1,,BAO_0000019
2559,,Autocuration,CHEMBL617106,,,12687,,B,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,H,8,1,,BAO_0000019
2560,,Expert,CHEMBL617107,723.0,,12687,,B,,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000219
2561,,Autocuration,CHEMBL617108,,,12687,,F,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2562,,Autocuration,CHEMBL617109,,,12687,,F,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2563,,Autocuration,CHEMBL617110,,,12687,,B,,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2564,,Autocuration,CHEMBL617111,,,12687,,B,,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,,H,8,1,,BAO_0000357
2565,Rattus norvegicus,Expert,CHEMBL617112,,,12687,,F,,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,,D,9,1,,BAO_0000019
2566,,Autocuration,CHEMBL617113,,,12687,,B,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2567,,Autocuration,CHEMBL617114,,,12687,,B,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2568,,Autocuration,CHEMBL617115,,,12687,,B,,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2569,,Autocuration,CHEMBL617116,,,12687,,F,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,H,8,1,,BAO_0000219
2570,,Autocuration,CHEMBL617117,,,12687,,F,,Efficacy at 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2571,,Autocuration,CHEMBL617118,,,12687,,B,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,H,8,1,,BAO_0000357
2572,Rattus norvegicus,Expert,CHEMBL617119,,,12687,,B,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,D,9,1,,BAO_0000357
2573,Rattus norvegicus,Expert,CHEMBL617120,,,12687,,B,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),,D,9,1,,BAO_0000357
2574,Rattus norvegicus,Expert,CHEMBL617121,,,12687,,F,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,D,9,1,,BAO_0000219
2575,,Autocuration,CHEMBL617122,,,12687,,F,,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,H,8,1,,BAO_0000219
2576,,Autocuration,CHEMBL617123,,,12687,,B,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2577,,Expert,CHEMBL617124,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,,H,8,1,,BAO_0000019
2578,,Expert,CHEMBL617600,,,12687,,B,,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,,H,8,1,,BAO_0000249
2579,,Expert,CHEMBL617601,,,12687,,B,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,,H,8,1,,BAO_0000357
2580,,Expert,CHEMBL882923,,,12687,,B,,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,,H,8,1,,BAO_0000019
2581,,Autocuration,CHEMBL617602,,,12687,,B,,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2582,,Autocuration,CHEMBL617603,,,12687,,B,,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,,H,8,1,,BAO_0000019
2583,,Autocuration,CHEMBL617604,,,12687,,B,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2584,,Expert,CHEMBL617605,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2585,,Expert,CHEMBL617606,,,12687,,B,,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2586,Rattus norvegicus,Expert,CHEMBL617607,,,12687,,B,,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000019
2587,,Autocuration,CHEMBL617455,,,12687,,B,,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2588,Rattus norvegicus,Expert,CHEMBL617456,,,12687,,B,,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,D,9,1,,BAO_0000019
2589,,Expert,CHEMBL617457,,,12687,,B,,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),,H,8,1,,BAO_0000357
2590,Rattus norvegicus,Expert,CHEMBL617458,,,12687,,B,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2591,Rattus norvegicus,Expert,CHEMBL617459,,,12687,,B,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,,D,9,1,,BAO_0000019
2592,,Expert,CHEMBL617460,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,,H,8,1,,BAO_0000357
2593,,Expert,CHEMBL617461,,,12687,,B,,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",,H,8,1,,BAO_0000357
2594,Rattus norvegicus,Expert,CHEMBL617462,,,12687,,B,,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,,D,9,1,,BAO_0000019
2595,,Autocuration,CHEMBL617463,,,12687,,B,,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,,H,8,1,,BAO_0000357
2596,,Autocuration,CHEMBL617464,,,12687,,B,,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",,H,8,1,,BAO_0000019
2597,,Autocuration,CHEMBL617465,,,12687,,B,,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",,H,8,1,,BAO_0000019
2598,,Expert,CHEMBL617466,,,12687,,B,,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,,H,8,1,,BAO_0000019
2599,,Autocuration,CHEMBL617467,,,12687,,B,,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,H,8,1,,BAO_0000019
2600,,Expert,CHEMBL617468,,,12687,,B,,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,,H,8,1,,BAO_0000019
2601,,Autocuration,CHEMBL617469,,,12687,,B,,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,H,8,1,,BAO_0000019
2602,,Autocuration,CHEMBL617470,,,12687,,B,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000019
2603,,Autocuration,CHEMBL617471,,,12687,,B,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,,H,8,1,,BAO_0000019
2604,,Expert,CHEMBL617472,723.0,,12687,,B,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,,H,8,1,,BAO_0000219
2605,,Expert,CHEMBL617473,,,12687,,B,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,,H,8,1,,BAO_0000357
2606,Rattus norvegicus,Expert,CHEMBL617474,,,12687,,B,,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,9,1,,BAO_0000019
2607,Rattus norvegicus,Expert,CHEMBL617475,,,12687,,B,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,9,1,,BAO_0000019
2608,,Autocuration,CHEMBL617476,,,12687,955.0,B,,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,,H,8,1,,BAO_0000221
2609,,Expert,CHEMBL617477,,,12687,,B,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2610,,Expert,CHEMBL617478,723.0,,12687,,B,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000219
2611,,Autocuration,CHEMBL617479,,,12687,,F,,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",,H,8,1,,BAO_0000221
2612,,Autocuration,CHEMBL617480,,,12687,,B,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,,H,8,1,,BAO_0000357
2613,,Expert,CHEMBL617481,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2614,,Expert,CHEMBL617482,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,,H,8,1,,BAO_0000019
2615,,Autocuration,CHEMBL617483,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2616,,Autocuration,CHEMBL621528,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2617,Rattus norvegicus,Expert,CHEMBL621529,723.0,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,,D,9,1,,BAO_0000219
2618,,Expert,CHEMBL621530,,,12687,,B,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2619,,Expert,CHEMBL621531,,,12687,,B,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2620,Rattus norvegicus,Expert,CHEMBL621532,,,12687,,B,,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000019
2621,,Expert,CHEMBL621533,,,12687,,B,,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2622,,Expert,CHEMBL621534,449.0,,12687,,B,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2623,,Autocuration,CHEMBL621535,,,12687,,B,,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,,H,8,1,,BAO_0000019
2624,,Autocuration,CHEMBL621536,,,12687,,B,,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,,H,8,1,,BAO_0000357
2625,,Autocuration,CHEMBL621537,,,12687,,B,,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2626,Rattus norvegicus,Expert,CHEMBL621538,,,12687,,B,,Binding affinity for 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000357
2627,,Autocuration,CHEMBL621539,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,,H,8,1,,BAO_0000019
2628,,Autocuration,CHEMBL621540,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,,H,8,1,,BAO_0000019
2629,,Autocuration,CHEMBL621541,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,,H,8,1,,BAO_0000019
2630,,Autocuration,CHEMBL621542,,,12687,,B,,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2631,,Expert,CHEMBL621543,,,12687,,B,,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,,H,8,1,,BAO_0000357
2632,,Expert,CHEMBL621544,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2633,Rattus norvegicus,Expert,CHEMBL621545,,,12687,,B,,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,,D,9,1,,BAO_0000357
2634,,Autocuration,CHEMBL621546,,,12687,,B,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2635,,Autocuration,CHEMBL621547,,,12687,,B,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,,H,8,1,,BAO_0000357
2636,,Expert,CHEMBL618692,723.0,,12687,,B,,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000219
2637,,Autocuration,CHEMBL618693,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2638,,Autocuration,CHEMBL872922,,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2639,,Autocuration,CHEMBL618694,,,12687,,B,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2640,Rattus norvegicus,Expert,CHEMBL618695,,,12687,,B,,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,,D,9,1,,BAO_0000357
2641,,Autocuration,CHEMBL618696,,,12687,,B,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,,H,8,1,,BAO_0000357
2642,,Expert,CHEMBL618697,,,12687,,B,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,,H,8,1,,BAO_0000357
2643,,Autocuration,CHEMBL618892,,,12687,,B,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2644,,Autocuration,CHEMBL618893,,,12687,,B,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2645,,Autocuration,CHEMBL618894,,,12687,,B,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2646,,Expert,CHEMBL618895,723.0,,12687,,B,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000219
2647,Rattus norvegicus,Expert,CHEMBL618896,,,12687,,B,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,D,9,1,,BAO_0000357
2648,,Autocuration,CHEMBL618897,,,12687,5383.0,B,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,,H,8,1,,BAO_0000019
2649,,Autocuration,CHEMBL618898,,,12687,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,,H,8,1,,BAO_0000357
2650,,Autocuration,CHEMBL618899,,,12687,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,,H,8,1,,BAO_0000357
2651,,Autocuration,CHEMBL618900,,,12687,,B,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,,H,8,1,,BAO_0000357
2652,,Autocuration,CHEMBL618901,,,12687,,B,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,,H,8,1,,BAO_0000019
2653,,Autocuration,CHEMBL618902,,,12687,,B,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2654,Rattus norvegicus,Expert,CHEMBL618903,,,12687,10000000.0,B,,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000221
2655,,Autocuration,CHEMBL618904,,,12687,,B,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2656,,Autocuration,CHEMBL618905,,,12687,,B,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,,H,8,1,,BAO_0000357
2657,,Autocuration,CHEMBL618906,,,12687,,B,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,,H,8,1,,BAO_0000357
2658,,Expert,CHEMBL618907,723.0,,12687,,B,,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,,H,8,1,,BAO_0000219
2659,,Autocuration,CHEMBL618908,,,12687,,B,,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,,H,8,1,,BAO_0000019
2660,,Autocuration,CHEMBL617909,,,12687,,B,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2661,,Expert,CHEMBL617910,,,12687,,B,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,H,8,1,,BAO_0000019
2662,,Autocuration,CHEMBL617911,,,12687,955.0,B,,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,,H,8,1,,BAO_0000221
2663,,Autocuration,CHEMBL872923,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2664,,Autocuration,CHEMBL617912,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2665,Rattus norvegicus,Expert,CHEMBL617913,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,,D,9,1,,BAO_0000019
2666,,Expert,CHEMBL617914,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2667,,Autocuration,CHEMBL617915,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2668,,Autocuration,CHEMBL617916,,,12687,,B,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,8,1,,BAO_0000249
2669,Rattus norvegicus,Expert,CHEMBL617917,,,12687,,B,,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,,D,9,1,,BAO_0000019
2670,,Expert,CHEMBL617918,,,12687,,B,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000019
2671,,Autocuration,CHEMBL617919,,,12687,,B,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,,H,8,1,,BAO_0000019
2672,Rattus norvegicus,Expert,CHEMBL617920,,,12687,,B,,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,D,9,1,,BAO_0000019
2673,Rattus norvegicus,Expert,CHEMBL617921,,,12687,,B,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,,D,9,1,,BAO_0000019
2674,Rattus norvegicus,Expert,CHEMBL617922,,,105102,,B,,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",,D,5,1,,BAO_0000224
2675,,Autocuration,CHEMBL617923,,,12687,,B,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2676,,Autocuration,CHEMBL617924,,,12687,,B,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,8,1,,BAO_0000357
2677,,Autocuration,CHEMBL617925,,,12687,,B,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,,H,8,1,,BAO_0000357
2678,Rattus norvegicus,Expert,CHEMBL617926,,,12687,,B,,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,,D,9,1,,BAO_0000357
2679,,Autocuration,CHEMBL617927,,,12687,,B,,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,,H,8,1,,BAO_0000357
2680,,Autocuration,CHEMBL617928,,,12687,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,,H,8,1,,BAO_0000357
2681,Rattus norvegicus,Expert,CHEMBL617929,,,12687,,B,,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,9,1,,BAO_0000019
2682,,Expert,CHEMBL617930,,,12687,,B,,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,,H,8,1,,BAO_0000019
2683,,Autocuration,CHEMBL617931,,,12687,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,,H,8,1,,BAO_0000019
2684,,Autocuration,CHEMBL617932,,,12687,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,,H,8,1,,BAO_0000019
2685,,Autocuration,CHEMBL617933,449.0,,12687,,B,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,,H,8,1,,BAO_0000219
2686,,Autocuration,CHEMBL617934,,,12687,,B,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,H,8,1,,BAO_0000019
2687,,Autocuration,CHEMBL617935,,,12687,,B,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,H,8,1,,BAO_0000019
2688,,Autocuration,CHEMBL617936,,,12687,,B,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,,H,8,1,,BAO_0000357
2689,,Autocuration,CHEMBL617937,,,12687,,B,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,,H,8,1,,BAO_0000019
2690,,Autocuration,CHEMBL617938,,,12687,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,,H,8,1,,BAO_0000019
2691,,Autocuration,CHEMBL617939,,,12687,,B,,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,,H,8,1,,BAO_0000218
2692,,Autocuration,CHEMBL617940,,,12687,,B,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,,H,8,1,,BAO_0000218
2693,,Autocuration,CHEMBL617941,,,12687,,B,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,,H,8,1,,BAO_0000218
2694,,Expert,CHEMBL617942,,,12687,,B,,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,,H,8,1,,BAO_0000357
2695,,Expert,CHEMBL617943,,,12687,,B,,Ratio of pKi of 5-HT2A to that of D2 receptor,,H,8,1,,BAO_0000357
2696,,Expert,CHEMBL617944,,,105093,,B,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,H,4,1,,BAO_0000224
2697,,Expert,CHEMBL617945,,,105093,,B,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,H,4,1,,BAO_0000224
2698,,Expert,CHEMBL617946,,,105075,,B,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,,H,4,1,,BAO_0000224
2699,,Autocuration,CHEMBL617947,,,12687,,B,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,,H,8,1,,BAO_0000357
2700,,Expert,CHEMBL617948,,,12687,,B,,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,,H,8,1,,BAO_0000357
2701,,Autocuration,CHEMBL858116,,,12687,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,,H,8,1,,BAO_0000019
2702,,Autocuration,CHEMBL617949,,,12687,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,,H,8,1,,BAO_0000019
2703,,Autocuration,CHEMBL617950,,,12687,,F,,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,,H,8,1,,BAO_0000019
2704,,Expert,CHEMBL617951,,,12687,1515.0,F,,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,,H,8,1,,BAO_0000019
2705,,Expert,CHEMBL617952,,,12687,1515.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,,H,8,1,,BAO_0000019
2706,,Autocuration,CHEMBL617953,,,12687,1515.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,,H,8,1,,BAO_0000019
2707,,Autocuration,CHEMBL617954,,,12687,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
2708,,Expert,CHEMBL617955,,,12687,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
2709,,Autocuration,CHEMBL857071,,,12687,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,H,8,1,,BAO_0000019
2710,,Expert,CHEMBL617270,,,12687,,B,,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,,H,8,1,,BAO_0000019
2711,,Autocuration,CHEMBL617271,339.0,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,,H,8,1,,BAO_0000219
2712,,Autocuration,CHEMBL617272,339.0,,12687,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,,H,8,1,,BAO_0000219
2713,,Autocuration,CHEMBL617273,,,12687,,B,,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,,H,8,1,,BAO_0000019
2714,Rattus norvegicus,Expert,CHEMBL617274,,,12687,,F,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,,D,9,1,,BAO_0000019
2715,,Autocuration,CHEMBL617275,,,108,,B,,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2716,,Autocuration,CHEMBL617276,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2717,,Autocuration,CHEMBL617277,,,108,,B,,Binding affinity towards human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2718,,Expert,CHEMBL617278,,,108,,B,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2719,,Expert,CHEMBL617279,,,108,,B,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,,H,8,1,,BAO_0000019
2720,,Expert,CHEMBL617280,,,108,,B,,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2721,,Autocuration,CHEMBL617281,,,108,,B,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2722,,Autocuration,CHEMBL617282,,,108,,B,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2723,,Expert,CHEMBL617283,,,108,,B,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,,H,8,1,,BAO_0000019
2724,,Expert,CHEMBL617284,,,108,,B,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,,H,8,1,,BAO_0000019
2725,,Autocuration,CHEMBL617285,722.0,,108,,B,,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2726,,Autocuration,CHEMBL617286,,,108,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2727,Homo sapiens,Expert,CHEMBL617287,,,108,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,,D,9,1,,BAO_0000357
2728,,Expert,CHEMBL617288,,,108,,B,,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,,H,8,1,,BAO_0000357
2729,,Autocuration,CHEMBL617289,,,108,,B,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,,H,8,1,,BAO_0000357
2730,,Autocuration,CHEMBL872917,,,108,,B,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2731,,Autocuration,CHEMBL617290,,,108,,B,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2732,,Autocuration,CHEMBL617291,449.0,,108,,B,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2733,,Autocuration,CHEMBL617292,449.0,,108,,B,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,,H,8,1,,BAO_0000219
2734,,Autocuration,CHEMBL617293,723.0,,108,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,8,1,,BAO_0000219
2735,Homo sapiens,Expert,CHEMBL617294,449.0,,108,,F,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,9,1,,BAO_0000219
2736,,Expert,CHEMBL617295,,,108,,B,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,H,8,1,,BAO_0000019
2737,,Autocuration,CHEMBL617296,,,108,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
2738,,Autocuration,CHEMBL617297,,,108,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
2739,,Expert,CHEMBL617298,449.0,,108,,B,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2740,,Expert,CHEMBL617299,449.0,,108,,B,,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,,H,8,1,,BAO_0000219
2741,,Autocuration,CHEMBL617300,449.0,,108,,B,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,,H,8,1,,BAO_0000219
2742,,Autocuration,CHEMBL617454,,,108,,B,,Binding affinity against 5-HT2C receptor,,H,8,1,,BAO_0000357
2743,,Autocuration,CHEMBL617505,722.0,,108,,B,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2744,Homo sapiens,Expert,CHEMBL617506,722.0,,108,,B,,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,,D,9,1,,BAO_0000219
2745,Homo sapiens,Expert,CHEMBL617507,722.0,,108,,B,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,D,9,1,,BAO_0000219
2746,,Expert,CHEMBL617508,,,108,,B,,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,,H,8,1,,BAO_0000357
2747,Homo sapiens,Expert,CHEMBL857982,722.0,,108,,B,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,D,9,1,,BAO_0000219
2748,Homo sapiens,Expert,CHEMBL617509,722.0,,108,,B,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,,D,9,1,,BAO_0000219
2749,Homo sapiens,Expert,CHEMBL617510,722.0,,108,,B,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,,D,9,1,,BAO_0000219
2750,,Autocuration,CHEMBL617511,,,108,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,,H,8,1,,BAO_0000357
2751,,Autocuration,CHEMBL617512,722.0,,108,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2752,,Autocuration,CHEMBL617749,722.0,,108,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2753,,Autocuration,CHEMBL617750,722.0,,108,,B,,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000219
2754,,Autocuration,CHEMBL617751,722.0,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000219
2755,,Expert,CHEMBL617752,722.0,,108,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2756,,Autocuration,CHEMBL617753,722.0,,108,,B,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",,H,8,1,,BAO_0000219
2757,,Expert,CHEMBL617754,722.0,,108,,B,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",,H,8,1,,BAO_0000219
2758,Homo sapiens,Expert,CHEMBL617755,722.0,,108,,B,,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,,D,9,1,,BAO_0000219
2759,,Autocuration,CHEMBL617756,722.0,,108,,B,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",,H,8,1,,BAO_0000219
2760,,Expert,CHEMBL617757,722.0,,108,,B,,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,,H,8,1,,BAO_0000219
2761,,Expert,CHEMBL617758,722.0,,108,,B,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,,H,8,1,,BAO_0000219
2762,,Autocuration,CHEMBL617759,723.0,,108,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
2763,,Autocuration,CHEMBL617760,722.0,,108,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,,H,8,1,,BAO_0000219
2764,,Expert,CHEMBL617761,485.0,,108,,B,,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,,H,8,1,,BAO_0000219
2765,Homo sapiens,Expert,CHEMBL617762,,,108,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
2766,,Autocuration,CHEMBL617763,,,108,,B,,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2767,,Autocuration,CHEMBL857983,722.0,,108,,B,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,,H,8,1,,BAO_0000219
2768,,Autocuration,CHEMBL617764,722.0,,108,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,,H,8,1,,BAO_0000219
2769,,Autocuration,CHEMBL617765,308.0,,108,,B,,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,,H,8,1,,BAO_0000219
2770,,Autocuration,CHEMBL617766,,,108,,F,,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000019
2771,,Autocuration,CHEMBL617767,,,108,10000000.0,F,,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,,H,8,1,,BAO_0000221
2772,,Autocuration,CHEMBL617768,722.0,,108,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,,H,8,1,,BAO_0000219
2773,,Autocuration,CHEMBL617769,722.0,,108,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",,H,8,1,,BAO_0000219
2774,,Autocuration,CHEMBL858023,,,11864,,B,,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2775,,Autocuration,CHEMBL617770,,,11864,945.0,B,,Binding affinity analysed on 5-HT 2C in rat stomach fundus,,H,8,1,,BAO_0000019
2776,,Autocuration,CHEMBL617771,,,11864,945.0,B,,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,,H,8,1,,BAO_0000019
2777,,Autocuration,CHEMBL617772,625.0,,11864,,F,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,,H,8,1,,BAO_0000219
2778,,Autocuration,CHEMBL617773,723.0,,11864,,B,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,H,8,1,,BAO_0000219
2779,,Autocuration,CHEMBL617850,723.0,,11864,,B,,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,,H,8,1,,BAO_0000219
2780,,Autocuration,CHEMBL617851,723.0,,11864,,B,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,H,8,1,,BAO_0000219
2781,,Autocuration,CHEMBL617852,,,11864,,F,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2782,Mus musculus,Autocuration,CHEMBL858024,,,12689,945.0,B,,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,,H,8,1,,BAO_0000019
2783,Rattus norvegicus,Expert,CHEMBL617853,,,12689,945.0,B,,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,,D,9,1,,BAO_0000019
2784,,Expert,CHEMBL617854,,,108,,B,,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,,H,8,1,,BAO_0000357
2785,Sus scrofa,Expert,CHEMBL873477,,,108,,B,,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2786,,Expert,CHEMBL617855,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2787,,Expert,CHEMBL617856,,,108,,B,,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,,H,8,1,,BAO_0000019
2788,,Autocuration,CHEMBL617857,,,108,,B,,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,,H,8,1,,BAO_0000019
2789,,Autocuration,CHEMBL617858,,,108,,B,,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,,H,8,1,,BAO_0000249
2790,,Autocuration,CHEMBL617859,,,108,,B,,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2791,,Autocuration,CHEMBL617860,,,108,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2792,,Autocuration,CHEMBL617861,,,108,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
2793,,Expert,CHEMBL617862,,,108,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
2794,,Autocuration,CHEMBL617863,,,108,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,H,8,1,,BAO_0000019
2795,,Autocuration,CHEMBL617864,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,,H,8,1,,BAO_0000249
2796,,Autocuration,CHEMBL617649,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,,H,8,1,,BAO_0000249
2797,Sus scrofa,Expert,CHEMBL617650,,,108,,F,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,H,8,1,,BAO_0000019
2798,Sus scrofa,Expert,CHEMBL617651,,,108,,F,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,H,8,1,,BAO_0000019
2799,Sus scrofa,Autocuration,CHEMBL617652,,,108,,B,,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,,H,8,1,,BAO_0000357
2800,Sus scrofa,Autocuration,CHEMBL857072,,,108,,B,,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,,H,8,1,,BAO_0000019
2801,Sus scrofa,Autocuration,CHEMBL617653,,,108,,B,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2802,,Autocuration,CHEMBL617654,,,12687,,B,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000019
2803,,Autocuration,CHEMBL617655,,,12689,,F,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2804,,Expert,CHEMBL617656,,,12689,,B,,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2805,,Autocuration,CHEMBL617657,,,12689,,B,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2806,,Autocuration,CHEMBL617658,,,12689,,B,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,,H,8,1,,BAO_0000357
2807,Rattus norvegicus,Expert,CHEMBL617659,,,12689,,B,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
2808,Rattus norvegicus,Expert,CHEMBL617838,,,12689,,B,,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
2809,Rattus norvegicus,Expert,CHEMBL617839,,,12689,,B,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,Brain membranes,D,9,1,,BAO_0000249
2810,,Autocuration,CHEMBL617840,,,12689,,B,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,,H,8,1,,BAO_0000357
2811,,Autocuration,CHEMBL617841,,,12689,,B,,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,,H,8,1,,BAO_0000019
2812,,Autocuration,CHEMBL875915,,,12689,,B,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,,H,8,1,,BAO_0000019
2813,,Expert,CHEMBL617842,,,12689,,B,,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,,H,8,1,,BAO_0000219
2814,,Expert,CHEMBL617843,723.0,,12689,,B,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,,H,8,1,,BAO_0000219
2815,,Expert,CHEMBL617844,,,12689,,B,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,,H,8,1,,BAO_0000357
2816,,Expert,CHEMBL617845,,,12689,,B,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2817,,Expert,CHEMBL617846,723.0,,12689,,B,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000219
2818,,Autocuration,CHEMBL617847,,,12689,,B,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,,H,8,1,,BAO_0000357
2819,,Expert,CHEMBL617848,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2820,,Autocuration,CHEMBL617849,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2821,,Expert,CHEMBL621507,,,12689,,B,,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2822,,Expert,CHEMBL621508,,,12689,,B,,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,,H,8,1,,BAO_0000357
2823,,Autocuration,CHEMBL621509,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,,H,8,1,,BAO_0000019
2824,,Autocuration,CHEMBL621510,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,,H,8,1,,BAO_0000019
2825,,Autocuration,CHEMBL621511,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,,H,8,1,,BAO_0000019
2826,,Expert,CHEMBL621512,625.0,,12689,,B,,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000219
2827,,Autocuration,CHEMBL621513,,,12689,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2828,,Expert,CHEMBL621514,,,12689,,B,,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,,H,8,1,,BAO_0000357
2829,,Expert,CHEMBL621515,,,12689,,B,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000219
2830,,Autocuration,CHEMBL621516,,,12689,,B,,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,,H,8,1,,BAO_0000219
2831,,Autocuration,CHEMBL621517,,,12689,5383.0,B,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,,H,8,1,,BAO_0000019
2832,,Autocuration,CHEMBL621518,,,12689,,B,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,,H,8,1,,BAO_0000357
2833,,Autocuration,CHEMBL621519,,,12689,,B,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,,H,8,1,,BAO_0000019
2834,,Autocuration,CHEMBL621520,,,12689,,B,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2835,,Autocuration,CHEMBL621521,,,12689,,B,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2836,,Autocuration,CHEMBL621522,,,12689,,B,,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2837,,Expert,CHEMBL621523,,,12689,,B,,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,,H,8,1,,BAO_0000219
2838,,Autocuration,CHEMBL621524,,,12689,,B,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2839,Rattus norvegicus,Expert,CHEMBL621525,,,12689,,B,,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,,D,9,1,,BAO_0000357
2840,,Autocuration,CHEMBL872921,,,12689,,B,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,,H,8,1,,BAO_0000357
2841,,Autocuration,CHEMBL621526,,,12689,,B,,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2842,,Expert,CHEMBL621527,,,12689,,B,,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,,H,8,1,,BAO_0000219
2843,Rattus norvegicus,Expert,CHEMBL617865,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,,D,9,1,,BAO_0000019
2844,,Autocuration,CHEMBL617866,,,12689,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2845,,Autocuration,CHEMBL617867,,,12689,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,,H,8,1,,BAO_0000019
2846,,Autocuration,CHEMBL617487,,,12689,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,,H,8,1,,BAO_0000357
2847,,Expert,CHEMBL617488,,,12689,,B,,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2848,,Autocuration,CHEMBL617489,,,12689,,B,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,,H,8,1,,BAO_0000357
2849,,Autocuration,CHEMBL617490,,,12689,,B,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,,H,8,1,,BAO_0000019
2850,,Autocuration,CHEMBL617491,,,12689,,B,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,,H,8,1,,BAO_0000019
2851,,Autocuration,CHEMBL617492,,,12689,,B,,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,,H,8,1,,BAO_0000019
2852,,Autocuration,CHEMBL617493,,,12689,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,,H,8,1,,BAO_0000019
2853,,Autocuration,CHEMBL617494,,,12689,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,,H,8,1,,BAO_0000357
2854,Rattus norvegicus,Expert,CHEMBL617495,,,12689,,B,,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,,D,9,1,,BAO_0000019
2855,,Autocuration,CHEMBL617496,,,12689,,B,,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2856,,Autocuration,CHEMBL617497,485.0,,12689,,B,,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,,H,8,1,,BAO_0000219
2857,,Autocuration,CHEMBL617498,,,12689,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
2858,,Autocuration,CHEMBL617499,,,12689,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,,H,8,1,,BAO_0000357
2859,,Autocuration,CHEMBL617500,,,12689,,F,,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000019
2860,,Autocuration,CHEMBL617501,,,108,,B,,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2861,,Expert,CHEMBL617502,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2862,,Autocuration,CHEMBL617503,,,227,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,,H,8,1,,BAO_0000357
2863,,Autocuration,CHEMBL617504,,,227,,B,,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,,H,8,1,,BAO_0000357
2864,,Autocuration,CHEMBL617406,,,227,,B,,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000357
2865,Homo sapiens,Expert,CHEMBL617407,,,227,,B,,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,,D,9,1,,BAO_0000019
2866,,Autocuration,CHEMBL617408,,,227,,B,,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
2867,,Autocuration,CHEMBL617409,,,227,,B,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2868,,Autocuration,CHEMBL617410,,,227,,B,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2869,,Autocuration,CHEMBL617411,,,227,,B,,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2870,,Autocuration,CHEMBL617412,,,227,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000019
2871,Homo sapiens,Expert,CHEMBL617774,,,227,,B,,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,,D,9,1,,BAO_0000357
2872,Homo sapiens,Expert,CHEMBL617775,722.0,,227,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,D,9,1,,BAO_0000219
2873,Homo sapiens,Expert,CHEMBL617776,722.0,,227,,B,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,D,9,1,,BAO_0000219
2874,Homo sapiens,Expert,CHEMBL617777,449.0,,227,,F,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,9,1,,BAO_0000219
2875,Homo sapiens,Expert,CHEMBL617778,449.0,,227,,F,,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,9,1,,BAO_0000219
2876,,Autocuration,CHEMBL617779,722.0,,227,,B,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2877,,Expert,CHEMBL617780,722.0,,227,,B,,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
2878,,Autocuration,CHEMBL617781,722.0,,227,,B,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",,H,8,1,,BAO_0000219
2879,Homo sapiens,Expert,CHEMBL617782,722.0,,227,,B,,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,,D,9,1,,BAO_0000219
2880,Homo sapiens,Expert,CHEMBL617783,722.0,,227,,B,,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,,D,9,1,,BAO_0000219
2881,,Autocuration,CHEMBL617784,,,227,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,,H,8,1,,BAO_0000357
2882,,Autocuration,CHEMBL617785,722.0,,227,,B,,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,,H,8,1,,BAO_0000219
2883,,Expert,CHEMBL857984,722.0,,227,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
2884,,Expert,CHEMBL617786,722.0,,227,,B,,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,,H,8,1,,BAO_0000219
2885,,Expert,CHEMBL617787,722.0,,227,,B,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,,H,8,1,,BAO_0000219
2886,Homo sapiens,Expert,CHEMBL617788,722.0,,227,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,,D,9,1,,BAO_0000219
2887,Homo sapiens,Expert,CHEMBL617789,722.0,,227,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,,D,9,1,,BAO_0000219
2888,,Autocuration,CHEMBL617790,722.0,,227,,B,,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,,H,8,1,,BAO_0000219
2889,,Expert,CHEMBL617791,485.0,,227,,B,,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,,H,8,1,,BAO_0000219
2890,,Expert,CHEMBL617608,,,227,,B,,Binding affinity against 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2891,,Autocuration,CHEMBL617609,722.0,,227,,B,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,,H,8,1,,BAO_0000219
2892,,Autocuration,CHEMBL617610,722.0,,227,,B,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,,H,8,1,,BAO_0000219
2893,,Autocuration,CHEMBL617611,722.0,,227,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,,H,8,1,,BAO_0000219
2894,,Autocuration,CHEMBL617612,722.0,,227,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2895,,Autocuration,CHEMBL617613,722.0,,227,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,8,1,,BAO_0000219
2896,Oryctolagus cuniculus,Autocuration,CHEMBL617614,,,227,,B,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,,H,8,1,,BAO_0000019
2897,,Expert,CHEMBL617615,,,12688,945.0,B,,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,,H,8,1,,BAO_0000019
2898,,Expert,CHEMBL858114,,,12688,945.0,B,,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,,H,8,1,,BAO_0000357
2899,,Autocuration,CHEMBL617616,,,12688,945.0,B,,Affinity against serotonergic receptor in the isolated rat stomach fundus,,H,8,1,,BAO_0000357
2900,Rattus norvegicus,Expert,CHEMBL617617,,,12688,945.0,F,,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,,D,9,1,,BAO_0000019
2901,Rattus norvegicus,Expert,CHEMBL875914,,,12688,,F,,Antagonistic against 5-hydroxytryptamine 2B receptor,,D,9,1,,BAO_0000019
2902,,Autocuration,CHEMBL617618,,,12688,945.0,F,,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,,H,8,1,,BAO_0000019
2903,Rattus norvegicus,Expert,CHEMBL617619,,,12688,945.0,B,,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,,D,9,1,,BAO_0000357
2904,,Autocuration,CHEMBL617620,,,12688,,F,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,,H,8,1,,BAO_0000019
2905,,Autocuration,CHEMBL617621,,,12688,,F,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,,H,8,1,,BAO_0000019
2906,,Autocuration,CHEMBL617622,,,12688,,F,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,,H,8,1,,BAO_0000019
2907,Rattus norvegicus,Expert,CHEMBL617623,,,12688,945.0,B,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,9,1,,BAO_0000357
2908,Rattus norvegicus,Expert,CHEMBL617624,,,12688,945.0,B,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,9,1,,BAO_0000357
2909,Rattus norvegicus,Expert,CHEMBL617625,,,12688,945.0,B,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,9,1,,BAO_0000357
2910,Rattus norvegicus,Expert,CHEMBL617626,,,12688,945.0,B,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,9,1,,BAO_0000357
2911,,Autocuration,CHEMBL617627,,,12688,945.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,H,8,1,,BAO_0000019
2912,,Expert,CHEMBL617628,,,12688,945.0,F,,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,H,8,1,,BAO_0000019
2913,,Autocuration,CHEMBL617629,,,12688,945.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,,H,8,1,,BAO_0000019
2914,,Autocuration,CHEMBL858115,,,12688,945.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,,H,8,1,,BAO_0000019
2915,Rattus norvegicus,Expert,CHEMBL617630,,,12688,945.0,F,,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,,D,9,1,,BAO_0000019
2916,,Autocuration,CHEMBL617631,,,12688,1515.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,,H,8,1,,BAO_0000019
2917,,Autocuration,CHEMBL617632,,,12688,,B,,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,H,8,1,,BAO_0000357
2918,,Expert,CHEMBL617633,,,12688,,B,,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,,H,8,1,,BAO_0000357
2919,,Autocuration,CHEMBL617634,,,12688,,B,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,H,8,1,,BAO_0000357
2920,,Autocuration,CHEMBL617635,,,12688,,B,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,,H,8,1,,BAO_0000357
2922,Rattus norvegicus,Autocuration,CHEMBL617637,,,12688,945.0,F,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,D,9,1,,BAO_0000019
2923,,Autocuration,CHEMBL617638,,,227,,B,,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,8,1,,BAO_0000357
2924,,Autocuration,CHEMBL617639,,,227,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,,H,8,1,,BAO_0000357
2925,,Autocuration,CHEMBL617640,,,227,,B,,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,,H,8,1,,BAO_0000357
2926,,Autocuration,CHEMBL617641,,,227,,B,,Evaluated for the binding affinity to 5-HT 2B receptor,,H,8,1,,BAO_0000357
2927,,Autocuration,CHEMBL617642,,,227,,B,,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2928,,Autocuration,CHEMBL617643,,,227,,B,,Binding affinities against 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2929,,Autocuration,CHEMBL617644,,,227,,B,,Binding affinities towards 5-hydroxytryptamine 2B receptor,,H,8,1,,BAO_0000357
2930,,Autocuration,CHEMBL617645,,,227,,B,,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000357
2931,,Expert,CHEMBL617646,,,108,,B,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,H,8,1,,BAO_0000357
2932,Bos taurus,Autocuration,CHEMBL617647,,,108,,B,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,H,8,1,,BAO_0000357
2933,Bos taurus,Autocuration,CHEMBL617648,,,108,,B,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,,H,8,1,,BAO_0000357
2934,Bos taurus,Autocuration,CHEMBL617875,,,108,,B,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,,H,8,1,,BAO_0000357
2935,Bos taurus,Autocuration,CHEMBL617876,,,108,,B,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,,H,8,1,,BAO_0000357
2936,Bos taurus,Expert,CHEMBL617877,,,108,,B,,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,,H,8,1,,BAO_0000357
2937,Bos taurus,Expert,CHEMBL617878,,,108,,B,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,H,8,1,,BAO_0000357
2938,Bos taurus,Autocuration,CHEMBL617879,,,108,,B,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,H,8,1,,BAO_0000357
2939,Cavia porcellus,Autocuration,CHEMBL617880,,,108,,B,,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,,H,8,1,,BAO_0000019
2940,Cavia porcellus,Intermediate,CHEMBL617881,,,20033,2435.0,B,,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,,D,9,1,,BAO_0000357
2941,,Autocuration,CHEMBL857073,,,51,,B,,Binding affinity against 5-HT1A receptor,,H,8,1,,BAO_0000357
2942,,Expert,CHEMBL617882,449.0,,108,,F,,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,,H,8,1,,BAO_0000219
2943,Homo sapiens,Expert,CHEMBL617883,449.0,,108,,F,,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,,D,9,1,,BAO_0000219
2944,,Autocuration,CHEMBL617884,,,108,,F,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,,H,8,1,,BAO_0000219
2945,,Autocuration,CHEMBL617885,449.0,,108,,B,,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,,H,8,1,,BAO_0000219
2946,,Autocuration,CHEMBL617886,449.0,,108,,B,,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",,H,8,1,,BAO_0000219
2947,Homo sapiens,Expert,CHEMBL617887,,,108,,B,,Inhibition of human 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
2948,,Autocuration,CHEMBL617888,,,108,,B,,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
2949,,Autocuration,CHEMBL617889,,,108,,B,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,H,8,1,,BAO_0000019
2950,,Autocuration,CHEMBL617890,,,108,,B,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
2951,,Autocuration,CHEMBL617891,,,108,,B,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,H,8,1,,BAO_0000357
2952,,Autocuration,CHEMBL617892,,,108,,B,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,H,8,1,,BAO_0000357
2953,,Expert,CHEMBL617893,449.0,,108,,B,,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,,H,8,1,,BAO_0000219
2954,,Expert,CHEMBL617894,449.0,,108,,B,,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,,H,8,1,,BAO_0000219
2955,,Expert,CHEMBL617895,449.0,,108,,B,,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2956,,Autocuration,CHEMBL617896,449.0,,108,,B,,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000219
2957,Homo sapiens,Expert,CHEMBL617897,,,108,,B,,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,,D,9,1,,BAO_0000357
2958,,Autocuration,CHEMBL617898,,,108,,F,,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,,H,8,1,,BAO_0000019
2959,,Autocuration,CHEMBL617899,,,108,,F,,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,8,1,,BAO_0000019
2960,Rattus norvegicus,Expert,CHEMBL617900,449.0,,108,,B,,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,,H,8,1,,BAO_0000219
2961,,Autocuration,CHEMBL617901,,,108,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,,H,8,1,,BAO_0000019
2962,,Autocuration,CHEMBL617902,,,108,,F,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,,H,8,1,,BAO_0000019
2963,,Autocuration,CHEMBL617903,,,108,,F,,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000019
2964,,Autocuration,CHEMBL617904,,,108,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,,H,8,1,,BAO_0000357
2965,,Autocuration,CHEMBL617905,,,108,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,,H,8,1,,BAO_0000357
2966,,Autocuration,CHEMBL617906,,,108,,B,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,,H,8,1,,BAO_0000357
2967,,Autocuration,CHEMBL617907,,,108,,B,,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,,H,8,1,,BAO_0000357
2968,,Autocuration,CHEMBL617908,,,108,,B,,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,,H,8,1,,BAO_0000357
2969,,Expert,CHEMBL620617,449.0,,108,,B,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
2970,Homo sapiens,Expert,CHEMBL620618,,,108,,B,,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,,D,9,1,,BAO_0000019
2971,,Expert,CHEMBL620619,,,108,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,,H,8,1,,BAO_0000357
2972,Homo sapiens,Expert,CHEMBL620620,,,108,,B,,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
2973,,Autocuration,CHEMBL620621,,,108,,B,,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,,H,8,1,,BAO_0000357
2974,Rattus norvegicus,Autocuration,CHEMBL872920,,,104698,,B,,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,Membranes,D,7,1,,BAO_0000249
2975,,Autocuration,CHEMBL620622,,,104698,,B,,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,,H,6,1,,BAO_0000223
2976,Rattus norvegicus,Autocuration,CHEMBL620623,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,,D,7,1,,BAO_0000019
2977,,Autocuration,CHEMBL620624,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,,H,6,1,,BAO_0000019
2978,,Autocuration,CHEMBL620625,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,,H,6,1,,BAO_0000019
2979,,Autocuration,CHEMBL620626,,,104698,,B,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,,H,6,1,,BAO_0000219
2980,,Autocuration,CHEMBL621307,,,104698,,B,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,,H,6,1,,BAO_0000019
2981,,Autocuration,CHEMBL621308,,,104698,,B,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,,H,6,1,,BAO_0000019
2982,,Autocuration,CHEMBL621309,,,104698,,B,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,,H,6,1,,BAO_0000223
2983,,Autocuration,CHEMBL621310,,,104698,,B,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,,H,6,1,,BAO_0000223
2984,,Autocuration,CHEMBL621311,,,104698,,B,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,,H,6,1,,BAO_0000223
2985,,Autocuration,CHEMBL621502,,,104698,,B,,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,H,6,1,,BAO_0000249
2986,,Autocuration,CHEMBL621503,,,104698,,B,,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,H,6,1,,BAO_0000249
2987,,Autocuration,CHEMBL621504,,,104698,,B,,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,Membranes,H,6,1,,BAO_0000249
2988,,Autocuration,CHEMBL621505,,,104698,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000223
2989,,Autocuration,CHEMBL621506,,,104698,,B,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,H,6,1,,BAO_0000019
2990,,Autocuration,CHEMBL619781,,,104698,,B,,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,,H,6,1,,BAO_0000223
2991,,Autocuration,CHEMBL619782,,,104698,,B,,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,,H,6,1,,BAO_0000223
2992,,Autocuration,CHEMBL619783,,,104698,,B,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,,H,6,1,,BAO_0000019
2993,Rattus norvegicus,Autocuration,CHEMBL619784,,,104698,,B,,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,,D,7,1,,BAO_0000019
2994,,Autocuration,CHEMBL619785,,,104698,,B,,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,6,1,,BAO_0000249
2995,,Autocuration,CHEMBL619786,,,104698,,B,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000223
2996,,Autocuration,CHEMBL619787,,,104698,,B,,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,,H,6,1,,BAO_0000019
2997,,Autocuration,CHEMBL872925,,,104698,,B,,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,,H,6,1,,BAO_0000019
2998,,Autocuration,CHEMBL619788,,,104698,,B,,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,,H,6,1,,BAO_0000019
2999,,Autocuration,CHEMBL619789,,,104698,,B,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,H,6,1,,BAO_0000249
3000,,Autocuration,CHEMBL619790,,,104698,,B,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,H,6,1,,BAO_0000249
3001,,Autocuration,CHEMBL619791,,,104698,,B,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,H,6,1,,BAO_0000019
3002,,Autocuration,CHEMBL619792,,,104698,,B,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,H,6,1,,BAO_0000019
3003,,Autocuration,CHEMBL619793,,,104698,,B,,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,Membranes,H,6,1,,BAO_0000249
3004,Rattus norvegicus,Autocuration,CHEMBL619794,,,104698,,B,,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3005,,Autocuration,CHEMBL619795,,,104698,955.0,B,,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,,H,6,1,,BAO_0000221
3006,,Autocuration,CHEMBL619796,,,104698,,B,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,,H,6,1,,BAO_0000019
3007,,Autocuration,CHEMBL620448,,,104698,,B,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,,H,6,1,,BAO_0000223
3008,,Autocuration,CHEMBL620449,,,104698,,B,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,H,6,1,,BAO_0000223
3009,,Autocuration,CHEMBL620450,,,104698,,B,,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,,H,6,1,,BAO_0000223
3010,,Autocuration,CHEMBL620451,,,104698,,B,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,,H,6,1,,BAO_0000223
3011,,Autocuration,CHEMBL620631,,,104698,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,,H,6,1,,BAO_0000223
3012,,Autocuration,CHEMBL620632,,,104698,,B,,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,,H,6,1,,BAO_0000019
3013,,Autocuration,CHEMBL620633,,,104698,,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,,H,6,1,,BAO_0000019
3014,,Autocuration,CHEMBL620634,,,104698,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,,H,6,1,,BAO_0000223
3015,,Autocuration,CHEMBL620635,,,104698,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,H,6,1,,BAO_0000019
3016,,Autocuration,CHEMBL620636,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3017,,Autocuration,CHEMBL620637,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3018,,Autocuration,CHEMBL620638,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3019,,Autocuration,CHEMBL620639,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3020,,Autocuration,CHEMBL620640,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3021,,Autocuration,CHEMBL620641,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3022,,Autocuration,CHEMBL620642,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3023,,Autocuration,CHEMBL620643,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3024,,Autocuration,CHEMBL620644,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3025,,Autocuration,CHEMBL620645,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3026,,Autocuration,CHEMBL620646,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3027,,Autocuration,CHEMBL620647,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3028,,Autocuration,CHEMBL620648,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3029,,Autocuration,CHEMBL620649,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3030,,Autocuration,CHEMBL620650,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3031,,Autocuration,CHEMBL620651,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3032,,Autocuration,CHEMBL872875,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3033,,Autocuration,CHEMBL620652,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3034,,Autocuration,CHEMBL620653,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,,H,6,1,,BAO_0000019
3035,,Autocuration,CHEMBL857076,,,104698,,B,,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,,H,6,1,,BAO_0000019
3036,Rattus norvegicus,Autocuration,CHEMBL620654,,,104698,,B,,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000019
3037,,Autocuration,CHEMBL620655,,,104698,,B,,Binding activity radioligand.,,H,6,1,,BAO_0000223
3038,,Autocuration,CHEMBL620656,,,104698,,B,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,Brain membranes,H,6,1,,BAO_0000249
3039,,Autocuration,CHEMBL620657,,,104698,,B,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,Brain membranes,H,6,1,,BAO_0000249
3040,,Autocuration,CHEMBL620658,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,,H,8,1,,BAO_0000357
3041,,Autocuration,CHEMBL620659,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,,H,8,1,,BAO_0000357
3042,,Autocuration,CHEMBL620660,,,108,,B,,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,,H,8,1,,BAO_0000357
3043,,Autocuration,CHEMBL620661,,,108,,B,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3044,,Autocuration,CHEMBL620662,,,108,,B,,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3045,,Expert,CHEMBL620663,,,108,,B,,Affinity for 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3046,,Autocuration,CHEMBL620664,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,8,1,,BAO_0000357
3047,,Expert,CHEMBL620665,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,,H,8,1,,BAO_0000357
3048,,Autocuration,CHEMBL620666,,,108,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,,H,8,1,,BAO_0000357
3049,,Autocuration,CHEMBL620667,,,108,,B,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,,H,8,1,,BAO_0000357
3050,,Expert,CHEMBL620668,,,108,,B,,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,,H,8,1,,BAO_0000357
3051,,Autocuration,CHEMBL620669,,,108,,B,,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,,H,8,1,,BAO_0000357
3052,,Expert,CHEMBL620670,,,108,,B,,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3053,,Autocuration,CHEMBL620671,,,108,,B,,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3054,,Autocuration,CHEMBL620672,,,108,,B,,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,,H,8,1,,BAO_0000357
3055,,Autocuration,CHEMBL620673,,,108,,B,,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,,H,8,1,,BAO_0000357
3056,,Autocuration,CHEMBL620674,,,108,,B,,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3057,,Autocuration,CHEMBL620675,,,108,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3058,,Autocuration,CHEMBL620676,,,108,,B,,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,,H,8,1,,BAO_0000357
3059,,Autocuration,CHEMBL621382,,,108,,B,,Affinity against 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3060,Homo sapiens,Expert,CHEMBL621383,,,108,,B,,Binding affinity against 5-hydroxytryptamine 2C receptor,,D,9,1,,BAO_0000357
3061,,Autocuration,CHEMBL621384,,,108,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,,H,8,1,,BAO_0000357
3062,Bos taurus,Autocuration,CHEMBL621385,,,144,,B,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,H,8,1,,BAO_0000357
3063,Bos taurus,Autocuration,CHEMBL617989,,,144,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,H,8,1,,BAO_0000357
3064,Cavia porcellus,Expert,CHEMBL617990,,,104714,,F,,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,,H,4,1,,BAO_0000019
3065,Cavia porcellus,Autocuration,CHEMBL875085,,,104714,2116.0,B,,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,H,4,1,,BAO_0000221
3066,Cavia porcellus,Autocuration,CHEMBL617991,,,104714,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,,H,4,1,,BAO_0000019
3067,Cavia porcellus,Autocuration,CHEMBL617992,,,104714,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,,H,4,1,,BAO_0000019
3068,Cavia porcellus,Autocuration,CHEMBL617993,,,104714,2116.0,B,,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,H,4,1,,BAO_0000221
3069,Cavia porcellus,Autocuration,CHEMBL617994,,,104714,2116.0,B,,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,,H,4,1,,BAO_0000221
3070,Cavia porcellus,Autocuration,CHEMBL617995,,,104714,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,,H,4,1,,BAO_0000019
3071,Cavia porcellus,Autocuration,CHEMBL617996,,,104714,,F,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,,H,4,1,,BAO_0000019
3072,Cavia porcellus,Autocuration,CHEMBL617997,,,104714,,F,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,,H,4,1,,BAO_0000019
3073,Cavia porcellus,Autocuration,CHEMBL617998,,,104714,,F,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,,H,4,1,,BAO_0000019
3074,Cavia porcellus,Autocuration,CHEMBL617999,,,104714,,F,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,,H,4,1,,BAO_0000019
3075,Cavia porcellus,Autocuration,CHEMBL618000,,,104714,,F,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,,H,4,1,,BAO_0000019
3076,Cavia porcellus,Autocuration,CHEMBL617815,,,104714,2116.0,F,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",,H,4,1,,BAO_0000221
3077,Cavia porcellus,Autocuration,CHEMBL617816,,,104714,2116.0,F,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",,H,4,1,,BAO_0000221
3078,Cavia porcellus,Autocuration,CHEMBL617817,,,104714,2116.0,F,,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,,H,4,1,,BAO_0000221
3079,Cavia porcellus,Autocuration,CHEMBL617818,,,104714,2116.0,B,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,,H,4,1,,BAO_0000221
3080,Cavia porcellus,Autocuration,CHEMBL617819,,,104714,2116.0,B,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,,H,4,1,,BAO_0000221
3081,Cavia porcellus,Autocuration,CHEMBL617820,,,104714,,B,,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,,H,4,1,,BAO_0000223
3082,Cavia porcellus,Autocuration,CHEMBL617821,,,104714,2116.0,B,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,4,1,,BAO_0000221
3083,Cavia porcellus,Autocuration,CHEMBL617822,,,104714,2116.0,F,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,4,1,,BAO_0000221
3084,Cavia porcellus,Autocuration,CHEMBL617823,,,104714,2116.0,F,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),,H,4,1,,BAO_0000221
3085,Cavia porcellus,Autocuration,CHEMBL617824,,,104714,2116.0,F,,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,,H,4,1,,BAO_0000221
3086,Cavia porcellus,Autocuration,CHEMBL617825,,,104714,2116.0,F,,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,,H,4,1,,BAO_0000221
3087,Cavia porcellus,Autocuration,CHEMBL617826,,,104714,2116.0,F,,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,,H,4,1,,BAO_0000221
3088,Cavia porcellus,Autocuration,CHEMBL617827,,,104714,2116.0,B,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,4,1,,BAO_0000221
3089,Cavia porcellus,Autocuration,CHEMBL617828,,,104714,2116.0,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,4,1,,BAO_0000221
3090,Cavia porcellus,Autocuration,CHEMBL617829,,,104714,2116.0,B,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,4,1,,BAO_0000221
3091,Cavia porcellus,Autocuration,CHEMBL617830,,,104714,2116.0,B,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,,H,4,1,,BAO_0000221
3092,Cavia porcellus,Autocuration,CHEMBL617831,,,104714,2116.0,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,,H,4,1,,BAO_0000221
3093,Cavia porcellus,Autocuration,CHEMBL617832,,,104714,2116.0,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,,H,4,1,,BAO_0000221
3094,Cavia porcellus,Autocuration,CHEMBL617833,,,22226,,B,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,U,0,1,,BAO_0000019
3095,,Autocuration,CHEMBL617834,,,51,,B,,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,,H,8,1,,BAO_0000357
3096,Homo sapiens,Expert,CHEMBL617835,,,104714,,B,,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,,D,5,1,,BAO_0000223
3097,,Autocuration,CHEMBL617836,,,104714,,B,,Binding affinity towards 5-HT3 receptor,,H,4,1,,BAO_0000223
3098,,Autocuration,CHEMBL617837,,,104714,,B,,Binding activity radioligand.,,H,4,1,,BAO_0000223
3099,,Autocuration,CHEMBL620392,,,104714,,B,,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,,H,4,1,,BAO_0000019
3100,,Autocuration,CHEMBL620393,,,104714,,B,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3101,,Autocuration,CHEMBL620394,,,104714,,B,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3102,,Autocuration,CHEMBL620395,,,104714,,B,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,,H,4,1,,BAO_0000223
3103,,Autocuration,CHEMBL620396,,,22226,,B,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,,U,0,1,,BAO_0000019
3104,,Expert,CHEMBL620582,433.0,,105030,,B,,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,,H,4,1,,BAO_0000219
3105,,Autocuration,CHEMBL620583,,,105030,,B,,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",,H,4,1,,BAO_0000218
3106,,Autocuration,CHEMBL620584,,,105030,,B,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,H,4,1,,BAO_0000019
3107,,Autocuration,CHEMBL620585,,,105030,,B,,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,,H,4,1,,BAO_0000224
3108,,Autocuration,CHEMBL620586,,,105030,,B,,Compound was evaluated for the binding affinity at 5- HT3 receptor,,H,4,1,,BAO_0000224
3109,,Autocuration,CHEMBL620587,,,105030,,B,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,H,4,1,,BAO_0000019
3110,,Autocuration,CHEMBL620588,,,105030,,B,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,H,4,1,,BAO_0000019
3111,,Autocuration,CHEMBL620589,,,105030,,F,,5-hydroxytryptamine 3 receptor agonism in mouse,,H,4,1,,BAO_0000218
3112,,Autocuration,CHEMBL620590,,,105030,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,,H,4,1,,BAO_0000219
3113,,Autocuration,CHEMBL617956,,,105030,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,H,4,1,,BAO_0000019
3114,,Autocuration,CHEMBL617957,,,105030,,B,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,H,4,1,,BAO_0000019
3115,,Autocuration,CHEMBL617958,,,105030,,B,,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,,H,4,1,,BAO_0000224
3116,,Autocuration,CHEMBL617959,,,105030,,B,,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,H,4,1,,BAO_0000219
3117,,Autocuration,CHEMBL617960,,,105030,,B,,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,H,4,1,,BAO_0000219
3118,,Autocuration,CHEMBL617961,,,105030,,B,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,H,4,1,,BAO_0000224
3119,,Autocuration,CHEMBL617962,,,105030,,B,,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,,H,4,1,,BAO_0000219
3120,,Autocuration,CHEMBL617963,339.0,,105030,,B,,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,,H,4,1,,BAO_0000219
3121,,Autocuration,CHEMBL617964,,,11765,,B,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,H,8,1,,BAO_0000019
3122,,Autocuration,CHEMBL617965,,,11765,,B,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,,H,8,1,,BAO_0000219
3123,Mus musculus,Autocuration,CHEMBL617966,,,10630,,B,,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,,D,9,1,,BAO_0000357
3124,,Autocuration,CHEMBL857074,,,17106,,B,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,8,1,,BAO_0000019
3125,Sus scrofa,Autocuration,CHEMBL617967,,,144,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3126,Sus scrofa,Autocuration,CHEMBL617968,,,144,,B,,Binding activity radioligand.,,H,8,1,,BAO_0000357
3127,Oryctolagus cuniculus,Autocuration,CHEMBL617969,,,104714,,B,,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,,H,4,1,,BAO_0000223
3128,Oryctolagus cuniculus,Autocuration,CHEMBL617970,,,104714,,B,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,H,4,1,,BAO_0000223
3129,Oryctolagus cuniculus,Autocuration,CHEMBL617971,,,104714,,B,,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,,H,4,1,,BAO_0000223
3130,Oryctolagus cuniculus,Autocuration,CHEMBL617972,,,104714,,B,,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,H,4,1,,BAO_0000019
3131,Oryctolagus cuniculus,Autocuration,CHEMBL617973,,,104714,,F,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,4,1,,BAO_0000019
3132,Oryctolagus cuniculus,Autocuration,CHEMBL617974,,,104714,,F,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,4,1,,BAO_0000019
3133,Oryctolagus cuniculus,Autocuration,CHEMBL617975,,,104714,2116.0,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,4,1,,BAO_0000221
3134,Oryctolagus cuniculus,Autocuration,CHEMBL617976,,,104714,,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,4,1,,BAO_0000019
3135,Oryctolagus cuniculus,Autocuration,CHEMBL617977,,,104714,,F,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,4,1,,BAO_0000019
3136,Oryctolagus cuniculus,Autocuration,CHEMBL617978,,,104714,,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,4,1,,BAO_0000019
3137,Oryctolagus cuniculus,Autocuration,CHEMBL617979,,,104714,,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,4,1,,BAO_0000019
3138,Oryctolagus cuniculus,Autocuration,CHEMBL617980,449.0,,104714,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,,H,4,1,,BAO_0000219
3139,Rattus norvegicus,Autocuration,CHEMBL617981,,,104698,,B,,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000019
3140,,Autocuration,CHEMBL617982,,,12020,,B,,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),,H,8,1,,BAO_0000019
3141,,Autocuration,CHEMBL617983,,,12020,,B,,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),,H,8,1,,BAO_0000357
3142,Rattus norvegicus,Autocuration,CHEMBL617984,,,104698,,B,,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,,D,7,1,,BAO_0000019
3143,,Autocuration,CHEMBL617985,,,104698,,B,,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",,H,6,1,,BAO_0000019
3144,,Autocuration,CHEMBL617986,,,104698,948.0,F,,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,H,6,1,,BAO_0000218
3145,,Autocuration,CHEMBL617987,,,104698,948.0,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,H,6,1,,BAO_0000019
3146,,Autocuration,CHEMBL617988,,,104698,948.0,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,H,6,1,,BAO_0000019
3147,,Autocuration,CHEMBL617792,,,104698,948.0,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",,H,6,1,,BAO_0000019
3148,,Autocuration,CHEMBL617793,,,104698,948.0,F,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,H,6,1,,BAO_0000019
3149,,Autocuration,CHEMBL617794,,,104698,,F,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",,H,6,1,,BAO_0000019
3150,,Autocuration,CHEMBL617795,,,104698,,F,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,H,6,1,,BAO_0000019
3151,,Autocuration,CHEMBL617796,,,104698,,F,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,H,6,1,,BAO_0000019
3152,,Autocuration,CHEMBL617797,,,104698,,F,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",,H,6,1,,BAO_0000019
3153,Rattus norvegicus,Autocuration,CHEMBL617798,,,104698,,F,,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),,D,7,1,,BAO_0000218
3154,,Autocuration,CHEMBL617799,,,104698,,F,,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),,H,6,1,,BAO_0000218
3155,Rattus norvegicus,Autocuration,CHEMBL617800,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,D,7,1,,BAO_0000218
3156,Rattus norvegicus,Autocuration,CHEMBL617801,,,104698,,F,,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,,D,7,1,,BAO_0000019
3157,Rattus norvegicus,Autocuration,CHEMBL617802,,,104698,,F,,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,,D,7,1,,BAO_0000218
3158,Rattus norvegicus,Autocuration,CHEMBL617803,,,104698,,F,,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),,D,7,1,,BAO_0000019
3159,,Autocuration,CHEMBL617804,,,104698,,B,,Binding affinity towards 5-HT3 receptor in rat was evaluated,,H,6,1,,BAO_0000019
3160,Rattus norvegicus,Autocuration,CHEMBL617805,,,104698,,B,,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000019
3161,,Autocuration,CHEMBL617806,,,104698,,B,,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000223
3162,,Autocuration,CHEMBL617807,,,104698,,B,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,,H,6,1,,BAO_0000019
3163,,Autocuration,CHEMBL617808,,,104698,,B,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,,H,6,1,,BAO_0000019
3164,,Autocuration,CHEMBL617809,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,,H,6,1,,BAO_0000249
3165,,Autocuration,CHEMBL617810,,,104698,,B,,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,,H,6,1,,BAO_0000019
3166,,Autocuration,CHEMBL617811,,,104698,955.0,B,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,,H,6,1,,BAO_0000249
3167,,Autocuration,CHEMBL617812,,,104698,955.0,B,,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,,H,6,1,,BAO_0000221
3168,,Autocuration,CHEMBL617813,,,104698,,B,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,6,1,,BAO_0000249
3169,,Autocuration,CHEMBL617814,,,104698,,B,,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,6,1,,BAO_0000249
3170,,Autocuration,CHEMBL617698,,,104698,,B,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,,H,6,1,,BAO_0000019
3171,Rattus norvegicus,Autocuration,CHEMBL617699,,,104698,,B,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,,D,7,1,,BAO_0000019
3172,Rattus norvegicus,Autocuration,CHEMBL617700,,,104698,,B,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,,D,7,1,,BAO_0000019
3173,Rattus norvegicus,Autocuration,CHEMBL617701,,,104698,,B,,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3174,,Autocuration,CHEMBL617702,,,104698,,B,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,H,6,1,,BAO_0000019
3175,,Autocuration,CHEMBL617703,,,104698,,B,,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",Membranes,H,6,1,,BAO_0000249
3176,Rattus norvegicus,Autocuration,CHEMBL617704,,,104698,,B,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,,D,7,1,,BAO_0000019
3177,,Autocuration,CHEMBL617705,,,104698,,B,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,H,6,1,,BAO_0000223
3178,Rattus norvegicus,Autocuration,CHEMBL617706,,,104698,,B,,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3179,,Autocuration,CHEMBL617707,433.0,,104698,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),,H,6,1,,BAO_0000219
3180,,Autocuration,CHEMBL617708,433.0,,104698,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,,H,6,1,,BAO_0000219
3181,,Autocuration,CHEMBL617709,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,,H,6,1,,BAO_0000019
3182,,Autocuration,CHEMBL617710,,,104698,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,,H,6,1,,BAO_0000019
3183,,Autocuration,CHEMBL882925,,,104698,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,,H,6,1,,BAO_0000019
3184,,Autocuration,CHEMBL617711,,,104698,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,,H,6,1,,BAO_0000019
3185,,Autocuration,CHEMBL617712,,,104698,,F,,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,,H,6,1,,BAO_0000019
3186,Rattus norvegicus,Autocuration,CHEMBL617713,,,104698,,F,,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,,D,7,1,,BAO_0000019
3187,,Autocuration,CHEMBL617714,,,104698,,F,,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",,H,6,1,,BAO_0000019
3188,,Autocuration,CHEMBL617715,,,104698,,F,,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,,H,6,1,,BAO_0000218
3189,,Autocuration,CHEMBL617716,,,104698,,F,,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,,H,6,1,,BAO_0000218
3190,,Autocuration,CHEMBL617717,,,104698,,F,,Inhibition of 5-HT evoked reflex bradycardia in rat.,,H,6,1,,BAO_0000218
3191,,Autocuration,CHEMBL617718,,,104698,,F,,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3192,,Autocuration,CHEMBL617719,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3193,,Autocuration,CHEMBL617720,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),,H,6,1,,BAO_0000218
3194,Rattus norvegicus,Autocuration,CHEMBL617721,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,,D,7,1,,BAO_0000218
3195,,Autocuration,CHEMBL617722,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3196,,Autocuration,CHEMBL617723,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,,H,6,1,,BAO_0000218
3197,,Autocuration,CHEMBL617724,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3198,,Autocuration,CHEMBL617725,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3199,,Autocuration,CHEMBL617726,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3200,,Autocuration,CHEMBL617727,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3201,,Autocuration,CHEMBL617728,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3202,,Autocuration,CHEMBL617729,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3203,,Autocuration,CHEMBL617730,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3204,,Autocuration,CHEMBL617731,,,104698,,F,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3205,,Autocuration,CHEMBL617732,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3206,,Autocuration,CHEMBL617733,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3207,,Autocuration,CHEMBL617734,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3208,,Autocuration,CHEMBL872874,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,,H,6,1,,BAO_0000218
3209,,Autocuration,CHEMBL617735,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,,H,6,1,,BAO_0000218
3210,,Autocuration,CHEMBL617736,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,,H,6,1,,BAO_0000218
3211,,Autocuration,CHEMBL617737,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,,H,6,1,,BAO_0000218
3212,,Autocuration,CHEMBL617738,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,,H,6,1,,BAO_0000218
3213,,Autocuration,CHEMBL617739,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3214,,Autocuration,CHEMBL617740,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3215,,Autocuration,CHEMBL617741,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3216,,Autocuration,CHEMBL617742,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3217,,Autocuration,CHEMBL617743,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3218,,Autocuration,CHEMBL617744,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3219,,Autocuration,CHEMBL617745,,,104698,,F,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,,H,6,1,,BAO_0000218
3220,,Autocuration,CHEMBL617746,,,104698,,F,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",,H,6,1,,BAO_0000218
3221,,Autocuration,CHEMBL617747,,,104698,,F,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",,H,6,1,,BAO_0000218
3222,,Autocuration,CHEMBL617748,,,104698,,F,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,,H,6,1,,BAO_0000218
3223,,Autocuration,CHEMBL618909,,,104698,,F,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,,H,6,1,,BAO_0000218
3224,,Autocuration,CHEMBL618910,,,104698,,F,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,,H,6,1,,BAO_0000218
3225,,Autocuration,CHEMBL618911,,,104698,,F,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,,H,6,1,,BAO_0000218
3226,,Autocuration,CHEMBL618912,,,104698,,F,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,,H,6,1,,BAO_0000218
3227,,Autocuration,CHEMBL618913,,,104698,,F,,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),,H,6,1,,BAO_0000218
3228,,Autocuration,CHEMBL618914,,,104698,,F,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,H,6,1,,BAO_0000019
3229,,Autocuration,CHEMBL618915,,,104698,,F,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,H,6,1,,BAO_0000019
3230,Rattus norvegicus,Autocuration,CHEMBL618916,,,104698,,B,,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3231,,Autocuration,CHEMBL618917,,,104698,,F,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,,H,6,1,,BAO_0000019
3232,,Intermediate,CHEMBL618918,,,104698,10000000.0,B,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,,D,7,1,,BAO_0000221
3233,Rattus norvegicus,Autocuration,CHEMBL618919,,,104698,,B,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,,D,7,1,,BAO_0000019
3234,Rattus norvegicus,Autocuration,CHEMBL618920,,,104698,,B,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000019
3235,,Autocuration,CHEMBL618921,,,104698,,B,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000223
3236,,Autocuration,CHEMBL618922,,,104698,,B,,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000019
3237,,Autocuration,CHEMBL618923,,,104698,,B,,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,,H,6,1,,BAO_0000019
3238,,Autocuration,CHEMBL618924,,,104698,,B,,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,,H,6,1,,BAO_0000019
3239,,Autocuration,CHEMBL618925,,,104698,,B,,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,,H,6,1,,BAO_0000019
3240,,Autocuration,CHEMBL618926,,,104698,,B,,Binding affinity towards 5-HT3 receptor in rat was evaluated,,H,6,1,,BAO_0000019
3241,Cavia porcellus,Intermediate,CHEMBL618927,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,,D,9,1,,BAO_0000221
3242,Cavia porcellus,Intermediate,CHEMBL618928,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,,D,9,1,,BAO_0000221
3243,Cavia porcellus,Intermediate,CHEMBL618929,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",,D,9,1,,BAO_0000221
3244,Cavia porcellus,Intermediate,CHEMBL618930,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",,D,9,1,,BAO_0000221
3245,Cavia porcellus,Intermediate,CHEMBL618931,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,D,9,1,,BAO_0000221
3246,Cavia porcellus,Intermediate,CHEMBL619594,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,D,9,1,,BAO_0000221
3247,Cavia porcellus,Intermediate,CHEMBL619595,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",,D,9,1,,BAO_0000221
3248,Cavia porcellus,Intermediate,CHEMBL619596,,,20033,2116.0,F,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,,D,9,1,,BAO_0000221
3249,Cavia porcellus,Intermediate,CHEMBL619755,,,20033,2116.0,F,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,,D,9,1,,BAO_0000221
3250,Cavia porcellus,Intermediate,CHEMBL619756,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,,D,9,1,,BAO_0000221
3251,Cavia porcellus,Intermediate,CHEMBL619757,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,,D,9,1,,BAO_0000221
3252,Cavia porcellus,Intermediate,CHEMBL619758,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,,D,9,1,,BAO_0000221
3253,Cavia porcellus,Intermediate,CHEMBL619759,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",,D,9,1,,BAO_0000221
3254,Cavia porcellus,Intermediate,CHEMBL619760,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",,D,9,1,,BAO_0000221
3255,Cavia porcellus,Intermediate,CHEMBL619761,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",,D,9,1,,BAO_0000221
3256,Cavia porcellus,Intermediate,CHEMBL619762,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,,D,9,1,,BAO_0000221
3257,Cavia porcellus,Intermediate,CHEMBL619763,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,D,9,1,,BAO_0000221
3258,Cavia porcellus,Intermediate,CHEMBL617868,,,20033,2116.0,F,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,D,9,1,,BAO_0000221
3259,Cavia porcellus,Intermediate,CHEMBL617869,,,20033,,B,,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,,D,9,1,,BAO_0000357
3260,Cavia porcellus,Intermediate,CHEMBL882926,,,20033,2435.0,B,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,9,1,,BAO_0000249
3261,Cavia porcellus,Intermediate,CHEMBL617870,,,20033,2435.0,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,9,1,,BAO_0000249
3262,Cavia porcellus,Intermediate,CHEMBL617871,,,20033,2435.0,B,,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,,D,9,1,,BAO_0000357
3263,Cavia porcellus,Intermediate,CHEMBL617872,,,20033,2435.0,B,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,,D,9,1,,BAO_0000357
3264,Cavia porcellus,Intermediate,CHEMBL617873,,,20033,2435.0,B,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,D,9,1,,BAO_0000357
3265,Cavia porcellus,Intermediate,CHEMBL617874,,,20033,2435.0,B,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,D,9,1,,BAO_0000357
3266,Cavia porcellus,Intermediate,CHEMBL619067,,,20033,2116.0,F,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,,D,9,1,,BAO_0000221
3267,Cavia porcellus,Intermediate,CHEMBL619068,,,20033,2116.0,F,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,,D,9,1,,BAO_0000221
3268,Cavia porcellus,Intermediate,CHEMBL619069,,,20033,2116.0,F,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,D,9,1,,BAO_0000221
3269,Cavia porcellus,Intermediate,CHEMBL619070,,,20033,,B,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,,D,9,1,,BAO_0000357
3270,Cavia porcellus,Intermediate,CHEMBL619071,,,20033,,B,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,,D,9,1,,BAO_0000357
3271,Cavia porcellus,Intermediate,CHEMBL619072,,,20033,,F,,Agonistic activity against 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000019
3272,Cavia porcellus,Intermediate,CHEMBL619073,,,20033,,F,,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,,D,9,1,,BAO_0000019
3273,Cavia porcellus,Intermediate,CHEMBL619074,,,20033,,F,,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000019
3274,Cavia porcellus,Intermediate,CHEMBL619075,,,20033,,B,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3275,Cavia porcellus,Intermediate,CHEMBL619076,,,20033,2435.0,B,,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3276,Cavia porcellus,Intermediate,CHEMBL619077,,,20033,2435.0,B,,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,,D,9,1,,BAO_0000357
3277,Cavia porcellus,Intermediate,CHEMBL619078,,,20033,2435.0,B,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,9,1,,BAO_0000249
3278,Cavia porcellus,Intermediate,CHEMBL619079,,,20033,2435.0,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,9,1,,BAO_0000249
3279,Cavia porcellus,Intermediate,CHEMBL619080,,,20033,2116.0,B,,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,,D,9,1,,BAO_0000221
3280,Cavia porcellus,Expert,CHEMBL619081,,,20033,,B,,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,,D,9,1,,BAO_0000357
3281,Cavia porcellus,Intermediate,CHEMBL619082,,,20033,,B,,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,D,9,1,,BAO_0000357
3282,Cavia porcellus,Intermediate,CHEMBL619083,,,20033,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,,D,9,1,,BAO_0000357
3283,Cavia porcellus,Intermediate,CHEMBL619084,,,20033,,B,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,D,9,1,,BAO_0000357
3284,Cavia porcellus,Intermediate,CHEMBL859397,,,20033,2116.0,F,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,D,9,1,,BAO_0000221
3285,Cavia porcellus,Intermediate,CHEMBL619085,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,,D,9,1,,BAO_0000221
3286,Cavia porcellus,Intermediate,CHEMBL619086,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,,D,9,1,,BAO_0000221
3287,Cavia porcellus,Intermediate,CHEMBL619087,,,20033,2116.0,F,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,,D,9,1,,BAO_0000221
3288,Cavia porcellus,Intermediate,CHEMBL619088,,,20033,2116.0,F,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,D,9,1,,BAO_0000221
3289,Cavia porcellus,Intermediate,CHEMBL619089,,,20033,,B,,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,,D,9,1,,BAO_0000357
3290,Cavia porcellus,Autocuration,CHEMBL619090,,,168,,B,,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3291,Cavia porcellus,Intermediate,CHEMBL619091,,,20033,,F,,Antagonistic activity against 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000019
3292,Cavia porcellus,Intermediate,CHEMBL619092,,,20033,,B,,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3293,Cavia porcellus,Intermediate,CHEMBL619093,,,20033,,B,,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,,D,9,1,,BAO_0000019
3294,Cavia porcellus,Autocuration,CHEMBL619094,722.0,,168,,B,,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,,H,8,1,,BAO_0000219
3295,Cavia porcellus,Intermediate,CHEMBL619095,,,20033,,B,,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,,D,9,1,,BAO_0000019
3296,Cavia porcellus,Intermediate,CHEMBL857988,,,20033,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,,D,9,1,,BAO_0000357
3297,Cavia porcellus,Intermediate,CHEMBL619096,,,20033,,B,,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,,D,9,1,,BAO_0000357
3298,Cavia porcellus,Intermediate,CHEMBL619097,,,20033,2435.0,B,,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,,D,9,1,,BAO_0000357
3299,Cavia porcellus,Intermediate,CHEMBL619098,,,20033,10000000.0,B,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,,D,9,1,,BAO_0000221
3300,Cavia porcellus,Intermediate,CHEMBL619751,,,20033,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,,D,9,1,,BAO_0000357
3301,Cavia porcellus,Intermediate,CHEMBL619752,,,20033,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,,D,9,1,,BAO_0000357
3302,Cavia porcellus,Intermediate,CHEMBL875096,,,20033,2116.0,F,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,D,9,1,,BAO_0000221
3303,,Autocuration,CHEMBL619004,,,108,,B,,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,,H,8,1,,BAO_0000357
3304,,Autocuration,CHEMBL619005,,,168,,B,,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
3305,,Autocuration,CHEMBL619006,,,168,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000019
3306,,Autocuration,CHEMBL619007,308.0,,168,,B,,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,,H,8,1,,BAO_0000219
3307,,Autocuration,CHEMBL619008,,,168,,B,,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3308,,Autocuration,CHEMBL619009,,,168,,B,,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3309,,Autocuration,CHEMBL619010,308.0,,168,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",,H,8,1,,BAO_0000219
3310,,Autocuration,CHEMBL619011,,,10622,,B,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,,H,8,1,,BAO_0000357
3311,,Autocuration,CHEMBL619012,,,10622,,B,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,,H,8,1,,BAO_0000357
3312,,Autocuration,CHEMBL619013,,,10622,,B,,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,,H,8,1,,BAO_0000219
3313,,Autocuration,CHEMBL619014,,,10622,,B,,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,,H,8,1,,BAO_0000357
3314,,Autocuration,CHEMBL857503,,,11249,2081.0,F,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,,H,8,1,,BAO_0000019
3315,,Autocuration,CHEMBL619015,,,11249,2081.0,F,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,,H,8,1,,BAO_0000019
3316,,Autocuration,CHEMBL619016,,,11249,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3317,,Autocuration,CHEMBL619017,,,11249,10000000.0,B,,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000221
3318,Sus scrofa,Autocuration,CHEMBL619018,,,168,10000000.0,B,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,,H,8,1,,BAO_0000221
3319,Oryctolagus cuniculus,Autocuration,CHEMBL619019,,,168,,B,,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,,H,8,1,,BAO_0000019
3320,Rattus norvegicus,Expert,CHEMBL619020,,,10623,,B,,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3321,,Autocuration,CHEMBL619021,,,10623,,F,,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,H,8,1,,BAO_0000019
3322,,Autocuration,CHEMBL619022,,,10623,,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,,H,8,1,,BAO_0000357
3323,,Autocuration,CHEMBL619023,,,10623,,B,,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,,H,8,1,,BAO_0000357
3324,,Autocuration,CHEMBL619024,,,10623,,F,,lntrinsic activity relative to 5-HT receptor,,H,8,1,,BAO_0000019
3325,,Autocuration,CHEMBL619025,,,10623,,F,,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,,H,8,1,,BAO_0000019
3326,,Expert,CHEMBL619026,,,10623,,F,,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,,H,8,1,,BAO_0000019
3327,,Autocuration,CHEMBL619027,,,10623,,F,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,,H,8,1,,BAO_0000019
3328,,Autocuration,CHEMBL619028,,,10623,,F,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,,H,8,1,,BAO_0000019
3329,,Autocuration,CHEMBL619029,,,10623,,F,,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,,H,8,1,,BAO_0000019
3330,,Autocuration,CHEMBL619030,,,10623,,F,,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,,H,8,1,,BAO_0000019
3331,,Expert,CHEMBL619031,,,10623,,B,,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,,H,8,1,,BAO_0000357
3332,,Autocuration,CHEMBL619032,,,10623,,F,,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,,H,8,1,,BAO_0000019
3333,Rattus norvegicus,Expert,CHEMBL619033,,,10623,,B,,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3334,,Autocuration,CHEMBL619034,,,10623,,B,,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,H,8,1,,BAO_0000357
3335,,Autocuration,CHEMBL619035,,,10623,,B,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,,H,8,1,,BAO_0000357
3336,,Autocuration,CHEMBL619036,,,10623,,B,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,,H,8,1,,BAO_0000357
3337,Rattus norvegicus,Expert,CHEMBL619037,,,10623,,B,,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,,D,9,1,,BAO_0000019
3338,,Autocuration,CHEMBL619038,,,10623,2435.0,B,,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,,H,8,1,,BAO_0000249
3339,,Autocuration,CHEMBL619039,,,10623,,B,,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,,H,8,1,,BAO_0000249
3340,,Expert,CHEMBL619040,,,10623,,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,,H,8,1,,BAO_0000249
3341,Rattus norvegicus,Expert,CHEMBL619041,,,10623,2435.0,B,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,D,9,1,,BAO_0000019
3342,,Autocuration,CHEMBL619042,,,10623,2435.0,B,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,H,8,1,,BAO_0000019
3343,,Expert,CHEMBL619043,,,10623,2435.0,B,,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,,H,8,1,,BAO_0000249
3344,,Expert,CHEMBL619044,,,10623,2435.0,B,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,,H,8,1,,BAO_0000019
3345,,Expert,CHEMBL619045,,,10623,2435.0,B,,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,,H,8,1,,BAO_0000249
3346,,Expert,CHEMBL619046,,,10623,2435.0,B,,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,,H,8,1,,BAO_0000249
3347,,Expert,CHEMBL619047,,,10623,,B,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,,H,8,1,,BAO_0000249
3348,,Autocuration,CHEMBL619048,,,10623,955.0,F,,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,,H,8,1,,BAO_0000221
3349,,Autocuration,CHEMBL859398,,,10623,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,,H,8,1,,BAO_0000019
3350,,Autocuration,CHEMBL619049,,,10623,,F,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,,H,8,1,,BAO_0000019
3351,,Autocuration,CHEMBL857886,,,10623,,F,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,,H,8,1,,BAO_0000019
3352,,Autocuration,CHEMBL619050,,,10623,,F,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,,H,8,1,,BAO_0000019
3353,,Autocuration,CHEMBL620591,,,10623,,F,,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,H,8,1,,BAO_0000019
3354,Rattus norvegicus,Expert,CHEMBL620592,,,10623,,B,,Binding affinity against rat 5-hydroxytryptamine 4 receptor,,D,9,1,,BAO_0000357
3355,,Expert,CHEMBL620593,,,10623,2435.0,B,,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,,H,8,1,,BAO_0000249
3356,Rattus norvegicus,Expert,CHEMBL620594,,,10623,,F,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,,D,9,1,,BAO_0000019
3357,,Expert,CHEMBL875079,,,10623,,F,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,,H,8,1,,BAO_0000019
3358,,Expert,CHEMBL620595,,,10623,,F,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,H,8,1,,BAO_0000019
3359,Rattus norvegicus,Expert,CHEMBL620596,,,10623,,F,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,,D,9,1,,BAO_0000019
3360,,Autocuration,CHEMBL620597,,,10623,,F,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,,H,8,1,,BAO_0000019
3361,,Expert,CHEMBL620598,,,10623,,F,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,,H,8,1,,BAO_0000019
3362,,Expert,CHEMBL620599,,,10623,,F,,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),,H,8,1,,BAO_0000218
3363,,Autocuration,CHEMBL620600,,,10623,,F,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,H,8,1,,BAO_0000019
3364,Rattus norvegicus,Autocuration,CHEMBL620601,,,168,,F,,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,,H,8,1,,BAO_0000019
3365,,Autocuration,CHEMBL620602,,,168,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,,H,8,1,,BAO_0000019
3366,,Autocuration,CHEMBL620603,,,168,,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3367,,Autocuration,CHEMBL620604,,,168,,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,,H,8,1,,BAO_0000357
3368,,Autocuration,CHEMBL620605,,,168,,B,,Compound was tested for 5-hydroxytryptamine 4 binding affinity,,H,8,1,,BAO_0000357
3369,,Autocuration,CHEMBL620606,,,168,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3370,,Autocuration,CHEMBL620607,,,168,,F,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,8,1,,BAO_0000019
3371,,Autocuration,CHEMBL620608,,,168,,B,,In vitro binding affinity towards 5-HT4 receptor was determined,,H,8,1,,BAO_0000357
3372,,Autocuration,CHEMBL620609,,,168,,F,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,8,1,,BAO_0000019
3373,,Autocuration,CHEMBL620610,,,168,,F,,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000019
3374,,Autocuration,CHEMBL620611,,,168,,B,,Tested for selectivity for 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3375,,Autocuration,CHEMBL620612,,,168,,B,,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,,H,8,1,,BAO_0000357
3376,,Autocuration,CHEMBL620613,,,168,,B,,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,,H,8,1,,BAO_0000357
3377,,Autocuration,CHEMBL620614,,,168,,B,,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,,H,8,1,,BAO_0000357
3378,,Expert,CHEMBL620615,,,168,,B,,Binding affinity against 5-Hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3379,,Autocuration,CHEMBL857075,,,104698,,B,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,Brain membranes,H,6,1,,BAO_0000249
3380,,Autocuration,CHEMBL620616,,,104698,,B,,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,Brain membranes,H,6,1,,BAO_0000249
3381,,Autocuration,CHEMBL619411,,,104698,,B,,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,Brain membranes,H,6,1,,BAO_0000249
3382,,Autocuration,CHEMBL619412,,,104698,,B,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,,H,6,1,,BAO_0000019
3383,Rattus norvegicus,Autocuration,CHEMBL619413,,,104698,,B,,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000019
3384,,Autocuration,CHEMBL619414,,,104698,10000000.0,B,,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,,H,6,1,,BAO_0000221
3385,,Autocuration,CHEMBL619415,,,104698,,B,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,H,6,1,,BAO_0000019
3386,,Autocuration,CHEMBL619416,,,104698,,B,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,,H,6,1,,BAO_0000019
3387,,Autocuration,CHEMBL619417,,,104698,,F,,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,,H,6,1,,BAO_0000019
3388,Rattus norvegicus,Autocuration,CHEMBL619418,,,104698,,B,,Binding affinity against rat 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3389,Rattus norvegicus,Autocuration,CHEMBL619419,,,104698,,B,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3390,,Autocuration,CHEMBL619420,,,104698,,B,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,,H,6,1,,BAO_0000019
3391,,Autocuration,CHEMBL619421,,,104698,,B,,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,,H,6,1,,BAO_0000249
3392,Rattus norvegicus,Autocuration,CHEMBL619422,,,104698,,B,,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,,D,7,1,,BAO_0000019
3393,,Autocuration,CHEMBL619423,,,104698,,B,,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,,H,6,1,,BAO_0000019
3394,,Autocuration,CHEMBL875080,,,104698,,B,,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,,H,6,1,,BAO_0000019
3395,,Autocuration,CHEMBL619424,,,104698,,B,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,,H,6,1,,BAO_0000019
3396,,Autocuration,CHEMBL619425,,,104698,,B,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,,H,6,1,,BAO_0000249
3397,,Autocuration,CHEMBL619426,,,104698,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,,H,6,1,,BAO_0000223
3398,,Autocuration,CHEMBL619427,,,104698,,B,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,,H,6,1,,BAO_0000223
3399,Rattus norvegicus,Autocuration,CHEMBL619645,,,104698,,B,,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,,D,7,1,,BAO_0000223
3400,,Expert,CHEMBL619646,,,10576,,B,,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,D,9,1,,BAO_0000249
3401,,Autocuration,CHEMBL619647,,,12020,955.0,F,,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,,H,8,1,,BAO_0000221
3402,,Autocuration,CHEMBL619648,,,12020,,F,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000019
3403,,Autocuration,CHEMBL619165,,,12020,,F,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,,H,8,1,,BAO_0000019
3404,,Autocuration,CHEMBL620719,,,12020,,F,,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000218
3405,,Autocuration,CHEMBL872924,,,12020,,B,,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,H,8,1,,BAO_0000019
3406,,Autocuration,CHEMBL620720,,,12020,,B,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3407,,Autocuration,CHEMBL620721,,,12020,,B,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,H,8,1,,BAO_0000019
3408,,Autocuration,CHEMBL620722,,,12020,,B,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,,H,8,1,,BAO_0000019
3409,,Autocuration,CHEMBL620723,,,104698,,B,,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",,H,6,1,,BAO_0000019
3410,,Autocuration,CHEMBL620724,,,12020,,B,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,H,8,1,,BAO_0000019
3411,,Autocuration,CHEMBL620725,,,104698,,B,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,,H,6,1,,BAO_0000249
3412,Rattus norvegicus,Autocuration,CHEMBL620726,,,12020,,F,,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,,D,9,1,,BAO_0000019
3413,,Expert,CHEMBL620727,,,144,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3414,,Autocuration,CHEMBL620728,,,104714,,B,,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,,H,4,1,,BAO_0000223
3415,,Autocuration,CHEMBL620729,,,22226,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,U,0,1,,BAO_0000019
3416,,Autocuration,CHEMBL858288,,,104714,,F,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,,H,4,1,,BAO_0000019
3417,,Autocuration,CHEMBL620730,,,104714,,B,,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3418,,Autocuration,CHEMBL620731,,,104714,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3419,Cavia porcellus,Autocuration,CHEMBL620732,,,104714,,F,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,,H,4,1,,BAO_0000019
3420,Cavia porcellus,Autocuration,CHEMBL618042,,,104714,,F,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,H,4,1,,BAO_0000019
3421,Cavia porcellus,Autocuration,CHEMBL618043,,,104714,,F,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,,H,4,1,,BAO_0000019
3422,,Autocuration,CHEMBL618044,,,104714,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3423,,Autocuration,CHEMBL618045,,,104714,,F,,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,,H,4,1,,BAO_0000019
3424,,Autocuration,CHEMBL618046,,,104714,,B,,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,,H,4,1,,BAO_0000223
3425,,Autocuration,CHEMBL618047,,,104714,,F,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,,H,4,1,,BAO_0000019
3426,,Autocuration,CHEMBL875084,,,104714,,F,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,,H,4,1,,BAO_0000019
3427,,Autocuration,CHEMBL618048,,,104714,,F,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,,H,4,1,,BAO_0000019
3428,,Autocuration,CHEMBL618049,,,104714,,B,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,,H,4,1,,BAO_0000223
3429,,Autocuration,CHEMBL619764,,,104714,,F,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,,H,4,1,,BAO_0000019
3430,,Autocuration,CHEMBL619765,,,104714,,F,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,,H,4,1,,BAO_0000019
3431,,Autocuration,CHEMBL619766,,,104714,,F,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,,H,4,1,,BAO_0000019
3432,,Autocuration,CHEMBL619767,,,104714,,B,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,,H,4,1,,BAO_0000223
3433,,Autocuration,CHEMBL619768,,,104714,,B,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,,H,4,1,,BAO_0000223
3434,,Autocuration,CHEMBL619769,,,104714,,F,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,,H,4,1,,BAO_0000019
3435,,Autocuration,CHEMBL619770,,,104714,,B,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,,H,4,1,,BAO_0000223
3436,,Autocuration,CHEMBL619771,,,104714,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3437,,Autocuration,CHEMBL619772,,,104714,,B,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,,H,4,1,,BAO_0000219
3438,,Autocuration,CHEMBL619773,,,104714,,B,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,,H,4,1,,BAO_0000223
3439,,Autocuration,CHEMBL619774,433.0,,104714,,B,,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,,H,4,1,,BAO_0000219
3440,,Autocuration,CHEMBL875083,,,104714,,B,,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,,H,4,1,,BAO_0000019
3441,,Autocuration,CHEMBL620718,433.0,,104714,,B,,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,,H,4,1,,BAO_0000219
3442,,Autocuration,CHEMBL618127,,,104714,,B,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,H,4,1,,BAO_0000223
3443,,Autocuration,CHEMBL618128,,,104714,,B,,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,,H,4,1,,BAO_0000223
3444,,Autocuration,CHEMBL618129,,,104714,,B,,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,,H,4,1,,BAO_0000219
3445,,Autocuration,CHEMBL618130,,,104714,,B,,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,H,4,1,,BAO_0000223
3446,,Autocuration,CHEMBL618131,,,104714,,F,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,,H,4,1,,BAO_0000019
3447,Cavia porcellus,Autocuration,CHEMBL618132,,,104714,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,,H,4,1,,BAO_0000019
3448,Cavia porcellus,Autocuration,CHEMBL618133,,,104714,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,,H,4,1,,BAO_0000019
3449,Cavia porcellus,Autocuration,CHEMBL618134,,,104714,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,,H,4,1,,BAO_0000019
3450,Cavia porcellus,Autocuration,CHEMBL618135,,,104714,,F,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,H,4,1,,BAO_0000019
3451,,Autocuration,CHEMBL618136,,,104714,,B,,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,,H,4,1,,BAO_0000223
3452,,Autocuration,CHEMBL618137,,,104714,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3453,,Autocuration,CHEMBL618138,,,104714,,B,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,,H,4,1,,BAO_0000223
3454,,Autocuration,CHEMBL618139,,,104714,,B,,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,,H,4,1,,BAO_0000223
3455,,Autocuration,CHEMBL618140,,,104714,,B,,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,,H,4,1,,BAO_0000223
3456,,Autocuration,CHEMBL618141,,,104714,,B,,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,,H,4,1,,BAO_0000223
3457,,Expert,CHEMBL873478,,,108,,B,,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,8,1,,BAO_0000357
3458,,Autocuration,CHEMBL618142,,,104698,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,6,1,,BAO_0000223
3459,,Autocuration,CHEMBL618143,,,144,,B,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3460,,Autocuration,CHEMBL618144,,,144,,B,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3461,,Autocuration,CHEMBL618145,,,144,,B,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3462,,Autocuration,CHEMBL618146,,,104714,,B,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,H,4,1,,BAO_0000223
3463,,Autocuration,CHEMBL618147,,,104714,,B,,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,,H,4,1,,BAO_0000223
3464,,Autocuration,CHEMBL618148,,,104714,,B,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,H,4,1,,BAO_0000223
3465,,Autocuration,CHEMBL618149,,,144,,B,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,H,8,1,,BAO_0000019
3466,,Autocuration,CHEMBL872927,,,144,,B,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3467,,Autocuration,CHEMBL618150,,,144,,B,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3468,,Autocuration,CHEMBL618151,,,144,,B,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,H,8,1,,BAO_0000357
3469,,Autocuration,CHEMBL875094,,,144,,B,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,H,8,1,,BAO_0000357
3470,,Autocuration,CHEMBL618152,,,144,,B,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,H,8,1,,BAO_0000019
3471,,Autocuration,CHEMBL618153,,,144,,B,,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,H,8,1,,BAO_0000357
3472,,Autocuration,CHEMBL618888,,,144,,B,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,H,8,1,,BAO_0000357
3473,,Autocuration,CHEMBL618889,,,144,,F,,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,H,8,1,,BAO_0000019
3474,,Autocuration,CHEMBL618890,,,144,,B,,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,H,8,1,,BAO_0000357
3475,,Autocuration,CHEMBL618891,,,144,,B,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,H,8,1,,BAO_0000019
3476,,Autocuration,CHEMBL619054,,,144,,B,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,H,8,1,,BAO_0000019
3477,,Autocuration,CHEMBL619055,,,104714,,B,,Binding affinity against the 5-hydroxytryptamine 3 receptor,,H,4,1,,BAO_0000223
3478,,Autocuration,CHEMBL619056,,,144,,B,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,H,8,1,,BAO_0000357
3479,,Autocuration,CHEMBL619057,,,144,,F,,Percent efficacy against 5-hydroxytryptamine 3A receptor,,H,8,1,,BAO_0000019
3480,,Autocuration,CHEMBL619058,,,144,,B,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,H,8,1,,BAO_0000357
3481,Rattus norvegicus,Expert,CHEMBL619059,,,12020,,F,,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,,D,9,1,,BAO_0000219
3482,Rattus norvegicus,Expert,CHEMBL619060,,,12020,,F,,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,,D,9,1,,BAO_0000219
3483,Rattus norvegicus,Expert,CHEMBL875095,,,12020,,F,,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,,D,9,1,,BAO_0000219
3484,Cavia porcellus,Intermediate,CHEMBL619061,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,,D,9,1,,BAO_0000221
3485,Cavia porcellus,Intermediate,CHEMBL619062,,,20033,2116.0,F,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,,D,9,1,,BAO_0000221
3486,Cavia porcellus,Intermediate,CHEMBL619063,,,20033,,F,,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,,D,9,1,,BAO_0000019
3487,Cavia porcellus,Intermediate,CHEMBL619064,,,20033,2116.0,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,,D,9,1,,BAO_0000221
3488,Cavia porcellus,Intermediate,CHEMBL619065,,,20033,,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,,D,9,1,,BAO_0000357
3489,Cavia porcellus,Intermediate,CHEMBL619066,,,20033,2116.0,B,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,,D,9,1,,BAO_0000221
3490,,Autocuration,CHEMBL619775,,,10209,2116.0,B,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,,H,8,1,,BAO_0000221
3491,,Autocuration,CHEMBL619776,,,10209,,B,,Affinity against 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3492,Cavia porcellus,Autocuration,CHEMBL619777,,,104841,,B,,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,H,4,1,,BAO_0000224
3493,Cavia porcellus,Autocuration,CHEMBL619778,,,104841,,B,,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,H,4,1,,BAO_0000224
3494,Cavia porcellus,Autocuration,CHEMBL619779,,,104841,2116.0,B,,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,,H,4,1,,BAO_0000221
3495,Cavia porcellus,Autocuration,CHEMBL619780,,,104841,,B,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",,H,4,1,,BAO_0000224
3496,Cavia porcellus,Autocuration,CHEMBL619166,,,104841,,B,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",,H,4,1,,BAO_0000224
3497,Cavia porcellus,Autocuration,CHEMBL619167,,,104841,,F,,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,H,4,1,,BAO_0000019
3498,Cavia porcellus,Autocuration,CHEMBL619168,,,104841,,F,,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,H,4,1,,BAO_0000019
3499,Homo sapiens,Expert,CHEMBL619169,,,168,2081.0,B,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,,D,9,1,,BAO_0000219
3500,Homo sapiens,Expert,CHEMBL619170,,,168,2081.0,B,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,,D,9,1,,BAO_0000219
3501,Homo sapiens,Autocuration,CHEMBL619171,,,104841,,F,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",,D,5,1,,BAO_0000019
3502,Homo sapiens,Expert,CHEMBL619172,,,168,2081.0,F,,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",,D,9,1,,BAO_0000219
3503,Mus musculus,Autocuration,CHEMBL619173,,,22226,,B,,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,,U,0,1,,BAO_0000019
3504,Mus musculus,Autocuration,CHEMBL619174,,,22226,,B,,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,,U,0,1,,BAO_0000019
3505,,Autocuration,CHEMBL619175,,,104705,,B,,5-hydroxytryptamine receptor binding affinity was determined in rats,,H,4,1,,BAO_0000019
3506,,Autocuration,CHEMBL619176,,,104705,,B,,Binding affinity at rat 5-hydroxytryptamine receptor.,,H,4,1,,BAO_0000224
3507,,Autocuration,CHEMBL619177,,,104705,,B,,Affinity against 5-hydroxytryptamine receptors in rat fundus model,,H,4,1,,BAO_0000019
3508,,Autocuration,CHEMBL619178,,,104705,,B,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,,H,4,1,,BAO_0000224
3509,,Autocuration,CHEMBL619179,,,104705,,B,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,,H,4,1,,BAO_0000224
3510,,Autocuration,CHEMBL619180,,,104705,945.0,F,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,,H,4,1,,BAO_0000019
3511,,Autocuration,CHEMBL619181,,,104705,945.0,F,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,,H,4,1,,BAO_0000019
3512,,Autocuration,CHEMBL619182,,,104705,,F,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,H,4,1,,BAO_0000019
3513,,Autocuration,CHEMBL619183,,,104705,,B,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,,H,4,1,,BAO_0000224
3514,,Autocuration,CHEMBL619184,,,104705,,B,,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",,H,4,1,,BAO_0000224
3515,,Autocuration,CHEMBL619185,,,10576,10000000.0,B,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,H,8,1,,BAO_0000221
3516,,Expert,CHEMBL619186,,,12198,,B,,Binding affinity for rat 5-hydroxytryptamine transporter.,,H,8,1,,BAO_0000357
3517,,Autocuration,CHEMBL619187,,,104705,,B,,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,,H,4,1,,BAO_0000019
3518,Rattus norvegicus,Autocuration,CHEMBL619188,,,104705,,B,,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,,D,5,1,,BAO_0000019
3519,Rattus norvegicus,Autocuration,CHEMBL619189,,,104705,,B,,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,,D,5,1,,BAO_0000224
3520,Rattus norvegicus,Expert,CHEMBL619190,,,12198,955.0,F,,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,,D,9,1,,BAO_0000019
3521,Rattus norvegicus,Expert,CHEMBL619191,,,12198,2037.0,F,,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,,D,9,1,,BAO_0000221
3522,Rattus norvegicus,Autocuration,CHEMBL619192,,,104705,,B,,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,,D,5,1,,BAO_0000019
3523,Rattus norvegicus,Autocuration,CHEMBL619193,,,104705,,B,,Percent binding affinity against 5-hydroxytryptamine receptor,,D,5,1,,BAO_0000224
3524,,Autocuration,CHEMBL619194,,,22226,,B,,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,,U,0,1,,BAO_0000019
3525,Rattus norvegicus,Autocuration,CHEMBL619195,,,104705,,B,,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,,D,5,1,,BAO_0000224
3526,Rattus norvegicus,Autocuration,CHEMBL619196,,,104705,,B,,Affinity against 5-hydroxytryptamine receptor was determined,,D,5,1,,BAO_0000224
3527,Rattus norvegicus,Autocuration,CHEMBL619197,,,104705,945.0,B,,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,,D,5,1,,BAO_0000019
3528,Homo sapiens,Expert,CHEMBL619198,,,121,,B,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,D,9,1,,BAO_0000219
3529,Homo sapiens,Expert,CHEMBL875081,,,121,,B,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,D,9,1,,BAO_0000219
3530,,Autocuration,CHEMBL884712,,,18065,,B,,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,,H,8,1,,BAO_0000357
3531,,Expert,CHEMBL884710,,,121,,B,,Inhibition of 5-hydroxytryptamine reuptake,,H,8,1,,BAO_0000357
3532,,Autocuration,CHEMBL619199,,,18065,,F,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",,H,8,1,,BAO_0000019
3533,,Autocuration,CHEMBL619200,,,18065,,F,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",,H,8,1,,BAO_0000019
3534,,Autocuration,CHEMBL619201,,,18065,,F,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",,H,8,1,,BAO_0000019
3535,,Autocuration,CHEMBL619202,,,18065,,F,,Tested for 5-hydroxytryptamine receptor uptake,,H,8,1,,BAO_0000019
3536,Homo sapiens,Expert,CHEMBL619203,449.0,,51,,B,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,D,9,1,,BAO_0000219
3537,Homo sapiens,Expert,CHEMBL619204,,,51,,F,,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,,D,9,1,,BAO_0000019
3538,Homo sapiens,Autocuration,CHEMBL619205,,,10576,,B,,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,,H,8,1,,BAO_0000249
3539,,Autocuration,CHEMBL619206,,,10576,,B,,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,,H,8,1,,BAO_0000357
3540,,Expert,CHEMBL619207,,,10576,,B,,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,,H,8,1,,BAO_0000249
3541,,Autocuration,CHEMBL619208,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,,H,8,1,,BAO_0000019
3542,,Autocuration,CHEMBL619209,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,,H,8,1,,BAO_0000019
3543,,Autocuration,CHEMBL619210,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,,H,8,1,,BAO_0000019
3544,,Autocuration,CHEMBL619211,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,,H,8,1,,BAO_0000019
3545,,Autocuration,CHEMBL619212,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,,H,8,1,,BAO_0000019
3546,,Autocuration,CHEMBL620681,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,,H,8,1,,BAO_0000019
3547,,Autocuration,CHEMBL620682,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,,H,8,1,,BAO_0000019
3548,,Autocuration,CHEMBL620683,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,,H,8,1,,BAO_0000019
3549,,Autocuration,CHEMBL620684,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,,H,8,1,,BAO_0000019
3550,,Autocuration,CHEMBL620685,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,,H,8,1,,BAO_0000019
3551,,Autocuration,CHEMBL620686,,,10825,2435.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,,H,8,1,,BAO_0000019
3552,,Autocuration,CHEMBL620687,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,,H,8,1,,BAO_0000019
3553,,Autocuration,CHEMBL620688,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,,H,8,1,,BAO_0000019
3554,,Autocuration,CHEMBL620689,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,,H,8,1,,BAO_0000019
3555,,Autocuration,CHEMBL620690,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,,H,8,1,,BAO_0000019
3556,,Autocuration,CHEMBL620691,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,,H,8,1,,BAO_0000019
3557,,Autocuration,CHEMBL620692,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,,H,8,1,,BAO_0000019
3558,,Autocuration,CHEMBL620693,,,10825,349.0,F,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,,H,8,1,,BAO_0000019
3559,,Expert,CHEMBL620694,,,168,,B,,Binding affinity against 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3560,,Autocuration,CHEMBL857986,,,168,,F,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,8,1,,BAO_0000019
3561,,Autocuration,CHEMBL620695,,,168,,B,,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,,H,8,1,,BAO_0000357
3562,,Expert,CHEMBL620696,,,168,,B,,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3563,,Autocuration,CHEMBL620697,,,168,,B,,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,,H,8,1,,BAO_0000357
3564,,Autocuration,CHEMBL620698,,,168,,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor,,H,8,1,,BAO_0000357
3565,,Autocuration,CHEMBL620699,,,168,,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,H,8,1,,BAO_0000357
3566,,Autocuration,CHEMBL620700,,,168,,B,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,H,8,1,,BAO_0000357
3567,,Autocuration,CHEMBL620701,643.0,,168,,B,,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,,H,8,1,,BAO_0000219
3568,,Autocuration,CHEMBL875082,643.0,,168,,B,,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,,H,8,1,,BAO_0000219
3569,,Autocuration,CHEMBL620702,643.0,,168,,B,,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,,H,8,1,,BAO_0000219
3570,,Autocuration,CHEMBL620703,643.0,,168,,B,,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,,H,8,1,,BAO_0000219
3571,,Autocuration,CHEMBL620704,673.0,,168,,B,,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,H,8,1,,BAO_0000219
3572,,Expert,CHEMBL620705,673.0,,168,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,H,8,1,,BAO_0000219
3573,,Expert,CHEMBL620706,673.0,,168,,B,,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,,H,8,1,,BAO_0000219
3574,,Expert,CHEMBL620707,673.0,,168,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,,H,8,1,,BAO_0000219
3575,,Expert,CHEMBL620708,,,10624,,B,,Binding affinity towards 5-hydroxytryptamine 5 receptor,,H,8,1,,BAO_0000357
3576,,Autocuration,CHEMBL620709,,,105,,B,,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,,H,8,1,,BAO_0000357
3577,Homo sapiens,Expert,CHEMBL620710,,,10624,,B,,Binding affinity against 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3578,,Autocuration,CHEMBL620711,449.0,,10624,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
3579,Homo sapiens,Expert,CHEMBL620712,,,10624,,B,,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,,D,9,1,,BAO_0000357
3580,Homo sapiens,Expert,CHEMBL620713,,,10624,,B,,Binding affinity towards human 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3581,Homo sapiens,Expert,CHEMBL620714,,,10624,,B,,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,,D,9,1,,BAO_0000357
3582,Homo sapiens,Expert,CHEMBL620715,,,10624,,B,,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3583,,Autocuration,CHEMBL620716,,,10624,,B,,Binding affinity towards 5-HT5A receptor,,H,8,1,,BAO_0000357
3584,,Expert,CHEMBL620717,,,10624,,B,,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,,H,8,1,,BAO_0000357
3585,,Autocuration,CHEMBL618072,,,10624,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,,H,8,1,,BAO_0000357
3586,,Autocuration,CHEMBL857987,,,10624,,B,,Binding affinity towards cloned human 5-HT5A receptor was determined,,H,8,1,,BAO_0000357
3587,,Autocuration,CHEMBL618073,722.0,,10624,,B,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000219
3588,,Autocuration,CHEMBL618074,722.0,,10624,,B,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,H,8,1,,BAO_0000219
3589,,Autocuration,CHEMBL618075,722.0,,10624,,B,,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),,H,8,1,,BAO_0000219
3590,Mus musculus,Expert,CHEMBL618076,,,10625,,B,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3591,Mus musculus,Expert,CHEMBL618077,,,10625,,B,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,,D,9,1,,BAO_0000357
3592,Mus musculus,Expert,CHEMBL618078,,,10625,,B,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,,D,9,1,,BAO_0000357
3593,Mus musculus,Expert,CHEMBL881821,,,10625,,B,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,,D,9,1,,BAO_0000357
3594,Mus musculus,Expert,CHEMBL618079,,,10625,,B,,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3595,,Expert,CHEMBL618080,,,10625,,B,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,,H,8,1,,BAO_0000357
3596,,Autocuration,CHEMBL618081,722.0,,10576,,B,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3597,,Autocuration,CHEMBL618082,722.0,,10626,,B,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3598,,Expert,CHEMBL618083,,,10624,,B,,Binding affinity towards 5-HT5a receptor,,H,8,1,,BAO_0000357
3599,Homo sapiens,Expert,CHEMBL618084,,,10624,,B,,Binding affinity towards 5-hydroxytryptamine 5A receptor,,D,9,1,,BAO_0000357
3600,,Expert,CHEMBL618085,,,10624,,B,,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,,H,8,1,,BAO_0000357
3601,,Expert,CHEMBL618086,,,10624,,B,,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,,H,8,1,,BAO_0000357
3602,,Autocuration,CHEMBL875092,,,10624,,B,,Binding affinities against 5-hydroxytryptamine 5A receptor,,H,8,1,,BAO_0000357
3603,,Autocuration,CHEMBL618087,,,10624,,B,,Binding affinities towards 5-hydroxytryptamine 5A receptor,,H,8,1,,BAO_0000357
3604,,Autocuration,CHEMBL872926,,,10624,,B,,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,,H,8,1,,BAO_0000357
3605,Cavia porcellus,Autocuration,CHEMBL618088,,,104714,,F,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,,H,4,1,,BAO_0000019
3606,,Autocuration,CHEMBL618089,,,104714,,B,,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,,H,4,1,,BAO_0000223
3607,Homo sapiens,Expert,CHEMBL618090,,,10627,,B,,Inhibition of human 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3608,Homo sapiens,Expert,CHEMBL618091,,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,,D,9,1,,BAO_0000357
3609,,Autocuration,CHEMBL618092,,,10627,,B,,Inhibition against human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3610,Homo sapiens,Expert,CHEMBL618093,,,10627,,B,,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,,D,9,1,,BAO_0000357
3611,,Expert,CHEMBL618094,308.0,,10627,,B,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,,H,8,1,,BAO_0000219
3612,Homo sapiens,Expert,CHEMBL618095,,,10627,,B,,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3613,Homo sapiens,Expert,CHEMBL875093,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3614,Homo sapiens,Expert,CHEMBL618096,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,,D,9,1,,BAO_0000357
3615,Homo sapiens,Expert,CHEMBL618118,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,,D,9,1,,BAO_0000357
3616,Homo sapiens,Expert,CHEMBL618119,,,10627,,B,,Binding affinity against 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3617,,Expert,CHEMBL618120,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3618,,Autocuration,CHEMBL618121,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3619,,Expert,CHEMBL618122,722.0,,10627,,B,,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",,H,8,1,,BAO_0000219
3620,,Autocuration,CHEMBL618123,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,,H,8,1,,BAO_0000357
3621,,Expert,CHEMBL618124,722.0,,10627,,B,,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,,H,8,1,,BAO_0000219
3622,,Autocuration,CHEMBL618125,,,10627,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3623,Homo sapiens,Expert,CHEMBL618126,722.0,,10627,,B,,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,D,9,1,,BAO_0000219
3624,,Expert,CHEMBL618236,,,10627,,B,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,,H,8,1,,BAO_0000019
3625,,Expert,CHEMBL618237,,,10627,,B,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,H,8,1,,BAO_0000019
3626,,Expert,CHEMBL618238,643.0,,10627,,B,,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,,H,8,1,,BAO_0000219
3627,Homo sapiens,Expert,CHEMBL618239,,,10627,,B,,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3628,,Autocuration,CHEMBL618240,,,10627,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000019
3629,,Autocuration,CHEMBL618241,,,10627,,B,,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,,H,8,1,,BAO_0000357
3630,,Autocuration,CHEMBL859399,722.0,,10627,,B,,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,H,8,1,,BAO_0000219
3631,,Autocuration,CHEMBL618242,,,10627,,F,,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,,H,8,1,,BAO_0000019
3632,,Autocuration,CHEMBL857991,,,10627,,B,,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3633,,Expert,CHEMBL619951,,,10627,,B,,Binding affinity against human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3634,Homo sapiens,Expert,CHEMBL619952,308.0,,10627,,B,,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,,D,9,1,,BAO_0000219
3635,Homo sapiens,Expert,CHEMBL619953,308.0,,10627,,B,,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,,D,9,1,,BAO_0000219
3636,,Autocuration,CHEMBL619954,308.0,,10627,,B,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,,H,8,1,,BAO_0000219
3637,,Autocuration,CHEMBL619955,308.0,,10627,,B,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3638,,Autocuration,CHEMBL619956,308.0,,10627,,B,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3639,,Autocuration,CHEMBL619957,449.0,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,8,1,,BAO_0000219
3640,,Autocuration,CHEMBL619958,722.0,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,8,1,,BAO_0000219
3641,,Autocuration,CHEMBL620627,722.0,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,,H,8,1,,BAO_0000219
3642,,Autocuration,CHEMBL620628,722.0,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,H,8,1,,BAO_0000219
3643,,Autocuration,CHEMBL620629,308.0,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,,H,8,1,,BAO_0000219
3644,,Autocuration,CHEMBL620630,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3645,,Autocuration,CHEMBL620782,308.0,,10627,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3646,,Autocuration,CHEMBL620783,,,10627,,B,,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3647,,Expert,CHEMBL620784,,,10627,,B,,Binding affinity against human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3648,,Expert,CHEMBL620785,308.0,,10627,,B,,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,,H,8,1,,BAO_0000219
3649,,Autocuration,CHEMBL857992,,,10627,,B,,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),,H,8,1,,BAO_0000357
3650,,Autocuration,CHEMBL620786,,,10627,,B,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,,H,8,1,,BAO_0000219
3651,,Autocuration,CHEMBL620787,308.0,,10627,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,,H,8,1,,BAO_0000219
3652,,Autocuration,CHEMBL620788,308.0,,10627,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",,H,8,1,,BAO_0000219
3653,,Autocuration,CHEMBL620789,308.0,,10627,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",,H,8,1,,BAO_0000219
3654,,Autocuration,CHEMBL620790,308.0,,10627,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",,H,8,1,,BAO_0000219
3655,,Autocuration,CHEMBL620791,449.0,,10628,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
3656,,Autocuration,CHEMBL620792,,,10628,,B,,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,,H,8,1,,BAO_0000019
3657,,Autocuration,CHEMBL620793,,,10628,,B,,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3658,,Autocuration,CHEMBL620794,,,10628,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,,H,8,1,,BAO_0000357
3659,Homo sapiens,Autocuration,CHEMBL620795,308.0,,10627,,B,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,,D,9,1,,BAO_0000219
3660,,Expert,CHEMBL620796,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3661,,Autocuration,CHEMBL620797,,,10627,,B,,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,,H,8,1,,BAO_0000357
3662,Homo sapiens,Expert,CHEMBL620798,,,10627,,F,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,D,9,1,,BAO_0000019
3663,,Autocuration,CHEMBL620799,,,10627,,B,,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,,H,8,1,,BAO_0000357
3664,,Expert,CHEMBL620800,,,10627,,B,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3665,,Autocuration,CHEMBL620801,,,10627,,B,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,,H,8,1,,BAO_0000357
3666,,Autocuration,CHEMBL875100,,,10627,,B,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3667,,Autocuration,CHEMBL620802,,,10627,,B,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,,H,8,1,,BAO_0000357
3668,,Expert,CHEMBL620803,,,10627,,F,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000019
3669,,Expert,CHEMBL620804,,,10627,,F,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,H,8,1,,BAO_0000019
3670,,Autocuration,CHEMBL620805,,,10627,,B,,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,,H,8,1,,BAO_0000357
3671,,Autocuration,CHEMBL620806,,,10627,,B,,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3672,,Autocuration,CHEMBL620807,,,10627,,B,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,,H,8,1,,BAO_0000357
3673,,Autocuration,CHEMBL620808,,,10627,,B,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,,H,8,1,,BAO_0000357
3674,,Autocuration,CHEMBL620809,,,10627,,B,,Binding affinities against 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3675,,Autocuration,CHEMBL620810,,,10627,,B,,Binding affinities towards 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3676,Homo sapiens,Expert,CHEMBL620811,,,10627,,B,,Binding affinity towards 5-hydroxytryptamine 6 receptor,,D,9,1,,BAO_0000357
3677,,Autocuration,CHEMBL620812,,,10627,,B,,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,,H,8,1,,BAO_0000357
3678,,Autocuration,CHEMBL620813,,,10627,,B,,Affinity against 5-hydroxytryptamine 6 receptor,,H,8,1,,BAO_0000357
3679,,Autocuration,CHEMBL620814,,,10627,,B,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],,H,8,1,,BAO_0000357
3680,Homo sapiens,Expert,CHEMBL620815,,,10209,,B,,Inhibition of human 5-hydroxytryptamine 7 receptor,,D,9,1,,BAO_0000357
3681,,Autocuration,CHEMBL620816,722.0,,10209,,B,,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,,H,8,1,,BAO_0000219
3682,,Autocuration,CHEMBL620817,,,10209,,B,,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3683,,Autocuration,CHEMBL620818,,,10209,,B,,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),,H,8,1,,BAO_0000357
3684,,Expert,CHEMBL620819,722.0,,10209,,B,,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,,H,8,1,,BAO_0000219
3685,Homo sapiens,Expert,CHEMBL620820,,,10209,,B,,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,,D,9,1,,BAO_0000357
3686,,Autocuration,CHEMBL620821,449.0,,10209,,B,,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,,H,8,1,,BAO_0000219
3687,Homo sapiens,Expert,CHEMBL620822,,,10209,,B,,Binding affinity towards human 5-hydroxytryptamine 7 receptor,,D,9,1,,BAO_0000357
3688,Homo sapiens,Expert,CHEMBL620823,,,10209,,B,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,,D,9,1,,BAO_0000357
3689,Homo sapiens,Expert,CHEMBL620824,,,10209,,B,,Binding affinity against 5-hydroxytryptamine 7 receptor,,D,9,1,,BAO_0000357
3690,,Expert,CHEMBL620825,449.0,,10209,,B,,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,,H,8,1,,BAO_0000219
3691,,Autocuration,CHEMBL872930,,,10209,,B,,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,,H,8,1,,BAO_0000357
3692,,Autocuration,CHEMBL620826,,,10209,,B,,Binding affinity towards 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3693,,Autocuration,CHEMBL620827,,,10209,,B,,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,,H,8,1,,BAO_0000357
3694,,Autocuration,CHEMBL620828,,,10209,,B,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3695,,Autocuration,CHEMBL620829,,,10209,,B,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3696,,Expert,CHEMBL620830,722.0,,10209,,B,,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,,H,8,1,,BAO_0000219
3697,,Expert,CHEMBL620831,,,10209,,B,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,,H,8,1,,BAO_0000019
3698,,Expert,CHEMBL620832,,,10209,,B,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,H,8,1,,BAO_0000019
3699,Homo sapiens,Expert,CHEMBL621548,,,10209,,B,,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,,D,9,1,,BAO_0000357
3700,,Autocuration,CHEMBL621549,,,10209,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000019
3701,,Autocuration,CHEMBL621550,,,10209,,B,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,,H,8,1,,BAO_0000357
3702,,Autocuration,CHEMBL621551,449.0,,10209,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,,H,8,1,,BAO_0000219
3703,,Autocuration,CHEMBL621552,,,10209,,B,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,,H,8,1,,BAO_0000019
3704,,Autocuration,CHEMBL857077,,,10209,,B,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3705,,Autocuration,CHEMBL618158,,,10209,,B,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,,H,8,1,,BAO_0000357
3706,Homo sapiens,Expert,CHEMBL618159,643.0,,10209,,B,,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,D,9,1,,BAO_0000219
3707,,Autocuration,CHEMBL875101,643.0,,10209,,B,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,H,8,1,,BAO_0000219
3708,Homo sapiens,Expert,CHEMBL618160,722.0,,10209,,B,,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,,D,9,1,,BAO_0000219
3709,,Expert,CHEMBL618161,,,10209,,B,,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,,H,8,1,,BAO_0000357
3710,,Expert,CHEMBL618162,722.0,,10209,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,,H,8,1,,BAO_0000219
3711,,Expert,CHEMBL618163,,,10209,,B,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,,H,8,1,,BAO_0000357
3712,,Autocuration,CHEMBL618164,,,10209,,B,,Binding affinity against 5-hydroxytryptamine 7 human receptors,,H,8,1,,BAO_0000357
3713,,Expert,CHEMBL618165,,,10209,,B,,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,,H,8,1,,BAO_0000219
3714,,Autocuration,CHEMBL618166,722.0,,10209,,B,,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,,H,8,1,,BAO_0000219
3715,,Autocuration,CHEMBL857989,722.0,,10209,,B,,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,8,1,,BAO_0000219
3716,,Autocuration,CHEMBL619888,722.0,,10209,,B,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,8,1,,BAO_0000219
3717,,Autocuration,CHEMBL619889,722.0,,10209,,B,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,8,1,,BAO_0000219
3718,,Autocuration,CHEMBL619890,722.0,,10209,,B,,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,,H,8,1,,BAO_0000219
3719,,Autocuration,CHEMBL619891,449.0,,10209,,B,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,,H,8,1,,BAO_0000219
3720,,Autocuration,CHEMBL619892,722.0,,10209,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),,H,8,1,,BAO_0000219
3721,,Expert,CHEMBL619893,722.0,,10209,,B,,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,,D,9,1,,BAO_0000219
3722,,Autocuration,CHEMBL619894,722.0,,10209,,B,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),,H,8,1,,BAO_0000219
3723,,Intermediate,CHEMBL619895,722.0,,10209,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,,D,9,1,,BAO_0000219
3724,,Intermediate,CHEMBL619896,,,10209,,B,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,,D,9,1,,BAO_0000357
3725,,Autocuration,CHEMBL619897,643.0,,10209,,B,,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,,H,8,1,,BAO_0000219
3726,,Autocuration,CHEMBL619898,722.0,,10209,,B,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,,H,8,1,,BAO_0000219
3727,,Expert,CHEMBL619899,722.0,,10209,,B,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,,H,8,1,,BAO_0000219
3728,,Autocuration,CHEMBL619900,722.0,,10209,,B,,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),,H,8,1,,BAO_0000219
3729,Homo sapiens,Expert,CHEMBL619901,722.0,,10209,,B,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,,D,9,1,,BAO_0000219
3730,,Autocuration,CHEMBL620580,722.0,,10209,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,,H,8,1,,BAO_0000219
3731,,Autocuration,CHEMBL620581,722.0,,10209,,B,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,,H,8,1,,BAO_0000219
3732,,Autocuration,CHEMBL620733,722.0,,10209,,B,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",,H,8,1,,BAO_0000219
3733,Homo sapiens,Autocuration,CHEMBL620734,,,10209,,B,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,,D,9,1,,BAO_0000357
3734,Mus musculus,Expert,CHEMBL620735,,,10022,,B,,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,D,9,1,,BAO_0000357
3735,Oryctolagus cuniculus,Autocuration,CHEMBL620736,,,10209,,B,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,,H,8,1,,BAO_0000019
3736,,Autocuration,CHEMBL620737,449.0,,11923,,B,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,,H,8,1,,BAO_0000219
3737,,Autocuration,CHEMBL620738,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,,H,8,1,,BAO_0000219
3738,,Autocuration,CHEMBL620739,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,,H,8,1,,BAO_0000219
3739,,Autocuration,CHEMBL620740,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,,H,8,1,,BAO_0000219
3740,,Autocuration,CHEMBL620741,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,,H,8,1,,BAO_0000219
3741,,Autocuration,CHEMBL620742,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,,H,8,1,,BAO_0000219
3742,,Autocuration,CHEMBL620743,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,,H,8,1,,BAO_0000219
3743,,Autocuration,CHEMBL620744,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,,H,8,1,,BAO_0000219
3744,,Autocuration,CHEMBL620745,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,,H,8,1,,BAO_0000219
3745,,Autocuration,CHEMBL620746,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,,H,8,1,,BAO_0000219
3746,,Autocuration,CHEMBL620747,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,,H,8,1,,BAO_0000219
3747,,Autocuration,CHEMBL620748,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,,H,8,1,,BAO_0000219
3748,,Autocuration,CHEMBL620749,449.0,,11923,,B,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,,H,8,1,,BAO_0000219
3749,,Expert,CHEMBL620750,,,11923,,B,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
3750,Rattus norvegicus,Expert,CHEMBL620751,,,11923,,B,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,D,9,1,,BAO_0000357
3751,,Expert,CHEMBL620752,,,11923,,B,,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,,H,8,1,,BAO_0000357
